Citrus Sinensis ID: 016158

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390----
Protein Sequence
MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPG
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccHHHHHHHccccccccccccccccccccccccccccEEEEEEEcccccccccEEEEEEEEEEEccccEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEEcEEEEcccccccEEEEEEEEcccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEccccccccccccccEEEEEEccccHHHHHHcccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccHHHHccccccccccccccccccccEccccccccEEEEEEEccccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccccc
Coil and Loop (DISEMBL)
masaslgnggvgssrsvngfksssSSVDWLGREMLEMRLRdqvdndedrdsepdiidgvgaetGHVIRttiggrngnskqKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLdhpnivalkhcffsttDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCigichrdikpqnllvnphthqlklcdfgsakvlvkgepnvsyicsryyrapelifgateyttaIDIWSTGCVMAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikphpwhkvfqkrlppeaVDLVCRffqyspnlrctaleacvhpffdelrdpntrlpngrplpplfnfkppg
Flexible Loop (DISEMBL)
masaslgnggvgssrsvngfksssSSVDWLGREMLEMRLRdqvdndedrdsepdiidgvgaetghvirttiggrngnskQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVaikkvlqdkrYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNysrihqrmpLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDpntrlpngrplpplfnfkppg
Low Complexity Region (SEG)
MASAslgnggvgssrsvngfksssssVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKeelylnlvleyvpeTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPG
Disordered region (IsUnstruct)
*******************************************************IDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL***********************
Disordered Region (DISOPRED)
*****************************************************************VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP**
Disordered Region (DISEMBL)
**************RSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPG
Disordered Region (DISPRO)
************************************************************AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	394	2.2.26 [Sep-21-2011]
Q39019	421	Shaggy-related protein ki	yes	no	0.992	0.928	0.880	0.0
Q9FVS6	420	Shaggy-related protein ki	no	no	0.984	0.923	0.868	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.964	0.924	0.767	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.964	0.924	0.772	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.959	0.921	0.765	1e-180
P43288	405	Shaggy-related protein ki	no	no	0.923	0.898	0.794	1e-179
Q40518	409	Shaggy-related protein ki	N/A	no	0.936	0.902	0.788	1e-179
P43289	409	Shaggy-related protein ki	no	no	0.967	0.931	0.754	1e-179
P51137	411	Glycogen synthase kinase-	N/A	no	0.969	0.929	0.763	1e-178
Q96287	472	Shaggy-related protein ki	no	no	0.921	0.769	0.769	1e-175

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  736 bits (1900), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/392 (88%), Positives = 369/392 (94%), Gaps = 1/392 (0%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKP 391

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  724 bits (1870), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/389 (86%), Positives = 366/389 (94%), Gaps = 1/389 (0%)

Query: 4   ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
           + LGNG VGSSRS    K++SSSVDWL R+MLEM++RD+ + DE+RDSEPDIIDGVGAE 
Sbjct: 3   SHLGNG-VGSSRSAKNTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEP 61

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           GHVI TT+ GRNG S+Q VSYIAEHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKN
Sbjct: 62  GHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKN 121

Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
           RELQIMQMLDHPN+V LKH F+S T+ EE+YLNLVLE+VPETVNR AR+YSR++Q MPLI
Sbjct: 122 RELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLI 181

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
           YVKLYTYQICR LAY+HNC G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+S
Sbjct: 182 YVKLYTYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNIS 241

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT
Sbjct: 242 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 301

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
           PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTA+EAC
Sbjct: 302 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEAC 361

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           +HPFFDELRDPN RLPNGRPLPPLFNFKP
Sbjct: 362 IHPFFDELRDPNARLPNGRPLPPLFNFKP 390

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  635 bits (1639), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/387 (76%), Positives = 335/387 (86%), Gaps = 7/387 (1%)

Query: 6   LGNGGVGSSRSVNGFKSSSS-SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETG 64
           +   GV  +  +    +SS+ +VD L  E+L MR++D      D++ E  ++DG   E G
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKD------DKEMEAHVVDGNSTEAG 54

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           HVI TTIGG+NG  KQ +SY+AE  VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55  HVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           ELQ M++LDHPN+V LKHCFFSTT+K+ELYLNLVLE+VPETV+R+ R+YS+++QRMPLIY
Sbjct: 115 ELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIY 174

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           VKLY+YQICR+LAYIHNC+G+ HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN+SY
Sbjct: 175 VKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 234

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           ICSRYYRAPELIFGATEYT+AIDIWS GCV+ ELLLGQPLFPG SGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTP 294

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           TREEIKCMNPNYTEFKFPQIK HPWHK+F+KR+PPEAVDLV R  QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354

Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNFK 391
           HPFFDELRDPNTRLPNGR LPPLFNFK
Sbjct: 355 HPFFDELRDPNTRLPNGRHLPPLFNFK 381

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  635 bits (1637), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 299/387 (77%), Positives = 338/387 (87%), Gaps = 7/387 (1%)

Query: 6   LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEP-DIIDGVGAETG 64
           + +GGV  +       +SS  V+ L  EM +M++RD      D++ E   I+DG G ETG
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRD------DKEMEAATIVDGNGTETG 54

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           H+I TTIGG+NG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55  HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           ELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ R+Y++++QRMP+IY
Sbjct: 115 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIY 174

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           VKLY+YQICRALAYIHN IG+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SY
Sbjct: 175 VKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISY 234

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           ICSRYYRAPELIFGATEYTTAIDIWS GCV+ ELLLGQPLFPGESGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTP 294

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           TREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354

Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNFK 391
           HPF+D++RDPNTRLPNGR LPPLFNFK
Sbjct: 355 HPFYDDVRDPNTRLPNGRFLPPLFNFK 381

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  631 bits (1627), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 294/384 (76%), Positives = 332/384 (86%), Gaps = 6/384 (1%)

Query: 9   GGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIR 68
           G + +S       ++S   + L   + EM+++D      D++ E  ++DG G ETGH+I 
Sbjct: 5   GTLPASSMATKQSNASICAEKLPEGINEMKIKD------DKEMEAAVVDGNGTETGHIIV 58

Query: 69  TTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI 128
           TTIGG+NG  KQ +SY+AE +VG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ 
Sbjct: 59  TTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
           M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV R++++YSR +QRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
           TYQICRALAYIH  +G+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSR
Sbjct: 179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           YYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           IKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R  QYSPNLR TA+EA VHPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358

Query: 369 DELRDPNTRLPNGRPLPPLFNFKP 392
           DELRDPNTRLPNGR LPPLFNFKP
Sbjct: 359 DELRDPNTRLPNGRALPPLFNFKP 382

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  629 bits (1622), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 294/370 (79%), Positives = 329/370 (88%), Gaps = 6/370 (1%)

Query: 23  SSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKV 82
            S+ VD L  EM +M++RD      D++ E  ++DG G ETGH+I TTIGGRNG  KQ +
Sbjct: 14  DSTGVDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTI 67

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKH
Sbjct: 68  SYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKH 127

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           CFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH C
Sbjct: 128 CFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRC 187

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
           IG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEY
Sbjct: 188 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 247

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
           TTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP
Sbjct: 248 TTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 307

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 382
           QIK HPWHK+F KR+PPEAVDLV R  QYSPNLR  AL+  VHPFFDELRDPN RLPNGR
Sbjct: 308 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGR 367

Query: 383 PLPPLFNFKP 392
            LPPLFNFKP
Sbjct: 368 FLPPLFNFKP 377

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  629 bits (1621), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 298/378 (78%), Positives = 332/378 (87%), Gaps = 9/378 (2%)

Query: 17  VNGFKSSSS---SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGG 73
           V+G + SSS    VD L  EM +MR+RD      D++ E  I+DG G ETGH+I TTIGG
Sbjct: 9   VSGLRESSSHSVGVDRLPEEMNDMRIRD------DKEIEAAIVDGNGTETGHIIVTTIGG 62

Query: 74  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLD 133
           R+G  KQ +SY+AE +VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LD
Sbjct: 63  RHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN+V LKHCFFSTT+K+E+YLNLVLEYVPETV+R+ ++Y++++QRMPLI VKLYTYQI 
Sbjct: 123 HPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIF 182

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
           RAL+YIH+ IG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAP
Sbjct: 183 RALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           ELIFGATEYTTAIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN
Sbjct: 243 ELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 302

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           PNY EFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEA  H FFDELRD
Sbjct: 303 PNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRD 362

Query: 374 PNTRLPNGRPLPPLFNFK 391
           PNTRLPNGR LPPLFNFK
Sbjct: 363 PNTRLPNGRVLPPLFNFK 380

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  628 bits (1619), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 292/387 (75%), Positives = 336/387 (86%), Gaps = 6/387 (1%)

Query: 6   LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGH 65
           + + G+  S +V     + +  D L  EM +M+++D      D++ E  I++G   ETGH
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQD------DKEMEATIVNGNVTETGH 54

Query: 66  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
           +I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRE
Sbjct: 55  IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 114

Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV 185
           LQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPL+YV
Sbjct: 115 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYV 174

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           KLYTYQI R+L+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYI
Sbjct: 175 KLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
           CSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPT
Sbjct: 235 CSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 294

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
           REEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLRC AL++ VH
Sbjct: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVH 354

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKP 392
           PFFDELRDPN RLPNGR LPPLFNFKP
Sbjct: 355 PFFDELRDPNARLPNGRFLPPLFNFKP 381

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  624 bits (1608), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 297/389 (76%), Positives = 330/389 (84%), Gaps = 7/389 (1%)

Query: 4   ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
           AS+G       R V G        D L  EM +M++RD      DR+ E  ++DG G ET
Sbjct: 2   ASVGVAPTSGFREVLG-DGEIGVDDILPEEMSDMKIRD------DREMEATVVDGNGTET 54

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           GH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKN
Sbjct: 55  GHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKN 114

Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
           RELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++YS+++QRMP+I
Sbjct: 115 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMI 174

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
           YVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+S
Sbjct: 175 YVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 234

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           YICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE GVDQLVEIIKVLGT
Sbjct: 235 YICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGT 294

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
           PTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+P EAVDLV R  QYSPNLRC AL+  
Sbjct: 295 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCL 354

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
            HPFFDELRDPN RLP GR LPPLFNFKP
Sbjct: 355 THPFFDELRDPNARLPTGRFLPPLFNFKP 383

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  615 bits (1586), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 280/364 (76%), Positives = 322/364 (88%), Gaps = 1/364 (0%)

Query: 28  DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
           D L   M+EM++RD+ + N ED+D E  +++G G ETG VI TT+GGR+G  KQ +SY+A
Sbjct: 81  DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
           + VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
           TTDK+ELYLNLVLEYVPETV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H  +G+C
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
           HRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AI
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320

Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
           D+WS GCVMAELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK 
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380

Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
           HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440

Query: 387 LFNF 390
           LFNF
Sbjct: 441 LFNF 444

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	394
449460309	428	PREDICTED: shaggy-related protein kinase	0.994	0.915	0.964	0.0
224119932	422	predicted protein [Populus trichocarpa]	0.994	0.928	0.961	0.0
224129720	422	predicted protein [Populus trichocarpa]	0.992	0.926	0.961	0.0
225465185	422	PREDICTED: shaggy-related protein kinase	0.994	0.928	0.961	0.0
359806970	420	uncharacterized protein LOC100799387 [Gl	0.941	0.883	0.957	0.0
359806021	420	uncharacterized protein LOC100820098 [Gl	0.941	0.883	0.943	0.0
116787454	424	unknown [Picea sitchensis]	0.994	0.924	0.888	0.0
297849298	421	hypothetical protein ARALYDRAFT_471093 [	0.992	0.928	0.877	0.0
15218288	421	Shaggy-related protein kinase kappa [Ara	0.992	0.928	0.880	0.0
357445263	428	Glycogen synthase kinase-3-like protein	0.994	0.915	0.912	0.0

>gi|449460309|ref|XP_004147888.1| PREDICTED: shaggy-related protein kinase kappa-like [Cucumis sativus]

 Score =  798 bits (2062), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/392 (96%), Positives = 385/392 (98%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MASASLGNGGVGSSRS+NGFK SSSSVDWLGREMLEMRLRD+ D DEDRDSEPDIIDGVG
Sbjct: 7   MASASLGNGGVGSSRSINGFKGSSSSVDWLGREMLEMRLRDKTDTDEDRDSEPDIIDGVG 66

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 67  AEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 126

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNRIARNYSRI QRM
Sbjct: 127 YKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNRIARNYSRISQRM 186

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 187 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 246

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG+PLFPGESGVDQLVEIIKV
Sbjct: 247 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGKPLFPGESGVDQLVEIIKV 306

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 307 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 366

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 367 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 398

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119932|ref|XP_002331098.1| predicted protein [Populus trichocarpa] gi|222872826|gb|EEF09957.1| predicted protein [Populus trichocarpa]

 Score =  790 bits (2040), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/392 (96%), Positives = 384/392 (97%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           M+SASLGNGGVGSSRSVNGFKSSSSS+DWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSMDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG S+Q VSYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTVSYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR + RM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRNNPRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           EAC+HPFFDELRDP TRLPNGRPLPPLFNFKP
Sbjct: 361 EACIHPFFDELRDPATRLPNGRPLPPLFNFKP 392

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224129720|ref|XP_002328786.1| predicted protein [Populus trichocarpa] gi|222839084|gb|EEE77435.1| predicted protein [Populus trichocarpa]

 Score =  789 bits (2037), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/391 (96%), Positives = 382/391 (97%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           M+SASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG S+Q +SYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTISYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKH FFSTTDKEELYLNLVLEYVP+TVNRIARNYSR  QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHSFFSTTDKEELYLNLVLEYVPDTVNRIARNYSRNSQRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
           EACVHPFFDELRDP TRLPNGRPLPPLFNFK
Sbjct: 361 EACVHPFFDELRDPTTRLPNGRPLPPLFNFK 391

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465185|ref|XP_002263398.1| PREDICTED: shaggy-related protein kinase kappa [Vitis vinifera] gi|297739515|emb|CBI29697.3| unnamed protein product [Vitis vinifera]

 Score =  768 bits (1982), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/392 (96%), Positives = 385/392 (98%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MASASLG+GGVGSSR+ NGFK SSSSVDWLGREMLEMRLRD+VD D+DRDSEPDIIDGVG
Sbjct: 1   MASASLGHGGVGSSRTANGFKGSSSSVDWLGREMLEMRLRDRVDQDDDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT GGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTFGGRNGQSKQTVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE+VPETVNRIARNYSRI+QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEFVPETVNRIARNYSRINQRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           EAC+HPFFDELRDP+TRLPNGRPLPPLFNFKP
Sbjct: 361 EACIHPFFDELRDPSTRLPNGRPLPPLFNFKP 392

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806970|ref|NP_001241073.1| uncharacterized protein LOC100799387 [Glycine max] gi|255641011|gb|ACU20785.1| unknown [Glycine max]

 Score =  751 bits (1938), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/374 (95%), Positives = 365/374 (97%), Gaps = 3/374 (0%)

Query: 19  GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
           GF+ SSSSVDWLGREMLEMRLRD  D   DRDSEPDIIDGVGAETGHVIRT+IGGRNG S
Sbjct: 20  GFRGSSSSVDWLGREMLEMRLRDHED---DRDSEPDIIDGVGAETGHVIRTSIGGRNGQS 76

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
           KQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77  KQNVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+HCFFSTTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFFSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
           FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376

Query: 379 PNGRPLPPLFNFKP 392
           PN RPLPPLFNFKP
Sbjct: 377 PNARPLPPLFNFKP 390

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806021|ref|NP_001240918.1| uncharacterized protein LOC100820098 [Glycine max] gi|255639602|gb|ACU20095.1| unknown [Glycine max]

 Score =  742 bits (1916), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/374 (94%), Positives = 364/374 (97%), Gaps = 3/374 (0%)

Query: 19  GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
           GF+ SSSSVDWLGREMLEM LRD  D    RDSEPDIIDG+GAETGHVIRT++GGRNG S
Sbjct: 20  GFRGSSSSVDWLGREMLEMSLRDHEDV---RDSEPDIIDGLGAETGHVIRTSVGGRNGQS 76

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
           KQ VSYI+EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77  KQNVSYISEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+HCF+STTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFYSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
           FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376

Query: 379 PNGRPLPPLFNFKP 392
           PNGRPLPPLFNFKP
Sbjct: 377 PNGRPLPPLFNFKP 390

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116787454|gb|ABK24513.1| unknown [Picea sitchensis]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/394 (88%), Positives = 375/394 (95%), Gaps = 2/394 (0%)

Query: 1   MASASLG-NGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD-QVDNDEDRDSEPDIIDG 58
           MASASLG +GGVGSSR++N  K   +SVDWLGREMLEMR+RD ++D D+++D EP I+DG
Sbjct: 1   MASASLGHSGGVGSSRTINRLKGPVNSVDWLGREMLEMRIRDNKLDVDDEKDIEPAIVDG 60

Query: 59  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
           +GAE+GH+I TTIGGRNG  KQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD
Sbjct: 61  MGAESGHIIATTIGGRNGQPKQTISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 120

Query: 119 KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ 178
           KRYKNRELQIM MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR+Y+R++Q
Sbjct: 121 KRYKNRELQIMHMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARHYNRMNQ 180

Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
           RMPLIYVKLY+YQICR+LAYIHNC+GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG
Sbjct: 181 RMPLIYVKLYSYQICRSLAYIHNCVGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 240

Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           EPN+SYICSRYYRAPELIFGATEYTTAID+WSTGCVMAELLLGQPLFPGESGVDQLVEII
Sbjct: 241 EPNISYICSRYYRAPELIFGATEYTTAIDMWSTGCVMAELLLGQPLFPGESGVDQLVEII 300

Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
           KVLGTPTREEIKCMNPNYTEFKFPQIK HPWHKVFQKRLPPEAVDLV R  QYSPNLRCT
Sbjct: 301 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFQKRLPPEAVDLVSRLLQYSPNLRCT 360

Query: 359 ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           ALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 361 ALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKP 394

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849298|ref|XP_002892530.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata] gi|297338372|gb|EFH68789.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata]

 Score =  736 bits (1901), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/392 (87%), Positives = 370/392 (94%), Gaps = 1/392 (0%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN+VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNVVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGA+EY+TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYSTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKP 391

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218288|ref|NP_172455.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|30681397|ref|NP_849627.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|42571421|ref|NP_973801.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|79317477|ref|NP_001031013.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323818|ref|NP_001077498.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323820|ref|NP_001077499.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|38503402|sp|Q39019.2|KSG10_ARATH RecName: Full=Shaggy-related protein kinase kappa; AltName: Full=ASK-kappa; Short=AtK-1 gi|20260176|gb|AAM12986.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|23197848|gb|AAN15451.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|332190380|gb|AEE28501.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190381|gb|AEE28502.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190382|gb|AEE28503.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190383|gb|AEE28504.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190384|gb|AEE28505.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190385|gb|AEE28506.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana]

 Score =  736 bits (1900), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/392 (88%), Positives = 369/392 (94%), Gaps = 1/392 (0%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKP 391

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357445263|ref|XP_003592909.1| Glycogen synthase kinase-3-like protein [Medicago truncatula] gi|92893880|gb|ABE91930.1| Protein kinase [Medicago truncatula] gi|355481957|gb|AES63160.1| Glycogen synthase kinase-3-like protein [Medicago truncatula]

 Score =  734 bits (1896), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/398 (91%), Positives = 372/398 (93%), Gaps = 6/398 (1%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSS-VDWLGREMLEMRLR-----DQVDNDEDRDSEPD 54
           MASASLGNGG+GSS        ++SS VDWLGREML M L      D  D D+ R+SEPD
Sbjct: 1   MASASLGNGGIGSSSRSAAALRAASSSVDWLGREMLHMNLNRDHDHDDDDEDDARESEPD 60

Query: 55  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 114
           IIDGVGAETGHVIRT+I  RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGEIVAIKK
Sbjct: 61  IIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGEIVAIKK 120

Query: 115 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 174
           VLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS
Sbjct: 121 VLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 180

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
           RI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV
Sbjct: 181 RINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 240

Query: 235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
           LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL
Sbjct: 241 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 300

Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
           VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN
Sbjct: 301 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 360

Query: 355 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           LRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP
Sbjct: 361 LRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKP 398

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	394
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.928	0.869	0.857	3.6e-176
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.913	0.888	0.765	1.3e-155
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.890	0.856	0.775	4.4e-155
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.911	0.877	0.756	3.1e-154
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.921	0.769	0.733	9.8e-151
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.895	0.867	0.722	2.5e-145
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.895	0.856	0.722	5.1e-145
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.875	0.907	0.718	6.8e-143
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.906	0.815	0.663	7.9e-133
UNIPROTKB|Q91757	420	gsk3b "Glycogen synthase kinas	0.840	0.788	0.653	5.6e-116

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1711 (607.4 bits), Expect = 3.6e-176, P = 3.6e-176
 Identities = 314/366 (85%), Positives = 334/366 (91%)

Query:    27 VDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
             VDWL R++ E R+RD+V+ D++RDSEPDIIDG GAE GHVIRTT+ GRNG S+Q VSYI+
Sbjct:    26 VDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYIS 85

Query:    87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
             EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKNRELQIMQMLDHPN VALKH FFS
Sbjct:    86 EHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFS 145

Query:   147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
              TD               TVNR+AR+YSR +Q MPLIYVKLYTYQICRALAYIHN  G+C
Sbjct:   146 RTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLC 205

Query:   207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
             HRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA+EYTTAI
Sbjct:   206 HRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAI 265

Query:   267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
             DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP
Sbjct:   266 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 325

Query:   327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
             HPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTALEAC+HP FDELRDPNTRLPNGRPLPP
Sbjct:   326 HPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPP 385

Query:   387 LFNFKP 392
             LFNFKP
Sbjct:   386 LFNFKP 391

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1517 (539.1 bits), Expect = 1.3e-155, P = 1.3e-155
 Identities = 280/366 (76%), Positives = 313/366 (85%)

Query:    27 VDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
             VD L  EM +M++RD      D++ E  ++DG G ETGH+I TTIGGRNG  KQ +SY+A
Sbjct:    18 VDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 71

Query:    87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
             E VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFS
Sbjct:    72 ERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFS 131

Query:   147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
             TT+K              TV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH CIG+C
Sbjct:   132 TTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVC 191

Query:   207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
             HRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAI
Sbjct:   192 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 251

Query:   267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
             D+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 
Sbjct:   252 DVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 311

Query:   327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
             HPWHK+F KR+PPEAVDLV R  QYSPNLR  AL+  VHPFFDELRDPN RLPNGR LPP
Sbjct:   312 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPP 371

Query:   387 LFNFKP 392
             LFNFKP
Sbjct:   372 LFNFKP 377

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1512 (537.3 bits), Expect = 4.4e-155, P = 4.4e-155
 Identities = 277/357 (77%), Positives = 308/357 (86%)

Query:    36 EMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSF 95
             EM+++D      D++ E  ++DG G ETGH+I TTIGG+NG  KQ +SY+AE +VG GSF
Sbjct:    32 EMKIKD------DKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSF 85

Query:    96 GVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXX 155
             G+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K     
Sbjct:    86 GIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL 145

Query:   156 XXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL 215
                      TV R++++YSR +QRMP+IYVKLYTYQICRALAYIH  +G+CHRDIKPQNL
Sbjct:   146 NLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNL 205

Query:   216 LVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM 275
             LVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+
Sbjct:   206 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVL 265

Query:   276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
             AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F K
Sbjct:   266 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 325

Query:   336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
             R PPEAVDLV R  QYSPNLR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP
Sbjct:   326 RTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKP 382

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1504 (534.5 bits), Expect = 3.1e-154, P = 3.1e-154
 Identities = 276/365 (75%), Positives = 313/365 (85%)

Query:    28 DWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAE 87
             D L  EM +M+++D      D++ E  I++G   ETGH+I TTIGGRNG  KQ +SY+AE
Sbjct:    23 DRLPEEMKDMKIQD------DKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAE 76

Query:    88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
              VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFST
Sbjct:    77 RVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFST 136

Query:   148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
             T+K              TV+R+ ++Y++++QRMPL+YVKLYTYQI R+L+YIH CIG+CH
Sbjct:   137 TEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCH 196

Query:   208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
             RDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID
Sbjct:   197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID 256

Query:   268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
             +WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK H
Sbjct:   257 VWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 316

Query:   328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 387
             PWHK+F KR+PPEAVDLV R  QYSPNLRC AL++ VHPFFDELRDPN RLPNGR LPPL
Sbjct:   317 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPL 376

Query:   388 FNFKP 392
             FNFKP
Sbjct:   377 FNFKP 381

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1471 (522.9 bits), Expect = 9.8e-151, P = 9.8e-151
 Identities = 267/364 (73%), Positives = 308/364 (84%)

Query:    28 DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
             D L   M+EM++RD+ + N ED+D E  +++G G ETG VI TT+GGR+G  KQ +SY+A
Sbjct:    81 DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140

Query:    87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
             + VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct:   141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200

Query:   147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
             TTDK              TV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H  +G+C
Sbjct:   201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260

Query:   207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
             HRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AI
Sbjct:   261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320

Query:   267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
             D+WS GCVMAELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK 
Sbjct:   321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380

Query:   327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 386
             HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPP
Sbjct:   381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440

Query:   387 LFNF 390
             LFNF
Sbjct:   441 LFNF 444

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1420 (504.9 bits), Expect = 2.5e-145, P = 2.5e-145
 Identities = 255/353 (72%), Positives = 297/353 (84%)

Query:    39 LRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVV 98
             L+ + + D D++    +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+V
Sbjct:    25 LKRRPELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIV 84

Query:    99 FQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXX 158
             FQAKC ETGE VAIKKVLQD+RYKNRELQ+M+ +DHPN+++LKHCFFSTT +        
Sbjct:    85 FQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLV 144

Query:   159 XXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
                   T+ R+ R+Y+  +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+
Sbjct:   145 MEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 204

Query:   219 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
             P THQ+KLCDFGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYT +IDIWS GCV+AEL
Sbjct:   205 PLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAEL 264

Query:   279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 338
             LLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+P
Sbjct:   265 LLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 324

Query:   339 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
             PEA+DL  R  QYSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK
Sbjct:   325 PEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1417 (503.9 bits), Expect = 5.1e-145, P = 5.1e-145
 Identities = 255/353 (72%), Positives = 297/353 (84%)

Query:    39 LRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVV 98
             L+ + D D D++    +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+V
Sbjct:    27 LKRRPDIDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIV 86

Query:    99 FQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXX 158
             FQAKC ETGE VAIKKVLQD+RYKNRELQ+M+++DHPN+V+LKHCFFSTT +        
Sbjct:    87 FQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLV 146

Query:   159 XXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
                   T+ R+ ++Y+  +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+
Sbjct:   147 MEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVD 206

Query:   219 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
             P THQ KLCDFGSAKVLVKGE N+SYICSRYYRAPELIFGATEYT++IDIWS GCV+AEL
Sbjct:   207 PLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAEL 266

Query:   279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 338
             LLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+P
Sbjct:   267 LLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 326

Query:   339 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
             PEA+DL  R  QYSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK
Sbjct:   327 PEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1397 (496.8 bits), Expect = 6.8e-143, P = 6.8e-143
 Identities = 248/345 (71%), Positives = 290/345 (84%)

Query:    47 EDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRET 106
             +D++    ++DG    TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:   107 GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV 166
             GE VAIKKVLQD+RYKNRELQ+M+++DHPN+V LKHCFFSTT K              ++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 226
              R+ ++YS  +QRMPL+YVKLY YQI R LAYIHN  G+CHRD+KPQNLLV+P THQ+K+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182

Query:   227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP 286
             CDFGSAK LVKGE N+SYICSR+YRAPELIFGATEYTT+IDIWS GCV+AELLLGQPLFP
Sbjct:   183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242

Query:   287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346
             GE+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIK HPWHK+F KR+PPEA+D   
Sbjct:   243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302

Query:   347 RFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
             R  QYSP+LRCTALEAC HPFFDELR+PN RLPNGRP PPLFNFK
Sbjct:   303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 347

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1302 (463.4 bits), Expect = 7.9e-133, P = 7.9e-133
 Identities = 241/363 (66%), Positives = 286/363 (78%)

Query:    28 DWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAE 87
             D L +E+ E+ L D      D+D +  II G G E+G +I T   G N    + +SY AE
Sbjct:    59 DHLPKEIREVGLGD------DKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAE 112

Query:    88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
             HV+GTGSFGVVFQAKC ET E VAIKKVLQDKRYKNRELQIM+MLDHPN+V LKH FFST
Sbjct:   113 HVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFST 172

Query:   148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
             T+K              T+ R +R+Y++++Q MPLIY++LYTYQICRA+ Y+H  +G+CH
Sbjct:   173 TEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCH 232

Query:   208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
             RDIKPQNLLVN  TH++K+CDFGSAK+L+ GEPN+SYICSRYYRAPELIFGATEYT+AID
Sbjct:   233 RDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAID 292

Query:   268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
             +WS GCVMAEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIK  
Sbjct:   293 MWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQ 352

Query:   328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL 387
             PWHK+F++++ PEA+DL  R  QYSPNLRCTALEAC HPFFD+LRDP   LPNGR LPPL
Sbjct:   353 PWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPL 412

Query:   388 FNF 390
             F+F
Sbjct:   413 FDF 415

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)]

 Score = 1143 (407.4 bits), Expect = 5.6e-116, P = 5.6e-116
 Identities = 219/335 (65%), Positives = 263/335 (78%)

Query:    57 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
             D  G++   V+ T   G+  + +Q+V+Y    V+G GSFGVV+QAK  +TGE+VAIKKVL
Sbjct:    31 DKDGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVL 88

Query:   117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
             QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct:    89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query:   176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
               Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   149 AKQALPIIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPETAVLKLCDFGSAKQL 207

Query:   236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
             V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct:   208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query:   296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct:   268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAIALCSRLLEYTPTS 327

Query:   356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
             R T L+AC H FFDELRDPN +LPNGR  P LFNF
Sbjct:   328 RLTPLDACAHSFFDELRDPNLKLPNGREFPALFNF 362

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IDA

GO:0060070 "canonical Wnt receptor signaling pathway" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7545	0.9670	0.9315	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7945	0.9238	0.8987	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6355	0.8172	0.8320	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7535	0.8959	0.8673	no	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6687	0.8147	0.8941	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7535	0.8959	0.8567	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7507	0.8756	0.9078	no	no
Q388M1	GSK3B_TRYB2	2, ., 7, ., 1, 1, ., 2, 6	0.5209	0.8248	0.9232	N/A	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.8801	0.9923	0.9287	yes	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5872	0.7436	0.7918	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6687	0.8147	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.8688	0.9847	0.9238	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.7883	0.9365	0.9022	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6895	0.8401	0.7880	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6774	0.7791	0.6573	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7634	0.9695	0.9294	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7674	0.9644	0.9245	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7726	0.9644	0.9245	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7369	0.9644	0.8119	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6895	0.8401	0.7880	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.7656	0.9593	0.9219	no	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6895	0.8401	0.7880	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: grail3.0150004202 hypothetical protein (422 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	394
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-135
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-91
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-88
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-87
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-84
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-82
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-82
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-79
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-77
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-74
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-73
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-69
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-66
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-66
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-66
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-64
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-63
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-63
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-62
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-62
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-60
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-60
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-59
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-59
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-58
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-58
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-57
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-57
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-57
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-55
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-55
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-54
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-54
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-53
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-52
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-51
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-51
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-50
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-50
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-50
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-49
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-49
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-49
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-49
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-48
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-48
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-46
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-43
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-41
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-40
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-39
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-39
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-36
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-36
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-35
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-34
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-34
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-31
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-29
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-28
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-28
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-25
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-24
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-23
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-20
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-17
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-17
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.002
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.002
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.002
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.003

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  393 bits (1011), Expect = e-135
 Identities = 173/318 (54%), Positives = 237/318 (74%), Gaps = 5/318 (1%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           N     SY   +++G GSFGVV++A C +T E VAIKKVLQD +YKNREL IM+ L+H N
Sbjct: 61  NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHIN 120

Query: 137 IVALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           I+ LK  +++     +++ ++LN+V+E++P+TV++  ++Y+R +  +PL  VKLY+YQ+C
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
           RALAYIH+   ICHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ +VSYICSR+YRAP
Sbjct: 181 RALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           EL+ GAT YTT ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MN
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           PNY + KFP +KP    KVF K  P +A++ + +F +Y P  R   +EA   PFFD+LRD
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Query: 374 PNTRLPNG-RPLPPLFNF 390
           P  +LP     LP LFNF
Sbjct: 360 PCIKLPKYIDKLPDLFNF 377

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  278 bits (714), Expect = 1e-91
 Identities = 113/309 (36%), Positives = 171/309 (55%), Gaps = 28/309 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G+G++GVV  A  + TG  VAIKK+      L D +   RE+++++ L H NI
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 138 VALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQIC 193
           + L       S  D  ++Y+  V E +   ++++      I    PL   +++ + YQI 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV------IKSPQPLTDDHIQYFLYQIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRY 249
           R L Y+H+   + HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+
Sbjct: 114 RGLKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 310 KCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           K + +     +    P+    P  K+F     PEA+DL+ +   + P  R TA EA  HP
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHP 290

Query: 367 FFDELRDPN 375
           +  +L DP 
Sbjct: 291 YLAQLHDPE 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  267 bits (684), Expect = 8e-88
 Identities = 117/302 (38%), Positives = 171/302 (56%), Gaps = 37/302 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           Y     +G G++GVV++A+ ++TGEIVA+KK+  D   +         RE+ +++ L HP
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICR 194
           NIV L     +   + +LYL  V EY    +    + Y  +    +    +K   YQ+ R
Sbjct: 59  NIVKLLDVIHT---ERKLYL--VFEYCDMDL----KKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYR 251
            LAY H    I HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YR
Sbjct: 110 GLAYCH-SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYR 165

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++ G+  Y+TA+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E    
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW-- 223

Query: 312 MNPNYTEFK-----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
             P  T+       FP+  P    KV   RL PE +DL+ +  QY+P  R +A EA  HP
Sbjct: 224 --PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280

Query: 367 FF 368
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  265 bits (679), Expect = 4e-87
 Identities = 116/298 (38%), Positives = 171/298 (57%), Gaps = 25/298 (8%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKN---RELQIMQMLD 133
           QK+  I     G G++GVV++A+ + TGEIVAIKK+              RE+++++ L+
Sbjct: 2   QKLGKI-----GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPNI+ L   F     K +LYL  V E++   + ++ ++  R    +P   +K Y YQ+ 
Sbjct: 57  HPNIIKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRA 252
           + LA+ H+  GI HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRA
Sbjct: 109 QGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PEL+ G   Y+T +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E     
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226

Query: 313 NPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                  +F FP+    P  K+F     P+A+DL+ +   Y P+ R TA +A  HP+F
Sbjct: 227 TSLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  259 bits (663), Expect = 1e-84
 Identities = 111/290 (38%), Positives = 167/290 (57%), Gaps = 23/290 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+ G+VF+AK RETGE VA+KKV   +          RE++ +Q   HP +V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F          L  V+EY+P  ++ + R+  R    +P   VK Y   + + +AY+H   
Sbjct: 68  F---PHGSGFVL--VMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA-N 118

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELIFGATE 261
           GI HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA +
Sbjct: 119 GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 318
           Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNK 236

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             FP+ KP P  ++F     PEA+DL+     Y P+ R +A EA  HP+F
Sbjct: 237 ITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  252 bits (647), Expect = 1e-82
 Identities = 105/292 (35%), Positives = 155/292 (53%), Gaps = 45/292 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
           Y     +G GSFG V+ A+ ++TG++VAIK +      +D+    RE++I++ L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L   F    D+++LYL  V+EY    +  + + +       R+     + Y  QI  AL
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y+H+  GI HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++
Sbjct: 111 EYLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   Y  A+DIWS G ++ ELL G+P FPG+   DQL+E+ K +G P            
Sbjct: 169 LG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK----------- 213

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                P   P  W       + PEA DL+ +     P  R TA EA  HPFF
Sbjct: 214 -----PPFPPPEW------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  252 bits (647), Expect = 4e-82
 Identities = 112/299 (37%), Positives = 162/299 (54%), Gaps = 29/299 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
           Y     +G G++ VV++A+ +ETG IVAIKK+   +R +          RE++++Q L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PNI+ L   F          +NLV E++   + ++ ++ S +        +K Y     R
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIKDKSIVLT---PADIKSYMLMTLR 113

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC---SRYYR 251
            L Y+H+   I HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 312 MN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +   P+Y EFK     P P  ++F      +A+DL+ R    +PN R TA +A  HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  245 bits (627), Expect = 3e-79
 Identities = 115/292 (39%), Positives = 164/292 (56%), Gaps = 21/292 (7%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALK 141
            VVG G++GVV + + + TGEIVAIKK  +   D+  K    RE+++++ L H NIV LK
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F     K  LYL  V EYV  T+  +          +P   V+ Y +Q+ +A+AY H+
Sbjct: 67  EAFRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS 118

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNVSYICSRYYRAPELIFGA 259
              I HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G 
Sbjct: 119 -HNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 317
           T Y   +D+W+ GC+MAELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP + 
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236

Query: 318 EFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              FP+   P    + +  ++   A+D +    +  P  R T  E   HP+F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  243 bits (623), Expect = 5e-79
 Identities = 98/292 (33%), Positives = 147/292 (50%), Gaps = 39/292 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G+GSFG V++AK + TG+IVA+K + +            RE++I++ L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L   F    DK+ LYL  V+EY          +Y      +     K    QI R L 
Sbjct: 61  VRLIDAF---EDKDHLYL--VMEYCEGGDLF---DYLSRGGPLSEDEAKKIALQILRGLE 112

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELI 256
           Y+H+  GI HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++
Sbjct: 113 YLHSN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL 170

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   Y   +D+WS G ++ ELL G+P F GE+ +DQL  I ++LG P            
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------- 219

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              +F + K              EA DL+ +     P+ R TA E   HP+F
Sbjct: 220 ---EFDEPKWSS--------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  239 bits (613), Expect = 3e-77
 Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 26/291 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQ-IMQMLDHPNIVALK 141
           +G G+FG V+ A+ +ETGE+VAIKK+ +  ++ +       RE++ + ++ +HPNIV LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    + +ELY   V EY+   + ++ +   R  +      ++   YQI + LA+IH 
Sbjct: 65  EVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +T 
Sbjct: 118 H-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYT 317
           Y++ +DIW+ GC+MAEL   +PLFPG S +DQL +I  VLGTPT+++     K  +    
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            F+FPQ  P   H++      PEA+DL+    ++ P  R TA +A  HP+F
Sbjct: 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  232 bits (594), Expect = 3e-74
 Identities = 97/292 (33%), Positives = 158/292 (54%), Gaps = 24/292 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G++G V++A+ ++TGE+VA+KK+  +   K        RE++++Q L HPNIV LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S   K  +Y+  V EY+   +  +  +      +     +K Y  Q+   L Y+H+ 
Sbjct: 66  IVTSK-GKGSIYM--VFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
            GI HRDIK  N+L+N     LKL DFG A+   K   +  Y   + + +YR PEL+ GA
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLGA 176

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 316
           T Y   +D+WS GC++AEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              K  +       + F+  + P A+DL+ +     P  R +A +A  H +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  231 bits (591), Expect = 3e-73
 Identities = 109/305 (35%), Positives = 176/305 (57%), Gaps = 35/305 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM---QMLDHPNIVAL 140
           +G G++G+V++A  R T E+VA+KK+        D +   RE  IM   ++ DHPNIV L
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDHPNIVKL 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQICRALAY 198
            +   +  DK+ +YL  V EY+   ++ + R      +H+R    Y+    YQ+ +AL Y
Sbjct: 73  LNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHKR----YI---MYQLLKALKY 122

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS------YICSRYYRA 252
           IH+   + HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R+YRA
Sbjct: 123 IHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G+T YT  +D+WS GC++ E+LLG+PLFPG S ++QL +II+V+G P+ E+I+ +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 313 NPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
              +        P     P  ++   +   +A+DL+ +   ++PN R TA EA  HP+  
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Query: 370 ELRDP 374
           +  +P
Sbjct: 300 QFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  219 bits (561), Expect = 9e-69
 Identities = 109/309 (35%), Positives = 166/309 (53%), Gaps = 28/309 (9%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPN 136
            Y     +G+G++GVV  A    +G+ VAIKK      V    +   REL+I++   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI--YVKLYTYQICR 194
           I+A++         +   + +V++ +   ++ I      IH   PL   +++ + YQ+ R
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHI------IHSDQPLTEEHIRYFLYQLLR 118

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRY 249
            L YIH+   + HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPEL+    EYTTAID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 310 KCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
             +       Y +   P+ +P PW K+F K   PEA+DL+ +  Q+ P  R T  +A  H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 366 PFFDELRDP 374
           PF  +  DP
Sbjct: 295 PFLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  212 bits (542), Expect = 1e-66
 Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 30/293 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGEIVA+KK+  +   +       RE+ +++ L+HPNIV L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIHN 201
             S     +LYL  V E++    +   + Y  S     +    +K Y YQ+ + +AY H+
Sbjct: 67  VHSEN---KLYL--VFEFL----DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
              + HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 118 H-RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 173

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 315
           + +Y+T +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PD 232

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           Y    FP+       KV    L  + +DL+ +   Y P  R +A  A  HP+F
Sbjct: 233 YKP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  211 bits (539), Expect = 5e-66
 Identities = 115/306 (37%), Positives = 170/306 (55%), Gaps = 37/306 (12%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
           +K++ I E     G++GVV++A+ ++TGEIVA+KK+  +K  +       RE+ I+  L 
Sbjct: 8   EKLNRIEE-----GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62

Query: 134 HPNIVALKHCFF-STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           HPNIV +K     S  DK  +Y+  V+EYV   +  +      + Q      VK    Q+
Sbjct: 63  HPNIVTVKEVVVGSNLDK--IYM--VMEYVEHDLKSL---METMKQPFLQSEVKCLMLQL 115

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +A++H+   I HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +
Sbjct: 116 LSGVAHLHD-NWILHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLW 171

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPEL+ GA EY+TAID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +  
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQ--KRLPP-----EAVDLVCRFFQYSPNLRCTALEA 362
               P ++E    + K    +   Q  K+ P         DL+ R   Y P  R +A +A
Sbjct: 232 ----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287

Query: 363 CVHPFF 368
             HP+F
Sbjct: 288 LKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  212 bits (542), Expect = 7e-66
 Identities = 108/305 (35%), Positives = 164/305 (53%), Gaps = 26/305 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     VG+G++G V  A   +TG  VAIKK+ +        KR Y  REL++++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 136 NIVALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           N++ L   F   +  E+   + LV   +   +N I +      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            L YIH+  GI HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 315 ----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
               NY +   PQ+    + +VF     P A+DL+ +     P+ R TA EA  HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 371 LRDPN 375
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  212 bits (541), Expect = 8e-66
 Identities = 106/325 (32%), Positives = 175/325 (53%), Gaps = 28/325 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G G++G+V  A  + TG  VAIKK+         +R   RE++I++   H NI
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65

Query: 138 VALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           + +       + +   ++Y+  V E +   + ++ +      Q +   +++ + YQI R 
Sbjct: 66  IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYYR 251
           L YIH+   + HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++  +  YT AIDIWS GC++AE+L  +PLFPG+  + QL  I+ VLGTP++E++ C
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 312 M-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           + +    NY +   P     PW+K+F     P+A+DL+ +   ++P+ R T  EA  HP+
Sbjct: 237 IISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Query: 368 FDELRDPNTRLPNGRPLPPLFNFKP 392
            ++  DP+       P P  F    
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFD 319

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  206 bits (525), Expect = 5e-64
 Identities = 109/292 (37%), Positives = 164/292 (56%), Gaps = 27/292 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + RETG+IVAIKK ++       K+   RE+++++ L HPN+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 144 FFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
           F     + +  L+LV EY   TV N + +N     + +P   +K   +Q  +A+ + H  
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 259
           NCI   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G 
Sbjct: 120 NCI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 317
           T+Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  + 
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 318 EFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               P+ +   P    F   +   A+  +    Q  P  R +  E   HP+F
Sbjct: 236 GLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  204 bits (521), Expect = 2e-63
 Identities = 116/291 (39%), Positives = 173/291 (59%), Gaps = 23/291 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALKH 142
           +VG GS+G+V + K +ETG+IVAIKK L+   DK  K    RE+++++ L H N+V L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 143 CFFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F     K+ LYL  V E+V  TV + + +  + + +      V+ Y +QI R + + H+
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGAT 260
              I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T
Sbjct: 119 H-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 318
           +Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP +  
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236

Query: 319 FKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            + P++K   P  K F K L    +DL  +  +  P+ R ++ +   H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  203 bits (518), Expect = 7e-63
 Identities = 103/295 (34%), Positives = 160/295 (54%), Gaps = 23/295 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNIVALKH 142
           +G G++G V++A+ + TG++VA+KK   +   +       RE+ ++QML     IV L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                    +  L LV EY+   + + +  N     + +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
             G+ HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           +T Y+T +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 319 FK----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
            +    FPQ KP    +     L PE +DL+ +  +Y P  R +A  A  HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  204 bits (520), Expect = 1e-62
 Identities = 112/316 (35%), Positives = 177/316 (56%), Gaps = 31/316 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G++G+V  AK  ET E VAIKK+        D +   RE+++++ LDH N++A+K  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 144 FFSTTDK--EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 +   ++Y+  V E +   +++I R+     Q +   + + + YQ+ R L YIH+
Sbjct: 73  MPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGAT 260
              + HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPEL+   +
Sbjct: 127 A-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 319
           EYTTAID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N     +
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244

Query: 320 KFPQIK--PHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
               I+  P+   + F +  P   P A+DL+ +   + P+ R T  EA  HP+   L DP
Sbjct: 245 ----IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300

Query: 375 NTRLPNGRPLPPLFNF 390
           +       P    F+F
Sbjct: 301 SDEPVCQTP----FSF 312

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  201 bits (514), Expect = 2e-62
 Identities = 102/287 (35%), Positives = 152/287 (52%), Gaps = 21/287 (7%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQML-DHPNIVALKH 142
           G G+F  V +A+ R+TG+  AIK +   K +K+       RE+Q ++ L  HPNI+ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D++   L LV E +   +  + +      + +P   VK Y YQ+ ++L ++H  
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +     Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKF 321
              +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  + F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           P  K     K+       E +DL+ +   Y P+ R TA +A  HP+F
Sbjct: 237 PSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  196 bits (501), Expect = 2e-60
 Identities = 107/292 (36%), Positives = 168/292 (57%), Gaps = 28/292 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G++  V++ + R TGEIVA+K++  D          RE+ +M+ L H NIV L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHN 201
             T +K    L LV EY+ + + +    Y   H     +    VK +TYQ+ + +A+ H 
Sbjct: 67  IHTENK----LMLVFEYMDKDLKK----YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
              + HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 316
           +  Y+T+IDIWS GC+MAE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            +  FP+  P    ++F     P  +DL+ R  Q +P LR +A +A  HP+F
Sbjct: 235 -KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  195 bits (498), Expect = 6e-60
 Identities = 103/298 (34%), Positives = 162/298 (54%), Gaps = 24/298 (8%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
           +Y     +G GS+  V++ + + TG++VA+K++ L+ +        RE  +++ L H NI
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T       L LV EY+   + +   +       + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQ-RRVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 311
           ++ G+TEY+T++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            NP +  + FP   P P      +    P   +L  +F QY P  R +A EA  HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  194 bits (495), Expect = 4e-59
 Identities = 104/295 (35%), Positives = 171/295 (57%), Gaps = 25/295 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           VG G+FG+V  A+ + TG+ VAIKK+++        +   REL++++ L H NI++L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F S    E++Y   V E +   ++R+  +     + +   +++ + YQI R L Y+H+  
Sbjct: 78  FISP--LEDIYF--VTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA- 127

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEY 262
           G+ HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAPE++    +Y
Sbjct: 128 GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 319
              +DIWS GC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + + N   F  
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
             P+ +P P+ + F+    P A+DL+ +   + P  R +A EA  HP+     DP
Sbjct: 244 SLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  194 bits (494), Expect = 4e-59
 Identities = 105/301 (34%), Positives = 150/301 (49%), Gaps = 36/301 (11%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
           + +G G++G+V++A+   +GEIVA+KKV  D           RE+ ++  L HPNIV LK
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
                   K    + LV+EY  + +  +  N            VK    Q+ R L Y+H 
Sbjct: 73  EV---VVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
           N I   HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ 
Sbjct: 127 NFI--IHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLL 181

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 315
           G T YTTAID+W+ GC++AELL  +PL PG+S ++QL  II++LGTP        +  P 
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 316 YTEFKFPQ-----IKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
             +F  P+     +K   PW       L    + L+     Y P  R TA EA    +F 
Sbjct: 242 VGKFTLPKQPYNNLKHKFPW-------LSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Query: 370 E 370
           E
Sbjct: 295 E 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  191 bits (488), Expect = 1e-58
 Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 41/306 (13%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
           QKV  I E     G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+
Sbjct: 3   QKVEKIGE-----GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPNIV L     +   + +LYL  V E++ + + +           +PLI  K Y +Q+ 
Sbjct: 58  HPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMDASPLSGIPLPLI--KSYLFQLL 110

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 250
           + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +Y
Sbjct: 111 QGLAFCHSH-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWY 166

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
           RAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP      
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV--- 223

Query: 311 CMNPNYTEFK-----FPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + P  T        FP+         F K +PP   +  DL+ +   Y PN R +A  A
Sbjct: 224 -VWPGVTSLPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278

Query: 363 CVHPFF 368
             HPFF
Sbjct: 279 LAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  191 bits (487), Expect = 9e-58
 Identities = 118/328 (35%), Positives = 178/328 (54%), Gaps = 33/328 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++++++L HP+I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR---NYSRIHQRMPLIYVKLYTYQICR 194
           V +KH     + +E   + +V E +   ++++ +   + +  H        + + YQ+ R
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-------QFFLYQLLR 114

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYY 250
           AL YIH    + HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+Y
Sbjct: 115 ALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 251 RAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           RAPEL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E 
Sbjct: 173 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231

Query: 309 I-KCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACV 364
           I +  N     +     K  P    F ++ P   P A+ L+ R   + P  R TA EA  
Sbjct: 232 ISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289

Query: 365 HPFFDELRDPNTRLPNGRPLPPL-FNFK 391
            P+F  L     R P+ +P+  L F F+
Sbjct: 290 DPYFKGLAKVE-REPSAQPITKLEFEFE 316

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  188 bits (480), Expect = 1e-57
 Identities = 97/291 (33%), Positives = 142/291 (48%), Gaps = 46/291 (15%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
            ++G GSFG V+ A  ++TGE++A+K V L     +      RE++I+  L HPNIV   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             + S  D+E+  LN+ LEYV   +++ + + + ++ + +    ++ YT QI   LAY+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 257
           +  GI HRDIK  N+LV+     +KL DFG AK L     GE   S   + Y+ APE+I 
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  EY  A DIWS GC + E+  G+P +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               P+I  H         L  EA D + +  +  P  R TA E   HPF 
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  188 bits (480), Expect = 2e-57
 Identities = 105/298 (35%), Positives = 171/298 (57%), Gaps = 29/298 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ R T E +A+KK+  ++  +       RE+ +++ + H NIV L+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 144 FFSTTDKEELYLNLVLEYVPETVNR---IARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             S     E  L LV EY+   + +    + ++++ + R+    +K Y YQI R +AY H
Sbjct: 70  VHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIAYCH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
           +   + HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE++ 
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILL 176

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 315
           G+  Y+T +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +   P+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           Y    FP+  P     V    L P  VDL+ +  +  P+ R TA  A  H +F +L D
Sbjct: 237 YKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  187 bits (477), Expect = 5e-57
 Identities = 110/296 (37%), Positives = 160/296 (54%), Gaps = 36/296 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK+   L LV EY  + + +    +   +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHS--DKK---LTLVFEYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E      P  +  
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW----PGVS-- 229

Query: 320 KFPQIKPHP-------WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           K P  KP+P          V   +L     DL+      +P  R +A EA  HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  184 bits (469), Expect = 4e-55
 Identities = 107/313 (34%), Positives = 159/313 (50%), Gaps = 45/313 (14%)

Query: 90  VGTGSFGVVFQAKCRET--GEIVAIKKV-------LQDKRYKNRELQIMQML-DHPNIVA 139
           +G G++G+V  A+  ET   E VAIKK+       +  KR   REL++++    H NI  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66

Query: 140 LKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           L            ELYL    E +   +++I R+     Q +   + + + YQI   L Y
Sbjct: 67  LYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKY 120

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVS-YICSRYYRAP 253
           IH+   + HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAP
Sbjct: 121 IHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------ 307
           E++     YT AID+WS GC++AELL  +P+F G+  VDQL +I++VLGTP  E      
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238

Query: 308 EIKCMN-----PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
             K  N     PN  +  F  I P+           P A+DL+ +   + P  R +  EA
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNA---------NPLALDLLEKLLAFDPTKRISVEEA 289

Query: 363 CVHPFFDELRDPN 375
             HP+     DP+
Sbjct: 290 LEHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  183 bits (467), Expect = 4e-55
 Identities = 99/304 (32%), Positives = 146/304 (48%), Gaps = 35/304 (11%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
           G G+FG V++A+  +TG +VA+KK+L     K+       RE++I++ L HPN+V L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 144 FFSTTDKE-----ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                DK       +Y+  V  Y+   ++ +  N   +      I  K Y  Q+   + Y
Sbjct: 76  AVERPDKSKRKRGSVYM--VTPYMDHDLSGLLEN-PSVKLTESQI--KCYMLQLLEGINY 130

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------------IC 246
           +H    I HRDIK  N+L++ +   LK+ DFG A+      PN               + 
Sbjct: 131 LH-ENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188

Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           +R+YR PEL+ G   YTTA+DIW  GCV AE+   +P+  G+S +DQL  I K+ GTPT 
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248

Query: 307 EEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           E        P           P    + F K   PE +DL+ +     P  R TA +A  
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG-PEGLDLLSKLLSLDPYKRLTASDALE 307

Query: 365 HPFF 368
           HP+F
Sbjct: 308 HPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  182 bits (463), Expect = 3e-54
 Identities = 108/301 (35%), Positives = 165/301 (54%), Gaps = 30/301 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A  R TG  VAIKK+       L  KR   REL++++ + H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81

Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      +  +   LV+ ++   + ++ +     H+++    ++   YQ+ + L YIH 
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     
Sbjct: 137 A-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           YT  +DIWS GC+MAE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY 
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252

Query: 318 EFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           + K P+ +     K F+  LP   P AV+++ +        R TA EA  HP+F+E  DP
Sbjct: 253 K-KLPRFR----KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 375 N 375
            
Sbjct: 308 E 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (452), Expect = 4e-54
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G FG V+ A+ ++TG+ VAIK + ++          RE++I++ L+HPNIV L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                ++E +L LV+EY    ++  + +       ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN- 111

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 262
           GI HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 321
           +   DIWS G ++ EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 322 PQIKPHP 328
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  180 bits (458), Expect = 4e-54
 Identities = 99/294 (33%), Positives = 162/294 (55%), Gaps = 31/294 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLDHPNIVA 139
           +G G++GVV++ + ++TG+IVA+KK+    R ++          RE+ +++ L HPNIV 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L+         +E  L L+ E++   + +   +     Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
           H+   + HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HS-RRVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 314
            G+  Y+T +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +Y    FP+ K     +   K L  + +DL+ +   Y P  R +A +A  HP+F
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  177 bits (450), Expect = 7e-53
 Identities = 97/295 (32%), Positives = 150/295 (50%), Gaps = 30/295 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD---HPN 136
           +G G++G V++A+   TG  VA+KKV    R             RE+ +++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L           EL L LV E+V + +        +    +P   +K    Q+ R +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGV 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++H    I HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE++
Sbjct: 121 DFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
             ++ Y T +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE    N + 
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVSL 236

Query: 317 TEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               FP   P      F+  +P    E +DL+ +   ++P+ R +A EA  HP+F
Sbjct: 237 PRSSFPSYTPRS----FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  176 bits (448), Expect = 5e-52
 Identities = 104/303 (34%), Positives = 160/303 (52%), Gaps = 23/303 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNI 137
           Y +   VG+G++G V  A  + TGE VAIKK+    Q + +  R   EL +++ + H N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           + L   F S    +E     LV+ Y+   + +I      +   +    V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            YIH+  GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--- 313
                Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ +    
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246

Query: 314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
             +Y +   P+     +  +F  +  P+AVDL+ +  +   + R TA EA  HP+FD  R
Sbjct: 247 AKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304

Query: 373 DPN 375
           D +
Sbjct: 305 DAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  177 bits (449), Expect = 6e-52
 Identities = 90/321 (28%), Positives = 135/321 (42%), Gaps = 48/321 (14%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHP 135
           SY     +G GSFG V+ A+ R+   +VA+K + +    K+       RE+QI+  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 136 -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
            NIV L   F     ++E  L LV+EYV                 +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-------SYICS 247
           AL Y+H+  GI HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG 302
             Y APE++ G +    +++ DIWS G  + ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
           TP                       P      + +   A DL+ +     P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 363 CVHPFFDELRDPNTRLPNGRP 383
             H     L+   + L +   
Sbjct: 273 LSHDLLAHLKLKESDLSDLLK 293

Length = 384

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  172 bits (438), Expect = 4e-51
 Identities = 114/295 (38%), Positives = 160/295 (54%), Gaps = 30/295 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
           VVG G++GVV + + +ET EIVAIKK          K    REL++++ L   NIV LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL----IYVKLYTYQICRALAY 198
            F     + +LYL  V EYV        +N   + + MP       V+ Y YQ+ +A+ +
Sbjct: 68  AF---RRRGKLYL--VFEYV-------EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYICSRYYRAPELI 256
            H    I HRDIKP+NLL++ H   LKLCDFG A+ L +G       Y+ +R+YR+PEL+
Sbjct: 116 CHKN-DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NP 314
            GA  Y  A+D+WS GC++ EL  GQPLFPGES +DQL  I KVLG    E++K    NP
Sbjct: 174 LGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232

Query: 315 NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            +   +FP +  P    + +   L    +DL+    + +P  R    +   HP F
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  173 bits (440), Expect = 4e-51
 Identities = 106/299 (35%), Positives = 164/299 (54%), Gaps = 23/299 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L       TDK    L LV EY+ + + +   +   I   M +  VK++ YQI R LA
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G++EY+T ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           N  +  + FP+ KP P       RL  E ++L+ +F QY    R +A EA  H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  174 bits (442), Expect = 1e-50
 Identities = 109/307 (35%), Positives = 158/307 (51%), Gaps = 43/307 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK---VLQD----KRYKNRELQIMQMLDHPNIV---- 138
           +G G+FGVV+       G+ VA+KK   V Q+    KR   REL+++    H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66

Query: 139 ----ALKHCFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQIC 193
                    F      EE+Y+  V E +   +++ I        Q +   +VK++ YQI 
Sbjct: 67  ILQPPHIDPF------EEIYV--VTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-----ICSR 248
           R L Y+H+  GI HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + ++
Sbjct: 114 RGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVVTQ 168

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ E 
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 365
           ++                 P   V          EAV L+CR   + P+ R +A +A  H
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Query: 366 PFFDELR 372
           P+ DE R
Sbjct: 289 PYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  171 bits (435), Expect = 5e-50
 Identities = 102/329 (31%), Positives = 154/329 (46%), Gaps = 54/329 (16%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------- 123
           +  ++      H+ G G++G V +A    TG+IVAIKKV +     N             
Sbjct: 5   SISERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCG 62

Query: 124 ------RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
                 REL+IM  + H NI+ L   +      E  ++NLV++ +   + ++     +I 
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYV-----EGDFINLVMDIMASDLKKVVD--RKI- 114

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---- 233
            R+    VK    QI   L  +H      HRD+ P N+ +N      K+ DFG A+    
Sbjct: 115 -RLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKG-ICKIADFGLARRYGY 171

Query: 234 -VLVKGEPNVSYICSR----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282
                       +  R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Query: 283 PLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 339
           PLFPGE+ +DQL  I ++LGTP  +   + K + P YTEF     KP     +F      
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTP--RKPKDLKTIFPNA-SD 287

Query: 340 EAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +A+DL+    + +P  R +A EA  H +F
Sbjct: 288 DAIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  170 bits (433), Expect = 5e-50
 Identities = 106/322 (32%), Positives = 151/322 (46%), Gaps = 56/322 (17%)

Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
           +G G++G V++AK +    G+  AIKK   DK           RE+ +++ L H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRA 195
              F    DK    + L+ +Y    + +I + + +     I   M    VK   +QI   
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNG 120

Query: 196 LAYIH-NCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNVSY 244
           + Y+H N +   HRD+KP N+LV    P    +K+ D G A       K L   +P V  
Sbjct: 121 VHYLHSNWV--LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV 295
           I   +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL 
Sbjct: 179 I---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 296 EIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----HKVFQKRLP--PEAVDLVC 346
            I +VLGTPT ++   IK M P Y                  K  +K      +  DL+ 
Sbjct: 236 RIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 347 RFFQYSPNLRCTALEACVHPFF 368
           +  +Y P  R TA EA  HP+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  168 bits (427), Expect = 1e-49
 Identities = 110/301 (36%), Positives = 166/301 (55%), Gaps = 30/301 (9%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
           SY+    +G GS+  V++   R  G++VA+K V+  K  +       RE  +++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           IV L H    T +     L  V EY+  +    + ++   +H       V+L+ +Q+ R 
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRA 252
           LAYIH    I HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR 
Sbjct: 116 LAYIHG-QHILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRP 171

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC 311
           P+++ GAT+Y++A+DIW  GC+  E+L GQP FPG S V +QL +I  VLG PT +    
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231

Query: 312 MN--PNYTEFKFPQIKPHPWHKVFQKRL--PPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           ++  PNY    F   KP     V+ KRL  PP+A DL  +     P  R +A +A +HP+
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Query: 368 F 368
           F
Sbjct: 291 F 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  170 bits (431), Expect = 2e-49
 Identities = 101/304 (33%), Positives = 158/304 (51%), Gaps = 21/304 (6%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ + H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F   T  E    + LV   +   +N I +      Q++   +V+   YQ+ R L YIH+ 
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE++     Y
Sbjct: 138 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMHY 193

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +K ++  +      
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253

Query: 323 QIKPHPWH---KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
            +   P     K+F +   P A+DL+ +      + R +A EA  HP+F +  DP    P
Sbjct: 254 SLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE-P 311

Query: 380 NGRP 383
              P
Sbjct: 312 EAEP 315

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  168 bits (427), Expect = 2e-49
 Identities = 98/308 (31%), Positives = 164/308 (53%), Gaps = 23/308 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  V++ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T    E  L LV EY+ + + +   +       + +  VKL+ +Q+ R L 
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           N  +  + +P+ +    H     RL  +  +L+ +  Q+    R +A EA  HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 373 DPNTRLPN 380
           +   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  169 bits (430), Expect = 2e-49
 Identities = 92/307 (29%), Positives = 158/307 (51%), Gaps = 44/307 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-VLQDKR---YKNRELQIMQMLDHPNIVALKHCFF 145
           +G GS G+VF A   +  + VA+KK VL D +   +  RE++I++ LDH NIV +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 146 S-----TTDKEELY----LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                 T D   L     + +V EY+   +  +          +   + +L+ YQ+ R L
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGL 127

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRY 249
            YIH+   + HRD+KP N+ +N     LK+ DFG A+++   +P+ S+       + +++
Sbjct: 128 KYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKW 183

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTR 306
           YR+P L+     YT AID+W+ GC+ AE+L G+PLF G   ++Q+   +E + V+    R
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 307 EEIKCMNPNYTEFKFPQIKPHPW--HKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALE 361
            E+  + P++       ++       +  +  LP   PEA+D + +   ++P  R TA E
Sbjct: 244 NELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 362 ACVHPFF 368
           A +HP+ 
Sbjct: 297 ALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  168 bits (426), Expect = 9e-49
 Identities = 104/298 (34%), Positives = 158/298 (53%), Gaps = 24/298 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      EE   + LV   +   +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 138

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  165 bits (420), Expect = 9e-49
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHC 143
             +G G FG V++A+ + TG+ VAIK + L+ K  K     E+QI++   HPNIV     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +     K+EL+  +V+E+    ++  + ++    +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
               DIWS G    EL  G+P +  E    + +  I   G P                  
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPP---------------GLR 218

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
              P  W          E  D + +  Q +P  R TA +   HPF
Sbjct: 219 --NPEKW--------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  164 bits (417), Expect = 2e-48
 Identities = 91/292 (31%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALKH 142
           +G GSFG V   + ++TG++ A+K     K+++ K   +   E  I+  ++HP IV L H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             F T +K    L LVLEY P  E  + +++       R      + Y  +I  AL Y+H
Sbjct: 60  YAFQTEEK----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLH 110

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
           +  GI +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y  A+D WS G ++ E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CV--HPFF 368
           +FP            + L PEA DL+    Q  P  R  +  A  +  HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  164 bits (417), Expect = 4e-48
 Identities = 97/296 (32%), Positives = 156/296 (52%), Gaps = 23/296 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +Y+    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T    E  L LV EY+   + +   N   +   M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    I HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 312
           ++ G+TEY+T ID+W  GC++ E+  G+P+FPG +  ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           N  +  + FPQ +  P       RL  + +DL+     Y    R +A  A  H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  159 bits (403), Expect = 8e-46
 Identities = 97/310 (31%), Positives = 150/310 (48%), Gaps = 53/310 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
            +G G++G V++A+ ++TGE+VA+KKV  D   +       RE++I++ L+H NIV LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 143 CFFSTTD-----KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY------- 190
                 D     K++    LV EY+              H  M L+   L  +       
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMD-------------HDLMGLLESGLVHFSEDHIKS 120

Query: 191 ---QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYI 245
              Q+   L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + +
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            + +YR PEL+ G   Y  AID+WS GC++ EL   +P+F     + QL  I ++ G+P 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 306 REEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRL-------PPEAVDLVCRFFQYSPNLRC 357
                 + P+  +   F  +KP    K +++RL       P  A+DL+       P+ RC
Sbjct: 239 ----PAVWPDVIKLPYFNTMKP---KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291

Query: 358 TALEACVHPF 367
           TA EA   P+
Sbjct: 292 TAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  154 bits (392), Expect = 1e-43
 Identities = 103/319 (32%), Positives = 161/319 (50%), Gaps = 44/319 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A    TG+ VAIKK       V   KR Y  REL +M++++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 136 NIVALKHCFFSTTDK-----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
           NI+ L + F  T  K     +++YL  V+E +   + ++       H+RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           Q+   + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
           RAPE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  +II+ LGTP+ E + 
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 311 CMNP---NYTEFKFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNL 355
            + P   NY E + P+   + + ++F             K    +A DL+ +     P  
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 356 RCTALEACVHPFFDELRDP 374
           R +  +A  HP+ +   DP
Sbjct: 302 RISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  148 bits (375), Expect = 1e-41
 Identities = 93/302 (30%), Positives = 141/302 (46%), Gaps = 34/302 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH- 142
           +G G+FG VF+A+ ++T +IVA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 143 CFFSTT----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           C    T     K   YL  V E+     + +A   S  + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAP 253
           IH    I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 312
           EL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 313 N-PNYTEFKFPQ-----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
               + + + PQ     +K      V      P A+DL+ +     P  R  A  A  H 
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKD----PHALDLIDKLLVLDPAKRIDADTALNHD 308

Query: 367 FF 368
           FF
Sbjct: 309 FF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  143 bits (362), Expect = 5e-40
 Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 32/296 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R +  E             L+ ++  DHPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 137 IVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQR-MPLIYVKLYTYQIC 193
           IV L   C  S TD+E   + LV E+V + +    R Y  ++    +P   +K    Q  
Sbjct: 64  IVRLMDVCATSRTDRE-TKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV     Q+KL DFG A++          + + +YRA
Sbjct: 119 RGLDFLHANCI--VHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 233

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +       F    P P   V  + +      L+     ++P+ R +A  A  HPFF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  141 bits (359), Expect = 9e-40
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G GSFG V+  + +  G++  +K++       +++     E++I++ L+HPNI
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +     F     +E+  L +V+EY     +++  +   +  +  P   +  +  Q+C AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRA 252
            Y+H+   I HRDIKPQN+ +      +KL DFG +KVL      V    +     YY +
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLS 171

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           PEL      Y    DIWS GCV+ EL   +  F GE+
Sbjct: 172 PELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  141 bits (356), Expect = 2e-39
 Identities = 90/287 (31%), Positives = 134/287 (46%), Gaps = 46/287 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL---QDKRYK------NRELQIMQMLDHPNIVAL 140
           +G+GSFG V++    + G+  A+K+V      +  +       +E+ ++  L HPNIV  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               +  T++EE  L + LE VP     +A+   + +   P   ++LYT QI   L Y+H
Sbjct: 67  ----YLGTEREEDNLYIFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I    
Sbjct: 120 D-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y  A DIWS GC + E+  G+P +    GV  + +I +    P                
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------------- 221

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                P P H      L  EA D + +  Q  P+LR TA E   HPF
Sbjct: 222 -----PIPDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  140 bits (355), Expect = 6e-39
 Identities = 101/302 (33%), Positives = 158/302 (52%), Gaps = 26/302 (8%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
           SY     +G GS+  V++ K +  G++VA+K + LQ++        RE  +++ L H NI
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V L H    T +     L LV EYV  +    + ++   +H       VKL+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
           +YIH    I HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPP 172

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 312
           +++ G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232

Query: 313 N--PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
           +  P++   +F    P    + + K      A DL  +  Q  P  R +A  A  H +F 
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292

Query: 370 EL 371
           +L
Sbjct: 293 DL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  136 bits (344), Expect = 1e-37
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 50/294 (17%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
           + +G G+FG V+ A   +TGE++A+K++ +QD   K       E++++++L HPN+V   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +     +E++Y+   +EY    T+  +   + RI   +    +++YT Q+   LAY+H
Sbjct: 64  -YYGVEVHREKVYI--FMEYCSGGTLEELLE-HGRI---LDEHVIRVYTLQLLEGLAYLH 116

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRAPEL 255
           +  GI HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+
Sbjct: 117 SH-GIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 256 IFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           I G     +  A DIWS GCV+ E+  G+  +       Q++  +     P         
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-------- 226

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                   P             +L PE  D + R  +  P  R TA E   HPF
Sbjct: 227 -------IPDS----------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  136 bits (344), Expect = 2e-37
 Identities = 88/320 (27%), Positives = 138/320 (43%), Gaps = 77/320 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLD-HP 135
           +    ++G GSF  V  AK +ET +  AIK     +++++K+  Y   E +++  L+ HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            I+ L + F    D+E LY   VLEY P   N     Y R +  +     + Y  +I  A
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAP---NGELLQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRY-- 249
           L Y+H+  GI HRD+KP+N+L++   H +K+ DFG+AKVL                    
Sbjct: 115 LEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 250 ---------------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
                          Y +PEL+        + D+W+ GC++ ++L G+P F G +  + L
Sbjct: 173 EKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYL 229

Query: 295 V--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
              +I+K                  E+ FP               PP+A DL+ +     
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260

Query: 353 PNLRCTALEACV----HPFF 368
           P  R    E       HPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 5e-37
 Identities = 87/288 (30%), Positives = 139/288 (48%), Gaps = 48/288 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALKH 142
           ++G G+FGVV++    ETG+ VAIK++ L+  + +      +E+ +++ L HPNIV    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  +    L ++LEY    ++ +I + +    + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELIFGAT 260
             G+ HRDIK  N+L       +KL DFG A K+    + + S + + Y+ APE+I   +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
             +TA DIWS GC + ELL G P +                          +NP    F+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNPMAALFR 210

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q   HP      + + PE  D + + FQ  PNLR TA +   HP+ 
Sbjct: 211 IVQ-DDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  131 bits (332), Expect = 8e-36
 Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 45/271 (16%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALKHCFF 145
           G++G VF AK + TG+I AIK +   D   KN+      E  I+     P +V L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           S   K+ LYL  V+EY+P   +  +  N   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNVSYICSRYYRAPEL 255
           I HRD+KP N+L++ + H LKL DFG +KV +             +   + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII--KVLGTPTREEI---- 309
           I G   ++  +D WS GC++ E L+G P F GE+  +++ + I    +  P   E+    
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEA 230

Query: 310 -----KCMNPNYTE---FK-FPQIKPHPWHK 331
                K + P+  +    K   +IK HP+ K
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  134 bits (337), Expect = 9e-36
 Identities = 98/305 (32%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + LV+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 138

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 318
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 319 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
                   FP++ P    P      K    +A DL+ +     P  R +  EA  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315

Query: 370 ELRDP 374
              DP
Sbjct: 316 VWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  134 bits (337), Expect = 1e-35
 Identities = 95/305 (31%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + LV+E +   + ++  +    H+RM  +      YQ+   + ++H+ 
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGIKHLHSA 142

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 143 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGY 199

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 319
              +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E 
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259

Query: 320 K-------FPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
           +       F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+  
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319

Query: 370 ELRDP 374
              DP
Sbjct: 320 VWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  129 bits (327), Expect = 4e-35
 Identities = 74/241 (30%), Positives = 127/241 (52%), Gaps = 21/241 (8%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYK-NRELQIMQMLDHPNIVALKH 142
            V+G GS GVV++ + + TG+I A+KK+     ++ R +  REL+ ++  + P +V    
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+      E  +++VLEY+   ++  + +       ++P   +     QI + L Y+H 
Sbjct: 67  AFYK-----EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGAT 260
              I HRDIKP NLL+N    ++K+ DFG +KVL    +   +++ +  Y +PE I G +
Sbjct: 118 KRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
            Y+ A DIWS G  + E  LG+ P L PG+    +L++ I   G P     +  +P + +
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRD 234

Query: 319 F 319
           F
Sbjct: 235 F 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  130 bits (329), Expect = 1e-34
 Identities = 96/306 (31%), Positives = 155/306 (50%), Gaps = 31/306 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + +V+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 145

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 319
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262

Query: 320 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  128 bits (323), Expect = 2e-34
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 47/290 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKN---RELQIMQMLDHPNIVALKHC 143
            +G G+ GVV +   R TG+I+A+K +    ++  +    REL I+   + P IV     
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F++  D     +++ +EY+      + +    +  R+P   +      + + L Y+H   
Sbjct: 68  FYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y+
Sbjct: 121 KIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYS 177

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              DIWS G  + EL  G+  +P E+       + L  I+               P    
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP---- 221

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              P++    +         P+  D V       P  R +  E   HPF 
Sbjct: 222 ---PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  127 bits (319), Expect = 8e-34
 Identities = 93/304 (30%), Positives = 154/304 (50%), Gaps = 29/304 (9%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQML 132
           Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L
Sbjct: 1   QQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 133 D---HPNIVAL-KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
           +   HPN+V L   C  S TD+E   L LV E+V + +             +P   +K  
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 115

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
            +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + 
Sbjct: 116 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTL 173

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+
Sbjct: 174 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE----AVDLVCRFFQYSPNLRCTALEACV 364
                P                 +  ++   +      DL+ +   ++P  R +A  A  
Sbjct: 233 W----PRDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286

Query: 365 HPFF 368
           HP+F
Sbjct: 287 HPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  126 bits (319), Expect = 1e-33
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 26/207 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + + +G+  A+K     K+++ K+ +    E +I+Q + HP +V L 
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F     +++  L LV+EYVP  E  + + ++      R P    + Y  Q+  AL Y+
Sbjct: 68  GSF-----QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYL 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   I +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I  
Sbjct: 118 HSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILS 172

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLF 285
              Y  A+D W+ G ++ E+L G P F
Sbjct: 173 -KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (308), Expect = 2e-32
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 48/238 (20%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V++   +         VA+K + +D   +      RE +IM+ LDHPNI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
           V L       T++E L   +V+EY+P        +Y R ++   L    L  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 196 LAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YY+  
Sbjct: 116 MEYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVK 162

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 299
                    APE +    ++T+  D+WS G ++ E+  LG+  +PG S   +++E +K
Sbjct: 163 GGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  121 bits (306), Expect = 4e-32
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 47/237 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V++ K +         VA+K + +D   +      RE +IM+ LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L       T++E LY  +V+EY+         +Y R ++ ++ L  +  +  QI R +
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 197 AYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 116 EYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 252 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 299
                   APE +    ++T+  D+WS G ++ E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 1e-31
 Identities = 90/320 (28%), Positives = 138/320 (43%), Gaps = 79/320 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G G+FG V+  + ++TG++ A+K + +    K  ++        I+   D P IV L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             ++S  D+E LY  LV+EY+P  + +N + R         P    + Y  ++  AL  +
Sbjct: 67  --YYSFQDEEHLY--LVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSV 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 236
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 237 KGEPNVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           +   +               Y APE++ G T Y    D WS G ++ E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
               L E        T  +I     N+ E  +FP   P          + PEA+DL+CR 
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPPDPP----------VSPEAIDLICRL 268

Query: 349 FQYSPNLRCTALEACVHPFF 368
                +   +  E   HPFF
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  118 bits (298), Expect = 5e-31
 Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 47/287 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFS 146
            +G GS+G V++A  +ETG++VAIK V  ++  +   +E+ I++  D P IV     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 147 TTDKEELYLNLVLEY-VPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            TD     L +V+EY    +V+ I    N +   + +  I      YQ  + L Y+H+  
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-----LYQTLKGLEYLHS-N 118

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGATE 261
              HRDIK  N+L+N    Q KL DFG +  L     + N + I + ++ APE+I     
Sbjct: 119 KKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRN-TVIGTPFWMAPEVIQE-IG 175

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y    DIWS G    E+  G+P                    P  +    ++P    F  
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMI 211

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           P  KP P      ++  PE  D V +     P  R +A++   HPF 
Sbjct: 212 PN-KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  118 bits (297), Expect = 1e-30
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 22/225 (9%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G GSFG V + + +  G+I+  K++       ++K+    E+ I++ L HPNIV    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 D+    L +V+EY     + ++ +   +  + +   ++     Q+  AL   HN
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 202 CIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
                  + HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  117 bits (295), Expect = 2e-30
 Identities = 93/308 (30%), Positives = 141/308 (45%), Gaps = 67/308 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKN------RELQIMQ 130
           +I   ++G+GSFG V+      +GE++A+K+V           R ++      RE+ +++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT 189
            L H NIV               +LN+ LEYVP  +V  +  NY    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGSSLDAD-----HLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV------- 242
            QI + L Y+HN  GI HRDIK  N+LV+ +   +K+ DFG +K   K E N        
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 243 ---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
              S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
           +                 E   P+I  +         +  EA+D + + F+   N R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258

Query: 360 LEACVHPF 367
            E   HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  116 bits (292), Expect = 4e-30
 Identities = 91/305 (29%), Positives = 142/305 (46%), Gaps = 53/305 (17%)

Query: 82  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYK------NRELQ 127
             ++   ++G G++G V+ A    TGE++A+K+V          D R K        E++
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVK 186
            ++ LDH NIV          +  E YL++ LEYVP  ++    R Y R  +++    V+
Sbjct: 61  TLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VR 111

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNVS 243
            +T Q+   LAY+H+  GI HRD+K  NLLV+      K+ DFG +K    +   + N+S
Sbjct: 112 FFTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 244 YICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
              S ++ APE+I   ++ Y+  +DIWS GCV+ E+  G+  +  E              
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------------- 215

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
               E I  M     +   P I P          L P A+D +   F  +P+ R TA E 
Sbjct: 216 ----EAIAAMFKLGNKRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTAREL 266

Query: 363 CVHPF 367
             HPF
Sbjct: 267 LQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (293), Expect = 6e-30
 Identities = 85/294 (28%), Positives = 129/294 (43%), Gaps = 58/294 (19%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
             +G G+ G V++A  R TG+ VAIKK+ L+ +  +    E+ IM+   HPNIV     +
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 145 FSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                 +EL++  V+EY+         T N +  N  +I       YV     ++ + L 
Sbjct: 85  L---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQI------AYVCR---EVLQGLE 130

Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPE 254
           Y+H  N I   HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I    +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K    
Sbjct: 187 VIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK---- 237

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                      P  W   F+        D + +     P  R +A E   HPF 
Sbjct: 238 ----------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  113 bits (285), Expect = 4e-29
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
            +G G+FG V++   +  GE     VA+K + +    +       E  IM+ L HPNIV 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
           L       T  E LY  +V EY+P        ++ R H +++ L  +     QI + + Y
Sbjct: 66  LLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 251
           +   N +   HRD+  +N LV      +K+ DFG ++ + + +         YYR     
Sbjct: 118 LESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGG 164

Query: 252 -------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                  APE +    ++T+  D+WS G ++ E+  LG+  +PG S  +
Sbjct: 165 KLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 7e-29
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 56/290 (19%)

Query: 93  GSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQ---IMQMLDHPNIVALKHCF 144
           G+FG V+ AK R TG+  AIK      ++   +  N + +   +M   + P +  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYIHN 201
           +S   K+  YL LV+EY+         + + + + +   P  + K Y  ++   +  +H 
Sbjct: 64  YSFQSKD--YLYLVMEYLN------GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  +
Sbjct: 116 -RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
                D WS GCV+ E L G P F  E+  D + + I          I            
Sbjct: 171 -DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRIN----------- 211

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF 368
                  W +  ++   PEAVDL+ R     P  R  A    E   HPFF
Sbjct: 212 -------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  112 bits (283), Expect = 7e-29
 Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 48/295 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPN 136
           +    V+G G+FG V   + R+T ++ A+K     K ++    +N   E +I+Q L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           +V L   ++S  D+E +YL  V++ +     R    Y    + +     VK +  +I  A
Sbjct: 62  LVNL---WYSFQDEENMYL--VVDLLLGGDLR----YHLSQKVKFSEEQVKFWICEIVLA 112

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           L Y+H+  GI HRDIKP N+L++   H + + DF  A  +       S   +  Y APE+
Sbjct: 113 LEYLHS-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     Y+ A+D WS G    E L G+  + G S                R++I      
Sbjct: 171 LCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQI------ 210

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEACVHPFF 368
               K            +      EA+D + +  +  P  R      +   HP+F
Sbjct: 211 --RAKQETADVL-----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  111 bits (280), Expect = 2e-28
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 56/296 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G FG V   K +      A+K V          + +   E +I++  +HP IV L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 143 CFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             F    K++ Y+ +++EY       T+ R    +     R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +HN  GI +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I  
Sbjct: 109 LHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y  ++D WS G ++ ELL G+P F GE   D +             +I   N     
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL-- 213

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFD 369
            +FP              +   A DL+ +  + +P  R   L+  +     H +F+
Sbjct: 214 -EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 5e-28
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 48/228 (21%)

Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
            +G G+FG V++ K +        VA+K + +D   + R     E ++M+ L HPN+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
                  T++E LY  LVLEY+         R +R      ++  L    L  +  QI +
Sbjct: 62  LGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 195 ALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + Y+     +   HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 117 GMEYLASKKFV---HRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 252 -----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
                      APE +     +T+  D+WS G ++ E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  110 bits (276), Expect = 9e-28
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNR---ELQIMQMLDHPN 136
           +  E  +G G F VV++A C   G +VA+KKV    + D + +     E+ +++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           ++     F      E   LN+VLE      ++R+ +++ +  + +P   +  Y  Q+C A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 254
           L ++H+   I HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  111 bits (278), Expect = 9e-28
 Identities = 95/318 (29%), Positives = 156/318 (49%), Gaps = 48/318 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN++AL+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 145 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            S +D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+
Sbjct: 68  LSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 200 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 249
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 300
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 301 LGTPTR---EEIKCMNPNY----TEFKFPQIKPHPWHKVFQK-RLPPEA--VDLVCRFFQ 350
           +G P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +   
Sbjct: 241 MGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299

Query: 351 YSPNLRCTALEACVHPFF 368
             P  R T+ +A   P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  111 bits (278), Expect = 1e-27
 Identities = 98/320 (30%), Positives = 158/320 (49%), Gaps = 52/320 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN+++L+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQR---MPLIYVKLYTYQICRALAYI 199
            S  D++   + L+ +Y    +  I + +  S+ +++   +P   VK   YQI   + Y+
Sbjct: 68  LSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 200 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 249
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 300
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 301 LGTPTR---EEIKCMNPNYTEFK-FPQ--------IKPHPWHKVFQKRLPPEAVDLVCRF 348
           +G P     E+IK M  + T  K F +        IK    HKV   +   +A  L+ + 
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKL 297

Query: 349 FQYSPNLRCTALEACVHPFF 368
               P  R T+ +A   P+F
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  109 bits (274), Expect = 2e-27
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 51/296 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYKN--RELQIMQMLDHPNIV 138
            +GTG+F   +QA+  +TG ++A+K+V         Q++  +   +E+++M  L+HP+I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                  +T   E+ + NL +E++   +V+ +   Y    +    + +  YT Q+ R L+
Sbjct: 67  ---RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGLS 117

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRA 252
           Y+H    I HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K         I   
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    P I  H         L P   D+  R  +  P  R  + E   HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 86/298 (28%), Positives = 126/298 (42%), Gaps = 59/298 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYKNRELQ---IMQMLDHPNIVALKH 142
           VG G +G VF AK ++TGEIVA+    K +L         L    I+       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHN 201
            F    D E LY  L +EYVP    R   N   +  +     + + Y  ++  A+  +H 
Sbjct: 69  AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   +D WS GC++ E L G P F G                          PN T   +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGS------------------------TPNET---W 207

Query: 322 PQIKPHPWHKVFQK--------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
             +K   W +  Q+         L  EA DL+ +          +  +   HPFF E+
Sbjct: 208 ENLK--YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 6e-26
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDH---PNIVAL 140
           ++G G++G V++ K   TG +VA+K +  D    +     RE+ ++  L     PNI   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              +          L +++EY      R       I ++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 259
             +G+ HRDIK  N+LV  +T  +KLCDFG A +L +     S ++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
             Y T  DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  102 bits (256), Expect = 9e-25
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 27/210 (12%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
             +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
           K C+       E    LV+EY   +    A +   +H++ PL  V++    +   + LAY
Sbjct: 81  KGCYL-----REHTAWLVMEYCLGS----ASDILEVHKK-PLQEVEIAAICHGALQGLAY 130

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +H+   I HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I  
Sbjct: 131 LHSHERI-HRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILA 185

Query: 259 ATE--YTTAIDIWSTGCVMAELLLGQ-PLF 285
             E  Y   +D+WS G    EL   + PLF
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  101 bits (252), Expect = 5e-24
 Identities = 84/290 (28%), Positives = 126/290 (43%), Gaps = 61/290 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  AK +  G+  A+ KVLQ K    K  +  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F T DK  LY   VL+YV   E    + R      +  P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTADK--LY--FVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y   +D W  G V+ E+L G P F       ++ +   +L  P R     + PN 
Sbjct: 169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPNI 219

Query: 317 T---------------------EFKFPQIKPHP------WHKVFQKRLPP 339
           +                     +  F +IK H       W  +  K++ P
Sbjct: 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  100 bits (251), Expect = 7e-24
 Identities = 95/319 (29%), Positives = 141/319 (44%), Gaps = 59/319 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKH 142
           +GTGSFG V  AK + TGE  AIK     ++L+ K+ +   +E  I+  L HP IV +  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+  +Y   +LE+V   V      + R   R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVY--FLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRAPELIFGAT 260
             I +RD+KP+NLL++   H +K+ DFG AK +    P+ ++ +C +  Y APE+I  + 
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            +  A+D W+ G ++ E + G P F  +              TP R   K +       K
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLK 233

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPN 375
           FP      W   F  R    A DLV    Q     R   L+  V     HP+F    + +
Sbjct: 234 FPN-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA-NWD 280

Query: 376 TRLPNGRPLPPLFNFKPPG 394
                  P P     K PG
Sbjct: 281 KLYARYYPAPIPVRVKSPG 299

Length = 329

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 99.1 bits (247), Expect = 9e-24
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 42/287 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+ A+   T   +AIK++  +D RY    + E+ +   L H NIV      
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----- 69

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +  +D E  +  + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYLHD- 126

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI-FGAT 260
             I HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  G  
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y    DIWS GC + E+  G+P F                       I+   P    FK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAAMFK 223

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               K HP      + L  EA + + R F+  P+ R +A +    PF
Sbjct: 224 VGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 37/285 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           ++  H +G GSFG V+ A    T E+VA+KK+    +  N       +E++ +Q L HPN
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
            +  K C+      +E    LV+EY   +    A +   +H++ PL  V++   T+   +
Sbjct: 83  TIEYKGCYL-----KEHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQ 132

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            LAY+H+   I HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE
Sbjct: 133 GLAYLHSHNMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPE 187

Query: 255 LIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           +I    E  Y   +D+WS G    EL   +P     + +  L  I +   +PT +  +  
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWT 246

Query: 313 NP-----NYTEFKFPQIKPHPW----HKVFQKRLPPEA-VDLVCR 347
           +      +Y   K PQ +P       H   ++  P    +DL+ R
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 52/293 (17%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK---RYKNRELQIMQMLDHPNIVALKHC 143
             +G+G++G V++A+   TGE+VAIK + L+         +E+ +++   HPNIVA    
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAYIHNC 202
           +          L +V+EY      +     +R       I YV   T +    LAY+H  
Sbjct: 69  YLRRD-----KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLHE- 119

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGAT 260
            G  HRDIK  N+L+      +KL DFG +  L     +   S+I + Y+ APE+   A 
Sbjct: 120 TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVA--AV 175

Query: 261 E----YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           E    Y    DIW+ G    EL   Q P+F         +  ++ L   ++         
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS-------- 219

Query: 316 YTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
              F  P++K    W  VF         D + +     P  R TA +   HPF
Sbjct: 220 --NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 36/215 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           VGTG+FG V   + R +    A+K +       L+ +++ + E ++++ + HP I+ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            F++  D+  LY+  ++EYVP  E  + + RN  R      L     Y  +I  AL Y+H
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELFSYL-RNSGRFSNSTGL----FYASEIVCALEYLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAPE 254
           +   I +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE
Sbjct: 119 S-KEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPE 168

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           +I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 169 VI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 96.1 bits (239), Expect = 8e-23
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 16/208 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKH 142
           VVG G+FG+V   + +   ++V IK++  ++  K+       E Q++++L HPNI+    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      E+  L +V+EY P  T+    +   R +  +    +  +  QI  AL ++H 
Sbjct: 67  NFL-----EDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + I HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL  G   
Sbjct: 120 KL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KP 177

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
           Y    DIW+ GCV+ EL   +  F   +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 51/292 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR------ELQIMQMLDHPNIVAL 140
           +G G+FG V+     +TG  +A+K+V         K        E+Q+++ L H  IV  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             C     D E L +   +EY+P       ++  + +  +     + YT QI   + Y+H
Sbjct: 70  YGCL---RDDETLSI--FMEYMP---GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPELI 256
           + + I HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +PE+I
Sbjct: 122 SNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT           
Sbjct: 180 SGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN---------- 225

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                PQ+  H         + P+A + + R F  +   R +A E   H F 
Sbjct: 226 -----PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 71/213 (33%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNI 137
           YI   V+G G+FG     +  E   +V  K+V L     K R     E+ I+ +L HPNI
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +A  + F      ++  L + +EY       ++I R   +  Q      V  Y +QI  A
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSA 113

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNVSYIC 246
           ++YIH   GI HRDIK  N+ +      +KL DFG +K+L         V G P      
Sbjct: 114 VSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------ 165

Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
             YY +PEL  G  +Y    DIW+ GCV+ ELL
Sbjct: 166 --YYMSPELCQGV-KYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 29/214 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQML-DHPNIVALKH 142
           V+G G++G V++A+ ++TG++VAIK  + D           E  I++   +HPNI     
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 143 CFF---STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            F       + ++L+  LV+E     +V  + +   +  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPEL 255
           +H    I   HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+
Sbjct: 129 LHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 256 IFGATE------YTTAIDIWSTGCVMAELLLGQP 283
           I  A +      Y    D+WS G    EL  G+P
Sbjct: 185 I--ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 95.2 bits (237), Expect = 3e-22
 Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 49/298 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + TG  VA+KK+  D R + R      E+ IM+   HPNIV +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           + S    +EL++  V+E++    +  I       H RM    +      + +AL+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA- 133

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATE 261
            G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     
Sbjct: 134 QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y T +DIWS G ++ E++ G+P +  E  +  +            + I+   P       
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP------- 232

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
           P++K    HKV      P     + R     P  R TA E   HPF  +   P++ +P
Sbjct: 233 PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 57/296 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
           +     +G GSFG V++A  + T ++VAIK +       +     +E+Q +     P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                F   +      L +++EY          +  +   ++   Y+     ++   L Y
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCG---GGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 251
           +H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++ 
Sbjct: 114 LHE-EGKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL        K 
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPKN 213

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            NP       P ++ + + K F+        D V       P  R +A E   H F
Sbjct: 214 -NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (235), Expect = 8e-22
 Identities = 90/314 (28%), Positives = 137/314 (43%), Gaps = 56/314 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 142
           +G GSFG V Q + R+T  I A+K + +       E+        ++  ++ P IV LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             FS    E+LYL L      E  + + R       R  L   + YT ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHK- 111

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATE 261
             + +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           YT A+D W+ G ++ E+L G P F  E+ V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--------------- 211

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDPNTRL 378
                      F      +A DL+       P  R     A E   HPFF +L     +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258

Query: 379 PNGRPLPPLFNFKP 392
                 PP   FKP
Sbjct: 259 LMKGIQPP---FKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 86/321 (26%), Positives = 134/321 (41%), Gaps = 61/321 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + + TG++ A KK L  KR K R        E +I++ +    IV+L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 142 HCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + F  T D   L + L+    L+Y    V       +R            Y  QI   L 
Sbjct: 60  YAF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR---------AIFYAAQIICGLE 109

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H    I +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ 
Sbjct: 110 HLHQ-RRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G   Y  ++D ++ GC + E++ G+  F       Q  E ++      +EE+K       
Sbjct: 168 GE-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-M 213

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 372
             ++P             +  PEA DL     Q  P  R      +A E   HP F +L 
Sbjct: 214 AVEYPD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Query: 373 DPNTRLPNGRPLPPLFNFKPP 393
               RL  G   PP   F P 
Sbjct: 262 WR--RLEAGMLEPP---FIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 58/299 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
           V+G GSFG V  A+ + T E+ A+K      +LQD   +    E +++ +   HP +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAY 198
            H  F T D+    L  V+EYV    N     +  I +  R      + Y  +I   L +
Sbjct: 62  -HSCFQTKDR----LFFVMEYV----NGGDLMF-HIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  A+D W+ G ++ E+L GQ  F G+   D+L + I             +     
Sbjct: 170 Y-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSI-------------LEDEV- 213

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDEL 371
                          + + L  EA  ++  F   +P  R   L         HPFF E+
Sbjct: 214 --------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           C+       E    LV+EY   + + +   + +  Q + +  V   T+   + LAY+H+ 
Sbjct: 83  CYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHSH 134

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 261
             + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    E 
Sbjct: 135 -NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEG 189

Query: 262 -YTTAIDIWSTGCVMAELLLGQP 283
            Y   +D+WS G    EL   +P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 51/303 (16%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKHCF 144
           G G++GVV + +   TG I+A+K++   +  +  K    +L I M+ +D P  V      
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F   D     + + +E +  ++++  +        +P   +      I +AL Y+H+ + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
           + HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y    D+WS G  M EL  G+  FP +S             TP                F
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTP----------------F 214

Query: 322 PQIK-----PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
            Q+K     P P  ++  ++  PE  D V +  + +   R    E   HPFF+     NT
Sbjct: 215 QQLKQVVEEPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272

Query: 377 RLP 379
            + 
Sbjct: 273 DVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 26/205 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q + HPN +  K 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+       E    LV+EY   +    A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 93  CYL-----REHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +   I HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SHNMI-HRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 261 E--YTTAIDIWSTGCVMAELLLGQP 283
           E  Y   +D+WS G    EL   +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.4 bits (227), Expect = 4e-21
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           G GS+G V++ K     +  A+K+V L     K R     E++I+  ++HPNI++ K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIH 200
               D  +L +  V+EY P  +    I++   R  +R  +   +++    Q+ R L  +H
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 201 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
               I HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++  
Sbjct: 121 E-QKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKG 175

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
             Y+   DIWS GC++ E+    P F   S  D   ++ +
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.3 bits (227), Expect = 6e-21
 Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 52/296 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHC 143
           V+G G+  VV+ A C    E VAIK++  +K   +     +E+Q M   +HPN+V   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F     +EL+  LV+ Y+     ++ +  +Y R      +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRYYRAPELI 256
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 312
                Y    DIWS G    EL  G        P +     L+  ++             
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQ------------- 221

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           N        P ++    +K + K        ++    Q  P+ R TA E   H FF
Sbjct: 222 ND------PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.1 bits (226), Expect = 6e-21
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYK--NRELQIMQMLDHPNIV 138
           V+G G++G V+       G+++A+K+V  D        K Y+    E+ +++ L H NIV
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                 +  T  ++  +++ +E+VP     I+   +R       ++ K YT QI   +AY
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPG--GSISSILNRFGPLPEPVFCK-YTKQILDGVAY 117

Query: 199 IH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI-------CSRYY 250
           +H NC+   HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 118 LHNNCV--VHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 36/286 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G+ G V + K   TG ++A K V    +        RELQIM     P IV+    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            +  +     + + +E++   +++RI +    I    P+  +      +   L Y++N  
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            I HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 264 TAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              D+WS G  + EL LG+ P        D   + + +L                     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           QI   P  ++     P +  D V       P  R T  + C  P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.8 bits (228), Expect = 7e-21
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 65/310 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALK 141
           ++  G++G V+  + +ET +  A+KK+  Q+   +N+      E  I+   ++P +V++ 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            C F T    + +L +V+EYV       + +N       +P+   ++Y  +   AL Y+H
Sbjct: 67  FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNV--------------SYI 245
           N  GI HRD+KP NLL+    H +KL DFG +K+ L+    N+                +
Sbjct: 119 N-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 246 C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           C +  Y APE+I     Y   +D W+ G ++ E L+G   F G++  +   ++I      
Sbjct: 177 CGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----- 230

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALE 361
             ++I    P   E                  LP +A DL+ R  + +P  R     A E
Sbjct: 231 --DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAFE 269

Query: 362 ACVHPFFDEL 371
              H FF  L
Sbjct: 270 VKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 39/301 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK-RYKN---RELQIMQMLDHPNIVALKHC 143
            +G G+ GVV +   R +G I+A K + L+ K   +N   REL+++   + P IV     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F+S  D E   +++ +E++   +++++ +   RI    P   +   +  + R L Y+   
Sbjct: 68  FYS--DGE---ISICMEHMDGGSLDQVLKKAGRI----PENILGKISIAVLRGLTYLREK 118

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
           T   DIWS G  + E+ +G+   P         E+  + G P   E +    +      P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPV-SEGEAKESHRPVSGHP 230

Query: 323 QIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPF 367
              P P   +F+           +LP      E  D V +  + +P  R    E   HPF
Sbjct: 231 PDSPRPM-AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289

Query: 368 F 368
            
Sbjct: 290 I 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C AL +
Sbjct: 67  YYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIF 257
           +H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I 
Sbjct: 122 MHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
               Y    DIWS GC++ E+   Q  F G+
Sbjct: 180 -ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALA 197
            K   +S   +    L LV+EY+P    R  + ++  R+  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSR 248
           Y+     +   HRD+  +N+LV      +K+ DFG  KVL          EP  S I   
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAEL 278
           ++ APE +   ++++ A D+WS G V+ EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 67/311 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + + ++ A+K + + +  K         E  IM   +   IV L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           H  F    +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 109 HYAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----IPEKWARFYTAEVVLALDAI 158

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPE 254
           H+ +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213

Query: 255 LIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           ++    G   Y    D WS G  + E+L+G   F  +S V          GT +    K 
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------GTYS----KI 259

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF- 368
           M+ +     FP              +  +A DL+C F         R    E   HPFF 
Sbjct: 260 MD-HKNSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308

Query: 369 ------DELRD 373
                 D +R+
Sbjct: 309 NDQWTFDNIRE 319

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 33/209 (15%)

Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
           +G G FG V    CR       TGE VA+K        Q +    RE++I++ LDH NIV
Sbjct: 12  LGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
             K             L L++EY+P    R    Y + H+ ++ L  + L++ QIC+ + 
Sbjct: 70  KYKGV---CEKPGGRSLRLIMEYLPSGSLRD---YLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYY 250
           Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        EP  S I   +Y
Sbjct: 124 YLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL 279
            APE +  +  +++A D+WS G  + EL 
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 85/310 (27%), Positives = 137/310 (44%), Gaps = 47/310 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF---- 144
           V+G GSFG V  A+ + T E  AIK + +D   ++ +++   +      +A +H F    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F T   +E +L  V+EY+      +  +      R      + Y  +I   L ++H   G
Sbjct: 62  FCTFQTKE-HLFFVMEYL--NGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK-G 116

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYT 263
           I +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G  +Y 
Sbjct: 117 IIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYN 174

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
            ++D WS G ++ E+L+GQ  F GE   D+L + I         +               
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR-------------- 212

Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFDELRDPNTRLPNGR 382
               P    F + +  EA D + + F+  P  R     +   HPFF   R  +      R
Sbjct: 213 ----PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWERLEKR 262

Query: 383 PLPPLFNFKP 392
            +PP   FKP
Sbjct: 263 EIPP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 49/285 (17%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPNIV 138
           V+G GSFG VF   +    + G++ A+K       KV    R K  E  I+  ++HP IV
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICRAL 196
            L H  F T  K    L L+L+++     R    ++R+ + +      VK Y  ++  AL
Sbjct: 62  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPEL 255
            ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 112 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPT--------- 305
           +     +T + D WS G +M E+L G   F G+   + +  I+K  LG P          
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228

Query: 306 -REEIKCMNPNYTEFKFPQ----IKPHP------WHKVFQKRLPP 339
            R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 229 LRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 22/217 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G GSFG ++ AK +   E   IK++      +++K    +E+ ++  + HPNIV    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT--- 63

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            FF++  +E   L +V+EY    + + RI R    +     ++    +  QI   L +IH
Sbjct: 64  -FFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHIH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 258
           +   I HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I  
Sbjct: 119 D-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-ICQ 175

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
              Y    DIWS GCV+ EL   +  F G + + QLV
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 50/281 (17%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFF 145
           G G+ G V + + + TG I A+K +  D     ++   REL+I +    P IV     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 146 STTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              D+    + + +EY     +     ++ +   RI ++  L  +      + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPELI 256
           +   I HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 305
            G   Y+   D+WS G  + E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 306 ----REEIK-----CMNPNYTEFKFP-QIKPHPWHKVFQKR 336
                EE K     C+  + T    P  +  HPW K   K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 68/304 (22%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           G G+FG V++A+ +ETG   A K +       L+D      E+ I+    HPNIV L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 144 FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 200
           +F         L +++E+     ++ I     R      L    ++    Q+  AL ++H
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI--- 256
           +   + HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++   
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
            F    Y    DIWS G  + EL   +P                    P  E    +NP 
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPM 214

Query: 316 YTEFKFPQ------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
               K  +       +P  W   F         D +       P+ R TA E   HPF  
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Query: 370 ELRD 373
           +  D
Sbjct: 267 DQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 88.7 bits (220), Expect = 9e-20
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 57/295 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG+  A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D     L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALGYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+C  + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 213

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                         F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 50/300 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           +G G++G V++   R TG  +A+K++   L + ++     EL I+     P IV     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F      E  + + +EY+   +++++        + +P   ++  TY + + L ++    
Sbjct: 69  F-----IEGAVYMCMEYMDAGSLDKLYAGGVAT-EGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-----FG 258
            I HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I       
Sbjct: 123 NIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQ 180

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPN 315
              YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSG 233

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           Y+                      +A D V +     PN R T  +   HP+  + ++ +
Sbjct: 234 YS---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 87/282 (30%), Positives = 128/282 (45%), Gaps = 45/282 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
           V+G GSFG V  AK +  G+  A+ KVLQ K   NR+ Q         +++ + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F TT+K    L  VL++V   E    + R  S      P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ I I +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I
Sbjct: 111 YLHS-INIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------ 305
                Y   +D W  G V+ E+L G P F      +    I+ K L    G         
Sbjct: 169 -RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSIL 227

Query: 306 REEIKCMNPNYTEFK--FPQIKPHP------WHKVFQKRLPP 339
            E ++         K  F +I+ HP      W  + QK++PP
Sbjct: 228 EELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 57/303 (18%)

Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF  +     + G++ A+K      ++Q  +         Q+L+     P 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L H  F T  K    L+L+L+YV   E    +   Y R  +      V++Y  +I  
Sbjct: 67  LVTL-HYAFQTDTK----LHLILDYVNGGELFTHL---YQR--EHFTESEVRVYIAEIVL 116

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
           AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y A
Sbjct: 117 ALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 253 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           PE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILKS 227

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 368
             P                  F K +  EA D + +  +  P  R     A E   HPFF
Sbjct: 228 KPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Query: 369 DEL 371
             +
Sbjct: 270 QGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 89/300 (29%), Positives = 130/300 (43%), Gaps = 63/300 (21%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPN 136
           V+G G +G VFQ +     +TG+I A+K VL+         D  +   E  I++ + HP 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           IV L    F T  K  LYL  +LEY+   E    + R    +           Y  +I  
Sbjct: 62  IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEISL 111

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAP 253
           AL ++H   GI +RD+KP+N+L++   H +KL DFG  K  +         C    Y AP
Sbjct: 112 ALEHLHQ-QGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E I   + +  A+D WS G +M ++L G P F  E+    + +I+K          K   
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
           P Y                    L PEA DL+ +  + +P+ R       A E   HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 24/227 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ--DKRYKN---RELQIMQMLDHPNI 137
           +   + +G GSFGVVF+   +    + A+K++ L   ++R +     E +++  LD   I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +     F      ++  LN+V+EY     ++++ +      + +P   V  +  QI   L
Sbjct: 62  IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGL 114

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 252
           A++H+   I HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +
Sbjct: 115 AHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLS 169

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PEL      Y    D+W+ G V+ E   G+  F   +    +++II+
Sbjct: 170 PELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 55/314 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           ++G GSFG VF A+ + T +  AIK + +D    + +++   +         +HP +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +C F T  KE L+   V+EY+      +  +    H +  L     Y  +I   L ++H
Sbjct: 62  -YCTFQT--KENLFF--VMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH 113

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
           +  GI +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G 
Sbjct: 114 S-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG- 170

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            +Y T++D WS G ++ E+L+GQ  F G    +              + I+  NP Y  +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPRW 218

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNTRL 378
                            L  EA D++ + F   P  R     +   HPFF E+    + L
Sbjct: 219 -----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID--WSAL 259

Query: 379 PNGRPLPPLFNFKP 392
                 PP   FKP
Sbjct: 260 EEREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 86/308 (27%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG I A+KK+ + +   K +      E  I+   D+P +V L 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F     ++E YL L++EY+P  + +  + +      +     Y+     +   A+  I
Sbjct: 68  YSF-----QDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIA----ETILAIDSI 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPN--VSYI 245
           H  +G  HRDIKP NLL++   H +KL DFG              ++L    P+  + +I
Sbjct: 118 HK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 246 CSRY-------------------------YRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
                                        Y APE +F  T Y    D WS G +M E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE 340
           G P F  +               P     K +N   T  +FP           +  L PE
Sbjct: 235 GYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSPE 269

Query: 341 AVDLVCRF 348
           A DL+ R 
Sbjct: 270 AKDLIKRL 277

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 92/305 (30%), Positives = 140/305 (45%), Gaps = 60/305 (19%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIKKVLQD----KRYKNRELQIM--QMLDH----P 135
           V+GTG++G VF   +    +TG++ A+K VLQ     ++ K  E       +L+H    P
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLIYVKLYTYQIC 193
            +V L H  F T  K    L+L+L+YV          ++ ++QR       V+ Y+ +I 
Sbjct: 66  FLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YR 251
            AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y 
Sbjct: 116 LALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +KC
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILKC 226

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 366
             P                  F   + PEA DL+ +  +  P  R       A E   HP
Sbjct: 227 DPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268

Query: 367 FFDEL 371
           FF  L
Sbjct: 269 FFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 30/233 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQ----IMQMLDHPNIVALKHC 143
           +G G+FG V +   + +G I+A+K++    D++ + R L     +M+  D P IV     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK---- 67

Query: 144 FFSTTDKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           F+    +E       EL +++ L+   + V      Y  +   +P   +        +AL
Sbjct: 68  FYGALFREGDCWICMEL-MDISLDKFYKYV------YEVLKSVIPEEILGKIAVATVKAL 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y+   + I HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179

Query: 257 --FGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 306
                  Y    D+WS G  + E+  G+  +P   S  DQL +++K  G P  
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 90/301 (29%), Positives = 137/301 (45%), Gaps = 60/301 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQM-LDHPNIVAL 140
           V+G GSFG V  A+ + T E+ AIK      +LQD        E +I+ +   HP + AL
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            HC F T D+    L  V+EYV   + + +I R+      R      + Y  ++  AL +
Sbjct: 62  -HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
           +H   G+ +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I 
Sbjct: 112 LHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-IL 168

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
              EY  ++D W+ G +M E++ GQP F  ++  D L E I                 + 
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL----------------HD 211

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC-----VHPFFDE 370
           +  +P      W       L  EAV ++  F   +PN R  C A +        HPFF E
Sbjct: 212 DVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Query: 371 L 371
           +
Sbjct: 260 I 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 67/224 (29%), Positives = 120/224 (53%), Gaps = 28/224 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVV + + + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+S  D E   +++ +E++   +++++ +   RI + +    +   +  + R LAY+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 304
           Y+   DIWS G  + EL +G+ P+ P ++      E+  + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 67/229 (29%), Positives = 122/229 (53%), Gaps = 23/229 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVVF+   + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+S  D E   +++ +E++   +++++ +   RI +++    +   +  + + L Y+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 309
           Y+   DIWS G  + E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 84/316 (26%), Positives = 142/316 (44%), Gaps = 59/316 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GSFG V  A+ +  GE  A+K + +D    + +++   +         ++P +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +C F T +    +L  V+E++   + +  I         R  L     Y  +I   L +
Sbjct: 62  -YCTFQTKE----HLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H+  GI +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ 
Sbjct: 112 LHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  +YT ++D WS G ++ E+L+GQ  F G+   D+L E I+V                 
Sbjct: 170 G-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV----------------- 210

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNT 376
                   PH     + + +  E+ D++ + F+  P  R   +     HPFF  +   N 
Sbjct: 211 ------DTPH-----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NW 256

Query: 377 RLPNGRPLPPLFNFKP 392
                R L P   FKP
Sbjct: 257 TALEKRELDP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHP 135
           ++  E  +G G F  V++A C    + VA+KKV    + D + +    +E+ +++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           N++     F    +     LN+VLE      ++++ + + +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAP 253
           A+ ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
           E I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 82.6 bits (204), Expect = 6e-18
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNI 137
           Y+    +G GSFG     K +E G+   IK++    +  K  +   +E+ ++  + HPNI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQIC 193
           V  +  F     +E   L +V++Y           Y +I+ +  +++    +  +  QIC
Sbjct: 62  VQYQESF-----EENGNLYIVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 252
            AL ++H+   I HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I     Y    DIW+ GCV+ E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.0 bits (202), Expect = 9e-18
 Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 61/297 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A+K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D  E  L++ +E++P  ++    ++Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSY 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 254
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT-------NP 228

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                                 LPP   D  CR F     L+   +EA + P  DEL
Sbjct: 229 ---------------------VLPPHVSDH-CRDF-----LKRIFVEAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  A+ +   +  A+K VLQ K    K  E  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F T DK    L  VL+Y+   E    + R    +  R      + Y  +I  AL 
Sbjct: 61  L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF 285
                Y   +D W  G V+ E+L G P F
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 86/321 (26%), Positives = 138/321 (42%), Gaps = 71/321 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK----VLQDKR---YKNRELQIMQMLDHPNIVALK 141
           +VG G FG V   + + TG+I A+K     VL  +    +   E  I+ + + P I  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    DK+ LYL  V+EY P  + ++ + R   +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELI- 256
           H  +G  HRDIKP+N+L++   H +KL DFGSA  L   +   S   + +  Y APE++ 
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 257 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
                G   Y    D WS G +  E++ G+  F   +       I+              
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222

Query: 313 NPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------CVH 365
             N+  F KFP+            ++  + +DL+        +L C   E       C H
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLI-------QSLLCGQKERLGYEGLCCH 263

Query: 366 PFFDELRDPNTRLPNGRPLPP 386
           PFF ++   N R      LPP
Sbjct: 264 PFFSKIDWNNIR----NSLPP 280

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
           V+G GSFG V  AK +  G   A+ KVLQ K    ++ Q         +++ L HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAV-KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L + F +    E+LY   VL+YV   E    + R    +  R      + Y  ++  A+ 
Sbjct: 61  LHYSFQTA---EKLY--FVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAIG 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE +
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-V 167

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF 285
                Y   +D W  G V+ E+L G P F
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE----------LQIMQMLDHPNIVA 139
           +G G+FG V+Q + ++T  I A+K + + +    +E          L    + + P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           LK  F + +D     L LV +Y+   E    + +       R      K Y  ++  AL 
Sbjct: 61  LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALE 110

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELI 256
           ++H    I +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++
Sbjct: 111 HLHK-YDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII---------KVLGTPTRE 307
                YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQ 227

Query: 308 EIKCM---NPNY---TEFKFPQIKPHP------WHKVFQKRLPP 339
            +K +   NP +         ++K HP      W  + +K++ P
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP 271

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y    VVG GSFG     +   + +  A+K++   K         +E  ++  + HPNIV
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           A K  F     + + +L +V+EY    + + +I     ++    P   +  +  Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPEL 255
            +IH    + HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHE-KRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 256 IFGATEYTTAIDIWSTGCVMAEL 278
           I+    Y    DIWS GC++ EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 65/235 (27%), Positives = 117/235 (49%), Gaps = 27/235 (11%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A+K+V  D   +           E+Q+++ L H  IV 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D EE  L++ +EY+P  ++    + Y  + + +     + YT QI + ++Y
Sbjct: 69  YYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVSYICSRYYRAPE 254
           +H+ + I HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           +I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 180 VISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 22/209 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKN----RELQIMQM-LDHPNIVALKHC 143
           +G+G+ G V++ + ++TG ++A+K++ +   + +N     +L ++    D P IV     
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIHNC 202
           F + +D     + + +E +   ++++ +   RI   +P  I  K+ T  I +AL Y+   
Sbjct: 83  FITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKM-TVAIVKALHYLKEK 133

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGAT- 260
            G+ HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I     
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191

Query: 261 --EYTTAIDIWSTGCVMAELLLGQPLFPG 287
             +Y    D+WS G  + EL  GQ  +  
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + +G++VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +EL+  +V+E++       A      H RM    +      + +AL+ +H   
Sbjct: 86  YLV---GDELW--VVMEFLEGG----ALTDIVTHTRMNEEQIAAVCLAVLKALSVLH-AQ 135

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEY 262
           G+ HRDIK  ++L+  H  ++KL DFG    + K  P   S + + Y+ APELI     Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 234

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
           ++K    HKV      P     + R     P  R TA E   HPF  +   P+  +P
Sbjct: 235 KLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 57/302 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 144 FFSTTDKEELYLNLVLEYV-----PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           + S    EEL++  ++E++      + V++   N  +I               + +AL Y
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQI---------ATVCESVLQALCY 132

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 257
           +H+  G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I 
Sbjct: 133 LHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI- 189

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
             T Y T +DIWS G ++ E++ G+P +  +S V  +  +        R+          
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS--------- 232

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
                   P P  K   K + P   D + R     P  R TA E   HPF  +   P   
Sbjct: 233 --------PPPKLKNAHK-ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECL 283

Query: 378 LP 379
           +P
Sbjct: 284 VP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 59/305 (19%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF   +    ++G++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICR 194
           +V L + F + T      L+L+L+Y+          ++ + QR       V++Y+ +I  
Sbjct: 67  LVTLHYAFQTDTK-----LHLILDYING-----GELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y A
Sbjct: 117 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 253 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 227

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 366
             P      +PQ             +   A D++ R     P  R       A E   HP
Sbjct: 228 EPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269

Query: 367 FFDEL 371
           FF ++
Sbjct: 270 FFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 52/293 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D+ E  L + +EY+P  +V    + Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 254
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-------NP 228

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                        P H     R      D +   F  + + R +A E   HPF
Sbjct: 229 -----------QLPSHISEHAR------DFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 43/237 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L  C F    +++ YL +V+EY+P  + VN ++ NY      +P  + K YT ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVL 153

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSY 244
           AL  IH+ +G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+   
Sbjct: 154 ALDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--- 208

Query: 245 ICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 80.6 bits (199), Expect = 7e-17
 Identities = 75/293 (25%), Positives = 137/293 (46%), Gaps = 55/293 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K + ++    + ++  +Q          +HP +V L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF     + E  L  V+E+V   + +  + R      +++P  + + Y+ +I  AL +
Sbjct: 62  HSCF-----QTESRLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 307
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 308 EIKC-------MNPNYTE-------FKFPQIKPHP------WHKVFQKR-LPP 339
            +K        +N +  E         F  IK HP      W  + QK+ LPP
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 48/239 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR----ELQIMQMLDHPNIVALK 141
           ++G G  G VF  + + TG++ A+K   K    KR K +    E +I+  LDHP +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             F + T     YL LV++Y P   + R+ +   +  + +     + Y  ++  AL Y+H
Sbjct: 68  ASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEPN 241
             +GI +RD+KP+N+L++   H + L DF                   GS +  V   P+
Sbjct: 121 -LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 242 VSYICS-----------RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
            ++                Y APE+I G   + +A+D W+ G ++ E+L G   F G +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 47/242 (19%)

Query: 90  VGTGSFGVVFQAKCRETG--EI-VAIK-----KVLQDKRYKNRELQIMQMLDHPNIVALK 141
           +G G+FG V +         E+ VA+K      +   K+   RE  +M  LDHP IV L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    E L   LV+E  P   + +    Y +  + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 201 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
           +     HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 252 ----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 304
               APE I     +++  D+WS G  + E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 305 TR 306
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG  +A  KV++ K  +       E++I+   +HP IV L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +  L +++E+ P   V+ I     R     P I  ++   Q+  AL Y+H+ +
Sbjct: 79  Y-----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QVICRQMLEALQYLHS-M 129

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT-- 260
            I HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   T  
Sbjct: 130 KIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 261 --EYTTAIDIWSTGCVMAELLLGQP 283
              Y    DIWS G  + E+   +P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 37/211 (17%)

Query: 89  VVGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
           V+G G FG V    +      TGE+VA+K + ++   +N      E+ I++ L H NIV 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            K C    +++    L L++EYVP       R+Y   H ++ L  + L+  QIC  +AY+
Sbjct: 71  YKGC---CSEQGGKGLQLIMEYVPLGS---LRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE----- 254
           H+   I HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E     
Sbjct: 124 HSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGDSP 173

Query: 255 LIFGATE------YTTAIDIWSTGCVMAELL 279
           + + A E      ++ A D+WS G  + ELL
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 21/219 (9%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ + D P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
           H  F T D+    L  V+EYV      +  +  ++ + + P      Y  +I   L ++H
Sbjct: 67  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEP--QAVFYAAEISVGLFFLH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 259
              GI +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I   
Sbjct: 119 R-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AY 175

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 91/315 (28%), Positives = 138/315 (43%), Gaps = 58/315 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
           V+G GSFG V  A+ +E+G + A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +C F T D+    L  V+E+V           SR   R      + Y  +I  AL ++H
Sbjct: 62  -YCCFQTPDR----LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH 113

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 259
           +  GI +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I   
Sbjct: 114 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQE 170

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y  ++D W+ G ++ E+L G   F  E+  D L E I        +E+          
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV---------- 213

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTAL--EACV--HPFFDELRD 373
                       V+   L  +AVD++  F   +P +R     L  E  +  HPFF EL  
Sbjct: 214 ------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL-- 259

Query: 374 PNTRLPNGRPLPPLF 388
            +    N R + P F
Sbjct: 260 -DWEKLNRRQIEPPF 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 37/245 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + + TG++ A KK L  KR K +        E +I++ ++ P IV L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 142 HCFFSTTDKEELYLNLV--------LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + F S T     +L LV        L+Y    V        R+      I+   Y+ QI 
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMERV------IH---YSAQIT 105

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             + ++H+ + I +RD+KP+N+L++      +L D G A  L  G+       +  Y AP
Sbjct: 106 CGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E I     Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  +
Sbjct: 164 E-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEH 219

Query: 314 PNYTE 318
            N+TE
Sbjct: 220 QNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 41/293 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHC 143
           ++G G+ G V++A    T  I+A+K +  D     ++    EL+I+   D P I+     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           FF      E  +++  E++             +++++P   +      + + L Y+ + +
Sbjct: 68  FFV-----ENRISICTEFMDG-------GSLDVYRKIPEHVLGRIAVAVVKGLTYLWS-L 114

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  +Y 
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
              D+WS G    EL LG+  +P        +  +++L     E+             P 
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219

Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
           +    + + F        V  + +  +  P  R        HPF  +  D N 
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 32/235 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--------PNIVAL 140
           V+G GS+  V   + ++  +I A+K V ++  + + ++  +Q   H        P +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF +T+      L LV+EYV   + +  + R      +++P  + + Y  +IC AL +
Sbjct: 62  HSCFQTTSR-----LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNF 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 306
           G  EY  ++D W+ G +M E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 170 GE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 43/232 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F     +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 110 YAF-----QDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLALDAI 158

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSYICSRY 249
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K          G P+        
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-------- 208

Query: 250 YRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 62/296 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKNRELQIM-QMLDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V        +D  +   E  +  Q  +HP +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF     + E  L  V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 62  HSCF-----QTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 111

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII----------- 298
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I           
Sbjct: 170 GE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 299 ---------KVLGTPTREEIKCMNPNYTEFKFPQIKPHP------WHKVFQKRLPP 339
                      L    +E + C      +  F  I+ HP      W  + QK++ P
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK + +D   ++ +++       ++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+        L +V E VN     Y  I Q  +    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-HIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+  GI +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              Y  ++D W+ G ++ E+L GQP F GE
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 54/289 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           V + + F  T DK    L+L+    L Y       ++++       M     + Y  +I 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQ----------------------PLFPGESGV 291
           E++     Y ++ D +S GC++ +LL G                          P     
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224

Query: 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
           +    +  +L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 9e-16
 Identities = 84/326 (25%), Positives = 134/326 (41%), Gaps = 71/326 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQI 192
            + +  T D   L L L+    L++              I+      +       Y  +I
Sbjct: 66  AYAY-ETKDALCLVLTLMNGGDLKF-------------HIYNMGNPGFDEERAVFYAAEI 111

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
              L  +H    I +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y A
Sbjct: 112 TCGLEDLHR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMA 169

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++     YT + D W  GC++ E++ G+  F          E +K      REE++  
Sbjct: 170 PEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERR 216

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--C---TALEACVHPF 367
                E              + ++    A  +  +     P  R  C    A E   HPF
Sbjct: 217 VKEDQE-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Query: 368 FDELRDPN-TRLPNGRPLPPLFNFKP 392
           F   R  N  RL  G   PP   F P
Sbjct: 264 F---RTANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +EL++  V+E++       A      H RM    +      + RAL+Y+HN  
Sbjct: 88  YLV---GDELWV--VMEFLEGG----ALTDIVTHTRMNEEQIATVCLSVLRALSYLHN-Q 137

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATEY 262
           G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 138 GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPY 195

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGE 288
            T +DIWS G ++ E++ G+P +  E
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
           +Y    VVG GS+G V   + R  G+   IKK+       ++++   +E Q++  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IVA +  +    + E+  L +V+ +  E  +   +   +  + +P   V  +  QI  AL
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPEL 255
            Y+H    I HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHE-KHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 256 IFGATEYTTAIDIWSTGCVMAEL 278
            F    Y    D+W+ GC + E+
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 91/348 (26%), Positives = 145/348 (41%), Gaps = 99/348 (28%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHP 135
           ++    +G G+FG V  A   +T  + A+K  L+ K   NR        E  I+   D+ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
            +V L   ++S  DK+ LY   V++Y+P  + ++ + R      +  P +  + Y  ++ 
Sbjct: 62  WVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELT 111

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG------ 238
            A+  +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG      
Sbjct: 112 LAIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 239 --EPN-------------------------------VSYICSRYYRAPELIFGATEYTTA 265
             EP+                                S + +  Y APE++     YT  
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQL 228

Query: 266 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 325
            D WS G ++ E+L+GQP F              +  TPT  ++K +N   T    PQ+K
Sbjct: 229 CDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK 274

Query: 326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDEL 371
                      L PEAVDL+ +    +     R  A +   HPFF E+
Sbjct: 275 -----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 49/285 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNI 137
           V+G G FG V  A+ ++TGE+ AIK  L+               + R  +      HP +
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L  CF     + E ++  V+EY    + +  I  +               Y   +   
Sbjct: 65  VNLFACF-----QTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLG 113

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L Y+H    I +RD+K  NLL++     +K+ DFG  K  +      S  C +  + APE
Sbjct: 114 LQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG---ESGVDQLV-EIIKVLGTPTREEIK 310
           ++   T YT A+D W  G ++ E+L+G+  FPG   E   D +V + ++     +RE I 
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS 230

Query: 311 CM------NPN----YTEFKFPQIKPHP------WHKVFQKRLPP 339
            M      NP       E     +K  P      W  +  +++ P
Sbjct: 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKP 275

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 87/308 (28%), Positives = 133/308 (43%), Gaps = 56/308 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
           V+G G+FG V   K + TG++ A+K   K    KR +      E  ++   D   I  L 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F     ++E  L LV++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKG--EPNVS-----YICSRYYRAP 253
            +G  HRDIKP N+L++ + H ++L DFGS  ++L  G  + NV+     YI     +A 
Sbjct: 121 -LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E   G   Y    D WS G  M E+L G+  F  ES V+   +I+               
Sbjct: 179 E--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--------------- 221

Query: 314 PNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFD 369
            N+ E F+FP              +  EA DL+ R    SP  R       +   HPFF+
Sbjct: 222 -NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFE 270

Query: 370 ELRDPNTR 377
            +   N R
Sbjct: 271 GIDWDNIR 278

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.2 bits (182), Expect = 7e-15
 Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             HPNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 302 GTPTREEIKCMNPNYTEF 319
           GTP  +  + ++  + +F
Sbjct: 231 GTPELQNPEKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 31/245 (12%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGE-IVAIKKVL-------QDKRYKNRELQ--------I 128
           + EH+ G+G+FG V++ + +  G+ ++A+K++        +DKR +++ +         I
Sbjct: 4   VLEHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVL-EYVP--ETVNRIARNYSRI-HQRMPLIY 184
            + L HPNIV     F    + + LY+ + L E  P  E  N +     R   +R+  I+
Sbjct: 63  KEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           V     Q+  AL Y+H    I HRD+ P N+++     ++ + DFG AK         S 
Sbjct: 120 V-----QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSV 173

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           + +  Y  PE++     Y    D+W+ GC++ ++   QP F   + +    +I++ +  P
Sbjct: 174 VGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232

Query: 305 TREEI 309
             E +
Sbjct: 233 LPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)

Query: 90  VGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALK 141
           +GTGSFG V  A  + E    VAIK+  + K  K +       E +I+  ++HP  V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F     K+E YL LVLE+V   +      + R ++R P      Y  QI     Y+ +
Sbjct: 98  GSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGAT 260
            + I +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++    
Sbjct: 150 -LNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG 204

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            +  A D W+ G  + E+L+G P F
Sbjct: 205 -HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 56/295 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALDYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   + +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +  
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLE 169

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 214

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                         F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 215 --------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 86/339 (25%), Positives = 136/339 (40%), Gaps = 97/339 (28%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG+I A+K +L+ + +K  +L        ++   D P +V+L 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + F     ++  YL L++E++P   +  +   Y    + +     + Y  +   A+  +H
Sbjct: 68  YSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNVSYICSR 248
             +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I +R
Sbjct: 119 K-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 249 Y------------------------------------YRAPELIFGATEYTTAIDIWSTG 272
                                                Y APE IF    Y    D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLG 235

Query: 273 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHK 331
            +M E L+G P F  E+  +   +II                N+ E   FP         
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-------- 271

Query: 332 VFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF 368
                L  EA DL+ R    + N   R  A E   HPFF
Sbjct: 272 --DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 86/317 (27%), Positives = 136/317 (42%), Gaps = 53/317 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + + +   K+ L L L L    +    I   Y              Y  +IC  L  +H
Sbjct: 66  AYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++    
Sbjct: 120 Q-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNE 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ +     E  
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE-- 222

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN 375
                       + ++  P+A  L        P  R       A E   HP F ++    
Sbjct: 223 -----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN--F 269

Query: 376 TRLPNGRPLPPLFNFKP 392
            RL  G   PP   FKP
Sbjct: 270 KRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G++G V++A+   TGE+ AIK +     +D     +E+ +M+   H NIVA    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
           S   +++L++   +E+      +   + +       + YV   T Q    L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 262 -YTTAIDIWSTGCVMAELL-LGQPLF 285
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 28/208 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCF 144
           +G+G+ G V++   R TG + A+K +  +     +R   RE++I++ ++HPN+V   H  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC-HDM 140

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F    +    + ++LE++    +  +   + I     L  V     QI   +AY+H    
Sbjct: 141 FDHNGE----IQVLLEFM----DGGSLEGTHIADEQFLADV---ARQILSGIAYLHR-RH 188

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI-----FG 258
           I HRDIKP NLL+N     +K+ DFG +++L +  +P  S + +  Y +PE I      G
Sbjct: 189 IVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFP 286
           A +   A DIWS G  + E  LG+  FP
Sbjct: 248 AYD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 62/319 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EY    E    ++R      +R      + Y  +I  AL Y+
Sbjct: 62  YAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR-------- 213

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 373
                         F + L PEA  L+    +  P  R       A E   H FF  +  
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259

Query: 374 PNTRLPNGRPLPPLFNFKP 392
            +  +   + LPP   FKP
Sbjct: 260 QD--VVQKKLLPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 72/258 (27%), Positives = 124/258 (48%), Gaps = 38/258 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQM 131
           G+ K+K  Y     +G G+ G VF A    TG+ VAIK++   K+ K      E+ +M+ 
Sbjct: 15  GDPKKK--YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
           L +PNIV     F      +EL++  V+EY+      + V     + ++I          
Sbjct: 73  LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H    + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR 172

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 302 GTPTREEIKCMNPNYTEF 319
           GTP  +  + ++P + +F
Sbjct: 231 GTPELQNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 31/212 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           V + + F  T DK    L+L+    L Y           +   H       ++ Y  +I 
Sbjct: 60  VCMTYAF-HTPDKLCFILDLMNGGDLHY-----------HLSQHGVFSEKEMRFYATEII 107

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           E++   T Y ++ D +S GC++ +LL G   F
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 27/243 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ETG ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 201
           +   +     L +++E+     V+ +     R     PL    +++   Q   AL Y+H 
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHE 121

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
              I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T
Sbjct: 122 N-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 261 E----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y    D+WS G  + E+   +P     + +  L++I K    PT  +    +  +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEF 238

Query: 317 TEF 319
            +F
Sbjct: 239 KDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 35/208 (16%)

Query: 89  VVGTGSFGVVFQA--KCRETGEI-VAIKKVLQDKRYKNREL-----QIMQMLDHPNIVAL 140
            +G G FG V+Q      E  +I VA+K          RE       IM+  DHP+IV L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYI 199
                      E  + +V+E  P       R+Y ++++  + L  + LY+YQ+  ALAY+
Sbjct: 73  IGVI------TENPVWIVMELAPLGE---LRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 200 H--NCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 251
                +   HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + 
Sbjct: 124 ESKRFV---HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWM 175

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE I     +T+A D+W  G  M E+L
Sbjct: 176 APESI-NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A K+ L+ KR K R        E QI++ ++   +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + + +   K+ L L L +    +    I   Y+  +          Y  +I   L  +H
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
                 +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++    
Sbjct: 120 R-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQ 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPG 287
            YT + D W  GC++ E++ GQ  F G
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 30/295 (10%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           GS G VF A  +       + K+ Q K     E  ++Q ++HP+++ +K    S      
Sbjct: 77  GSEGRVFVAT-KPGQPDPVVLKIGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVS----GA 130

Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
           +   ++  Y  +    + +    +     LI  K    QI   L Y+H    I HRD+K 
Sbjct: 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK----QILEGLRYLHA-QRIIHRDVKT 185

Query: 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 272
           +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +  DIWS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 273 CVMAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPNYT 317
            V+ E+L             P    +S    L++II  L       P     + +   + 
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302

Query: 318 EFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           E+   + +P+  +  FQ+  LP +   LV +   +   +R +A E   +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           VG+G++G V++A+   TGE+ A+K +      D     +E+ +++   H NIVA    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
           S   +E+L+  + +EY      +   + +     + + YV   T Q    LAY+H+  G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 261
            HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 262 -YTTAIDIWSTGCVMAELLLGQP 283
            Y    DIW+ G    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 81/344 (23%), Positives = 122/344 (35%), Gaps = 113/344 (32%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G+FG V   +  +T  + A+K  L+      R        E  I+   D+  +V L 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVKL- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAY 198
             ++S  DK+ LY   V++Y+P        +   +  R+        + Y  ++  A+  
Sbjct: 67  --YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 199 IHNCIGICHRDIKPQNLLVNPH----------------THQLKL---------------- 226
           +H  +G  HRDIKP N+L++                  TH  K                 
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 227 -------CDFGSAKVLVK------------GEPNVSYICSRYYRAPELIFGATEYTTAID 267
                  C     +   K            G PN        Y APE++   T YT   D
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLCD 226

Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
            WS G ++ E+L+GQP F  +              TP   ++K +N   T    P     
Sbjct: 227 WWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP----- 266

Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 368
                 Q +L  EA DL+ R        R     A E   HPFF
Sbjct: 267 -----SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.7 bits (169), Expect = 4e-13
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKE 151
           G FG V   K + T + + ++K+++ K +   E  + Q M D+PN + L +    TT K 
Sbjct: 27  GKFGKVSVLKHKPTQK-LFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSV--TTLKG 83

Query: 152 ELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            +   L+++Y+      + +        +   ++    VK    Q+  AL  +H    I 
Sbjct: 84  HV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNII 131

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 266
           H DIK +N+L +    ++ LCD+G  K  + G P+  Y  +  Y +PE I G   Y  + 
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSC-YDGTLDYFSPEKIKGHN-YDVSF 187

Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
           D W+ G +  ELL G+   P +   D   E +         +++ +              
Sbjct: 188 DWWAVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQQ--------- 224

Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFF 368
                 F K +   A D V    +Y+ N R T     + HPF 
Sbjct: 225 --KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 70.9 bits (173), Expect = 4e-13
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 41/244 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G G FG VF  K + T E    K +      +R K++   E+ +M+ L H NIV     
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI---YVKLYTYQICRALAYIH 200
           F +  +++   L +++E+       ++RN  + ++    I    +   T Q+  ALAY H
Sbjct: 81  FLNKANQK---LYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135

Query: 201 NCIG------ICHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKVLVKG 238
           N         + HRD+KPQN+ ++     +                K+ DFG +K +  G
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI--G 193

Query: 239 EPNVSYIC--SRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
             ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +   QL+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253

Query: 296 EIIK 299
             +K
Sbjct: 254 SELK 257

Length = 1021

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 86/327 (26%), Positives = 131/327 (40%), Gaps = 83/327 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA------LKH 142
           V+G G+FG V   + ++TG I A+K +L+      +E Q+  +    +I+       +  
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKE-QVAHIRAERDILVEADGAWVVK 65

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  IH
Sbjct: 66  MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIH 118

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------------------------ 230
             +G  HRDIKP NLL++   H +KL DFG                              
Sbjct: 119 Q-LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 231 ----SAKVLVKGEPNVSY--ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
                A+   K    ++Y  + +  Y APE +F  T Y    D WS G +M E+L+G P 
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 344
           F  E              TP     K MN   T   FP   P          +  +A DL
Sbjct: 236 FCSE--------------TPQETYRKVMNWKET-LVFPPEVP----------ISEKAKDL 270

Query: 345 VCRFFQYSPNL--RCTALEACVHPFFD 369
           + RF   S N        E   HPFF+
Sbjct: 271 ILRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 54/264 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++   +   E VA+K          KR   +E +I++  DHPNIV L    
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---I 58

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
                K+ +Y  +V+E VP    +  + +  +    R+ +  +   +      + Y+   
Sbjct: 59  GVCVQKQPIY--IVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK 112

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------AP 253
           NCI   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 254 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           E L +G   YT+  D+WS G ++ E   LG   +PG S               TRE I+ 
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------------TRERIE- 209

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQK 335
               Y     PQ+ P   +++  +
Sbjct: 210 --SGY-RMPAPQLCPEEIYRLMLQ 230

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 34/206 (16%)

Query: 105 ETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
            TG  VAIK +  D         R++ RE  +   L HPNIVAL      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216
            V EYVP    R  R        +P         Q+  ALA  HN  GI HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 217 VN-----PHTHQLKLCDFGSAKVLVK-GEPNVS-------YICSRYYRAPELIFGATEYT 263
           V+     PH    K+ DFG   +L    + +V+        + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGES 289
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+        L +V E VN     Y +I Q  R    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-QIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 258
           H+  GI +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 16/220 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 148
           V+G G+FG V   K + T  I A+K + + +  K  E    +  +  N++    C + TT
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWITT 65

Query: 149 ----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
                ++E YL LV++Y       +    S+   R+P    + Y  ++  A+  IH  + 
Sbjct: 66  LHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LH 122

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF----G 258
             HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     G
Sbjct: 123 YVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 48/234 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK + ++   K       E  +M  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 140 L-------KHCFFSTTDKEELYLNLVLEYVPETVNRIAR----NYSRIHQRMPLIYVKLY 188
           L       +    +    + + L  +L+YV    + I      N+               
Sbjct: 74  LLGICLSSQVQLIT----QLMPLGCLLDYVRNHKDNIGSQYLLNWCV------------- 116

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI + ++Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +
Sbjct: 117 --QIAKGMSYLEE-KRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 249 Y---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
               + A E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 173 VPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + +G+  A+K + ++      E+       ++++   HP + +LK
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EYV   E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDYL 111

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H+   I +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLE 168

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 39/229 (17%)

Query: 90  VGTGSFGVVFQAKCRE-TGEI--VAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALK 141
           +G GSFGVV + +     G++  VA+K +  DK         +E  IM  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR----MPLIYVKLYTYQICRALA 197
               +        L +V E  P     +     R+ +       +  +  Y  QI   + 
Sbjct: 63  GVVLTHP------LMMVTELAP-----LGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+     I   HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +    
Sbjct: 112 YLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFA 165

Query: 252 --APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
             APE +   T ++ A D+W  G  + E+   G+  + G SG   L +I
Sbjct: 166 WCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 59/251 (23%)

Query: 88  HVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
             +G G+FG V +A+            VA+K +  D   K+      E+++M+M+  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNR-IARNYSRIHQRMPLIYVKLY 188
           I+ L       T +  LY  +V+EY             R      S    R P   +   
Sbjct: 78  IINLLGV---CTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 189 -----TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                 YQ+ R + ++    CI   HRD+  +N+LV    H +K+ DFG A+       +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVT-EDHVMKIADFGLAR-------D 181

Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
           + +I   YYR            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 182 IHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI 238

Query: 289 SGVDQLVEIIK 299
             V++L +++K
Sbjct: 239 P-VEELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 85/343 (24%), Positives = 152/343 (44%), Gaps = 60/343 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQML------DHPNIVA 139
           ++G G+FG V +A  R+  E  A+K V    +Y      E+Q M+ +      D   ++ 
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 140 LKHCFFSTTDKEELYLNLVL-EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           ++  F      E  ++ +V+ +Y P  ++ I ++    H+ +  I      +Q   AL Y
Sbjct: 196 IQRYF----QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDY 246

Query: 199 IHNCIGICHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEPNVS 243
            H  + + H D+KP+N+L       V+P T++        +++CD G      +     +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304

Query: 244 YICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
            + +R+YR+PE++ G    Y+T  D+WS GC++ EL  G+ L+     ++ L  + K LG
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362

Query: 303 T-PTREEIKCMNPNYTEF--KFPQIKP--HPWH--KVFQKRLPPEAV------DLVCRFF 349
             P+    +C             Q++P   P H  ++ + R   E +      DL+    
Sbjct: 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422

Query: 350 QYSPNLRCTALEACVHP----FFDELRD-PNTRLPNGRP-LPP 386
            Y    R  A +   HP    ++ E R  PN   P+ R  L P
Sbjct: 423 HYDRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463

Length = 467

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)

Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           K      T+     + L++E++P    +  + RN ++I+ +  L     Y  QIC+ + Y
Sbjct: 72  KGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL----KYAVQICKGMDY 124

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 251
           + +   + HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +       ++ 
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +  +  Y  A D+WS G  + ELL
Sbjct: 180 APECLIQSKFYI-ASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.5 bits (157), Expect = 8e-12
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 30/221 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G+G FGVV   K R   + VAIK + +    +     E ++M  L HP +V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQL---YGV 67

Query: 147 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            T ++ LY+  V E++     +N + +   ++ + M L   +     +C  + Y+     
Sbjct: 68  CTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLERN-S 120

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELIFG 258
             HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +  PE +F 
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWSPPE-VFN 174

Query: 259 ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII 298
            ++Y++  D+WS G +M E+   G+  F  +S   ++VE+I
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 77/307 (25%), Positives = 122/307 (39%), Gaps = 49/307 (15%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           G+ G  F     +T E V IK     +     E  I++ ++HP+I+ LK  F        
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF-------- 152

Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
            Y       +P     +   Y    + + +  +      + RA+ Y+H    I HRDIK 
Sbjct: 153 TYNKFTCLILPRYKTDL-YCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKA 210

Query: 213 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY--------RAPELIFGATEYTT 264
           +N+ +N H   + L DFG+A   V    N      +YY         APEL+     Y  
Sbjct: 211 ENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGP 262

Query: 265 AIDIWSTGCVMAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTRE---------- 307
           A+DIWS G V+ E+         + G+D       Q+  II+  GT   E          
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           EI       +  K P  +P  W  +++  LP +   L+C+   +  + R +A        
Sbjct: 323 EIYIGLAKKSSRK-PGSRP-LWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378

Query: 368 FDELRDP 374
           F ++ DP
Sbjct: 379 FQDIPDP 385

Length = 391

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 23/225 (10%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEIVAIKKV-LQDKR---YKNRELQIMQM 131
           N+ ++  Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +  
Sbjct: 62  NNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA 121

Query: 132 LDHPNIVALKHCF-FSTTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPL--IYVKL 187
            DH  IV  KH   F + DK    L L++EY     +N+  +   R+ + +P     V L
Sbjct: 122 CDHFGIV--KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGL 173

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSY 244
             YQI  AL  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+
Sbjct: 174 LFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
             + YY APEL +    Y+   D+WS G ++ ELL     F G S
Sbjct: 232 CGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T      L +++EY+         +   + +  PL   ++ T   +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATE 261
             I HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E +I++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAY 198
            + + +   K+ L L L +    +    I    N     QR        Y  ++C  L  
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR-----AIFYAAELCCGLED 117

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +     I +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I  
Sbjct: 118 LQR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-N 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLF 285
             +YT + D W  GC++ E++ GQ  F
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 89  VVGTGSFGVVFQAKC----RETGEI-VAIKKVLQDKRYKNR-----ELQIMQML-DHPNI 137
            +G G+FG V +A      +    + VA+K +        R     EL+IM  L +H NI
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 138 VALKHCFFSTTDKEELYLNLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L     + T    + +  + EY    + +N + R          L+    ++YQ+ + 
Sbjct: 102 VNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS---FSYQVAKG 153

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           +A++   NCI   HRD+  +N+L+  H   +K+CDFG A+ ++     V    +R    +
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T      L +++EY+         +   + +  P    ++ T   +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 63/307 (20%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
           GTP     +  NP                    +RL     D + R  +   + R +A E
Sbjct: 231 GTP-----ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKE 265

Query: 362 ACVHPFF 368
              HPF 
Sbjct: 266 LLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K + + +  K         E  ++   D+  I  L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+  LYL  V++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF-- 257
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 121 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 258 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 62/322 (19%)

Query: 96  GVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHCFFSTTD 149
            +V  AK + T  +VA+KK+  D   K        E+   + L HPNI+     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 150 KEELYL-----------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             ELY+           +L+  + PE               +P + +      +  AL Y
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNVSYICSRYY 250
           IH+  G  HR +K  ++L++     + L     +  ++K         +   S + +  +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 251 RAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--- 306
            +PE++    + Y    DI+S G    EL  G   F        L+E  KV GT      
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232

Query: 307 -----EEIKCMNPNYTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
                     M+ + +  + P  +    HP+ + F           V    Q  P  R +
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFS----EHFHQFVELCLQRDPESRPS 288

Query: 359 ALEACVHPFFDELRDPNTRLPN 380
           A +   H FF + +  NT L +
Sbjct: 289 ASQLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 58/242 (23%)

Query: 90  VGTGSFGVVFQAKCRE-----TGEI-VAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
           +G+G+FG V++    +     +G I VA+K        Q+K+   +E  +M   +HPNIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 139 A-LKHCFFSTTDKEELYLNL-------VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
             L  C       E  Y+ +       +L Y+ +   R+ R    +     L+ + L   
Sbjct: 63  KLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVA 116

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYIC 246
           + C  L  +H      HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 117 KGCVYLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 247 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
           S YYR            APE L+ G   +TT  D+WS G +M E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 293 QL 294
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 79/305 (25%), Positives = 121/305 (39%), Gaps = 83/305 (27%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG + A+K      +L+ ++  +   E  I+   D   +V + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  I
Sbjct: 67  --FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSI 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--------------- 244
           H  +G  HRDIKP NLL++   H +KL DFG    L K      Y               
Sbjct: 118 HQ-LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 245 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
                                + +  Y APE +F  T Y    D WS G +M E+L+G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 284 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 343
            F  E              TP     K MN   T   FP   P          +  +A D
Sbjct: 235 PFCSE--------------TPQETYKKVMNWKET-LIFPPEVP----------ISEKAKD 269

Query: 344 LVCRF 348
           L+ RF
Sbjct: 270 LILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.6 bits (154), Expect = 3e-11
 Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 74  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 120

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 241
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 121 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 173

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN 231

Query: 302 GTPTREEIKCMNPNYTEF 319
           GTP  +  + ++  + +F
Sbjct: 232 GTPELQNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 26/207 (12%)

Query: 87  EHVVGTGSFGVVFQAKCRETG--EI-VAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G  EI VAIK +     +K+ ++   E  IM   DHPNI+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L+     T  K  +   +V EY+    N     + R H  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYME---NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 252
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
           +G G++G V++   ++ G + A+ K+L      + E++    I+Q L +HPN+V     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAV-KILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +         L LVLE     +V  + +      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 263 TTA----IDIWSTGCVMAELLLGQP 283
             +     D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 26/199 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEI-VAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           +G+G FGVV   K R  G+I VAIK + +    ++    E ++M  L HPN+V L   + 
Sbjct: 12  LGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YG 66

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIG 204
             T +  +++  V EY+    N    NY R  +        L     +C A+ Y+ +  G
Sbjct: 67  VCTKQRPIFI--VTEYM---ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-G 120

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-----APELIFGA 259
             HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F  
Sbjct: 121 FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDY 175

Query: 260 TEYTTAIDIWSTGCVMAEL 278
           + +++  D+WS G +M E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 84  YIAEHVVGTGSFGVVF---QAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDH 134
           YI +  +G GSFG V+     K      +  +K++        +    N+E Q++  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           P IV     F      E     ++ EY     ++          + +    V  +  Q+ 
Sbjct: 62  PAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 252
             + Y+H    I HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PE +     Y +  DIWS GC++ E+      F G++ +  ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           VVG G++G V++ +  +TG++ AIK   V +D+  +   E+ +++   H   +A  +  F
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 146 --STTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +    +  L LV+E+    +V  + +N       +   ++     +I R LA++H  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH-A 139

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 140 HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197

Query: 258 -GATEYTTAIDIWSTGCVMAELLLGQP 283
                Y    DIWS G    E+  G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 31/209 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V + + +  G+    VAIK +     DK+  +   E  IM   DHPNI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
            L+     +       + ++ EY+    N     + R +  +      V +    I   +
Sbjct: 69  RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYY 250
            Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+ 
Sbjct: 120 KYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL 279
            APE I    ++T+A D+WS G VM E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG V++     T E+VAIK + L++   +     +E+ ++   D P I      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 202
              T      L +++EY+         +   + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y    DIWS G    EL  G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
           +G G++G VF+   ++ G   A+K +L      + E++    I++ L DHPN+V     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +    K    L LVLE     +V  + + + +  +RM    +    ++    L ++H   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA--- 259
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I      
Sbjct: 145 TI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 260 -TEYTTAIDIWSTGCVMAELLLGQP 283
            + Y    D+WS G    EL  G P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFST 147
           G G FG V+      T + VA+K +           +E QIM+ L H  +V L   +   
Sbjct: 15  GAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70

Query: 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIH--NCI 203
           +++E +Y  +V EY+ + ++    ++      R+P L+ +     QI   +AY+   N I
Sbjct: 71  SEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQIAEGMAYLESRNYI 125

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI-FGA 259
              HRD+  +N+LV  +    K+ DFG A+++   E   +   +++   + APE   +G 
Sbjct: 126 ---HRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYG- 179

Query: 260 TEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
             +T   D+WS G ++ E++  G+  +PG
Sbjct: 180 -RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIGI 205
            T +  +Y  +V EY+    N    NY R H +       L     +C  +AY+ +   I
Sbjct: 68  CTKQRPIY--IVTEYMS---NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEY 262
            HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   +++
Sbjct: 123 -HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKF 178

Query: 263 TTAIDIWSTGCVMAEL 278
           ++  D+W+ G +M E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 17/160 (10%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK------HCFFS 146
           G+FG V+  + +   ++ A+K V++     N+ + + Q+    + +AL       H ++S
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNM-VHQVQAERDALALSKSPFIVHLYYS 72

Query: 147 TTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
                 +YL  V+EY +   V  +   Y    + M + Y+     ++  AL Y+H   GI
Sbjct: 73  LQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-GI 125

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
            HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 126 IHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + R TG++ A KK L  KR K R        E +I+  +    IV+L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + F + TD     L LV+  +     R    N    +   P      YT QI   L ++H
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGA 259
               I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ G 
Sbjct: 115 Q-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 260 TEYTTAIDIWSTGCVMAELL 279
            EY  ++D ++ G  + E++
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 26/228 (11%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLD 133
           Q   Y    V+G+G+ G V  AK    GE  A+K V        DK     E+  +   D
Sbjct: 30  QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 134 HPNIVALKHCFFSTTDKEE---LYLNLVLEYV------PETVNRIARNYSRIHQRMPLIY 184
             +IV     F     +     L + LVL+Y        E  +R   N +       L++
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPN 241
           +     Q+  A+ ++H+   I HRDIK  N+L+  +   +KL DFG +K+    V  +  
Sbjct: 150 I-----QVLLAVHHVHSKHMI-HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVG 202

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
            ++  + YY APE I+    Y+   D++S G ++ ELL  +  F GE+
Sbjct: 203 RTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.6 bits (141), Expect = 1e-09
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 146 STTDKEEL--YLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +   +   L LV+E+    +V  + +N       +   ++     +I R L+++H  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 130

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 131 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 187

Query: 258 -GATEYTTAIDIWSTGCVMAELLLGQP 283
                Y    D+WS G    E+  G P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VS +  E V+G G FG V + + +  G+    VAIK +      K R     E  IM   
Sbjct: 3   VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           DHPNI+ L+     T  +  + +   +E      N    ++ R +  +  +I +      
Sbjct: 63  DHPNIIHLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 248
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S    
Sbjct: 115 IAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               + APE I    ++T+A D+WS G VM E++
Sbjct: 173 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + V+G G FG VF+   +  G     VAIK +      K R     E  IM    H NI+
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
            L+               ++ EY+    N     Y R H  +      V +    I   +
Sbjct: 70  RLEGVVTKFKP-----AMIITEYME---NGALDKYLRDHDGEFSSYQLVGMLR-GIAAGM 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 251
            Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 121 KYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE I    ++T+A D+WS G VM E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 60/236 (25%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNI 137
            +G G+FG VF  +C         E+VA+ K L++      ++   RE +++    H NI
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRM--------PLIYVKLY 188
           V         T+ +     +V EY+    +N+  R++      +         L   +L 
Sbjct: 71  VKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 189 --TYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
               QI   + Y+   H      HRD+  +N LV  +   +K+ DFG ++ +        
Sbjct: 126 QIAVQIASGMVYLASQH----FVHRDLATRNCLVG-YDLVVKIGDFGMSRDV-------- 172

Query: 244 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 285
           Y    YYR             PE I     +TT  D+WS G V+ E+     QP +
Sbjct: 173 YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL- 140
             +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L 
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 141 -----KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
                +  F+  T+    Y NL L+Y+ E  NR         Q +  + +     QI  A
Sbjct: 69  GVCTREPPFYIITEFMT-YGNL-LDYLREC-NR---------QEVNAVVLLYMATQISSA 116

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRA 252
           + Y+     I HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + A
Sbjct: 117 MEYLEKKNFI-HRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTA 173

Query: 253 PELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           PE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 174 PESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 184 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 239

Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 301
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +  
Sbjct: 240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 291

Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
               +E  +   P+YT  +  Q     WH
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 89  VVGTGSFGVVFQAK----CRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIV 138
            +G G FG VF AK      E GE + + K LQ  + +N      REL + + L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYT--YQI 192
            L        + E  Y+  +LEY      +   R  ++     +  PL   +      QI
Sbjct: 72  RL---LGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
              + ++ N     HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSN-ARFVHRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 252 ----------APELIFGATEYTTAIDIWSTGCVMAEL 278
                     APE +    +++T  D+WS G +M E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 38/225 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V++     T   VA+K +            E QIM+ L HP ++ L   +  
Sbjct: 14  LGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAV 69

Query: 147 TTDKEELYL-------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            T +E +Y+         +LEY    +   A    ++ Q + +        Q+   +AY+
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEY----LQGGAGRALKLPQLIDM------AAQVASGMAYL 119

Query: 200 --HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 254
              N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + APE
Sbjct: 120 EAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPE 174

Query: 255 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
                  ++   D+WS G ++ E++  G+  +PG +   V Q V+
Sbjct: 175 AAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 26/197 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V     R  G+ VA+K +  D         E  +M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
                 LY  +V EY+    + +    SR    + L     +   +C  + Y+       
Sbjct: 71  --QGNPLY--IVTEYM-AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFV 124

Query: 207 HRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATE 261
           HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +    +
Sbjct: 125 HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175

Query: 262 YTTAIDIWSTGCVMAEL 278
           ++T  D+WS G ++ E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-- 243
           +TYQ+ R + ++   NC+   HRD+  +N+L+      +K+CDFG A+ ++     VS  
Sbjct: 242 FTYQVARGMEFLASKNCV---HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 244 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
                  + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 16/95 (16%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           Q+  A+ YIH   GI HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIH-GEGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 251 --------RAPELIFGATEYTTAIDIWSTGCVMAE 277
                    APE++ G   YT ++DIWS G V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 179 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 234

Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 235 SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 19/110 (17%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 238
           ++ Q+ + + ++   NCI   HRD+  +N+L+       K+CDFG A+        +VKG
Sbjct: 217 FSSQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
              +       + APE IF    YT   D+WS G ++ E+  LG+  +PG
Sbjct: 273 NARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 54/237 (22%), Positives = 104/237 (43%), Gaps = 49/237 (20%)

Query: 89  VVGTGSFGVV-----FQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 138
            +G G FG V     F+ K R     VA+K + ++      R    E  +++ ++HP+++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL----------- 187
            L   + + +    L L  ++EY         R++ R  +++   Y+             
Sbjct: 67  KL---YGACSQDGPLLL--IVEYAKYGS---LRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 188 -------------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
                        + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++ 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLV-AEGRKMKISDFGLSRD 176

Query: 235 LVKGEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           + + +  V     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 58/283 (20%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+         +    VA+K +  D   K+      E+++M+M+  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR--------IARNYSRIHQRMP---LIYV 185
           I+ L     + T    LY+  ++EY  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 186 KLY--TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
            L   TYQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVT-ENNVMKIADFG----LARDVNN 189

Query: 242 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
           + Y            + APE +F    YT   D+WS G +M E+  LG   +PG   V++
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEE 247

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
           L +++K  G    +   C N  Y   +        WH +   R
Sbjct: 248 LFKLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 67/311 (21%), Positives = 119/311 (38%), Gaps = 93/311 (29%)

Query: 90  VGTGSFGVVFQ--AKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
           +G GSFG+V++  AK    GE    VAIK V ++   + R     E  +M+  +  ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETV--NRIA----RNYSRIHQ--------RMPLIYV 185
           L              L +V    P  V    +A    ++Y R  +          P    
Sbjct: 74  L--------------LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 186 KLYTY--QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
           K      +I   +AY+       HRD+  +N +V      +K+ DFG  + + + +    
Sbjct: 120 KFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETD---- 173

Query: 244 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG 290
                YYR            APE +     +TT  D+WS G V+ E+  L +  + G S 
Sbjct: 174 -----YYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227

Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
            +++++ +         +   ++        P+  P    ++ +              +Q
Sbjct: 228 -EEVLKFVI--------DGGHLDL-------PENCPDKLLELMR------------MCWQ 259

Query: 351 YSPNLRCTALE 361
           Y+P +R T LE
Sbjct: 260 YNPKMRPTFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 68/243 (27%)

Query: 78  SKQKVSYIAEHVVGTGSFGVV-----FQAKCRETGEIVAIK--------KVLQDKRYKNR 124
               V ++ E  +G G+FG V          R +   VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIA 170
           E ++M  L HPNIV    C      KE+    L  EY+                 V   +
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCD 228
            + +         ++ +   QI   + Y+  H+     HRD+  +N LV      +K+ D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISD 167

Query: 229 FGSAKVLVKGEPNVSYICSRYYR------------APELI-FGATEYTTAIDIWSTGCVM 275
           FG ++ +   +         YYR             PE I +G  ++TT  DIWS G V+
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216

Query: 276 AEL 278
            E+
Sbjct: 217 WEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 19/110 (17%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 238
           ++YQ+ + ++++   NCI   HRD+  +N+L+  H    K+CDFG A+        +VKG
Sbjct: 219 FSYQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKG 274

Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
              +       + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYK-NREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK++ +    K N+E+     +M  +D+P++  
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 140 LKH-CFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L   C  ST     + +    +L+YV E  + I              Y+  +  QI + +
Sbjct: 74  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I     YT   D+WS G  + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 24/198 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G FG+V+     E  + VAIK +    + ++ +   E Q+M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIHNCI 203
             +      + LV E++    +    +Y R  QR       L      +C  +AY+ +  
Sbjct: 70  ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGAT 260
            I HRD+  +N LV      +K+ DFG  + ++  +   S   +++   + +PE +F  +
Sbjct: 121 VI-HRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFS 176

Query: 261 EYTTAIDIWSTGCVMAEL 278
           +Y++  D+WS G +M E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 178 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 233

Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 234 DARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 27/270 (10%)

Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR 171
           I K +   +   RE+ I++ + H  I+ L H +         + + V   +P+    +  
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLF- 173

Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
            Y      +PL        ++  ALAY+H   GI HRD+K +N+ ++   + + L DFG+
Sbjct: 174 TYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAV-LGDFGA 231

Query: 232 AKVLVKGEPNVSYICSRY-----YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF 285
           A  L       +  C  +       +PEL+     Y    DIWS G V+ E+ +    LF
Sbjct: 232 ACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 286 PGE--SGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPP 339
             +  S   QL  II+ +     E  +  + N    + ++      P+    V +K    
Sbjct: 289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMH 348

Query: 340 EAVD-LVCRFFQYSPNLRCTALEACVHPFF 368
             V+ L+ +   +    R +A +    P F
Sbjct: 349 MDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V+        + VAIK + Q          E  +M+ L HP +V L    ++
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL----YA 68

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH--NC 202
              +E +Y+  + EY+    N    ++ +  + + L   KL     QI   +A+I   N 
Sbjct: 69  VVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELI 256
           I   HRD++  N+LV+  T   K+ DFG A+++   E    Y           + APE I
Sbjct: 124 I---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEAI 175

Query: 257 -FGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 176 NYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 41/218 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNR---ELQIMQMLDHPNIVALKHC 143
           ++G G+FG VF+   ++    VA+K   +D  +  K +   E +I++  DHPNIV L   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 144 FFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
               T ++ +Y  +V+E VP     +  R  ++  +  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 200 H--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 251
              NCI   HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + 
Sbjct: 110 ESKNCI---HRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWT 161

Query: 252 APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           APE L +G   Y++  D+WS G ++ E   LG   +PG
Sbjct: 162 APEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 90  VGTGSFGVVFQA--KCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
           +G+G+FG V +   K R+    VAIK VL+++  K+      RE +IM  LD+P IV + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  + E L   LV+E        + +  S     + +  V    +Q+   + Y+  
Sbjct: 61  ---IGVCEAEALM--LVMEMASG--GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 202 CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-------YRAP 253
                HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + AP
Sbjct: 114 -KNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++++  D+WS G  M E  
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 23/151 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALKH 142
           +G G+FG V  A+  +T  + A+K + + D   +N+      E  I+   D+  +V L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-- 66

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYI 199
            ++S  DK+ LY   V++Y+P        +   +  RM   P    + Y  ++  A+  +
Sbjct: 67  -YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 118 HK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 79/317 (24%), Positives = 124/317 (39%), Gaps = 81/317 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 140 LKHCFFSTTDKEELYL---NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L     S T +    L     +L+YV E  + I               +  +  QI + +
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQ-----------LLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A 
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           E I    ++T   D+WS G  + EL+   G+P                  G PTRE    
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTREI--- 220

Query: 312 MNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
             P+  E   + PQ              PP     +C    Y   ++C  ++A   P F 
Sbjct: 221 --PDLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFK 259

Query: 370 EL--------RDPNTRL 378
           EL        RDP   L
Sbjct: 260 ELAAEFSRMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 50/236 (21%)

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKV-----LQDKRYKNRELQI 128
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K +        +    RE  +
Sbjct: 4   RNNIEYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 129 MQMLDHPNIVAL--------KHC----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRI 176
           M   DHPNIV L          C    + +  D  E   +          +  +      
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 177 HQRMPLIYVKLY--TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
              +PL   +      Q+   +AY+     + HRD+  +N LV  +   +K+ DFG ++ 
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSRN 179

Query: 235 LVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAEL 278
           +   +         YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 180 IYSAD---------YYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 44/191 (23%)

Query: 111 AIKKVLQDKRYKNRELQIMQMLDHPNIVAL-------KHCFFSTTDKEELYLNLVL-EYV 162
           A     +D     +E++I+  L  PNI  L                 E   LN  L ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPH 220
            ET        S+      L+Y+     QI   + Y+   N +   HRD+  +N LV   
Sbjct: 115 AETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK- 165

Query: 221 THQLKLCDFGSAKVLVKGEPNVSYICSRYY----RAP--------ELIFGATEYTTAIDI 268
            + +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+
Sbjct: 166 NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDV 215

Query: 269 WSTGCVMAELL 279
           W+ G  + E+L
Sbjct: 216 WAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 89  VVGTGSFGVVFQAKCR-ETGEI--VAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
           ++G G FG V + +   + G    VA+K +  D    +       E   M+  DHPN++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRA 195
           L    F  +  +++   +V L ++          YSR+    +++PL  +  +   I   
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAP 253
           + Y+ N   I HRD+  +N ++      + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSNRNFI-HRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 254 ELI-----FGATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +      + A E      YT+  D+W+ G  M E+   GQ  +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 49/243 (20%)

Query: 90  VGTGSFGVVFQA--KCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALK 141
           +G+G+FG V +   K +++ + VA+K +  D      K    RE  +MQ LD+P IV + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYI- 199
                  + E   L + L  +      + +N +        L+      +Q+   + Y+ 
Sbjct: 62  ---IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV------HQVSMGMKYLE 112

Query: 200 -HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------- 251
             N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+       
Sbjct: 113 ETNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKW 160

Query: 252 -----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVEIIKVLGT 303
                APE +    ++++  D+WS G +M E    GQ  + G  G  V Q++E  + +  
Sbjct: 161 PVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219

Query: 304 PTR 306
           P R
Sbjct: 220 PQR 222

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 44/218 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVALKHCFF 145
           +G+G FG V++   +     VAIK +  D   K +    E+Q ++ L H ++++L   F 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL---FA 69

Query: 146 STTDKEELYL--------NLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
             +  E +Y+        +L L ++  PE          ++     LI +     Q+   
Sbjct: 70  VCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQVAEG 116

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 250
           +AY+       HRD+  +N+LV       K+ DFG A+++   E    Y+ S       +
Sbjct: 117 MAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI--KED--VYLSSDKKIPYKW 170

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG 287
            APE       ++T  D+WS G ++ E+   GQ  +PG
Sbjct: 171 TAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 21/187 (11%)

Query: 160 EYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNL 215
           +Y+P    R  R+ + I++   L Y+ L  ++YQ+   + ++   NC+   HRD+  +N+
Sbjct: 215 QYLPSAPERTRRD-TLINESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNV 270

Query: 216 LVNPHTHQLKLCDFGSAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTG 272
           L+      +K+CDFG A+ +++    +S         + APE IF    YTT  D+WS G
Sbjct: 271 LIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFG 328

Query: 273 CVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK 331
            ++ E+  LG   +P     +Q    IK          +   P +   +  +I    W +
Sbjct: 329 ILLWEIFTLGGTPYPELPMNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEE 381

Query: 332 VFQKRLP 338
            F+ R  
Sbjct: 382 KFEIRPD 388

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 26/69 (37%), Positives = 38/69 (55%), Gaps = 9/69 (13%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY- 249
           QI  AL  +H+  GI HRD+KPQN++ +  +   K+ D G+A  L  G   ++YI   + 
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 250 ----YRAPE 254
               Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQI 192
           PN+V L     S     E  + LVL++         + +S I +   +P   VK +  ++
Sbjct: 45  PNMVCLHKYIVS-----EDSVFLVLQHAEG-----GKLWSHISKFLNIPEECVKRWAAEM 94

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 251
             AL  +H   GI  RD+ P N+L++   H ++L  F       + E +         Y 
Sbjct: 95  VVALDALHR-EGIVCRDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYC 149

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK 310
           APE + G +E T A D WS G ++ ELL G+ L     SG++                  
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------------- 191

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----H 365
                +T    P+             +  EA  L+ +  Q++P  R  A  A V     H
Sbjct: 192 -----HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234

Query: 366 PFF 368
           PFF
Sbjct: 235 PFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 90  VGTGSFGVVFQAKC--------RETGEIVAIKKVLQDKRYK-NRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C        +    + A+K+  +  R    RE +++ +L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY---------SRIHQRMPLIYVKLY-- 188
              F+    +    L +V EY+    +NR  R++                 L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI   + Y+ + +   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 249 YYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YYR             PE I    ++TT  DIWS G V+ E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 56/231 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNR---ELQIMQMLDHPNIVALKH 142
           +G G  G V+ A        VA+KK+ +D       K R   E +I   L HP IV +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67

Query: 143 CFFSTTDKEELYLNLVLEYVP-ETVNRIARNY-------SRIHQRMPL-----IYVKLYT 189
            +   +D + +Y  +   Y+   T+  + ++          + ++  +     I+ K   
Sbjct: 68  -YSICSDGDPVYYTM--PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV 242
             IC  + Y+H+  G+ HRD+KP N+L+      + L D+G+A         L+  + + 
Sbjct: 122 --ICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDE 177

Query: 243 SYICSRY------------YRAPELIFG--ATEYTTAIDIWSTGCVMAELL 279
             IC               Y APE + G  A+E T   DI++ G ++ ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 139
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 140 -LKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L  C  ST     + +    +L+YV E  +RI               +  +  QI + +
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQ-----------DLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
           +Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A 
Sbjct: 123 SYLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I     +T   D+WS G  + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 83/317 (26%), Positives = 131/317 (41%), Gaps = 75/317 (23%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+              VA+K +  D   K+      E+++M+M+  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR---IAR-----NYSRIHQRMP---LIYV 185
           I+ L     + T    LY+  ++EY  +   R    AR     +YS    ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 186 KLYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
            L +  YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVT-EDNVMKIADFG----LARDVHN 186

Query: 242 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
           + Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEE 244

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR----------------- 336
           L +++K       E  +   P     +   I    WH V  +R                 
Sbjct: 245 LFKLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297

Query: 337 LPPEAVDLVCRFFQYSP 353
              E +DL   F QYSP
Sbjct: 298 STDEYLDLSVPFEQYSP 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEI--VAIK--KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
           +G G FG V + +  +   I  VA+K  K+    R +      E   M+  DHPN++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 142 HCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALA 197
                T + E     +V L ++          YSR+    Q +P   +  +   I   + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           Y+ +   I HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + P + +
Sbjct: 127 YLSSKSFI-HRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP-VKW 180

Query: 258 GATE------YTTAIDIWSTGCVMAELLL-GQPLFPG 287
            A E      YTT  D+WS G  M E+   GQ  +PG
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 77/318 (24%), Positives = 134/318 (42%), Gaps = 76/318 (23%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQMLD-HPN 136
           +G G FG V +A+         +    VA+K +  +   K+      E+++M+++  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR------------IARNYSRIHQRMPLIY 184
           I+ L       T +  LY+  ++EY  +   R               + +++ +   L +
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133

Query: 185 VKLYT--YQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
             L +  YQ+ R + Y+ +  CI   HRD+  +N+LV    + +K+ DFG    L +G  
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVT-EDNVMKIADFG----LARGVH 185

Query: 241 NVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
           ++ Y            + APE +F    YT   D+WS G +M E+  LG   +PG     
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241

Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---------------- 336
            + E+ K+L    RE  +   P+    +   +    WH V  +R                
Sbjct: 242 -VEELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296

Query: 337 LPPEAVDLVCRFFQYSPN 354
           +  E +DL   F QYSP+
Sbjct: 297 VSEEYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 53/226 (23%)

Query: 89  VVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKRYKNRELQIMQML---------DHP 135
           ++  G+FG +F     +      E V +K V         E+Q+  +L          H 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68

Query: 136 NIVALKH-CFFSTTDKEELY-------LNLVLE---YVPETVNRIARNYSRIHQRMPLIY 184
           NI+ + H C         LY       L L L+          +       +H  M +  
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH--MAI-- 124

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
                 QI   ++Y+H   G+ H+DI  +N +++    Q+K+ D   ++ L   +    Y
Sbjct: 125 ------QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----Y 172

Query: 245 IC-----SRYYR--APELIFGATEYTTAIDIWSTGCVMAELL-LGQ 282
            C     +R  +  A E +    EY++A D+WS G ++ EL+ LGQ
Sbjct: 173 HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 40/226 (17%)

Query: 89  VVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
           ++G G FG V +A+ +    + + VA+K +  D    +      RE   M+  DHPN++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRA 195
           L      +  K  L + +V L ++           SRI +    +PL  +  +   I   
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 252 -APELIFG--ATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 287
            A +L     A E      YTT  D+W+ G  M E++  GQ  + G
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 37/218 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G  +  AIK++ +     D R    EL+++  L  HPNI+
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 139 -ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK----------- 186
             L  C      +   YL L +EY P          SR+ +  P   +            
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 187 --LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPN 241
              +   + R + Y+     I HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 181

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 61/249 (24%), Positives = 107/249 (42%), Gaps = 39/249 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEI---VAIKKV-----LQDKRYKNRELQIMQMLDHPNIVAL 140
           V+G G FG V+     ++       A+K +     L++     +E  IM+   HPN+++L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICRAL 196
                     E   L +VL Y+    +   RN+ R     P    LI   L   Q+ + +
Sbjct: 62  LGICL---PSEGSPL-VVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGL---QVAKGM 111

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL- 255
            Y+ +     HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L 
Sbjct: 112 EYLAS-KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLP 165

Query: 256 -IFGATE------YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 307
             + A E      +TT  D+WS G ++ EL+  G P +P     D  V +++  G    +
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQ 223

Query: 308 EIKCMNPNY 316
              C +P Y
Sbjct: 224 PEYCPDPLY 232

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 68/288 (23%)

Query: 90  VGTGSFGVVFQAKC-----RETGEI--VAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+       +   +  VA+K +  D   K+      E+++M+M+  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR----------IARNYSRIHQRMPLIYVK 186
           I+ L     + T    LY+  ++EY  +   R          +   Y+        +  K
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 187 LY---TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                 YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+       +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVT-EDNVMKIADFGLAR-------D 189

Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
           + +I   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 190 IHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
             V++L +++K  G    +   C N  Y   +        WH V  +R
Sbjct: 247 P-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+FG VF  + R     VA+K         L+ K  +  E +I++   HPNIV L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA---YI 199
                T K+ +Y  +V+E V     +     + +    P + VK     +  A A   Y+
Sbjct: 59  -IGVCTQKQPIY--IVMELV-----QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 200 HN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 254
            +  CI   HRD+  +N LV    + LK+ DFG ++    G    +    +    + APE
Sbjct: 111 ESKHCI---HRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166

Query: 255 -LIFGATEYTTAIDIWSTGCVMAE 277
            L +G   Y++  D+WS G ++ E
Sbjct: 167 ALNYG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 77/347 (22%), Positives = 131/347 (37%), Gaps = 85/347 (24%)

Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F    D E   +   + Y     + I  ++      + + Y+      + +AL YIH
Sbjct: 65  RATFI--ADNELWVVTSFMAY-GSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIH 118

Query: 201 NCIGICHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGEP 240
           + +G  HR +K  ++L++                  H  +L++  DF   S KVL    P
Sbjct: 119 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL----P 173

Query: 241 NVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
            +S         PE++    + Y    DI+S G    EL  G   F        L+E  K
Sbjct: 174 WLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--K 222

Query: 300 VLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKPHPWHKVF 333
           + GT                  P+R        E      P  +     +   HP+++ F
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRTF 279

Query: 334 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL-RDPNTRLP 379
                P     V +  Q +P+ R +A     H FF ++ R  +  LP
Sbjct: 280 S----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V+      T + VAIK +           +E QIM+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              +E +Y+  V E++ + ++    +     + ++P + V +   QI   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIER-MNY 123

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 261
            HRD++  N+LV  +    K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 262 YTTAIDIWSTGCVMAELLL-GQPLFPG 287
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 27/189 (14%)

Query: 109 IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 163
           +VA+K +  D  K  +N   +E++IM  L +PNI+ L      + D     L ++ EY+ 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL-GVCVSDDP----LCMITEYME 100

Query: 164 E------TVNRIARNYSRIHQRMPLIYVKLYTY---QICRALAYIHNCIGICHRDIKPQN 214
                     R   +       +P + +    Y   QI   + Y+ + +   HRD+  +N
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRN 159

Query: 215 LLVNPHTHQLKLCDFGSAKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWS 270
            LV  H + +K+ DFG ++ L  G+       + +  R+     ++ G  ++TTA D+W+
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWA 216

Query: 271 TGCVMAELL 279
            G  + E+ 
Sbjct: 217 FGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 175 RIHQRMP-----LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 229
           +I   MP     +  +K    Q+   L  +H  IGI HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 230 GSAKVLVKG---EPNVSYICSRYYRAPELI 256
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V+        + VA+K +            E QIM+ L H  +V L    ++
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL----YA 68

Query: 147 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              +E +Y+  V EY+ + ++    ++      ++P + V +   Q+   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAYIER-MNY 123

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 261
            HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 262 YTTAIDIWSTGCVMAELLL-GQPLFPG 287
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 51/225 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIMQML-DHPNIV 138
           E V+G G+FG V +A  ++ G ++ A  K+L++   +N       EL+++  L  HPNI+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 139 AL-KHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRM 180
            L   C      +   YL + +EY P              ET    A+ +   S +  + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
            L     +   +   + Y+     I HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LL----QFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 241 NVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 279
              Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.7 bits (95), Expect = 9e-04
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 29/121 (23%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           QI   + Y+ + +   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYLSS-LNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 251 R------------APELIFGATEYTTAIDIWSTGCVMAELLL---GQPLFPGESGVDQLV 295
           R            A E I    ++TTA D+W+ G  + E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 296 E 296
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 48/218 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRE----TGEIVA----------------------IKKVLQ 117
           +  + ++G G FG V++ +C        + VA                      I K+  
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
            K   N        +DH  I     C      +   Y  ++LE + E    I   + RI 
Sbjct: 74  WKNIHN--------IDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEI---FKRIK 121

Query: 178 QR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            +   LI  K     +   L YIH   GI H DIKP+N++V+ + ++  + D+G A   +
Sbjct: 122 CKNKKLI--KNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGN-NRGYIIDYGIASHFI 177

Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCV 274
               ++      Y +  + +   T Y   +D  +  CV
Sbjct: 178 IHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 49/232 (21%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
            +G G+FG V++   R          VA+K + +    ++      E  IM   +H NIV
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 139 ALKHCFFSTTDKEELYLNLVL-------EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
                   + ++   ++ L L        ++ E   R  R  S   +   L++      +
Sbjct: 73  ---RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--LLFCARDVAK 127

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRY 249
            C+ L   H      HRDI  +N L+         K+ DFG A+ + +         + Y
Sbjct: 128 GCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASY 174

Query: 250 YR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
           YR            P   F    +T+  D+WS G ++ E+  LG   +PG +
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 8/116 (6%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSR 248
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVL 301
              +PE++ G   Y    DIWS G ++ ++L       G+ G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 51/223 (22%)

Query: 89  VVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIM-QMLDHPNIV-A 139
           V+G G+FG V +A+ ++ G  + A  K +++   K+       EL+++ ++  HPNI+  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRMPL 182
           L  C      +   YL L +EY P              ET    A      S +  +  L
Sbjct: 62  LGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
            +       + R + Y+     I HRD+  +N+LV  +    K+ DFG    L +G+   
Sbjct: 116 HFAA----DVARGMDYLSQKQFI-HRDLAARNILVGENYVA-KIADFG----LSRGQE-- 163

Query: 243 SYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 279
            Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 164 VYVKKTMGRLP-VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 52/201 (25%)

Query: 109 IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVAL--------KHC----FFSTTDKE 151
           +VA+K + +D  K  +N   +E++IM  L  PNI+ L          C    +    D  
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK 211
           +       +   E  + +  +YS       LI++     QI   + Y+ + +   HRD+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYST------LIFMAT---QIASGMKYLSS-LNFVHRDLA 157

Query: 212 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA-------------PELIFG 258
            +N LV    + +K+ DFG ++ L  G+         YYR                ++ G
Sbjct: 158 TRNCLVG-KNYTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMSWESILLG 207

Query: 259 ATEYTTAIDIWSTGCVMAELL 279
             ++TTA D+W+ G  + E+L
Sbjct: 208 --KFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 31/207 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQI------MQMLDHPNIVA 139
           ++G+G FG V +      G+ + I    K +QD+  +    +I      M  LDH  IV 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 140 LKH-CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L   C  ++       L LV +  P    ++ + ++   +  +  L +      QI + +
Sbjct: 74  LLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 252
            Y+     + HR++  +N+L+   +  +++ DFG A +L   +    Y       ++   
Sbjct: 123 YYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
             ++FG   YT   D+WS G  + E++
Sbjct: 181 ESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 78/331 (23%), Positives = 138/331 (41%), Gaps = 85/331 (25%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLI 183
           +M+     ++V L         K +  L +V+E +     ++  R  R  +  +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 184 YVK---LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 241 NVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFP 286
                   YYR            APE +     +TT+ D+WS G V+ E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 346
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 347 RFFQYSPNLRCTALEAC------VHPFFDEL 371
             +Q++P +R T LE        +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 54/224 (24%)

Query: 90  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C     E  +I+   K L+D     ++  +RE +++  L H +IV  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK- 71

Query: 141 KHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVKL 187
               F     E   L +V EY+             P+ V     N      +  ++++  
Sbjct: 72  ----FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI-- 125

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
              QI   + Y+ +     HRD+  +N LV  +   +K+ DFG ++ +   +        
Sbjct: 126 -AQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTD-------- 174

Query: 248 RYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
            YYR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	394
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
smart00090	237	RIO RIO-like kinase.	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG1243	690	consensus Protein kinase [General function predict	99.42
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
PRK09902	216	hypothetical protein; Provisional	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.7
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.56
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.53
PF01636	239	APH: Phosphotransferase enzyme family This family	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.28
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.25
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.17
PLN02876	822	acyl-CoA dehydrogenase	98.03
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.98
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.97
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.9
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.85
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.8
KOG2270	520	consensus Serine/threonine protein kinase involved	97.76
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.64
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.58
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.54
PRK10593	297	hypothetical protein; Provisional	97.51
PRK05231	319	homoserine kinase; Provisional	97.49
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.49
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.41
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.37
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.19
PLN02236	344	choline kinase	97.18
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.13
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.02
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.97
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.95
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.89
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.88
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.75
PRK12396	409	5-methylribose kinase; Reviewed	96.75
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.69
COG2334	331	Putative homoserine kinase type II (protein kinase	96.53
PLN02756	418	S-methyl-5-thioribose kinase	96.36
PTZ00384	383	choline kinase; Provisional	96.11
PRK11768	325	serine/threonine protein kinase; Provisional	95.95
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.33
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	95.29
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.19
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	95.12
KOG2269	531	consensus Serine/threonine protein kinase [Signal	94.85
PRK06148	1013	hypothetical protein; Provisional	94.81

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-69  Score=473.08  Aligned_cols=326  Identities=75%  Similarity=1.238  Sum_probs=308.6

Q ss_pred             eeeecccCcCCCCcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEE
Q 016158           66 VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFF  145 (394)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  145 (394)
                      .................+|.-.+++|.|+||.||+|....+++.||||++..+.+...+|+++|+.+.|||||++..+|.
T Consensus         8 ~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~   87 (364)
T KOG0658|consen    8 VIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFS   87 (364)
T ss_pred             EEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEE
Confidence            34444555555556677899999999999999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEE
Q 016158          146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (394)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vk  225 (394)
                      ...+.+..+..+||||++.+|.+.++.+.....+++...++-+.+||++||.|||+ .||+||||||.|+|+|.+.+.+|
T Consensus        88 ~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LK  166 (364)
T KOG0658|consen   88 SSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLK  166 (364)
T ss_pred             ecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEE
Confidence            77766567889999999999999999888888999999999999999999999999 99999999999999999977999


Q ss_pred             EEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      |||||+|+....++++.++.+|..|+|||.+.+...|+.+.||||.||++.||+-|++.|.|.+..+++..|++.+|.|.
T Consensus       167 icDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  167 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             eccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP  385 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~  385 (394)
                      .+.+.++++++.+..+++....+|...+....++++.+|+.++|+.+|.+|.++.|+|.||||.++++++.++|++++.|
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp  326 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLP  326 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCC
Confidence            99999999999999999999999999888999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 016158          386 PLFNFKP  392 (394)
Q Consensus       386 ~~~~~~~  392 (394)
                      |+|+|++
T Consensus       327 ~lf~f~~  333 (364)
T KOG0658|consen  327 PLFNFKR  333 (364)
T ss_pred             CccCchH
Confidence            9999975

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-59  Score=420.58  Aligned_cols=286  Identities=35%  Similarity=0.650  Sum_probs=254.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|.++++||.|.||.||+|+.+.+|+.||||.+++.-     ....||+..|++|+ ||||+++.+++.+..    ..+
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L   85 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RIL   85 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceE
Confidence            46999999999999999999999999999999886543     33348999999998 999999999884322    268


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||||..+|+++++..   ...+++..++.|+.||++||+|+|+ +|+.||||||||||+.... .+||+|||+|+.+
T Consensus        86 ~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev  160 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLAREV  160 (538)
T ss_pred             eeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEeccccccccc
Confidence            999999999999999875   5899999999999999999999999 8999999999999999655 7999999999999


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc--C
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~  313 (394)
                      ....+...++.|..|+|||++.....|+.+.|+||+|||++|+.+-++.|+|.++.+++.+|.+++|.|....|...  -
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            88888889999999999999998888999999999999999999999999999999999999999999998777542  1


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      .+.-.+.+|...+.+...+++. .+.++.+||.+||.+||.+||||.++|+||||+.......+
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~~  303 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGSS  303 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccccc
Confidence            1223467788788888777766 99999999999999999999999999999999987665443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.2e-58  Score=393.10  Aligned_cols=279  Identities=37%  Similarity=0.682  Sum_probs=241.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh------hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .|+.+.++|+|+||.||+|+++.||+.||||++.....      ...+|+++|++|+|+|+|.++++|     .....++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence            58999999999999999999999999999999865432      234899999999999999999999     6666688


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|+|||+.++.+.+.   +....++...++.+++|++.|+.|+|+ ++++||||||+||||+.++ .+||||||+|+...
T Consensus        78 LVFE~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence            999999987655444   445789999999999999999999999 8999999999999999988 89999999999886


Q ss_pred             -cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc--cC
Q 016158          237 -KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC--MN  313 (394)
Q Consensus       237 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--~~  313 (394)
                       .++.-..++.|..|+|||.+.+...|+..+||||+||++.||++|.+.|++.++.+++..|+..+|...+.-..-  .+
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             455556778899999999999988899999999999999999999999999999999999999999888766653  34


Q ss_pred             CCCcccCCCCCCCC-CccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       314 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      +-+....+|..... +.+.-+ ..++..+.+|++.||..||.+|++.+++|.||+|.++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            55666777766533 333333 45677899999999999999999999999999997653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-56  Score=415.53  Aligned_cols=267  Identities=30%  Similarity=0.503  Sum_probs=231.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .+|...++||+|||+.||++++..+|+.||+|++.+.       .....+|+++.+.|+|||||+++++|     .+..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            4699999999999999999999999999999998652       34456899999999999999999999     56666


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|||.|+|.. +|.++++    ..+.++|.+++.+++||+.||.|||+ ++|+|||||..|+|++++. +|||+|||+|+
T Consensus        93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-cEEecccceee
Confidence            9999999994 6666655    34899999999999999999999999 8999999999999999988 69999999999


Q ss_pred             ccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ..... +...+.+|||.|.|||++.... .+..+||||+||++|.|++|++||...+-.+.+..|..             
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------  232 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------  232 (592)
T ss_pred             eecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence            88644 6778899999999999997544 89999999999999999999999998887777777765             


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  389 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  389 (394)
                          .++.+|            ..++.++++||.++|+.||.+|||++++|.|+||+.-.-+..-....-+..|.|-
T Consensus       233 ----~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~~  293 (592)
T KOG0575|consen  233 ----NEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRFG  293 (592)
T ss_pred             ----cCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcCC
Confidence                344443            5789999999999999999999999999999999766666655555555666664

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-57  Score=405.37  Aligned_cols=260  Identities=34%  Similarity=0.476  Sum_probs=213.7

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----------hhhHHHHHHHHHcCCCceeeeceEEEecC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  148 (394)
                      ....|.+.+.||+|+||.|-+|..+.||+.||||++.+..           ....+|+++|++|+|||||+++++|    
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence            3456999999999999999999999999999999986432           1235899999999999999999999    


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC--CCcEE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLK  225 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vk  225 (394)
                       ....+.||||||++| .|.+.+-    .++.+.+..-+.++.|++.|+.|||+ .||+||||||+|||+..+  ...+|
T Consensus       246 -~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  246 -EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             -ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence             444457899999996 3433322    24778888889999999999999999 899999999999999765  22699


Q ss_pred             EEeecCccccccCCCCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Q 016158          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKVLG  302 (394)
Q Consensus       226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~  302 (394)
                      |+|||+|+...+.....+.+|||.|.|||++.+.  ..+..++|+|||||+||-+++|.+||.+..... ...+|.+.- 
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~-  398 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR-  398 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc-
Confidence            9999999998877777789999999999999543  225568999999999999999999999876655 444444321 


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                      +        .+....+..+++++++||.+||..||++|||++|+|+||||+.....
T Consensus       399 ----------------y--------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~  446 (475)
T KOG0615|consen  399 ----------------Y--------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL  446 (475)
T ss_pred             ----------------c--------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence                            0        01111235789999999999999999999999999999999976533

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-55  Score=425.85  Aligned_cols=309  Identities=56%  Similarity=1.034  Sum_probs=271.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecC---CCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~lv  158 (394)
                      .+|++.+.||+|+||.||+|.+..+++.||||++........+|+.+++.++|+||+++++++....   .....++++|
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            4699999999999999999999999999999998776666778999999999999999988875432   2334567899


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      |||+++++..++..+......+++..++.++.||+.||+|||+ .||+||||||+|||++.++..+||+|||+|+.....
T Consensus       146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  224 (440)
T PTZ00036        146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG  224 (440)
T ss_pred             EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence            9999999888877766667889999999999999999999999 899999999999999977657999999999877655


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+.+.++.+..+.+..+++++..
T Consensus       225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~  304 (440)
T PTZ00036        225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD  304 (440)
T ss_pred             CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence            55556788999999999877666899999999999999999999999999989999999999999999888888888888


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC-CCCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG-RPLPPLFNFK  391 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~-~~~~~~~~~~  391 (394)
                      ..++......+...++...++++++||.+||++||.+|||+.|+|+||||++++++...++.. ...|++|++.
T Consensus       305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  378 (440)
T PTZ00036        305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFC  378 (440)
T ss_pred             ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCC
Confidence            888887777777788888999999999999999999999999999999999999887776653 4677777764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-56  Score=391.35  Aligned_cols=261  Identities=30%  Similarity=0.543  Sum_probs=218.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...+.++.||+|+.|+||+++|+.|++.+|+|++...     ...+.+|+++++..+|||||.++++|+....    .+.
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3577789999999999999999999999999998432     3445689999999999999999999965542    378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |+||||++ +|..++..    .+++++..+..++.+|++||.|||+.++||||||||+||||+..| .|||||||.++.+
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHh
Confidence            99999995 77666654    378999999999999999999999558999999999999999998 7999999999887


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE--SGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ... ...+..||..|||||.+.+.. |+.++||||||+.++|+++|+.||...  .....+..+..+...+++.      
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~------  301 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR------  301 (364)
T ss_pred             hhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC------
Confidence            665 556889999999999997765 999999999999999999999999874  1222333333332222221      


Q ss_pred             CCCcccCCCCCCCCCccccccc-cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL  378 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~  378 (394)
                                         ++. .+|+++++||..||++||.+|||+.||++|||+++...+.+.+
T Consensus       302 -------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~  348 (364)
T KOG0581|consen  302 -------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDM  348 (364)
T ss_pred             -------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccH
Confidence                               123 3899999999999999999999999999999999998877753

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6e-55  Score=378.35  Aligned_cols=288  Identities=34%  Similarity=0.560  Sum_probs=247.0

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh------hHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      +....|+.+..|++|+||.||+|+++.|++.||+|+++.+...      ..+|+.+|.+++|||||.+.+++....   -
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~  149 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---M  149 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---c
Confidence            3445799999999999999999999999999999998754421      248999999999999999999875432   2


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..+|||||||+.+|..++....   +++...+++.++.|++.||+|||. +.|+||||||+|+|++..| .+||+|||+|
T Consensus       150 d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaDFGLA  224 (419)
T KOG0663|consen  150 DKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIADFGLA  224 (419)
T ss_pred             ceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecccchh
Confidence            2378999999999988887644   789999999999999999999999 8999999999999999888 7999999999


Q ss_pred             cccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.+..... ....+.|..|+|||.+.+...|+++.|+||+|||+.||+++++.|++....+++..|++.+|.|....|..
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            98865533 34567799999999999999999999999999999999999999999999999999999999999988875


Q ss_pred             cC--CCCcccCCCCCCCCCcccccccc-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          312 MN--PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       312 ~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      +.  +.+..+.++......++..|... +++...+|+..+|.+||.+|.||+|.|+|+||.+...+
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence            54  23333455555555555555444 78999999999999999999999999999999995433

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.1e-55  Score=369.24  Aligned_cols=280  Identities=38%  Similarity=0.702  Sum_probs=239.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|...++||+|.||.||+|++..+|+.||||++....      ....+|++.|+.++|+||+.++++|     .....+.
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l~   77 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNLS   77 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCceE
Confidence            5889999999999999999999999999999986432      2235899999999999999999999     3333477


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|+||++.+|...++..   ...++...++.++.++++||+|||+ +.|+||||||.|+||+.+| .+||+|||+|+.+.
T Consensus        78 lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   78 LVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFFG  152 (318)
T ss_pred             EEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhccC
Confidence            99999999988777653   4678999999999999999999999 8999999999999999998 79999999999876


Q ss_pred             cCCCCcc-ccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC-
Q 016158          237 KGEPNVS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  314 (394)
Q Consensus       237 ~~~~~~~-~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  314 (394)
                      ....... .+.|..|+|||.+.|...|+...|+||.|||+.||+-|.+.|++.++.+++..|++.+|.|.++.|..+.. 
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            5444332 36799999999999999999999999999999999999999999999999999999999999999987653 


Q ss_pred             -CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          315 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                       ++..+.  .....+....| ...+.++.+|+.+||..||.+|+|+.|+|+|+||+...-++
T Consensus       233 pdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  233 PDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             ccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence             333332  23333333344 45688889999999999999999999999999999854443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-55  Score=385.32  Aligned_cols=267  Identities=33%  Similarity=0.507  Sum_probs=224.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ...|+++++||+|+||+||+++.+.+++.+|+|++++..       .....|..+|..++||.||+++..|     +...
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence            446999999999999999999999999999999986543       3445799999999999999998888     5666


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+|+|+||+.| .|...+.    ....+++..++.++..|+.||.|||+ +|||||||||+|||+|.+|| ++|+|||++
T Consensus        99 kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GH-i~LtDFgL~  172 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGH-IKLTDFGLC  172 (357)
T ss_pred             eEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCc-EEEeccccc
Confidence            69999999997 4443333    35889999999999999999999999 99999999999999999995 999999999


Q ss_pred             ccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.... +....+.+||+.|||||++.+.. |+.++|+||||+++|+|++|.+||.+.+....+..|...-..        
T Consensus       173 k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~--------  243 (357)
T KOG0598|consen  173 KEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP--------  243 (357)
T ss_pred             hhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC--------
Confidence            85543 34555679999999999998764 999999999999999999999999999888888777663100        


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELRDPNTRLPNGRPLPPL  387 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~  387 (394)
                                          ..+..++.++++||+++|++||++|.    .+.++-+||||+.++...+.  +. .+.|+
T Consensus       244 --------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~--~k-~l~Pp  300 (357)
T KOG0598|consen  244 --------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL--AK-KLSPP  300 (357)
T ss_pred             --------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH--hc-CCCCC
Confidence                                11234899999999999999999995    78899999999999766553  22 33356


Q ss_pred             CCC
Q 016158          388 FNF  390 (394)
Q Consensus       388 ~~~  390 (394)
                      |.+
T Consensus       301 F~P  303 (357)
T KOG0598|consen  301 FKP  303 (357)
T ss_pred             eec
Confidence            655

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-54  Score=393.81  Aligned_cols=281  Identities=35%  Similarity=0.583  Sum_probs=236.5

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      +....|+.+++||+|.||.||+|++..+|+.||+|+++.+.      ....+|+.+|++|.||||+++.+.+...   ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~  190 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LS  190 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CC
Confidence            34557999999999999999999999999999999986543      2335899999999999999999988554   23


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..+|||+|||+.+|..++..   ..-.|++.+++.++.||+.||+|+|. +||+|||||..|||||.+| .+||+|||+|
T Consensus       191 ~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDFGLA  265 (560)
T KOG0600|consen  191 GSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADFGLA  265 (560)
T ss_pred             ceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEeccccce
Confidence            45889999999988877765   23589999999999999999999999 8999999999999999988 7999999999


Q ss_pred             cccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          233 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       233 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      +.+....  .....+.|..|+|||.+.|...|+.+.|+||.||||.||++|+++|++.++.+++..|++..|.|....|.
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            9765443  34566779999999999999999999999999999999999999999999999999999999999998886


Q ss_pred             ccCCCCcccCCCCCC-CCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          311 CMNPNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ...--+....-+... .....+. -..+++.+.+|+..||..||.+|.||.++|+|+||
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            222111111111111 1112222 35689999999999999999999999999999999

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-54  Score=379.56  Aligned_cols=288  Identities=40%  Similarity=0.707  Sum_probs=251.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .|...+.||.|+||.|..|.++.+|+.||||++..      .....-+|+.+|++++|+||+.+.+++.........-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            36668999999999999999999999999998863      223445899999999999999999998664444455688


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|+|+|+.+|.++++.    ++.++...+..+++|+++||+|+|+ .+|+||||||.|+|++.+. .+||+|||+|+...
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeecc
Confidence            9999999888888776    3449999999999999999999999 8999999999999999987 69999999999875


Q ss_pred             c---CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 K---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .   ......++.|..|.|||.+.....|+.+.||||+|||+.||++|++.|.|.+..+++..|...+|.|..+.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   3334567789999999999888889999999999999999999999999999999999999999999998887654


Q ss_pred             CCC---cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          314 PNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       314 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      +..   --.+.+.....+|...|+ +.++.+.+|+.+||.+||.+|+|++|+|.||||..+.++.-.
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE  322 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE  322 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence            221   123567777888888886 899999999999999999999999999999999999888875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-53  Score=390.06  Aligned_cols=257  Identities=31%  Similarity=0.574  Sum_probs=224.0

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHc-CCCceeeeceEEEecCCC
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  150 (394)
                      +...+|..++.||+|+|++|++|+.+.+++.||||++.+.       ..+..+|-.+|.+| .||.|++++..|     +
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence            3445799999999999999999999999999999988543       34556799999999 899999999888     5


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      +...+|+|+||++ |.|..++..+    +.+++..++.++.+|+.||+|||+ +|||||||||+|||+|.|+ .++|+||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF  218 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF  218 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence            5555889999999 4676766654    789999999999999999999999 8999999999999999999 5999999


Q ss_pred             cCccccccCCC--------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016158          230 GSAKVLVKGEP--------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  295 (394)
Q Consensus       230 g~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  295 (394)
                      |.|+.+.....              ..+++||..|.+||++.. ...+..+|||+||||||.|+.|.+||.+.++...++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            99987743211              145789999999999954 458999999999999999999999999999999999


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      +|+.+                 ++.            |++++++.+++||+++|..||.+|+|+.+|.+||||.++...+
T Consensus       298 kI~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  298 KIQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            99884                 233            3367899999999999999999999999999999999998777


Q ss_pred             C
Q 016158          376 T  376 (394)
Q Consensus       376 ~  376 (394)
                      +
T Consensus       349 l  349 (604)
T KOG0592|consen  349 L  349 (604)
T ss_pred             h
Confidence            4

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-52  Score=358.52  Aligned_cols=253  Identities=29%  Similarity=0.482  Sum_probs=220.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||.|+||.|.+++++.+|..+|+|++.+..       ....+|..+|+.+.||+++++++.+     .+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence            346999999999999999999999999999999986543       2334699999999999999999888     6666


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      +++|||||++| .+..+++    ..+++++..++.++.||+.||+|||+ ++|++|||||||||+|.+|+ +||+|||+|
T Consensus       118 ~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~-iKitDFGFA  191 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGH-IKITDFGFA  191 (355)
T ss_pred             eEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCc-EEEEeccce
Confidence            79999999997 3433333    35789999999999999999999999 89999999999999999995 999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      +....  ...+.+|||.|+|||++.. ..++.++|.|||||++|||+.|.+||.+.+....+.+|...            
T Consensus       192 K~v~~--rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------  256 (355)
T KOG0616|consen  192 KRVSG--RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------  256 (355)
T ss_pred             EEecC--cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------------
Confidence            87643  3678899999999999965 45999999999999999999999999999998888888773            


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT  376 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~  376 (394)
                           .+.            ++..++.++++||+++|++|-.+|.     ...++.+||||+++....+
T Consensus       257 -----~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  257 -----KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             -----ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence                 233            3357899999999999999999994     5679999999999876655

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.3e-52  Score=381.55  Aligned_cols=271  Identities=32%  Similarity=0.514  Sum_probs=225.9

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..++|.++.+||+|+||.||+|+-+.||..+|+|++++..-       ....|..+|....+++||+++..|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            45679999999999999999999999999999999876532       234688899999999999999998     777


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .++|+||||++| ++..++..    ...+++..++.++.+++.|++.||+ .|+|||||||+|+|||..|| +||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GH-iKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGH-IKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCC-Eeeccccc
Confidence            789999999996 55555544    4789999999999999999999999 99999999999999999995 99999999


Q ss_pred             cccccc------------------------CC------------------------CCccccccccccccccccCCCCCC
Q 016158          232 AKVLVK------------------------GE------------------------PNVSYICSRYYRAPELIFGATEYT  263 (394)
Q Consensus       232 a~~~~~------------------------~~------------------------~~~~~~~t~~y~aPE~~~~~~~~~  263 (394)
                      +.....                        ..                        ...+.+|||.|+|||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            853311                        00                        002356899999999998766 99


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHH
Q 016158          264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD  343 (394)
Q Consensus       264 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (394)
                      ..+|+||||||+||||.|.+||.+.++.+...+|+..-.               .+.+|.          ...++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~----------~~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPE----------EVDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCC----------cCcccHHHHH
Confidence            999999999999999999999999999988888876321               111111          1357899999


Q ss_pred             HHHHhcccCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          344 LVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLPNGRPLPPLF  388 (394)
Q Consensus       344 li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  388 (394)
                      ||++||+ ||++|..   ++||..||||+.+...+++--.+..+|...
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~  468 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN  468 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence            9999999 9999994   899999999999999998755555554443

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.3e-52  Score=389.06  Aligned_cols=279  Identities=36%  Similarity=0.596  Sum_probs=231.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhH---HHHHHHHHcC-C-----CceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-H-----PNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|+|+++||+|+||.|.+|.+..|++.||||+++.......   .|+.+|..|+ |     -|+|+++++|     ....
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence            69999999999999999999999999999999988776654   4888898886 3     4899999999     5556


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC-CCcEEEEeecCc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a  232 (394)
                      +.|||+|.+.-+|+++++....  .+++...++.++.||+.||.+||+ .||||+||||||||+... ...|||+|||+|
T Consensus       262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            6999999999999999997554  679999999999999999999999 999999999999999643 337999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      +...  .....++.+..|+|||++.+.+ |+.+.||||||||++||++|.+.|++.+..+++..|++.+|.|+..++...
T Consensus       339 c~~~--q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFES--QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccC--CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            7643  3334788899999999998876 999999999999999999999999999999999999999999999887543


Q ss_pred             CCCCcccCC------------------------------CCC----CCCCccccccccCCHHHHHHHHHhcccCCCCCCC
Q 016158          313 NPNYTEFKF------------------------------PQI----KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  358 (394)
Q Consensus       313 ~~~~~~~~~------------------------------~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  358 (394)
                      ......+.-                              ...    ....+...........+.+||++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            221111100                              000    1111222222233456899999999999999999


Q ss_pred             HHHHhcCCCCCCCC
Q 016158          359 ALEACVHPFFDELR  372 (394)
Q Consensus       359 ~~ell~hp~f~~~~  372 (394)
                      +.++|+||||....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999999643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-52  Score=388.31  Aligned_cols=255  Identities=31%  Similarity=0.504  Sum_probs=226.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      -|.+++.||.|+-|.|-+|++..||+.+|||++.+.       ...+++|+.+|+.+.||||+.+++++     .+..++
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l   87 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL   87 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence            499999999999999999999999999999999766       45678999999999999999999999     555668


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      |+|.||+++ .|.++    ....+++++.++.++++||+.|+.|+|. .+|+||||||+|+|+|.+++ +||+|||+|..
T Consensus        88 ylvlEyv~gGELFdy----lv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~n-IKIADFGMAsL  161 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDY----LVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNN-IKIADFGMASL  161 (786)
T ss_pred             EEEEEecCCchhHHH----HHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccC-Eeeeccceeec
Confidence            999999996 33332    3335899999999999999999999999 89999999999999999885 99999999998


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...+.-..+.+|+|.|.|||++.+.++.+.++||||.|||||.|+||+.||.+.+-...+.++.+               
T Consensus       162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~---------------  226 (786)
T KOG0588|consen  162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR---------------  226 (786)
T ss_pred             ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc---------------
Confidence            87777778899999999999999999889999999999999999999999997776666666655               


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                        +.+.+|            ..+++++++||++||.+||++|.|.+||++|||+.........
T Consensus       227 --G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  227 --GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             --CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence              344444            4689999999999999999999999999999999998666553

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-51  Score=380.81  Aligned_cols=252  Identities=35%  Similarity=0.510  Sum_probs=216.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcC-CCceeeeceEEEecCC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTD  149 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  149 (394)
                      ..+.|.+.+.||+|+||+|++|.+..+|..||+|++.+.         .....+|+.+++.+. ||||+++++++.... 
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-   93 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-   93 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence            345699999999999999999999999999999977553         223457999999999 999999999984333 


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC-CCcEEEE
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLC  227 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~  227 (394)
                          .+++||||+.| .|.+.+..    .+++.+..++.++.|++.|++|+|+ +||+||||||+|||++.+ + ++||+
T Consensus        94 ----~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl~  163 (370)
T KOG0583|consen   94 ----KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKLS  163 (370)
T ss_pred             ----eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEEe
Confidence                38899999997 55554443    5889999999999999999999999 899999999999999998 6 79999


Q ss_pred             eecCcccc-ccCCCCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          228 DFGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       228 Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      |||++... .......+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+....+..+..      
T Consensus       164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------  237 (370)
T KOG0583|consen  164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------  237 (370)
T ss_pred             ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence            99999887 4566677889999999999998766 557899999999999999999999998777666666544      


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccC-CHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                 ..+.+|            ..+ |+++++||++||..||.+|+|+.++++||||+..
T Consensus       238 -----------~~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  238 -----------GEFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             -----------CCccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence                       223333            345 9999999999999999999999999999999983

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=366.77  Aligned_cols=255  Identities=31%  Similarity=0.528  Sum_probs=217.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|.+.+.||+|+||+||+|+++.++..||||.+.+..      .....|+.+|+.++|||||.+++++     ....+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence            446999999999999999999999999999999986542      3345799999999999999999998     44446


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC-C----CcEEEEe
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-T----HQLKLCD  228 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~----~~vkl~D  228 (394)
                      +|+|||||. |+|..++..    .+.+++..++.++.||+.||++||+ ++||||||||.|||++.. .    ..+||+|
T Consensus        84 i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999 577776665    4689999999999999999999999 899999999999999864 1    2599999


Q ss_pred             ecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ||+|+...++.-..+.+|+|.|||||++... .|+.|+|+||+|+|+|++++|+.||...+..+.+..+.+.-...    
T Consensus       159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~----  233 (429)
T KOG0595|consen  159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV----  233 (429)
T ss_pred             cchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc----
Confidence            9999999888777889999999999999644 59999999999999999999999999988888777554421110    


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                            ..++..++..+.+|+..+|+++|..|.+..+-+.|+++....
T Consensus       234 ----------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  234 ----------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ----------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                                  112245677788999999999999999999999999987653

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.2e-51  Score=359.32  Aligned_cols=292  Identities=35%  Similarity=0.696  Sum_probs=243.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh------hhHHHHHHHHHcCCCc-eeeeceEEEecCC-Ccee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPN-IVALKHCFFSTTD-KEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~-~~~~  153 (394)
                      ..|..+++||+|+||+||+|+.+.+|+.||+|+++-+..      ...+|+.+++.++|+| |+.+++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            347788889999999999999999999999999865433      2358999999999999 9999999865442 3334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|+||+.-+|...+.........++...++.+++||+.||+|||+ +||+||||||.||||+..| .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchHH
Confidence            688999999988888777755443578889999999999999999999 8999999999999999988 79999999998


Q ss_pred             ccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ... .........+|..|+|||++.+...|+...||||+|||++||++++..|++..+.+++..|.+.+|.|..+.|...
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            665 3333556778999999999999988999999999999999999999999999999999999999999999888654


Q ss_pred             C--CCCcccCCCCCC-CCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          313 N--PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       313 ~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      .  +++.. .++... ...+.... +..+++..+++.+||+.||.+|.||+.+|.||||+++......
T Consensus       249 ~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  249 SSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             cccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence            3  22222 333333 22333322 3455799999999999999999999999999999998766554

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-50  Score=358.18  Aligned_cols=275  Identities=27%  Similarity=0.461  Sum_probs=233.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .-..|++++.||.|.-|+||+|+.+.++..+|+|++.+..-       ..+.|.+||+.+.||.++.++..|     ...
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~  149 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD  149 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence            34468999999999999999999999999999999976432       223589999999999999999999     777


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .|.|++||||+| +|..+...  ..++.+++..++.++.+|+.||+|||- .|||+||||||||||.++|| |.|+||.+
T Consensus       150 ~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGH-IMLsDFDL  225 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGH-IMLSDFDL  225 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCc-EEeeeccc
Confidence            789999999996 66665554  345889999999999999999999999 99999999999999999995 99999998


Q ss_pred             cccccc---------------------------------C-C-----------------------CCccccccccccccc
Q 016158          232 AKVLVK---------------------------------G-E-----------------------PNVSYICSRYYRAPE  254 (394)
Q Consensus       232 a~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aPE  254 (394)
                      +.....                                 . .                       ...+.+||-.|.|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            743210                                 0 0                       012356789999999


Q ss_pred             cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcccccc
Q 016158          255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ  334 (394)
Q Consensus       255 ~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (394)
                      ++.+.. -+.++|+|+||+++|||+.|..||.+.+..+.+.+++.                 .+..+|..          
T Consensus       306 vI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~----------  357 (459)
T KOG0610|consen  306 VIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEE----------  357 (459)
T ss_pred             eeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCC----------
Confidence            998776 89999999999999999999999999999999888875                 23333331          


Q ss_pred             ccCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          335 KRLPPEAVDLVCRFFQYSPNLRCT----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (394)
Q Consensus       335 ~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (394)
                      ..++..++|||+++|.+||++|..    |.||.+||||+.+++.-++......+|.+....
T Consensus       358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG  418 (459)
T ss_pred             CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence            357889999999999999999998    999999999999999998888888888777664

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=365.66  Aligned_cols=265  Identities=29%  Similarity=0.457  Sum_probs=219.4

Q ss_pred             CcCCCCcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------------------hhhHHHHHHHHHcCC
Q 016158           73 GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDH  134 (394)
Q Consensus        73 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h  134 (394)
                      ......++.++|++.+.||+|.||.|-+|++..+++.||||++.+..                  ....+|+.+|+++.|
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            33444566779999999999999999999999999999999985422                  234579999999999


Q ss_pred             CceeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCC
Q 016158          135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (394)
Q Consensus       135 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~  213 (394)
                      +|||+++++.   ++.+...+|||+|||..+-..  .  ....+. +.+.+++.|+++++.||+|||. +|||||||||.
T Consensus       168 ~nVV~LiEvL---DDP~s~~~YlVley~s~G~v~--w--~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPs  239 (576)
T KOG0585|consen  168 PNVVKLIEVL---DDPESDKLYLVLEYCSKGEVK--W--CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPS  239 (576)
T ss_pred             cCeeEEEEee---cCcccCceEEEEEeccCCccc--c--CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchh
Confidence            9999999988   556667799999999843211  1  112244 8999999999999999999999 89999999999


Q ss_pred             cEEEeCCCCcEEEEeecCccccccC------CCCccccccccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCC
Q 016158          214 NLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPL  284 (394)
Q Consensus       214 Nil~~~~~~~vkl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~p  284 (394)
                      |+||+.+| +|||+|||.+.....+      .......|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.|
T Consensus       240 NLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P  318 (576)
T KOG0585|consen  240 NLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP  318 (576)
T ss_pred             heEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence            99999998 7999999998765222      22345789999999999976   23357799999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      |-+....+.+.+|+.                 ....+|..          +.+.+++++||.+||++||.+|+++.++..
T Consensus       319 F~~~~~~~l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  319 FFDDFELELFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             cccchHHHHHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            999998888888876                 23333331          347899999999999999999999999999


Q ss_pred             CCCCCCCCC
Q 016158          365 HPFFDELRD  373 (394)
Q Consensus       365 hp~f~~~~~  373 (394)
                      |||...-.+
T Consensus       372 Hpwvt~~g~  380 (576)
T KOG0585|consen  372 HPWVTRDGD  380 (576)
T ss_pred             cceeccCCC
Confidence            999987633

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-51  Score=383.89  Aligned_cols=267  Identities=28%  Similarity=0.477  Sum_probs=226.3

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCc
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...+|+++++||+|+||+|++|..+.+++.+|||+++++.       .....|..|+... +||.++.++.+|     +.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence            3457999999999999999999999999999999987643       3334577777777 599999999999     66


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..++|+||||+.|+.  +..  ......+++..++.|+..|+.||.|||+ +||||||||.+|||+|.+|+ +||+|||+
T Consensus       441 ~~~l~fvmey~~Ggd--m~~--~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh-~kiADFGl  514 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGD--LMH--HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGH-VKIADFGL  514 (694)
T ss_pred             CCeEEEEEEecCCCc--EEE--EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCc-EEeccccc
Confidence            667999999999754  221  2223789999999999999999999999 89999999999999999995 99999999


Q ss_pred             ccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++... .+....+.+|||.|||||++.+.. |+.++|+|||||+||||+.|..||.+.+..+.+..|+..          
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------  583 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------  583 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence            98765 556677889999999999997655 999999999999999999999999999999999888762          


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLP  385 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~  385 (394)
                             +..            ++..+|.++.++++++|++||++|..     +++|..||||+.+....   ...+.++
T Consensus       584 -------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~---L~~r~i~  641 (694)
T KOG0694|consen  584 -------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD---LLNRRIK  641 (694)
T ss_pred             -------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH---HhhccCC
Confidence                   222            33568999999999999999999995     57999999999997433   3345566


Q ss_pred             CCCCC
Q 016158          386 PLFNF  390 (394)
Q Consensus       386 ~~~~~  390 (394)
                      |+|.+
T Consensus       642 PPf~P  646 (694)
T KOG0694|consen  642 PPFVP  646 (694)
T ss_pred             CCCCc
Confidence            77766

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-49  Score=363.85  Aligned_cols=276  Identities=33%  Similarity=0.644  Sum_probs=226.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.+.||.|+||.||+|++..+++.||+|++....     ....+|+.+++.++|+||+++++++     ....+.+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            45999999999999999999999999999999885322     2345799999999999999999987     3334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~  154 (288)
T cd07871          80 LVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAKS  154 (288)
T ss_pred             EEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence            9999999887766543   23467899999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......+++.|+|||.+.+...++.++||||+||++|+|+||+.||.+.+..+.+..+.+..+.++.+.+......
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            322 2234567899999999876666899999999999999999999999999888889999999999888877654322


Q ss_pred             --CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                        +....++.....++... ...++.++++||++||++||.+|||++|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              22223333333333222 24678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=363.82  Aligned_cols=257  Identities=34%  Similarity=0.566  Sum_probs=209.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|...+.||+|+||+||++.+..+|..+|||.+...    ...+.+|+.+|+.++|||||++++......+   ..+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence            3588899999999999999999999999999988765    4556899999999999999999886422221   46789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC-CCCcEEEEeecCcccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVL  235 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~~~  235 (394)
                      +|||+++ ++.+++..+.   ..+++..++.+..||+.||+|||+ +|||||||||+|||++. ++ .+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence            9999995 7777766532   279999999999999999999999 89999999999999998 56 7999999999876


Q ss_pred             cc----CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VK----GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ..    ........||+.|||||++........++|||||||++.||+||..||... .....+..+...   .      
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C------
Confidence            53    223446789999999999974322345999999999999999999999873 333333322211   0      


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                               ..|         .++..+|+++++||.+||.+||++||||+++|+|||.+....
T Consensus       240 ---------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 ---------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ---------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                     011         244679999999999999999999999999999999988655

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-52  Score=355.27  Aligned_cols=247  Identities=28%  Similarity=0.484  Sum_probs=207.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEec------cchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ...|+|+++||+|+||.||++.+..+|+.||.|.+.      +.....-.|+.+|++|+|||||++++.-+   ..+...
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence            346999999999999999999999999999999874      23344557999999999999999987332   233344


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--C-CCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C-IGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~-~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ++||||||. |+|.++++.+....+.+++..+|+++.|++.||..+|.  . .-|+||||||.||+++.+| .|||+|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence            789999998 69999999999999999999999999999999999997  2 2389999999999999888 79999999


Q ss_pred             CccccccCCCC-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          231 SAKVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       231 ~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      +++.+...... .+.+|||+||+||.+.+.+ |+.++||||+||++|||+.-++||.+.+-.+.-.+|.++ ..++.   
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~---  248 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPL---  248 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCC---
Confidence            99987654433 4678999999999997665 999999999999999999999999998655555555543 11111   


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  359 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  359 (394)
                                  |           ...+|.++..||..|+..||+.||+.
T Consensus       249 ------------p-----------~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  249 ------------P-----------DEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ------------c-----------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence                        0           14578999999999999999999985

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-52  Score=346.80  Aligned_cols=254  Identities=32%  Similarity=0.461  Sum_probs=217.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .+.|.+.++||+|.|+.||++.+..+|+.+|+|++..      +...+++|+.+.+.|+||||+++.+.+     .+..+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence            3469999999999999999999999999999998743      345567899999999999999999887     67778


Q ss_pred             EEEEEeccccc--HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC--CCcEEEEeec
Q 016158          155 LNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFG  230 (394)
Q Consensus       155 ~~lv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vkl~Dfg  230 (394)
                      .++|+|++.|.  ..+++..     .-.++..+-.++.||+.||.|+|. +||||||+||+|+|+-..  +--+||+|||
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             eEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccc
Confidence            89999999973  2233332     457888999999999999999999 899999999999999543  3369999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      +|.....+.......|||.|||||++...+ |+..+|||+.||+||-|+.|++||.+.+....++.|++.-         
T Consensus       159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~---------  228 (355)
T KOG0033|consen  159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA---------  228 (355)
T ss_pred             eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc---------
Confidence            999888666777889999999999997655 9999999999999999999999999988888888887732         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                              +.++.   .     .++++++++++||++||..||.+|.|+.|+|+|||+++-
T Consensus       229 --------yd~~~---~-----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  229 --------YDYPS---P-----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             --------cCCCC---c-----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                    11111   1     126789999999999999999999999999999999863

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.5e-51  Score=373.76  Aligned_cols=250  Identities=31%  Similarity=0.494  Sum_probs=215.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..      ....+|+++++.++||||+.+++.|     .....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            35899999999999999999999999999999986543      2356899999999999999999999     555569


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|+||+.|+|..++..    .+.++++.++.++.+++.||.|||+ .+|.|||+||.|||++..+ .+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence            99999999988777765    4789999999999999999999999 8999999999999999888 6999999999987


Q ss_pred             ccCCCC-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..+... .+.-|||.|||||.+.+. .|+..+|+||||||+||+++|++||....-......|...--.           
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-----------  218 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-----------  218 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-----------
Confidence            654433 456789999999999755 5999999999999999999999999877665555555441111           


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                    |    +..++..+..||..+|.+||.+|.|..+++.|||+++..
T Consensus       219 --------------~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  219 --------------P----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             --------------C----cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence                          1    136789999999999999999999999999999998743

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=355.12  Aligned_cols=269  Identities=26%  Similarity=0.430  Sum_probs=221.5

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ....|++..+||.|..++||+|++..+++.||||++.-++     ..+.+|+..++.++||||++++.+|....     .
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----E   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----e
Confidence            3446999999999999999999999999999999986432     45678999999999999999999884433     3


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +++||.||. |++.++++.+..  ..+.+..+..++++++.||.|||. +|.||||||+.||||+.+| .|||+|||.+.
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLadFgvsa  174 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLADFGVSA  174 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEcCceeee
Confidence            899999998 589999988776  669999999999999999999999 8999999999999999999 79999999876


Q ss_pred             ccccCCCC-----ccccccccccccccc-cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          234 VLVKGEPN-----VSYICSRYYRAPELI-FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       234 ~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      .+......     ....||++|||||++ .....|+.|+||||||++..||.+|..||....+...+..-.  .+.|+..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~  252 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTL  252 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCc
Confidence            66443321     345789999999994 444459999999999999999999999999888776654433  3444422


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      .....+.                 .-...++..++.+|..||+.||.+||||+++|+|+||+..+...-
T Consensus       253 ~t~~~~~-----------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  253 LTSGLDK-----------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             ccccCCh-----------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence            2111100                 011346789999999999999999999999999999999876554

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-48  Score=366.94  Aligned_cols=288  Identities=37%  Similarity=0.669  Sum_probs=226.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.++||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            499999999999999999999999999999987532      22345799999999999999999988655444445678


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999887766543    3568999999999999999999999 8999999999999999888 79999999987543


Q ss_pred             cCCC----CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          237 KGEP----NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       237 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ....    .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.++......
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221    1235689999999998542 4589999999999999999999999999888888888888888877665543


Q ss_pred             cCCCCcc-c--CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          312 MNPNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       312 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ....... +  .+......+....+ ..+++++.+||.+||+.||++|||++++|+||||+++......
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~  302 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE  302 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc
Confidence            2211000 0  00001111111111 3468889999999999999999999999999999988765443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-48  Score=359.84  Aligned_cols=282  Identities=32%  Similarity=0.560  Sum_probs=217.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++||||+++++++.     .....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            356999999999999999999999999999999886432     23457999999999999999999883     33458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            89999999887666543   23568999999999999999999999 8999999999999999887 6999999998654


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+..+. +.+..+...++.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            322 22234567899999999876666899999999999999999999999876543 5566666666666554443221


Q ss_pred             C--CCcccCCCCCCCCCccccc-cccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          314 P--NYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       314 ~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      .  .+....+.......+.... ....+.++.+||.+||+.||++|||+.++|+||||+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            1  0000001111111111111 123567899999999999999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.1e-49  Score=358.49  Aligned_cols=271  Identities=23%  Similarity=0.376  Sum_probs=216.3

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      |.+.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+.+.+++     ....+.+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            889999999999999999999999999999875432       2245799999999999999998887     3334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++ +|...+...  ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++...
T Consensus        77 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQI  152 (285)
T ss_pred             EEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEc
Confidence            99999985 565444322  23468999999999999999999999 8999999999999999887 6999999999876


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...+....          
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  221 (285)
T cd05631         153 PEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ----------  221 (285)
T ss_pred             CCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc----------
Confidence            444444456789999999999654 489999999999999999999999987654333333322211100          


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (394)
                                     ..++..++.++.+||++||+.||.+||+     ++++++||||+++....   ......+|+|.+
T Consensus       222 ---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~---~~~~~~~~~~~~  283 (285)
T cd05631         222 ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR---LEANMLEPPFCP  283 (285)
T ss_pred             ---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH---HHhCcCCcCCCC
Confidence                           0122457899999999999999999997     89999999999985333   335567788888


Q ss_pred             CC
Q 016158          391 KP  392 (394)
Q Consensus       391 ~~  392 (394)
                      ||
T Consensus       284 ~~  285 (285)
T cd05631         284 DP  285 (285)
T ss_pred             CC
Confidence            76

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-50  Score=369.04  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=215.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..|....+||+|+.|.||.|+...+++.||||.+...    +..+.+|+.+|+..+|+|||.+++.|+...+     +++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEE
Confidence            3588889999999999999999999999999998643    3445689999999999999999999865533     889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||++| +|.+++..     ..+++..+..++++++.||+|||. +||+|||||.+|||++.+| .+||+|||++..+.
T Consensus       348 VMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeeeccc
Confidence            9999996 66666654     569999999999999999999999 8999999999999999998 69999999988775


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ...+.+|||+|||||++. ...|+.+.||||||++++||+-|.+||-..+....+..|... |.|...        
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk--------  490 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK--------  490 (550)
T ss_pred             cccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC--------
Confidence            554 456778999999999995 455999999999999999999999999887777777666543 333221        


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                       .+..+|+.+++||.+||+.|+.+|++|.|||+||||+..
T Consensus       491 -----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  491 -----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             -----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                             125789999999999999999999999999999999554

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.8e-48  Score=354.07  Aligned_cols=279  Identities=32%  Similarity=0.570  Sum_probs=219.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECC-CCcEEEEEEeccch------hhhHHHHHHHHHc---CCCceeeeceEEEecCCCce
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~  152 (394)
                      +|++.+.||+|+||.||+|++.. +++.||+|++....      ....+|+.+++.+   .||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            59999999999999999999854 46889999875321      2334677777665   69999999998854433444


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..+++||||+++++.+++....  ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5678999999988877765422  2568999999999999999999999 8999999999999999887 7999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .............+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+....+.+..+....+.+....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            766544444456789999999998654 4899999999999999999999999999888899999888777665544321


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      .. .....+......+... +...++..+.+||.+||+.||++|||+.++|+||||
T Consensus       237 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            10 0011111111111222 234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.2e-48  Score=352.51  Aligned_cols=275  Identities=40%  Similarity=0.713  Sum_probs=218.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||+|+++.+++.||+|++...      .....+|+.+++.++|+||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            599999999999999999999999999999988643      22345799999999999999999988     3344588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++...+..   ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            9999999876554432   23578999999999999999999999 8999999999999999887 79999999997654


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016158          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (394)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (394)
                      ...  ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+..+...+.... 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  222356789999999996554 8999999999999999999999999888777777777777776665543221 


Q ss_pred             -CCCcccCCCCCC-CCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          314 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       314 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                       +.+.....+... ...+.......++.++.+||++||++||++|||++++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             111111111111 1112222334578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.3e-48  Score=355.95  Aligned_cols=287  Identities=35%  Similarity=0.662  Sum_probs=230.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||+++++++..     ....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            45999999999999999999999999999999876332     234579999999999999999998833     33478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++.+.+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            9999999887665543   23568899999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+.+..+....+.+....+......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            322 2223456889999999876666899999999999999999999999998888888889888888888776544322


Q ss_pred             --CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 016158          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP  379 (394)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~  379 (394)
                        +....++.....++... ...++.++++||.+||+.||.+|||+.|+|+||||+.+.....+.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~  300 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINH-APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLP  300 (309)
T ss_pred             hhhhhhhcCccCCCchhhh-ccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCC
Confidence              11222333222222221 2457899999999999999999999999999999998854444433

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-47  Score=370.72  Aligned_cols=291  Identities=22%  Similarity=0.366  Sum_probs=217.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCC------ceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHP------NIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.++||+|+||+||+|.+..+++.||||++...   ......|+.+++.+.|.      +++.+++++..    +
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            35799999999999999999999999999999998642   22345688888877554      47777777632    2


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC---------
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---------  222 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---------  222 (394)
                      ..+.|+||+++++++.+++..    ...+++..++.++.||+.||+|||+..|||||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            345789999998887766543    3579999999999999999999997249999999999999986542         


Q ss_pred             ------cEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 016158          223 ------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  296 (394)
Q Consensus       223 ------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  296 (394)
                            .+||+|||.+...  ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  4999999987543  2233456789999999999765 489999999999999999999999999888888888


Q ss_pred             HHHHhCCCChhhhhccCCCC-ccc-C-----CCCCCCCCcccc------ccccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016158          297 IIKVLGTPTREEIKCMNPNY-TEF-K-----FPQIKPHPWHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (394)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~-~~~-~-----~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  363 (394)
                      +...++..+........... ..+ .     .+......+...      ......+.+.+||.+||++||.+|||++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            88888887765443211000 000 0     000000000000      0001246788999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCCCC
Q 016158          364 VHPFFDELRDPNTRLPNGR  382 (394)
Q Consensus       364 ~hp~f~~~~~~~~~~~~~~  382 (394)
                      +||||++....-..+|.-.
T Consensus       437 ~Hp~~~~~~~~~~~~~~~~  455 (467)
T PTZ00284        437 THPYVLKYYPECRQHPNYP  455 (467)
T ss_pred             cCccccccCCccccCCCCC
Confidence            9999998655443344433

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-47  Score=362.14  Aligned_cols=287  Identities=31%  Similarity=0.537  Sum_probs=226.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++|+||+++++++..... .....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            4699999999999999999999999999999988642      1234579999999999999999988743321 22345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+++++...+.      ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus       104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  175 (364)
T cd07875         104 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  175 (364)
T ss_pred             EEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCccc
Confidence            78999999988766553      357888999999999999999999 8999999999999999887 799999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+.+
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            6444444456789999999999654 489999999999999999999999999988888888888888877665443322


Q ss_pred             C----------CcccCCCCCC---CCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          315 N----------YTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       315 ~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      .          +..+.+....   ..++........+..+++||.+||+.||.+|||+.++|+||||....++...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~  330 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA  330 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccC
Confidence            1          1111110000   0011111222346789999999999999999999999999999988777654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-47  Score=362.53  Aligned_cols=286  Identities=31%  Similarity=0.548  Sum_probs=222.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4699999999999999999999999999999988542      2334579999999999999999998743322 12235


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+++++...+.      ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus       101 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~  172 (359)
T cd07876         101 VYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  172 (359)
T ss_pred             eEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCccc
Confidence            78999999987765543      458889999999999999999999 8999999999999999888 799999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (394)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+......... 
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            5444444456789999999999654 48999999999999999999999999988888888888887777665432211 


Q ss_pred             ---------CCCcccCCCCCCC---CCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          314 ---------PNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       314 ---------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                               +.+....+.....   .+.........++.+++||.+||+.||++|||+.|+|+||||+....+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~  326 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE  326 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence                     1111111000000   00001112345788999999999999999999999999999998665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.9e-47  Score=349.01  Aligned_cols=279  Identities=30%  Similarity=0.547  Sum_probs=220.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|++.+.||+|+||.||+|+++.+|+.||+|.+....      ....+|+++++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4999999999999999999999999999999876421      2334677777665   799999999988654444456


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ..+++|||+++++..++....  ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999988777665422  2458999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ............+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            66544444456778999999998654 48999999999999999999999999888888888888877766654443210


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                       ......+.......+.. ....++..+.+||.+||+.||++|||+.+++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 -TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             -cccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence             00001111111111211 224578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-47  Score=364.34  Aligned_cols=278  Identities=24%  Similarity=0.350  Sum_probs=212.8

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ...+|.+.+.||+|+||.||+|++..+++.||+|....  ....+|+++++.++||||+++++++.     ...+.++++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~  162 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLIL  162 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEE
Confidence            34569999999999999999999999999999997543  34568999999999999999999883     334578999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC-
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-  238 (394)
                      |++.+++...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...... 
T Consensus       163 e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        163 PRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDIN  236 (391)
T ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCccccccccc
Confidence            9999877665543    3568999999999999999999999 8999999999999999887 6999999998653222 


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCChhhhh
Q 016158          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~  310 (394)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....       ....+..+....+.++.+...
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             ccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence             222345789999999998654 48999999999999999999998775432       235566677766665533211


Q ss_pred             ccCCCCc---------ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          311 CMNPNYT---------EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       311 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      .......         ....+. ....|...  ..++.++.+||++||++||.+|||++|+|+||||+++..+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPG-SRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCC-CCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            0000000         000000 00111111  2367789999999999999999999999999999886443

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.4e-47  Score=349.54  Aligned_cols=288  Identities=32%  Similarity=0.616  Sum_probs=230.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..+|++.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||+++++++.     ...+.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            346999999999999999999999999999999875322     23457999999999999999999883     33457


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            89999999887666543   23568899999999999999999999 8999999999999999887 6999999998754


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..... .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+..+..
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            33222 22345688999999987666688999999999999999999999998888888888888888777766543321


Q ss_pred             C--CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 016158          315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP  379 (394)
Q Consensus       315 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~  379 (394)
                      .  +....++....... ......+++++++||.+||+.||.+|||++++|+||||+.+.+...++|
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~  300 (301)
T cd07873         235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP  300 (301)
T ss_pred             cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCC
Confidence            1  11122222111111 1223467899999999999999999999999999999999987766654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.8e-47  Score=357.94  Aligned_cols=284  Identities=32%  Similarity=0.561  Sum_probs=223.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++|+||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            4699999999999999999999999999999988642      1233468999999999999999998754332 22345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .+++|||+++++...+.      ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        97 ~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~~~  168 (355)
T cd07874          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_pred             eEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCccccc
Confidence            78999999987765543      358889999999999999999999 8999999999999999887 799999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+..+.+
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            6544444556789999999999654 489999999999999999999999999888888888888777776655443321


Q ss_pred             C----------CcccCCCCCCCC---CccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          315 N----------YTEFKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       315 ~----------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      .          +....++.....   +.........+.++++||.+||+.||++|||+.|+|+||||....++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            1          111111111000   11111223356789999999999999999999999999999877554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=354.31  Aligned_cols=257  Identities=32%  Similarity=0.544  Sum_probs=217.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcC-CCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..|++.+.||.|.||.||+|+.+.+|+.+|+|++.+..       ....+|+.+|+++. ||||+.+.+.|.     ...
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e-----~~~  109 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE-----DPD  109 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-----cCC
Confidence            35999999999999999999999999999999986543       35678999999998 999999999993     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC---CcEEEEee
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDF  229 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~---~~vkl~Df  229 (394)
                      .+++|||++.| .|.+.+...     .+++..+..++.|++.|++|||+ .||+||||||+|+|+....   ..+|++||
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            58899999995 444444332     39999999999999999999999 8999999999999996542   26999999


Q ss_pred             cCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      |++.....+......+||+.|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+.......+...-        
T Consensus       184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~--------  254 (382)
T KOG0032|consen  184 GLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD--------  254 (382)
T ss_pred             CCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC--------
Confidence            99998877666778899999999999954 459999999999999999999999999998877777665521        


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                               +   .....+|     ..++..+++||++||..||.+|+|+.++|+|||++......
T Consensus       255 ---------~---~f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  255 ---------F---DFTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             ---------C---CCCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence                     1   1112223     56899999999999999999999999999999998874443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-47  Score=361.54  Aligned_cols=283  Identities=35%  Similarity=0.574  Sum_probs=223.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+++++.++|+||+++++++...........++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            78899999999999999999999999999987532      123457999999999999999999885433222236789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||+.+++...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++....
T Consensus        82 v~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~  155 (372)
T cd07853          82 VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEP  155 (372)
T ss_pred             EeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeeccc
Confidence            999999877665532    4678999999999999999999999 8999999999999999887 799999999975433


Q ss_pred             CC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          238 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       238 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            22  1223456889999999977666899999999999999999999999999988999999998888877655322111


Q ss_pred             CcccCCCCCC-CCCcc--ccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          316 YTEFKFPQIK-PHPWH--KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       316 ~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      .......... .....  -.+....++++.+||.+||+.||.+|||+.++|+||||++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            0000000000 00000  012345688999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.5e-47  Score=353.57  Aligned_cols=252  Identities=29%  Similarity=0.426  Sum_probs=207.5

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     ..
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~   90 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DE   90 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cC
Confidence            3456999999999999999999999999999999986432       23457999999999999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~  164 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGF  164 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccC
Confidence            458899999985 56555443    4678999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+...           
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-----------  230 (329)
T PTZ00263        165 AKKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-----------  230 (329)
T ss_pred             ceEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence            9765332  23457899999999996544 799999999999999999999999877665555444321           


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  374 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~  374 (394)
                            ...            ++..++..+++||++||+.||.+|++     ++++++||||++....
T Consensus       231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                  001            12346889999999999999999997     7999999999985433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-47  Score=348.79  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=207.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++     .+..+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            599999999999999999999999999999988542       23355799999999999999998877     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            899999985 66665543    3678999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....             
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  214 (291)
T cd05612         151 LRD--RTWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------  214 (291)
T ss_pred             ccC--CcccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            533  22345689999999998654 48999999999999999999999998877665555554310             


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  374 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~  374 (394)
                          ..            ++..++..+++||++||+.||.+|++     ++++++||||+.+...
T Consensus       215 ----~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         215 ----LE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             ----cC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                00            12456889999999999999999995     9999999999986543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-48  Score=322.52  Aligned_cols=254  Identities=29%  Similarity=0.453  Sum_probs=218.3

Q ss_pred             CcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ....++|++++.||.|-||.||+|+.+.++-.||+|++.+..       ..+.+|+++-..|+||||++++++|     .
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----h   92 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----H   92 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----e
Confidence            344567999999999999999999999999999999986543       4456899999999999999999999     4


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      +...+|+++||.+ |.+...+..  ....++++...+.++.|++.||.|+|. ++|+||||||+|+|++.++ .+||+||
T Consensus        93 d~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdf  168 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADF  168 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCC
Confidence            4445899999998 455555543  234779999999999999999999999 8999999999999999998 6999999


Q ss_pred             cCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      |-+-... .....+.+||..|.+||...+. ..+...|+|++|++.||++.|.+||......+.+..|.+.         
T Consensus       169 GwsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---------  237 (281)
T KOG0580|consen  169 GWSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---------  237 (281)
T ss_pred             CceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------
Confidence            9886544 4455678899999999999655 4899999999999999999999999998877888888763         


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                              ++.            ++..++.+++|||.+||.++|.+|.+..|++.|||....
T Consensus       238 --------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 --------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             --------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                    222            235789999999999999999999999999999999765

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=338.41  Aligned_cols=307  Identities=26%  Similarity=0.426  Sum_probs=252.2

Q ss_pred             CCCCCcCceeeecccCcCCCCcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhH---HHHHHHHHcC-
Q 016158           58 GVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-  133 (394)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-  133 (394)
                      ...+..|...+..+|+.+..    .+|.+.++||.|.|++||+|.+....+.||+|+++....+.+   .|+++|++++ 
T Consensus        58 ~~dY~kGGYHpV~IGD~F~~----gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~  133 (590)
T KOG1290|consen   58 PEDYRKGGYHPVRIGDVFNG----GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE  133 (590)
T ss_pred             hhhhhcCCCceeeccccccC----ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence            34566777888888877654    359999999999999999999999999999999987765554   6999999882 


Q ss_pred             -------CCceeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCce
Q 016158          134 -------HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC  206 (394)
Q Consensus       134 -------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~giv  206 (394)
                             ..+||++++.|-. .+.++.++|||+|+++.+|..++....  .+.++...++.|++||+.||.|||+..|||
T Consensus       134 ~Dp~~~~~~~VV~LlD~Fkh-sGpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgII  210 (590)
T KOG1290|consen  134 GDPNDPGKKCVVQLLDHFKH-SGPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGII  210 (590)
T ss_pred             cCCCCCCCceeeeeecccee-cCCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCcc
Confidence                   2479999998743 447888999999999999988887655  488999999999999999999999988999


Q ss_pred             eecCCCCcEEEe--------------------------------------------------------------------
Q 016158          207 HRDIKPQNLLVN--------------------------------------------------------------------  218 (394)
Q Consensus       207 H~Dlkp~Nil~~--------------------------------------------------------------------  218 (394)
                      |.||||+|||+.                                                                    
T Consensus       211 HTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~  290 (590)
T KOG1290|consen  211 HTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAG  290 (590)
T ss_pred             ccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcc
Confidence            999999999982                                                                    


Q ss_pred             ----------------------------------------------CC---------------------------C----
Q 016158          219 ----------------------------------------------PH---------------------------T----  221 (394)
Q Consensus       219 ----------------------------------------------~~---------------------------~----  221 (394)
                                                                    ..                           .    
T Consensus       291 ~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s  370 (590)
T KOG1290|consen  291 LEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSS  370 (590)
T ss_pred             cccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCC
Confidence                                                          00                           0    


Q ss_pred             --------------------CcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC
Q 016158          222 --------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  281 (394)
Q Consensus       222 --------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg  281 (394)
                                          -.|||+|||-|+...  ........|..|+|||++.+.. |+..+||||++|++|||+||
T Consensus       371 ~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTG  447 (590)
T KOG1290|consen  371 PGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATG  447 (590)
T ss_pred             ccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcC
Confidence                                036788888876642  3344556789999999998876 99999999999999999999


Q ss_pred             CCCCCCC------CcHHHHHHHHHHhCCCChhhhh-------ccCCCCcccCCCCCCCCCcccccccc------CCHHHH
Q 016158          282 QPLFPGE------SGVDQLVEIIKVLGTPTREEIK-------CMNPNYTEFKFPQIKPHPWHKVFQKR------LPPEAV  342 (394)
Q Consensus       282 ~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  342 (394)
                      ...|...      .+.++++.|+..+|..|.....       .++.......+..+++.++.+++.+.      ...++.
T Consensus       448 DyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fs  527 (590)
T KOG1290|consen  448 DYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFS  527 (590)
T ss_pred             ceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHH
Confidence            9999643      4678999999999999987764       44555556677777887776665433      245688


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          343 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       343 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      +||.-||+++|++||||.+.|+|||+..+-.+
T Consensus       528 dFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  528 DFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            99999999999999999999999999987665

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=344.17  Aligned_cols=272  Identities=24%  Similarity=0.374  Sum_probs=215.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|++.++||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++|+||+++++++     ....+.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            3899999999999999999999999999999886432       2234699999999999999998887     333458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+.+ +|...+...  ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            899999985 565544321  23568999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.........+...+....         
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------  221 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence            6444433445788999999998654 489999999999999999999999987665444333333211100         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPLFN  389 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  389 (394)
                                      ..++..++..+.+||.+||..||.+||     +++++++||||++......   +....+|+|.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~---~~~~~~~~~~  282 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL---EAGMLEPPFC  282 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH---hhCCCCCCCC
Confidence                            001245788999999999999999999     9999999999998644433   2344558888


Q ss_pred             CCC
Q 016158          390 FKP  392 (394)
Q Consensus       390 ~~~  392 (394)
                      ++|
T Consensus       283 ~~~  285 (285)
T cd05605         283 PDP  285 (285)
T ss_pred             CCC
Confidence            776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-48  Score=330.29  Aligned_cols=253  Identities=28%  Similarity=0.484  Sum_probs=215.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------------hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      .|.-.+.||.|..++|.++.++.+|+.+|+|++...            .....+|+.+|+++ .||+|+++.+.|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            377788999999999999999999999999987421            12234699999998 899999999998     


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      ....++++|+|.|+ |.|.+.+..    ...++++..+.+++|++.|++|||. ++||||||||+|||++++. ++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEec
Confidence            66667889999998 455554443    4779999999999999999999999 8999999999999999877 699999


Q ss_pred             ecCccccccCCCCccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016158          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  303 (394)
Q Consensus       229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  303 (394)
                      ||+|+.+..++.....+|||+|.|||.+..     .+.|+...|+|++|||+|.|+.|.+||.-..+..++..|++..  
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk--  244 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK--  244 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc--
Confidence            999999999998899999999999999843     4458889999999999999999999998777777777776632  


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                     +.+.   ...|     .+++.+.++||.+||++||.+|.|++|+|.||||..+
T Consensus       245 ---------------yqF~---speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  245 ---------------YQFR---SPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             ---------------cccC---Ccch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence                           1111   1112     5689999999999999999999999999999999554

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.4e-47  Score=354.32  Aligned_cols=285  Identities=34%  Similarity=0.615  Sum_probs=226.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      ++|++.+.||.|+||.||+|.+..+++.||||++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            35999999999999999999999999999999886432      234479999999999999999988743221 22244


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .+++++++++++..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        95 ~~~~~~~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            689999998888766543     679999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.......
T Consensus       168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            533  233457899999999987656689999999999999999999999998888888888888777776655443222


Q ss_pred             CCccc---CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      .....   .++......+...+ ...++.+.+||.+||+.||.+|||+.++|+||||.....+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~  309 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED  309 (343)
T ss_pred             hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence            11100   11111111111112 346788999999999999999999999999999998876654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-46  Score=353.60  Aligned_cols=277  Identities=23%  Similarity=0.336  Sum_probs=206.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      ..|++.+.||+|+||.||+|++..+++.||+|+....  ....|+.+++.++|+||+++++++..     ..+.++|||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence            3699999999999999999999999999999975433  33569999999999999999998843     3457899999


Q ss_pred             ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      +.+++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.........
T Consensus       139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            99888776653   24678999999999999999999999 8999999999999999887 6999999999754443344


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCc---------HHHHHHHHHHhCCCChhhhhc
Q 016158          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP-LFPGESG---------VDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~-pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ....||+.|+|||++.+. .++.++|||||||++|+|+++.. +|.....         ...+..+...++..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            456789999999999654 48999999999999999998654 4443211         123344444444433221100


Q ss_pred             cCCCCc--ccCCCCCCC---CCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          312 MNPNYT--EFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       312 ~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ......  .........   ..+.......++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            000000  000000000   011111123568889999999999999999999999999999874

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.6e-47  Score=352.72  Aligned_cols=244  Identities=27%  Similarity=0.457  Sum_probs=199.5

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++     ....+.++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986432       2234689999999999999998887     33445889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-C
Q 016158          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  238 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-~  238 (394)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9986 55444432    4678999999999999999999999 8999999999999999887 699999999875422 2


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            233345789999999999654 4899999999999999999999999876654444433221                 0


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                      ..            ++..+++++.+||++||+.||++||     ++.++++||||+.+.
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            11            2246789999999999999999999     899999999998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=346.89  Aligned_cols=245  Identities=31%  Similarity=0.471  Sum_probs=201.9

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcE-EEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEI-VAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..+...||.|+||+||+|.++  |+. ||||++...      ...+.+|+.+|.+++|||||++++++.....    ..+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~  116 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLC  116 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceE
Confidence            445566999999999999997  556 999998653      2467789999999999999999999943321    488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g-ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +||||+++ +|.+++...  ....++...+..++.||+.||+|||+ .+ ||||||||+|||++.++.++||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999994 777777653  35789999999999999999999999 79 999999999999998864699999999987


Q ss_pred             cccC-CCCccccccccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          235 LVKG-EPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       235 ~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .... .......||+.|||||++.+ ...|+.|+||||||+++|||+||+.||.+.........+.....++.       
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-------  266 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-------  266 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------
Confidence            6544 33334789999999999974 34599999999999999999999999999887555555544322222       


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                          ++..+++.+..|+.+||..||.+||+..+++.
T Consensus       267 --------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 --------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                22458899999999999999999999988873

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=346.73  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=226.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      -|.+.+.||+|.|+.|-+|++..+|+.||||++.+.+      ..+.+|++.|+.++|||||+++++.     .....+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKly   93 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKLY   93 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceEE
Confidence            4999999999999999999999999999999997643      3445799999999999999999987     3344488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +|+|+-.+ +|.+++..   ....+.+..+++++.||+.|+.|+|+ ..+|||||||+||.+.+.-+-|||.|||++..+
T Consensus        94 LiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99998875 77666554   34789999999999999999999999 999999999999988776558999999999999


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..+....+.+|+..|.|||++.+..+...+.||||||||||-|++|++||...++.+.+..|+++-              
T Consensus       170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--------------  235 (864)
T KOG4717|consen  170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--------------  235 (864)
T ss_pred             CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--------------
Confidence            999999999999999999999999877889999999999999999999999999999999988752              


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                         +.            ++..++.++++||..||..||.+|.|.++|..|+|+|.+-.+-
T Consensus       236 ---Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  236 ---YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             ---cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence               22            2367899999999999999999999999999999999875543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-46  Score=353.13  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=203.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||+||+|++..+++.||||++.+..       ....+|+.++..++|+||+++++.+     .....+
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            5999999999999999999999999999999986532       2345789999999999999999888     334458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            899999985 66555543    4679999999999999999999999 8999999999999999888 699999999875


Q ss_pred             cccCC------------------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 016158          235 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  278 (394)
Q Consensus       235 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  278 (394)
                      .....                                    ......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence            42210                                    01234689999999999654 489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCC---C
Q 016158          279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN---L  355 (394)
Q Consensus       279 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~  355 (394)
                      ++|+.||.+.+..+.+..+......               ..++.          ...+++++++||.+|+. +|.   .
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            9999999887766666555432110               01110          02468899999999775 444   4


Q ss_pred             CCCHHHHhcCCCCCCCCCCC
Q 016158          356 RCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       356 Rpt~~ell~hp~f~~~~~~~  375 (394)
                      ||+++|+++||||+++....
T Consensus       284 r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         284 APGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCHHHHhCCCCCCCCCHHH
Confidence            68999999999999874433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3e-46  Score=340.93  Aligned_cols=265  Identities=24%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ||+|+||+||+|.+..+|+.||+|++....       .....|+.+++.++|+||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999886432       2234689999999999999998887     3334578999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC-
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  240 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~-  240 (394)
                      ++ +|...+.........+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 6655554433445679999999999999999999999 8999999999999999877 699999999876543322 


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccC
Q 016158          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  320 (394)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  320 (394)
                      .....+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+.......+               
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  217 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS---------------  217 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---------------
Confidence            2235678999999999654 489999999999999999999999986543322222222110000               


Q ss_pred             CCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (394)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (394)
                                ..++..++..+.+|+.+||+.||++||     |++++++||||+.......   .....|++|++
T Consensus       218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~---~~~~~~~~~~~  279 (280)
T cd05608         218 ----------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL---EAGMLPPPFVP  279 (280)
T ss_pred             ----------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH---hhccCCCCCCC
Confidence                      012245789999999999999999999     8899999999998754432   23334567765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.3e-46  Score=344.95  Aligned_cols=277  Identities=29%  Similarity=0.496  Sum_probs=207.1

Q ss_pred             eeEeeecCceEEEEEEEC--CCCcEEEEEEeccch--hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           87 EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      .++||+|+||.||+|+++  .+++.||+|.+....  ....+|+.+++.++||||+++++++...   ....++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            357999999999999975  467899999886532  3456899999999999999999887432   234578999999


Q ss_pred             cccHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe----CCCCcEEEEeecCcc
Q 016158          163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAK  233 (394)
Q Consensus       163 ~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~----~~~~~vkl~Dfg~a~  233 (394)
                      ++++..++.....     ....+++..++.++.||+.||+|||+ .||+||||||+|||++    ..+ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence            9988777654321     12358999999999999999999999 8999999999999994    334 69999999997


Q ss_pred             ccccCC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 016158          234 VLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKV  300 (394)
Q Consensus       234 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~  300 (394)
                      ......    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.....         ...+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322    123456799999999997766689999999999999999999999975432         3556677777


Q ss_pred             hCCCChhhhhccCCCCc---------ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          301 LGTPTREEIKCMNPNYT---------EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ++.+....+.....-..         ...........+........+..+.+||++||++||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            77776655443211000         000000000000011112346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-46  Score=354.22  Aligned_cols=253  Identities=32%  Similarity=0.515  Sum_probs=204.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++|+||+++++++     ....+.
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            5999999999999999999999999999999986432       2345799999999999999999988     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            899999975 56555443    3578999999999999999999999 8999999999999999888 699999999865


Q ss_pred             cccCCC---------------------------------------CccccccccccccccccCCCCCCchhhHHHHHHHH
Q 016158          235 LVKGEP---------------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM  275 (394)
Q Consensus       235 ~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  275 (394)
                      ......                                       .....||+.|+|||++.+. .++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence            422110                                       0124589999999998654 489999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC
Q 016158          276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL  355 (394)
Q Consensus       276 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  355 (394)
                      |+|++|..||.+.+..+....+.....               ...++.          ...+++++.+||++||. ||.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            999999999988776665555443110               001110          02468999999999997 9999


Q ss_pred             CCC---HHHHhcCCCCCCCCC
Q 016158          356 RCT---ALEACVHPFFDELRD  373 (394)
Q Consensus       356 Rpt---~~ell~hp~f~~~~~  373 (394)
                      |++   +.++++||||++...
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCH
Confidence            998   999999999998743

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-46  Score=348.77  Aligned_cols=257  Identities=30%  Similarity=0.471  Sum_probs=209.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|++++..++||||+++++++     ....+.
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            5999999999999999999999999999999986432       2345689999999999999999888     334458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            899999975 77666643    3578999999999999999999999 8999999999999999887 699999999975


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+........         
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------  218 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---------  218 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence            533  33456789999999999665 589999999999999999999999988776665555443211000         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                            .+...      .....++.++.+||.+||..+|.+||++.++++||||++....
T Consensus       219 ------~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         219 ------RPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             ------CCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence                  00000      0002468999999999999999999999999999999987443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-46  Score=352.60  Aligned_cols=256  Identities=32%  Similarity=0.547  Sum_probs=209.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.++..++|+||+++++++     ....+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            5999999999999999999999999999999986432       2345799999999999999999887     344468


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            899999975 67666554    2679999999999999999999999 8999999999999999888 699999999876


Q ss_pred             cccCC------------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 016158          235 LVKGE------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  284 (394)
Q Consensus       235 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p  284 (394)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54332                              22345689999999999665 589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-HHHHh
Q 016158          285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEAC  363 (394)
Q Consensus       285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell  363 (394)
                      |...+.......+......               ..++.          ...+++++.+||.+||. ||.+|++ +++++
T Consensus       230 f~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            9887765555554431100               01111          12368999999999998 9999999 99999


Q ss_pred             cCCCCCCCCCCCC
Q 016158          364 VHPFFDELRDPNT  376 (394)
Q Consensus       364 ~hp~f~~~~~~~~  376 (394)
                      +||||+++.....
T Consensus       284 ~hp~~~~~~~~~~  296 (350)
T cd05573         284 SHPFFKGIDWENL  296 (350)
T ss_pred             cCCCcCCCCHHHH
Confidence            9999998754433

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-45  Score=350.90  Aligned_cols=278  Identities=23%  Similarity=0.328  Sum_probs=211.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC--CCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..+|.+.+.||.|+||.||+|...  .+++.||+|.+... ....+|+++++.++|+||+++++++     ......|++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            346999999999999999999764  35678999987654 3446899999999999999999887     333457899


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||++.+++...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++......
T Consensus       165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            9999988776663    24679999999999999999999999 8999999999999999888 6999999998765433


Q ss_pred             CC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCChhhhhcc
Q 016158          239 EP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       239 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..   ....+..+.+.++..+.+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   2245689999999999654 48999999999999999999999997654   34566667766665443322110


Q ss_pred             CCC----CcccCCCCCCCCCcccc-ccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          313 NPN----YTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       313 ~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ...    +..+............. ....++.++.+||++||+.||.+|||+.++|+||||++.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            000    00011000000011111 123467889999999999999999999999999999775

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-45  Score=337.41  Aligned_cols=276  Identities=34%  Similarity=0.552  Sum_probs=215.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||.|+||.||+|++..+|+.||+|.+....      ....+|+++++.++|+||+++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            4899999999999999999999999999999885421      23457999999999999999999883     334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +++||+++++...+..   ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            9999999887665543   23568999999999999999999999 8999999999999999887 79999999987553


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|+||..|| .+.+....+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            322 1223456888999999876666799999999999999999998775 55555667777777777766655443221


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ......++..............+++++.+||.+||+.||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111111111111111111234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.2e-46  Score=347.43  Aligned_cols=250  Identities=30%  Similarity=0.435  Sum_probs=205.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC-cEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|.+..++ ..||+|++....       ....+|+.+++.++||||+++++++     ...
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            446999999999999999999976655 689999885432       2345699999999999999999988     333


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .+.++||||+.+ +|.+++..    ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG~  177 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFGF  177 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCCC
Confidence            458899999975 66655543    4678999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....          
T Consensus       178 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~----------  244 (340)
T PTZ00426        178 AKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI----------  244 (340)
T ss_pred             CeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------
Confidence            976532  23456789999999999654 48999999999999999999999998877655555544311          


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~  373 (394)
                             ..            ++..+++.+.++|++||+.||.+|+     |++++++||||+++..
T Consensus       245 -------~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        245 -------IY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             -------CC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                   01            1245788999999999999999995     8999999999998653

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-46  Score=354.86  Aligned_cols=253  Identities=30%  Similarity=0.492  Sum_probs=202.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+++++.++||||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            5999999999999999999999999999999885432       2345699999999999999999988     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      |+||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            899999974 66665543    3678999999999999999999999 8999999999999999887 699999999863


Q ss_pred             cccCCC------------------------------------------------CccccccccccccccccCCCCCCchh
Q 016158          235 LVKGEP------------------------------------------------NVSYICSRYYRAPELIFGATEYTTAI  266 (394)
Q Consensus       235 ~~~~~~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~  266 (394)
                      ......                                                .....||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence            211000                                                0124689999999998654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHH
Q 016158          267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  346 (394)
Q Consensus       267 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  346 (394)
                      |||||||++|+|++|..||.+.+..+.+..+.....               ...++.          ...++.++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHH
Confidence            999999999999999999988776665555443110               011111          0246889999999


Q ss_pred             HhcccCCCCC---CCHHHHhcCCCCCCCCC
Q 016158          347 RFFQYSPNLR---CTALEACVHPFFDELRD  373 (394)
Q Consensus       347 ~~L~~dP~~R---pt~~ell~hp~f~~~~~  373 (394)
                      +||. +|.+|   +|+.++++||||++...
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9998 67765   59999999999997643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.1e-45  Score=336.07  Aligned_cols=276  Identities=34%  Similarity=0.628  Sum_probs=215.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .|++.+.||+|++|.||+|++..+++.||+|++...      .....+|+.+++.++|+||+++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            389999999999999999999999999999987532      133567999999999999999999884     334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+.+++...+.... ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988766665422 23568999999999999999999999 8999999999999999888 69999999987543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......+++.|+|||.+.+...++.++|+||||+++|+|+||+.||.+....+....+....+.+....+.....-
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 1123356888999999866666789999999999999999999999988877777777776666554444321100


Q ss_pred             Cccc--CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                       ..+  .++..... ........+++++.+||++||+.||.+|||+.++++||||
T Consensus       233 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 -PDYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             -HHHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             000  00110000 1111124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-45  Score=349.75  Aligned_cols=256  Identities=29%  Similarity=0.495  Sum_probs=206.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~  116 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDK  116 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCC
Confidence            34699999999999999999999999999999988542       22345799999999999999999988     3445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ++++||||+++ +|.+++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~a  189 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEecccc
Confidence            68899999975 77766653     468999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCC--CccccccccccccccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ........  .....||+.|+|||++.+..   .++.++|+|||||++|+|++|+.||.+.+....+..+......    
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~----  265 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS----  265 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc----
Confidence            76543221  23456899999999985432   3788999999999999999999999887766666555442110    


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~  373 (394)
                                 ..++.          ...++..+++||.+||+.++.+  |+|+.++++||||+....
T Consensus       266 -----------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         266 -----------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             -----------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence                       11110          1246889999999999866544  899999999999998543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-45  Score=351.31  Aligned_cols=254  Identities=28%  Similarity=0.469  Sum_probs=201.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|++++.||+|+||+||+|++..+++.||||++.+..       ....+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            4899999999999999999999999999999986432       23457999999999999999999883     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            899999975 66555543    3578999999999999999999999 8999999999999999887 699999998753


Q ss_pred             cccCC------------------------------------------------CCccccccccccccccccCCCCCCchh
Q 016158          235 LVKGE------------------------------------------------PNVSYICSRYYRAPELIFGATEYTTAI  266 (394)
Q Consensus       235 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  266 (394)
                      .....                                                ......||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence            21000                                                01134689999999998654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHH
Q 016158          267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  346 (394)
Q Consensus       267 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  346 (394)
                      |||||||++|+|++|+.||...+..+....+......               ..++.          ...+++++.+||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPP----------QVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCC----------CCCCCHHHHHHHH
Confidence            9999999999999999999887665544444321100               01110          1247899999999


Q ss_pred             Hhcc--cCCCCCCCHHHHhcCCCCCCCCC
Q 016158          347 RFFQ--YSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       347 ~~L~--~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      +|+.  .+|..|++++++++||||+++..
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            9654  45556999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-46  Score=297.63  Aligned_cols=278  Identities=35%  Similarity=0.632  Sum_probs=231.1

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |.-.++||+|.||+||+|+++.+++.||+|.++.+.      ....+|+.+++.++|.|||++++..     ..+..+-+
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkkltl   78 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLTL   78 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeEE
Confidence            666688999999999999999999999999986543      2345899999999999999999988     44445789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |+|||...|   .+.+...++.++...++.++.|+++||.|+|+ +++.||||||.|.||+.+| ++||+|||+++.+.-
T Consensus        79 vfe~cdqdl---kkyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafgi  153 (292)
T KOG0662|consen   79 VFEFCDQDL---KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGI  153 (292)
T ss_pred             eHHHhhHHH---HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcCC
Confidence            999999665   44445566889999999999999999999999 8999999999999999998 799999999987643


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .- -......|..|.+|.++.+.+-|++..|+||.|||+.|+.. |++.|++.+-.+++..|+..+|.+.++.|..+..=
T Consensus       154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            32 22334568999999999999889999999999999999985 89999999999999999999999999888765421


Q ss_pred             CcccCCCCCCCC-CccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          316 YTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       316 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      -....+|..... .|.. +-+.++..-++|++++|.-+|.+|.+|++.++||+|.+..
T Consensus       234 pdyk~yp~ypattswsq-ivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQ-IVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCcccCCccccchHHH-HhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            111122322222 2333 3356788899999999999999999999999999998764

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-45  Score=349.95  Aligned_cols=255  Identities=28%  Similarity=0.482  Sum_probs=207.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            446999999999999999999999999999999986421       2345789999999999999999887     3445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      +.++||||+++ +|..++..     ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~~  189 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEeccce
Confidence            68899999975 67666543     468899999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCC--CccccccccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEP--NVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ........  .....||+.|+|||++.+.   ..++.++|||||||++|+|++|+.||.+.+....+..+.....     
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----  264 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-----  264 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----
Confidence            76543221  2345689999999998543   2378899999999999999999999988776655555543110     


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELR  372 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~  372 (394)
                                ...++.          ...++.++.+||++||+.+|.+  |+|++++++||||++..
T Consensus       265 ----------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         265 ----------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             ----------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence                      011111          1247899999999999999988  99999999999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-45  Score=342.37  Aligned_cols=300  Identities=34%  Similarity=0.643  Sum_probs=230.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+++.++|+||+++++++...........+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4699999999999999999999999999999987531     12344699999999999999999887544433445678


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +++||+++++.+.+..     ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus        85 lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD  157 (336)
T ss_pred             EEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence            9999999887665543     679999999999999999999999 8999999999999999887 69999999987653


Q ss_pred             cCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          237 KGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       237 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .....    ....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211    23467889999998766556899999999999999999999999988877778888888877766555332


Q ss_pred             CCCCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          313 NPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  389 (394)
Q Consensus       313 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  389 (394)
                      ......   ...+.....++.. ....+++++.+||.+||+.||++|||+.++++||||+...++.. .+-..+ |.+|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~-~~~~~~-~~~~~  314 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD-EPVAEE-PFPFD  314 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC-cccCCC-CCChh
Confidence            211000   0011111111111 12346888999999999999999999999999999999987644 233322 23555


Q ss_pred             CC
Q 016158          390 FK  391 (394)
Q Consensus       390 ~~  391 (394)
                      ++
T Consensus       315 ~~  316 (336)
T cd07849         315 FE  316 (336)
T ss_pred             hc
Confidence            53

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-45  Score=342.89  Aligned_cols=247  Identities=27%  Similarity=0.455  Sum_probs=200.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHH---HHcCCCceeeeceEEEecCCCcee
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM---QMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      |++.+.||+|+||.||+|.+..+|+.||||++.+..       ....+|..++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            678999999999999999999999999999986432       2233455544   4568999999999883     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..|+||||+++ +|...+.     ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            58899999986 4443332     2579999999999999999999999 8999999999999999888 7999999998


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ...... .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....          
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------  217 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------  217 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            653222 223345689999999998654 48999999999999999999999998877665555443310          


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                             .            .++..++..+.+||++||+.||.+||     ++.++++||||+++.
T Consensus       218 -------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         218 -------V------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence                   0            01245789999999999999999999     799999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-47  Score=335.82  Aligned_cols=250  Identities=25%  Similarity=0.435  Sum_probs=218.5

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      +.+.+|++.+.||+|.||+|-+|.....|+.||||.++++.       ..+++|+++|..|+||||+.++++|     .+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN  124 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN  124 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence            34558999999999999999999999999999999887643       3356899999999999999999998     44


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ...+.|||||..+ .|++++..    .+.+++.+++.+++||+.|+.|+|. ++++|||||.+|||+|.++ ++||+|||
T Consensus       125 kdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIADFG  198 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIADFG  198 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeeccc
Confidence            4458899999984 77777665    4789999999999999999999999 8999999999999999888 69999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++..+.......+++|+|.|.+||++.+.++-+...|.|||||+||.|+.|..||.+.+....+.+|.+.-         
T Consensus       199 LSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga---------  269 (668)
T KOG0611|consen  199 LSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA---------  269 (668)
T ss_pred             hhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc---------
Confidence            99988777777889999999999999888877899999999999999999999999988777776665521         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                              +.             .+.-+.++.-||++||-+||.+|.|++++.+|=|+.
T Consensus       270 --------Yr-------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  270 --------YR-------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             --------cc-------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                    11             133477899999999999999999999999997763

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-45  Score=342.94  Aligned_cols=245  Identities=29%  Similarity=0.501  Sum_probs=198.1

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|+++.+++.||||++.+..       ....+|..++..+ .||||+++++++     ......++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986432       2233577777766 799999999988     3334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-  237 (394)
                      ||+++ +|...+.    ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99986 5544443    24679999999999999999999999 8999999999999999888 699999999875422 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------  212 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------  212 (320)
T ss_pred             CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2223345689999999998654 48999999999999999999999998877665555443310                


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  373 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~  373 (394)
                       ..            ++..++.++.+||++||+.||.+|+++      +++++||||+.+..
T Consensus       213 -~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         213 -VV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             -CC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence             00            123478899999999999999999998      89999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-45  Score=344.31  Aligned_cols=244  Identities=26%  Similarity=0.425  Sum_probs=197.8

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.+.||||+++.+++     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986432       2334688999999999999998887     33345889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC-
Q 016158          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-  238 (394)
                      |+++ ++...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9986 5544333    24678999999999999999999999 8999999999999999887 6999999998754222 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            222345689999999998654 4899999999999999999999999876654443332210                 0


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                      ..            ++..+++++.+||++||+.||++|+     ++.++++||||....
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         212 IK------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             cc------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            11            2246789999999999999999997     899999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.4e-45  Score=335.84  Aligned_cols=271  Identities=25%  Similarity=0.408  Sum_probs=211.6

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|++++.+.+.+.     ...+.+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence            788899999999999999999999999999875431       22346999999999999999988873     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++ +|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~  152 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVHV  152 (285)
T ss_pred             EEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence            99999975 676655432  22568999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...................           
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-----------  220 (285)
T cd05630         153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----------  220 (285)
T ss_pred             CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----------
Confidence            444333445789999999999654 48999999999999999999999998654322111111110000           


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (394)
                                    ...+...+++++.+||++||+.||++|||     ++++++||||+++..-  +.. ....+|+|.+
T Consensus       221 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~--~~~-~~~~~~~~~~  283 (285)
T cd05630         221 --------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK--RLE-AGMLEPPFKP  283 (285)
T ss_pred             --------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH--HHh-cCCCCCCCCC
Confidence                          00122457889999999999999999999     9999999999986333  322 3445578887


Q ss_pred             CC
Q 016158          391 KP  392 (394)
Q Consensus       391 ~~  392 (394)
                      +|
T Consensus       284 ~~  285 (285)
T cd05630         284 DP  285 (285)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=342.31  Aligned_cols=242  Identities=31%  Similarity=0.535  Sum_probs=197.8

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++.     .....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence            699999999999999999999999886432       22346899999999999999988873     334578999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC-CC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  240 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-~~  240 (394)
                      ++ +|...+..    ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .++|+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 56555443    4678999999999999999999999 8999999999999999888 6999999998754322 22


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccC
Q 016158          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  320 (394)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  320 (394)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+...                 ...
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~~  211 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PLR  211 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CCC
Confidence            2345689999999999654 4899999999999999999999999877655544443321                 001


Q ss_pred             CCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 016158          321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELR  372 (394)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~  372 (394)
                                  ++..+++++.+||.+||+.||.+||   ++.++|+||||++..
T Consensus       212 ------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         212 ------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                        2245789999999999999999997   589999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-45  Score=342.94  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=199.1

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++.     .....++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46999999999999999999999999986432       22346899999999999999998883     3345889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC-
Q 016158          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-  238 (394)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9986 5544433    24578999999999999999999999 8999999999999999887 6999999998754222 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            222345689999999998654 4899999999999999999999999877665544443321                 0


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                      ..            ++..+++++.+||.+||+.||.+|+     ++.++++||||.+..
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            11            2245789999999999999999998     899999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.3e-46  Score=346.86  Aligned_cols=258  Identities=27%  Similarity=0.475  Sum_probs=208.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|.+.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++|+||+++++++     ....+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            5999999999999999999999999999999986532       2345789999999999999998887     333458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            899999975 676665542   2579999999999999999999999 8999999999999999888 699999999976


Q ss_pred             cccCCCC--ccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          235 LVKGEPN--VSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      .......  ....+|+.|+|||++..     ...++.++|||||||++|+|++|+.||........+..+.....     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-----  226 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-----  226 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            5433322  23467999999999852     33478899999999999999999999988776665555543210     


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                ...++.          ...++.++.+||..||+ ||.+|||++++++||||+++.....
T Consensus       227 ----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         227 ----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             ----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence                      001110          13478999999999998 9999999999999999998755444

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-45  Score=341.52  Aligned_cols=279  Identities=26%  Similarity=0.436  Sum_probs=207.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ++|++.+.||+|+||.||+|++..+|..||+|++...     ...+.+|+++++.++|+||+++++++..     ....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEE
Confidence            4699999999999999999999999999999988643     2345679999999999999999998843     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  154 (331)
T cd06649          80 ICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (331)
T ss_pred             EEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence            99999986 67666543    356899999999999999999999833699999999999999888 6999999998765


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh----c
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK----C  311 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----~  311 (394)
                      ... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+... +   ++.+......    .
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~---~~~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-I---FGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H---hcccccccccCCccc
Confidence            332 23345689999999999654 48999999999999999999999997665433222 1   2211110000    0


Q ss_pred             cCCCCcc----------cCCCC---------CCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          312 MNPNYTE----------FKFPQ---------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       312 ~~~~~~~----------~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      ..+....          ...+.         .............+++++++||.+||++||++|||+.++++||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            0000000          00000         0000000001124688999999999999999999999999999998865


Q ss_pred             CCCC
Q 016158          373 DPNT  376 (394)
Q Consensus       373 ~~~~  376 (394)
                      ....
T Consensus       309 ~~~~  312 (331)
T cd06649         309 VEEV  312 (331)
T ss_pred             cccc
Confidence            4433

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-45  Score=351.64  Aligned_cols=253  Identities=28%  Similarity=0.476  Sum_probs=202.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|++++.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            4999999999999999999999999999999986532       23457999999999999999999883     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            899999985 66555543    3568999999999999999999999 8999999999999999888 699999999753


Q ss_pred             cccC------------------------------------------------CCCccccccccccccccccCCCCCCchh
Q 016158          235 LVKG------------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAI  266 (394)
Q Consensus       235 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  266 (394)
                      ....                                                .......||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001124689999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHH
Q 016158          267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  346 (394)
Q Consensus       267 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  346 (394)
                      |||||||++|+|++|+.||.+.+..+....+......               ..++          ....+++++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence            9999999999999999999887765555444331100               0011          01357899999999


Q ss_pred             HhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 016158          347 RFFQYSPNLRCT---ALEACVHPFFDELRD  373 (394)
Q Consensus       347 ~~L~~dP~~Rpt---~~ell~hp~f~~~~~  373 (394)
                      +|+ .||.+|++   ++++++||||+.+..
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            976 59999997   999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-44  Score=340.81  Aligned_cols=268  Identities=25%  Similarity=0.352  Sum_probs=203.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ...|++.+.||+|+||.||+|++..+|+.||||++...     ...+.+|+++++.++|+||+++++++     .....+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            45689999999999999999999999999999998543     23456899999999999999999988     334457


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+.+...   ..    .....+..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus       148 ~lv~e~~~~~~L---~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~  218 (353)
T PLN00034        148 QVLLEFMDGGSL---EG----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSRIL  218 (353)
T ss_pred             EEEEecCCCCcc---cc----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEcccccceec
Confidence            899999986421   11    1345677888999999999999999 8999999999999999887 7999999998765


Q ss_pred             ccCC-CCccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      .... ......||..|+|||++...    ...+.++|||||||++|+|++|+.||......+....+........     
T Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  293 (353)
T PLN00034        219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-----  293 (353)
T ss_pred             ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-----
Confidence            4322 22345789999999987432    2245689999999999999999999974432222111111100000     


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (394)
                                          ......++.++++||.+||+.||++|||+.|+|+||||.+....   ..++....+++.+
T Consensus       294 --------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~---~~~~~~~~~~~~~  350 (353)
T PLN00034        294 --------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG---QGQGGPNLHQLLP  350 (353)
T ss_pred             --------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc---cccCCCCccCCCC
Confidence                                00124578899999999999999999999999999999986333   2334444444444

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-48  Score=344.87  Aligned_cols=250  Identities=27%  Similarity=0.449  Sum_probs=208.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .|+...+||+|+||.||+|.+..+++.||+|++..+.     ..+++|+.+|..++++||.++++.|+....     +++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi   88 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI   88 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence            4888899999999999999999999999999986443     445689999999999999999999965443     889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||.| ++.++++.    ...+.+..+..++++++.||.|||. .+.+|||||+.|||+..+| .|||+|||.+....
T Consensus        89 iMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceeeeee
Confidence            9999986 66565554    3445888888899999999999999 8999999999999999997 79999999987664


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... ..+++|||.|||||++.+. .|+.++||||||++.+||++|.+|+....++..+..|                  
T Consensus       163 ~~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------------  223 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------------  223 (467)
T ss_pred             chhhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------------
Confidence            4332 3678999999999999744 5999999999999999999999999887763322222                  


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                            ++..+..    +...+++.+++||..||.+||+.||||.+||+|+|++...
T Consensus       224 ------pk~~PP~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  224 ------PKSAPPR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             ------cCCCCCc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                  2211111    2246799999999999999999999999999999999843

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.6e-45  Score=341.93  Aligned_cols=284  Identities=32%  Similarity=0.570  Sum_probs=222.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||.+.+.      .....+|+.+++.++|+||+++++++..... .+..+
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4599999999999999999999999999999987542      1233469999999999999999998753322 22345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+.+++...+..      .+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~  167 (353)
T cd07850          96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  167 (353)
T ss_pred             EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence            789999999887665542      38889999999999999999999 8999999999999999888 699999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+...++.++.+....+..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         168 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            6444333445678899999999654 489999999999999999999999998888888888888888887655443322


Q ss_pred             CCcccC--CCCCCCCCccccc------------cccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          315 NYTEFK--FPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       315 ~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      ....+.  .+.....++...+            ....++.+++||.+||+.||++|||+.|+|+||||+....+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence            111110  0000001111111            12356779999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-45  Score=341.97  Aligned_cols=301  Identities=35%  Similarity=0.629  Sum_probs=232.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|.+.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++|+||+++++++...........+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            599999999999999999999999999999987532      22344699999999999999999987544333334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +++||+++++...+..    ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++....
T Consensus        86 lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~  159 (337)
T cd07858          86 IVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTTS  159 (337)
T ss_pred             EEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCccccccC
Confidence            9999999887665543    3679999999999999999999999 8999999999999999887 69999999997654


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .. .......++..|+|||.+.....++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..+.+......
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            33 22234467888999999865445899999999999999999999999988877777777777777666554322111


Q ss_pred             Cccc---CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          316 YTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP  392 (394)
Q Consensus       316 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  392 (394)
                      ....   ..+........ .....+++++.+||++||+.||++|||+.++++||||+.++++..-..  ...|..|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~--~~~~~~~~~~~  316 (337)
T cd07858         240 KARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV--CQTPFSFDFEE  316 (337)
T ss_pred             hhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc--CCCccchhhhh
Confidence            0000   01111111111 122468899999999999999999999999999999999988876322  23445555543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.5e-45  Score=343.07  Aligned_cols=254  Identities=30%  Similarity=0.466  Sum_probs=199.5

Q ss_pred             cEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCceeeeceEEEecCCC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  150 (394)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.+ .|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            3899999999999999999874   478999999886421        2235688999999 589999998887     3


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      ....+++||||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeC
Confidence            34457899999985 56555432    3678999999999999999999999 8999999999999999888 7999999


Q ss_pred             cCccccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          230 GSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       230 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      |+++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+.......   
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---  226 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC---  226 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---
Confidence            9987653322  22345689999999999765557899999999999999999999997543221111121111000   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                                            ...++..++..+.+||.+||+.||++||     +++++++||||++..
T Consensus       227 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         227 ----------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                                  0012245789999999999999999999     889999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-45  Score=351.04  Aligned_cols=252  Identities=27%  Similarity=0.460  Sum_probs=201.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|++++.||+|+||.||+|++..+++.||||++.+.       .....+|+++++.++|+||+++++.+     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            499999999999999999999999999999998642       23345799999999999999999888     334468


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            899999975 67666543    3568999999999999999999999 8999999999999999888 699999999742


Q ss_pred             cccC--------------------------------------------CCCccccccccccccccccCCCCCCchhhHHH
Q 016158          235 LVKG--------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWS  270 (394)
Q Consensus       235 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  270 (394)
                      ....                                            .......||+.|+|||++.+. .++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence            2100                                            001124689999999999654 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcc
Q 016158          271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  350 (394)
Q Consensus       271 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  350 (394)
                      |||++|+|++|+.||.+.+..+....+......               ..++          ....+++++.+||.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence            999999999999999887765554443321100               0000          01357899999999976 


Q ss_pred             cCCCCCC---CHHHHhcCCCCCCCC
Q 016158          351 YSPNLRC---TALEACVHPFFDELR  372 (394)
Q Consensus       351 ~dP~~Rp---t~~ell~hp~f~~~~  372 (394)
                      .+|.+|+   |+.++++||||+.+.
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            5999999   999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-44  Score=333.37  Aligned_cols=285  Identities=35%  Similarity=0.550  Sum_probs=223.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+||+++++++...   ....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            346999999999999999999999999999999875332      1234799999999999999999987432   2234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+.+++..++...   ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++..
T Consensus        83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLART  157 (309)
T ss_pred             EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence            6899999998877766542   2678999999999999999999999 8999999999999999887 799999999976


Q ss_pred             cccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ..... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+.+..+.+....+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            64332 22233457789999998765668999999999999999999999999998888888888888777665543221


Q ss_pred             C--CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          314 P--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       314 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      .  ....+..+......+.. ....+++.+.+||++||++||++|||+.++++||||++...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKH-KFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccccCCCCCchHH-hccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            1  11111111111111111 112368899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4e-45  Score=340.31  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=201.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHc-CCCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      +|.+.+.||+|+||.||+|++..+++.||+|++.+...       ....|..++..+ .|++|+.+++++     .....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            38899999999999999999999999999999865321       223466777766 578888888887     33345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            7899999985 55444432    3678999999999999999999999 8999999999999999888 69999999987


Q ss_pred             cccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .... ........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+....+..+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 2223345689999999999654 48999999999999999999999998877666665554311           


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~  372 (394)
                            .            .++..++.++.+||.+||+.||.+|++     ..++++||||+.+.
T Consensus       218 ------~------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         218 ------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             ------C------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence                  0            012457899999999999999999998     48999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.8e-44  Score=331.72  Aligned_cols=285  Identities=35%  Similarity=0.613  Sum_probs=220.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.+. |+||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5999999999999999999999999999999875432      23457999999995 6999999988855444344557


Q ss_pred             EEEEecccccHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+++++.+++...... ...+++..++.++.||+.||.|||+ .||+||||||+||+++.+...++|+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999887776654332 4568999999999999999999999 89999999999999998344799999999875


Q ss_pred             cccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          235 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       235 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+...++.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            4322 111223557889999998665568999999999999999999999999988888888887777666554432211


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                      .......++....... ....+.++..+.+||.+||..||.+|||+.+++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            1111111111111111 111245789999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.5e-45  Score=332.10  Aligned_cols=264  Identities=25%  Similarity=0.392  Sum_probs=202.6

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ||+|+||.||+++++.+|+.||+|.+....       .....|+++++.++||||+++.+++     ....+.++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885321       2234589999999999999998887     3344588999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      ++ +|...+...  ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            75 665554332  23458889999999999999999999 8999999999999999887 6999999998766544443


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016158          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (394)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (394)
                      ....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+.......             ....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------EVKF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------cccc
Confidence            4456889999999996655 8999999999999999999999997654322222222111000             0000


Q ss_pred             CCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (394)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (394)
                                 ....++.++++||.+||+.||.+||++    +++++||||+.+..+...   ....||+|++
T Consensus       218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~---~~~~~~~~~~  276 (277)
T cd05607         218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLE---AGLIPPPFVP  276 (277)
T ss_pred             -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHh---cCcCCCCCCC
Confidence                       013578899999999999999999999    678899999987543332   2344566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.5e-45  Score=339.03  Aligned_cols=250  Identities=27%  Similarity=0.435  Sum_probs=201.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCC-ceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~  154 (394)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       .....|.+++..+.|+ +|+.+++++.     ....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            3899999999999999999999999999999986432       2234688888888775 5777777762     2335


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            7899999985 66554432    3568999999999999999999999 8999999999999999887 69999999986


Q ss_pred             cccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .... ........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            4322 2223345689999999999654 48999999999999999999999998877666555544310           


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  373 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~  373 (394)
                            .            .++..++.++.+||++||+.||.+|++.     .++++||||+.+..
T Consensus       218 ------~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         218 ------V------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             ------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                  0            0124578999999999999999999976     89999999998643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-44  Score=336.08  Aligned_cols=276  Identities=29%  Similarity=0.528  Sum_probs=204.3

Q ss_pred             eEeeecCceEEEEEEECC--CCcEEEEEEeccch--hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEeccc
Q 016158           88 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP  163 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~  163 (394)
                      .+||+|+||.||+|++..  ++..||+|.+....  ....+|+++++.++||||+++++++....   ....+++|||++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEeeeC
Confidence            579999999999999753  56889999886542  34568999999999999999999885432   345789999999


Q ss_pred             ccHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe----CCCCcEEEEeecCccc
Q 016158          164 ETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKV  234 (394)
Q Consensus       164 ~~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~----~~~~~vkl~Dfg~a~~  234 (394)
                      +++...+.....     ....+++..++.++.||+.||+|||+ .||+||||||+|||+.    .++ .+||+|||+++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~  161 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFARL  161 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceec
Confidence            988777654321     12358899999999999999999999 8999999999999994    334 799999999976


Q ss_pred             cccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 016158          235 LVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKVL  301 (394)
Q Consensus       235 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~~  301 (394)
                      ......    .....+|+.|+|||++.+...++.++|||||||++|+|+||++||.....         ...+..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            543221    22346789999999987656689999999999999999999999975432         24456666666


Q ss_pred             CCCChhhhhccCCC--Ccc----c---CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          302 GTPTREEIKCMNPN--YTE----F---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       302 ~~~~~~~~~~~~~~--~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      +.+....+......  +..    +   ..................+..+++||.+||+.||.+|||+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            66655544322110  000    0   0000000000011112346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-45  Score=342.93  Aligned_cols=245  Identities=28%  Similarity=0.434  Sum_probs=197.7

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +.||+|+||.||+|.+..+|+.||+|++....       ....+|+++++.++||||+++.+++     .....+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986532       2234688899999999999998887     33345889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC-
Q 016158          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-  238 (394)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence            9986 4544333    2467899999999999999999999635999999999999999888 6999999998754322 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  212 (325)
T ss_pred             cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            222345689999999999654 4899999999999999999999999877654444433221                 0


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                      ..            ++..+++++.+||.+||+.||++|+     ++.++++||||++..
T Consensus       213 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         213 IR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             CC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            11            2245789999999999999999997     999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.9e-45  Score=343.67  Aligned_cols=256  Identities=29%  Similarity=0.481  Sum_probs=205.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~  116 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR  116 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence            45799999999999999999999999999999988542       12345789999999999999999888     3445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      +.++||||+++ +|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEeCCce
Confidence            68899999975 67666643     568999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCC--CccccccccccccccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ........  .....||+.|+|||++.+..   .++.++|||||||++|+|++|+.||.+.+.......+......    
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----  265 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----  265 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence            76543221  23456899999999985432   3788999999999999999999999887766555555431110    


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~  373 (394)
                                 ..++.          ...++..+++||..||..++.+  |++++++++||||++...
T Consensus       266 -----------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         266 -----------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             -----------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                       11111          1357899999999999844433  789999999999988543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-46  Score=341.76  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=222.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .+|..++++|+|+||.+++++++.+++.+++|.+.-.      .+...+|+.+++++.|||||.+.+.|.    .++.++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            3599999999999999999999999999999988532      234457999999999999999999883    344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +|||+||+| ++.+.+....  +..++++.+..|+.|++.|+.|||+ ++|+|||||+.||+++.++ .|+|+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999996 7777777654  5789999999999999999999998 8999999999999999998 589999999999


Q ss_pred             cccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      +.... ...+..||+.||+||.+.+ .+|+.|+|||||||++|||++-+++|.+.+-...+.++.+....|.        
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl--------  226 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL--------  226 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC--------
Confidence            87776 6677899999999999965 4599999999999999999999999999988888888887653332        


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                          +...+.+++.||+.||..+|..||++.+||.+|.++..
T Consensus       227 --------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  227 --------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             --------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                                25679999999999999999999999999999999843

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.8e-44  Score=328.84  Aligned_cols=276  Identities=40%  Similarity=0.756  Sum_probs=223.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||.|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            4899999999999999999999999999999886432      34567999999999999999999883     344578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|+||++++|.+++....   ..+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            999999778877765432   668999999999999999999999 8999999999999999887 69999999987664


Q ss_pred             cCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016158          237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (394)
Q Consensus       237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (394)
                      ....  .....++..|+|||.+.+...++.++||||+|+++|+|++|.+||.+......+..+....+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4321  2345678899999998766667899999999999999999999998888888888888888777665554322 


Q ss_pred             -CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                       ..+....++.....++...+ ...+.++.+||.+||..||++|||++++|+||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             12222333333333333322 45678999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.3e-45  Score=336.99  Aligned_cols=244  Identities=29%  Similarity=0.498  Sum_probs=195.2

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++||+|+||.||+|++..+++.||||++....       .....|..++.. ..||||+++++++     ....+.++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999886532       122345566654 4899999999887     3334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|...+..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99975 55544432    4679999999999999999999999 8999999999999999887 6999999998754322


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------------  212 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----------------  212 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345689999999999655 48999999999999999999999998877655554443210                


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR  372 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~hp~f~~~~  372 (394)
                                   ..++..++.++.+||.+||+.||.+||++ .++++||||+.+.
T Consensus       213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                         01224578899999999999999999986 5899999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.3e-45  Score=338.69  Aligned_cols=244  Identities=30%  Similarity=0.484  Sum_probs=198.2

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++||+|+||.||+|++..+++.||||++.+..       .....|.+++..+ +||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            36999999999999999999999999986532       1233577788765 8999999999883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus        76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99986 5544443    24678999999999999999999999 8999999999999999888 6999999998754322


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345689999999998654 48999999999999999999999998887666665554310                


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-------CHHHHhcCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-------TALEACVHPFFDELR  372 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------t~~ell~hp~f~~~~  372 (394)
                       ..            ++..++.++.+||.+||+.||++|+       ++.++++||||+.+.
T Consensus       213 -~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         213 -VL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             -CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence             00            1234689999999999999999999       999999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=330.49  Aligned_cols=281  Identities=28%  Similarity=0.501  Sum_probs=221.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhh---HHHHHHHHHcCC--C----ceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDH--P----NIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~h--~----~iv~~~~~~~~~~~~~  151 (394)
                      ..+|.|.+.+|+|.||.|-++.+..++..||||+++.-..+.   .-|+++|+++.+  |    -++.+.++|     +.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            457999999999999999999999999999999886544333   348999999943  2    356777777     66


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC-----------
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-----------  220 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-----------  220 (394)
                      ..++|+|+|.++.++.+.+..-.  ..+++...++.+++|++.+++|||+ .+++|.||||+|||+...           
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence            67799999999988888777533  3679999999999999999999999 899999999999998311           


Q ss_pred             --------CCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016158          221 --------THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (394)
Q Consensus       221 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  292 (394)
                              ...|+|+|||.|+..  .+.....+.|..|.|||++.+-. ++.++||||+||||+|+.||...|++.++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    125999999999754  33446778899999999998765 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCChhhhhccC---------CCCcccCCCC------CCCCCcccccc--ccCCHHHHHHHHHhcccCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMN---------PNYTEFKFPQ------IKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNL  355 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~  355 (394)
                      +++.|..++|+.|...+....         -+|.+.....      ..+.+......  +..-..+.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            999999999988876664331         1111111111      00111111111  112235999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCC
Q 016158          356 RCTALEACVHPFFDELR  372 (394)
Q Consensus       356 Rpt~~ell~hp~f~~~~  372 (394)
                      |+|+.|+|.||||+...
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998764

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-44  Score=347.53  Aligned_cols=274  Identities=25%  Similarity=0.327  Sum_probs=204.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      ..|.+.+.||+|+||.||+|++..+++.||||....  ....+|++++++++|+||+++++++..     ....+++||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEEc
Confidence            469999999999999999999999999999996432  345689999999999999999998733     3347789999


Q ss_pred             ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC-
Q 016158          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  240 (394)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~-  240 (394)
                      +.+++...+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....... 
T Consensus       242 ~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 YRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWST  316 (461)
T ss_pred             cCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccc
Confidence            988877665432   2468999999999999999999999 8999999999999999887 699999999976533221 


Q ss_pred             --CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCChhhhhc
Q 016158          241 --NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       241 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                        .....||+.|+|||++.+. .++.++|||||||++|||++|..++....       ....+..+++..+....+....
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence              1234689999999999655 48999999999999999999876543321       1234455554433221111000


Q ss_pred             --------cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          312 --------MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       312 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                              ..........+......|...  ..++.++.+||++||+.||.+|||+.|+|+||||+.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                    000000001111111223222  145778999999999999999999999999999974

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-46  Score=333.04  Aligned_cols=274  Identities=27%  Similarity=0.394  Sum_probs=223.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .+.|..-++||+|+||.||-++.+.||+.+|+|.+.+..       ....+|..+|.+++.+.||.+--.|.+.+     
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-----  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-----  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----
Confidence            346889999999999999999999999999999875432       22236889999999999999877663333     


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+|+|+..|.| +|.-.+.+  .....+++..++.++.+|+.||++||+ .+||+|||||+|||+|++|| |+|+|+|+|
T Consensus       259 ~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~Gh-vRISDLGLA  334 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGH-VRISDLGLA  334 (591)
T ss_pred             ceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCC-eEeeccceE
Confidence            38999999986 44322222  223589999999999999999999999 89999999999999999995 999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ..+..+.......||.+|||||++.+.. |+...|+|||||+||+|+.|+.||........-.++-+.....+.      
T Consensus       335 vei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~------  407 (591)
T KOG0986|consen  335 VEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE------  407 (591)
T ss_pred             EecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh------
Confidence            9998888888889999999999997665 999999999999999999999999876554444333332222111      


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPL  387 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~  387 (394)
                                         .+++.+|+++++|++.+|++||++|.     +++++.+||||+.++.....   ..-.+||
T Consensus       408 -------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle---agml~PP  465 (591)
T KOG0986|consen  408 -------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE---AGMLEPP  465 (591)
T ss_pred             -------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh---ccCCCCC
Confidence                               13367899999999999999999998     67899999999998665543   4556788


Q ss_pred             CCCCC
Q 016158          388 FNFKP  392 (394)
Q Consensus       388 ~~~~~  392 (394)
                      |-+||
T Consensus       466 fiPdp  470 (591)
T KOG0986|consen  466 FIPDP  470 (591)
T ss_pred             CCCCc
Confidence            88876

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.8e-44  Score=325.84  Aligned_cols=276  Identities=36%  Similarity=0.642  Sum_probs=213.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|++|.||+|++..+|+.||+|++....      ....+|+.+++.++|+|++++++++.     .....+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence            5999999999999999999999999999999875332      23457999999999999999999883     334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ++|||+++++...+   ......+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        77 ~v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence            99999997553332   2234568999999999999999999999 8999999999999999887 79999999997664


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+....+.............
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            433 2223456788999999876566889999999999999999999999988877777776665554433222211111


Q ss_pred             --CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                        +.....+......-.......++..+.+||.+||+.||++|||+.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              01111111111111111124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.3e-44  Score=329.67  Aligned_cols=283  Identities=37%  Similarity=0.643  Sum_probs=222.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh---------hhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|++.+.||.|++|.||+|.+..+|+.||||.+.....         ....|+++++.++|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            38899999999999999999999999999999864322         23468999999999999999998833     44


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +.++||||+.++|.+++....   ..+++..++.++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            578999999778877665421   368999999999999999999999 8999999999999999887 79999999997


Q ss_pred             ccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ....... .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+....+.+..+....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            6644322 223355788999999866556899999999999999999999999888888888887777776665554322


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ...............+.. ......+..+.+||.+||..||.+|||+.++++||||++...++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLK-QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             ccccccccccccCCcchh-hhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence            111111111111111111 122456889999999999999999999999999999999877764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.4e-44  Score=329.26  Aligned_cols=271  Identities=25%  Similarity=0.373  Sum_probs=214.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      |++.+.||+|+||+||+|.+..+++.||+|.+....       ....+|+++++.++|+|++.+.+++     ......+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            788899999999999999999999999999875431       2245699999999999999998887     3334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+.+ ++...+..  .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05632          77 LVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVKI  152 (285)
T ss_pred             EEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCcceec
Confidence            99999986 55544432  123469999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.........+.........         
T Consensus       153 ~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~---------  222 (285)
T cd05632         153 PEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE---------  222 (285)
T ss_pred             CCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc---------
Confidence            444333455789999999999654 4899999999999999999999999876654444443332111100         


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (394)
                                      .+...++.++.+|+.+||+.||++|||     +.++++||||+.......  - .....|+|.+
T Consensus       223 ----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~--~-~~~~~~~~~~  283 (285)
T cd05632         223 ----------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL--E-AGMLDPPFVP  283 (285)
T ss_pred             ----------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH--h-cCcCCCCCCC
Confidence                            112457889999999999999999999     899999999999844433  2 3334477776


Q ss_pred             CC
Q 016158          391 KP  392 (394)
Q Consensus       391 ~~  392 (394)
                      +|
T Consensus       284 ~~  285 (285)
T cd05632         284 DP  285 (285)
T ss_pred             CC
Confidence            55

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.1e-44  Score=329.24  Aligned_cols=282  Identities=35%  Similarity=0.618  Sum_probs=219.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.+....      ....+|+++++.++|+||+++++++.     ...+.+
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRLY   77 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeEE
Confidence            5999999999999999999999999999999875421      33457999999999999999999883     334588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++...+....  ...+++..++.++.||+.||+|||+ +|++|+||+|+||+++.++..+||+|||++....
T Consensus        78 lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         78 LVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            999999987766654321  2346788899999999999999999 8999999999999999765579999999997543


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....+++.|+|||.+.+...++.++||||||+++|+|+||+.||...+..+.+..+....+.+....+.....-
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            3221 223456788999999866556899999999999999999999999988888888888887777766555422110


Q ss_pred             Cc-ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          316 YT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       316 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      .. ...++.... .........+++++.++|.+||+.||++||++.++++||||+++.+
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        235 PDYKSAFPKWPP-KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhhhcccCCC-CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            00 000111000 1111123457889999999999999999999999999999998753

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=311.55  Aligned_cols=259  Identities=25%  Similarity=0.418  Sum_probs=208.5

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhh-----HHHHHHHHH-cCCCceeeeceEEEecCCCce
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQM-LDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...+..+++..||.|+.|+|++++++.+|...|||.+.+.....     ...+.++.. ...|+||+.+++|....+   
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d---  165 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD---  165 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch---
Confidence            33445677889999999999999999999999999997643322     123333332 358999999999977665   


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                        +++-||.|..-+..+++.   ..+++++..+-++...++.||.||.+.+||+|||+||+|||+|..| ++||||||.+
T Consensus       166 --V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIs  239 (391)
T KOG0983|consen  166 --VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGIS  239 (391)
T ss_pred             --HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccccc
Confidence              667888887544444443   3478999999999999999999998878999999999999999988 6999999999


Q ss_pred             cccccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhh
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~  309 (394)
                      .++.+........|.+.|||||.+.-  ...|+.++||||||++++||+||+.||.+.+ +.+.+..+.+.  .||.-  
T Consensus       240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~L--  315 (391)
T KOG0983|consen  240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPLL--  315 (391)
T ss_pred             ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCCC--
Confidence            99988888888899999999999842  3458999999999999999999999999864 44666666552  11110  


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                  +          -...+|+++++|+..||++|+.+||.-.+||+|||++...
T Consensus       316 ------------~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  316 ------------P----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             ------------C----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                        0          0134799999999999999999999999999999877654

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-44  Score=336.14  Aligned_cols=244  Identities=29%  Similarity=0.496  Sum_probs=197.9

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|++..+++.||||++.+..       ....+|.++++.+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999987532       2234677888877 7999999999883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-  237 (394)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99985 55444432    3579999999999999999999999 8999999999999999888 699999999865322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      ........+++.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2223345689999999999654 4899999999999999999999999877655544443321                 


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELR  372 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~  372 (394)
                      ..            .++..++..+.+||++||+.||.+|||+     .++++||||+...
T Consensus       212 ~~------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         212 EV------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             CC------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            00            1224578999999999999999999999     9999999998864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.7e-45  Score=343.83  Aligned_cols=256  Identities=28%  Similarity=0.456  Sum_probs=204.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.++..++|++|+++++.+     ....++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            5999999999999999999999999999999986422       2345689999999999999999888     344458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            899999985 66665543    3678999999999999999999999 8999999999999999888 699999999864


Q ss_pred             cccCC------------------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 016158          235 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  278 (394)
Q Consensus       235 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  278 (394)
                      .....                                    ......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence            42110                                    01134689999999998654 489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-
Q 016158          279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-  357 (394)
Q Consensus       279 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-  357 (394)
                      ++|+.||.+.+....+..+.....               ...++.          ...+++++++||.+|+. ||.+|+ 
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcCC
Confidence            999999988776665555443110               000110          02368899999999874 999998 


Q ss_pred             --CHHHHhcCCCCCCCCCCCC
Q 016158          358 --TALEACVHPFFDELRDPNT  376 (394)
Q Consensus       358 --t~~ell~hp~f~~~~~~~~  376 (394)
                        +++++++||||+++.....
T Consensus       284 ~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             CCCHHHHhcCCCCCCCCHHHH
Confidence              4899999999998754443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=336.30  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=203.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||++++..+++.||+|++.+.       ...+.+|+.++..++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            599999999999999999999999999999998642       12345788999999999999999988     334468


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+.+ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            899999975 67666543   23678999999999999999999999 8999999999999999888 699999999876


Q ss_pred             cccCCCC--ccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          235 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .......  ....||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+..+....+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------  225 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence            5433222  22468999999999853    23478899999999999999999999988766555554433110      


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~  373 (394)
                               ...++.         ....++.++++||++||..++.+  |+++.++++||||..+..
T Consensus       226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence                     000110         01347899999999999765544  889999999999987643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-44  Score=336.39  Aligned_cols=243  Identities=31%  Similarity=0.485  Sum_probs=197.1

Q ss_pred             eEeeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           88 HVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +.||+|+||.||+|++.   .+++.||+|++....        ....+|+.+++.++||||+++++++.     .....+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            67999999999999874   478899999886432        22356999999999999999998883     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+.+ +|...+.    ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999986 5544443    24668889999999999999999999 8999999999999999888 7999999998754


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....             
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------  216 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------  216 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            322 223345689999999998654 48899999999999999999999998877655555443310             


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDEL  371 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~  371 (394)
                          ..            ++..+++++.+||++||+.||++||     +++++++||||+..
T Consensus       217 ----~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         217 ----LN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             ----CC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence                01            1245788999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.8e-44  Score=328.55  Aligned_cols=276  Identities=36%  Similarity=0.645  Sum_probs=215.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||.|++|.||+|++..+|+.||||.+....      ....+|++++++++|+||+++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            3899999999999999999999999999999875432      2456799999999999999999987     3334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ++|||+.+++...+....  ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            999999887766654322  3568999999999999999999999 8999999999999999888 79999999987553


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....+++.|+|||.+.+...++.++||||||+++|+|+||+.||.+.+..+.+..+.+..+.+....+.....-
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3221 223345788999999876555789999999999999999999999988888888888877777665433211100


Q ss_pred             C-cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      - ....++......... ....++++++++|.+||+.||.+|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0 000111111111111 124578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-44  Score=350.73  Aligned_cols=261  Identities=24%  Similarity=0.329  Sum_probs=211.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC---Cce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~  152 (394)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...      .....+|+.++..++|+|+++++..+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4699999999999999999999999999999988542      2334578899999999999998877643322   223


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .++++||||+. ++|.+.+.........+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            35789999998 47887777655556789999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccC---CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          232 AKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       232 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ++.....   .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....      
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence            8765322   122345689999999999654 489999999999999999999999987765544444332100      


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                            ..++..+++++.+||.+||+.||.+||++.++++|||++....
T Consensus       263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence                                  0122467899999999999999999999999999999987544

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-44  Score=334.82  Aligned_cols=245  Identities=27%  Similarity=0.486  Sum_probs=196.1

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++||+|+||.||+|+++.+|+.||+|++....       .....|..++.. +.|+||+++++++     ....++++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986532       223456677765 4899999999888     3344688999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ +|...+..    ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||+++.....
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 55544432    3678999999999999999999999 8999999999999999888 6999999998643222


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....  +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~-------------  213 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--P-------------  213 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-------------
Confidence             223345689999999999654 48999999999999999999999998776554444332210  0             


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELRD  373 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~hp~f~~~~~  373 (394)
                                    .++..++.++++||++||+.||++|+++ +++++||||+....
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence                          0123478899999999999999999998 58999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.1e-44  Score=325.89  Aligned_cols=275  Identities=36%  Similarity=0.628  Sum_probs=216.4

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-----hhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.+.||+|+||.||+|.+..+++.||+|++.....     ...+|+.+++++. |+|++++++++...   ...+.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            6788999999999999999999999999998764321     2235888888885 99999999988433   1234789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||+++++.+.+...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++. + .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999998876665432   2568999999999999999999999 89999999999999998 6 799999999987654


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC-C
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  316 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  316 (394)
                      ........+++.|+|||.+.....++.++|||||||++|+|++|..||.+.+..+.+..+...++.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444445567889999998755555789999999999999999999999998888888888887777776553322211 1


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ..+.++....... ..+...++.++.+||.+||+.||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1112222111111 11224578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=317.41  Aligned_cols=263  Identities=29%  Similarity=0.464  Sum_probs=207.8

Q ss_pred             ccEEEe-eEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++|.|. ++||-|-.|.|..+.++.||+.+|+|++... ...++|+++--.. .|+|||.++++|.... .....+.+||
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVm  138 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-PKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVM  138 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-HHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeee
Confidence            357664 6799999999999999999999999976543 4445788875444 8999999999884433 3456788999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecCccccc
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV  236 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~~~  236 (394)
                      |.++| .|...+..  +....+++.++..|+.||..|+.|||+ .+|.||||||+|+|....+  ..+||+|||+|+...
T Consensus       139 E~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  139 ECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             ecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            99997 34333332  334679999999999999999999999 9999999999999997532  269999999999877


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      ......+.+.||+|.|||++ +...|+..+|+||+||++|.|++|.+||.+......-..+.+.+.             .
T Consensus       216 ~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~-------------~  281 (400)
T KOG0604|consen  216 EPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR-------------T  281 (400)
T ss_pred             CCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh-------------c
Confidence            66666777889999999998 566699999999999999999999999988754322222222110             0


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ..+.||+   ..|     ..+|++++++|+.+|..+|.+|.|+++++.|||+...
T Consensus       282 gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  282 GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            2223332   112     5689999999999999999999999999999999764

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-44  Score=336.40  Aligned_cols=245  Identities=27%  Similarity=0.505  Sum_probs=193.9

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++||+|+||.||+|++..+++.||||++.+..       ....+|..+++.+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986532       2245688888888 799999999988     3334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc-c
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~-~  237 (394)
                      ||+++ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99986 5544433    24679999999999999999999999 8999999999999999887 69999999987532 2


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCChhhh
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  309 (394)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....        .+.+...+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            2333456789999999999654 489999999999999999999999963211        1111111110         


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR  372 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~f~~~~  372 (394)
                             ....            ++..++..+.+||++||+.||.+|+|      ++++++||||+.+.
T Consensus       220 -------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         220 -------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             -------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                   0001            22457889999999999999999997      78999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.7e-44  Score=329.31  Aligned_cols=279  Identities=38%  Similarity=0.625  Sum_probs=221.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..|++.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++....   ..+.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            35999999999999999999999999999999885432      12346999999999999999999874331   2458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++|||+++++..++...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            899999998887766542   2468999999999999999999999 8999999999999999887 6999999998766


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||......+.+..+....+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            543 2223455688899999987655578999999999999999999999999888888888888877776665543221


Q ss_pred             --CCcccCCCCCCCCCcccccccc-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 --NYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                        ..............+...++.. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              0011111111222223334343 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-44  Score=333.12  Aligned_cols=245  Identities=29%  Similarity=0.510  Sum_probs=196.5

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|++..+++.||||++....       .....|..++.. +.||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999886532       223356777765 49999999998883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|...+..    ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99975 66555543    3578999999999999999999999 8999999999999999887 6999999998754222


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~--------------  212 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N--------------  212 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence             223345689999999998654 4899999999999999999999999877655444443221  0              


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  373 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~f~~~~~  373 (394)
                                   ..++..++.++.+||.+||+.||.+||++. ++++||||+++..
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence                         001234688999999999999999999996 8999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-44  Score=336.70  Aligned_cols=245  Identities=27%  Similarity=0.451  Sum_probs=195.4

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHH-HHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||+||+|++..+|+.||||++.....       ...+|. .+++.++||||+++++++.     .....++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            469999999999999999999999999864321       112233 3567899999999988873     334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99986 55444432    4678999999999999999999999 8999999999999999888 6999999998754222


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345689999999998654 48999999999999999999999998876555544443210                


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  373 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~  373 (394)
                       ..            +...++..+.+||++||+.||.+||++    .++++||||.....
T Consensus       213 -~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 -LR------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             -CC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence             00            124578999999999999999999998    69999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.9e-44  Score=359.95  Aligned_cols=262  Identities=27%  Similarity=0.420  Sum_probs=211.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++++.||.|+||.||+|.+..+++.||+|++...      ...+..|+.+++.|.||||++++++|....   ...
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~~~   88 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---NQK   88 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---CCE
Confidence            34699999999999999999999999999999987532      233457999999999999999999885432   345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-------ceeecCCCCcEEEeCCC-----
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-------ICHRDIKPQNLLVNPHT-----  221 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g-------ivH~Dlkp~Nil~~~~~-----  221 (394)
                      ++|||||+++ +|..++.........+++..++.|+.||+.||.|||+ .+       ||||||||+||||+.+.     
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCcccccc
Confidence            7899999984 8888877655555789999999999999999999998 44       99999999999996421     


Q ss_pred             -----------CcEEEEeecCccccccCCCCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016158          222 -----------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGES  289 (394)
Q Consensus       222 -----------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~  289 (394)
                                 ..+||+|||++.............+|+.|+|||++.+. ..++.++|||||||++|+|+||..||...+
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                       14899999999866444444456789999999998543 347899999999999999999999998766


Q ss_pred             cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                      ....+...+...  +.               ++           ....+.++.+||..||+.||.+|||+.++|.|||++
T Consensus       248 ~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        248 NFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             cHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            555443333211  00               00           024688999999999999999999999999999999


Q ss_pred             CCCCC
Q 016158          370 ELRDP  374 (394)
Q Consensus       370 ~~~~~  374 (394)
                      .+..+
T Consensus       300 ~i~~p  304 (1021)
T PTZ00266        300 NVGPP  304 (1021)
T ss_pred             hcCCC
Confidence            87654

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-44  Score=324.03  Aligned_cols=252  Identities=35%  Similarity=0.564  Sum_probs=204.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh------hHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.+.||+|+||+||+|++..+++.||+|++......      ..+|+.+++.++|+||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            88999999999999999999999999999998654322      1348899999999999999998844     445779


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc-
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  235 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~-  235 (394)
                      +||++.+ ++.+++.    ....+++..++.++.|++.||++||+ .||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence            9999998 8877776    34788999999999999999999999 8999999999999999877 7999999998753 


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........++..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+............    
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  225 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ----  225 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc----
Confidence            2233334567789999999986345689999999999999999999999988744444444433322111111000    


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                        ....+..+.++|++||+.||++|||+.++++||||
T Consensus       226 ------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  226 ------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             ------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                              01123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-44  Score=337.52  Aligned_cols=244  Identities=28%  Similarity=0.465  Sum_probs=194.2

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHH-HHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|++..+|+.||+|++.+..       ....+|. .+++.++||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence            46999999999999999999999999986432       1122343 3567789999999988873     334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-  237 (394)
                      ||+++ ++...+.    ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99986 4544333    34678999999999999999999999 8999999999999999888 699999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------  211 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------  211 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2223345689999999999654 4899999999999999999999999887665555444321                 


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELR  372 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~  372 (394)
                      ..            .+....+..+.++|++||+.||.+||++    .++++||||+...
T Consensus       212 ~~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         212 PL------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             Cc------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            00            0113578899999999999999999977    5999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-43  Score=333.34  Aligned_cols=286  Identities=29%  Similarity=0.522  Sum_probs=214.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCC-------
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-------  150 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-------  150 (394)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|.+....    ....+|+++++.++|+||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            46999999999999999999999999999999875432    3355799999999999999998876432211       


Q ss_pred             --ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          151 --EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       151 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                        +....+++|||+++++.+.+..     ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++..++|+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence              1235789999999877655532     578999999999999999999999 89999999999999986655799999


Q ss_pred             ecCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          229 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       229 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      ||.+........    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...........+.......
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999875532211    1223568889999987655568899999999999999999999998887766666665544333


Q ss_pred             ChhhhhccCCCCcccCC--CCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKF--PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      .................  ......+... +...++.++.+||++||+.||.+|||+.++|+||||+.+..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            33222111100000000  0001111111 224578899999999999999999999999999999976443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=319.27  Aligned_cols=266  Identities=28%  Similarity=0.445  Sum_probs=219.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhH-------HHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|..+++||+|.||+|-+++.+.+|+.+|+|+++++.-..+       .|-++|+..+||.+..+.-.|     +...
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence            3468889999999999999999999999999998876543222       467899999999998887666     4444


Q ss_pred             EEEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+|+||||+.|+ |...+.    ....+++...+.+...|+.||.|||+ .+||+||||.+|+|+|.+|+ +||+|||++
T Consensus       242 rlCFVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGH-IKitDFGLC  315 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGH-IKITDFGLC  315 (516)
T ss_pred             eEEEEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCc-eEeeecccc
Confidence            589999999863 322222    24779999999999999999999999 89999999999999999995 999999999


Q ss_pred             ccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.-.. +......+|||.|.|||++. ...|+.+.|+|.+||++|||++|+.||...+....+..|...           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            76543 44556789999999999995 455999999999999999999999999988877777666542           


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPP  386 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~  386 (394)
                            +..            |+..++++++.|+..+|.+||.+|.     .|.|+.+|+||..+....+.   ...++|
T Consensus       384 ------d~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~---~Kki~P  442 (516)
T KOG0690|consen  384 ------DLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATY---RKKIEP  442 (516)
T ss_pred             ------hcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHH---HhccCC
Confidence                  222            3468999999999999999999998     47899999999999876663   234556


Q ss_pred             CCCC
Q 016158          387 LFNF  390 (394)
Q Consensus       387 ~~~~  390 (394)
                      +|-+
T Consensus       443 PfKP  446 (516)
T KOG0690|consen  443 PFKP  446 (516)
T ss_pred             CCCC
Confidence            6654

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=323.78  Aligned_cols=276  Identities=35%  Similarity=0.669  Sum_probs=213.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ++|++.+.||.|++|.||+|.++.+++.||||.+....     ....+|+++++.++|+||+++++++     ....+.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            46999999999999999999999899999999885432     2345799999999999999999987     3334588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++.+++...   ...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence            99999998877665532   2478999999999999999999999 8999999999999999888 69999999986543


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhhhccCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .... .....++..|+|||.+.+...++.++||||+|+++|+|++|+.||.+.. ..+.+..+.+..+.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            2211 1223457889999998765568999999999999999999999998765 4566666667777766655533221


Q ss_pred             C--CcccCCCCCCCCCccccccccCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 N--YTEFKFPQIKPHPWHKVFQKRLP--PEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      .  +...........+....+ ..++  .++.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1  111111111111111111 1234  789999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=329.37  Aligned_cols=281  Identities=34%  Similarity=0.590  Sum_probs=213.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECC--CCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|.+.++||+|+||.||+|.+..  +++.||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            38999999999999999999988  89999999887632       3345799999999999999999988432   224


Q ss_pred             EEEEEEecccccHHHHHHHhhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC----CCCcEEEEe
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----HTHQLKLCD  228 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~----~~~~vkl~D  228 (394)
                      ..++||||+++++.+++....... ..+++..++.++.|++.||.|||+ .||+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            688999999988877766544433 378999999999999999999999 89999999999999998    66 799999


Q ss_pred             ecCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 016158          229 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------DQLV  295 (394)
Q Consensus       229 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------~~~~  295 (394)
                      ||++........    .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+....         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533222    123456888999999876666899999999999999999999999865432         3455


Q ss_pred             HHHHHhCCCChhhhhccCC--CCcc----cCCCCCCCCCccccccc--cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          296 EIIKVLGTPTREEIKCMNP--NYTE----FKFPQIKPHPWHKVFQK--RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                      .+...++.+....+.....  .+..    ..............+..  ..+.++.++|.+||+.||++|||+.++++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            5566666555543321110  0000    00000000011111122  57789999999999999999999999999999


Q ss_pred             C
Q 016158          368 F  368 (394)
Q Consensus       368 f  368 (394)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.5e-44  Score=347.86  Aligned_cols=253  Identities=27%  Similarity=0.356  Sum_probs=207.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCC-CcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .|.+.+.||+|+||.||+|....+ ++.||+|.+...    .....+|+.+++.++||||+++++++.     .....++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence            499999999999999999998877 788999976432    234457999999999999999999883     3345889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||++ ++|.+.+.........+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~  220 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS  220 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence            999997 47877776555555678999999999999999999999 8999999999999999887 69999999998654


Q ss_pred             cCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ....   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......          
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------  289 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----------  289 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence            3321   2345689999999998654 5899999999999999999999999877665555544331100          


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                        .++..++.++.+||.+||+.||++|||+.+++.|||++.+
T Consensus       290 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 ------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                              0123578899999999999999999999999999998753

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.3e-44  Score=333.46  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=204.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+++++.+++.||+|++.+..       ..+.+|+.++..++|++|+++++++     ......
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            5999999999999999999999999999999985421       2245688899999999999999887     333457


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+.+ +|.+++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            899999974 67666653   23578999999999999999999999 8999999999999999887 699999999875


Q ss_pred             cccCCCC--ccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          235 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .......  ....||+.|+|||++..    ...++.++|||||||++|+|++|+.||...+..+.+..+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------  225 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence            5333221  23568999999999852    33478899999999999999999999988776666655543110      


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~  373 (394)
                               ...++.         ....++.++++||++||..++.+  |++++++++||||+++..
T Consensus       226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                     001111         11357899999999999765554  789999999999998653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-44  Score=332.53  Aligned_cols=294  Identities=36%  Similarity=0.649  Sum_probs=233.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||.|++|.||+|++..+++.||||++....      ....+|+.+++.++|+||+++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4899999999999999999999899999999875432      3456799999999999999999988554433334678


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ++|||+++++.+.+..    ...+++..++.++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999876665543    3479999999999999999999999 8999999999999999887 79999999998765


Q ss_pred             cCC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          237 KGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       237 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ...    ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+....+.++...+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    2334567889999999976646899999999999999999999999999988888888888888877655422


Q ss_pred             CCCCcc-c--CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 016158          313 NPNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP  383 (394)
Q Consensus       313 ~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~  383 (394)
                      ...... +  ........++... ...++.++.+||.+||++||.+|||++++++||||++++++....+...+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~  307 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP  307 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCc
Confidence            111100 0  0111111122222 24478999999999999999999999999999999999887665444443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8e-44  Score=333.16  Aligned_cols=288  Identities=35%  Similarity=0.661  Sum_probs=228.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .+|++.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+||+++++++.... ......
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            46999999999999999999999999999999876432      23346999999999999999998764333 334567


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+++++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999998876655432    3568999999999999999999999 8999999999999999888 6999999998765


Q ss_pred             ccCCCC-----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ......     ....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....|.++...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            332211     234678889999998655558999999999999999999999999988888888888888888776654


Q ss_pred             ccCCCCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          311 CMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       311 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ......-.   ..++.....+|.. +...++.++.++|++||+.||.+|||+.+++.||||++...+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~  306 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE  306 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence            32211100   0111111222222 224578999999999999999999999999999999988777764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8e-44  Score=332.76  Aligned_cols=278  Identities=26%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ++|++.+.||.|+||.||+|.+..++..+|+|.+...     ...+.+|+++++.++|+||+++++++..     ..+.+
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence            4699999999999999999999999999999987543     1345689999999999999999998843     33588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+.+ +|.+++..    ...+++..+..++.|++.||.|||+..+|+|+||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~  154 (333)
T cd06650          80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (333)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence            99999975 77666643    356899999999999999999999734799999999999999887 6999999998755


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH--hCCCChhhhhcc-
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--LGTPTREEIKCM-  312 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~-  312 (394)
                      ... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||......... .+...  .+.+........ 
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCccc
Confidence            322 22345678999999999654 4899999999999999999999999765543222 11110  011100000000 


Q ss_pred             ------CCCCcccCCCCC---------CCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          313 ------NPNYTEFKFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       313 ------~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                            ...+.....+..         ........-...++.++++||.+||++||++|||+.|+++||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                  000000000000         000000000123678899999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.1e-44  Score=332.97  Aligned_cols=245  Identities=28%  Similarity=0.507  Sum_probs=192.4

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986532       2234677777766 8999999999883     334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-  237 (394)
                      ||+++ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99986 5544333    24679999999999999999999999 8999999999999999888 699999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhCCCChhhh
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--------GVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....        ....+......         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            2233345789999999999654 48999999999999999999999995311        11111111110         


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR  372 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~f~~~~  372 (394)
                             ...            .++..++..+.+||++||+.||.+|+|      +.++++||||+++.
T Consensus       220 -------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         220 -------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             -------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                   000            123467899999999999999999998      57999999998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.3e-44  Score=333.27  Aligned_cols=257  Identities=27%  Similarity=0.418  Sum_probs=203.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||++++..+++.||+|++.+..       ....+|..++..+.|++|+.+++++     ....+.
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            5999999999999999999999999999999886421       2245688899999999999999888     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+.+ +|..++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            899999975 676666532   3578999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCCC--ccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          235 LVKGEPN--VSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       235 ~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .......  ....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||...+..+.+..+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER-----  226 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-----
Confidence            5433221  234689999999998542    34788999999999999999999999887766555554431100     


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  373 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~  373 (394)
                                ..++.         ....+++++++||.+||..++.+  |++++++++||||+....
T Consensus       227 ----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         227 ----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             ----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence                      00110         01347899999999999976655  569999999999998643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-43  Score=329.84  Aligned_cols=249  Identities=27%  Similarity=0.438  Sum_probs=200.2

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCC-CceeeeceEEEecCCCceeEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      |+..+.||+|+||.||+|+++.+|+.||+|++.+..       .....|..+++.+.| ++|+++.+++     .....+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCEE
Confidence            788899999999999999999999999999886532       123457788887765 6677787777     233358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|...+.    ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~  150 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE  150 (323)
T ss_pred             EEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeccccccc
Confidence            899999985 5554443    24679999999999999999999999 8999999999999999888 699999999875


Q ss_pred             cccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          235 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....            
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------  217 (323)
T cd05615         151 HMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------  217 (323)
T ss_pred             cCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence            43222 22345689999999998654 48999999999999999999999998877665555554311            


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~  373 (394)
                           ..            ++..++.++.+|+.+||+.||.+|++     .+++++||||+.+..
T Consensus       218 -----~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         218 -----VS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             -----CC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                 01            12457889999999999999999997     579999999998743

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.7e-43  Score=322.04  Aligned_cols=276  Identities=36%  Similarity=0.671  Sum_probs=217.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||.|++|.||+|++..+|+.||||++...     .....+|+.+++.++|+||+++++++..     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            489999999999999999999999999999988643     2344579999999999999999998843     334789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||+++++.+++..... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999987776654221 3468999999999999999999999 8999999999999999887 699999999875533


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .. ......+++.|++||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+......+....+..+. ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            21 12234567889999998665567899999999999999999999999988888888887777766665543322 11


Q ss_pred             ccc--CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          317 TEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       317 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ..+  .++....... ..+...++..+.++|.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            111  1111111111 11223568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-44  Score=335.32  Aligned_cols=244  Identities=30%  Similarity=0.478  Sum_probs=198.5

Q ss_pred             eEeeecCceEEEEEEE---CCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           88 HVVGTGSFGVVFQAKC---RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      +.||+|+||.||++++   ..+|+.||+|++....      ....+|+++++.++||||+++++++.     .....++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            5799999999999986   3578999999986432      23346899999999999999998883     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            999975 66554432    3578999999999999999999999 8999999999999999887 699999999876543


Q ss_pred             C-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 G-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      . .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+....+..+....               
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------  214 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------  214 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            3 223345789999999998654 47899999999999999999999998877655555443310               


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~  372 (394)
                        ..            ++..+++++.+||++||+.||.+|||     +.++++||||+.+.
T Consensus       215 --~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         215 --LG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             --CC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence              11            12457899999999999999999999     77899999998753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.1e-45  Score=314.29  Aligned_cols=286  Identities=33%  Similarity=0.574  Sum_probs=227.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCC----cEEEEEEeccchh------hhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..|++.+.||+|.||.||+|..+.++    +.+|||.+..++.      ..-+|+.+++.++|+|++.+..+|+..    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            45999999999999999999765554    3689998865522      223799999999999999999988643    


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC----CCcEEE
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKL  226 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~----~~~vkl  226 (394)
                      +..+++++||.+.+|.++++.+... ...++...++.+++||+.|+.|||+ +-|+||||||.||||..+    | .|||
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~VKI  177 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RVKI  177 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-eeEe
Confidence            4458899999999999998876543 3568999999999999999999999 799999999999999877    5 7999


Q ss_pred             EeecCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CcHHH
Q 016158          227 CDFGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE---------SGVDQ  293 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---------~~~~~  293 (394)
                      +|||+++.+...-.    ....+.|..|+|||.+.+...|+.+.||||+|||+.||+|-.+.|.+.         ...++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999987754322    224566999999999999999999999999999999999999999764         23578


Q ss_pred             HHHHHHHhCCCChhhhhccCC--CCcccCCCCCCCCCccc-----cc--cccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          294 LVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKPHPWHK-----VF--QKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-----~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      +..|+..+|.|....|..+..  .+.. .+.......+..     .+  ...-++...+|+.+||+.||-+|.|++++|+
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~-~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQT-LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHH-HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            899999999999988875431  1100 000001111111     11  1223556999999999999999999999999


Q ss_pred             CCCCCCCCCC
Q 016158          365 HPFFDELRDP  374 (394)
Q Consensus       365 hp~f~~~~~~  374 (394)
                      |+||++-.-+
T Consensus       337 h~yF~~d~lp  346 (438)
T KOG0666|consen  337 HPYFTEDPLP  346 (438)
T ss_pred             ccccccCCCC
Confidence            9999987555

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.9e-44  Score=332.75  Aligned_cols=245  Identities=27%  Similarity=0.433  Sum_probs=193.7

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHH-HHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++||+|+||.||+|++..+|+.||+|++.+...       ...+|. .+++.++||||+++++++     ......++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            469999999999999999999999999864321       122333 467889999999998887     3334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-  237 (394)
                      ||+++ +|...+.    ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99986 5544333    24678999999999999999999999 8999999999999999888 699999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-----------------  211 (321)
T ss_pred             CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            2223345689999999998654 4899999999999999999999999887655444443321                 


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  373 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~  373 (394)
                      ...            ++...+..+.++|.+||+.||.+|+++    .++++||||..+..
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         212 PLQ------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            000            124568899999999999999999976    49999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.8e-43  Score=319.88  Aligned_cols=277  Identities=36%  Similarity=0.621  Sum_probs=209.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++|+||+++.+++.     .....+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            46999999999999999999999999999999885432     23457999999999999999999873     334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+.+++...+..   ....+++..++.++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            9999998877655432   22457888899999999999999999 8999999999999999887 79999999987543


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhhhccC-
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN-  313 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~-  313 (394)
                      ... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+... .+.+..+....+.+......... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            221 223345688899999986655578899999999999999999999986553 35566666666766655433221 


Q ss_pred             -CCCcccCCCCCCCCCccccc-cccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          314 -PNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                       +.+................. .-..+.++.+++.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             11111111110011110000 01236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-43  Score=330.99  Aligned_cols=246  Identities=27%  Similarity=0.483  Sum_probs=194.6

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|..++..+ .|+||+.+++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999987532       2244688888877 699999999988     3334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-  237 (394)
                      ||+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99985 5544443    23679999999999999999999999 8999999999999999888 699999999875322 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCChhhhhc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....      .+.+......  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            2233456789999999999654 489999999999999999999999964221      1122222110  0        


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  373 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~f~~~~~  373 (394)
                            ..            .++..++..+.++|++||..||.+|++      .+++++||||+.+..
T Consensus       219 ------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         219 ------PI------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             ------CC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence                  00            022457899999999999999999998      579999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=326.91  Aligned_cols=259  Identities=29%  Similarity=0.496  Sum_probs=210.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+....       ....+|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            5999999999999999999999999999999886432       2345789999999999999999887     334568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+.+ +|.+++...  ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999975 776665532  23678999999999999999999999 8999999999999999887 699999999865


Q ss_pred             cccCCC------------------------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 016158          235 LVKGEP------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  284 (394)
Q Consensus       235 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p  284 (394)
                      ......                              .....|+..|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            432211                              0123568889999999654 489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC----HH
Q 016158          285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT----AL  360 (394)
Q Consensus       285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~  360 (394)
                      |.+.+....+..+....                 ..++.          ...++..++++|.+||..||++|||    ++
T Consensus       232 f~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKKE-----------------VTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcCC-----------------ccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            98877665555443210                 00000          0236899999999999999999999    99


Q ss_pred             HHhcCCCCCCCCCCCCCC
Q 016158          361 EACVHPFFDELRDPNTRL  378 (394)
Q Consensus       361 ell~hp~f~~~~~~~~~~  378 (394)
                      ++|+||||+....+..++
T Consensus       285 ~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         285 EIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHHcCchhhcCChhhccc
Confidence            999999999998888876

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-43  Score=331.98  Aligned_cols=298  Identities=35%  Similarity=0.661  Sum_probs=233.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|.+..+|+.+|+|++...      .....+|+.+++.+ +|+||+++++++..   .....
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~~   83 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDKD   83 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCce
Confidence            4699999999999999999999989999999987432      22344699999999 99999999998732   22345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+++++...+..     ..+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++..
T Consensus        84 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~  156 (337)
T cd07852          84 IYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLARS  156 (337)
T ss_pred             EEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccchhc
Confidence            789999999877665543     377888889999999999999999 8999999999999999988 699999999876


Q ss_pred             cccCC------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          235 LVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       235 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .....      ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+....+....+.+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            54332      112345788999999886656688999999999999999999999998888888888888777776655


Q ss_pred             hhccCCCCcccC---CCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016158          309 IKCMNPNYTEFK---FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP  385 (394)
Q Consensus       309 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~  385 (394)
                      +..+........   ............+ ..++.++.+||.+||+.||++|||+.++++||||+....++.......+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~  315 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPIT  315 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCcc
Confidence            443321111100   0111111111122 347899999999999999999999999999999999988877766666655


Q ss_pred             CCCCC
Q 016158          386 PLFNF  390 (394)
Q Consensus       386 ~~~~~  390 (394)
                      ++|..
T Consensus       316 ~~~~~  320 (337)
T cd07852         316 IPLDD  320 (337)
T ss_pred             CCccc
Confidence            66654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-43  Score=321.35  Aligned_cols=275  Identities=35%  Similarity=0.628  Sum_probs=215.2

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.+.||.|++|.||+|.+..+|+.||+|++....      ....+|+++++.++|+|++++++++.     ...+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            677899999999999999999999999999875432      23457999999999999999999883     3356889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      +|||+++++..++.....  ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            999998887776654221  468999999999999999999999 8999999999999999877 799999999875432


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .. ......+++.|+|||++.+...++.++|+||||+++|+|++|+.||...+....+..+.+..+.+....+.......
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 11233457889999988665557899999999999999999999999888877788887777776655442211100


Q ss_pred             c-ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          317 T-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       317 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      . ...++....... ......++.++.++|.+||+.||.+|||+++++.||||
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0 001111111111 11235678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-44  Score=335.34  Aligned_cols=244  Identities=28%  Similarity=0.480  Sum_probs=193.9

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHHHHHc---CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ||+|+||+||+|++..+|+.||||++.+...       ....|..++..+   .||||+.++.++     ......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999999999999999864321       112355566554   799999999888     3334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ +|...+.    ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 5544443    24679999999999999999999999 8999999999999999887 6999999998754332


Q ss_pred             -CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                       .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22334568999999999876555899999999999999999999999877655544443321                 


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELR  372 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~f~~~~  372 (394)
                      ...++           ...+++++.+||++||+.||.+||    ++.++++||||++..
T Consensus       213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            01111           124688999999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.4e-43  Score=327.89  Aligned_cols=298  Identities=34%  Similarity=0.581  Sum_probs=229.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCC--CcEEEEEEeccc------hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRET--GEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|++.+.||+|+||.||+|++..+  +..||+|.+...      .....+|+++++.+ .|+||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            489999999999999999999888  899999987542      12345689999998 5999999988654322 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++++++|++++|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4678999999887666543    4678999999999999999999999 8999999999999999887 69999999997


Q ss_pred             ccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          234 VLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       234 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .......     .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..++..++.++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6532211     22346788999999886655689999999999999999999999999888888999999888877765


Q ss_pred             hhccCCCCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016158          309 IKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP  385 (394)
Q Consensus       309 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~  385 (394)
                      +..+......   ..........+.. .....+..+.+||.+||+.||.+|||+.+++.||||++.+++.....+..+-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~  312 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFD  312 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccccccc
Confidence            4433211000   0011111111111 12346889999999999999999999999999999999988766544544443


Q ss_pred             CCC
Q 016158          386 PLF  388 (394)
Q Consensus       386 ~~~  388 (394)
                      +.|
T Consensus       313 ~~~  315 (332)
T cd07857         313 FSF  315 (332)
T ss_pred             CCc
Confidence            333

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=341.85  Aligned_cols=256  Identities=24%  Similarity=0.378  Sum_probs=211.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hh---hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +.|.|+..||.|+||.||+|..+.++-..|.|++... ..   .+.-|++||..+.||+||++++.|+..+.     ++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence            3489999999999999999999999988999987532 22   23358999999999999999999865444     889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc-c
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-V  236 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~-~  236 (394)
                      +.|||+|+..+.+.  ...+..+.+..+..+++|++.||.|||+ ++|||||||..|||++.+| .++|+|||.+... .
T Consensus       107 liEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccchh
Confidence            99999986544433  2345889999999999999999999999 8999999999999999999 6999999986543 2


Q ss_pred             cCCCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          237 KGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ......++.|||+|||||++.    ...+|+.++||||||++|.+|..+.+|-...+.+..+..|...  .||       
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePP-------  253 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-------  253 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCC-------
Confidence            223345789999999999974    3456999999999999999999999999988888777766541  111       


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                       .-+.+...+..+.||+.+||.+||..||++.+||+||||+++.
T Consensus       254 -----------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  254 -----------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             -----------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                             1112345678899999999999999999999999999999763

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.3e-43  Score=322.32  Aligned_cols=260  Identities=26%  Similarity=0.395  Sum_probs=204.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHH-HHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||+|++..+|+.||||++....     .....|+. .++.+.|+||+++++++...     ...+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEE
Confidence            5999999999999999999999999999999886432     12223444 46677999999999988432     3478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++++.+++.........+++..++.++.|++.||+|||+ + +++||||||+||+++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~  154 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL  154 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence            999999998888777655445679999999999999999999998 6 999999999999999887 7999999998765


Q ss_pred             ccCCCCccccccccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhhhc
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ..........++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||.... ..+.+..+....   .      
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~------  225 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---S------  225 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC---C------
Confidence            433333334678889999988542   336889999999999999999999996532 223333322210   0      


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                             ..+           ....++.++.+||.+||..||.+|||+.++++||||++......
T Consensus       226 -------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  272 (283)
T cd06617         226 -------PQL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT  272 (283)
T ss_pred             -------CCC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccH
Confidence                   000           01347889999999999999999999999999999999865543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-43  Score=330.87  Aligned_cols=244  Identities=25%  Similarity=0.431  Sum_probs=194.9

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHH-HHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRE-LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|++..+++.||+|++.+...       ...+| ..+++.++|+||+++++++.     .....++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            369999999999999999999999999864321       11223 33567889999999988873     334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc-
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  237 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-  237 (394)
                      ||+++ ++...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99986 55554432    4668899999999999999999999 8999999999999999888 699999999875432 


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            2223445689999999999654 48999999999999999999999998877665555443310                


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH----HHhcCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL----EACVHPFFDELR  372 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~f~~~~  372 (394)
                       .            .+...++..+.++|.+||+.||.+|+++.    ++++|+||....
T Consensus       213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         213 -L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             -c------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence             0            01245789999999999999999999876    899999997753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.7e-43  Score=327.61  Aligned_cols=276  Identities=36%  Similarity=0.576  Sum_probs=216.1

Q ss_pred             cEE-EeeEeeecCceEEEEEEECCCCcEEEEEEeccchh------------------hhHHHHHHHHHcCCCceeeeceE
Q 016158           83 SYI-AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALKHC  143 (394)
Q Consensus        83 ~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~~~~~  143 (394)
                      +|. +.+.||.|+||.||+|++..+++.||||++.....                  ...+|+++++.++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            465 46789999999999999999999999998754321                  24579999999999999999998


Q ss_pred             EEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc
Q 016158          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (394)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~  223 (394)
                      +.     ...+.+++|||+.+++.+.+..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .
T Consensus        89 ~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~-~  157 (335)
T PTZ00024         89 YV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG-I  157 (335)
T ss_pred             Ee-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC-C
Confidence            83     3345889999999887776643    3568999999999999999999999 8999999999999999887 6


Q ss_pred             EEEEeecCccccccC---------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 016158          224 LKLCDFGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  288 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  288 (394)
                      ++|+|||++......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999998765411               11112345778999999876555799999999999999999999999998


Q ss_pred             CcHHHHHHHHHHhCCCChhhhhccCC--CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016158          289 SGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (394)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  366 (394)
                      +..+.+..+....+.+....+.....  .+..+  ......... ......+.++.+||.+||+.||++|||++++|.||
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            88888888888777766543332110  00000  000011111 11235688999999999999999999999999999


Q ss_pred             CCCCCC
Q 016158          367 FFDELR  372 (394)
Q Consensus       367 ~f~~~~  372 (394)
                      ||+...
T Consensus       315 ~~~~~~  320 (335)
T PTZ00024        315 YFKSDP  320 (335)
T ss_pred             ccCCCC
Confidence            998663

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=338.51  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=218.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|.-++.||.|+||.||.|++..+.+.||||++.-..       ..+.+|+..|+.+.|||++.+.+||+....     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            4777899999999999999999999999999985321       234579999999999999999999965554     7


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||||-|+-.+++..+.   +++-+.++..|+.+.+.||+|||+ ++.||||||..|||+++.| .|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            8999999999989888765   789999999999999999999999 9999999999999999888 7999999999765


Q ss_pred             ccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .   +..+++|||+|||||++..  ...|+-++||||||++..||.-.++|+...+.+..+..|.+.-.           
T Consensus       177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-----------  242 (948)
T KOG0577|consen  177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------  242 (948)
T ss_pred             C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-----------
Confidence            3   4457899999999999853  44599999999999999999999999999999998888876311           


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                              |.+.        ....|..++.|+..||++-|.+|||.+++|+|+|...-+-+++
T Consensus       243 --------PtLq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv  289 (948)
T KOG0577|consen  243 --------PTLQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV  289 (948)
T ss_pred             --------CCCC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence                    1111        1345788999999999999999999999999999987665543

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-43  Score=319.36  Aligned_cols=276  Identities=39%  Similarity=0.693  Sum_probs=218.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            599999999999999999999999999999987532      2345679999999999999999998843     33478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ++|||+++++...+.   .....+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            999999987654433   223568999999999999999999999 8999999999999999887 69999999987665


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......++..|+|||++.+...++.++|+||||+++|+|++|+.||.+....+.+..+....+..+......+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            443  223456688899999997664689999999999999999999999998887777777777766655544332221


Q ss_pred             --CCcccCCCCCC-CCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 --NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                        .+....++... ...+...++..++.++.+||++||..||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              11111111111 1112223344568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.2e-43  Score=320.44  Aligned_cols=276  Identities=37%  Similarity=0.655  Sum_probs=212.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++|+||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            5999999999999999999999899999999875422      2345799999999999999999988     3445588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|+||+.++....+   ......+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            99999997543322   2223568999999999999999999999 8999999999999999887 79999999987654


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....++..|+|||.+.+...++.++||||||+++|+|++|++||......+....+....+.........+...
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 223457888999999866555789999999999999999999999887777777777766655433222111100


Q ss_pred             --CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                        ......+..............++..+.+|+++||+.||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              01111111111111111234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-42  Score=321.99  Aligned_cols=283  Identities=30%  Similarity=0.501  Sum_probs=214.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC---Cc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  151 (394)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.++||||+++++++.....   ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            346999999999999999999999999999999875321      123469999999999999999998754322   22


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ....++||||+++++...+..   ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||+
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCCC
Confidence            345689999999887666543   22468999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCC-----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +.........     ....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+....+..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            8765332211     22356788999999866555788999999999999999999999988777776666666665555


Q ss_pred             hhhhccCC--CCcccCCCCCCCCCccc-cccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          307 EEIKCMNP--NYTEFKFPQIKPHPWHK-VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       307 ~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      +.+.....  .+....++......... ......+..+.+||.+||..||.+|||++++|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            43322210  00111111111100000 0111246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-42  Score=318.61  Aligned_cols=261  Identities=24%  Similarity=0.366  Sum_probs=208.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .++|.+.+.||+|+||.||+|....+++.+|+|++...   .....+|+.+++.+ +|+|++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            45699999999999999999999999999999988543   23445788999988 899999999988654433345578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+++.........+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999975 7777776554455778999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCC-CCccccccccccccccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      .... ......++..|+|||.+....    .++.++|||||||++|+|++|+.||........+..+....  ++     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~-----  251 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--PP-----  251 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--CC-----
Confidence            4322 122345788899999875332    26889999999999999999999998766554444332210  00     


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                               .+          ......+..+.+||.+||+.||++||++.++++||||+
T Consensus       252 ---------~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 ---------TL----------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---------CC----------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                     00          01134577899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=358.83  Aligned_cols=268  Identities=29%  Similarity=0.469  Sum_probs=225.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc-------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...+|.|+++||+|+||.|.+++++.+++.||.|++.+       +...+..|..+|...+.+-|++++-.|     .+.
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            34579999999999999999999999999999998865       234566789999999999999998888     778


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .|+|+||||++| +|..++..+    .++|+.+++.|+..|+.||..||+ .|+|||||||+|||+|..|| +||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GH-ikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGH-IKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCc-Eeeccchh
Confidence            889999999986 676766653    379999999999999999999999 99999999999999999995 99999999


Q ss_pred             ccccccCCCC--ccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          232 AKVLVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       232 a~~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      +-.+..++..  ...+|||.|++||++..    ...|+..+|+||+||++|||+.|..||....-.+.+.+|+..-    
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence            9777644432  35689999999999842    2458999999999999999999999999998888888887631    


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLPNGR  382 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~~~~~~~~~~  382 (394)
                                 ..+.||..          ..+|+++++||+++++ +|+.|..   ++++.+||||.++.+.++|-...+
T Consensus       298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP  355 (1317)
T KOG0612|consen  298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP  355 (1317)
T ss_pred             -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence                       22333321          3489999999999886 4778887   999999999999988777644333


Q ss_pred             CC
Q 016158          383 PL  384 (394)
Q Consensus       383 ~~  384 (394)
                      -+
T Consensus       356 ~v  357 (1317)
T KOG0612|consen  356 VV  357 (1317)
T ss_pred             CC
Confidence            33

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.6e-43  Score=322.50  Aligned_cols=282  Identities=33%  Similarity=0.575  Sum_probs=218.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC---Cc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  151 (394)
                      .++|++.+.||.|+||.||+|++..+++.||||++....      ....+|+++++.++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            457999999999999999999999999999999875321      234679999999999999999987754332   23


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...+++++||+.+++...+..   ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            446789999999877555443   23579999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCCCC------------ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 016158          232 AKVLVKGEPN------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  299 (394)
Q Consensus       232 a~~~~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~  299 (394)
                      +.........            ....+++.|+|||.+.+...++.++||||||+++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8755332211            1234578899999986655689999999999999999999999998888888888887


Q ss_pred             HhCCCChhhhhccCC--CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          300 VLGTPTREEIKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ..+.+....+..+..  ................. ....+++.+.+||.+||+.||.+|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            777666554432211  00000000001111111 113456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-43  Score=315.65  Aligned_cols=247  Identities=28%  Similarity=0.456  Sum_probs=200.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+...         .....+|+++++.++||||+++++++.     ...
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence            499999999999999999999999999999987532         123457999999999999999999883     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++++||+++ ++.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~~  151 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS  151 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            68899999975 66555543    3568899999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.....      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------  224 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT------  224 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC------
Confidence            755332111    2345678899999997654 89999999999999999999999987655544433322100      


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                           ...++..++..+.++|++||..||.+|||+.++++||||
T Consensus       225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ---------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                 011234678899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=309.57  Aligned_cols=270  Identities=24%  Similarity=0.437  Sum_probs=209.9

Q ss_pred             cEEE-eeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      -|.+ .+.||+|+|+.|--+....+|+.||||++.+.    .....+|++++.+. .|+||++++++|     .++..+|
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY  152 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY  152 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence            3544 46799999999999999999999999999764    34455899999888 699999999998     4444478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC--cEEEEeecCcc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK  233 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~a~  233 (394)
                      +|||-|.| .+...+..    ...+++.++..+..+|+.||.|||. +||.||||||+|||......  -||||||.+..
T Consensus       153 LVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             EEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence            99999986 44333332    4789999999999999999999999 99999999999999864322  49999999875


Q ss_pred             ccccCC--------CCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----------
Q 016158          234 VLVKGE--------PNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV----------  291 (394)
Q Consensus       234 ~~~~~~--------~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----------  291 (394)
                      -+....        ...+.+|+..|||||++.    ....|+.++|.||||||+|.|++|++||.+....          
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            442221        223456778899999972    2334899999999999999999999999875321          


Q ss_pred             -----HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016158          292 -----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (394)
Q Consensus       292 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  366 (394)
                           ..+..|..                 ..+.+|.   ..|     ..+|.++++||+.+|.+|+..|.++.++++||
T Consensus       308 r~CQ~~LFesIQE-----------------GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  308 RVCQNKLFESIQE-----------------GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             HHHHHHHHHHHhc-----------------cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence                 12222222                 2233332   122     46899999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          367 FFDELRDPNTRLPNGRPLPPLFNFKP  392 (394)
Q Consensus       367 ~f~~~~~~~~~~~~~~~~~~~~~~~~  392 (394)
                      |++.....     ++.++|+.++.++
T Consensus       363 w~~~~~~e-----kalptp~v~~r~~  383 (463)
T KOG0607|consen  363 WVQRCAPE-----KALPTPQVLQRNS  383 (463)
T ss_pred             cccccchh-----ccCCCCcccccCc
Confidence            99887554     6777888777654

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-42  Score=325.58  Aligned_cols=283  Identities=36%  Similarity=0.615  Sum_probs=220.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.+.|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            3599999999999999999999999999999988542      1234579999999999999999998744322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++++||+..++....      ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6799999987654432      2468999999999999999999999 8999999999999999887 799999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            422  223456688899999986655589999999999999999999999998887777777777777666655443321


Q ss_pred             CCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      ....   ...+......+... ....+.++.+||.+||+.||.+||++.+++.||||+.++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             cchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            1100   00111111111111 134688899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=330.25  Aligned_cols=244  Identities=26%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc---chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..+..++.||+|.||.||+|.+.. ...||+|.+..   ....+.+|+++|++|+|++||++++++....     -++||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIV  279 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIV  279 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEE
Confidence            345667889999999999999964 34699998764   3355668999999999999999999994322     48899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||+ |+|.+++..  ..+..+.......++.|||.|++||++ +++|||||...||||+.+. .+||+|||+|+...+
T Consensus       280 tE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLIGD  355 (468)
T ss_pred             EEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEcccccccccCC
Confidence            99999 678887776  345789999999999999999999999 8999999999999999887 799999999995443


Q ss_pred             CCCCccccc--cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPNVSYIC--SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      +.-....-+  ...|.|||.+.. ..++.+||||||||+||||+| |+.||.+.+..+.+..+.+...-|.         
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------  425 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------  425 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------
Confidence            332222222  556999999964 459999999999999999998 9999999998888888776432222         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                         +..+|+++.+++..||..+|++|||.+.+..
T Consensus       426 -------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  426 -------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             -------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                               2578999999999999999999999997653

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-43  Score=328.37  Aligned_cols=285  Identities=35%  Similarity=0.638  Sum_probs=224.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      ++|++.+.||+|++|.||+|++..+++.||+|++...      .....+|+.+++.+.|+|++++.+++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            4599999999999999999999999999999987532      1223469999999999999999887743322 23345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++|+||++++|.+++..     ..+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~  167 (343)
T cd07851          95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLARH  167 (343)
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEcccccccc
Confidence            789999998888777653     679999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+.+....+..+.+..+.++...+.....
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            5332  33446788899999986555688999999999999999999999998888888888888777766655433221


Q ss_pred             CCc-cc--CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYT-EF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ... .+  ..+......+... ...+++.+.+||++||+.||.+|||+.+|++||||++...+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~  309 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED  309 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence            100 00  0111111111111 1346889999999999999999999999999999999877754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=319.43  Aligned_cols=253  Identities=29%  Similarity=0.454  Sum_probs=212.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      -|.++.+||+|+||.||+|.++.+|..+|||.+.-  +...+-+|+.+++++..+++|++++.|+...+     +++|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            48899999999999999999999999999998754  45566789999999999999999999988777     899999


Q ss_pred             ccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC-
Q 016158          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  238 (394)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-  238 (394)
                      ||+ |+..++++..   .+.+.+.++..++...+.||+|||. ..-+|||||..|||++.+| ..||+|||.|..+... 
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            999 6777776653   4889999999999999999999999 8999999999999999999 5999999998655322 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      ....+..|||.|||||++..-. |+.++||||||++..||.-|++||.+..++..+..                      
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM----------------------  240 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM----------------------  240 (502)
T ss_pred             HhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEe----------------------
Confidence            2334678999999999996544 99999999999999999999999987655433222                      


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                        +|...+..+..  ++..|.++.+||+.||.+.|++|.||.+|++|||.++..
T Consensus       241 --IPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  241 --IPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             --ccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence              22211111111  134578899999999999999999999999999998764

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-42  Score=326.24  Aligned_cols=286  Identities=34%  Similarity=0.570  Sum_probs=223.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            46999999999999999999999999999999886432      234569999999999999999988743322 22234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .+++++++++++.+++..     ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus        97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  169 (345)
T ss_pred             EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence            678999998887766543     568999999999999999999999 8999999999999999888 699999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+.+..+.++.........
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            432  233456788899999986655688999999999999999999999988887777777777777666655443322


Q ss_pred             CCccc---CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       315 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      .....   ..+......+.. .....++++.+||.+||+.||.+|||+.++++||||++...+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~  312 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  312 (345)
T ss_pred             HhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence            11000   001100111111 112468899999999999999999999999999999998776654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.2e-43  Score=326.72  Aligned_cols=278  Identities=21%  Similarity=0.335  Sum_probs=199.2

Q ss_pred             EeeEeeec--CceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           86 AEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        86 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ++++||+|  +|++||+++++.+|+.||+|++....      ....+|+++++.++||||+++++++..     ....++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            46789999  78999999999999999999986431      345579999999999999999998843     334789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ ++.+++....  ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999985 6766665422  2468999999999999999999999 8999999999999999887 79999998654332


Q ss_pred             cCCC--------CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC----
Q 016158          237 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT----  303 (394)
Q Consensus       237 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~----  303 (394)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||................-.    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1111        1123456779999998653 34889999999999999999999999876544433332211000    


Q ss_pred             ---CChhhhhc-c-----CCCCcccCC----CCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          304 ---PTREEIKC-M-----NPNYTEFKF----PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       304 ---~~~~~~~~-~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                         .+.+.... .     .........    ...............+++++.+||++||+.||++|||++++++||||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence               00000000 0     000000000    0000000111123456889999999999999999999999999999998


Q ss_pred             CC
Q 016158          371 LR  372 (394)
Q Consensus       371 ~~  372 (394)
                      +.
T Consensus       313 ~~  314 (327)
T cd08227         313 IK  314 (327)
T ss_pred             cc
Confidence            65

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.3e-42  Score=321.13  Aligned_cols=283  Identities=36%  Similarity=0.712  Sum_probs=223.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||.|+||.||+|.+..+++.||||++.+.      .....+|+++++.++||||+++.+++....    ..
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----ED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----Cc
Confidence            34699999999999999999999999999999987432      234457999999999999999999874322    23


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++++||+++++..++..     ..+++..+..++.|++.||+|||+ .||+|+||+|.||+++.++ .++|+|||.+..
T Consensus        85 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence            678999998887666543     568888899999999999999999 8999999999999999887 699999999875


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...........+.+.++.++.+.......
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            432  223446688899999886545689999999999999999999999998888777888888888877665543211


Q ss_pred             CCc-cc--CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          315 NYT-EF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       315 ~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      .-. .+  ..+.....+... ....++..+.++|++||+.||++|||+++++.||||+....+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             hhhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            100 00  011111111111 123578899999999999999999999999999999998887664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=317.49  Aligned_cols=277  Identities=34%  Similarity=0.611  Sum_probs=216.2

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.+.||.|++|.||+|++..+|+.+|+|.+....      ....+|+++++.++|+|++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678999999999999999999999999999986542      23457999999999999999999884321   245789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |+||+++++..++...   ...+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998776665432   2578999999999999999999999 8999999999999999888 699999999976644


Q ss_pred             CCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ...  .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+....+.+....+.....-
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            331  223455788999998866556899999999999999999999999988877777777777766665544322110


Q ss_pred             --CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                        .................+...++..+.++|++||+.||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000001111122223358999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-42  Score=324.96  Aligned_cols=286  Identities=35%  Similarity=0.636  Sum_probs=222.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCC-cee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  153 (394)
                      .++|++.+.||+|+||.||+|.+..+|..||||++...      .....+|+.+++.++|+||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            34699999999999999999999999999999987532      12345799999999999999999987433221 223


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ..++||||+++++..++..     ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            4689999998877666543     578999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .....  .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+....+.++.+......
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            65332  2334568889999998654558899999999999999999999999888777777777766666554433222


Q ss_pred             CCCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          314 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       314 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      .....   ...+....... ..+...++.++.++|.+||+.||++|||+.+++.||||+..++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~  309 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED  309 (343)
T ss_pred             chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence            11000   00111111111 1123567889999999999999999999999999999999877544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.7e-43  Score=316.33  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=202.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCceeeeceEEEecCCC-ceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~~  156 (394)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++...   .....+|+.+++.+ +|+||+++++++...... ....++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            4599999999999999999999999999999988543   33456788999988 799999999988654322 234678


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++ ++.+++...  ....+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++ .++|+|||++...
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~  161 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceec
Confidence            99999985 676666542  23568999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccC-CCCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ... .......+++.|+|||++.+    ...++.++|+|||||++|+|++|..||................         
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---------  232 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---------  232 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC---------
Confidence            322 22234567889999999853    2347889999999999999999999997654433222221100         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                        ........++.++.+||.+||..||.+|||+.++++||||
T Consensus       233 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 ------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                              0001123467899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.3e-42  Score=316.20  Aligned_cols=261  Identities=23%  Similarity=0.342  Sum_probs=206.7

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ...+|++.+.||+|+||.||+|.+..+++.+|+|++...   .....+|+.+++.+ +|+||+++++++.........+.
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            345699999999999999999999999999999987542   23456789999998 79999999998865444445668


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+++ +|.+++.........+++..++.++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCceee
Confidence            899999975 7777766554445678999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          235 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ..... ......+++.|+|||++..    ...++.++|||||||++|+|++|+.||........+..+...  .++    
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~----  247 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPP----  247 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCC----
Confidence            54322 2233467899999998742    233788999999999999999999999766543333221110  000    


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                          ....+...+..+.+||.+||+.||++|||+.++++||||
T Consensus       248 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 --------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             --------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                000113457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.4e-42  Score=316.80  Aligned_cols=247  Identities=30%  Similarity=0.504  Sum_probs=205.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+++++++.||||+++++++.     .....
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            599999999999999999999999999999988542       233457999999999999999999883     34457


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||++ ++|.+.+..    ...+++..+..++.|++.||+|||+ .|++|+||+|.|||++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 577665543    3678999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+...  .           
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  214 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K-----------  214 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence            6443  3345678899999998654 4789999999999999999999999877644444433321  0           


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                          ..            ++..++..++++|.+||+.||.+|+     +++++++||||+.+.
T Consensus       215 ----~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         215 ----VR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             ----cc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence                00            1235688999999999999999999     999999999999875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-42  Score=317.02  Aligned_cols=255  Identities=26%  Similarity=0.436  Sum_probs=199.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.++||+|+||.||+|++..+++.||+|++...     ...+.+|++++++++||||+++++.+...     ...++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence            488899999999999999999999999999987543     13345799999999999999999988432     34679


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      +|||+++......       ..+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997443211       357888999999999999999999 8999999999999999988 699999999876533


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      . ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........   .............        
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  217 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------  217 (279)
T ss_pred             c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------
Confidence            2 23345778999999998654 489999999999999999999999965322110   1111111100000        


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                          .           .......++++.+||.+||+.||++||+++++++||||+.......
T Consensus       218 ----~-----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~  264 (279)
T cd06619         218 ----P-----------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA  264 (279)
T ss_pred             ----C-----------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence                0           0011346789999999999999999999999999999998865544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=316.91  Aligned_cols=274  Identities=40%  Similarity=0.728  Sum_probs=219.4

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|+||+++++.+..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            567889999999999999999899999999875432      234578999999999999999998732     345789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ++||+++++...+...   ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999998876665542   2578999999999999999999999 8999999999999999887 699999999876644


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC--
Q 016158          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  314 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  314 (394)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+...++.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 222345678899999987654689999999999999999999999998888888888888777776665544332  


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ......++....... ......++.++++||.+||+.||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            111122222222222 11234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-42  Score=326.25  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=192.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      +++|++.++||.|+||.||+|.+.     .++..||||++...     .....+|+.+++.+ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            356999999999999999999852     34578999988642     23355799999999 899999999987422  


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSR-----------------------------------------------------  175 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  175 (394)
                        ...++++|||+++ +|.+++.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              2346789999984 77776654211                                                     


Q ss_pred             -----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC---Ccccccc
Q 016158          176 -----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICS  247 (394)
Q Consensus       176 -----~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t  247 (394)
                           ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.......   .....++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence                 12357888899999999999999999 8999999999999999887 799999999976533221   1123446


Q ss_pred             ccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCC
Q 016158          248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP  326 (394)
Q Consensus       248 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (394)
                      +.|+|||++.+. .++.++|||||||++|+|++ |..||.+......+.........               .       
T Consensus       240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---------------~-------  296 (338)
T cd05102         240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---------------M-------  296 (338)
T ss_pred             ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC---------------C-------
Confidence            789999998654 48999999999999999997 99999876544333332221000               0       


Q ss_pred             CCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       327 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                           ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=315.84  Aligned_cols=275  Identities=39%  Similarity=0.692  Sum_probs=218.9

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.+.||.|++|.||+|+...+++.||||.+....     ....+|+..++.+. |+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            678899999999999999999889999999875432     22346888999998 9999999998833     345789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||+++++.+.+....  ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888876665422  2578999999999999999999999 8999999999999999887 799999999987655


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC--
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--  315 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--  315 (394)
                      ........++..|+|||.+.....++.++|+||||+++|+|++|+.||......+.+..+...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            444445667889999999866556899999999999999999999999999888888888888887776544322110  


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      .....++..........+ ...+.++.+||++||+.||++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            011111111111111222 2347889999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-42  Score=341.13  Aligned_cols=287  Identities=21%  Similarity=0.275  Sum_probs=198.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCc-EEEEE------------------Eecc---chhhhHHHHHHHHHcCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE-IVAIK------------------KVLQ---DKRYKNRELQIMQMLDHPNIV  138 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK------------------~~~~---~~~~~~~E~~~l~~l~h~~iv  138 (394)
                      ..+|++++.||+|+||+||+|..+.... .+++|                  .+..   ....+.+|+.+++.++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3579999999999999999987643321 12222                  1111   123346799999999999999


Q ss_pred             eeceEEEecCCCceeEEEEEEecccccHHHHHHHhh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE
Q 016158          139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  217 (394)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~  217 (394)
                      ++++++..     ....+++++++.+++...+.... ..........++.++.||+.||+|||+ +||+||||||+|||+
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            99998833     33477899999887766554321 112334466788899999999999999 899999999999999


Q ss_pred             eCCCCcEEEEeecCccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCC--CcHH
Q 016158          218 NPHTHQLKLCDFGSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGE--SGVD  292 (394)
Q Consensus       218 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~--~~~~  292 (394)
                      +.++ .+||+|||++........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..+ |...  ....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9888 699999999976643322  2245789999999999655 489999999999999999998754 4332  3345


Q ss_pred             HHHHHHHHhCCCChhhhhccC---CCCcccCCCCCCCCCcccc-ccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMN---PNYTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      .+.+++..++....+......   .......+... ....... ....++.++.++|.+||++||.+|||+.|+|.||||
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            555555554433222110000   00000000000 0011111 112467889999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 016158          369 DELRDPNT  376 (394)
Q Consensus       369 ~~~~~~~~  376 (394)
                      ........
T Consensus       458 ~~~~~~~~  465 (501)
T PHA03210        458 SAEEEEEI  465 (501)
T ss_pred             hcCCchHH
Confidence            88654443

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=334.41  Aligned_cols=248  Identities=31%  Similarity=0.474  Sum_probs=205.4

Q ss_pred             EeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecccc
Q 016158           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE  164 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (394)
                      +||+|.||+||.|++..+...+|||.+...    ..-..+|+.+-++|+|.|||++++++     .+..++-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            699999999999999999999999988543    23346899999999999999999998     556678899999985


Q ss_pred             -cHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC-C
Q 016158          165 -TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-P  240 (394)
Q Consensus       165 -~l~~~~~~~~~~~~~~--~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-~  240 (394)
                       +|..+++.-+   +++  .+..+..+..||+.||.|||+ +.|||||||-+||||+...+.+||+|||-+++...-. -
T Consensus       657 GSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             7877777643   555  788899999999999999999 8999999999999999987799999999998774333 3


Q ss_pred             CccccccccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016158          241 NVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  319 (394)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  319 (394)
                      ..++.||..|||||++.. ...|+.++|||||||++.||.||++||.......  +.|++...                +
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGm----------------y  794 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGM----------------Y  794 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhhcc----------------e
Confidence            446789999999999953 3449999999999999999999999997654332  22333211                0


Q ss_pred             CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                              .....++..++.+++.||.+|+..||.+||+|.+||..||++..
T Consensus       795 --------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 --------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             --------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                    01112456789999999999999999999999999999999987

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.6e-42  Score=308.18  Aligned_cols=249  Identities=28%  Similarity=0.433  Sum_probs=200.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .|++.+.||.|++|.||++.+..+++.||+|.+....      ....+|+++++.++|+|++++.+.+.    ....+.+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            3999999999999999999999999999999875321      23457899999999999999887662    2234578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++ ++.+.+...  ....+++..++.++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999985 666666542  23568999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..... .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......+....  .          
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L----------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C----------
Confidence            43222 2234578899999998654 48899999999999999999999998766444433332210  0          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                             +         ..+..+++.+.+||.+||+.||.+|||+.++++||||
T Consensus       220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   0         0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=315.73  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||.|++|.||+|++..+++.||+|.+....     ..+.+|+.+++.++|+|++++.+++.     ...+.++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence            5889999999999999999999999999999875432     33567999999999999999999874     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      |+||+++ ++.+.+..     ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999986 66665543     378999999999999999999999 8999999999999999887 69999999997765


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .. .......+++.|+|||.+.+.. ++.++||||||+++|+|+||..||...+.......+.....             
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------  215 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-------------  215 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC-------------
Confidence            43 2233456788899999996554 89999999999999999999999977654443333222100             


Q ss_pred             CcccCCCCCCCCCcccccccc-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                     ..+... ++.++.++|.+||..||++|||++++++||||++....
T Consensus       216 ---------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         216 ---------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             ---------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence                           001122 68899999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-43  Score=326.13  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=197.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..|+++++||.||.+.||++... +.+.||+|.+..      ....+.+|+..|.+| .|.+|++++++-     -.+.+
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            36999999999999999999984 446677776532      123456899999999 689999999976     34677


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +||||||-+.+|..++....   ..++.-.++.+..||+.|+.++|. .||||.||||.|+|+- .| .+||+|||.|..
T Consensus       435 lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV-KG-RLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE-ee-eEEeeeechhcc
Confidence            99999999999998888643   334444888999999999999999 8999999999999987 35 699999999987


Q ss_pred             cccCCCC---ccccccccccccccccCCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016158          235 LVKGEPN---VSYICSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (394)
Q Consensus       235 ~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  301 (394)
                      +..+...   .+.+||+.||+||.+....          ..++++||||||||||+|+.|++||..-.  ..++++..+ 
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI-  585 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI-  585 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-
Confidence            7655433   3678999999999984321          15679999999999999999999996432  122222221 


Q ss_pred             CCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      ..|          + ..+.++..           .-..++.++++.||++||.+|||+.+||+|||++-..-+.
T Consensus       586 ~~P----------~-~~Iefp~~-----------~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~  637 (677)
T KOG0596|consen  586 TDP----------N-HEIEFPDI-----------PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV  637 (677)
T ss_pred             cCC----------C-ccccccCC-----------CCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence            111          1 11222221           1122399999999999999999999999999998754443

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.8e-43  Score=319.07  Aligned_cols=265  Identities=22%  Similarity=0.363  Sum_probs=204.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .|...+.||+|+||.||++.+..+++.||+|.+...     .....+|+.++.++. |+||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            467778899999999999999999999999988643     233457888898886 99999999987432     2367


Q ss_pred             EEEecccccHHHHHHHh-hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||++.++..+.... ......+++..+..++.|++.||+|||+..|++||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            89999987766554332 222467999999999999999999999735999999999999999887 6999999999766


Q ss_pred             ccCCCCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ..........+++.|+|||++.+.  ..++.++|||||||++|+|++|+.||....  .....+.+.....+.       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~-------  229 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP-------  229 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC-------
Confidence            544444445678899999998655  358999999999999999999999997654  222222221111000       


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                               ...     ......++.++.+||.+||+.||++|||++++++||||++....+.
T Consensus       230 ---------~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~  278 (288)
T cd06616         230 ---------ILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNV  278 (288)
T ss_pred             ---------cCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcch
Confidence                     000     0011347889999999999999999999999999999998765543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=339.66  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=203.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcC-CCceeeece-EEEecCCCc-eeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKH-CFFSTTDKE-ELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~-~~~~~~~~~-~~~~  155 (394)
                      +++|.++|.+|||+.||+|++...|..||+|++...    .+...+|+++|++|. |+|||.+++ ......... ..-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            599999999999999999999988899999987533    344568999999995 999999999 444333333 4567


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .|+||||. ++|.+++..+..  .+|++.++++|+.++++|+.+||. ..  |||||||-|||||+.++ ..||||||.|
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGSa  193 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGSA  193 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCccccc
Confidence            78999999 699888886554  669999999999999999999998 66  99999999999999988 6999999998


Q ss_pred             cccccCCC----------Ccccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016158          233 KVLVKGEP----------NVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       233 ~~~~~~~~----------~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~  300 (394)
                      +.......          ......|+.|+|||++.  .....++|+|||+|||+||.|+....||.......    |+. 
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln-  268 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN-  268 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe-
Confidence            65432221          12234599999999972  34458999999999999999999999997653211    111 


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc--------CCCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--------HPFFDELR  372 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--------hp~f~~~~  372 (394)
                                      ..|.+|..          +.++..+.+||+.||+.||.+||++-+++.        ++|+.++.
T Consensus       269 ----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  269 ----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             ----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                            12333321          467899999999999999999999998884        46666655

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=294.03  Aligned_cols=257  Identities=25%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|+|.+.||+|||+.||+++...++..||+|++.-.    .....+|++..++++|||+++++++.+....+.....|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            3699999999999999999999999999999988543    334457999999999999999988876555445566789


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|.. |++.+.+......+..+++..+..|+.+|+.||++||+ ..  ++||||||.|||+...+ .++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence            999877 67989888888777899999999999999999999999 78  99999999999999877 799999999876


Q ss_pred             cccCC----------CCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016158          235 LVKGE----------PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (394)
Q Consensus       235 ~~~~~----------~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  302 (394)
                      ..-.-          ......+|..|+|||.+.-  ....++++|||||||++|+|+.|..||....         +..|
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCC
Confidence            53221          1123457999999999832  2236889999999999999999999995321         1111


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .....   -.+   ..+.+|+          ...+|+.+.+||+.||++||.+||++.+++.+
T Consensus       250 SlaLA---v~n---~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLALA---VQN---AQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEEEe---eec---cccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            10000   000   1222332          13589999999999999999999999999864

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-42  Score=316.88  Aligned_cols=261  Identities=26%  Similarity=0.439  Sum_probs=204.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+...     .....+|+.++++++|+||+++++++.     ...+.++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            589999999999999999999999999999987542     123457999999999999999999873     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||+++ ++..++... .....+++..+..++.|++.||.|||+..||+|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999986 565554431 11347899999999999999999999635999999999999999877 79999999987553


Q ss_pred             cCCCCccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          237 KGEPNVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      .. ......+++.|+|||.+.+..     .++.++|+|||||++|+|++|+.||...........+.......+.     
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  228 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP-----  228 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-----
Confidence            22 222345678899999985432     2578999999999999999999999765544333333222111100     


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                          .++..++.++.+||.+||+.||++||++.++++||||........
T Consensus       229 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~  273 (286)
T cd06622         229 --------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV  273 (286)
T ss_pred             --------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCcc
Confidence                                012357899999999999999999999999999999998876643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3e-42  Score=314.86  Aligned_cols=256  Identities=26%  Similarity=0.396  Sum_probs=201.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCceeeeceEEEecCC-CceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~~  156 (394)
                      +.|++.+.||.|+||.||+|++..+++.||+|++....   .....|+.+++++ +|+||+++++++..... ....+.+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            35999999999999999999999999999999875432   3445688888888 79999999998854322 2345688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++ ++.+++....  ...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus        96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~  171 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhh
Confidence            99999986 7777665422  3568888899999999999999999 8999999999999999887 6999999998754


Q ss_pred             ccC-CCCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ... .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||........+..+...   ..     
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~-----  243 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP-----  243 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC-----
Confidence            322 22234567889999998752    234788999999999999999999999765543333222110   00     


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                         .......++.++.+||.+||+.||.+|||+.+||+||||
T Consensus       244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                               000113578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.1e-42  Score=316.15  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=203.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+...    .....+|+.+++.+.|+||+++++.+..     ....++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence            4699999999999999999999999999999987543    2345578999999999999999998843     335789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ ++.+++..     ..+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence            9999985 67666543     568899999999999999999999 8999999999999999887 79999999987553


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||........+..+.. .+.+..         
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~---------  236 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL---------  236 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCCC---------
Confidence            3222 2234678899999998654 478999999999999999999999987665433322211 000000         


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                      ..+..++..+.+||.+||..||++|||+.++++||||+..+.
T Consensus       237 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         237 ----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             ----------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence                            012357889999999999999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.6e-42  Score=308.35  Aligned_cols=249  Identities=27%  Similarity=0.450  Sum_probs=204.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      ...+.+|+++++.++|+|++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            489999999999999999999999999999987543      234567999999999999999998773     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+++....  ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999975 7777665422  3558999999999999999999999 899999999999999876657899999999876


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+......            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------  219 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------
Confidence            555444456678899999998654 4789999999999999999999999877655544443321100            


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                      .++..++.++.++|.+||..||++|||+.++++||||
T Consensus       220 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 ----------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ----------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                            0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-41  Score=313.18  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=204.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|++.+.||.|++|.||+|.+..+|+.||+|.+...    .....+|+.+++.++|+|++++++.+.     .....++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            4699999999999999999999999999999987543    233457899999999999999999883     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      |+||+.+ ++..++..     ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~  166 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchhcc
Confidence            9999985 66555432     568999999999999999999999 8999999999999999887 79999999987653


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+... ..+..         
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~---------  235 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL---------  235 (296)
T ss_pred             cccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCccc---------
Confidence            3322 2234678899999998644 4889999999999999999999999887655444333221 11000         


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                      ..+..+++.+.+||++||..||.+|||+.+++.||||+....
T Consensus       236 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         236 ----------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             ----------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                            011357889999999999999999999999999999987764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.7e-42  Score=314.90  Aligned_cols=282  Identities=31%  Similarity=0.505  Sum_probs=217.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC-----
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-----  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----  149 (394)
                      ..+|++.+.||+|+||.||+|.++.+|+.||+|++....      ....+|+++++.++||||+++++++....+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            346999999999999999999999999999999885432      234579999999999999999988744331     


Q ss_pred             CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      ....++++++||+++++...+...   ...+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCcc
Confidence            112368899999998776655432   3578999999999999999999999 8999999999999999887 6999999


Q ss_pred             cCccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          230 GSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       230 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      |++........  .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99876543321  1223457789999988655557899999999999999999999999888888888888877766655


Q ss_pred             hhhccCCC--CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          308 EIKCMNPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       308 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      .+......  +............+.. ....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            44322110  0000000000001111 123468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.6e-42  Score=314.73  Aligned_cols=258  Identities=28%  Similarity=0.423  Sum_probs=202.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +.|++.+.||.|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+||+++++++..     ....++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            35999999999999999999999999999999986432    234568999999999999999998843     335789


Q ss_pred             EEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||++++ +..++..   ....+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            99999874 4333322   23568999999999999999999999 8999999999999999877 79999999886543


Q ss_pred             cCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          237 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ... ......+++.|+|||.+.+    ...++.++|+|||||++|+|++|..||...+.......+....  .+      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~------  233 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP------  233 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc------
Confidence            221 1234457889999999842    2346889999999999999999999997765444333332210  00      


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                                        ....+..++.++.++|++||..||++||+++++++||||+.+....
T Consensus       234 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         234 ------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             ------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence                              0001235688999999999999999999999999999998775544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-42  Score=311.77  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=207.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCceeeeceEEEecCC-CceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~  155 (394)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++....   ..+.+|+.+++.+ .|+||+++++++..... ....+.
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            457999999999999999999999899999999876432   3456799999998 79999999999865543 345667


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+++ ++.+++.........+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~  162 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCcccee
Confidence            899999996 7777766544445789999999999999999999999 8999999999999999887 699999999875


Q ss_pred             cccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          235 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ..... ......++..|+|||.+..    ...++.++||||||+++|+|++|..||........+..+....   ..   
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~---  236 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP---  236 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC---
Confidence            43322 2234567889999998743    2346789999999999999999999997665544444333210   00   


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                   .     +  ......+.++.+||.+||..||++|||+.++++|||+
T Consensus       237 -------------~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 -------------T-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -------------C-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                         0     0  0012367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=311.61  Aligned_cols=278  Identities=35%  Similarity=0.608  Sum_probs=214.9

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCceeeeceEEEecCCCceeE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      |++.+.||.|+||.||+|++..+++.||+|++....      ....+|+.+++++   .|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999998889999999886321      2234577777666   6999999999986655444456


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .+++|||+.+++.+++....  ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999988776665422  2468999999999999999999999 8999999999999999987 799999999977


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+....+.+..+.+..+.+....+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence            65444444455788899999996544 8999999999999999999999999888888888887766554433221110 


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ......++....... ......+++.+.+||++||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            000011111111111 11223567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.9e-42  Score=316.47  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+||+++++++.     ...+.+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence            35699999999999999999999999999999988542    233457899999999999999999883     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ ++.+++..     ..+++..+..++.|++.||.|||+ .|++|+||||+|||++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccceEc
Confidence            99999985 66665543     568889999999999999999999 8999999999999999887 7999999998765


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+.. .+.+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~---------  234 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------  234 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------
Confidence            33322 223467889999999865 4488999999999999999999999976554322211111 00000         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                      ...+..++..+.+||.+||..||++||++.++++||||+..+....
T Consensus       235 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         235 ----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence                            0012357888999999999999999999999999999998766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-41  Score=306.20  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=201.6

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++|+|++++++++.     .....++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   76 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLNI   76 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEEE
Confidence            88999999999999999999999999999987532      233457899999999999999999883     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||+++ +|.+++...  ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~  152 (256)
T cd08529          77 VMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceecc
Confidence            9999974 777766643  23678999999999999999999999 8999999999999999887 69999999987654


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08529         153 DNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-------------  218 (256)
T ss_pred             CccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            3322 2234578889999998654 488999999999999999999999987765444443322100             


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                     ..+...++.++.++|++||+.+|++||++.++++|||+
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 ---------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ---------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                           00123578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.1e-42  Score=316.37  Aligned_cols=279  Identities=25%  Similarity=0.404  Sum_probs=203.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+...     .....+|+++++.++||||+++++++..     ..+.++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            499999999999999999999999999999987543     1234579999999999999999998833     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+++|+||||+|||++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 67666543    367899999999999999999999734899999999999999887 69999999987553


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+... ...+...................
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             cc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            32 22345678899999998654 48899999999999999999999997655322 22222111000000000000000


Q ss_pred             cccCCCC----------CCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          317 TEFKFPQ----------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       317 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      .....+.          .........-...++.++.+||.+||..||++|||+.++++||||++...+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence            0000000          000000000012367889999999999999999999999999999875433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-42  Score=311.76  Aligned_cols=274  Identities=41%  Similarity=0.709  Sum_probs=220.5

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.+.||+|++|.||+|++..+++.||+|++....      ....+|+.+++.++|+|++++++++.     ...+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            567889999999999999999999999999886532      23346899999999999999999883     3345789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |+||+++++.+++....   ..+++..+..++.|++.||++||+ .||+|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999988877766422   479999999999999999999999 8999999999999999887 799999999876543


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC-
Q 016158          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  315 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  315 (394)
                      .. .......+..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+.+..+.+....+..+... 
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 2223445778999999876646899999999999999999999999998888888888888888877666433221 


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      .....++..........+ ..++..+.++|++||..||++||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            112222332222222222 3458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-41  Score=307.55  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=205.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||+++++++...   .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            389999999999999999999999999999987532      22345689999999999999998877432   234577


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-----hCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-----NCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-----~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ++|||+++ +|.+++.........+++..++.++.|++.||.|||     + .+++|+||||+||+++.++ .+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999975 787777765555678999999999999999999999     8 7999999999999999887 79999999


Q ss_pred             CccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          231 SAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       231 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  226 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------  226 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence            9987654433 3345678999999998654 48899999999999999999999998776433333222100        


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                          ...++...+..+.+++.+||+.||++|||+.++++|||+
T Consensus       227 --------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 --------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             --------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                001224578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8e-42  Score=309.20  Aligned_cols=255  Identities=26%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||.|+||.||+|....++..+|+|++...     .....+|+++++.++|+|++++++.+.     .....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEEE
Confidence            599999999999999999999889999999987542     234567999999999999999988773     2345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||++++ ++.+++..... ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999985 66665543211 2568999999999999999999999 8999999999999999887 69999999987664


Q ss_pred             cCCCC-----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          237 KGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       237 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      .....     ....++..|+|||++.....++.++|+||||+++|+|++|+.||...+....+......   .+..    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~----  226 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS----  226 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC----
Confidence            43222     23457889999999866545899999999999999999999999876655444443331   0000    


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                               ++.       ......+++.+.+|+.+||..||++|||+.++++||||
T Consensus       227 ---------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         227 ---------LET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ---------cCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                     000       00013578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.9e-42  Score=309.87  Aligned_cols=246  Identities=33%  Similarity=0.539  Sum_probs=198.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------------hhhHHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      +|++...||.|++|.||+|.+..+++.||+|.+....             ....+|+.+++.++|+||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            3888899999999999999998899999999875321             234578999999999999999998733   


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                        ..+.+++|||+++ +|..++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEecc
Confidence              3457799999976 66665543    3568899999999999999999999 8999999999999999887 699999


Q ss_pred             ecCccccccCCC-------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016158          229 FGSAKVLVKGEP-------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (394)
Q Consensus       229 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  301 (394)
                      ||.++.......       .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....+..+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999876642111       1123467889999998654 47899999999999999999999998765544333322210


Q ss_pred             CCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                                  ...++..++..+.++|++||+.||.+||++.++++||||
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                        001224578899999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-44  Score=324.85  Aligned_cols=251  Identities=31%  Similarity=0.549  Sum_probs=211.1

Q ss_pred             EEE--eeEeeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           84 YIA--EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        84 y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      |+|  .++||+|.||+||-|.++.+|+.||||++.+      .....++|+.+|+.+.||.||.+...|..     ...+
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~erv  638 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERV  638 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceE
Confidence            555  4789999999999999999999999999854      34566789999999999999998776622     2237


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC--CCcEEEEeecCcc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAK  233 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vkl~Dfg~a~  233 (394)
                      ++|||-+.|++.+++-...+  +++++...+.++.||+.||.|||- ++|+|+||||+|||+...  ...+||||||+|+
T Consensus       639 FVVMEKl~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  639 FVVMEKLHGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEEehhhcchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeecccccee
Confidence            79999999988777765444  899999999999999999999999 899999999999999753  3479999999999


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .+.+..-..+..|||.|.|||+++.. .|++.-|+||+|||+|--+.|..||....+. +++++.               
T Consensus       716 iIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA---------------  779 (888)
T KOG4236|consen  716 IIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA---------------  779 (888)
T ss_pred             ecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhcc---------------
Confidence            99887777788999999999999755 4999999999999999999999999754432 222221               


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                           .+.+   .+.+|     ..+++++.+||..+|++.-++|.|.+..|.|||+|+.
T Consensus       780 -----aFMy---Pp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  780 -----AFMY---PPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             -----cccc---CCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                 1111   23455     5689999999999999999999999999999999974

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.5e-42  Score=309.23  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=197.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|++.+.||+|+||.||+|.+..++..||+|.+...         .....+|+.+++.++|+||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence            589999999999999999999999999999987532         1235679999999999999999987743   2234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++++||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~~  153 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence            57799999985 66665543    3568899999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ......    .......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||........+..+....   .   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~---~---  226 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP---T---  226 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC---C---
Confidence            754321    111234578889999998654 48999999999999999999999998765444333222110   0   


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                                           ...++..+++.+++|| +||..||++||+++|+++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                 0012245688899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=325.27  Aligned_cols=244  Identities=19%  Similarity=0.275  Sum_probs=195.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...+...||+|+||+||+|++..   .||||++..+      ...+++|+.++++-+|.||+-+.|++     .+..+ .
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~-A  463 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL-A  463 (678)
T ss_pred             Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce-e
Confidence            45678899999999999999964   4999988543      35677899999999999999999998     44444 7


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ||+.+|+| +|+.+++...   ..|.....+.|+.||++|+.|||. ++|||||||..||++.+++ +|||+|||++..-
T Consensus       464 IiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEecccceeee
Confidence            99999998 7888777644   678999999999999999999999 9999999999999999887 8999999998543


Q ss_pred             c---cCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 V---KGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      .   .........+...|||||+++.  ..+|+..+||||||+++|||+||..||........+..+-+....+....  
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~--  616 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK--  616 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh--
Confidence            1   1222233456788999999853  34589999999999999999999999985554444443333222222211  


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                            .....+.++++|+..||.+++++||+..+||.
T Consensus       617 ----------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 ----------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ----------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                  12457889999999999999999999998886

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.5e-42  Score=309.75  Aligned_cols=252  Identities=28%  Similarity=0.500  Sum_probs=200.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      +|+..+.||+|++|.||+|.+..+++.||+|++....          ..+.+|+.+++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            3888899999999999999999999999999885422          3445799999999999999999988     334


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++|+||+.+ +|.+++..    ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            457899999985 67666543    3578999999999999999999999 89999999999999987765799999999


Q ss_pred             ccccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +........     .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--  227 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence            876543211     1234568889999998654 48899999999999999999999997554333333222211000  


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                                            ....++..+++++.+++.+||..||.+|||+.++++||||+
T Consensus       228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                  00112245789999999999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=313.52  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=204.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....    ..+.+|+++++.++|+||+++++.+.     .....++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence            45999999999999999999998899999999875432    23457999999999999999999884     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ ++.+++..   ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence            9999986 66555543   23568999999999999999999999 8999999999999999887 79999999886543


Q ss_pred             cCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          237 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ... ......+++.|+|||.+..    ...++.++|+||||+++|+|++|+.||...+....+..+....  ++      
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------  226 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PP------  226 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CC------
Confidence            222 2233467889999999742    2347889999999999999999999998766554443332210  00      


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                            ..            ..+..++.++.+||.+||+.||.+||++.++++||||.+..+
T Consensus       227 ------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         227 ------TL------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             ------Cc------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence                  00            012356889999999999999999999999999999988743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-41  Score=307.21  Aligned_cols=247  Identities=28%  Similarity=0.461  Sum_probs=197.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      +|++.+.||.|+||.||+|.. .+|+.+|+|.+....          ....+|+++++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            388999999999999999987 578899999875321          2355799999999999999999988     333


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .+.++++||+++ +|.+++..    ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568899999986 66665543    3568899999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccC-------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          232 AKVLVKG-------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       232 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      +......       .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  227 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM  227 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC
Confidence            8754211       111234578889999998654 48899999999999999999999998765444333322211000


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                                ..++..++.++.++|++||+.||.+||++.++++||||
T Consensus       228 --------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         228 --------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                      01224578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-41  Score=308.55  Aligned_cols=267  Identities=25%  Similarity=0.432  Sum_probs=204.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+...     .....+|+++++.++|+||+++++++...   ....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            589999999999999999999999999999988643     23456799999999999999999988432   2334779


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999975 7777665544445678999999999999999999999 8999999999999999887 69999999987553


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhhhccCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....  .... +....+.......      
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~------  227 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPE------  227 (287)
T ss_pred             cccc-ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCchh------
Confidence            3221 234567889999998544 489999999999999999999999976522  0111 1111111100000      


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                            ++.   ..   ......++.+.+||.+||..||++|||+.|+++||||++....+
T Consensus       228 ------~~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         228 ------LKD---EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             ------hcc---CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence                  000   00   00012467899999999999999999999999999997765543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-41  Score=310.15  Aligned_cols=263  Identities=26%  Similarity=0.391  Sum_probs=202.4

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ||+|+||+||+|.+..+|+.||+|.+....       ....+|+++++.++||||+++++.+     ......|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999999999999999875421       2234699999999999999998887     3334578999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 6665554322  2468999999999999999999999 8999999999999999887 6999999998765443333


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016158          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (394)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (394)
                      ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+......                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            4456678899999986554 899999999999999999999999776542222222111000                  


Q ss_pred             CCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  390 (394)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  390 (394)
                             ....++..+++.+.++|++||+.||.+||     ++.++++||||+++.....   .....+|+|-+
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~---~~~~~~~~~~~  276 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL---EAGMLEPPFIP  276 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh---hcCCCCCCCCC
Confidence                   00012245689999999999999999999     9999999999988753333   23333355543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-41  Score=310.84  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=201.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      -|++.+.||.|+||.||+|.+..++..+++|.+....    ....+|+++++.+.|+|++++++++..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            3788999999999999999999999999999875432    234568999999999999999998843     3357899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      +||+++ ++...+..   ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEccccccccccc
Confidence            999986 44443332   23578999999999999999999999 8999999999999999887 799999999865432


Q ss_pred             CC-CCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          238 GE-PNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .. ......+++.|+|||++.    ....++.++|+|||||++|+|++|..||...+.......+.......        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------  227 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------
Confidence            21 223346788999999874    23347789999999999999999999998776555544443311000        


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                        ...+..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         228 ------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence                              001234688999999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=325.86  Aligned_cols=236  Identities=24%  Similarity=0.406  Sum_probs=198.2

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEeccc-cc
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ET  165 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~  165 (394)
                      ++.||.|+.|.||+|+..  ++.||||+++.-   .+.+++-|++|+|+||+.+.++|     ....++|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el---kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL---KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhh---hhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            356999999999999986  789999987532   23578889999999999999999     66677999999999 56


Q ss_pred             HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCcccc
Q 016158          166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI  245 (394)
Q Consensus       166 l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  245 (394)
                      |..+++.    +..+....+..|..+|+.|+.|||. +.|||||||.-||||..+. .|||+|||-++.........++.
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            6666664    5778889999999999999999999 8999999999999999887 79999999998887777778899


Q ss_pred             ccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCC
Q 016158          246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  325 (394)
Q Consensus       246 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (394)
                      ||..|||||++.+.+ .+.|+|||||||+||||+||..||.+.+....+.-+    |.                      
T Consensus       273 GTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----Gs----------------------  325 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GS----------------------  325 (904)
T ss_pred             hhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEec----cC----------------------
Confidence            999999999997654 999999999999999999999999766543222211    10                      


Q ss_pred             CCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016158          326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (394)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  366 (394)
                       -.+.-..+..++.-++-||++||.-.|..||+..++|.|=
T Consensus       326 -NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  326 -NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             -CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence             0111123467899999999999999999999999999983

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-41  Score=309.37  Aligned_cols=248  Identities=24%  Similarity=0.379  Sum_probs=190.6

Q ss_pred             EeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHH---cCCCceeeeceEEEecCCCceeEEEEE
Q 016158           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM---LDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .||+|+||.||+|.+..+++.+|+|.+.+..       ....+|..+++.   ..|+||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999875432       112234433333   479999999888732     3347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ +|...+.    ....+++..+..++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999985 5554443    24679999999999999999999999 8999999999999999887 799999999865433


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhccCCC
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD--QLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .. .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.......  .+......               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------  213 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------  213 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc---------------
Confidence            22 2334678999999998644558999999999999999999999997643321  11111100               


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT  376 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~  376 (394)
                                   ....++..++.++.++|++||..||++|+     |+.++++||||+++.....
T Consensus       214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence                         00012245789999999999999999999     6999999999999764444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-42  Score=323.48  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=217.9

Q ss_pred             CcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ......|.+.+.||+|.|+.|.+|++..++..||||.+.+..      ....+|+++|+.++|||||+++.+......  
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~--  129 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT--  129 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce--
Confidence            344456999999999999999999999999999999986542      234589999999999999999999844443  


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                         +|+||||+.++-   +..+...+.++.+..++.++.|++.|++|||+ ++|||||||++|||++.+. ++||+|||+
T Consensus       130 ---lylV~eya~~ge---~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaDfgf  201 (596)
T KOG0586|consen  130 ---LYLVMEYASGGE---LFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIADFGF  201 (596)
T ss_pred             ---eEEEEEeccCch---hHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeecccc
Confidence               899999998632   33344446788889999999999999999999 8999999999999999988 599999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +..+..+....+.+|++.|.|||++.+..+.+..+|+||+|+++|.|+.|..||.+.+-.+.-...+.            
T Consensus       202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------------  269 (596)
T KOG0586|consen  202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------------  269 (596)
T ss_pred             ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee------------
Confidence            99998888888999999999999998888789999999999999999999999998764333222211            


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                           ..+.            ++--++.++.+||+++|..+|.+|++.+++..|.|.-.....
T Consensus       270 -----gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 -----GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             -----eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                 1111            123578999999999999999999999999999999877665

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.8e-42  Score=309.58  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=197.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++|+||+++++.+..     ....++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            4599999999999999999999999999999988532    2345679999999999999999998843     234789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++..    ...+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999985 66655542    3578999999999999999999999 8999999999999999887 69999999987653


Q ss_pred             cCC-CCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ... ......+++.|+|||.+..  ...++.++|+||+||++|+|++|+.||...........+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 1234467889999998742  233688999999999999999999999655433222111110             


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                          .+..+.     +.  ....++..+.+||++||+.||++|||++++|+|+|
T Consensus       225 ----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 ----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                000000     00  01346889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-44  Score=300.59  Aligned_cols=284  Identities=31%  Similarity=0.515  Sum_probs=227.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hh----hhHHHHHHHHHcCCCceeeeceEEEe---cCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KR----YKNRELQIMQMLDHPNIVALKHCFFS---TTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~----~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~  153 (394)
                      .|+-..+||+|.||.||+|+.+.+|+.||+|++.-+  +.    ...+|+.+|..|+|+|++.+++.|-.   +......
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            477788999999999999999999999999976432  11    22479999999999999999887733   2233445


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++||.+|+.+|..++.+.   ..+++...++.++.+++.||.|+|+ ..|+|||+|++|+||+.++ .+||+|||+++
T Consensus        98 t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence            68899999999988887763   3689999999999999999999999 8999999999999999998 79999999997


Q ss_pred             ccccCCCC-----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          234 VLVKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       234 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .+......     ...+.|..|.+||.+.+...|+.+.|||..|||+.+|+|+.+.+.+.+...++..|....|....+.
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            66433221     2344589999999999999999999999999999999999999999999999999999999988888


Q ss_pred             hhccCCC--CcccCCCCCCCCCccc---cc-cccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          309 IKCMNPN--YTEFKFPQIKPHPWHK---VF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       309 ~~~~~~~--~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      |..++.-  +..++.+-+.....+.   .. +-.-.+++.+|+..+|..||.+|++++++|+|.||..=
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            8765421  1111111111111111   00 01125689999999999999999999999999999653

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-41  Score=304.25  Aligned_cols=248  Identities=34%  Similarity=0.539  Sum_probs=200.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|+..+.||+|++|.||+|....+++.|++|.+....         ..+.+|+.+++.++|+||+++++++     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            3788899999999999999998899999999875422         3355799999999999999999877     3334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++++||+++ ++.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||.+
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            57899999985 66665543    3568899999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .............++..|+|||.+.....++.++|+||||+++|+|++|+.||...........+......         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  220 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------  220 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence            76544443345567889999999854333789999999999999999999999776544333332221100         


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                        ..++..+++++.+|+++||+.||.+||++.++++|||+
T Consensus       221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                              01224578999999999999999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-41  Score=305.11  Aligned_cols=250  Identities=29%  Similarity=0.455  Sum_probs=201.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+...  ...+.+|+++++.++|+||+++++++..     ..+.++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            3599999999999999999999988999999988654  3456689999999999999999998843     34588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|.+++..   ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99986 66665543   23678999999999999999999999 8999999999999999887 6999999998766443


Q ss_pred             C-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      . ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+...   ..           .
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-----------~  217 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP-----------P  217 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC-----------C
Confidence            3 22234568889999998654 4899999999999999999999999765543322211110   00           0


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                      ..            ..+..++.++.++|.+||+.||.+|||+.++|.||||
T Consensus       218 ~~------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         218 TL------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             CC------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            00            0123467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.2e-42  Score=313.19  Aligned_cols=255  Identities=29%  Similarity=0.443  Sum_probs=204.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .|.....||+|+||.||++.+..+++.||||.+...    .....+|+.+++.++|+||+++++.+.     ...+.+++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence            466677899999999999999999999999987542    233457999999999999999999873     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ ++..++.     ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus        98 ~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~  170 (292)
T cd06658          98 MEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSK  170 (292)
T ss_pred             EeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhccc
Confidence            999986 5555443     2568999999999999999999999 8999999999999999887 799999999865432


Q ss_pred             CCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      ... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....+..+.........          
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  239 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK----------  239 (292)
T ss_pred             ccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc----------
Confidence            222 2335678899999998544 4899999999999999999999999877665544433321110000          


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                      ....++..+.++|.+||..||.+|||++++++||||+....+..
T Consensus       240 ----------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         240 ----------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             ----------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence                            01246889999999999999999999999999999998877764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.1e-41  Score=303.92  Aligned_cols=249  Identities=29%  Similarity=0.457  Sum_probs=196.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|++.+.||+|+||.||+|.+..+|+.||||.+...         .....+|+.+++.+.|+||+++++++..   ....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence            599999999999999999999999999999987421         1234579999999999999999987732   2234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .++++|||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~  153 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGAS  153 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCccc
Confidence            57789999985 66655543    3568889999999999999999999 8999999999999999887 7999999998


Q ss_pred             cccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ......    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---  226 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence            754321    112234578889999998654 489999999999999999999999976654443332221   110   


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                                           ...++..++..+.++|++||. +|++||+++++++|||+.
T Consensus       227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                 011224567889999999994 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-41  Score=303.00  Aligned_cols=248  Identities=27%  Similarity=0.433  Sum_probs=201.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...      .....+|+.+++.++|+||+++.+++     ....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            489999999999999999999999999999987532      23456799999999999999999987     3344688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +|+||+.+ ++.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999975 666655431  22467899999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCCCC-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...... ....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+....  .+         
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~---------  219 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YP---------  219 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--CC---------
Confidence            432221 234568889999998654 48899999999999999999999998766555544443211  00         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                       ..+..++.++.++|.+||+.||.+||++.++++||||
T Consensus       220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                             0124578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-41  Score=308.84  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.++||||+++++.+.     .....++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence            46999999999999999999999999999999875432    23457999999999999999999873     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||+++ +|.+++..    ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999985 66665543    3678999999999999999999999 8999999999999999887 69999999986553


Q ss_pred             cCC-CCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGE-PNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ... ......+++.|+|||.+.  ....++.++|+|||||++|+|++|..||........+..+....-.++        
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------  229 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--------  229 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--------
Confidence            221 223456789999999874  123478899999999999999999999976554433332221100000        


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                                    .+.  ....++..+.+||.+||+.||++|||++++++|||
T Consensus       230 --------------~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 --------------KLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             --------------ccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                          000  01246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=322.69  Aligned_cols=244  Identities=30%  Similarity=0.453  Sum_probs=199.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ..+|.+...+|.|+|+.|-.+.+..+++..++|++.+......+|+.++... +|+||+++.+.+     .+....++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeeee
Confidence            4469999999999999999999999999999999988877777888766655 899999999988     6666789999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE-eCCCCcEEEEeecCccccccC
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~-~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      |.+.|...  +.. ... .+.....+..|+.+|+.|+.|||+ +|+|||||||+|||+ +..+ .++|+|||.++.....
T Consensus       396 e~l~g~el--l~r-i~~-~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGEL--LRR-IRS-KPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHH--HHH-HHh-cchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCchh
Confidence            99997321  221 111 333337778899999999999999 899999999999999 4666 6999999999866443


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                        ....+-|..|.|||++. ...|+.++||||||++||+|++|+.||......   .++...++.+.             
T Consensus       470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~-------------  530 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK-------------  530 (612)
T ss_pred             --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-------------
Confidence              22334578899999996 455999999999999999999999999887665   33333333322             


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                    +...+|.++++||++||++||.+|+++.+++.||||
T Consensus       531 --------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 --------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                          125689999999999999999999999999999999

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-41  Score=303.40  Aligned_cols=252  Identities=28%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|++...    .....+|+.+++.++|+||+++++++..     ....++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            4699999999999999999999989999999987643    2345679999999999999999988733     334789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||+++ ++..++..   ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999986 56554443   12578999999999999999999999 8999999999999999887 69999999987654


Q ss_pred             cCC-CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ... ......++..|+|||.+.+.  ..++.++|+||||+++|+|++|..||...........+....-.+..       
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------  225 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-------  225 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-------
Confidence            322 22334678889999998543  14788999999999999999999999877655544433221000000       


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                                       .......+.++.+||++||..||.+|||+.+++.|||
T Consensus       226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 -----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                             0011345788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-41  Score=305.12  Aligned_cols=246  Identities=28%  Similarity=0.454  Sum_probs=201.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.       .....+|++++++++||||+++++++     ......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            489999999999999999999999999999988643       23445789999999999999999887     444568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++|+||+.+ +|...+..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            899999986 66555543    2578999999999999999999999 8999999999999999888 699999999876


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhcc
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..  ..+.....   .         
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~---------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T---------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c---------
Confidence            65443444566788899999986544 899999999999999999999999876642  22221111   0         


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFF  368 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~f  368 (394)
                                      ....++..++..+.++|.+||+.||.+||++  .|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0011224578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1e-40  Score=300.25  Aligned_cols=248  Identities=32%  Similarity=0.469  Sum_probs=203.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||.|+||.||.+++..+++.+++|.+...      .....+|++++++++|+||+++++++..     ....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            499999999999999999999999999999987532      1334579999999999999999999843     34578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++ +|.+.+....  ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999985 7777665422  3568999999999999999999999 8999999999999999887 6999999998765


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+....  ..         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--YT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CC---------
Confidence            4333 223456789999999986544 7899999999999999999999998776655555543310  00         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                       .....++.++.++|.+||..||.+||++.++++|||+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                             0113568899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-40  Score=307.67  Aligned_cols=253  Identities=28%  Similarity=0.489  Sum_probs=201.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....       ..+.+|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            4999999999999999999999999999999876432       2334789999999999999999887     334468


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+++ +|..++..    ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            899999986 66666543    3568999999999999999999999 8999999999999999887 799999998863


Q ss_pred             cccCC----------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 016158          235 LVKGE----------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  298 (394)
Q Consensus       235 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~  298 (394)
                      .....                ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21000                00123467789999998654 48999999999999999999999998776555444443


Q ss_pred             HHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 016158          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  373 (394)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~  373 (394)
                      .....                 .+.         ....++.++.++|.+||+.||++||+   +.++|+||||+....
T Consensus       230 ~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         230 SDDIE-----------------WPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             hcccC-----------------CCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            31100                 000         01247889999999999999999997   799999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-41  Score=304.36  Aligned_cols=244  Identities=29%  Similarity=0.485  Sum_probs=197.4

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ||.|++|.||+|++..+++.||+|++.+..       ..+.+|+.+++.++|+||+++++.+.     .....++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            689999999999999999999999885422       33567999999999999999999873     334478999998


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      ++ +|.+.+..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            74 77666543    2458999999999999999999999 8999999999999999888 6999999999876554333


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016158          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  319 (394)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  319 (394)
                      ....+++.|++||.+.+. .++.++|+||||+++|+|++|..||....  .......+....               ...
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~  213 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKL  213 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCC
Confidence            445678899999998544 48999999999999999999999998765  333333322100               000


Q ss_pred             CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 016158          320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  372 (394)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~  372 (394)
                                  .++...++++.++|.+||+.||++|||     ++|+++||||++..
T Consensus       214 ------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         214 ------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             ------------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence                        112345889999999999999999999     99999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.9e-41  Score=301.87  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=200.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|.+.+.||.|+||.||+|.++.+|..||+|.+...      .....+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            489999999999999999999999999999988542      23456799999999999999999987     3344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++||+++ ++.+.+...  ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 666655432  22457899999999999999999999 899999999999999988656899999998765


Q ss_pred             ccCCCC-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...... ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....  .          
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------  219 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY--F----------  219 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--C----------
Confidence            433222 234578889999988544 48899999999999999999999997765544443322210  0          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                      ..+...++.++.++|.+||..+|++|||+.++++||||
T Consensus       220 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 ----------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                            00123568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.3e-41  Score=310.44  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=202.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|++....       ..+.+|+++++.++||||+++.+++...     ...
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~   90 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTA   90 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeE
Confidence            4999999999999999999999899999999875321       2345799999999999999999988432     337


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+.+++.+++...   ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~  165 (307)
T cd06607          91 WLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV  165 (307)
T ss_pred             EEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence            799999998876665432   3568999999999999999999999 8999999999999999887 7999999998654


Q ss_pred             ccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ...   ....+++.|+|||++.+  ...++.++||||||+++|+|++|+.||...+.......+...  .+         
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~---------  231 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS---------  231 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC---------
Confidence            322   23467888999998742  344788999999999999999999999876654443332210  00         


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                              +.        ......+..+.++|.+||+.||++||++.+++.||||.....
T Consensus       232 --------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         232 --------PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             --------CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence                    00        001235788999999999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.7e-41  Score=306.91  Aligned_cols=255  Identities=29%  Similarity=0.519  Sum_probs=201.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||.|++|.||+|.++.+++.||+|.+....     ....+|+++++.+.|+||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            4888899999999999999999999999999876432     234578999999999999999998833     345889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ++||++ ++|.+++....   ..+++..+..++.|++.||+|||+..|++|+||||+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~  152 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhH
Confidence            999999 57776665422   67899999999999999999999735999999999999999887 69999999987653


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHH-HhCCCChhhhhccCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIK-VLGTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~~~~~~  314 (394)
                      ..... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ........+ ........       
T Consensus       153 ~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  223 (265)
T cd06605         153 NSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR-------  223 (265)
T ss_pred             HHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC-------
Confidence            32222 26678889999998655 589999999999999999999999976521 111111111 11110000       


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                            .           ....++..+.++|.+||..||.+|||+.+++.||||++..
T Consensus       224 ------~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         224 ------L-----------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ------C-----------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                  0           0012788999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.1e-41  Score=303.43  Aligned_cols=252  Identities=33%  Similarity=0.528  Sum_probs=197.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--------------hhhhHHHHHHHHHcCCCceeeeceEEEecC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  148 (394)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+...              ...+.+|+.+++.++|+|++++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            599999999999999999999989999999987421              123456899999999999999998873   


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                        .....++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEe
Confidence              33447899999975 66665543    2578999999999999999999999 8999999999999999887 79999


Q ss_pred             eecCccccccCC---CCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016158          228 DFGSAKVLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  303 (394)
Q Consensus       228 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  303 (394)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|++++|..||........+.++......
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA  230 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence            999987543221   122345688899999986543 3789999999999999999999999765544333322110000


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                             ..........++.++.++|.+||..||.+|||++++|+||||
T Consensus       231 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 -----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                   000011224578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=306.22  Aligned_cols=254  Identities=27%  Similarity=0.477  Sum_probs=201.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcC---CCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |+|++++++++.     ....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            388889999999999999999999999999987532     234567889999986   999999999873     2345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|||+++ +|.+++..     ..+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            7899999976 66555432     478999999999999999999999 8999999999999999877 79999999987


Q ss_pred             ccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ....... .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            6644332 233467888999999866555789999999999999999999999765433222111000            


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                             ..+.        ......+.++.+++.+||+.||++||++.++++||||++.....
T Consensus       218 -------~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~  265 (277)
T cd06917         218 -------KPPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTP  265 (277)
T ss_pred             -------CCCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccCc
Confidence                   0000        00123678999999999999999999999999999998875443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-41  Score=317.07  Aligned_cols=280  Identities=20%  Similarity=0.303  Sum_probs=199.4

Q ss_pred             eEeeec--CceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ..||.|  +||+||+|.+..+|+.||+|++....      ..+.+|+.+++.++||||+++++++.     ...+.++++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            345666  99999999999999999999875422      34467888999999999999999883     334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ ++..++....  ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99985 7766665532  2468999999999999999999999 8999999999999999887 6999999865433221


Q ss_pred             CCC--------ccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          239 EPN--------VSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       239 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ...        ....++..|+|||++.+. ..++.++|||||||++|+|++|+.||........+..........+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            111        012235669999998653 34789999999999999999999999877655444443332111110000


Q ss_pred             ---------hccCCCC----cccCCC-----CCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          310 ---------KCMNPNY----TEFKFP-----QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       310 ---------~~~~~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                               .......    ......     ......+.......++..+.+||++||+.||++|||+.++|+||||+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                     0000000    000000     0000111111223467889999999999999999999999999999998


Q ss_pred             CCCCC
Q 016158          372 RDPNT  376 (394)
Q Consensus       372 ~~~~~  376 (394)
                      ...+.
T Consensus       315 ~~~~~  319 (328)
T cd08226         315 KEQTQ  319 (328)
T ss_pred             HHhcc
Confidence            87654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.1e-40  Score=300.47  Aligned_cols=248  Identities=29%  Similarity=0.472  Sum_probs=192.3

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      ....||+|+||.||+|++..++..||+|.+...    .....+|+.+++.++|+||+++++++.     ...+.++++||
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   86 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQ   86 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEec
Confidence            345799999999999999999999999987543    234568999999999999999999873     33457899999


Q ss_pred             ccc-cHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          162 VPE-TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~--~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      +++ +|...+....   ..+  ++..+..++.|++.||+|||+ .||+||||||+||+++.+...++|+|||++......
T Consensus        87 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          87 VPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             CCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            985 7766665421   334  778888899999999999999 899999999999999874447999999998765332


Q ss_pred             CC-CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          239 EP-NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       239 ~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .. .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||.................              
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  228 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------------  228 (268)
T ss_pred             CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--------------
Confidence            22 2234578899999998543 2378899999999999999999999975432211111100000              


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                  ....++..+++++.+|+++||+.+|.+|||+.+++.||||
T Consensus       229 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 ------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                        0001234578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.3e-42  Score=286.94  Aligned_cols=286  Identities=31%  Similarity=0.580  Sum_probs=230.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      +++|++.+++|+|-|+.||.|....+++.++||+++.- ...+.+|+.+|+.|. ||||+++++++-   +.......++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~---Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVK---DPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhc---CccccCchhH
Confidence            34699999999999999999999999999999988653 456789999999995 999999999883   3444456789


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      +||+...-.      ...-..++...++.++.+++.||.|+|+ .||+|||+||.|++||.....++|+|+|+|...-.+
T Consensus       114 FE~v~n~Df------k~ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDF------KQLYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccH------HHHhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999986321      1223568888999999999999999999 899999999999999988778999999999988766


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhh-----cc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CM  312 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~  312 (394)
                      ..-.....+..|-.||.+..-..|+..-|+|||||++..|+..+.| |.+.++.+++..|.+.+|........     .+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            6666677788999999998888899999999999999999998766 56788999999999999875443221     12


Q ss_pred             CCCCcccCCCCCCCCCcccccccc----CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKR----LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ++.+... +..-...+|...+...    +++++.|||.++|..|-.+|+||.|++.||||.-+.....+
T Consensus       267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~  334 (338)
T KOG0668|consen  267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS  334 (338)
T ss_pred             ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence            2332221 1112334555554332    57999999999999999999999999999999877655443

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-40  Score=304.15  Aligned_cols=255  Identities=29%  Similarity=0.469  Sum_probs=203.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .|...+.||+|++|.||+|.+..+++.+|+|++...    .....+|+.+++.++|+||+++++++..     ..+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            466678999999999999999989999999987532    2234578999999999999999998743     3347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      +||+.+ +|.+.+..     ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999975 66665543     568999999999999999999999 8999999999999999887 799999998765433


Q ss_pred             CCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      ... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+.... .+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~-----------  234 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK-----------  234 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC-----------
Confidence            221 22345788999999986544 8999999999999999999999998766554444333210 000           


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                          .          .....++..+.+||++||+.||++|||+.++++||||++.+++..
T Consensus       235 ----~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  280 (285)
T cd06648         235 ----L----------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS  280 (285)
T ss_pred             ----C----------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcch
Confidence                0          001236889999999999999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-40  Score=303.70  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=191.4

Q ss_pred             EeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHH---HHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .||+|+||.||+|++..+++.||+|.+.+...       ....|.   ..++...|++|+.+.+++     ......++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            48999999999999999999999998754321       112233   334445899999998887     333457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+.+ +|...+.    ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999986 5544443    24679999999999999999999999 8999999999999999887 799999999875533


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      . ......++..|+|||.+.+...++.++||||+|+++|+|++|+.||..................              
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------  214 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------------  214 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------------
Confidence            2 2234568899999999865545899999999999999999999999765322111111000000              


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT  376 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~  376 (394)
                      .            ..++..++.++.++|.+||..||.+||     ++.++++||||++....-.
T Consensus       215 ~------------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~  266 (278)
T cd05606         215 A------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV  266 (278)
T ss_pred             C------------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence            0            011234689999999999999999999     9999999999999764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.4e-41  Score=305.80  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=202.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .|+..+.||.|+||.||+|.+..++..||||++....     ..+.+|+.+++.+.|+||+++++++.     ...+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            4888899999999999999999899999999876432     23457999999999999999999883     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++..     ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999986 66665543     568899999999999999999999 8999999999999999887 69999999987654


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+... . +           
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~-~-----------  218 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-N-P-----------  218 (277)
T ss_pred             CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-C-C-----------
Confidence            3322 2234567889999998654 4899999999999999999999999876544333222110 0 0           


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                     ..+...++..+.++|.+||+.||.+||++.++++||||.+....
T Consensus       219 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         219 ---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             ---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence                           01123467889999999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.8e-41  Score=317.96  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=192.2

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCC-----cEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  148 (394)
                      ..++|++.+.||+|+||.||+|++..+|     ..||+|++....     ....+|+++++.+ +|+||+++++++    
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~----  111 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC----  111 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe----
Confidence            3456999999999999999999865443     579999886432     2345799999999 899999999988    


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhh----------------------------------------------------
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------  175 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------  175 (394)
                       ......++||||+.+ +|.+++.....                                                    
T Consensus       112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence             333457899999984 67666643211                                                    


Q ss_pred             --------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          176 --------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       176 --------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                                    ...++++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++........
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcce
Confidence                          11347888899999999999999999 8999999999999999877 7999999998765433211


Q ss_pred             ---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          242 ---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       242 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                         ....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||........+..+......+             
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-------------  334 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-------------  334 (374)
T ss_pred             eeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-------------
Confidence               112235679999998654 48999999999999999997 999998765444333333211000             


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                    ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus       335 --------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 --------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             --------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          011346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-40  Score=307.85  Aligned_cols=255  Identities=20%  Similarity=0.290  Sum_probs=192.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC----------------CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVA  139 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~  139 (394)
                      ..+|++.+.||+|+||.||+|.+..                ++..||+|++...     ...+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3469999999999999999998632                3457999987643     124557999999999999999


Q ss_pred             eceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016158          140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR---------------IHQRMPLIYVKLYTYQICRALAYIHNCI  203 (394)
Q Consensus       140 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~LH~~~  203 (394)
                      +++++...     ...+++|||+.+ +|.+++.....               ....+++..+..++.||+.||.|||+ .
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~  157 (304)
T cd05096          84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L  157 (304)
T ss_pred             EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence            99988432     337899999975 77776654221               11346778899999999999999999 8


Q ss_pred             CceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 016158          204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  280 (394)
Q Consensus       204 givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt  280 (394)
                      ||+||||||+|||++.++ .+||+|||+++.......   .....++..|+|||++... .++.++||||||+++|+|++
T Consensus       158 ~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         158 NFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             CccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence            999999999999999887 699999999976533321   1123346789999998654 48999999999999999986


Q ss_pred             --CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC
Q 016158          281 --GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  358 (394)
Q Consensus       281 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  358 (394)
                        +..||......+.+..+..........           .          ....+..++..+.+||.+||+.||.+|||
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGRQ-----------V----------YLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhcccc-----------c----------cccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence              567887766555544443321100000           0          00012356889999999999999999999


Q ss_pred             HHHHhc
Q 016158          359 ALEACV  364 (394)
Q Consensus       359 ~~ell~  364 (394)
                      +.++.+
T Consensus       295 ~~~i~~  300 (304)
T cd05096         295 FSDIHA  300 (304)
T ss_pred             HHHHHH
Confidence            999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.3e-41  Score=309.48  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=202.5

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      |.....||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.+.|||++++++++..     ....++++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            55556799999999999999989999999987532    2344578999999999999999998843     33478999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ ++..++..     ..+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus        98 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~  170 (297)
T cd06659          98 EFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKD  170 (297)
T ss_pred             ecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhcccc
Confidence            99986 55554432     568999999999999999999999 8999999999999999888 6999999998654332


Q ss_pred             CC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 EP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      .. .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+.+..+...   +..           
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-----------  235 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP-----------  235 (297)
T ss_pred             cccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC-----------
Confidence            21 2345678899999998654 4899999999999999999999999876655544333211   000           


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                .+  .....++..+.++|.+||+.||.+||++.++++||||.+...+..
T Consensus       236 ----------~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         236 ----------KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             ----------Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence                      00  011346889999999999999999999999999999998766555

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-40  Score=303.75  Aligned_cols=240  Identities=17%  Similarity=0.209  Sum_probs=191.7

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      ..||+|+++.||+|.+  +|+.||||++....       ..+.+|+.++++++||||+++++++.... ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5689999999999998  58999999886432       33458999999999999999999885421 22345789999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC
Q 016158          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~  239 (394)
                      |+.+ +|.+++..    ...+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++....  
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~--  175 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS--  175 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--
Confidence            9996 67666553    357889999999999999999999734899999999999999887 799999999876532  


Q ss_pred             CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          240 PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+....+......+.             
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------  242 (283)
T PHA02988        176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK-------------  242 (283)
T ss_pred             ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Confidence            22345678899999998542 4589999999999999999999999987765555544433111100             


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                    ++..+++.+.+||.+||+.||++|||+.++++
T Consensus       243 --------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 --------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             --------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                          11356889999999999999999999999985

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.9e-40  Score=298.38  Aligned_cols=250  Identities=29%  Similarity=0.476  Sum_probs=204.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|.+.+.||.|+||.||++.+..+++.||+|++...      .....+|+++++.++|+|++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            489999999999999999999989999999988643      2345579999999999999999988743     24578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++||+++ ++...+.........+++..+..++.+++.||.+||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 7777776644345789999999999999999999999 8999999999999999877 6999999998765


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.............            
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  220 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------  220 (258)
T ss_pred             ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence            4432 222346788899999986544 88999999999999999999999977664443333322100            


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                      ..++..++..+.+++.+||..||++|||+.++|+||||
T Consensus       221 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 ----------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                            00123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-41  Score=309.98  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=201.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+....     ..+.+|+++++.++|+||+++++++.     .....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            3778889999999999999999899999999876332     24567999999999999999999883     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ ++.+++.     ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            9999986 5655543     2568999999999999999999999 8999999999999999887 79999999987654


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+...               
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence            3321 1233568889999998654 4899999999999999999999999765543333221110               


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                                   ....+...++.++.++|.+||+.+|++|||+.++++||||+.....+
T Consensus       217 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         217 -------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKT  263 (277)
T ss_pred             -------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence                         00011235678899999999999999999999999999998765443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-40  Score=306.22  Aligned_cols=259  Identities=24%  Similarity=0.394  Sum_probs=199.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.++... .|+||+++++++.     ....
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence            346999999999999999999999889999999986432     1223466555555 5999999999883     3345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .+++|||+++.+..+....   ...+++..+..++.|++.||+|||+..||+||||+|+||+++.++ .++|+|||++..
T Consensus        89 ~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~  164 (296)
T cd06618          89 VFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGR  164 (296)
T ss_pred             EEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchh
Confidence            8899999988776655442   357899999999999999999999625999999999999999887 799999999876


Q ss_pred             cccCCCCccccccccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhh
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  310 (394)
                      ...........++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||...... +.+..+...   ...    
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~----  237 (296)
T cd06618         165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EPP----  237 (296)
T ss_pred             ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CCC----
Confidence            6444333344567889999998543   23788999999999999999999999754322 222222211   000    


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                               ..+          ....++.++.+||.+||..||.+||+++++++||||+..+..
T Consensus       238 ---------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         238 ---------SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             ---------CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence                     000          002468899999999999999999999999999999876544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-40  Score=306.13  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..+|.+.+.||+|+||.||++.+..+++.||+|.+...    .....+|+.+++.++||||+++++.+..     ....+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            45799999999999999999999888999999987532    2334578899999999999999998843     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +|+||+++ ++.+++..     ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 66665543     467888999999999999999999 8999999999999999887 7999999988655


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..... .....+++.|+|||.+... .++.++|+||||+++|++++|+.||...+....+..+.. .+.+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~---------  234 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------  234 (293)
T ss_pred             cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence            33222 2234578889999998654 488999999999999999999999987654332222111 00000         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                    +  .....++..+.++|++||+.||++||++.+++.||||+..+.
T Consensus       235 --------------~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         235 --------------L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             --------------C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                          0  011346788999999999999999999999999999988753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.2e-40  Score=300.15  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=191.6

Q ss_pred             cEEEeeEe--eecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVV--GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .|.+.+.+  |+|+||.||+++++.++..+|+|.+...... ..|+.....+ +|+||+++++++..     ....++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence            46666665  9999999999999999999999987653221 2234333333 79999999998843     33588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|.+++..    ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++..++|+|||++......
T Consensus        89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            99974 77666653    2488999999999999999999999 899999999999999988756999999998765322


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                         ....++..|+|||++.+. .++.++|+||+|+++|+|++|+.||........ ...+........            
T Consensus       164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  227 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL------------  227 (267)
T ss_pred             ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC------------
Confidence               234678899999999654 489999999999999999999999986543321 122222110000            


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDE  370 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell~hp~f~~  370 (394)
                                    ...+.+++.+.+||.+||+.||.+|++ .+++|+||||+.
T Consensus       228 --------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        228 --------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                          011357899999999999999999996 599999999974

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.1e-41  Score=305.76  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=199.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.+.||+|+||+||+|.+..+|+.||+|++...     ...+.+|+++++.++|+||+++++++..     ....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence            4699999999999999999999999999999987543     2345579999999999999999998833     34578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ ++..++..    .+.+++..+..++.+++.||.|||+..|++|+||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999986 55554432    357899999999999999999999635899999999999999887 7999999998654


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------HHHHHHHhCCCChhh
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-------LVEIIKVLGTPTREE  308 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~i~~~~~~~~~~~  308 (394)
                      ... ......++..|+|||++.+. .++.++|+|||||++|+|++|+.||........       +.......-...   
T Consensus       155 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  229 (284)
T cd06620         155 INS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---  229 (284)
T ss_pred             hhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence            322 22245678899999998654 589999999999999999999999986543210       111111100000   


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                               ...+           ....++.++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus       230 ---------~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         230 ---------PPRL-----------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             ---------CCCC-----------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                     0000           0023678899999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.1e-40  Score=298.26  Aligned_cols=251  Identities=31%  Similarity=0.514  Sum_probs=204.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||.|++|.||+|++..+++.||+|++...     .....+|+..+..++|+|++++++++.     .....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEEE
Confidence            489999999999999999999999999999988654     234567999999999999999999883     3355889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||++ ++|.+++..    ...+++..++.++.|++.||.|||+..|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~  151 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLE  151 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecc
Confidence            999999 577666654    267899999999999999999999735999999999999999887 79999999987664


Q ss_pred             cCCCCc-cccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--H-HHHHHHHHHhCCCChhhhhcc
Q 016158          237 KGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--V-DQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       237 ~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~-~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....  . +....+..   ....      
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~------  221 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPP------  221 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCC------
Confidence            433332 45678889999998654 589999999999999999999999987642  2 22222211   0000      


Q ss_pred             CCCCcccCCCCCCCCCcccccccc-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                         .+... ++..+.++|.+||..+|++|||+.++++||||+...
T Consensus       222 -------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         222 -------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                               01123 788999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-40  Score=298.12  Aligned_cols=250  Identities=30%  Similarity=0.519  Sum_probs=197.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ..+.+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            4899999999999999999998899999999876432      3445799999999999999999876     2334478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +|+||+++ ++.+++..    ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 66665543    3458899999999999999999999 8999999999999999877 7999999998766


Q ss_pred             ccCCCCc-----cccccccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          236 VKGEPNV-----SYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       236 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .......     ...+++.|+|||++.+..  ..+.++||||||+++|+|++|+.||...+........... +..+   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence            4332221     235678899999985432  2788999999999999999999999765433222211111 1000   


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                 .++.          ...++..+.+||++||+.||.+|||+.++++|||+
T Consensus       226 -----------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                       0000          02358889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-40  Score=302.35  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      |.+.+.||.|+||.||+|.+..+++.||||.+....     ..+.+|+.+++.++|+||+++++++.     ...+.++|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence            788899999999999999998899999999875322     34557999999999999999999883     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ ++..++..     ..+++..+..++.|++.||.+||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~  153 (277)
T cd06641          81 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTD  153 (277)
T ss_pred             EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceeccc
Confidence            999986 56555542     568999999999999999999999 8999999999999999887 699999999876533


Q ss_pred             CCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      ... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+... ..             
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~-------------  218 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP-------------  218 (277)
T ss_pred             chhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC-------------
Confidence            221 1234568889999998544 4789999999999999999999999765544333332110 00             


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                    ..+...++.++.++|.+||+.||.+||++.++++||||.+....
T Consensus       219 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         219 --------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             --------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence                          01124578899999999999999999999999999999987554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.9e-40  Score=305.40  Aligned_cols=250  Identities=29%  Similarity=0.445  Sum_probs=201.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|...+.||+|+||.||+|++..+|+.||+|++....       ....+|+++++.++|+|++++++++..     ....
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            3777888999999999999999999999999875321       234578999999999999999998843     3447


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++|||+.+++...+..   ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        97 ~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCccc
Confidence            89999999887666543   23568999999999999999999999 8999999999999999887 6999999998643


Q ss_pred             ccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .   ......++..|+|||.+..  ...++.++|+|||||++|+|++|..||...+.......+....  .+        
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~--------  238 (313)
T cd06633         172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SP--------  238 (313)
T ss_pred             C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC--------
Confidence            2   2234567888999999842  2447889999999999999999999998776655554443210  00        


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                               .        .....++..+.+||.+||+.+|.+||++.++++||||+...
T Consensus       239 ---------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         239 ---------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             ---------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                     0        01134677899999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-42  Score=318.82  Aligned_cols=250  Identities=27%  Similarity=0.431  Sum_probs=204.4

Q ss_pred             EEeeEeeecCceEEEEEEECCCCcEEEEEEec------cc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~------~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ....+||+|+|-+||+|.+..+|..||--.++      ..  ...+..|+.+|+.|+|+||++++..+.....   ..+.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            34578999999999999999999988765332      12  2455679999999999999999998865443   5678


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +|+|++.. +|    +.|.+..+.++.+.++.|++||+.||.|||++ -.|+|||||.+||+|+.+.+.|||+|+|+|+.
T Consensus       120 ~iTEL~TSGtL----r~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTL----REYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcH----HHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            89999984 54    45555578899999999999999999999983 35999999999999998877999999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..... .....|||.|||||.+.  ..|+...||||||+.++||+|+.+||.......++.+.+.- |..|..       
T Consensus       196 ~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s-------  264 (632)
T KOG0584|consen  196 LRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA-------  264 (632)
T ss_pred             hhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH-------
Confidence            64433 33489999999999994  45999999999999999999999999988777666554432 222222       


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                        +.+--.+++++||.+||.. .++|+|+.|||.||||+.-
T Consensus       265 ------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 ------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                              1123378899999999999 9999999999999999984

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1e-40  Score=306.20  Aligned_cols=260  Identities=28%  Similarity=0.437  Sum_probs=205.8

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      |.....||+|+||.||++....+|+.||||++...    .....+|+.+++.++|+|++++++++..     ..+.+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence            44557899999999999999999999999987432    2334578999999999999999998843     34578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ ++.+++.     ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence            99986 5555443     2568999999999999999999999 8999999999999999887 6999999988655332


Q ss_pred             C-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      . ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........+.......             
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  235 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-------------  235 (292)
T ss_pred             cccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-------------
Confidence            2 1223467888999998854 447899999999999999999999998766555444333211000             


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR  382 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~  382 (394)
                         +.          ....++..+.+++.+||+.||.+||++.++++||||.+...++...+.-+
T Consensus       236 ---~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~~~~~~  287 (292)
T cd06657         236 ---LK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLMR  287 (292)
T ss_pred             ---cC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcccccHHH
Confidence               00          01346889999999999999999999999999999999987776444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-42  Score=303.67  Aligned_cols=268  Identities=28%  Similarity=0.433  Sum_probs=217.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhh-------HHHHHHHHHcC-CCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLD-HPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|..+.+||+|+||+|.+|..+.+.+.+|||+++++.-..       ..|-++|.... -|.+++++.||     +.-
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence            346889999999999999999999999999999887653222       24667777664 46777888877     333


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+|+||||+.| +|--    +...-+++.+..+..++..|+.||-+||+ +||++||||.+|||++.+|+ +||+|||+
T Consensus       423 DRLyFVMEyvnGGDLMy----hiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGH-iKi~DFGm  496 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMY----HIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGH-IKIADFGM  496 (683)
T ss_pred             hheeeEEEEecCchhhh----HHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCc-eEeeeccc
Confidence            338899999986 3322    22234788899999999999999999999 89999999999999999995 99999999


Q ss_pred             ccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++.-.-+ ....+.+|||.|+|||++. ..+|+..+|+||+||+||||+.|++||.+.+..+.++.|.+..         
T Consensus       497 cKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------  566 (683)
T KOG0696|consen  497 CKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------  566 (683)
T ss_pred             ccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---------
Confidence            9765443 3445678999999999995 4459999999999999999999999999999999999988721         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPNTRLPNGRPLP  385 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~~~~~~~~~~  385 (394)
                              .            .+++.+|.++.++++.+|.+.|.+|...     .++-.||||+.+-..+.   ..+-++
T Consensus       567 --------v------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~---E~~eiq  623 (683)
T KOG0696|consen  567 --------V------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL---ERREIQ  623 (683)
T ss_pred             --------C------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH---hhccCC
Confidence                    1            2346799999999999999999999854     58999999999865544   345567


Q ss_pred             CCCCCCC
Q 016158          386 PLFNFKP  392 (394)
Q Consensus       386 ~~~~~~~  392 (394)
                      |+|-+++
T Consensus       624 PPfkPk~  630 (683)
T KOG0696|consen  624 PPFKPKI  630 (683)
T ss_pred             CCCCCcc
Confidence            7776643

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-40  Score=315.29  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=192.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.+.||+|+||.||+|++     ..++..||||++....     ....+|+.+++.+ +||||+++++++.    
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~----  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT----  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence            34699999999999999999974     3456789999885422     2345799999999 8999999999883    


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSR-----------------------------------------------------  175 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  175 (394)
                       .....++||||+++ +|.+++.....                                                     
T Consensus       110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence             33347899999984 67666643210                                                     


Q ss_pred             ------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          176 ------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       176 ------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                                        ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                              11257888899999999999999999 8999999999999999876 799999999976543


Q ss_pred             CCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          238 GEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       238 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ....   ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||........+.........          
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR----------  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------
Confidence            3211   112335679999999654 48999999999999999998 88999876554444433331100          


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                       ...+...+.++.+||.+||+.||++|||+.++++.
T Consensus       336 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 -----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                             00113457899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=298.43  Aligned_cols=245  Identities=33%  Similarity=0.525  Sum_probs=192.3

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHH-HHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||.|+||.||+|.+..+|+.||+|++.+...       ....|..+ .....|+|++++++++.     .....++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999999999999998864321       11234333 34458999999999883     334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|..++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99975 67666543    3578999999999999999999999 8999999999999999887 699999999875433 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                        .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+......               
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  211 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN---------------  211 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC---------------
Confidence              22345788899999986654 899999999999999999999999877655544433321100               


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELR  372 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~  372 (394)
                                +.......++.++.++|.+||+.||++|||   ++|+|.||||++++
T Consensus       212 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         212 ----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence                      001112357899999999999999999995   47999999998865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-40  Score=297.13  Aligned_cols=245  Identities=27%  Similarity=0.429  Sum_probs=196.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||.|+||.||++.+..+++.||+|.+...     .....+|+.+++.++|+||+++.+.+     ....+.++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            489999999999999999999999999999987532     23445789999999999999999988     33345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||+++ ++.+.+...  ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999985 665555432  23568899999999999999999999 8999999999999999887 79999999987654


Q ss_pred             cCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.... .            
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~------------  217 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-Y------------  217 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-C------------
Confidence            3222 2345678889999998554 48999999999999999999999998766544444332210 0            


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                     ..++..++..+.+||.+||+.||++|||+.++++-
T Consensus       218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                           00123568889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-40  Score=308.81  Aligned_cols=274  Identities=20%  Similarity=0.306  Sum_probs=193.7

Q ss_pred             CceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecccc-cH
Q 016158           94 SFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TV  166 (394)
Q Consensus        94 ~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l  166 (394)
                      ++|.||.++...+++.||||++...      ...+.+|+++++.++|+||+++++++..     ....+++|||+++ ++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence            4455666666678999999987543      1345679999999999999999998843     3347899999984 67


Q ss_pred             HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC------
Q 016158          167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP------  240 (394)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~------  240 (394)
                      .+++....  ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||.+........      
T Consensus        87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeeccccccccccc
Confidence            66665432  3568899999999999999999999 8999999999999999887 699999998865532211      


Q ss_pred             --CccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh--hhccCCC
Q 016158          241 --NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE--IKCMNPN  315 (394)
Q Consensus       241 --~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~  315 (394)
                        .....++..|+|||++... ..++.++|+|||||++|+|++|..||........+.+............  .......
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence              1223457789999998543 3478899999999999999999999987655443332222110000000  0000000


Q ss_pred             Ccc----cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          316 YTE----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       316 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ...    ...+. ............++.++.+|+.+||+.||++|||+.++|+||||+.++.....
T Consensus       243 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~  307 (314)
T cd08216         243 MSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS  307 (314)
T ss_pred             cCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchh
Confidence            000    00000 00111112223456789999999999999999999999999999998865553

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.2e-40  Score=301.92  Aligned_cols=268  Identities=27%  Similarity=0.465  Sum_probs=204.8

Q ss_pred             cEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCceeeeceEEEecCCC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  150 (394)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|++....        ....+|+.+++.+ +|+||+.+++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            3899999999999999999875   478999999886421        3345799999999 589999998887     3


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      .....++||||+++ ++.+.+..    ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeC
Confidence            34457899999985 56554433    3568899999999999999999999 8999999999999999887 7999999


Q ss_pred             cCccccccCC--CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          230 GSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       230 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      |++.......  ......++..|+|||.+... ..++.++||||||+++|+|++|..||...........+........ 
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-  228 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-  228 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-
Confidence            9987653322  12234578899999998542 2367899999999999999999999975433222222222110000 


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLPNG  381 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~  381 (394)
                                              ..++..+++.+.+|+++||+.||.+||     ++++++.||||++.+....   ..
T Consensus       229 ------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~---~~  281 (290)
T cd05613         229 ------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL---AA  281 (290)
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH---hh
Confidence                                    001245788999999999999999997     8999999999999874332   34


Q ss_pred             CCCCCCCC
Q 016158          382 RPLPPLFN  389 (394)
Q Consensus       382 ~~~~~~~~  389 (394)
                      ...+++|+
T Consensus       282 ~~~~~~~~  289 (290)
T cd05613         282 KKVPAPFK  289 (290)
T ss_pred             ccCCCCCC
Confidence            44555553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-40  Score=298.83  Aligned_cols=244  Identities=21%  Similarity=0.249  Sum_probs=191.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+....     ..+.+|+.+++.++||||+++++++.     ...
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            45999999999999999999875   446789999876432     23457999999999999999999873     233


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .|++||||||+|||++.++ .++++|||.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~~  154 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRRL  154 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCccc
Confidence            47899999986 565555431   2578999999999999999999999 8999999999999999887 7999999987


Q ss_pred             cccccCCCCc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          233 KVLVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       233 ~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ..........  ...++..|+|||.+.+. .++.++|||||||++|++++ |..||......+.+..+.+...       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------  226 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-------  226 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------
Confidence            5432221111  22345689999998654 48999999999999999775 9999987766554444432110       


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                 .          ..+..++..+.+++.+||+.||.+|||+++|++
T Consensus       227 -----------~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 -----------L----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -----------C----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                       0          012457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.6e-40  Score=302.20  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=195.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCC-----cEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ..+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            36999999999999999999986555     679999885432     33567999999999999999999873     2


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~  218 (394)
                      ....+++|||+++ +|.+++.....            ....+++..+..++.|++.||.|||+ .|++|+||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence            3347799999984 77776654321            11468889999999999999999999 8999999999999999


Q ss_pred             CCCCcEEEEeecCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016158          219 PHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  294 (394)
Q Consensus       219 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  294 (394)
                      .++ .++|+|||++.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 69999999987553322   12233457889999998654 48999999999999999998 99999887665544


Q ss_pred             HHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       295 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..+......                            ..+..++.++.+|+.+||+.||.+||++.+++++
T Consensus       237 ~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433321000                            0124678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.5e-40  Score=304.52  Aligned_cols=253  Identities=28%  Similarity=0.415  Sum_probs=203.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|...+.||+|+||.||+|++..++..||+|++....       ..+.+|+++++.++|+|++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            3888999999999999999999999999999875321       234568999999999999999998843     3347


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+.+++.+++...   ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            799999998876665432   3568999999999999999999999 8999999999999999887 6999999998654


Q ss_pred             ccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ..   .....+++.|+|||.+..  ...++.++|+|||||++|+|++|..||...+....+..+.......         
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            32   234467888999999742  2347889999999999999999999998766555555444321100         


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                                        ......+..+.+||.+||+.||.+||++.++++|||+.......
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence                              01134678899999999999999999999999999997654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.9e-40  Score=297.71  Aligned_cols=248  Identities=26%  Similarity=0.426  Sum_probs=196.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||+|+||.||+|++..+++.||||.+...       ...+.+|+++++.++||||+++++++...     ...
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NEL   77 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----CeE
Confidence            599999999999999999999999999999976431       12345799999999999999999987432     347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++++||+++ ++..++.........+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~  155 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECcccccee
Confidence            799999985 7777776555445668999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhhhcc
Q 016158          235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ...... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||..... ...+.......+.++.      
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  228 (267)
T cd08228         156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL------  228 (267)
T ss_pred             ccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC------
Confidence            543221 1234578889999998654 488999999999999999999999965432 1222222221111110      


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                          .....+..+.++|.+||+.||++|||+.++++
T Consensus       229 --------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         229 --------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             --------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                11346788999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.9e-40  Score=294.27  Aligned_cols=249  Identities=26%  Similarity=0.420  Sum_probs=202.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...      .....+|+++++.++|+||+++.+++..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            489999999999999999999999999999987542      2233468899999999999999988843     34578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++||+++ ++...+.........+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999975 7777766554445778999999999999999999999 8999999999999999877 7999999999766


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+....              
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--------------  217 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            444 33345678899999998654 48889999999999999999999998776543333322110              


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                           ++         .+...++.+++++|.+||+.||++|||+.++++||++
T Consensus       218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 -----YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -----CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                 00         0113568899999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=295.25  Aligned_cols=248  Identities=28%  Similarity=0.457  Sum_probs=197.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+...         ...+.+|+++++.++|+||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence            599999999999999999999999999999986421         12445799999999999999999987332   223


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++++||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~  153 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECccccc
Confidence            46789999975 66555543    3568899999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      +.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+.++.   ..+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~---  226 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT---  226 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC---
Confidence            765321    111234578889999998654 48899999999999999999999998765444333322   1111   


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                           ...++..+++.+.++|.+||+ +|.+|||+.++++|||.
T Consensus       227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                 112335688999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-40  Score=296.89  Aligned_cols=244  Identities=21%  Similarity=0.348  Sum_probs=194.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+++++.++|+||+++++++.     .....+++|
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~   81 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYIIT   81 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEEE
Confidence            5999999999999999999999999999999886543   23557999999999999999999873     233478999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|.+.+....  ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCccccccccc
Confidence            99974 6766654322  3568899999999999999999999 8999999999999999887 7999999998765432


Q ss_pred             CCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ...  .....+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....             
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------  223 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-------------  223 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------------
Confidence            211  112235679999988554 48999999999999999998 9999987665444333322100             


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                     ...+..++.++.++|.+||+.||++|||+.++++
T Consensus       224 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ---------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                           0112457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-39  Score=292.65  Aligned_cols=250  Identities=35%  Similarity=0.531  Sum_probs=201.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++....      ....+|+.++++++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            3888999999999999999999899999999876543      34567999999999999999998874321   24578


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++||++ +++.+++..    ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999995 577666554    2388999999999999999999999 8999999999999999877 7999999998876


Q ss_pred             ccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .....   .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||.......  ..+.....          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc----------
Confidence            55443   34456788999999985544 8999999999999999999999998765221  11111100          


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                    ......++..++..+.+||.+||+.||++||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000001224568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-40  Score=309.50  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=192.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecCCC
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  150 (394)
                      .+|++.+.||+|+||.||+|.+..     +++.||+|++....     ....+|+.+++++ .|+||+++++++...   
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~---   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP---   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence            469999999999999999997543     45789999875321     2344699999999 899999999987432   


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  175 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  175 (394)
                       ...++++|||+++ +|.+++.....                                                      
T Consensus        84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             2347789999985 67666643211                                                      


Q ss_pred             ---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC---Ccccccccc
Q 016158          176 ---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRY  249 (394)
Q Consensus       176 ---~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~  249 (394)
                         ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++..+.....   .....++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12368899999999999999999999 8999999999999999887 799999999986533221   112344677


Q ss_pred             ccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCC
Q 016158          250 YRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP  328 (394)
Q Consensus       250 y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (394)
                      |+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........+                        
T Consensus       241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------------  295 (337)
T cd05054         241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM------------------------  295 (337)
T ss_pred             ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC------------------------
Confidence            9999998655 48999999999999999998 999998755444333332211000                        


Q ss_pred             ccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          329 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       329 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                         ..+...++++.+++.+||+.+|++||++.++++|
T Consensus       296 ---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         296 ---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               0123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-39  Score=298.96  Aligned_cols=255  Identities=23%  Similarity=0.323  Sum_probs=196.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ..+|++.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-----   79 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----
Confidence            3469999999999999999997652     34589999875332     23456889999999999999999873     


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~  223 (394)
                      .....+++|||++ ++|.+++......      ........+..++.|++.||.|||+ +||+||||||+|||++.++ .
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~-~  157 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF-T  157 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-c
Confidence            2234789999997 5787777653221      1334667888999999999999999 8999999999999999887 7


Q ss_pred             EEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016158          224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  299 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~  299 (394)
                      ++|+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999875533221   1122346679999998654 48999999999999999998 7889987665443333322


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCC
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL  371 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~  371 (394)
                      . +.+                           .++...++.+.+++.+||+.||++|||+.++++      ||||+.+
T Consensus       237 ~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         237 G-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             C-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            1 000                           011346789999999999999999999999986      9999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.3e-40  Score=297.33  Aligned_cols=244  Identities=33%  Similarity=0.578  Sum_probs=196.7

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ||.|+||.||+|++..+|+.+|+|++....       ....+|+++++.++|+||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999899999999886432       2345788999999999999998877     3345578999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC--
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  239 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~--  239 (394)
                      .+ +|.+++..    ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            75 77666654    2478999999999999999999999 8999999999999999888 79999999987553332  


Q ss_pred             -------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          240 -------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       240 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                             ......++..|+|||.+.... .+.++|+||||+++|+|++|..||...........+...  .         
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~---------  217 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K---------  217 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence                   122345678899999986554 889999999999999999999999877655544443321  0         


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~f~~~~  372 (394)
                            ...+.          ...++..+.+||++||+.||.+|||+   .++|+||||+++.
T Consensus       218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                  00000          01248899999999999999999999   9999999998763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-39  Score=290.98  Aligned_cols=247  Identities=29%  Similarity=0.489  Sum_probs=200.9

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      |++.+.||+|++|.||+|.+..+++.+++|++....    ....+|+++++.++|+|++++++++...     ...++++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~~   76 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIVM   76 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEE
Confidence            888999999999999999999899999999886543    4556899999999999999999988433     3477999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||++ +++.+++....   ..+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        77 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~  151 (253)
T cd05122          77 EFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDT  151 (253)
T ss_pred             ecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeecccccccccc
Confidence            9999 57766555421   578999999999999999999999 8999999999999999877 7999999998776544


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      .......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+... ..+.             
T Consensus       152 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------  216 (253)
T cd05122         152 KARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------  216 (253)
T ss_pred             ccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC-------------
Confidence            3334556788899999986544 889999999999999999999999876544444333221 0000             


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                        .+          ....++..+.++|++||+.||++|||+.++++|||
T Consensus       217 --~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 --LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence              00          00124789999999999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.5e-41  Score=308.49  Aligned_cols=280  Identities=32%  Similarity=0.543  Sum_probs=226.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh---hHHHHHHHHHcCC------CceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLDH------PNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|.+....|+|-|++|..|.+..-|..||||+|..+...   -.+|+++|++|+.      -|++.++..|     ...
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk  506 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK  506 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence            3699999999999999999999999999999999876543   3479999999953      4778888777     556


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .++|||+|.+.-+|.++++.+.. ...+....++.|+.|+..||..|-. .||+|.||||+||||++..+.+||||||.|
T Consensus       507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence            67999999999999999988655 5678999999999999999999999 799999999999999998889999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ......+ ...+..+..|.|||++.|-. |+...|+||+||+||||.||+..|++.++..++...+.+-|..+...+...
T Consensus       585 ~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             ccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            7665443 34667788899999998765 999999999999999999999999999999999999999898887766422


Q ss_pred             C-------CCCccc--------------CCCCCCCCC-ccccc--cccCC-------HHHHHHHHHhcccCCCCCCCHHH
Q 016158          313 N-------PNYTEF--------------KFPQIKPHP-WHKVF--QKRLP-------PEAVDLVCRFFQYSPNLRCTALE  361 (394)
Q Consensus       313 ~-------~~~~~~--------------~~~~~~~~~-~~~~~--~~~~~-------~~~~~li~~~L~~dP~~Rpt~~e  361 (394)
                      .       .+...+              .+...++.. +...+  ...++       ..+++||.+||..||++|.|+.+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence            1       010000              111111110 11111  01122       35899999999999999999999


Q ss_pred             HhcCCCCCC
Q 016158          362 ACVHPFFDE  370 (394)
Q Consensus       362 ll~hp~f~~  370 (394)
                      +|.||||++
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999975

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.3e-40  Score=298.90  Aligned_cols=245  Identities=33%  Similarity=0.587  Sum_probs=200.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|++...       .....+|.++++.+. |+||+++++++     .....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            599999999999999999999999999999988642       233457889999998 99999999887     33345


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++||++. ++|.+++..    ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            789999995 577666654    3479999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCCC---------------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016158          234 VLVKGEP---------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (394)
Q Consensus       234 ~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  292 (394)
                      .......                     .....++..|+|||.+... .++.++|+||||+++|++++|+.||.......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            6533221                     1223467889999998654 48899999999999999999999998777555


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFF  368 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f  368 (394)
                      .+..+....                 .            .++..+++.+.+||.+||+.||.+|||+    +++++||||
T Consensus       230 ~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKLE-----------------Y------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhcC-----------------C------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            444443210                 0            1124568899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.1e-40  Score=305.14  Aligned_cols=244  Identities=23%  Similarity=0.359  Sum_probs=189.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcE----EEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|++.+.||+|+||.||+|++..+++.    ||+|++...     ...+.+|+.+++.++|+||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            4599999999999999999998766654    899987532     23445789999999999999999987421     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                       ..+++++|+.+ ++.+.+...   ...++...+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG~  155 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEccccc
Confidence             14578898874 666655432   3468889999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          232 AKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       232 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++.........   ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+ +..+.......   
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~---  230 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL---  230 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCC---
Confidence            98664333221   12235679999998654 48999999999999999997 999997665433 23332211000   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                    +          .+..++.++.+++.+||..||.+|||+.+++.+
T Consensus       231 --------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 --------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             --------------C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          0          113467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.6e-40  Score=304.27  Aligned_cols=254  Identities=27%  Similarity=0.416  Sum_probs=203.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|...+.||+|+||.||+|++..+++.+|+|.+...       .....+|+++++.++|+|++++.+++..     ....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence            488889999999999999999999999999987532       1223468999999999999999998843     2347


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+.+++...+...   ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence            799999998876655432   3568899999999999999999999 8999999999999999887 7999999998754


Q ss_pred             ccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ...   ....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+..... +         
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~---------  232 (308)
T cd06634         166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P---------  232 (308)
T ss_pred             cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C---------
Confidence            322   23457888999999742  23478899999999999999999999977655444443332100 0         


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                       ......++..+.+||++||+.+|.+||++.++++|||+.....++.
T Consensus       233 -----------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~  278 (308)
T cd06634         233 -----------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV  278 (308)
T ss_pred             -----------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhH
Confidence                             0011356888999999999999999999999999999998765554

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.1e-40  Score=300.36  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=195.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ..+|.+.+.||+|+||.||+|.+..     +++.||+|.+...     ...+.+|+++++.+.|+||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            3469999999999999999998743     3578999988643     23456799999999999999999988433   


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhh----------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYS----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~  219 (394)
                        ...+++|||+++ +|.+++....          .....+++..+..++.|++.||.|||+ +|++||||||+||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~  157 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY  157 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence              447899999985 7766665431          122457888999999999999999999 89999999999999998


Q ss_pred             CCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016158          220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (394)
Q Consensus       220 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  295 (394)
                      ++ .++|+|||++........   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+...
T Consensus       158 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         158 DL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CC-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            87 799999999875432221   1233456789999998654 48999999999999999998 999998776655444


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+....  ..                          ..+..++..+.+||++||+.||++|||+.|+++
T Consensus       236 ~~~~~~--~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         236 CITQGR--LL--------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcCC--cC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            433210  00                          011357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-39  Score=297.21  Aligned_cols=249  Identities=21%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....     ..+.+|+.+++.++|+||+++++++     .
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence            456999999999999999999874     235679999875422     2345789999999999999999887     3


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~  223 (394)
                      .....++||||+++ +|.+++......      ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~-~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-C
Confidence            33447899999984 777766542211      1345777888999999999999999 8999999999999999887 6


Q ss_pred             EEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016158          224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  299 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~  299 (394)
                      ++|+|||+++.......   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.........+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999875533221   1122346779999998654 48999999999999999999 7899987665444433322


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .. .+                           .++..++..+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 GG-LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CC-cC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            10 00                           0123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-39  Score=327.59  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=191.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|++.++||+|+||.||+|++..+|+.||||++...       ...+.+|+++++.++||||+++++++.     ....
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            3699999999999999999999999999999998643       223457999999999999999998873     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEE
Q 016158          155 LNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                      .+++|||+++ +|.+++.....       ....++...+..++.||+.||+|||+ .||+||||||+|||++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEE
Confidence            7899999985 77777664321       12345667788999999999999999 8999999999999999888 6999


Q ss_pred             EeecCccccccCC-------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016158          227 CDFGSAKVLVKGE-------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  287 (394)
Q Consensus       227 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  287 (394)
                      +|||++.......                   ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997652110                   01124689999999998655 489999999999999999999999977


Q ss_pred             CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .........  .....+. .             .     .+     ...+++.+.+++.+||+.||++|++..+.+.
T Consensus       234 ~~~~ki~~~--~~i~~P~-~-------------~-----~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        234 KKGRKISYR--DVILSPI-E-------------V-----AP-----YREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             cchhhhhhh--hhccChh-h-------------c-----cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            543322111  1000000 0             0     00     1357889999999999999999987665553

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=311.15  Aligned_cols=266  Identities=27%  Similarity=0.420  Sum_probs=227.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +..++..||-|+||.|-++........+|+|++++..       .....|..+|.....|.||+++..|     .+..|+
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence            4677788999999999999987666668999876532       2234688999999999999999988     778889


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ||+||-|-| .+..+++.    .+.+....++.++..++.|++|||+ +|||+|||||+|.+++.+| -+||.|||+|+.
T Consensus       496 YmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAKk  569 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAKK  569 (732)
T ss_pred             hhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHHH
Confidence            999998865 66666654    4789999999999999999999999 9999999999999999998 699999999999


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      +..+..+-+++|||.|.|||++.+.. .+.++|.||||+++|||++|.+||.+.+++..+..|.+.+             
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------------  635 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------------  635 (732)
T ss_pred             hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------------
Confidence            99999999999999999999997655 8999999999999999999999999999999999888754             


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPPLFN  389 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  389 (394)
                        +.+.            +++.++..+.+||+++-..+|.+|..     +.+|.+|-||........+   .+.+||||.
T Consensus       636 --d~i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr---~~~L~pPi~  698 (732)
T KOG0614|consen  636 --DKIE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR---SRTLPPPII  698 (732)
T ss_pred             --hhhh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh---hccCCCCcc
Confidence              2222            33678999999999999999999995     8899999999998655543   344555555


Q ss_pred             C
Q 016158          390 F  390 (394)
Q Consensus       390 ~  390 (394)
                      +
T Consensus       699 ~  699 (732)
T KOG0614|consen  699 P  699 (732)
T ss_pred             c
Confidence            4

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.7e-40  Score=302.92  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=190.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcE--EEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ++|++.+.||+|+||.||+|.+..++..  +|+|.+...     ...+.+|++++.++ +|+||+++++++     ....
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence            4699999999999999999999877754  577765432     22445799999999 899999999987     3334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~  220 (394)
                      +.+++|||++ ++|.+++.....            ....+++..++.++.|++.||+|||+ .|++||||||+|||++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCC
Confidence            5789999997 477776654321            12357899999999999999999999 899999999999999988


Q ss_pred             CCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016158          221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  299 (394)
Q Consensus       221 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~  299 (394)
                      + .+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|+| |..||.+.+..+....+..
T Consensus       161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             C-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            7 7999999998643221111122335679999988544 48899999999999999998 9999977665443332211


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..                  ..          ..+..+++++.+||.+||+.||++||++++++.+
T Consensus       239 ~~------------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 GY------------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CC------------------cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00                  00          0113467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=291.00  Aligned_cols=265  Identities=24%  Similarity=0.351  Sum_probs=208.2

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHH-HHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+-+..||.|+||+|++..++.+|+..|||.++...     ..+..|.+. ++.-+.||||++++.++...+     .+|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cWi  140 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CWI  140 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----eee
Confidence            444567999999999999999999999999986533     233345544 344478999999999876665     788


Q ss_pred             EEecccccHHHHHH-HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPETVNRIAR-NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      -||+|.-++..+-+ .+.-....+++..+-.+....+.||.||-+...|+|||+||+|||++..| .|||||||.+..+.
T Consensus       141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV  219 (361)
T ss_pred             eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence            99999977765533 23344578999999999999999999998878999999999999999998 69999999997776


Q ss_pred             cCCCCccccccccccccccccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCChhhhhccCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~  314 (394)
                      ..-......|...|||||.+..... |+.++|+||||++|||+.||..||...+.  .+.++.+.. |.|+.-....   
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~---  294 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDK---  294 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcc---
Confidence            6555566778899999999965444 89999999999999999999999976543  344443332 3333221110   


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                                        -.-+++..+..+|..||.+|-+.||.-.+|++|||++.......+
T Consensus       295 ------------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~  339 (361)
T KOG1006|consen  295 ------------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD  339 (361)
T ss_pred             ------------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence                              012478899999999999999999999999999999986554443

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7e-40  Score=295.62  Aligned_cols=249  Identities=24%  Similarity=0.437  Sum_probs=197.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc---------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|.+.+.||+|+||.||++++..++..+++|++..         ......+|+.+++.++||||+++++++..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            48999999999999999999987777777776542         11223468889999999999999988732     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++++||+++ ++..++.........+++..++.++.|++.||.|||+ .|++|+||||+||+++. + .++|+|||.+
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-C-CEeecccCce
Confidence            47799999985 7777776655556789999999999999999999999 89999999999999985 3 5999999998


Q ss_pred             cccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...  ..+      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~------  223 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP------  223 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC------
Confidence            76533322 2234568889999998544 4788999999999999999999999765544333332220  000      


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                          .++..++.++.++|.+||..||++||++.++++||||
T Consensus       224 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         224 --------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             --------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                                0124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-39  Score=298.00  Aligned_cols=248  Identities=24%  Similarity=0.354  Sum_probs=194.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      +.+|.+.+.||+|+||.||++.+.     .++..+|+|.+...    .....+|+++++.++|+||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            346999999999999999999852     34567999987643    233567999999999999999999873     3


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhh---------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSR---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~  221 (394)
                      ..+.+++|||++ ++|.+++.....         ....+++..+..++.|++.||+|||+ .|++||||||+|||++.++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            345789999998 477776654321         12358999999999999999999999 8999999999999999887


Q ss_pred             CcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016158          222 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  297 (394)
Q Consensus       222 ~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i  297 (394)
                       .++|+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+.+..+
T Consensus       158 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         158 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             -cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             699999999876533221   1123346789999998654 48999999999999999998 89999877655544444


Q ss_pred             HHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ....  ..                          .....++.++.+|+.+||+.||.+|||+.+++.
T Consensus       236 ~~~~--~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         236 TQGR--VL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HcCC--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3210  00                          011346889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-39  Score=292.68  Aligned_cols=245  Identities=24%  Similarity=0.328  Sum_probs=193.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..+|++.++||+|+||.||+|.+. ++..||+|.+...   .....+|+.+++.++|+||+++++++     ......++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            346999999999999999999975 5677999987643   23456799999999999999998887     33344789


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||++ +++.+++...  ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 4777666542  23568888999999999999999999 8999999999999999887 79999999997654


Q ss_pred             cCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .....  ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+.....           
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  222 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-----------  222 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            32211  122346679999998554 48899999999999999998 9999987665554444332110           


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                             .+          ....++.++.+++.+||..||++|||++++++
T Consensus       223 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 -------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                   00          11357889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-39  Score=291.92  Aligned_cols=243  Identities=22%  Similarity=0.319  Sum_probs=192.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..|++.+.||+|+||.||+|..+ ++..+|+|.+...   ...+.+|+.+++.++||||+++++++.     .....+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence            35899999999999999999885 4567999987643   234567999999999999999999873     33347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ +|.+.+...   ...+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            999974 666555431   2468899999999999999999999 8999999999999999887 799999999876533


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+.+....           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------  220 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----------  220 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence            2221  122345679999998644 48999999999999999999 89999887766655554331100           


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             011235778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-39  Score=300.30  Aligned_cols=247  Identities=22%  Similarity=0.298  Sum_probs=190.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCc--EEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      +|++.++||+|+||.||+|....++.  .+++|.+...     ...+.+|+.+++++ +||||+++++++.     ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~~   77 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRGY   77 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCCc
Confidence            59999999999999999999877765  4688876531     12355799999999 7999999999873     3334


Q ss_pred             EEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC
Q 016158          155 LNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~  221 (394)
                      .+++|||++ ++|.+++.....            ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCC
Confidence            789999997 477777654221            12358889999999999999999999 8999999999999999887


Q ss_pred             CcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016158          222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       222 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~  300 (394)
                       .+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+...
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~  234 (297)
T cd05089         157 -ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  234 (297)
T ss_pred             -eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence             6999999998643221111112234569999998554 48999999999999999997 99999877655544433221


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..                            ...+..++.++.+||.+||+.||.+|||++++++.
T Consensus       235 ~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         235 YR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            10                            00123578899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-39  Score=289.74  Aligned_cols=246  Identities=35%  Similarity=0.586  Sum_probs=201.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|++|.||+|++..+++.||+|.+....      ....+|++++++++|+|++++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4889999999999999999999899999999886543      23467999999999999999998873     234578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||+++ +|.+++..    ...+++..++.++.|++.||.+||+ .||+|+||||+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 66655543    2678999999999999999999999 8999999999999999877 7999999999766


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...........+....             
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  215 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-------------  215 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-------------
Confidence            44332 23346788899999986554 8899999999999999999999998766444333332100             


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                     ...++..++..+.++|.+||..||++|||+.++++||||
T Consensus       216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                           001224678999999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.5e-39  Score=294.86  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=193.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|.+.+.||+|++|.||+|.+..     ++..||+|.+...     ...+.+|+.+++.++|+||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            3469999999999999999999976     6788999987532     22345789999999999999999987432   


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcE
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL  224 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~v  224 (394)
                        ...+++|||+. ++|.+++.....   ....+++..+..++.||+.||+|||+ .+++|+||||+||+++.++  ..+
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence              23578999996 477777655321   11358899999999999999999999 8999999999999998654  259


Q ss_pred             EEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016158          225 KLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       225 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~  300 (394)
                      ||+|||+++.......   ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999976532211   11222346799999986544 8999999999999999997 99999876655433322211


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                       ...                           ..+..++..+.+++.+||+.||++|||+.++++|
T Consensus       238 -~~~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 -GRL---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CcC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             000                           0124578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-39  Score=319.90  Aligned_cols=290  Identities=21%  Similarity=0.258  Sum_probs=187.0

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCC----CcEEEEEEeccchhhhHHHHHHH---HHcCCCceeeeceEEEecC-CC
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQDKRYKNRELQIM---QMLDHPNIVALKHCFFSTT-DK  150 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~-~~  150 (394)
                      ...++|.+.+.||+|+||.||+|++..+    +..||||++.....   .|..+.   +...+.++..+...+.... ..
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence            3556899999999999999999999988    89999998754321   222222   2222333333333222111 13


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhh----------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCC
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSR----------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~----------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~  213 (394)
                      .....++|+||+++ +|.+++.....                .........+..++.||+.||+|||+ .||+||||||+
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~  284 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQ  284 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHH
Confidence            34457799999985 67666543210                00112234567899999999999999 89999999999


Q ss_pred             cEEEeCCCCcEEEEeecCccccccCC--CCccccccccccccccccCCC---------------------CCCchhhHHH
Q 016158          214 NLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT---------------------EYTTAIDIWS  270 (394)
Q Consensus       214 Nil~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diws  270 (394)
                      |||++.+...+||+|||+|+......  ......+++.|+|||.+....                     .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            99999754479999999997553322  223457789999999763211                     2345679999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcc
Q 016158          271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  350 (394)
Q Consensus       271 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  350 (394)
                      |||++|||+++..++  ......+..++...+...........+...    +...  .... +.........+||++||+
T Consensus       365 lGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----~~~~--~~~~-~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        365 AGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRAS----PDLR--RGFE-VLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhccccc----hhhh--hhhh-hccccchHHHHHHHHHcc
Confidence            999999999976554  333334444444333322221111111000    0000  0000 012234567799999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016158          351 YSPNLRCTALEACVHPFFDELRDPNTRLPNG  381 (394)
Q Consensus       351 ~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~  381 (394)
                      +||++|||+.++|+||||++......+..+.
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~~~~~~~~~~  466 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREGLLGLSVMQN  466 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCCccccccccc
Confidence            9999999999999999999876655544444

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-39  Score=308.47  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=191.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCC-----CcEEEEEEeccch-----hhhHHHHHHHHHcC-CCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.++||+|+||.||+|++...     +..||||++....     ..+.+|+++++.+. ||||+++++++     
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence            44699999999999999999987433     3469999885432     33457999999996 99999999988     


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSR-----------------------------------------------------  175 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  175 (394)
                      ......++||||+++ +|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            333457899999984 77666543211                                                     


Q ss_pred             ---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          176 ---------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       176 ---------------------------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                                                             ....+++..+..++.|++.||+|||+ .||+||||||+|||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence                                                   11347888889999999999999999 89999999999999


Q ss_pred             EeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016158          217 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  292 (394)
Q Consensus       217 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  292 (394)
                      ++.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus       270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99887 699999999876533221   1233456789999998654 48999999999999999997 999998754443


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+.........+                           ..+..++.++.+++.+||+.||++|||+.++.+
T Consensus       348 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333322211000                           012357889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-39  Score=295.29  Aligned_cols=248  Identities=28%  Similarity=0.444  Sum_probs=195.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +|++.+.||.|+||.||+|++..+++.||||.+...       .....+|+.+++.++|+||+++++++..     ....
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCeE
Confidence            588999999999999999999999999999977532       1234578999999999999999998843     3347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+++ ++.+++.........+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~  155 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhhc
Confidence            799999985 7777776544445678999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhcc
Q 016158          235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... ............+        
T Consensus       156 ~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  226 (267)
T cd08229         156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--------  226 (267)
T ss_pred             cccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC--------
Confidence            543322 2234678899999998654 4889999999999999999999999754321 1111111100000        


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                        ......+++.+.+||.+||+.||.+|||+.++++
T Consensus       227 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         227 ------------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                              0011347889999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-39  Score=294.88  Aligned_cols=251  Identities=20%  Similarity=0.261  Sum_probs=190.9

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCc--EEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      |.+.+.||+|+||.||+|++..++.  .||+|.+...      .....+|+++++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999877765  5899987532      2334578999999999999999987754332 12234


Q ss_pred             EEEEEecccc-cHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .+++|||+.+ ++.+.+....  .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCc
Confidence            6789999984 6666553322  122458899999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          232 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       232 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++.......   .....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.........+.... .+   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---  233 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RL---  233 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CC---
Confidence            986643321   1122346779999998554 48999999999999999999 889998765544333332210 00   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                              .....++..+.++|.+||+.||.+|||+.+++++
T Consensus       234 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 ------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    0113567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-39  Score=291.47  Aligned_cols=244  Identities=22%  Similarity=0.304  Sum_probs=193.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|++.+.||+|++|.||+|.+. +++.||+|.+...   .....+|+.+++.++|+||+++++++.     .....+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeeee
Confidence            45999999999999999999975 4578999988653   234567999999999999999998773     23347899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||++ ++|.+++....  ...+++..+..++.|++.||.+||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99995 67777665422  3568999999999999999999999 8999999999999999888 699999999976643


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  .....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+......+..+......           
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  223 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-----------  223 (261)
T ss_pred             CcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2211  111223579999988654 48999999999999999999 99999877655555444321100           


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ..+..++..+.+++.+||+.||.+||++.++++
T Consensus       224 -----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 -----------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                             011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.4e-39  Score=325.74  Aligned_cols=141  Identities=26%  Similarity=0.440  Sum_probs=122.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+++.++|+||++++.++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            46999999999999999999999999999999986532       4456789999999999999998877     33345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|+||||+.+ +|..++..    ...+++..++.++.||+.||+|||. .||+||||||+|||++.++ .+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            8899999964 77666643    3568899999999999999999999 8999999999999999887 69999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=294.40  Aligned_cols=251  Identities=20%  Similarity=0.288  Sum_probs=193.9

Q ss_pred             EEEeeEeeecCceEEEEEEECCC---CcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC-Ccee
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  153 (394)
                      |.+.+.||+|+||.||+|....+   +..||+|.+....      ....+|+++++.++|+||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56789999999999999987643   4789999886432      234578999999999999999988754333 2334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      +.+++|||+++ ++...+.....  ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence            57899999984 67666644322  22468999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +++........   .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+..+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            99765433211   11233567999999854 458999999999999999999 889998766555443332210     


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                 ..            ..+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       233 -----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -----------RL------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -----------CC------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       00            0124578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3e-39  Score=290.86  Aligned_cols=244  Identities=20%  Similarity=0.291  Sum_probs=191.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..|++.+.||+|+||.||+|.+.. +..+|+|.+...   ...+.+|+.+++.++||||+++++++.     .....+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence            359999999999999999998753 456999987643   234567999999999999999999873     22346899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+.+ ++.+++...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999975 566655431   2468999999999999999999999 8999999999999999887 799999999876543


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.+.....          
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  221 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY----------  221 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC----------
Confidence            3211  122345679999998654 48999999999999999998 999998766554444443311000          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                        .....+..+.+++.+||..||.+|||+.+++.+
T Consensus       222 ------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         222 ------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                              112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-39  Score=296.20  Aligned_cols=248  Identities=20%  Similarity=0.312  Sum_probs=192.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC----CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..|++.+.||+|+||.||+|...    .++..||+|.+....     ..+.+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            35899999999999999999853    456789999886321     345679999999999999999998732     2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhh-------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSR-------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~-------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~  218 (394)
                      ...+++|||+++ +|.+++.....             ....+++..+..++.|++.||+|||+ +|++|+||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence            347899999985 77666542210             12357888899999999999999999 8999999999999999


Q ss_pred             CCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016158          219 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  294 (394)
Q Consensus       219 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  294 (394)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.......
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 699999999976533221   1223446679999998654 48999999999999999998 99999876544333


Q ss_pred             HHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       295 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..+... ..+                           ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       237 ~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            333221 000                           0124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.3e-39  Score=296.44  Aligned_cols=253  Identities=31%  Similarity=0.461  Sum_probs=204.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..|++...||+|++|.||+|.+..+++.||+|++....   ....+|+++++.++|+|++++++++...     ...+++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv   93 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWVV   93 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEEE
Confidence            45999999999999999999999889999999886543   3456799999999999999999988443     457899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      +||++ ++|.+++....   ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  168 (286)
T cd06614          94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTK  168 (286)
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhhcc
Confidence            99999 57877766522   378999999999999999999999 8999999999999999887 699999998765433


Q ss_pred             CCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      ... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+... +.+..          
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~----------  236 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPL----------  236 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCC----------
Confidence            221 1234567889999998654 4899999999999999999999999876655444333221 00000          


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                     .....++..+.+||++||+.||.+|||+.++++||||++.
T Consensus       237 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         237 ---------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             ---------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence                           0012368899999999999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-39  Score=298.06  Aligned_cols=246  Identities=20%  Similarity=0.265  Sum_probs=191.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCC-----CcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .|.+.+.||.|+||.||+|.+..+     ++.||+|++....     ..+.+|+.++..++||||+++++++.     ..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence            588899999999999999987543     5789999986432     23457889999999999999999873     22


Q ss_pred             eEEEEEEecccc-cHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~  219 (394)
                      ...++++||+.+ ++..++....            .....+++..+..++.|++.||.|||+ .||+||||||+||+++.
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecC
Confidence            347789999874 6666553211            112458888899999999999999999 89999999999999998


Q ss_pred             CCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016158          220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (394)
Q Consensus       220 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  295 (394)
                      ++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+.
T Consensus       160 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05091         160 KL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE  237 (283)
T ss_pred             CC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            77 699999999876533221   12234467899999986544 8999999999999999998 888998776655544


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+.+....                            ..+..++..+.+|+.+||+.||.+||++.+++.
T Consensus       238 ~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         238 MIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            44331100                            012467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.7e-39  Score=289.41  Aligned_cols=248  Identities=29%  Similarity=0.482  Sum_probs=196.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc-------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+..       ......+|+++++.++|+|++++++++..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            359999999999999999999998999999998742       12345679999999999999999998843     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|||+++ +|..++.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 7877776544445668999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhh
Q 016158          234 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       234 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  310 (394)
                      ....... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||......  +....+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD---------  224 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC---------
Confidence            6533221 2234678889999998654 4899999999999999999999999654311  1111111100         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                .+        ......++..+.++|.+||..+|++|||+.++++
T Consensus       225 ----------~~--------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         225 ----------YP--------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ----------CC--------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                      00        0001256789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-39  Score=289.77  Aligned_cols=238  Identities=23%  Similarity=0.315  Sum_probs=184.8

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      +.||+|+||.||+|++..+++.||+|.+...     ...+.+|+++++.++|+||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            3689999999999999999999999987532     234567999999999999999999883     233478999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      ++ ++.+++..   ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++.........
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            75 66655542   23468899999999999999999999 8999999999999999887 6999999998754322111


Q ss_pred             c---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          242 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       242 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      .   ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+.... .              
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~-~--------------  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV-R--------------  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-C--------------
Confidence            1   111245699999986544 8999999999999999997 889997655433322222110 0              


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                   ...+..++..+.+|+.+||+.||++|||+.++++
T Consensus       215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0012356889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-39  Score=293.30  Aligned_cols=246  Identities=21%  Similarity=0.322  Sum_probs=197.2

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .+.+|++.+.||.|+||.||+|.+.. ++.+|+|++....    ....+|+.+++.++|+||+++++++.     .....
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence            34569999999999999999999977 8899999886443    34567999999999999999998873     23347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+++ +|.+++....  ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||.+..
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~  153 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARL  153 (261)
T ss_pred             EEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhh
Confidence            899999985 7777765432  3568999999999999999999999 8999999999999999887 799999999876


Q ss_pred             cccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          235 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       235 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ...... .....++..|+|||.+... .++.++||||||+++|+|++ |+.||......+.+..+......         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  223 (261)
T cd05148         154 IKEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------  223 (261)
T ss_pred             cCCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------
Confidence            533211 1122346679999998554 58999999999999999998 89999877655555544321110         


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                         ..+..+++.+.+++.+||+.||.+|||+.+|++
T Consensus       224 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 -------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                               012457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=304.71  Aligned_cols=263  Identities=25%  Similarity=0.361  Sum_probs=193.9

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..++|.-...||+|+||.||+|... +|..||||++...    ...+.+|++++.+++|||+|+++|||.....    ..
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            3456888889999999999999985 4589999987543    3457899999999999999999999954332    47


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ++|+||++ |+|.+.+......  .++|....+|+.+++.||+|||...  .|+|||||+.|||+|.+. +.||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence            79999999 5887777653321  8899999999999999999999843  499999999999999988 6999999999


Q ss_pred             ccccc-CCCCccc-cccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHH-HHhCCCChh
Q 016158          233 KVLVK-GEPNVSY-ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEII-KVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~-~~~~~~~~~  307 (394)
                      +.... ....... .||.+|+|||++.. ...+.++|||||||++.||+||+.+.....  ....+..+. ..+...  .
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--~  301 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--K  301 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--c
Confidence            76554 3333333 78999999999854 458999999999999999999998876432  222233322 111111  1


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ....+++....        .....   ...-..+..+..+|++.+|.+||+..++++
T Consensus       302 ~~eiiD~~l~~--------~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  302 LREIVDPRLKE--------GEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             hhheeCCCccC--------CCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11111111110        00000   011123778899999999999999998754

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=292.59  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=194.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCC-----CcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            45799999999999999999998643     3789999875432     23457899999999999999999883     


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~  223 (394)
                      .....+++|||++ ++|.+++......      ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++ .
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-C
Confidence            3345789999997 5787776543321      2347888899999999999999999 8999999999999999888 7


Q ss_pred             EEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 016158          224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  299 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~  299 (394)
                      +||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            99999999876543321   1233457789999998654 48999999999999999998 9999987665544433321


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                       ...               ..            ++..++..+.+||.+||+.||++|||+.++++
T Consensus       237 -~~~---------------~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 -GGH---------------LD------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -CCC---------------CC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             100               00            12346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-39  Score=289.69  Aligned_cols=242  Identities=26%  Similarity=0.387  Sum_probs=195.6

Q ss_pred             eEeeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+++++.++|+|++++++++..     ....+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999999866   8899999886532     345679999999999999999998833     44578999


Q ss_pred             eccc-ccHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          160 EYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       160 e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ||++ ++|.+.+......     ...+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence            9995 6787776654221     3779999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ......   ......++..|+|||.+... .++.++||||||+++|+|++ |..||......+....+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            765432   22334567889999998654 58999999999999999999 699998876555444433210        


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                          ....+..++.++.+++.+||..||.+|||+.++++|
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                001124568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.9e-39  Score=289.53  Aligned_cols=243  Identities=25%  Similarity=0.355  Sum_probs=190.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|++.+.||+|+||.||+|++..+ ..||+|++....   ....+|+++++.++|+||+++++.+.     . ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence            4599999999999999999998655 459999886432   34567999999999999999987651     1 125799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ ++.+++...  ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 776666532  23467889999999999999999999 8999999999999999887 699999999976543


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  ....++..|+|||...+. .++.++|+||||+++|+|++ |..||.+.........+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------  222 (262)
T ss_pred             cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------
Confidence            3221  123346679999988544 48999999999999999999 88899876655444333221000           


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       .....++..+.+||.+||+.||++||++.+++.
T Consensus       223 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                             011357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.8e-40  Score=319.63  Aligned_cols=245  Identities=25%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             cEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      +-...+.||+|+||+||+|+..     .+...||||.++..     ...+++|++++..|+|||||+++|+|     .++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-----REG  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----ccC
Confidence            3556788999999999999864     33467999988653     34578999999999999999999999     444


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhh------cC----CCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRI------HQ----RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~------~~----~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~  221 (394)
                      .-+|||+|||. |+|.+++......      +.    +++..+...|+.||+.|++||-+ +.+|||||-..|.||+++.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence            44889999998 6898888764432      12    27888999999999999999999 8999999999999999887


Q ss_pred             CcEEEEeecCccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016158          222 HQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  297 (394)
Q Consensus       222 ~~vkl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i  297 (394)
                       .|||+|||+++.....+-..   ...-..+|||||.+.-. .|+++|||||+||+|||+++ |+.||.+..+.+.++.+
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             79999999998765443221   22336779999999755 49999999999999999997 99999999999888887


Q ss_pred             HHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016158          298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (394)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  363 (394)
                      .+..-                ..            -++++|.++.+|+..||+.+|.+||++.||-
T Consensus       719 ~~g~l----------------L~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  719 RAGQL----------------LS------------CPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HcCCc----------------cc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            66311                11            1367999999999999999999999999883

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=287.53  Aligned_cols=238  Identities=35%  Similarity=0.598  Sum_probs=194.5

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ||.|+||.||++.+..+++.||+|++....       ....+|+.+++.++|+||+++++.+     ....+.+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            689999999999999889999999876532       2456789999999999999999887     4445688999999


Q ss_pred             c-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC-CC
Q 016158          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  240 (394)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~-~~  240 (394)
                      + ++|.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 577666543    2468999999999999999999999 8999999999999999887 7999999998765443 22


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccC
Q 016158          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  320 (394)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  320 (394)
                      .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.+  .               ...
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~~~  211 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------PLR  211 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------CCC
Confidence            33456788899999986544 78899999999999999999999977665333333322  0               001


Q ss_pred             CCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 016158          321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF  368 (394)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~f  368 (394)
                                  ++..++..+.++|++||..||++|||+   +++++||||
T Consensus       212 ------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         212 ------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                        124468899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.6e-39  Score=294.20  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=193.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....    ....+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            45999999999999999999864     345679999875432    34568999999999999999999873     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~  219 (394)
                      ...++||||++ ++|.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence            34789999997 477777654321            12458899999999999999999999 89999999999999998


Q ss_pred             CCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016158          220 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (394)
Q Consensus       220 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  295 (394)
                      ++ .++|+|||++........   .....++..|+|||.+.+. .++.++||||||+++|+|+| |..||......+...
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 799999999875533221   2234457789999998654 48999999999999999998 999998776555443


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+....  .                 +         ......+..+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~--~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQGR--V-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCCC--C-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            322210  0                 0         011346889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-39  Score=289.70  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=191.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +|++.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+++++.++|+||+++++++     ....+.+++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence            4899999999999999999985 4678999987643   23455799999999999999998887     3334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||+++.....
T Consensus        79 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~  153 (256)
T cd05059          79 EYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD  153 (256)
T ss_pred             ecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence            99975 666655432   2468999999999999999999999 8999999999999999887 6999999998765432


Q ss_pred             CCCc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          239 EPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       239 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ....  ...++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.....             
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------  219 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-------------  219 (256)
T ss_pred             cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence            2111  11234579999998654 48999999999999999999 8999987665544443322100             


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                           .          ..+...+.++.+++.+||..+|++|||+.++++.
T Consensus       220 -----~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 -----L----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -----C----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                 0          0113468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.6e-39  Score=293.70  Aligned_cols=255  Identities=29%  Similarity=0.457  Sum_probs=195.8

Q ss_pred             EEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCc
Q 016158           84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  151 (394)
                      |++.+.||+|++|.||+|++.   .+++.||||++.+..        ....+|+.++..+ +|+||+++.+++     ..
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~~   76 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----QT   76 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----ec
Confidence            889999999999999999864   467889999886421        2345789999999 599999998887     33


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ....++||||+.+ ++...+..    ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~dfg  150 (288)
T cd05583          77 DTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDFG  150 (288)
T ss_pred             CCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEECc
Confidence            3457899999985 55544432    3568899999999999999999999 8999999999999999887 69999999


Q ss_pred             CccccccCCC--CccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          231 SAKVLVKGEP--NVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+.....   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---  227 (288)
T cd05583         151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS---  227 (288)
T ss_pred             cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc---
Confidence            9876533322  12345788999999985432 26789999999999999999999996543322222221111000   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDP  374 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~~  374 (394)
                                .            ...+..++..+.++|.+||+.||++|||   +.++|+||||+.+...
T Consensus       228 ----------~------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         228 ----------K------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             ----------C------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                      0            0012346889999999999999999998   5688999999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-39  Score=289.84  Aligned_cols=245  Identities=25%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ++|++.+.||+|+||.||+|.+..+   ...||+|.+....     ..+.+|+.+++.++|+||+++++.+.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            4599999999999999999998644   4579999875432     23456899999999999999999873     233


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..+++|||+++ +|.+++...   ...+++..+..++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999985 676665432   2478999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ..........   ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+......+    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----  228 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----  228 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence            8764221111   12335679999998644 48999999999999999998 999997766544443332210000    


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                              .+..++..+.+|+.+||+.||++||++.+++++
T Consensus       229 ------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 ------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    113568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.4e-39  Score=294.99  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=193.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC-----cEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.+.||+|+||.||+|.+...+     ..+|+|.+....     ....+|+++++.+ +|+||+++++++.    
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   86 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT----   86 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence            346999999999999999999986443     789999876432     2345789999999 8999999999873    


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                       .....+++|||+++ ++..++....            .....+++..+..++.|++.||.|||+ .||+||||||+|||
T Consensus        87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil  164 (293)
T cd05053          87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL  164 (293)
T ss_pred             -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence             23347899999874 7777665421            234578899999999999999999999 89999999999999


Q ss_pred             EeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016158          217 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  292 (394)
Q Consensus       217 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  292 (394)
                      ++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus       165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99887 799999999976543221   1122335679999998544 48999999999999999997 999998766544


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ....+.....                .            ..+...+..+.+|+.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~----------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYR----------------M------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCc----------------C------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4433322100                0            0123468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=285.32  Aligned_cols=277  Identities=33%  Similarity=0.577  Sum_probs=225.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  155 (394)
                      +|.-++.+|.|.- .|-.|.+.-+++.||+|++...      .....+|..++..++|+||++++.+|.-... .+..-+
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            5899999999999 8888999889999999987543      2333479999999999999999998843322 122347


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |+|||+|..++.....      ..++-..+..++.|++.|++|||+ .||+||||||+||++..+. .+||.|||+|+..
T Consensus        97 y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   97 YLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGLARTE  168 (369)
T ss_pred             HHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchhhccc
Confidence            8999999988876655      456677889999999999999999 8999999999999999887 7999999999876


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC-
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  314 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  314 (394)
                      ...-....+..|..|.|||++.+.. +...+||||+||++.||++|...|.+.+..++..++.+.+|.|.+.....+.+ 
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            5554556788899999999998877 99999999999999999999999999999999999999999999988765542 


Q ss_pred             ---------CCcccCCCCCCCC-Ccccccc--ccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          315 ---------NYTEFKFPQIKPH-PWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       315 ---------~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                               .+..+.+...-++ .|.....  ..-...+++|+.+||..||++|.+++++|+||+|+
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                     2222232222222 1221111  12244689999999999999999999999999999

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-38  Score=291.30  Aligned_cols=251  Identities=19%  Similarity=0.198  Sum_probs=184.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCC---CcEEEEEEeccchhhhH---------------HHHHHHHHcCCCceeeeceEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVALKHCF  144 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~~iv~~~~~~  144 (394)
                      +|.+.+.||+|+||.||+|.+..+   +..+|+|+.........               .+...+..+.|++++.++++.
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            599999999999999999999877   67788886432221111               122334556899999998876


Q ss_pred             EecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcE
Q 016158          145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (394)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v  224 (394)
                      .... ....+.+++++++..++..++..    ....++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+
T Consensus        93 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~~  165 (294)
T PHA02882         93 SFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-RG  165 (294)
T ss_pred             eEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-cE
Confidence            4333 23345678899887776655543    2346788899999999999999999 8999999999999999887 69


Q ss_pred             EEEeecCccccccCC--------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 016158          225 KLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  296 (394)
Q Consensus       225 kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  296 (394)
                      +|+|||+|+......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999997653221        11234689999999998654 489999999999999999999999987643322221


Q ss_pred             HHH--HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          297 IIK--VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       297 i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ...  ........          ..             .....+..+.+++..|+..+|++||+..+|++
T Consensus       245 ~~~~~~~~~~~~~----------~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 AAKCDFIKRLHEG----------KI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HhHHHHHHHhhhh----------hh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111  11000000          00             01346889999999999999999999999875

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-38  Score=291.11  Aligned_cols=243  Identities=21%  Similarity=0.309  Sum_probs=188.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|++.+.||+|+||.||+|++..+|.    .||+|++...     ...+.+|+.+++.+.|+||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   81 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-----   81 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence            469999999999999999999877776    4899987532     23345788899999999999999887321     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                       ..+++++|++ +++.+.+..   ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG~  155 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFGL  155 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCCc
Confidence             2557899988 466655543   23568999999999999999999999 8999999999999999877 699999999


Q ss_pred             ccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          232 AKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       232 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++.........   ...+++.|+|||.+.+. .++.++|||||||++|||++ |..||.......... .......++  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~--  231 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP--  231 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC--
Confidence            97664332211   12335679999998654 48999999999999999998 899997665443332 222111100  


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                               .+...+.++.+++.+||..||++||++.+++.
T Consensus       232 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 -------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     11346889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.4e-39  Score=293.71  Aligned_cols=246  Identities=21%  Similarity=0.360  Sum_probs=189.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      +|++.+.||+|+||.||+|++..     ....+|+|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            37889999999999999998753     23568999875432     23557999999999999999999873     23


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK  211 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlk  211 (394)
                      ...++++||+. ++|.+++.....                    ....+++..++.++.|++.||+|||+ .|++|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence            33678999998 477766654221                    12457889999999999999999999 899999999


Q ss_pred             CCcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 016158          212 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG  287 (394)
Q Consensus       212 p~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  287 (394)
                      |+|||++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999877 799999999876533221   1122346679999988554 48999999999999999998 9999977


Q ss_pred             CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .........+....                  .          ...+..++.++.+|+.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGY------------------R----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCC------------------C----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            65443332221100                  0          0012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-38  Score=286.22  Aligned_cols=243  Identities=24%  Similarity=0.319  Sum_probs=191.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|.+.+.||+|++|.||+|.+..+ ..+|+|.+....   ....+|+.+++.+.|+|++++++++.     . ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence            4599999999999999999998654 459999876432   34567999999999999999988762     1 125799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+.+ +|.+++...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 777766542  23457889999999999999999999 8999999999999999887 699999999976533


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  ....++..|+|||...+. .++.++|+||||+++|+|++ |..||.+....+....+..... +          
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~----------  222 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M----------  222 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence            2211  123346679999988544 48999999999999999999 8999988765554444322100 0          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ..+...+..+.+++++||..||++||+++++++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 -----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             012356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=335.14  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=205.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|.-..+||.|.||.||-|.+..+|+..|+|-+.-.      .....+|..++..++|||+|+++++-.....     
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----- 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----- 1308 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----
Confidence            34688888999999999999999999999999976432      2344689999999999999999987643332     


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ++|.||||.+ +|.+++..    +...++...+.+..|++.|+.|||+ +|||||||||+||+++.+| .+|++|||.|.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeeccccee
Confidence            6789999995 66665553    4557777888889999999999999 8999999999999999888 79999999998


Q ss_pred             ccccCC-----CCccccccccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          234 VLVKGE-----PNVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       234 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      .+...-     ......||+.|||||++.+..  .-..++|||||||++.||+||+.||...+..=++.-.+.....|. 
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq- 1461 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ- 1461 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC-
Confidence            765442     123568999999999997654  256789999999999999999999987554322222222211111 


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                                ++.+++.+.++||.+||..||.+|.++.|||.|-|-+...+.
T Consensus      1462 --------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1462 --------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             --------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                                      345689999999999999999999999999999998766554

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-38  Score=293.07  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=192.9

Q ss_pred             ccccEEEeeEeeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  148 (394)
                      ..++|.+.+.||+|+||.||+|.+     ..++..||+|.+....     ..+.+|+.+++++ +|+||+++++++..  
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence            345799999999999999999975     3345689999876432     2355799999999 79999999998732  


Q ss_pred             CCceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          149 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                         ....+++|||+. ++|.+++....  ...+++..+..++.|++.||+|||+ .||+|+||||+|||++.++ .++|+
T Consensus       111 ---~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~  183 (302)
T cd05055         111 ---GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKIC  183 (302)
T ss_pred             ---CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEEC
Confidence               234789999998 46766654311  2348999999999999999999999 8999999999999999777 79999


Q ss_pred             eecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016158          228 DFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  303 (394)
Q Consensus       228 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~  303 (394)
                      |||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+.........
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~  262 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR  262 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence            9999876543221   11233467899999986554 8999999999999999998 99999877655544443321100


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                 ...+...++.+.+|+.+||..||++|||+.++++
T Consensus       263 ---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 ---------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                       0011346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-38  Score=285.95  Aligned_cols=242  Identities=23%  Similarity=0.331  Sum_probs=190.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .+|++.+.||+|+||.||+|...  |..||+|.+....  ..+.+|+.+++.++|+|++++++++...    ....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            35999999999999999999875  7889999886543  2456799999999999999999876432    22367899


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ ++.+++....  ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99985 7766655321  2458889999999999999999999 8999999999999999887 7999999998754332


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      .  ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+....                
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  216 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  216 (256)
T ss_pred             C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2  223345679999998554 48999999999999999997 999997665444333332210                


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                  .......+++.+.++|.+||+.||++|||+.++++
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        00012457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-38  Score=288.66  Aligned_cols=248  Identities=22%  Similarity=0.381  Sum_probs=195.9

Q ss_pred             EEEeeEeeecCceEEEEEEECC-CCcEEEEEEeccch--------------hhhHHHHHHHHH-cCCCceeeeceEEEec
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK--------------RYKNRELQIMQM-LDHPNIVALKHCFFST  147 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~  147 (394)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.. ++|+||+++++++   
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~---   78 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF---   78 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE---
Confidence            8889999999999999999987 67899999874221              112346666654 7999999999988   


Q ss_pred             CCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEE
Q 016158          148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                        ....+.+++|||+++ ++.+++.........+++..++.++.|++.||.|||...|++|+||+|+||+++.++ .++|
T Consensus        79 --~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l  155 (269)
T cd08528          79 --LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTI  155 (269)
T ss_pred             --ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEE
Confidence              334458899999985 777777655555577999999999999999999999536899999999999999887 7999


Q ss_pred             EeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +|||.+.............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+......+. 
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  233 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-  233 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-
Confidence            999999766544433455678889999999654 489999999999999999999999976655444443332111100 


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                                ....+++.+.++|++||+.||++||++.|+..+
T Consensus       234 --------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 --------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             --------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                      012468899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-39  Score=291.81  Aligned_cols=256  Identities=26%  Similarity=0.362  Sum_probs=188.3

Q ss_pred             EEEeeEeeecCceEEEEEEE----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      |.+.+.||+|+||+||++..    ..++..||+|.+...     ...+.+|+++++.++||||+++++++..   .....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence            49999999999999988653    456889999988643     2344579999999999999999987743   22345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|||+.+ ++.+++..     ..+++..++.++.|++.||+|||+ +||+|+||||+|||++.++ .++|+|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeeccccc
Confidence            7899999985 66655543     469999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCChhh
Q 016158          234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREE  308 (394)
Q Consensus       234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~  308 (394)
                      ........    ....++..|+|||.+.+. .++.++||||||+++|+|+||..||......  +..+.... +......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~  232 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVR  232 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhh
Confidence            65433221    122345679999998654 4899999999999999999999998654321  11111100 0000000


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ....            .........+..++..+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         233 LIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000            0000001123457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-39  Score=289.82  Aligned_cols=242  Identities=26%  Similarity=0.391  Sum_probs=187.4

Q ss_pred             EEeeEeeecCceEEEEEEEC----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           85 IAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+...     ...+.+|++.++.++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999997    44678999998532     2455679999999999999999999963222     7


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++|+||++ ++|.+.+...  ....+++..+..++.|++.||.|||+ .+++|+||+++|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence            78999998 5787777763  13678999999999999999999999 8999999999999999888 799999999876


Q ss_pred             cccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          235 LVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       235 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ......   .........|+|||.+.... ++.++||||||+++|||++ |+.||...+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            622211   12334567899999986544 8999999999999999999 7899988866665555533110        


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                          ..++..++..+.++|..||..||.+|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                0122467899999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-38  Score=292.78  Aligned_cols=254  Identities=19%  Similarity=0.268  Sum_probs=193.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCC----------------cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETG----------------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL  140 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~  140 (394)
                      .+|++.+.||+|+||.||+|.+...+                ..||+|.+...     ...+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            46999999999999999999876543                56899987643     2344579999999999999999


Q ss_pred             ceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCC
Q 016158          141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (394)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp  212 (394)
                      ++++..     ..+.+++||++.+ +|..++.....       ....+++..++.++.|++.||+|||+ .||+|+||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp  158 (296)
T cd05051          85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence            998732     2457899999974 67766654321       11268999999999999999999999 8999999999


Q ss_pred             CcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 016158          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  287 (394)
Q Consensus       213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  287 (394)
                      +||+++.++ .++|+|||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999887 799999999876533321   1233456789999998654 48999999999999999998  6788876


Q ss_pred             CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ....+.+...........           ..          .....+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-----------~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDDG-----------RQ----------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhcccccc-----------cc----------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            665554444433110000           00          000012346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.9e-38  Score=286.31  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=192.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ++|++.++||+|+||.||+|... +++.||+|.+....   ..+.+|+.+++.++|+||+++++.+.    .  ...+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT----Q--EPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc----c--CCcEEE
Confidence            46999999999999999999874 57889999886533   34567999999999999999987651    1  136799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+.+ ++.+.+...  ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence            999974 676665432  23578899999999999999999999 8999999999999999887 699999999876542


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  ....++..|+|||.+... .++.++||||||+++|+|++ |+.||.+.+..+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-----------  222 (260)
T ss_pred             CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----------
Confidence            2211  123346679999998544 48899999999999999999 99999877655544443221100           


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ......+.++.++|.+||..||++|||++++++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 -----------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                             011346889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-38  Score=299.38  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=190.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      .++|++.+.||.|+||.||+|.+     ..+++.||||++....     ....+|+.++..+ +|+||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            34699999999999999999985     3467899999886422     2345799999999 689999999877432  


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSR-----------------------------------------------------  175 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  175 (394)
                        ....+++|||+++ +|.+++.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              2346799999985 67666543210                                                     


Q ss_pred             ----------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC---Cc
Q 016158          176 ----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NV  242 (394)
Q Consensus       176 ----------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~  242 (394)
                                ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++........   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcC
Confidence                      01346788889999999999999999 8999999999999999887 799999999876532211   11


Q ss_pred             cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016158          243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (394)
Q Consensus       243 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (394)
                      ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||........+..........               . 
T Consensus       240 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~-  302 (343)
T cd05103         240 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------R-  302 (343)
T ss_pred             CCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC---------------C-
Confidence            22345679999998654 48999999999999999997 999997755433332222211000               0 


Q ss_pred             CCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                 .+...++++.+++.+||+.||.+|||+.++++|
T Consensus       303 -----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         303 -----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       112357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=286.82  Aligned_cols=287  Identities=33%  Similarity=0.539  Sum_probs=225.7

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+-.+.||.|+||.||.+.+..+|+.||+|++..      ......+|.++|..++|.|++..+++.-...-.....+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            4455789999999999999999999999998743      2334457999999999999999888763222121222567


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ++|++..+|..++-.    .+.++...++.+++||++||+|||+ .||.||||||.|+|++.+- .+||||||+|+....
T Consensus       135 ~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEecccccccccch
Confidence            888887766555443    4778889999999999999999999 9999999999999999886 799999999987644


Q ss_pred             CCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          238 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       238 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ++.  ......|.+|.|||++.+...|+.+.||||+|||+.||+..+..|....+.+++..|.+.+|.|..+.+....++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            332  223456889999999999999999999999999999999999999999999999999999999999988765543


Q ss_pred             CcccCCCCCCCCC----cccc-ccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHP----WHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       316 ~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      -..-.+......+    +..+ -+..-..+..+++..+|.+||++|.+.++.+.|+++.+.+-...
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~  354 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFH  354 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeee
Confidence            2211111000000    1111 11233457889999999999999999999999999999876544

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-38  Score=286.68  Aligned_cols=243  Identities=23%  Similarity=0.318  Sum_probs=191.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.+...   ...+.+|+.+++.++|+|++++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEEE
Confidence            46999999999999999999875 5677999988643   234568999999999999999988662    1  125699


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ +|.+++...  ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            999975 776666532  23468999999999999999999999 8999999999999999887 799999999976543


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+..... +          
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~----------  222 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-M----------  222 (260)
T ss_pred             cccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence            2211  122345679999988544 48999999999999999999 8999987665554444332100 0          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ..+...+..+.+|+.+||..||++|||+.++++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 -----------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                             012356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=284.30  Aligned_cols=241  Identities=25%  Similarity=0.370  Sum_probs=192.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh---hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..|++.+.||.|+||.||+|...  |+.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            35899999999999999999875  78999999876543   45579999999999999999998743     3347799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ ++.+++....  ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            999984 7776665422  1368999999999999999999999 8999999999999999887 799999999976632


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      ...  ....+..|+|||.+... .++.++|+||||+++|+|++ |..||......+....+....               
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------  216 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---------------  216 (256)
T ss_pred             ccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------------
Confidence            222  23345679999998644 48899999999999999997 999997765444333222100               


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                   ....+..+++.+.++|.+||..+|++|||+.+++.
T Consensus       217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 -------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         00012356899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=285.17  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .++|++.+.||+|+||.||+|.+. .++.||||.+...   .....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            456999999999999999999985 4578999988643   234568999999999999999998873     2234789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|||+++ +|.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999975 676666542  23568999999999999999999999 8999999999999999887 79999999987654


Q ss_pred             cCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .....  .....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+......+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------  223 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32111  122235679999998654 48999999999999999998 99999877665555554331100          


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                        ..+...+.++.+++.+||+.||.+||+++++++
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 ------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                              011345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-38  Score=293.76  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=190.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC-------CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecC
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  148 (394)
                      .+|.+.+.||+|+||.||+|++..       ++..+|+|.+....     ....+|+++++.+ +|+||+++++++.   
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~---   94 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---   94 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence            469999999999999999998743       23569999886432     2344689999999 7999999999883   


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Ni  215 (394)
                        .....++||||+++ +|.+++.....            ....+++..+..++.|++.||+|||+ .|++||||||+||
T Consensus        95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  171 (307)
T cd05098          95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  171 (307)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHhe
Confidence              23347899999985 77777764321            12358889999999999999999999 8999999999999


Q ss_pred             EEeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 016158          216 LVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (394)
Q Consensus       216 l~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~  291 (394)
                      +++.++ .++|+|||.+.........   ....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....
T Consensus       172 ll~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         172 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             EEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999887 7999999998765332211   112234679999998654 48999999999999999998 88898765543


Q ss_pred             HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      +....+.. ...                           ...+..++.++.+||.+||..+|.+|||+.+++++
T Consensus       250 ~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKE-GHR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHc-CCC---------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            33332221 000                           00124578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-38  Score=292.11  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=193.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEEC-------CCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEe
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFS  146 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  146 (394)
                      ...+|.+.+.||+|+||.||+|++.       .++..||+|.+...     .....+|+.+++.+ +|+||+++++++. 
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-   91 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-   91 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence            3557999999999999999999753       23457999987542     23355799999999 8999999999883 


Q ss_pred             cCCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCC
Q 016158          147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (394)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~  213 (394)
                          .....+++|||+++ +|.+++.....            ....+++..+..++.||+.||.|||+ +|++||||||+
T Consensus        92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~  166 (304)
T cd05101          92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR  166 (304)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence                33457899999985 77777765321            12457888899999999999999999 89999999999


Q ss_pred             cEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016158          214 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  289 (394)
Q Consensus       214 Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  289 (394)
                      |||++.++ .+||+|||+++.......   .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+..
T Consensus       167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999887 799999999976643221   1122345779999998654 48999999999999999998 788887765


Q ss_pred             cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..+....+.... .                           ...+..++.++.+||.+||..+|.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEGH-R---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            444433332110 0                           00113578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=292.15  Aligned_cols=255  Identities=21%  Similarity=0.308  Sum_probs=191.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC--------------cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeec
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG--------------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALK  141 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~  141 (394)
                      +.+|++.+.||+|+||.||+|++..++              ..||+|.+...     ...+.+|+++++.++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            457999999999999999999875432              35899988643     12355799999999999999999


Q ss_pred             eEEEecCCCceeEEEEEEecccc-cHHHHHHHhhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCC
Q 016158          142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR--------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (394)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp  212 (394)
                      +++.     .....++||||+.+ ++.+++.....        ....+++..+..++.|++.||.|||+ .|++|+||||
T Consensus        84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp  157 (295)
T cd05097          84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT  157 (295)
T ss_pred             EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence            9883     33347899999985 77776643211        01246788899999999999999999 8999999999


Q ss_pred             CcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 016158          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  287 (394)
Q Consensus       213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  287 (394)
                      +||+++.++ .+||+|||++........   .....++..|+|||.+.+.. ++.++|+|||||++|+|++  |..||..
T Consensus       158 ~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         158 RNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999887 699999999876533221   11223467899999986544 8999999999999999998  6688887


Q ss_pred             CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ....+.+..+.........           .. .         .......++.+.+|+.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-----------~~-~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGR-----------QI-Y---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cChHHHHHHHHHhhhhccc-----------cc-c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            6665555444331100000           00 0         0012346889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-38  Score=285.64  Aligned_cols=235  Identities=25%  Similarity=0.346  Sum_probs=183.2

Q ss_pred             EeeecCceEEEEEEE--CCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           89 VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.+.|+||+++++++.     .. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence            589999999999965  4667899999875432      23457899999999999999988761     11 2578999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC
Q 016158          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~  239 (394)
                      |+++ +|.+++..    ...+++..+..++.|++.||+|||+ +||+||||||.||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9985 56665543    3568999999999999999999999 8999999999999999887 69999999997654332


Q ss_pred             CC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          240 PN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       240 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..    ....+++.|+|||.+.. ..++.++|+|||||++|+|++ |..||......+....+... ..+          
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~----------  217 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERM----------  217 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCC----------
Confidence            21    11223578999998854 348899999999999999998 99999876654443333221 000          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ..+..+++++.+||.+||+.||++||++.+|..
T Consensus       218 -----------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 -----------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                             012457899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-38  Score=289.69  Aligned_cols=247  Identities=24%  Similarity=0.374  Sum_probs=191.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|.+.++||+|+||.||+|...     .++..+|+|.+...    ...+.+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            35889999999999999999743     35678999987542    2345679999999999999999887732     2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~  220 (394)
                      ...+++|||+++ +|.+++.....           ....+++..+..++.|++.||+|||+ .|++|+||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCC
Confidence            347899999984 77776654321           01357889999999999999999999 899999999999999987


Q ss_pred             CCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016158          221 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  296 (394)
Q Consensus       221 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~  296 (394)
                      + .++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+.+..
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 799999999875532221   1223346789999998654 48999999999999999998 9999977665554444


Q ss_pred             HHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      +.....                .            ..+..+++.+.+||.+||+.||.+||++.++++
T Consensus       237 ~~~~~~----------------~------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGRE----------------L------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCcc----------------C------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            332100                0            011357889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-38  Score=286.68  Aligned_cols=244  Identities=27%  Similarity=0.381  Sum_probs=191.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+...     ...+.+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            369999999999999999999865443   7999987542     234567999999999999999998873     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      +.+++|||+++ +|.+++..   ....+++..+..++.|++.||.|||+ .|++|+||||+|||++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            57899999985 67666543   22468999999999999999999999 8999999999999999887 7999999998


Q ss_pred             cccccCCCCc----cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ..........    ...++..|+|||.+.+. .++.++|+||||+++|++++ |..||......+....+.+...     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-----  227 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-----  227 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence            7654332211    11224579999998654 48999999999999999886 9999987665544443332110     


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                   .+          ....+++.+.+++.+||+.+|.+||++.++++
T Consensus       228 -------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 -------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                         00          11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-38  Score=287.77  Aligned_cols=249  Identities=18%  Similarity=0.249  Sum_probs=193.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      .++|++.+.||+|+||.||+|.+..    ++..|++|.+...     .....+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3469999999999999999999875    3578999987543     23345789999999999999999987432    


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEE
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                      ....+++++|++ +++..++......    ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEE
Confidence            223568999987 5777766553321    1568999999999999999999999 8999999999999999887 7999


Q ss_pred             EeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016158          227 CDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  302 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  302 (394)
                      +|||+++.+......   ....++..|+|||.+.+. .++.++||||||+++|++++ |+.||...+..+....+.... 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence            999999765332211   123346679999998654 48999999999999999998 999998765544333222110 


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ..+          ....+++++.+++.+||..||++|||+.++++
T Consensus       237 -----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 -----------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                             000          01346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.2e-38  Score=290.21  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=192.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|++...     ...+.+|+.+++.+.|+||+++++++.     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----~   79 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----V   79 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----C
Confidence            469999999999999999998753     6788999987643     234567999999999999999998873     2


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhh------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCC
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSR------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp  212 (394)
                      ....+++|||+++ +|.+++.....                  ....+++..++.++.|++.||.|||+ .|++||||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p  158 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLAT  158 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccH
Confidence            3347899999985 77777654211                  11347888899999999999999999 8999999999


Q ss_pred             CcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 016158          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  288 (394)
Q Consensus       213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  288 (394)
                      +||+++.++ .++|+|||++........   ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999888 699999999875432211   1122345679999998554 48999999999999999997 88899776


Q ss_pred             CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ...+....+....                ..            ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDGN----------------VL------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcCC----------------CC------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6554443332210                00            011356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.4e-38  Score=300.32  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=194.2

Q ss_pred             cccccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCceeeeceEEEec
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFST  147 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  147 (394)
                      ....+|.+.+.||+|+||.||+|++.     .+++.||+|++....     ..+.+|+.++.++. ||||+++++++.. 
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence            34456999999999999999999964     345689999986432     23457999999997 9999999998833 


Q ss_pred             CCCceeEEEEEEecccc-cHHHHHHHhhh---------------------------------------------------
Q 016158          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR---------------------------------------------------  175 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------------------------------------------  175 (394)
                          ....++||||+.+ +|.+++.....                                                   
T Consensus       113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                2347899999984 77776653211                                                   


Q ss_pred             -------------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCC
Q 016158          176 -------------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (394)
Q Consensus       176 -------------------------------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp  212 (394)
                                                                 ....+++..++.++.|++.||+|||+ .|++||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp  267 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAA  267 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCc
Confidence                                                       11246677788999999999999999 8999999999


Q ss_pred             CcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 016158          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  288 (394)
Q Consensus       213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  288 (394)
                      +|||++.++ .+||+|||+++.......   .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...
T Consensus       268 ~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         268 RNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             ceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999877 799999999976532221   1233567889999998654 48999999999999999998 88999876


Q ss_pred             CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ...+.+...+...-.+                           ..+..++.++.+|+.+||..||.+||++.+|++.
T Consensus       346 ~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         346 PMNEQFYNAIKRGYRM---------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CchHHHHHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6555444433211000                           0123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.7e-38  Score=284.96  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=190.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .|+..+.||+|+||.||+|++..+++   .+|+|.+...     .....+|+++++.++|+|++++.+++.     ....
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   80 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFKP   80 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCCC
Confidence            58899999999999999999876654   7999987543     233457899999999999999998873     2334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|||+++ +|..++..   ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~  155 (268)
T cd05063          81 AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLSR  155 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccce
Confidence            7799999986 66555543   23568999999999999999999999 8999999999999999887 69999999987


Q ss_pred             ccccCCCCc----cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          234 VLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       234 ~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .........    ....+..|+|||.+... .++.++|||||||++|+|++ |+.||...+..+....+......+    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~----  230 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP----  230 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC----
Confidence            654322111    11224569999998654 48999999999999999997 999998776555444443211000    


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                              ....++.++.+++.+||+.||++||++.++++
T Consensus       231 ------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 ------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                    01346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.1e-38  Score=292.04  Aligned_cols=248  Identities=22%  Similarity=0.331  Sum_probs=191.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-------CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEec
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  147 (394)
                      ..+|.+.+.||+|+||.||+|++..       ....||+|.+....     ....+|+.+++.+ +|+||+++++++.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            3569999999999999999998632       34579999876432     2345789999999 6999999999873  


Q ss_pred             CCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                         ...+.+++|||+++ +|.+++.....            ....+++..+..++.|++.||.|||+ +|++||||||+|
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  164 (314)
T cd05099          89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARN  164 (314)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccccee
Confidence               23347899999984 77777765321            12458889999999999999999999 899999999999


Q ss_pred             EEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016158          215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  290 (394)
                      ||++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+...
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 699999999976533211   1112234579999998654 48999999999999999999 8899977655


Q ss_pred             HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+.+..+....                ..            .++..++.++.+||.+||..||++|||+.++++
T Consensus       243 ~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 EELFKLLREGH----------------RM------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcCC----------------CC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            44443332210                00            012356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-38  Score=294.99  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=191.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCC-------CcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEec
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFST  147 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  147 (394)
                      ..+|++.+.||+|+||.||+|++...       +..||+|.+...     .....+|+++++++ +|+||+++++++.  
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence            34699999999999999999986432       236899987642     23455799999999 8999999999883  


Q ss_pred             CCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                         .....++++||+++ +|.+++.....            ....++...+..++.|++.||.|||+ +|++||||||+|
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  164 (334)
T cd05100          89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN  164 (334)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence               33347899999985 77777654221            12357888889999999999999999 899999999999


Q ss_pred             EEEeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016158          215 LLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  290 (394)
                      ||++.++ .+||+|||+++........   ....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+.
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999887 7999999998765432211   112234679999998654 48999999999999999998 8899987665


Q ss_pred             HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+....+.....                            ...+..++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            444433322100                            00123567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.3e-38  Score=285.39  Aligned_cols=243  Identities=26%  Similarity=0.405  Sum_probs=190.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .|.+.+.||+|+||.||+|.+..+++   .||||.+...     ...+.+|+.+++.+.||||+++.+++     .....
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence            48999999999999999999987665   5999987643     23455799999999999999999887     33334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|||+++ +|.+++...   ...+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~~  154 (269)
T cd05065          80 VMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR  154 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCcccc
Confidence            7799999986 666555432   3568999999999999999999999 8999999999999999887 79999999987


Q ss_pred             ccccCCCCccc---c---ccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          234 VLVKGEPNVSY---I---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       234 ~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      ...........   .   .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-----  228 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-----  228 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            55432221111   1   13469999998644 48999999999999999886 999998766554444332210     


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                   ..+          .+..++..+.+++.+||..||++||++.+++.
T Consensus       229 -------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 -------------RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -------------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         000          11356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.6e-39  Score=320.12  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=193.0

Q ss_pred             CcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEec-----
Q 016158           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFST-----  147 (394)
Q Consensus        78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  147 (394)
                      ++-...|+.+.+||+||||.||+++++-+|+.||||++...     ...+.+|+.+|.+|+|||||+++..+.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            34455688899999999999999999999999999998643     23346899999999999999986652100     


Q ss_pred             -------------------------------------------------C------------------------------
Q 016158          148 -------------------------------------------------T------------------------------  148 (394)
Q Consensus       148 -------------------------------------------------~------------------------------  148 (394)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             -----------------------CC-------ceeEEEEEEecccccHHHHHHHhhhhcCCC-CHHHHHHHHHHHHHHHH
Q 016158          149 -----------------------DK-------EELYLNLVLEYVPETVNRIARNYSRIHQRM-PLIYVKLYTYQICRALA  197 (394)
Q Consensus       149 -----------------------~~-------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~qi~~al~  197 (394)
                                             ..       ...++||-||||+.++.+.+-...   ... ....+|+++++|+.||.
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence                                   00       015789999999976544433322   222 46788999999999999


Q ss_pred             HHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc-------------------cCCCCccccccccccccccccC
Q 016158          198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNVSYICSRYYRAPELIFG  258 (394)
Q Consensus       198 ~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~  258 (394)
                      |+|+ .|||||||||.||+++++. .|||+|||+|+...                   ......+.+||.-|+|||++.+
T Consensus       712 YIH~-~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  712 YIHD-QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHHh-CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9999 8999999999999999887 69999999998621                   1113345788999999999976


Q ss_pred             CC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcccccccc
Q 016158          259 AT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR  336 (394)
Q Consensus       259 ~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (394)
                      ..  .|+.|.|+||||+|++||+.   ||..  .++-.. ++..+..+               .+|..      ..|...
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~-iL~~LR~g---------------~iP~~------~~f~~~  842 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERAS-ILTNLRKG---------------SIPEP------ADFFDP  842 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHH-HHHhcccC---------------CCCCC------cccccc
Confidence            66  69999999999999999984   4543  222222 22222111               11110      011122


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          337 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       337 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                      --+.-..+|++||++||++||||.|||++.||-
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            234567899999999999999999999999996

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=287.10  Aligned_cols=240  Identities=24%  Similarity=0.335  Sum_probs=183.5

Q ss_pred             EeeecCceEEEEEEECCCCc--EEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           89 VVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      .||+|+||.||+|++..++.  .+|+|.+...     .....+|++++.++ .||||+++++++.     ...+.+++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEEE
Confidence            58999999999999988775  4688877532     23445799999999 8999999999883     2334789999


Q ss_pred             ccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          161 YVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       161 ~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                      |++ ++|.+++.....            ....+++..++.++.|++.||+|||+ .|++|+||||+|||++.++ .+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEEC
Confidence            997 477777654321            12357899999999999999999999 8999999999999999887 79999


Q ss_pred             eecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      |||++..............+..|+|||++.. ..++.++|+||||+++|+|++ |..||.+.+..+....+....     
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----  228 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----  228 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----
Confidence            9999853322111112223567999999854 448999999999999999997 999997765444333322100     


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                   ..          .....++.++.+|+.+||..||.+|||+.+++.
T Consensus       229 -------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 -------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                         00          011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5e-38  Score=283.10  Aligned_cols=236  Identities=24%  Similarity=0.298  Sum_probs=183.0

Q ss_pred             EeeecCceEEEEEEEC--CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           89 VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      .||+|+||.||+|.+.  ..+..||+|++....     ..+.+|+.+++.++|+||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999875  445679999875432     23557999999999999999998762     1 136799999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC
Q 016158          162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  240 (394)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~  240 (394)
                      +++ +|.+++..   ....+++..++.++.|++.||.|||+ +|++|+||||+|||++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            985 66655442   23578999999999999999999999 8999999999999999877 799999999875533322


Q ss_pred             C----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          241 N----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       241 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .    ....++..|+|||.+... .++.++|||||||++|+|++ |..||......+....+.... .            
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C------------
Confidence            1    111225679999998544 48999999999999999996 999998776655443332210 0            


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                     ..++...++++.++|.+||..||++||++.++++
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0012456899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.7e-38  Score=281.57  Aligned_cols=243  Identities=21%  Similarity=0.328  Sum_probs=191.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .|++.+.||.|+||.||+|.+. .+..+|+|.+...   ...+.+|+++++.++|+|++++++++     ......+++|
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence            5999999999999999999885 4678999987643   23566799999999999999999887     3333578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ +|.+.+..   ....+++..++.++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~  153 (256)
T cd05112          79 EFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeecccC
Confidence            99985 56555442   12457899999999999999999999 8999999999999999877 6999999998755332


Q ss_pred             CCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ...  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...........+.....             
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------  219 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-------------  219 (256)
T ss_pred             cccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-------------
Confidence            211  122345679999998654 48899999999999999998 9999987665544444322100             


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                     ...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       220 ---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 ---------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                           00113357899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.4e-38  Score=287.05  Aligned_cols=259  Identities=26%  Similarity=0.386  Sum_probs=188.3

Q ss_pred             cEEEeeEeeecCceEEEEEEE----CCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      +|++.+.||+|+||.||+|..    ..++..||+|.+....    ..+.+|+++++.++|+||+++++++....   ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CCc
Confidence            599999999999999999984    4578899999875432    34567999999999999999988774322   234


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~  156 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLTK  156 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCcccc
Confidence            789999997 4777666432   2458999999999999999999999 8999999999999999887 69999999998


Q ss_pred             ccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChh-
Q 016158          234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-TPTRE-  307 (394)
Q Consensus       234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~-~~~~~-  307 (394)
                      ........    ....++..|+|||.+.+. .++.++||||||+++|+|++|..++...... ....+..... ..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHH
Confidence            65433221    111234569999998654 4899999999999999999988776443211 1100000000 00000 


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ........   ...          .....++.++.+||.+||..||++|||+.++++
T Consensus       235 ~~~~~~~~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         235 LIELLKNN---GRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHhcC---CcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            00000000   000          012457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-38  Score=283.79  Aligned_cols=228  Identities=25%  Similarity=0.325  Sum_probs=180.3

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecccc-cHHHHHH
Q 016158           93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIAR  171 (394)
Q Consensus        93 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  171 (394)
                      |.+|.||+|++..+++.||+|.+..... ..+|...+....||||+++++++.     .....+++|||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8999999999999999999999876543 345556666678999999999873     33457899999985 6766554


Q ss_pred             HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCcccccccccc
Q 016158          172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR  251 (394)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~  251 (394)
                      .    ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            3    2468999999999999999999999 8999999999999999888 6999999987654322  22334567799


Q ss_pred             ccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccc
Q 016158          252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  331 (394)
Q Consensus       252 aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (394)
                      |||.+.+. .++.++|+||+|+++|+|++|+.||......     + .               .....            
T Consensus       150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~---------------~~~~~------------  195 (237)
T cd05576         150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N---------------THTTL------------  195 (237)
T ss_pred             CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c---------------ccccc------------
Confidence            99988543 4789999999999999999999887432110     0 0               00000            


Q ss_pred             cccccCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 016158          332 VFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFF  368 (394)
Q Consensus       332 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f  368 (394)
                      .++..+++.+++||.+||+.||++|+|+     +++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1224578899999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7e-38  Score=281.82  Aligned_cols=242  Identities=27%  Similarity=0.387  Sum_probs=192.7

Q ss_pred             EEeeEeeecCceEEEEEEECCCC----cEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           85 IAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++.+.||.|+||.||+|++...+    ..||+|++....     ....+|+.+++.++|+||+++++++...     ...
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence            56788999999999999998766    899999986433     3456799999999999999999988332     457


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+++ ++.+++.....  ..+++..+..++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCcee
Confidence            899999975 77666654221  228999999999999999999999 8999999999999999887 799999999976


Q ss_pred             cccCCCCc--cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          235 LVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       235 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ........  ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+.....         
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  222 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------  222 (258)
T ss_pred             cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            65432221  1235688999999844 458999999999999999998 8899987665555544432110         


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                         ......++.++.+++.+||..||++|||+.++++
T Consensus       223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                               0012347889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.2e-38  Score=282.36  Aligned_cols=239  Identities=25%  Similarity=0.346  Sum_probs=188.5

Q ss_pred             eEeeecCceEEEEEEECC-CC--cEEEEEEeccchh-----hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRE-TG--EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|++|.||+|.+.. .+  ..||||.+.....     .+.+|+.++++++|+||+++++.+..      ...+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            368999999999999865 33  3699998865433     45579999999999999999988733      4578999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||++ ++|.+.+.....  ..+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 577766654322  468999999999999999999999 8999999999999999887 7999999998766442


Q ss_pred             CCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          239 EPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       239 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ...    ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....           
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-----------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            211    123456789999998544 48999999999999999998 9999987766555444432100           


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                          ..            ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus       219 ----~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         219 ----RL------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ----cC------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                00            011346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.9e-38  Score=289.11  Aligned_cols=254  Identities=20%  Similarity=0.300  Sum_probs=189.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC----------------CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  140 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~  140 (394)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|++....     ..+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986532                34579999886432     345679999999999999999


Q ss_pred             ceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCC
Q 016158          141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (394)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp  212 (394)
                      ++++..     ....+++|||+.+ +|.+++......       ...+++..+..++.|++.||+|||+ .|++|+||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            998733     2347899999974 777766553211       1347788899999999999999999 8999999999


Q ss_pred             CcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 016158          213 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  287 (394)
Q Consensus       213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  287 (394)
                      +|||++.++ .++|+|||++........   ......+..|++||...+. .++.++|+|||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 699999999876533221   1122335679999987654 48999999999999999998  7789876


Q ss_pred             CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+..+.+........           ........+          .+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~-----------~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFR-----------DQGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHh-----------hccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            655444433221100           000000000          11346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=278.55  Aligned_cols=270  Identities=26%  Similarity=0.448  Sum_probs=210.2

Q ss_pred             CcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      ......|.++++||+|+|++|.+++++.|.+.+|+|+++++-       ...+.|-.+..+. +||.+|-+..||     
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----  320 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----  320 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----
Confidence            334457999999999999999999999999999999987542       2334566666665 799999999998     


Q ss_pred             CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      +....+++|.||++|+-   +..+......+|++.++.+...|+.||.|||+ .||++||||.+|||+|.+|+ +||+|+
T Consensus       321 qtesrlffvieyv~ggd---lmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaegh-ikltdy  395 (593)
T KOG0695|consen  321 QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDY  395 (593)
T ss_pred             cccceEEEEEEEecCcc---eeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCc-eeeccc
Confidence            44455788999999732   12223345789999999999999999999999 89999999999999999995 999999


Q ss_pred             cCcccc-ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC--C-----CcHHHHHHH-HHH
Q 016158          230 GSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG--E-----SGVDQLVEI-IKV  300 (394)
Q Consensus       230 g~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~--~-----~~~~~~~~i-~~~  300 (394)
                      |+++.- ..+....+.+|||.|.|||++++.. |+...|+|+|||+++||+.|+.||.-  .     +..+.+.++ ...
T Consensus       396 gmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             chhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence            999764 3455667789999999999998765 99999999999999999999999962  1     112222222 221


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC------CHHHHhcCCCCCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC------TALEACVHPFFDELRDP  374 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~f~~~~~~  374 (394)
                                       .+            .++..+|..+..+++..|.+||.+|.      ...++..||||+.+-..
T Consensus       475 -----------------qi------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd  525 (593)
T KOG0695|consen  475 -----------------QI------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD  525 (593)
T ss_pred             -----------------cc------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence                             11            13356788899999999999999998      46799999999966333


Q ss_pred             CCCCCCCCCCCCCCCC
Q 016158          375 NTRLPNGRPLPPLFNF  390 (394)
Q Consensus       375 ~~~~~~~~~~~~~~~~  390 (394)
                      .  +.+-+-. |+|++
T Consensus       526 ~--leqk~v~-ppf~p  538 (593)
T KOG0695|consen  526 L--LEQKQVL-PPFQP  538 (593)
T ss_pred             H--HhhcccC-CCCCC
Confidence            2  2333334 55554

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.7e-38  Score=285.03  Aligned_cols=249  Identities=23%  Similarity=0.312  Sum_probs=193.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      .+|++.+.||.|+||.||+|+.+.     +.+.||+|.+....     ....+|++++++++|+||+++++++     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            469999999999999999999753     34679999875432     2356799999999999999999877     33


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEE
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIH-----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vk  225 (394)
                      ..+.++||||++ ++|.+++.......     ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence            345789999998 57777765433111     268999999999999999999999 8999999999999999887 699


Q ss_pred             EEeecCccccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 016158          226 LCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  302 (394)
Q Consensus       226 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~  302 (394)
                      |+|||++.......  ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+.... 
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-  235 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-  235 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-
Confidence            99999986443221  11233456779999988654 47899999999999999998 888997655444333322100 


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                      ..        |  .....++..+.+++.+||+.||.+|||+.+++.+
T Consensus       236 ----------------~~--------~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 ----------------LE--------L--PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ----------------cC--------C--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                            00        0  0123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=306.29  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=216.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .|+|..+||.|.+|.||+++++.+|+.+|+|+....   ...++.|.++|+.+ .|||++.++++|.......+..+++|
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            399999999999999999999999999999987543   34556678888887 69999999999987776677779999


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||++ +..++++...  +.++.+..+..|++.++.||.+||. ..++|||||-.|||++.++ .|||+|||.+.....
T Consensus       100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDS  175 (953)
T ss_pred             eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeeeeeeec
Confidence            999995 8888888876  7899999999999999999999999 8999999999999999998 699999999866543


Q ss_pred             C-CCCccccccccccccccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          238 G-EPNVSYICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       238 ~-~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      . ....+..|||+|||||++....    .|+..+|+||||++..||.-|.+|+.+.-+...+..|   ..-|++.+.   
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkLk---  249 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKLK---  249 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcccc---
Confidence            2 3445678999999999995432    3778999999999999999999999877655444333   222322211   


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                          -++.-+..+.+||..||.+|..+||+..++|+|||+++.
T Consensus       250 --------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  250 --------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             --------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                                013457889999999999999999999999999999854

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.1e-38  Score=284.88  Aligned_cols=243  Identities=21%  Similarity=0.295  Sum_probs=186.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..|++.+.||+|+||.||+|.+..+++    .+++|.+....     .....|+.+++.+.||||+++++++.     ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence            459999999999999999999987776    46777764321     22345667888999999999998762     11


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                       ..++++||++ ++|.+++..   ....+++..+..++.||+.||+|||+ .|++||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence             2457889987 577666653   23568999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          232 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       232 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++........   ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+...... .++......+.  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~--  231 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA--  231 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC--
Confidence            9765433221   123456789999998654 48999999999999999998 9999987654332 22222110000  


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                               .+..++.++.+++.+||..||++|||+.++++
T Consensus       232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 -------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                     01235778999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-38  Score=281.60  Aligned_cols=236  Identities=25%  Similarity=0.342  Sum_probs=184.5

Q ss_pred             eEeeecCceEEEEEEECCCC---cEEEEEEeccchh-----hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++||+|+||.||+|.+...+   ..+|+|.+.....     ...+|+.+++.+.|+||+++++++.     . ...+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence            46999999999999876555   7899998764432     3457899999999999999988762     1 1257899


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ +|.+++..    ...+++..+..++.|++.||+|||. .|++|+||||+|||++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            99874 67666553    2468999999999999999999999 8999999999999999887 6999999999766433


Q ss_pred             CCCc----cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          239 EPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       239 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ....    ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+..+....+... ..          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~----------  216 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ER----------  216 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-Cc----------
Confidence            3221    11224579999998554 48999999999999999998 99999876654433333221 00          


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       ...+..++..+.++|.+||..||.+|||+.++++
T Consensus       217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             0012457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6e-38  Score=286.82  Aligned_cols=259  Identities=23%  Similarity=0.354  Sum_probs=188.0

Q ss_pred             cEEEeeEeeecCceEEEEEEE----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      -|++.+.||+|+||.||+|+.    ..++..||+|.+...     .....+|+.+++.+.|+|++++.+++...   ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            489999999999999999984    456889999987533     23456799999999999999998877332   234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..+++|||+++ +|..++...   ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCccc
Confidence            47799999974 676655431   2468999999999999999999999 8999999999999999887 6999999998


Q ss_pred             cccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCChh
Q 016158          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-VLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~-~~~~~~~~  307 (394)
                      .........    ....++..|+|||.+.+. .++.++||||||+++|+|++++.|+.....  ....... ..+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVT  233 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccHH
Confidence            765433221    123456679999998654 488999999999999999998766533211  1100000 00000000


Q ss_pred             -hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          308 -EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       308 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                       ........   .          .......++..+.+||.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~---~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         234 RLVRVLEEG---K----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHHcC---c----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             00000000   0          000124578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-37  Score=282.66  Aligned_cols=246  Identities=21%  Similarity=0.291  Sum_probs=183.0

Q ss_pred             eEeeecCceEEEEEEECC--CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +.||+|+||.||+|....  ....+|+|.+....     ..+.+|+.+++.++|+||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            358999999999997532  34578888765322     23457899999999999999999873     3344789999


Q ss_pred             cccc-cHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          161 YVPE-TVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      |+++ +|.+++...... ....++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccc
Confidence            9985 777776653321 2345677888999999999999999 8999999999999999887 7999999998654322


Q ss_pred             CC---CccccccccccccccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          239 EP---NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       239 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ..   .....+++.|+|||++..      ...++.++|||||||++|+|++ |..||......+.+...........   
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---  230 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL---  230 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC---
Confidence            11   122334667999998742      2346889999999999999999 7889987766655554433211100   


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                   +       ...+...++..+.+++..|+ .||++|||++++++
T Consensus       231 -------------~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 -------------P-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -------------C-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                         0       01122457888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-37  Score=280.12  Aligned_cols=243  Identities=24%  Similarity=0.362  Sum_probs=190.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|.+.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+++++.++|+||+++.+.+..      ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v   78 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII   78 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence            46999999999999999999865 45679999876533   345579999999999999999887732      236789


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ ++.+++...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence            999974 777666542  23567888899999999999999999 8999999999999999887 799999999876533


Q ss_pred             CCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          238 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       238 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ....  ....++..|+|||.+... .++.++|+|||||++|++++ |..||.+.+.......+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------  220 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-------------  220 (260)
T ss_pred             CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------------
Confidence            2211  122345679999998544 48999999999999999998 999998766544443332210             


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                           ..+          .....+.++.+++.+||+.||++||++.++++
T Consensus       221 -----~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 -----RMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -----CCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                 000          11356889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=283.38  Aligned_cols=243  Identities=25%  Similarity=0.329  Sum_probs=190.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|++.+.||+|+||.||+|.++.+|.    .||+|.+....     ....+|+.+++.++|+||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            459999999999999999999876665    58999875432     334579999999999999999998743      


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...+++|||+++ ++.+.+...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg~  155 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCcc
Confidence            236789999974 666655432   2458999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCCcc---ccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          232 AKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       232 a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++..........   ..++..|+|||.+.. ..++.++|+||||+++|++++ |+.||.+....+....+.... ..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---  230 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL---  230 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC---
Confidence            976643322211   122567999998854 348999999999999999998 999998776544333332210 00   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                              ..+...+..+.+++.+||..||.+|||+.++++
T Consensus       231 ------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 ------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                    011346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.5e-37  Score=281.97  Aligned_cols=246  Identities=20%  Similarity=0.244  Sum_probs=182.0

Q ss_pred             eEeeecCceEEEEEEEC--CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +.||+|+||.||+|...  .++..+|+|.+....     ..+.+|+.+++.++||||+++++++.     .....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            35899999999999864  345679999875432     24557999999999999999998873     3334789999


Q ss_pred             ccc-ccHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          161 YVP-ETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       161 ~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      |++ ++|.+++...... ....++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 5777776543321 2345677888899999999999999 8999999999999999887 6999999998654322


Q ss_pred             CC---CccccccccccccccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          239 EP---NVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       239 ~~---~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ..   .....++..|+|||++.+.      ..++.++|+||||+++|+|++ |+.||......+...........     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----  228 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence            21   1123457789999998432      135789999999999999996 99999876655443322221000     


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                 ..+       ...+....+..+.+++..|+ .||++|||+++|+.
T Consensus       229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                       000       00111346788999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-37  Score=280.22  Aligned_cols=240  Identities=23%  Similarity=0.358  Sum_probs=189.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .+|++.+.||+|+||.||++..  +++.||+|.+...  .....+|+.+++.++|+|++++++++..    +.  .+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~--~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH----NG--LYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC----CC--cEEEE
Confidence            3599999999999999999874  5788999987643  2345679999999999999999988732    11  57899


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ +|.+++....  ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            99984 7777665422  2468899999999999999999999 8999999999999999887 7999999998754322


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                        ......+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.+...               
T Consensus       154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------  215 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---------------  215 (254)
T ss_pred             --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---------------
Confidence              1222335679999988544 48999999999999999997 9999987665443333221100               


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                         .          .....++..+.+++++||+.+|.+||++.+++.
T Consensus       216 ---~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 ---M----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ---C----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               0          011357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=305.89  Aligned_cols=205  Identities=28%  Similarity=0.424  Sum_probs=171.2

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecC-CCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~  156 (394)
                      .|...+.||+|+||.||+++++.+|+.||||.+...     ....-+|+++|++++|+|||+++++-.... .--...-.
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            378889999999999999999999999999988652     334457999999999999999977541111 00023356


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC--CC-CcEEEEeecCc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HT-HQLKLCDFGSA  232 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~-~~vkl~Dfg~a  232 (394)
                      ++||||.| +|...+.. .....++++.++..++..++.||.|||+ +|||||||||.||++-.  +| ...||+|||.|
T Consensus        94 lvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            89999996 66655554 4557889999999999999999999999 89999999999999743  22 25899999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES  289 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  289 (394)
                      +...++....+.+||+.|.+||.+.....|+..+|.|||||++|+.+||..||-...
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            999988888899999999999999655679999999999999999999999996543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.9e-38  Score=283.84  Aligned_cols=235  Identities=17%  Similarity=0.230  Sum_probs=178.0

Q ss_pred             EeeecCceEEEEEEECCC------------------------CcEEEEEEeccch----hhhHHHHHHHHHcCCCceeee
Q 016158           89 VVGTGSFGVVFQAKCRET------------------------GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVAL  140 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~  140 (394)
                      .||+|+||.||+|....+                        ...||+|++....    ..+.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999985322                        2458899875432    234568889999999999999


Q ss_pred             ceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC
Q 016158          141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (394)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~  219 (394)
                      ++++...     .+.++||||+++ +|..++..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++.
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence            9988432     347799999996 45444432   23578999999999999999999999 89999999999999975


Q ss_pred             CCC------cEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 016158          220 HTH------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD  292 (394)
Q Consensus       220 ~~~------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~  292 (394)
                      .+.      .++++|||++......   ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||......+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            431      3899999987544222   22356778999999866556899999999999999995 6999997765433


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ... .....                 ..            ++...++.+.++|.+||+.||++|||+.++|++
T Consensus       230 ~~~-~~~~~-----------------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KER-FYEKK-----------------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHhc-----------------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            222 11100                 00            112345689999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-37  Score=281.84  Aligned_cols=236  Identities=17%  Similarity=0.200  Sum_probs=176.7

Q ss_pred             eEeeecCceEEEEEEECCC------------CcEEEEEEeccchh----hhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           88 HVVGTGSFGVVFQAKCRET------------GEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      +.||+|+||.||+|.....            ...||+|++.....    .+.+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            3589999999999985322            23588898754322    345678899999999999999987432    


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC------cE
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QL  224 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~------~v  224 (394)
                       ...+++|||+++ ++..++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.      .+
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCcee
Confidence             235799999986 44433322   23568999999999999999999999 89999999999999986552      28


Q ss_pred             EEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCC
Q 016158          225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGT  303 (394)
Q Consensus       225 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~  303 (394)
                      +++|||++......   ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            99999998654322   23456788999998865556899999999999999998 588888765432221 11110   


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                    ...            .....+.++.+||.+||+.||.+||++.+|+++
T Consensus       225 --------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 --------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                          000            012245789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-38  Score=284.47  Aligned_cols=235  Identities=19%  Similarity=0.269  Sum_probs=180.1

Q ss_pred             EeeecCceEEEEEEECCCCc-------EEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           89 VVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .||.|+||.||+|.+...+.       .||+|.+....    ....+|+.+++.+.||||+++++.+...     ...++
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~l   76 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIM   76 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEE
Confidence            58999999999999865544       38888775432    2345688999999999999999988433     23678


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc-------EEEEee
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-------LKLCDF  229 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~-------vkl~Df  229 (394)
                      ||||+++ +|..++...   ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++..       ++++||
T Consensus        77 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          77 VQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            9999985 565555431   2468899999999999999999999 899999999999999876632       799999


Q ss_pred             cCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      |.+.....   .....++..|+|||.+.+...++.++||||||+++|+|++|. .||...+...... ....        
T Consensus       153 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--------  220 (258)
T cd05078         153 GISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--------  220 (258)
T ss_pred             ccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--------
Confidence            99865432   223456788999999976555799999999999999999985 6665544333222 1110        


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                               ...            ++...+.++.+||.+||+.||++|||++++++.
T Consensus       221 ---------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ---------RHQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ---------ccc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                     000            113456789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-38  Score=296.90  Aligned_cols=257  Identities=26%  Similarity=0.455  Sum_probs=200.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh-------hHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .-|..++.||-|+||.|.+++...|...||.|.+++....       .+.|..||.....+-||+|+-.|     .+...
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence            3588999999999999999999999999999988664332       34689999999999999998877     44445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|+||+|++| ++-.++-.    -+-|++..++.++..+..|+++.|+ .|+|||||||+|||||.+|+ +||+|||+++
T Consensus       704 LYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGH-IKLTDFGLCT  777 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFGLCT  777 (1034)
T ss_pred             eEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCc-eeeeeccccc
Confidence            8899999996 44443332    2678999999999999999999999 89999999999999999995 9999999985


Q ss_pred             ccc---------cCC----------------------------------CCccccccccccccccccCCCCCCchhhHHH
Q 016158          234 VLV---------KGE----------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWS  270 (394)
Q Consensus       234 ~~~---------~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  270 (394)
                      -+.         .+.                                  ..-..+||+.|+|||++.... ++.-+|+||
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws  856 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWS  856 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhH
Confidence            431         000                                  001346899999999996554 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcc
Q 016158          271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  350 (394)
Q Consensus       271 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  350 (394)
                      .|||||||+.|++||......+.-..++....               ...+          .....++.++.+||.++. 
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~---------------~l~~----------~~~~~ls~e~~~li~kLc-  910 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQYKVINWRN---------------FLHI----------PYQGNLSKEALDLIQKLC-  910 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCcceeeeeehhh---------------cccc----------ccccccCHHHHHHHHHHh-
Confidence            99999999999999988765544333322100               0001          122568999999998765 


Q ss_pred             cCCCCCC---CHHHHhcCCCCCCCCCCCC
Q 016158          351 YSPNLRC---TALEACVHPFFDELRDPNT  376 (394)
Q Consensus       351 ~dP~~Rp---t~~ell~hp~f~~~~~~~~  376 (394)
                      .+++.|.   .++++..||||+.+--...
T Consensus       911 ~sad~RLGkng~d~vKaHpfFkgIDfssl  939 (1034)
T KOG0608|consen  911 CSADSRLGKNGADQVKAHPFFKGIDFSSL  939 (1034)
T ss_pred             cChhhhhcccchhhhhcCccccccchHhh
Confidence            4677777   5778999999998754443

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-37  Score=280.86  Aligned_cols=244  Identities=27%  Similarity=0.369  Sum_probs=190.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|.+...   ...||||......     ..+.+|+.+++.+.|+||+++++++..     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C
Confidence            34699999999999999999987543   3568999875432     245679999999999999999987731     1


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                       ..+++|||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~  153 (270)
T cd05056          80 -PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGL  153 (270)
T ss_pred             -CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCce
Confidence             25689999974 676666432   2468999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          232 AKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       232 a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      +.........  ....++..|+|||.+... .++.++||||||+++|+|++ |..||.+.+..+....+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----  227 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-----  227 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-----
Confidence            8765433211  112234579999988544 48999999999999999986 99999877765554443221000     


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                             ..+..++..+.++|.+||..+|++|||+.+++.
T Consensus       228 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         228 -----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   012457889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=315.17  Aligned_cols=247  Identities=20%  Similarity=0.335  Sum_probs=200.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCc-----EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      .+-+..+.||+|.||.||.|....-..     .||||.+.+.     ...+-+|..+|+.++|||||+++++++....  
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~--  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP--  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence            357788999999999999999864433     4999988653     3445579999999999999999999976333  


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                         .+|++|||.+ +|..+++..+..   ...++......++.+|++|++||++ +++|||||...|+|++... .|||+
T Consensus       770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEEc
Confidence               6689999985 777777654211   4568899999999999999999999 8999999999999999886 89999


Q ss_pred             eecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 016158          228 DFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  303 (394)
Q Consensus       228 Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~  303 (394)
                      |||+|+.+...+..   ....-...|||||.+.. ..++.|+|||||||++||++| |..||.+.++.+.+....... +
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R  922 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R  922 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence            99999854332211   11222467999999965 559999999999999999998 899999999888877666533 1


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+                           .+..++..+.+++..||+.+|++||+...|++
T Consensus       923 L~---------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 LD---------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cC---------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            11                           12578999999999999999999999999986

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-37  Score=286.40  Aligned_cols=245  Identities=22%  Similarity=0.320  Sum_probs=188.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...|++.+.||+|+||.||+|.+..+|.    .||+|.+....     ....+|+.+++.+.|+||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            3468999999999999999999887776    46888775432     2345789999999999999999987321    


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                        ..++++||++ +++.+.+..   ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Dfg  154 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDFG  154 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEcccc
Confidence              1457899998 466655543   23468899999999999999999999 8999999999999999877 69999999


Q ss_pred             CccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +++........   ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+..... ...+......++ 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-  231 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLP-  231 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCC-
Confidence            99765432221   123346789999998544 48999999999999999997 899997654332 333322111000 


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                                .+...+..+.+++.+||..||++||++.++++.
T Consensus       232 --------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         232 --------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             --------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      013457889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=277.81  Aligned_cols=237  Identities=25%  Similarity=0.367  Sum_probs=184.5

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ++||.|+||.||+|.+.. ++.||+|.+...     ...+.+|+++++.+.|+||+++++++.     .....+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            368999999999999977 999999987643     234567999999999999999998873     233478999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      ++ ++.+.+..   ....+++..+..++.+++.||+|||+ +|++||||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            75 56555433   23467889999999999999999999 8999999999999999887 7999999998755322111


Q ss_pred             ---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          242 ---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       242 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                         .....+..|+|||.+.+. .++.++|+||||+++|+|+| |..||...........+.....               
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~---------------  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR---------------  213 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence               111224569999998654 48999999999999999999 8899977664433333221000               


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                   ...+..++.++.+++.+||..+|.+|||+.++++
T Consensus       214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         0012356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.4e-37  Score=277.38  Aligned_cols=237  Identities=24%  Similarity=0.357  Sum_probs=183.8

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ++||+|+||.||+|... ++..+|+|.+....     ..+.+|+++++.+.|+||+++++++..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            36899999999999864 68899999875432     234579999999999999999998732     23478999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      ++ ++.+.+..   ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            75 66555432   23457899999999999999999999 8999999999999999887 7999999998654322111


Q ss_pred             --ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          242 --VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       242 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                        ....++..|+|||++.+ ..++.++||||||+++|++++ |..||.+.........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence              11233567999999854 448999999999999999998 999998765544433332210                 


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                 ...++..++..+.+++.+||..||++|||+.++++
T Consensus       212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       00012357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-37  Score=280.96  Aligned_cols=242  Identities=23%  Similarity=0.345  Sum_probs=185.8

Q ss_pred             eEeeecCceEEEEEEECCCC------cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           88 HVVGTGSFGVVFQAKCRETG------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +.||+|+||.||+|++....      +.+|+|.+...     .....+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36899999999999986543      68999987543     2344579999999999999999998732     23478


Q ss_pred             EEEecccc-cHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC----CcEEEEe
Q 016158          157 LVLEYVPE-TVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCD  228 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~D  228 (394)
                      ++|||+++ +|.+.+.....   ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999984 77776654322   12447889999999999999999999 8999999999999998754    2599999


Q ss_pred             ecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          229 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       229 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      ||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... .. 
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~-  231 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR-  231 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc-
Confidence            999876533221   1123446789999998654 48999999999999999998 99999876655444333210 00 


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                    .            .....++..+.+||.+||..+|.+||++.++++
T Consensus       232 --------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 --------------L------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------c------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                          0            012356889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.1e-37  Score=277.77  Aligned_cols=239  Identities=21%  Similarity=0.327  Sum_probs=179.1

Q ss_pred             eEeeecCceEEEEEEECC---CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           88 HVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +.||+|+||.||+|.+..   .+..||+|.+...     .....+|+.+++.++||||+++++++...    ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            368999999999998653   3457999987432     22445688999999999999999866432    22356899


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ ++..++...   ....++..+..++.|++.||+|||+ .+++||||||+|||++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            99884 676665431   2446777888899999999999999 8999999999999999887 6999999998754322


Q ss_pred             CC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          239 EP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       239 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ..     .....++..|+|||.+.+. .++.++||||||+++|+|++| .+||...+..+....+...  ..+       
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~-------  221 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRL-------  221 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC-------
Confidence            11     1123346679999998654 489999999999999999995 5677665544433322210  000       


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                         ..+..++..+.+++.+||..||++||++.++++
T Consensus       222 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 -------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             -------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                               011346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.6e-37  Score=277.14  Aligned_cols=245  Identities=19%  Similarity=0.252  Sum_probs=181.1

Q ss_pred             EeeecCceEEEEEEECCC--CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           89 VVGTGSFGVVFQAKCRET--GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      .||+|+||.||+|.....  ...+++|.+...     ...+.+|+.+++.++||||+++++.+.     .....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            589999999999976433  234667765432     234557888999999999999999883     33447899999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC-
Q 016158          162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  239 (394)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-  239 (394)
                      +++ +|.+++..........++..++.++.||+.||+|||+ .+++||||||+|||++.++ .++|+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            984 7777766533333557778888999999999999999 8999999999999999888 69999999986432211 


Q ss_pred             --CCccccccccccccccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          240 --PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       240 --~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                        ......++..|+|||++...      ..++.++||||||+++|+|++ |..||...+..+.+..+.......      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence              12234567889999987421      235789999999999999997 567887766655555443311100      


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                       .+...+...+++.+.+++..|| .||.+|||++++++
T Consensus       229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                             0011112346788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.6e-37  Score=279.18  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=188.4

Q ss_pred             EEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCc-ee
Q 016158           84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-EL  153 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-~~  153 (394)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++....      ....+|+.+++.++||||+++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999864   357899999876432      23457899999999999999999775443222 23


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ..+++++|+. +++..++.....  ....+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence            3567889887 466555432211  12357889999999999999999999 8999999999999999877 69999999


Q ss_pred             CccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          231 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       231 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +++.......   .....+++.|++||.+.+. .++.++||||||+++|+|++ |+.||.+.+..+....+... ..   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~---  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NR---  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-Cc---
Confidence            9876533221   1122345679999998544 48899999999999999999 88999776554433333221 00   


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                  ..            .....+..+.+++.+||+.+|++|||+.+++.
T Consensus       234 ------------~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         234 ------------LK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             ------------CC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        00            11346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-38  Score=292.66  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=192.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCc---E-EEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGE---I-VAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      +-.+.++||+|+||.||+|+.+..+.   . ||+|....+       ...+-+|+++++.++|||||+++|+.....   
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~---  234 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE---  234 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence            34456799999999999999865432   3 899987642       233447999999999999999999883322   


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                        -+++|||+|.| +|.+.+...   ...++..+...++.+.+.||+|||+ ++++||||-.+|+|++.++ .+||+|||
T Consensus       235 --Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKISDFG  307 (474)
T KOG0194|consen  235 --PLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKISDFG  307 (474)
T ss_pred             --ccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeCccc
Confidence              27799999996 676666542   2369999999999999999999999 8999999999999999876 68999999


Q ss_pred             CccccccCCCCc-cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          231 SAKVLVKGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       231 ~a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      +++......... ..--...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+....       
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~-------  379 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG-------  379 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC-------
Confidence            987543111111 11235679999999655 69999999999999999998 889999999887777774421       


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                          ++...+...+.++..++.+|+..||+.|||+.++.+
T Consensus       380 --------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  380 --------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             --------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                                111123467889999999999999999999998875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.6e-37  Score=275.85  Aligned_cols=234  Identities=20%  Similarity=0.220  Sum_probs=179.6

Q ss_pred             eEeeecCceEEEEEEECCCC----------cEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           88 HVVGTGSFGVVFQAKCRETG----------EIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ..+.+|+.+++.++|+||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            36899999999999998766          358888765433   345678999999999999999998744      22


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC------cEEEE
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QLKLC  227 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~------~vkl~  227 (394)
                      .++||||+++ +|..++...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.      .++|+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeC
Confidence            5789999985 565555432   2368999999999999999999999 89999999999999997652      49999


Q ss_pred             eecCccccccCCCCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      |||++.....   .....++..|+|||++.+. ..++.++||||||+++|+|++ |..||...+.......... .    
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~----  222 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-Q----  222 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-C----
Confidence            9999876543   2233456779999998655 358999999999999999999 5788866543222111110 0    


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                 ..              .+......+.++|.+||..||.+|||+.++++
T Consensus       223 -----------~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 -----------HR--------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----------CC--------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       00              00112378999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=284.57  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=203.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhh-----------HHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----------NRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|.++++||+|||+.||+|.+....+.||||+-...+...           -+|..+-+.|.||.||+++++|....+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            347999999999999999999999999999999754322211           168899999999999999999854443


Q ss_pred             CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCceeecCCCCcEEEeCC--CCcEEE
Q 016158          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPH--THQLKL  226 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~givH~Dlkp~Nil~~~~--~~~vkl  226 (394)
                      .    +|-|+|||+|+-   +..+.+.++.+++++++.|+.||+.||.||..- -.|||-||||.|||+-..  .+.+||
T Consensus       542 s----FCTVLEYceGND---LDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  542 S----FCTVLEYCEGND---LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             c----ceeeeeecCCCc---hhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence            2    789999999854   333444568899999999999999999999862 369999999999998532  126999


Q ss_pred             EeecCccccccCCCC--------ccccccccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016158          227 CDFGSAKVLVKGEPN--------VSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  295 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  295 (394)
                      +|||+++.+......        ....||..|.+||.+.-   .+..+.++||||+|||+|..+.|+.||...-....+.
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL  694 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL  694 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence            999999988654332        34568999999999842   3457899999999999999999999997553332222


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      ..-.++             +-.+..||.          .+.++.++++||++||++.-+.|....+|..||+|.-..
T Consensus       695 qeNTIl-------------kAtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  695 QENTIL-------------KATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             hhhchh-------------cceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence            211111             012223332          146899999999999999999999999999999997643

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-36  Score=276.99  Aligned_cols=249  Identities=25%  Similarity=0.390  Sum_probs=189.0

Q ss_pred             cEEEeeEeeecCceEEEEEEEC----CCCcEEEEEEeccchh-----hhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .|++.+.||+|+||.||+|+..    .+++.||||++.....     .+.+|+++++.+.|+||+++++++..   ....
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence            5888899999999999999864    3478999998865433     45689999999999999999887732   2234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      +.+++|||+++ ++.+++...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence            57899999974 776666542   2358999999999999999999999 8999999999999999887 7999999999


Q ss_pred             cccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----------HHHH
Q 016158          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-----------LVEI  297 (394)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-----------~~~i  297 (394)
                      .........    ....++..|+|||.+.+. .++.++||||||+++|+|++|..||........           ...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            766432211    112335569999998654 489999999999999999999998865422110           1111


Q ss_pred             HHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ...+..           .   ...          ..+..++.++.+|+.+||..||.+|||+.++++
T Consensus       236 ~~~~~~-----------~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         236 LELLKE-----------G---ERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHc-----------C---CcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            111000           0   000          011346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=286.82  Aligned_cols=242  Identities=22%  Similarity=0.370  Sum_probs=198.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ..++.++||.|.||.||.|.++...-.||||.++.+   ...+.+|+.+|+.+.|||+|+++++|     ....-+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEEE
Confidence            456778999999999999999998899999998765   45566899999999999999999999     3334478999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      |||. |+|.++++...+  ..++...+..++.||..|++||.. +++|||||...|.||.++. .||++|||+++.+..+
T Consensus       343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD  418 (1157)
T ss_pred             ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence            9988 788888877655  567778888999999999999999 8999999999999999875 8999999999977433


Q ss_pred             CCCccccc---cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          239 EPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       239 ~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .. ....|   ...|.|||.+. ...++.|+|||+|||+|||+.| |..||++.+..+.+..+...              
T Consensus       419 TY-TAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--------------  482 (1157)
T KOG4278|consen  419 TY-TAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--------------  482 (1157)
T ss_pred             ce-ecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------
Confidence            22 22222   55699999984 4458999999999999999997 88999988755444433321              


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  363 (394)
                          +          +..-++.+++.+.+|++.||++.|+.||+..|+-
T Consensus       483 ----y----------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  483 ----Y----------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ----c----------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                1          1112368999999999999999999999988773

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=294.96  Aligned_cols=243  Identities=26%  Similarity=0.391  Sum_probs=206.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCC---cEEEEEEecc-----chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .-.|.++||.|.||.|++|+.+..|   ..||||.++.     ....+..|+.||-++.||||+++.+++     ....-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence            3578999999999999999998766   4699999864     345566799999999999999999998     44444


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +.||+|||+ |+|..+++...   +.+...++..+++.|+.|++||-+ .|+|||||...||||+.+- .+|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEecccccee
Confidence            789999999 57888777644   669999999999999999999999 8999999999999999988 79999999999


Q ss_pred             ccccCCC-Cccccc---cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          234 VLVKGEP-NVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       234 ~~~~~~~-~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ...++.. ..+..|   ..+|.|||.+. ...++.++||||+|++|||.++ |..||-+..+.+.+..|.+..+-|++  
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--  856 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--  856 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence            7755442 122222   46799999994 5569999999999999999885 99999999999999999887665554  


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                .++|..+-+|+..||++|-.+||...+|+.
T Consensus       857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                      468999999999999999999999998886

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-37  Score=285.68  Aligned_cols=240  Identities=30%  Similarity=0.459  Sum_probs=191.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCC----CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .+..++||.|-||.||+|.+..-    .-.||||..+.+     ...+..|.-+++.+.||||++++|++....      
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------  464 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------  464 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------
Confidence            44556899999999999987432    235899987653     344557999999999999999999983322      


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ++||||+++ |.|..++..   ....++......++.||+.||.|||+ +.+|||||...|||+.... .|||+|||+++
T Consensus       465 ~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecccchhh
Confidence            679999998 556555543   34779999999999999999999999 8999999999999999887 69999999999


Q ss_pred             ccccCCCCccccc--cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          234 VLVKGEPNVSYIC--SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       234 ~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      .+..........|  ...|||||.+ +...++.++|||.|||.+||++. |..||.+..+.+.+..+.+.-..|      
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------  612 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------  612 (974)
T ss_pred             hccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------
Confidence            8765543322233  4559999998 55669999999999999999985 999999987766555443321111      


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  363 (394)
                                            .++.+|+.+..|+.+||++||.+||...+|.
T Consensus       613 ----------------------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  613 ----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                  2367999999999999999999999877654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=286.60  Aligned_cols=274  Identities=21%  Similarity=0.284  Sum_probs=182.4

Q ss_pred             cccccEEEeeEeeecCceEEEEEEEC----------------CCCcEEEEEEeccchh------------------hhHH
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCR----------------ETGEIVAIKKVLQDKR------------------YKNR  124 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~  124 (394)
                      ...++|.+.++||+|+||.||+|...                ..++.||||.+.....                  ....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34568999999999999999999752                2356799998754221                  1123


Q ss_pred             HHHHHHHcCCCce-----eeeceEEEecCC---CceeEEEEEEecccc-cHHHHHHHhh-----------h---------
Q 016158          125 ELQIMQMLDHPNI-----VALKHCFFSTTD---KEELYLNLVLEYVPE-TVNRIARNYS-----------R---------  175 (394)
Q Consensus       125 E~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~---------  175 (394)
                      |+.++.+++|.++     +.++++|.....   ......++|+||+++ +|.+++....           .         
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666777776654     566666543211   112346799999985 7766665311           0         


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCcc--cccccccccc
Q 016158          176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAP  253 (394)
Q Consensus       176 ~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~t~~y~aP  253 (394)
                      ....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||++...........  ..+++.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11234667888999999999999999 8999999999999999887 699999999975543322222  2347899999


Q ss_pred             ccccCCCC-------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          254 ELIFGATE-------------------Y--TTAIDIWSTGCVMAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       254 E~~~~~~~-------------------~--~~~~DiwslG~il~~lltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      |.+.....                   +  ..+.|+||+||++|+|++|.. ||.+........   .... .....|..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~---~~~~-~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL---RQYD-NDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH---hhcc-chHHHHHh
Confidence            99743211                   1  124799999999999999875 775432111100   0000 00000100


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP---NLRCTALEACVHPFFDE  370 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpt~~ell~hp~f~~  370 (394)
                      ...  ..+.++          .....++..++|+++||..+|   .+|+|++|+|+||||..
T Consensus       456 ~~~--~~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        456 YKG--QKYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hcc--cCCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            000  000111          124578999999999999876   68999999999999953

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.8e-37  Score=276.63  Aligned_cols=282  Identities=29%  Similarity=0.478  Sum_probs=213.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC---CCcEEEEEEecc--chhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQ--DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..|.++++||+|.|++||+|.+..   ....||+|.+..  ......+|+++|..+ .+.||+++.+++     ......
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~v  110 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQV  110 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCee
Confidence            349999999999999999999877   778999998753  345567899999988 688999999988     445558


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++|+||++. ...++.       ..++...++.+++.++.||+++|. +|||||||||.|+|.+.....-.|+|||+|..
T Consensus       111 ~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             EEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHH
Confidence            899999996 332222       457789999999999999999999 89999999999999998877899999999862


Q ss_pred             cc-----------------c--C--------------------------CCCccccccccccccccccCCCCCCchhhHH
Q 016158          235 LV-----------------K--G--------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIW  269 (394)
Q Consensus       235 ~~-----------------~--~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  269 (394)
                      ..                 .  +                          .......||++|.|||++......+++.|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            11                 0  0                          0012345799999999999888889999999


Q ss_pred             HHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCChhhhhccCCC------------------CcccCCCCCCC-C--
Q 016158          270 STGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKP-H--  327 (394)
Q Consensus       270 slG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-~--  327 (394)
                      |.|||+..+++++.||.. .++.+.+.++....|.........+...                  +.......... .  
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999998764 4556777777766665333222211111                  11010000000 0  


Q ss_pred             -CccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          328 -PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       328 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                       .+.....+..+..+.+|+.+||..||.+|.||+++|+||||.+..+...
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~  392 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTER  392 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhh
Confidence             1222333455778999999999999999999999999999997655443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.5e-35  Score=262.13  Aligned_cols=238  Identities=38%  Similarity=0.632  Sum_probs=191.6

Q ss_pred             CceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecccc-cHH
Q 016158           94 SFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN  167 (394)
Q Consensus        94 ~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  167 (394)
                      +||.||+|.+..+|+.+|+|++...     .....+|++.+++++|+|++++++++..     ....++++|++++ ++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999988999999998643     3456689999999999999999998843     2457899999997 777


Q ss_pred             HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCcccccc
Q 016158          168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS  247 (394)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t  247 (394)
                      ..+..    ...++...++.++.+++.++.+||+ .+++|+||+|.||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            66554    2338899999999999999999999 8999999999999999887 7999999999876555444556678


Q ss_pred             ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCC
Q 016158          248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH  327 (394)
Q Consensus       248 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (394)
                      ..|++||.+.+. .++.++|+||||+++|+|++|..||.....................                     
T Consensus       150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------  207 (244)
T smart00220      150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP---------------------  207 (244)
T ss_pred             cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Confidence            889999998644 4788999999999999999999999774444333333221100000                     


Q ss_pred             CccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       328 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                          .....++.++.+++.+||..||++||++.++++||||
T Consensus       208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                0001178899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=246.29  Aligned_cols=217  Identities=24%  Similarity=0.416  Sum_probs=178.2

Q ss_pred             CCcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHH-HcCCCceeeeceEEEecCCC
Q 016158           77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQ-MLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        77 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ..-..+....+..||+|++|.|-+.++..+|...|+|.+....     ....+|+.+.. ...+|.+|.+++.++...+ 
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-
Confidence            3334445666778999999999999999999999999885432     22234555443 3478999999998865554 


Q ss_pred             ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                          +++.||.|..++..+.......++.+++..+-+++..++.||.|||+...++|||+||.||||+.+| +||+||||
T Consensus       120 ----vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG  194 (282)
T KOG0984|consen  120 ----VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG  194 (282)
T ss_pred             ----EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence                7899999999998888888888999999999999999999999999978999999999999999999 79999999


Q ss_pred             CccccccCCCCccccccccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHH
Q 016158          231 SAKVLVKGEPNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIK  299 (394)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~  299 (394)
                      .+..+.+.-......|...|||||.+..   ...|+.++||||||+++.||.+++.||... ++.+++.+++.
T Consensus       195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9987766555555678889999999842   235899999999999999999999999764 44455555544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-37  Score=293.17  Aligned_cols=249  Identities=29%  Similarity=0.440  Sum_probs=190.1

Q ss_pred             EEEeeEeeecCce-EEEEEEECCCCcEEEEEEeccchh-hhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           84 YIAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        84 y~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      |.-.+.+|.|+.| .||+|...  |+.||||.+..+.. ..++|+..|+.- .||||+++++.-     ....+.||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence            4455678999998 58999984  88999998876654 567899999987 799999976533     66678889999


Q ss_pred             cccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC---CC-CcEEEEeecCccccc
Q 016158          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVLV  236 (394)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~-~~vkl~Dfg~a~~~~  236 (394)
                      .|..+|.++++..............+.+..|++.||++||+ .+||||||||.||||+.   ++ -.++|+|||+++...
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99999999988731111111114556778899999999999 89999999999999986   33 369999999999886


Q ss_pred             cCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          237 KGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       237 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      .+..    .....||-+|+|||++.... .+.++|||||||++|+.++| ..||.+...  .-.+|..            
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~------------  727 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILT------------  727 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhc------------
Confidence            5543    34457899999999997655 57799999999999999986 799965422  2222322            


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                           ..+...++.         .....++.+||.+||.+||..||+|.++|+||||=
T Consensus       728 -----~~~~L~~L~---------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  728 -----GNYTLVHLE---------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             -----Cccceeeec---------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                 111111111         11122899999999999999999999999999993

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-36  Score=275.74  Aligned_cols=255  Identities=22%  Similarity=0.287  Sum_probs=199.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ....+.++||+|-||.|.+|... .+..||+|+++..     ...+.+|+++|.+|+||||+.++++|...+.     +|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence            35788999999999999999874 3689999998653     3556789999999999999999999954433     88


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++||++ |.|.+++......  .+.-.....++.||+.|++||.+ .++|||||.+.|+|++.++ ++||+|||+++.+
T Consensus       612 mI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCccccccc
Confidence            9999998 5777777664321  13344556699999999999999 8999999999999999998 6999999999877


Q ss_pred             ccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL--LGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ..++..   ....-...|||+|.+...+ +++++|+|+||+++||++  +...||....+.+...+.-..+.......  
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--  764 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--  764 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--
Confidence            655432   2233467899999997654 999999999999999987  57799988877766655544332222110  


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                                         ....+.-++..+.+|+.+||.+|-.+|||.++|-  -+|++
T Consensus       765 -------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh--~~lq~  803 (807)
T KOG1094|consen  765 -------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH--LFLQE  803 (807)
T ss_pred             -------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH--HHHHH
Confidence                               0112345788999999999999999999999984  34443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-36  Score=283.02  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             EEEeeEeeecCceEEEEEEECCCC---cEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..+.++||+|+||.|++|.+...+   ..||||.+..+.     ..+.+|+.+|.+|+|+|++++++++...      -+
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~  185 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PA  185 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hh
Confidence            556688999999999999986433   358999886543     4567899999999999999999998542      25


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .||||+++ |+|.+-+..  .....|....+..|+.||+.||.||.. +++|||||-..|+|+-... .|||+|||+.+.
T Consensus       186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLmRa  261 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLMRA  261 (1039)
T ss_pred             hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeecccceec
Confidence            68999998 577666655  234778899999999999999999999 8999999999999998765 799999999988


Q ss_pred             cccCCCCccccc----cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          235 LVKGEPNVSYIC----SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       235 ~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      +..++.......    ...|+|||.+. ...++.++|+|++||+||||+| |..||.+....+.+..+-..- ..+    
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLp----  335 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLP----  335 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCC----
Confidence            866655432221    45599999995 4559999999999999999997 789999999887777664210 000    


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                             -++.+++++.+++..||+++|++|||...|...-++++.
T Consensus       336 -----------------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  336 -----------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             -----------------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence                                   125689999999999999999999999988655444443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=306.11  Aligned_cols=258  Identities=21%  Similarity=0.291  Sum_probs=186.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecc
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      .|...++||+|+||.||+|++..+|..||||.+........+|++++++++||||+++++++...     ...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            36667899999999999999998999999999876555556789999999999999999998432     3367999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH---NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ++ +|.+++.       .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++ ..++. ||.+..... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            84 6766653       3788899999999999999999   5 6999999999999999776 56664 665543221 


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                        .....+++.|+|||++.+. .++.++|||||||++|||+||+.||...... ..+..+.+..-....         ..
T Consensus       835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  902 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH---------LD  902 (968)
T ss_pred             --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc---------hh
Confidence              1233678999999998654 5899999999999999999999998543211 112222111100000         00


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      .+..+.....   .........++.+++.+||+.||++|||+.|+++.  ++++..
T Consensus       903 ~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~  953 (968)
T PLN00113        903 MWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESASR  953 (968)
T ss_pred             heeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHhhc
Confidence            0000000000   00011123467899999999999999999999874  555443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=257.81  Aligned_cols=255  Identities=24%  Similarity=0.285  Sum_probs=188.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc-chhhhHHHHHHHHH--cCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +-++.+.||+|.||.||+|+++  |+.||||++.. +.....+|.++++.  |+|+||+.+++.=.... ..-..+++|+
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvT  288 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVT  288 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEee
Confidence            4889999999999999999997  88999999864 55666788888876  59999999877532222 3345689999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      +|.+ |+|.+++..     ..++.....+++..++.||++||..       -.|.|||||..||||..++ .+.|+|+|+
T Consensus       289 dYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGL  362 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL  362 (513)
T ss_pred             ecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeecee
Confidence            9998 688888876     7789999999999999999999952       3499999999999999998 799999999


Q ss_pred             ccccccC-----CCCccccccccccccccccCCCCC-----CchhhHHHHHHHHHHHHh-----C-----CCCCCCCCcH
Q 016158          232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEY-----TTAIDIWSTGCVMAELLL-----G-----QPLFPGESGV  291 (394)
Q Consensus       232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~llt-----g-----~~pf~~~~~~  291 (394)
                      |-.....     ......+||.+|||||++......     -..+||||||+++||++.     |     ++||.+..+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            9655433     223467899999999999554321     226899999999999984     2     3777654322


Q ss_pred             -HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          292 -DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       292 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                       ..+.+|.+.+                  ....+++..-..+.....-..+.+|++.||..+|.-|.||--+.+
T Consensus       443 DPs~eeMrkVV------------------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  443 DPSFEEMRKVV------------------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCHHHHhcce------------------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence             2233332211                  111111111111111223345778999999999999999876643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=267.00  Aligned_cols=199  Identities=29%  Similarity=0.441  Sum_probs=171.5

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhh------------HHHHHHHHHcC---CCceeeeceE
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK------------NRELQIMQMLD---HPNIVALKHC  143 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~E~~~l~~l~---h~~iv~~~~~  143 (394)
                      ++..+|+..+.||.|+||.|++|.++.....|+||.+.+++-..            --|+.+|..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34457999999999999999999999999999999887654222            25999999997   9999999999


Q ss_pred             EEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc
Q 016158          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (394)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~  223 (394)
                      |     .+..|+|++||-.+.++ + +..+......+++.+++.|+.||+.|+++||+ .||||||||-+||.++.+| -
T Consensus       638 F-----Eddd~yyl~te~hg~gI-D-LFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g-~  708 (772)
T KOG1152|consen  638 F-----EDDDYYYLETEVHGEGI-D-LFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNG-F  708 (772)
T ss_pred             e-----ecCCeeEEEecCCCCCc-c-hhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCC-e
Confidence            9     55667889999887542 2 22334556889999999999999999999999 8999999999999999999 6


Q ss_pred             EEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016158          224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  287 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  287 (394)
                      +||+|||.|... ..++...+.||..|.|||++.+.++.+...|||+||++||.++....||..
T Consensus       709 ~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  709 VKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999998754 445666789999999999998888889999999999999999999999863

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-34  Score=256.73  Aligned_cols=269  Identities=25%  Similarity=0.322  Sum_probs=188.4

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEecc-chhhhHHHHHHHHH--cCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      .+...+||+|.||.||+|...  ++.||||++.. ++..+..|.+|++.  ++|+||+++++.--... ....-+++|++
T Consensus       212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt~  288 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVTE  288 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEee
Confidence            667789999999999999975  69999999864 45667778888776  48999999987542222 12344679999


Q ss_pred             ccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--------IGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      |.+ |+|.++++.     ..+++....+++..+++||+|||+.        ..|+|||||..||||..|. +..|+|||+
T Consensus       289 fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGL  362 (534)
T KOG3653|consen  289 FHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGL  362 (534)
T ss_pred             eccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccce
Confidence            998 689888886     7799999999999999999999962        3599999999999999998 799999999


Q ss_pred             ccccccCCC---CccccccccccccccccCCCCCC-----chhhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhC
Q 016158          232 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYT-----TAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLG  302 (394)
Q Consensus       232 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~  302 (394)
                      |.++..+..   ....+||.+|||||++.+...+.     .+.||||+|.++|||++...-+. +..+.-++.--.....
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            988765433   33478899999999997765554     36899999999999997643332 1111100000001111


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH------HHhcCCC
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL------EACVHPF  367 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~------ell~hp~  367 (394)
                      .|..+.+...--  .....|. .++.|..   -.--..+++.+..||+.||+-|.||.      ..+.|.|
T Consensus       443 hPt~e~mq~~VV--~kK~RP~-~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  443 HPTLEEMQELVV--RKKQRPK-IPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCCHHHHHHHHH--hhccCCC-Chhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            222222110000  0000000 0112222   12345689999999999999999986      3345555

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-32  Score=269.16  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=189.9

Q ss_pred             cEEEeeEeeecCceEEEEEEEC---C----CCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCR---E----TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      +..+.+.||+|.||.|++|...   .    ....||||.....     ...+..|+++|+.+ .|+||+.+++++..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            3456679999999999999743   1    1457999987543     34456799999988 59999999999943   


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhh---hh-------c--CCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYS---RI-------H--QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~~-------~--~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                        ....++|+||+. |+|..+++..+   ..       .  ..++......++.||+.|++||++ .++|||||-..|||
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL  450 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence              445789999998 57777777644   00       1  138899999999999999999999 89999999999999


Q ss_pred             EeCCCCcEEEEeecCccccccCCCCcc--cc--ccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcH
Q 016158          217 VNPHTHQLKLCDFGSAKVLVKGEPNVS--YI--CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  291 (394)
Q Consensus       217 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~  291 (394)
                      ++.+. .+||+|||+|+..........  ..  -...|||||.+.. ..|+.++||||+|++||||+| |..||.+....
T Consensus       451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99876 899999999986544332211  11  1344999999976 559999999999999999998 88999885533


Q ss_pred             HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       292 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..+.+..+...+.                           ..+..++.++.++++.||..+|++||+..++..
T Consensus       529 ~~l~~~l~~G~r~---------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  529 EELLEFLKEGNRM---------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            3333333321111                           123567999999999999999999999998764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=263.40  Aligned_cols=240  Identities=25%  Similarity=0.363  Sum_probs=191.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ....++||.|+||+||+|.+...|+    +||||++...     ...+.+|+-+|..+.|||++++++++....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4456789999999999999876665    5788876432     345567899999999999999999884333      


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +.||++|++ |.|.++++..   ...+-......|..||++||.|||. +++|||||-..||||.+-. .+||.|||+++
T Consensus       772 ~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecchhh
Confidence            568999999 5777777663   3678889999999999999999999 8999999999999999877 59999999999


Q ss_pred             ccccCCCCccccc---cccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          234 VLVKGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       234 ~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      .....+......+   .+.|||-|.+... .|+.++||||+||++||++| |..|+.+....+ +.+.++...+      
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geR------  918 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGER------  918 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhcccc------
Confidence            8766655443333   5669999998654 49999999999999999998 999998766433 2222221100      


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  363 (394)
                                 +          ..++.++.++..++.+||..|+..||+++++.
T Consensus       919 -----------L----------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  919 -----------L----------SQPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             -----------C----------CCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence                       1          12356889999999999999999999998875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-33  Score=264.12  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +.+|..+..+|.|.||.||+|+++.+++..|+|+++..    ....++|+-+++..+|+||+.+++.|.....     .+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cE
Confidence            45699999999999999999999999999999998643    3455789999999999999999999854433     78


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +.||||++ ++.++-    ...+.+++..+..+++..+.+|+|||+ .|-+|||||-.|||++..+ .+|++|||.+..+
T Consensus        89 icMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsaqi  162 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSAQI  162 (829)
T ss_pred             EEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchhhh
Confidence            99999996 554432    234788999999999999999999999 8999999999999999888 6999999987554


Q ss_pred             ccC-CCCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKG-EPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ... ....+..||++|||||+..  ....|...+|||++|+...|+---++|....-++..+..+.+-.-+|+..     
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l-----  237 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL-----  237 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----
Confidence            322 2334678999999999862  22348999999999999999988888876666666555554432222211     


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                               .  ..        ..-++.+-+|++.+|..+|.+|||++.+|.|||....
T Consensus       238 ---------k--Dk--------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  238 ---------K--DK--------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             ---------c--CC--------ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                     0  01        2346778899999999999999999999999998764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-33  Score=235.64  Aligned_cols=256  Identities=23%  Similarity=0.294  Sum_probs=188.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +.|.|.+.||+|.||.+.+|+++.++..+++|.+.+..   ..+.+|...--.| .|.||+..+++-+...+    ++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eEEE
Confidence            45999999999999999999999999999999886543   3444565544444 58899988777654443    5678


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE-eCCCCcEEEEeecCcccc
Q 016158          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~-~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||++ |+|..-+..     .++.+...+.++.|++.|+.|||+ +++||||||.+|||| +.|..+|||||||+.+..
T Consensus       100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999 566444433     678899999999999999999999 899999999999998 445558999999998654


Q ss_pred             ccCCCCccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhh
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  310 (394)
                      ...  ....-.+..|.+||....-    ...+..+|+|.||+++|.++||.+||+..... ..+.+..+..+........
T Consensus       174 g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  174 GTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             Cce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            221  1112225568999987432    22466799999999999999999999854322 3344454443332211100


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDEL  371 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~ell~hp~f~~~  371 (394)
                                           .| ..+++.+..+.++-|+++|++|   -++......-|....
T Consensus       252 ---------------------~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  252 ---------------------KF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             ---------------------hh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence                                 01 4578999999999999999999   566666566666543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.3e-29  Score=220.04  Aligned_cols=207  Identities=35%  Similarity=0.584  Sum_probs=174.1

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEeccc-
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-  163 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-  163 (394)
                      ||+|++|.||++....+++.+++|++....     ....+|++.++.+.|++++++++++..     ....++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            689999999999998889999999987654     357789999999999999999988833     245789999999 


Q ss_pred             ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC-CCCcEEEEeecCccccccCC-CC
Q 016158          164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  241 (394)
Q Consensus       164 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~~~~~~~-~~  241 (394)
                      +++.+++....   ..++...++.++.+++.+|.+||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            57777665421   468899999999999999999999 89999999999999998 56 79999999987654332 12


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016158          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (394)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (394)
                      ....+...|++||.+.....++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3345678899999985542578999999999999999                                           


Q ss_pred             CCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016158          322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (394)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  366 (394)
                                       ..+.+++.+||+.||++||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1467899999999999999999999985

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1e-30  Score=270.18  Aligned_cols=207  Identities=16%  Similarity=0.173  Sum_probs=144.5

Q ss_pred             HcCC-CceeeeceEEEecC--CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 016158          131 MLDH-PNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  207 (394)
Q Consensus       131 ~l~h-~~iv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH  207 (394)
                      .+.| .||+.+++.|-...  ......+++++|+++++|..++..   ....+++..++.++.||+.||+|||+ +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence            4455 47777777651111  112234667899999898887753   23569999999999999999999999 89999


Q ss_pred             ecCCCCcEEEeCCC------------------CcEEEEeecCccccccCC-----------------CCccccccccccc
Q 016158          208 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNVSYICSRYYRA  252 (394)
Q Consensus       208 ~Dlkp~Nil~~~~~------------------~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a  252 (394)
                      |||||+||||+..+                  ..+|++|||+++......                 ......+|+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996433                  146666666665321100                 0011357888999


Q ss_pred             cccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCcccc
Q 016158          253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV  332 (394)
Q Consensus       253 PE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (394)
                      ||++.+.. ++.++|||||||+||||++|.+|+....  ..+..+.... .++ ..                        
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~~------------------------  234 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-QI------------------------  234 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-hh------------------------
Confidence            99986654 8999999999999999999988875321  1122221110 000 00                        


Q ss_pred             ccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       333 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                        ....+...+++.+||+.||.+|||+.|+|+||||++..
T Consensus       235 --~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        235 --LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             --hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence              01134567899999999999999999999999998753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=9.7e-29  Score=217.39  Aligned_cols=201  Identities=35%  Similarity=0.576  Sum_probs=165.4

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+...     .....+|++.++.++|+|++++++.+..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            56788999999999999999988999999998653     3455679999999999999999988732     2347789


Q ss_pred             Eecccc-cHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +|++++ +|.+++...    .. +++..++.++.+++.+|.+||+ .+++|+||+|.||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999997 777666542    23 8899999999999999999999 8999999999999999886 79999999987765


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCcHHHHH
Q 016158          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLV  295 (394)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~  295 (394)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+....+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~  211 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS  211 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence            443  334456678899999884334477899999999999999999999977 44443333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=8.3e-30  Score=226.17  Aligned_cols=250  Identities=18%  Similarity=0.253  Sum_probs=190.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCC-----cEEEEEEeccchhhh-----HHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~-----~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      .+.+++...++-+|.||.||.|.++..+     +.|.+|.++.....+     ..|...+.-+.|||+..+.++..+..+
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            4456888889999999999999776443     345666665443332     357777888899999999998855332


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcE
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v  224 (394)
                          ..++++.+++ ++|..++...+.    ..+.+.-.++..++.|++.|++|||+ +|+||.||...|.+|++.- +|
T Consensus       362 ----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qV  435 (563)
T KOG1024|consen  362 ----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QV  435 (563)
T ss_pred             ----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eE
Confidence                2345677776 577666663221    22445666788899999999999999 9999999999999999776 79


Q ss_pred             EEEeecCccccccCCCCc---cccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016158          225 KLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       225 kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~  300 (394)
                      ||+|=.+++-....+-..   .......||+||.+.. ..|+.++|+|||||++|||+| |+.||...++.+....+.+.
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            999999988665443321   1223566999999965 459999999999999999998 99999988887776665542


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .                            +-..+-++|.++..++..||+.+|++||+.+++..
T Consensus       515 y----------------------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 Y----------------------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             c----------------------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            1                            11123579999999999999999999999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5e-28  Score=202.14  Aligned_cols=205  Identities=24%  Similarity=0.324  Sum_probs=167.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCC-CceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +|.+++.||.|+||-+|+|....+|+.||||+-...  ......|..+.+.|++ ..|..+..+.     .+..|-.+||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlVM   90 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLVM   90 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceeee
Confidence            599999999999999999999999999999976543  3445679999999965 5666665554     5556677999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC--CCCcEEEEeecCcccccc
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~~~vkl~Dfg~a~~~~~  237 (394)
                      ++++.+|.+++..   ....++.+++..++-|++.-++|+|. ++++||||||+|+|..-  ..+.+.|+|||+|+...+
T Consensus        91 dLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            9999999887654   34789999999999999999999999 89999999999999754  445799999999987743


Q ss_pred             CC--------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 016158          238 GE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI  297 (394)
Q Consensus       238 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i  297 (394)
                      ..        ......||..|.+-....+. ..+++.|+-|+|++|.++.-|..||++.......++.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy  233 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY  233 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence            32        23356789999998777544 3789999999999999999999999997665544433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.3e-28  Score=206.22  Aligned_cols=167  Identities=21%  Similarity=0.159  Sum_probs=124.4

Q ss_pred             ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCcc
Q 016158          164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS  243 (394)
Q Consensus       164 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~  243 (394)
                      |+|.+++...   ...+++..++.++.|++.||+|||+ .+      ||+|||++.++ .+++  ||++......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            4565655532   3569999999999999999999999 67      99999999887 6888  9998765332    2


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhccCCCCcccCCC
Q 016158          244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  322 (394)
Q Consensus       244 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  322 (394)
                      ..+|+.|+|||++.+. .++.++|||||||++|+|+||+.||...... ..+..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            3678999999999654 4899999999999999999999999765433 2223322211100000               


Q ss_pred             CCCCCCccccccccCCH--HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          323 QIKPHPWHKVFQKRLPP--EAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       323 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                             .......++.  ++.++|.+||..||.+|||+.++++|+|+..
T Consensus       128 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 -------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                   0000112333  6999999999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-26  Score=214.42  Aligned_cols=250  Identities=20%  Similarity=0.214  Sum_probs=189.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCC-cEEEEEEeccch----hhhHHHHHHHHHcCC----CceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK----RYKNRELQIMQMLDH----PNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|+.....    ..+..|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            5999999999999999999997764 678999765431    156789999999873    57777766541    3455


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC----CcEEEEee
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDF  229 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~Df  229 (394)
                      +-++||+.++.+|.++.....  .+.++..++..++.|++.+|++||+ .|++||||||.|++++...    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988776654  5889999999999999999999999 8999999999999998653    46999999


Q ss_pred             cCcc--ccccCC--------C-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 016158          230 GSAK--VLVKGE--------P-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  298 (394)
Q Consensus       230 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~  298 (394)
                      |+++  ......        . .....||..|+++....+. ..+++.|+||+++++.+++.|..||.............
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 2235589999999988654 48999999999999999999999998766544433333


Q ss_pred             HHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      +.........                        .....+..+.++...+-..+...+|....+..
T Consensus       251 ~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  251 KDPRKLLTDR------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             HHhhhhcccc------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            3211000000                        11234567777777777788888997776654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-26  Score=202.62  Aligned_cols=199  Identities=24%  Similarity=0.310  Sum_probs=168.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEe--ccchhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .|.++++||+|+||.++.|++.-++++||||.-  +.+...+..|...++.|. .++|..++-+-     .++.|-.+|+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence            499999999999999999999999999999964  334556778999999884 57887765433     6667778999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC----CCcEEEEeecCcccc
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVL  235 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~----~~~vkl~Dfg~a~~~  235 (394)
                      |+++.+|.+++.-   ++..|+.+.+..++.|++.-++++|+ +.+|.|||||+|+||...    .+.+.++|||+|+.+
T Consensus       104 dLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            9999999887664   45889999999999999999999999 899999999999999753    346999999999877


Q ss_pred             ccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q 016158          236 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV  291 (394)
Q Consensus       236 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  291 (394)
                      .+...        ..+..||..||+-....+.. .+++.|+-|||-++++.+-|..||.+....
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            54332        34567899999998887655 799999999999999999999999987544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.6e-28  Score=239.30  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=191.2

Q ss_pred             EEeeEeeecCceEEEEEEECCCCcEEEEEEecc----chhh------hHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .-..++|.|++|.|+.+......+.++.|.+..    ....      ...|+.+-..+.|+|++..+..+.....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            356789999999999998877777777775541    1111      2246666677899999877665532221     


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ..-.||||+.+|..++..    ...+....+..++.|++.|++|||. .||.|||+|++|++++.++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCccee
Confidence            222399999866555543    2478888999999999999999999 8999999999999999988 799999999876


Q ss_pred             cccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCChhh
Q 016158          235 LVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREE  308 (394)
Q Consensus       235 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~  308 (394)
                      ......     .....|+..|+|||++.+.....+..||||.|++++.|++|+.||.-....+... ....         
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---------  540 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---------  540 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------
Confidence            533322     2456789999999999777656678999999999999999999997654332211 1000         


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                             ..+.....   .+  ..+...++...+.+|.+||++||.+|.|+++|++.+||+.+..=.+
T Consensus       541 -------~~~~~~~~---~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  541 -------SDQRNIFE---GP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             -------cccccccc---Ch--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence                   00111110   00  1123567889999999999999999999999999999999865444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=3e-25  Score=197.06  Aligned_cols=237  Identities=22%  Similarity=0.287  Sum_probs=146.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh-------hHHHHHHHHHcC----------CCceeeeceEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQMLD----------HPNIVALKHCFF  145 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~----------h~~iv~~~~~~~  145 (394)
                      .+...+.||.|+++.||.+++..||+.+|+|++......       .++|.-....+.          |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            477889999999999999999999999999987533221       122222222221          112222222221


Q ss_pred             --------ecC-CCcee---EEEEEEecccccHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCceeecC
Q 016158          146 --------STT-DKEEL---YLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDI  210 (394)
Q Consensus       146 --------~~~-~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~~givH~Dl  210 (394)
                              ... +....   ..+++|+-+.++|..++.........   +.......+..|++..+++||. .|+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence                    111 11122   24678888888888877654443333   2222334455799999999999 89999999


Q ss_pred             CCCcEEEeCCCCcEEEEeecCccccccCCCCccccccccccccccccCC-------CCCCchhhHHHHHHHHHHHHhCCC
Q 016158          211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQP  283 (394)
Q Consensus       211 kp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~  283 (394)
                      +|+|++++.+| .++|+||+...........  ...+..|.+||.....       ..++.+.|.|+||+++|.|+||+.
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 6999999987654332211  3345779999976332       237889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCC
Q 016158          284 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  356 (394)
Q Consensus       284 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  356 (394)
                      ||..........                       .        .+..+  .++|+.+++||+.+|++||.+|
T Consensus       249 Pf~~~~~~~~~~-----------------------~--------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPE-----------------------W--------DFSRC--RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSG-----------------------G--------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccccc-----------------------c--------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence            997553210000                       0        11111  3689999999999999999988

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=4e-23  Score=191.77  Aligned_cols=263  Identities=33%  Similarity=0.495  Sum_probs=196.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCC-ceeeeceEEEecCCCceeEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~  155 (394)
                      |.+...||.|+||.||++.+.   ..+++|.+...       ...+.+|+.+++.+.|+ +++.+.+.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            788899999999999999997   77899987543       23456788999999988 7999988882     22226


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++++++.+ .+..++...... ..+....+..++.|++.++.|+|+ .+++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            789999986 444333321110 278999999999999999999999 89999999999999998764599999999875


Q ss_pred             cccCC-------CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 016158          235 LVKGE-------PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG  302 (394)
Q Consensus       235 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~  302 (394)
                      .....       ......++..|++||.+.+.  ..+....|+||+|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54332       23566789999999999663  4689999999999999999999999877664   334444333222


Q ss_pred             CC-ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          303 TP-TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       303 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      .+ ....            ...    .    ........+.+++..++..+|..|.+..+...++|.........
T Consensus       232 ~~~~~~~------------~~~----~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~  286 (384)
T COG0515         232 TPSLASP------------LSP----S----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES  286 (384)
T ss_pred             Ccccccc------------cCc----c----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence            21 0000            000    0    00112367899999999999999999999998877766544444

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.6e-24  Score=200.70  Aligned_cols=156  Identities=20%  Similarity=0.280  Sum_probs=117.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC-CCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      .+|.+.+.||+|+||+||+|++.. +++.||||++...         ...+.+|+++|+.++|+|++..+..+   .   
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~---   91 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G---   91 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C---
Confidence            359999999999999999999876 6788899986422         23467899999999999998532211   1   


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecC-CCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dl-kp~Nil~~~~~~~vkl~Dfg  230 (394)
                        ..++||||++|......       ....   ...++.|++.||.|||+ .||+|||| ||+|||++.++ .+||+|||
T Consensus        92 --~~~LVmE~~~G~~L~~~-------~~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLiDFG  157 (365)
T PRK09188         92 --KDGLVRGWTEGVPLHLA-------RPHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVIDFQ  157 (365)
T ss_pred             --CcEEEEEccCCCCHHHh-------Cccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEEECc
Confidence              25799999987432211       1111   14567899999999999 89999999 99999998777 69999999


Q ss_pred             CccccccCCCC---------cccccccccccccccc
Q 016158          231 SAKVLVKGEPN---------VSYICSRYYRAPELIF  257 (394)
Q Consensus       231 ~a~~~~~~~~~---------~~~~~t~~y~aPE~~~  257 (394)
                      +|+........         ....+++.|+|||.+.
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99866443221         2345677799999873

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=4.7e-25  Score=217.84  Aligned_cols=223  Identities=28%  Similarity=0.481  Sum_probs=169.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      ..|..++.|-.|+||.||.++|+.+.+.+|+| +.++.-..++   ++.....|.+|                       
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv-----------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV-----------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee-----------------------
Confidence            46999999999999999999999999999995 4544333222   22222233222                       


Q ss_pred             ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC--
Q 016158          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  239 (394)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~--  239 (394)
                        |+...+++.    -+.++.        +++.|++|||+ .||+|||+||+|.+|+.-| .+|+.|||+.+......  
T Consensus       136 --gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccc
Confidence              222222332    133443        34789999999 9999999999999999988 59999999986432110  


Q ss_pred             --------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          240 --------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       240 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                                    .....+|||.|+|||++.... |+..+|+|++|+|+|+.+.|..||.+.+..+.+...+......+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence                          112357899999999996554 99999999999999999999999999999998888877443322


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCCC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDP  374 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~~~  374 (394)
                      ++                          ...++++++++|.++|+.+|..|.   .+-++.+|+||+.+-..
T Consensus       279 E~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  279 EE--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cc--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            22                          145789999999999999999997   56688899999998544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-24  Score=193.49  Aligned_cols=195  Identities=24%  Similarity=0.351  Sum_probs=142.0

Q ss_pred             CCCceeeeceEEEec----------------------CCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHH
Q 016158          133 DHPNIVALKHCFFST----------------------TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY  190 (394)
Q Consensus       133 ~h~~iv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  190 (394)
                      +|||||.+...|...                      .-.+...+|+||.....+|.+++..     ...+......++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            699999998876321                      1234456889999999888887775     5667777888889


Q ss_pred             HHHHHHHHHHhCCCceeecCCCCcEEEeCCC---CcEEEEeecCcccccc-------CCCCccccccccccccccccCCC
Q 016158          191 QICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRAPELIFGAT  260 (394)
Q Consensus       191 qi~~al~~LH~~~givH~Dlkp~Nil~~~~~---~~vkl~Dfg~a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~  260 (394)
                      |+++|+.|||+ +||.|||+|.+|||+.-+.   ..+.|+|||++-....       .......-|.-.-||||+....+
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999999 8999999999999984332   2588999999743221       11223345677789999984332


Q ss_pred             C-----CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccc
Q 016158          261 E-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK  335 (394)
Q Consensus       261 ~-----~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (394)
                      .     .-.++|.|+.|.+.||+++...||.+......-.                  .+|.+-.+|         .+++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------------r~Yqe~qLP---------alp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------------RTYQESQLP---------ALPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------------hhhhhhhCC---------CCcc
Confidence            1     1348999999999999999999998733211000                  001111222         2346


Q ss_pred             cCCHHHHHHHHHhcccCCCCCCCHH
Q 016158          336 RLPPEAVDLVCRFFQYSPNLRCTAL  360 (394)
Q Consensus       336 ~~~~~~~~li~~~L~~dP~~Rpt~~  360 (394)
                      .+++.+++|+..+|+.||++|+++.
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCcc
Confidence            7999999999999999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-25  Score=212.14  Aligned_cols=239  Identities=30%  Similarity=0.434  Sum_probs=185.3

Q ss_pred             EeeecCceEEEEEEE---CCCCcEEEEEEeccc------hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEEE
Q 016158           89 VVGTGSFGVVFQAKC---RETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ++|+|+||.|++++-   ...|..+|+|+..+.      ......|..++...+ ||.++++..++..     ....+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence            379999999998754   345677888876432      123345888888886 9999999887733     3337788


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      +++..++.   +.........+.+...+.+...++.|++++|+ .||+|||+|++||+++.+|+ +++.|||+++.....
T Consensus        76 ld~~rgg~---lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGGD---LFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccch---hhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCc-cccCCchhhhHhHhh
Confidence            88887632   11222234567788888889999999999999 99999999999999999994 999999999877554


Q ss_pred             CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       239 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      +..   +||..|||||++.   .....+|.||+|+++++|+||..||.+    +....|...-                 
T Consensus       151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----------------  203 (612)
T KOG0603|consen  151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----------------  203 (612)
T ss_pred             hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------
Confidence            433   8899999999985   367889999999999999999999987    3333333310                 


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPNT  376 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~~  376 (394)
                      .            .++..++..+++++..++..+|..|..+     .++++|+||+.+.....
T Consensus       204 ~------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l  254 (612)
T KOG0603|consen  204 L------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL  254 (612)
T ss_pred             c------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence            0            0224678899999999999999999954     69999999999866533

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=6.5e-25  Score=217.11  Aligned_cols=241  Identities=29%  Similarity=0.414  Sum_probs=172.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhH---HHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .|...+.||.+.|=+|.+|++.+ |. |+||++.+..     +.+.   +|++ ...+++||++.+....     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            47888999999999999999853 55 8999986543     1122   3444 6667999999876554     23334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .|||-+|+..+|++-+...    .-+.+.+.+.|+.|++.||..+|+ .||+|||||.+||||+.= +.+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSW-NW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSW-NWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeee-chhhhhcccccCC
Confidence            5678888888887766652    446777888899999999999999 999999999999999964 4799999998765


Q ss_pred             cccCCCCcc----cc----ccccccccccccCCC----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 016158          235 LVKGEPNVS----YI----CSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  295 (394)
Q Consensus       235 ~~~~~~~~~----~~----~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  295 (394)
                      ..-.+.+..    ++    .-.+|.|||.+....          ..+.+.||||+||++.||++ |++||.    ..++-
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHH
Confidence            533332221    11    235699999985421          14678999999999999997 788884    22222


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .........+...+.                        .--+..++.||..|++.||++|.+|++.|+-
T Consensus       246 aYr~~~~~~~e~~Le------------------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGNADDPEQLLE------------------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccCccCHHHHHH------------------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222211111111111                        1124479999999999999999999999975

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=5.5e-23  Score=175.41  Aligned_cols=135  Identities=17%  Similarity=0.204  Sum_probs=102.3

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccchh------------------------------hhHHHHHHHHHcCCCc
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN  136 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~~  136 (394)
                      ...||+|+||.||+|.+. +|+.||||++.....                              ...+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999996 899999999864311                              1124889999998877


Q ss_pred             eeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCceeecCCCCcE
Q 016158          137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGICHRDIKPQNL  215 (394)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L-H~~~givH~Dlkp~Ni  215 (394)
                      +....... . ..     .++||||++++.....   ......+++..+..++.|++.+|.+| |+ .||+||||||+||
T Consensus        81 v~~p~~~~-~-~~-----~~iVmE~i~g~~l~~~---~~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL-L-KS-----HVLVMEFIGDDGWAAP---RLKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE-e-cC-----CEEEEEEeCCCCCcch---hhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            64322211 1 11     2589999997432111   11135789999999999999999999 68 8999999999999


Q ss_pred             EEeCCCCcEEEEeecCcccc
Q 016158          216 LVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       216 l~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |++. + .++|+|||+|...
T Consensus       150 li~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-C-cEEEEEccccccC
Confidence            9994 4 6999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.7e-22  Score=174.43  Aligned_cols=170  Identities=12%  Similarity=0.153  Sum_probs=123.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhh---------hHHHHHHHHHcCCCceeeeceEEEec
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRY---------KNRELQIMQMLDHPNIVALKHCFFST  147 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~  147 (394)
                      .++|.+.++||.|+||.||++..  ++..+|||++...    ...         .++|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            34699999999999999999765  4668999998532    111         46788899999999999988876533


Q ss_pred             CCC---ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc
Q 016158          148 TDK---EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (394)
Q Consensus       148 ~~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~  223 (394)
                      ...   .....+++|||++| ++.++.        .+++.    ...+++.+|..||+ .|++|||+||.||+++.++  
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~~----~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISED----VKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh--------hccHH----HHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--
Confidence            211   12236789999997 554431        12222    35599999999999 8999999999999999766  


Q ss_pred             EEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHH
Q 016158          224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  279 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  279 (394)
                      ++|+|||........... .          ..+... .++.++|+|+||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~-d----------~~vler-~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-D----------RIDLER-HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-H----------HHHHHh-HhcccccccceeEeehHHH
Confidence            999999988654222111 0          022223 3668999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.3e-21  Score=167.47  Aligned_cols=136  Identities=17%  Similarity=0.223  Sum_probs=104.9

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccchh------------------------------hhHHHHHHHHHcCCC
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHP  135 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~  135 (394)
                      +.+.||+|++|.||+|.+. +|+.||||++.....                              ...+|.+.+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3568999999999999987 899999998764311                              124688889999998


Q ss_pred             ceeeeceEEEecCCCceeEEEEEEeccccc-HH-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCC
Q 016158          136 NIVALKHCFFSTTDKEELYLNLVLEYVPET-VN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (394)
Q Consensus       136 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~  213 (394)
                      ++.....+...   .    .++||||+++. +. ..+.     ...++...+..++.|++.+|.+||...||+||||||+
T Consensus        80 ~i~~p~~~~~~---~----~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~  147 (190)
T cd05145          80 GVPVPEPILLK---K----NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY  147 (190)
T ss_pred             CCCCceEEEec---C----CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence            87543332211   1    36899999974 22 1122     2567888999999999999999997459999999999


Q ss_pred             cEEEeCCCCcEEEEeecCccccc
Q 016158          214 NLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       214 Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      |||++ ++ .++|+|||++....
T Consensus       148 NIll~-~~-~~~liDFG~a~~~~  168 (190)
T cd05145         148 NILYH-DG-KPYIIDVSQAVELD  168 (190)
T ss_pred             hEEEE-CC-CEEEEEcccceecC
Confidence            99999 55 69999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.7e-21  Score=164.64  Aligned_cols=181  Identities=17%  Similarity=0.123  Sum_probs=130.5

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh--------hhHHHHHHHHHcC-CCceeeeceEEEecCCCceeE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+...|+.|+||+||++..  .+..++.+.+.....        ...+|+++|++|. |+++++++++.     .    
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----
Confidence            34667899999999998776  467787776643322        3568999999995 47788886642     1    


Q ss_pred             EEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecC-CCCcEEEeCCCCcEEEEeecCc
Q 016158          155 LNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       155 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dl-kp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+++|+|+.|. |....          +.. ...++.|++.+|+++|+ .||+|||| ||+|||++.++ .++|+|||+|
T Consensus        73 ~~lvmeyI~G~~L~~~~----------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A  139 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRP----------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLA  139 (218)
T ss_pred             EEEEEeeecCccHHhhh----------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCc
Confidence            57899999874 32211          111 13467799999999999 89999999 79999999887 6999999999


Q ss_pred             cccccCCCCc--------------cccccccccccccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 016158          233 KVLVKGEPNV--------------SYICSRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGE  288 (394)
Q Consensus       233 ~~~~~~~~~~--------------~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~  288 (394)
                      ..........              ....++.|+.|+.-.--...+ ...+.++.|+-+|.++|++.++.+.
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            8554332210              112377788887653222234 4678889999999999999887554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.7e-22  Score=170.00  Aligned_cols=238  Identities=16%  Similarity=0.209  Sum_probs=178.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +..+..+|.+...|..|+|++.  |..+++|++.-      -.+.++.|.-.|+.+.||||+.+++.|     .......
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence            3456677999999999999996  45566776532      235566788889999999999999998     4445578


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceee-cCCCCcEEEeCCCCcEEEE--eecCc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR-DIKPQNLLVNPHTHQLKLC--DFGSA  232 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~-Dlkp~Nil~~~~~~~vkl~--Dfg~a  232 (394)
                      ++..||+ ++|+..+....  ..-.+-.++.+++.++++|++|||+-..++-| -|+...++||++- +.+|+  |--++
T Consensus       264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence            8999999 68888777533  24466678889999999999999984355555 6888999999876 45543  32222


Q ss_pred             cccccCCCCccccccccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      .      ........|.||+||.+...+.  .-+++|+|||++++|||.|...||.+..+++.-.++.-           
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----------  403 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----------  403 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----------
Confidence            1      1223345788999999965433  24579999999999999999999998887765544432           


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  363 (394)
                                      +.++..+++.++..+..|+.-|+..||.+||..+.++
T Consensus       404 ----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 ----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                            1123345678999999999999999999999887653

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=1e-19  Score=156.68  Aligned_cols=134  Identities=20%  Similarity=0.237  Sum_probs=101.0

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHc-----CCCceeeeceEEEecCCCceeEEEE
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-----DHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     .||||+++++++.+.. ..+..+.+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~-g~g~v~~~   82 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC-GTGYVYDV   82 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC-CCeEEEEE
Confidence            46899999999995  7767665 69987643    44567899999999     5799999999885432 22333457


Q ss_pred             EEeccc---ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCceeecCCCCcEEEeCCC---CcEEEEeec
Q 016158          158 VLEYVP---ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL-AYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFG  230 (394)
Q Consensus       158 v~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al-~~LH~~~givH~Dlkp~Nil~~~~~---~~vkl~Dfg  230 (394)
                      |+||.+   ++|.+++..     ..+++.  ..++.|++.++ +|||+ ++|+||||||+|||++..+   ..++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            899955   588777754     345555  34577888777 99999 8999999999999997432   269999955


Q ss_pred             Cc
Q 016158          231 SA  232 (394)
Q Consensus       231 ~a  232 (394)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            44

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.3e-19  Score=182.59  Aligned_cols=191  Identities=26%  Similarity=0.411  Sum_probs=143.9

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh-hHHHHHHHHHcC---CCceeeeceEEEecCCCceeEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ....|.|.+.||+|+||+||+|.+.. |+.||||+-+..... +---.+++.+|+   -+.|+.+..++...+.     .
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S  769 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----S  769 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----c
Confidence            34469999999999999999999976 999999975433211 101123344444   2334444444432222     5


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC------CCCcEEEEe
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP------HTHQLKLCD  228 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~------~~~~vkl~D  228 (394)
                      ++|+||.+ |+|.+++.    ..+.+++..+..+..|++..++.||. .+|||+||||+|+||..      +...++|+|
T Consensus       770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEe
Confidence            68999998 67777665    46889999999999999999999999 89999999999999842      222599999


Q ss_pred             ecCccccc---cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 016158          229 FGSAKVLV---KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  282 (394)
Q Consensus       229 fg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  282 (394)
                      ||.+.-+.   ++........|-.+-.+|...|.. ++...|.|.|+.+++-||.|+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence            99985542   333344566788899999986654 999999999999999999997

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1e-19  Score=160.53  Aligned_cols=138  Identities=16%  Similarity=0.140  Sum_probs=103.7

Q ss_pred             cEEEeeEeeecCceEEEEEE-ECCCCcEEEEEEeccch----------------------------hhhHHHHHHHHHcC
Q 016158           83 SYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD  133 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~  133 (394)
                      -|.+.+.||+|+||.||+|. +..+|+.||||++....                            ....+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 66789999999876321                            11346899999997


Q ss_pred             CCceeeeceEEEecCCCceeEEEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-ceeecCC
Q 016158          134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIK  211 (394)
Q Consensus       134 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g-ivH~Dlk  211 (394)
                      +.. +.+...+.. . .    .++||||+++. +....    .....+....+..++.|++.+|.+||. .| |+|||||
T Consensus       109 ~~~-i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dik  176 (237)
T smart00090      109 EAG-VPVPKPIAW-R-R----NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLS  176 (237)
T ss_pred             hcC-CCCCeeeEe-c-C----ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCC
Confidence            533 222232211 1 1    36999999983 32211    112345566678899999999999999 89 9999999


Q ss_pred             CCcEEEeCCCCcEEEEeecCccc
Q 016158          212 PQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       212 p~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 55 799999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=3.7e-20  Score=171.85  Aligned_cols=180  Identities=29%  Similarity=0.468  Sum_probs=133.4

Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ..|++|.|++|.. +|.+++.. .+.....+......++.|++.|++|    +|.+|+|+||.||++..+. .+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhh
Confidence            4468899999985 55555543 4445667888899999999999999    4999999999999998777 79999999


Q ss_pred             CccccccCC-------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhC
Q 016158          231 SAKVLVKGE-------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLG  302 (394)
Q Consensus       231 ~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~  302 (394)
                      +........       ......||..||+||++.+.. |+.++||||||++++|+++- ...|.    .......++. |
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~-g  475 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRD-G  475 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhc-C
Confidence            998776555       345678899999999997665 99999999999999999972 22221    1111111111 1


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                      ..++.                         +..+ .+.-..|+.+||...|.+||++.+.-.|+|.+
T Consensus       476 ~ip~~-------------------------~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  476 IIPPE-------------------------FLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             CCChH-------------------------Hhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            11111                         1111 24456899999999999999988888888864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2.5e-17  Score=143.64  Aligned_cols=129  Identities=19%  Similarity=0.332  Sum_probs=99.8

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +.||+|++|.||+|++  .|..|++|+.....            ....+|++++..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999987  57789999754211            23446889999999988776555543222     25


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||++| ++.+++...       .. ....++.+++.+|.+||+ .|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            689999986 665554321       11 677889999999999999 8999999999999999 55 699999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.2e-17  Score=144.12  Aligned_cols=130  Identities=18%  Similarity=0.182  Sum_probs=98.3

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch--------------------------hhhHHHHHHHHHcCCCce
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------------RYKNRELQIMQMLDHPNI  137 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~~i  137 (394)
                      |.+.+.||.|+||.||+|... +|+.||||++....                          ....+|..++..+.|+++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888899999999999999874 79999999864321                          113467888888877743


Q ss_pred             --eeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          138 --VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       138 --v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                        +..++.         ...+++|||+++ ++..+..          ......++.+++.++.++|. .||+|+||||+|
T Consensus        96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N  155 (198)
T cd05144          96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN  155 (198)
T ss_pred             CCCceeec---------CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence              332221         114689999997 3322211          13345678899999999999 899999999999


Q ss_pred             EEEeCCCCcEEEEeecCcccc
Q 016158          215 LLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |+++.++ .++|+|||.+...
T Consensus       156 ill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCC-cEEEEECCccccC
Confidence            9999877 7999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=1.1e-17  Score=158.17  Aligned_cols=205  Identities=27%  Similarity=0.349  Sum_probs=148.3

Q ss_pred             HHHcCCCceeeeceEEEecCCCceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 016158          129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  207 (394)
Q Consensus       129 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH  207 (394)
                      |+.+.|.|+.++++.++..     ..+++|.+||. |++.+.+..   ....++......++++++.||.|||......|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            3568999999999999655     33778999998 688887776   34678888888899999999999998433399


Q ss_pred             ecCCCCcEEEeCCCCcEEEEeecCccccccC---CCCccccccccccccccccCCCC------CCchhhHHHHHHHHHHH
Q 016158          208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAEL  278 (394)
Q Consensus       208 ~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l  278 (394)
                      +.++..|.+++... .+||+|||+.......   .......-..-|.|||.+.+...      .+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999988 7999999998765321   11111223455999999965321      36679999999999999


Q ss_pred             HhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCC
Q 016158          279 LLGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN  354 (394)
Q Consensus       279 ltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  354 (394)
                      ++...||......    +.+..+......+...                   ..+.  . ....+++..++++||..+|.
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP-------------------~i~~--~-~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRP-------------------SIEL--L-NELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCCcCc-------------------chhh--h-hhcchHHHHHHHHhcccChh
Confidence            9999999864322    2222222201111110                   0010  0 13566899999999999999


Q ss_pred             CCCCHHHHhc
Q 016158          355 LRCTALEACV  364 (394)
Q Consensus       355 ~Rpt~~ell~  364 (394)
                      +||+++++-.
T Consensus       210 ~rPs~~~i~~  219 (484)
T KOG1023|consen  210 KRPSIEQIRS  219 (484)
T ss_pred             hCccHHHHHh
Confidence            9999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=7.5e-17  Score=139.33  Aligned_cols=125  Identities=18%  Similarity=0.324  Sum_probs=92.7

Q ss_pred             EeeecCceEEEEEEECCCCcEEEEEEeccc------------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .||+|+||.||+|.+  +|..|++|+....            .....+|+++++.+.|+++.....++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            379999999999985  4778999975421            122346999999998877544333332211     146


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++|||++| ++...+...    . .      .++.+++.+|.+||+ .|++|+|++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----N-D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhc----H-H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999986 554443321    0 0      678899999999999 8999999999999999 55 799999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.2e-18  Score=172.04  Aligned_cols=256  Identities=23%  Similarity=0.280  Sum_probs=186.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCC-CcEEEEEEeccch---h---hhHHHHHHHHHcC-CCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK---R---YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~---~---~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..|.+.+.||+|+|+.|-.+....+ ...+|.|.+....   .   ....|..+-..+. |+|++.+++..     ....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            3588899999999999998877433 3446666553321   1   1223666666666 99999998876     5555


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH-~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      +.+++++|..+ .+.....   .... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++..+..++++|||
T Consensus        95 ~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             ccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCch
Confidence            57789999665 2222111   1122 6677788889999999999999 7 8999999999999999776359999999


Q ss_pred             Ccccccc-CCCC---ccccc-cccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          231 SAKVLVK-GEPN---VSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       231 ~a~~~~~-~~~~---~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      +|..... .+..   ....| ++.|+|||...+........|+||.|+++..+++|..||......+....         
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~---------  241 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS---------  241 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---------
Confidence            9987755 2222   34567 99999999997755678889999999999999999999976543321100         


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                                 ......    ..........++....+++.++|..+|+.|.+.+++..+||+..
T Consensus       242 -----------~~~~~~----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  242 -----------SWKSNK----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----------eecccc----cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                       000000    00011122567889999999999999999999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=2.1e-16  Score=156.58  Aligned_cols=130  Identities=18%  Similarity=0.286  Sum_probs=97.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEec-cc-----------hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .|...+.||+|+||.||+|.+...  .+++|+.. +.           .....+|+++++.++|++++....+.....  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--  409 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--  409 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence            356788999999999999987533  34444321 10           123457999999999999887655443221  


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                         ..++||||+++ +|.+.+.            ....++.+++.+|.+||+ .|++||||||+|||++ ++ .++|+||
T Consensus       410 ---~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liDF  471 (535)
T PRK09605        410 ---EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLIDF  471 (535)
T ss_pred             ---CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEeC
Confidence               24689999986 5555443            235678899999999999 8999999999999995 44 6999999


Q ss_pred             cCccc
Q 016158          230 GSAKV  234 (394)
Q Consensus       230 g~a~~  234 (394)
                      |+++.
T Consensus       472 Gla~~  476 (535)
T PRK09605        472 GLGKY  476 (535)
T ss_pred             ccccc
Confidence            99965

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.8e-16  Score=134.36  Aligned_cols=131  Identities=19%  Similarity=0.178  Sum_probs=90.9

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccchhhh----------------------------HHHHHHHHHcCCCc--
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK----------------------------NRELQIMQMLDHPN--  136 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~~--  136 (394)
                      .+.||+|+||.||+|.+. +|+.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 89999999876432110                            23444455554332  


Q ss_pred             eeeeceEEEecCCCceeEEEEEEecccccH--HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          137 IVALKHCFFSTTDKEELYLNLVLEYVPETV--NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l--~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                      +.+.+.+.         ..+++|||+++..  ...+....     .. ..++.++.+++.++.++|...||+|+||||+|
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            22222211         1479999999721  01122111     11 56778899999999999974699999999999


Q ss_pred             EEEeCCCCcEEEEeecCcccc
Q 016158          215 LLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |+++ ++ .++|+|||.+...
T Consensus       146 ili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CC-cEEEEECcccccc
Confidence            9999 65 6999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=2.1e-16  Score=149.70  Aligned_cols=259  Identities=25%  Similarity=0.250  Sum_probs=192.8

Q ss_pred             ccCcCCCCcccccEEEeeEeee--cCceEEEEEEE--CCCCcEEEEEEecc------chhhhHHHHHHHHHc-CCCceee
Q 016158           71 IGGRNGNSKQKVSYIAEHVVGT--GSFGVVFQAKC--RETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVA  139 (394)
Q Consensus        71 ~~~~~~~~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l-~h~~iv~  139 (394)
                      ++.....+.....+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-..      ......+|+...+.+ .|++.++
T Consensus       103 ~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~  182 (524)
T KOG0601|consen  103 YGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVR  182 (524)
T ss_pred             cCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccc
Confidence            3444444455556888899999  99999999999  88999999997321      122223466555555 5888888


Q ss_pred             eceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHH----HHHHHHhCCCceeecCCCCcE
Q 016158          140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIHNCIGICHRDIKPQNL  215 (394)
Q Consensus       140 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~----al~~LH~~~givH~Dlkp~Ni  215 (394)
                      .+..+     .+....++-+|+++.++......   ....++...++..+.+...    ||..+|. .+++|-|+||.||
T Consensus       183 ~~~~~-----e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i  253 (524)
T KOG0601|consen  183 DSPAW-----EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANI  253 (524)
T ss_pred             cCccc-----ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhhe
Confidence            66655     44555788999999776554443   3355888999999999999    9999999 8999999999999


Q ss_pred             EEeCCCCcEEEEeecCccccccCCCCc------cccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-
Q 016158          216 LVNPHTHQLKLCDFGSAKVLVKGEPNV------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-  288 (394)
Q Consensus       216 l~~~~~~~vkl~Dfg~a~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-  288 (394)
                      +...+....+++|||+...+.......      ...+...|++||...+  -++..+|+|++|.++.+..++..+.... 
T Consensus       254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~  331 (524)
T KOG0601|consen  254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGK  331 (524)
T ss_pred             ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCC
Confidence            999984479999999988775544221      1256677999999843  4899999999999999999987666544 


Q ss_pred             -CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          289 -SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       289 -~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                       +.|..+..+.                              ....+....+.++...+..+++.||..|+++..+++|++
T Consensus       332 ~~~W~~~r~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~  381 (524)
T KOG0601|consen  332 NSSWSQLRQGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNV  381 (524)
T ss_pred             CCCcccccccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccc
Confidence             3332222111                              111233456777888999999999999999999999999


Q ss_pred             CCC
Q 016158          368 FDE  370 (394)
Q Consensus       368 f~~  370 (394)
                      ...
T Consensus       382 i~s  384 (524)
T KOG0601|consen  382 IHS  384 (524)
T ss_pred             ccc
Confidence            874

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=1.9e-15  Score=133.59  Aligned_cols=133  Identities=15%  Similarity=0.244  Sum_probs=96.8

Q ss_pred             eEee-ecCceEEEEEEECCCCcEEEEEEeccc-----------------hhhhHHHHHHHHHcCCCce--eeeceEEEec
Q 016158           88 HVVG-TGSFGVVFQAKCRETGEIVAIKKVLQD-----------------KRYKNRELQIMQMLDHPNI--VALKHCFFST  147 (394)
Q Consensus        88 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~  147 (394)
                      ..|| .|+.|+||.+...  +..++||.+...                 .....+|++++..|.|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 8888999988774  778999977421                 1223569999999998875  4555543222


Q ss_pred             CCCceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEE
Q 016158          148 TDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vk  225 (394)
                      . ......++|||++++  ++..++..     ..+++..    +.+++.+|.+||+ .||+|+||||+|||++.++ .++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence            1 112234589999986  56555432     3455543    5689999999999 8999999999999999877 799


Q ss_pred             EEeecCccc
Q 016158          226 LCDFGSAKV  234 (394)
Q Consensus       226 l~Dfg~a~~  234 (394)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=2.1e-16  Score=138.51  Aligned_cols=244  Identities=19%  Similarity=0.217  Sum_probs=164.2

Q ss_pred             eEEEEEEECCCCcEEEEEEec----cc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEeccc-ccH
Q 016158           96 GVVFQAKCRETGEIVAIKKVL----QD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETV  166 (394)
Q Consensus        96 g~V~~~~~~~~~~~vaiK~~~----~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l  166 (394)
                      -.||++.+...|..|.--.+.    ++    ....+.-+..|-.+-|.||++++.++-.....+.....+++||+. +++
T Consensus        80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            457888887777766443321    11    111112234466678999999998885555445555778999998 688


Q ss_pred             HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCceeecCCCCcEEEeCCCCcEEEEeecCccccc-----cCCC
Q 016158          167 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-----KGEP  240 (394)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~-----~~~~  240 (394)
                      ..+++...+.+..+.....++|+.||+.||.|||++ --|+|+++..+.|++..++ -+|+.--.-.....     ....
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~E  238 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAE  238 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhh
Confidence            899999899999999999999999999999999985 3599999999999999776 56653211111000     0011


Q ss_pred             CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016158          241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  319 (394)
Q Consensus       241 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  319 (394)
                      .....+-++|.+||.=. ....+.++|||++|....+|..+..- -.+......-..+...+                  
T Consensus       239 k~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------  299 (458)
T KOG1266|consen  239 KSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------  299 (458)
T ss_pred             hhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe------------------
Confidence            12234567899999642 23367799999999999999987632 22222111111111110                  


Q ss_pred             CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                    ...-...-++++..||+-.|..||++.++|.||.+-++..
T Consensus       300 --------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  300 --------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             --------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence                          0001122346899999999999999999999999877643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=6.8e-15  Score=120.77  Aligned_cols=131  Identities=19%  Similarity=0.246  Sum_probs=100.7

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccch--hhhHHHHHHHHHcCC--CceeeeceEEEecCCCceeEEEEEEec
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      +.+.||.|.++.||++...  +..+++|.+....  ....+|..+++.+.+  .++++++..+.     .....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence            4577999999999999985  3789999886654  356789999999976  47777766552     22346789999


Q ss_pred             ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +.+....          .++......++.+++.+|++||..  .+++|+|++|+||+++..+ .++++|||.+..
T Consensus        75 ~~g~~~~----------~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecc----------cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            9863211          114455667788999999999972  2699999999999999765 799999998853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.48  E-value=1.9e-14  Score=143.57  Aligned_cols=270  Identities=23%  Similarity=0.263  Sum_probs=191.5

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+.+.+.+-+-.|+++.++.+.-..+|...++|+.....       .....+-.++-...+|.++.....+     ...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence            3456788889999999999999988888777777543322       1222233333333445555433222     122


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .-.+++++|+++ ++...++.    ....+...++.+...+..++++||. ..+.|+|++|.|+|+..++ ..++.|||.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t  950 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGT  950 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCcccc
Confidence            226689999864 55444443    2346666777778889999999998 6799999999999999888 499999984


Q ss_pred             ccccccC--------------------------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHH
Q 016158          232 AKVLVKG--------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  279 (394)
Q Consensus       232 a~~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  279 (394)
                      .......                                .......+|+.|.+||...+.. ....+|+|++|+++++.+
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence            3222100                                0112345789999999997655 788899999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH
Q 016158          280 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  359 (394)
Q Consensus       280 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  359 (394)
                      +|.+||........+..+....-.                         |.. -+...+.++++++..+|..+|.+|..+
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~~~-------------------------~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIP-------------------------WPE-GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCCCC-------------------------CCC-CccccChhhhhhhhhhhccCchhccCc
Confidence            999999988877766655442111                         110 123468899999999999999999988


Q ss_pred             H---HHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          360 L---EACVHPFFDELRDPNTRLPNGRPLPPL  387 (394)
Q Consensus       360 ~---ell~hp~f~~~~~~~~~~~~~~~~~~~  387 (394)
                      .   ++-.||||+.....+..+-+.-++|.+
T Consensus      1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~ 1114 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVPQP 1114 (1205)
T ss_pred             ccccccccCCccCCCCccccccccCccCCCC
Confidence            8   999999999998887765555555544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=1.1e-12  Score=126.09  Aligned_cols=137  Identities=22%  Similarity=0.261  Sum_probs=88.8

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccchh--------------------------------------------hh
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------------------------YK  122 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------------------~~  122 (394)
                      .+.||.|++|.||+|+.+ +|+.||||+......                                            .+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            357999999999999974 799999998743210                                            01


Q ss_pred             HHHHHHHHHc----CCCceeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHH-HH
Q 016158          123 NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR-AL  196 (394)
Q Consensus       123 ~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~-al  196 (394)
                      .+|...+.++    .+.+-+.+..++....+    ..++||||++| .+.++.... .  ....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~-~--~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALD-E--AGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHH-h--cCCC---HHHHHHHHHHHHH
Confidence            1244444443    23333444444422111    14689999987 444433221 1  1122   2334555555 46


Q ss_pred             HHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       197 ~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ..+|. .|++|+|+||.||+++.++ .++|+|||++..+.
T Consensus       271 ~ql~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            78898 8999999999999999887 79999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.42  E-value=5.1e-12  Score=121.38  Aligned_cols=181  Identities=22%  Similarity=0.270  Sum_probs=126.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh----hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      -|.+ ...+-++.+..-.|..+.++.+|.|........    ..++-++.|+.++||||+++++.+     .....+|+|
T Consensus        14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylv   87 (690)
T KOG1243|consen   14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLV   87 (690)
T ss_pred             Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEE
Confidence            3666 444444444322577778899999987754433    245677889999999999999988     344458899


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      +|.+... ...++.       +....+..-++||+.||.|||...+++|++|.-.-|+|+..| ..||++|.++......
T Consensus        88 TErV~Pl-~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~  158 (690)
T KOG1243|consen   88 TERVRPL-ETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGF  158 (690)
T ss_pred             eeccccH-HHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccC
Confidence            9998752 222222       225667777889999999998547999999999999999998 6999999987544222


Q ss_pred             CC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC
Q 016158          239 EP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  281 (394)
Q Consensus       239 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg  281 (394)
                      .. ......--.|..|+.+..   -.-..|.|-|||++++++.|
T Consensus       159 ~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  159 NAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            21 111111223666665421   22457999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=3e-12  Score=108.45  Aligned_cols=132  Identities=16%  Similarity=0.199  Sum_probs=92.1

Q ss_pred             eeEeeecCceEEEEEEECC------CCcEEEEEEecc--------------ch------------hhh----HHHHHHHH
Q 016158           87 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQ--------------DK------------RYK----NRELQIMQ  130 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~--------------~~------------~~~----~~E~~~l~  130 (394)
                      ...||.|--+.||.|....      .+..+|||+.+.              +.            ...    ++|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998643      357899997621              00            011    26888888


Q ss_pred             HcCCC--ceeeeceEEEecCCCceeEEEEEEeccccc-H-HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCc
Q 016158          131 MLDHP--NIVALKHCFFSTTDKEELYLNLVLEYVPET-V-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGI  205 (394)
Q Consensus       131 ~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L-H~~~gi  205 (394)
                      ++..-  +++..+.+.    .     -++||||+++. + ...+..     ..++...+..+..+++.+|..| |+ .|+
T Consensus        82 rl~~~Gv~vP~pi~~~----~-----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~-~gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVLK----K-----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE-CNL  146 (197)
T ss_pred             HHHHcCCCCCeEEEec----C-----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            88543  344444321    1     35899999863 1 111221     2345556677788999999998 88 899


Q ss_pred             eeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       206 vH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ||+||++.|||++. + .+.|+|||.+-..
T Consensus       147 VHGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            99999999999984 4 6999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.40  E-value=1.7e-11  Score=114.34  Aligned_cols=216  Identities=18%  Similarity=0.227  Sum_probs=154.7

Q ss_pred             CceEEEEEEECCCCcEEEEEEeccchh----hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecccc--cHH
Q 016158           94 SFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVN  167 (394)
Q Consensus        94 ~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~  167 (394)
                      --.+.|++....+|..|++|++...+.    ....-+++++++.|.|+|++.++|.+.. -.+..+++|++|.++  +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            346889999999999999999833221    2235689999999999999999886333 345568899999985  554


Q ss_pred             HHHHHh-----------hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          168 RIARNY-----------SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       168 ~~~~~~-----------~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ++...-           ...+...++..+|.++.|+..||.++|+ .|+.-+-|.|.+||++.+. +++|+..|......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence            443221           1123457889999999999999999999 8999999999999999776 68888777665443


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .+.           .  |-+    .--.+-|.-.||.++..|.||..- +............+                 
T Consensus       445 ~d~-----------~--~~l----e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------------  490 (655)
T KOG3741|consen  445 EDP-----------T--EPL----ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------------  490 (655)
T ss_pred             CCC-----------C--cch----hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------------
Confidence            322           0  111    123456999999999999999632 22222222211111                 


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                        ...++.+++++|..+...++++ -++.+++.|
T Consensus       491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                              1457889999999999988887 677777754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=1.1e-13  Score=131.28  Aligned_cols=252  Identities=22%  Similarity=0.190  Sum_probs=174.0

Q ss_pred             ccccEEEeeEeeecCceEEEEEEEC-CCCcEEEEEEeccchhhhH------HHHHHHHHc-CCCceeeeceEEEecCCCc
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKN------RELQIMQML-DHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~------~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...+|..+..||.|.|+.|+..... .++..|++|...+......      .|+-+...+ .|.+++.....+..     
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----
Confidence            4456888999999999999998766 6788899997765433222      355554444 57777776555522     


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ....++-.|||.+....+-.   .....+.+...+.+..|++.++.++|+ ..++|+|+||+||++..++...++.|||+
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccc
Confidence            22245788999764433322   333567788888899999999999999 99999999999999998644799999999


Q ss_pred             ccccccCCCCcccccccccc-ccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKGEPNVSYICSRYYR-APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++.+.-.  .......-.+. ..|++.....+..+.|++|||..+.+.++|...-.....+.   .+.+.          
T Consensus       414 ~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~----------  478 (524)
T KOG0601|consen  414 WTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG----------  478 (524)
T ss_pred             cccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc----------
Confidence            8653211  11122233344 35666566668999999999999999999974332222211   11110          


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                               ..+          ........+..+.+.++..|+..|+.+.++..|.-|....++
T Consensus       479 ---------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~~  523 (524)
T KOG0601|consen  479 ---------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDSRP  523 (524)
T ss_pred             ---------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhccC
Confidence                     000          012334678889999999999999999999999887665443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=2.7e-12  Score=107.80  Aligned_cols=124  Identities=16%  Similarity=0.168  Sum_probs=88.9

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCcee-eeceEEEecCCCceeEEEEEEecc
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      .+.|+.|.++.||+++..  ++.|++|+.....   ....+|+.+++.+.+.+++ +++...     ...  .++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            356899999999999874  7889999875443   3457899999998665544 333322     111  25899999


Q ss_pred             cccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCc-----eeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~gi-----vH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|....   ..     .   .....++.+++.+|..||. .++     +|+|++|.||+++ ++ .++++||+.+.
T Consensus        74 ~G~~l~---~~-----~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELL---TE-----D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccc---cc-----c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            973211   00     0   1112346789999999998 775     9999999999999 44 69999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=2e-12  Score=125.80  Aligned_cols=139  Identities=19%  Similarity=0.245  Sum_probs=86.8

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh------------------------------------------
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------------------------------------------  121 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------------------  121 (394)
                      |.. +.||.|++|+||+|+.+.+|+.||||+.......                                          
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            555 7899999999999999888999999988543100                                          


Q ss_pred             --hHHHHHHHHHc----CCCceeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhc---CCCCHHHHHHHHHH
Q 016158          122 --KNRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIH---QRMPLIYVKLYTYQ  191 (394)
Q Consensus       122 --~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~~~~q  191 (394)
                        +.+|+..+.++    .+.+.+.+..++..-.    ...++||||+.| .+.++.. ....+   ..+.+..+..++.|
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~-l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAA-LRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHH-HHhcCCCHHHHHHHHHHHHHHH
Confidence              01233333333    2344444444442211    125699999997 4433211 11111   12333333444444


Q ss_pred             HHHHHHHHHhCCCceeecCCCCcEEEeCCC---CcEEEEeecCccccc
Q 016158          192 ICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLV  236 (394)
Q Consensus       192 i~~al~~LH~~~givH~Dlkp~Nil~~~~~---~~vkl~Dfg~a~~~~  236 (394)
                      +       .. .|++|+|+||.||+++.++   ..++++|||++....
T Consensus       276 i-------f~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 V-------FR-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             H-------Hh-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            3       45 7999999999999999775   269999999987664

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=9.8e-11  Score=95.51  Aligned_cols=140  Identities=19%  Similarity=0.254  Sum_probs=97.0

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEe-cc-----------chhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ-----------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .+.+|-+|+-+.|+++.+.  |+.+.||.= .+           ......+|++.|.++.--.|..-.-++....   . 
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~---~-   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY---G-   84 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC---C-
Confidence            5677899999999999875  888888842 11           1233456888888875444432222222222   1 


Q ss_pred             EEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcE--EEEee
Q 016158          154 YLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDF  229 (394)
Q Consensus       154 ~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v--kl~Df  229 (394)
                       -+++|||++|  ++.+.+.....  ..........++.+|-..+.-||. .+|+|+||..+||++.++++.+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence             3479999998  55555444332  333333346778899999999999 8999999999999998887655  89999


Q ss_pred             cCcccc
Q 016158          230 GSAKVL  235 (394)
Q Consensus       230 g~a~~~  235 (394)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=3.8e-12  Score=122.70  Aligned_cols=163  Identities=20%  Similarity=0.301  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC--------C--ccccccccccccccccCCC
Q 016158          191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------N--VSYICSRYYRAPELIFGAT  260 (394)
Q Consensus       191 qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~--------~--~~~~~t~~y~aPE~~~~~~  260 (394)
                      +++.|+.|+|+..++||++|.|++|.++..+ .+||+.|+++-.......        .  ....-...|.|||.+.. .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3448999999888999999999999999888 799999998754322110        0  01122456999999965 4


Q ss_pred             CCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCH
Q 016158          261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP  339 (394)
Q Consensus       261 ~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (394)
                      ..+.++|+||+|+++|.+. .|+..+...........-.... .                        .-.......++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-~------------------------~~~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-N------------------------AGAFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-c------------------------cccccccccCcH
Confidence            4788999999999999998 5666665443322211111100 0                        000112257899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 016158          340 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN  380 (394)
Q Consensus       340 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~  380 (394)
                      ++++=|.++|..|+..||++..++.-|||.+..-.+.++..
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aLrfLD  280 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKALRFLD  280 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhhhhcc
Confidence            99999999999999999999999999999998877776544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=3.6e-10  Score=92.66  Aligned_cols=126  Identities=15%  Similarity=0.282  Sum_probs=84.2

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEe-ccc-----------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..+++|+-+.+|.+.+.  |..+++|.= .+.           .....+|+.++.++..-.|..-.-+.+.+..     .
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G   74 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence            35789999999999764  555677742 111           1223468999888855444322222222222     3


Q ss_pred             EEEEecccccH-HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .|+|||++|.+ .+.+..    .   .    ..++..+-.-+.-||. .||||+||.++||++..+  .+.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            48999999854 223332    1   1    3345677777888999 899999999999999955  499999999964

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=2.2e-09  Score=98.25  Aligned_cols=259  Identities=15%  Similarity=0.152  Sum_probs=153.0

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh-hHHHHHHHHHc-CCCceeeeceEE--EecCCCceeEEEEEEec
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQML-DHPNIVALKHCF--FSTTDKEELYLNLVLEY  161 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~l~~l-~h~~iv~~~~~~--~~~~~~~~~~~~lv~e~  161 (394)
                      ..+.||+|+-+.+|-.-..  + ..+.|+....... ..+-++.|... .||-+-.-+.+-  ..........+.++|+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CCccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            3467999999999965432  2 2345666443222 22233333333 454332201100  00111233346778888


Q ss_pred             cccc--HHHHHH--HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          162 VPET--VNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       162 ~~~~--l~~~~~--~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      +.+.  ...+..  ..+.......+..+.++++.++.|.+.||. .|.+-+|++++|+|+++++ .|.|.|=..-....+
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~n  169 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINAN  169 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceeeccC
Confidence            8752  222211  111222346778889999999999999999 8999999999999999887 799998554433334


Q ss_pred             CCCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcH----HHHH-HHHHHhCCCChh
Q 016158          238 GEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGV----DQLV-EIIKVLGTPTRE  307 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~----~~~~-~i~~~~~~~~~~  307 (394)
                      +.......|.+.|.+||.-.    ....-+...|.|.||+++++++.| +.||.+....    ..+. .|.... .    
T Consensus       170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~-f----  244 (637)
T COG4248         170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR-F----  244 (637)
T ss_pred             CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce-e----
Confidence            44444556788999999752    112246689999999999999986 8999874210    1111 111000 0    


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhccc--CCCCCCCHHHH
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY--SPNLRCTALEA  362 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~Rpt~~el  362 (394)
                         ...++-..-..+.....+|     .-+++++.-|..+|++.  ++.-|||++..
T Consensus       245 ---~ya~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW  293 (637)
T COG4248         245 ---AYASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAKAW  293 (637)
T ss_pred             ---eechhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence               0000001111112222233     34789999999999974  57789998644

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=4e-10  Score=95.16  Aligned_cols=121  Identities=21%  Similarity=0.273  Sum_probs=75.2

Q ss_pred             EEEEEEECCCCcEEEEEEeccch------------------------------hhhHHHHHHHHHcCCCc--eeeeceEE
Q 016158           97 VVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQMLDHPN--IVALKHCF  144 (394)
Q Consensus        97 ~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~~l~h~~--iv~~~~~~  144 (394)
                      .||.|.. .+|..+|||+.+...                              ...++|.+.|.++..-+  +.+.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899988 467899999763210                              11236999999997764  44554322


Q ss_pred             EecCCCceeEEEEEEeccc--ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCceeecCCCCcEEEeCCC
Q 016158          145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY-IHNCIGICHRDIKPQNLLVNPHT  221 (394)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~-LH~~~givH~Dlkp~Nil~~~~~  221 (394)
                           .    -++||||++  |.....+..     ..+.......++.+++..+.. +|. .||+|+||++.|||++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence                 1    248999999  632222222     111133445567788885555 578 899999999999999965 


Q ss_pred             CcEEEEeecCcccc
Q 016158          222 HQLKLCDFGSAKVL  235 (394)
Q Consensus       222 ~~vkl~Dfg~a~~~  235 (394)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             5999999988543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=4.5e-09  Score=94.12  Aligned_cols=133  Identities=12%  Similarity=0.119  Sum_probs=88.9

Q ss_pred             eEEEEEEECCCCcEEEEEEeccch---------------hhhHHHHHHHHHcCCCceeee--ceEEEecCCCceeEEEEE
Q 016158           96 GVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVAL--KHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        96 g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv  158 (394)
                      ..|+++..  .|+.|.||......               ....+|...+.++...+|...  +.+.....+......++|
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            33555543  36677788542211               124578888888855444433  333322222223346689


Q ss_pred             Eecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC------CCcEEEEeec
Q 016158          159 LEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH------THQLKLCDFG  230 (394)
Q Consensus       159 ~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~------~~~vkl~Dfg  230 (394)
                      ||++++  ++.+++....  ....+......++.+++..+.-||. .||+|+|+++.|||++.+      ...+.|+||+
T Consensus       114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999997  5666654322  2445667778899999999999999 899999999999999852      2379999999


Q ss_pred             Ccc
Q 016158          231 SAK  233 (394)
Q Consensus       231 ~a~  233 (394)
                      .+.
T Consensus       191 r~~  193 (268)
T PRK15123        191 RAQ  193 (268)
T ss_pred             ccc
Confidence            875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.03  E-value=2.4e-09  Score=93.80  Aligned_cols=138  Identities=14%  Similarity=0.165  Sum_probs=88.3

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCc--eeeeceEEEecCCCceeEEEEEEe
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +.|+.|..+.||++... +|+.+++|.....     .....+|+++++.+.+.+  +.+++.+..  ........++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~--~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCE--DPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECC--CCCccCCceEEEE
Confidence            56899999999999874 3678999987543     345678999999997644  445544331  1111123468999


Q ss_pred             ccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 016158          161 YVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--------------------------------------  201 (394)
Q Consensus       161 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--------------------------------------  201 (394)
                      |++|. +.....     ...+++.....++.+++.+|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99863 211110     0123344444444455555555442                                      


Q ss_pred             -----------------CCCceeecCCCCcEEEeCC-CCcEEEEeecCcc
Q 016158          202 -----------------CIGICHRDIKPQNLLVNPH-THQLKLCDFGSAK  233 (394)
Q Consensus       202 -----------------~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~  233 (394)
                                       ...++|+|++|.||+++.+ +..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                             1357999999999999973 2258999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=9.1e-09  Score=89.55  Aligned_cols=131  Identities=20%  Similarity=0.172  Sum_probs=91.6

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--------------------------hhhhHHHHHHHHHcCCC--
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------------------KRYKNRELQIMQMLDHP--  135 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~E~~~l~~l~h~--  135 (394)
                      +.+...||-|--+.||.|.+. .|..+|||.-+..                          ....++|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            557788999999999999985 6889999953211                          11124789999998655  


Q ss_pred             ceeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcE
Q 016158          136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (394)
Q Consensus       136 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Ni  215 (394)
                      .+.+.+++         ..-++|||++.|..   +..     -++.......++..|+.-+..+-. .||||+|+++-||
T Consensus       172 ~VP~P~~~---------nRHaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIAW---------NRHAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCcccc---------ccceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence            45554331         11458999999832   111     122344445555666666665556 7999999999999


Q ss_pred             EEeCCCCcEEEEeecCccc
Q 016158          216 LVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       216 l~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++++| .+.++||--+..
T Consensus       234 lV~~dg-~~~vIDwPQ~v~  251 (304)
T COG0478         234 LVTEDG-DIVVIDWPQAVP  251 (304)
T ss_pred             EEecCC-CEEEEeCccccc
Confidence            999998 699999987643

>PRK09902 hypothetical protein; Provisional

Probab=98.83  E-value=1.5e-07  Score=80.01  Aligned_cols=138  Identities=11%  Similarity=0.088  Sum_probs=97.3

Q ss_pred             eecCceEEEEEEECCCCcEEEEEEec----------cchhhhHHHHHHHHHcCCCcee--eeceEEEecCCCceeEEEEE
Q 016158           91 GTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        91 g~G~~g~V~~~~~~~~~~~vaiK~~~----------~~~~~~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv  158 (394)
                      |.||-+-|+.....  |+.+-+|.-.          .....+.+|+..+..|...+|.  +.. ++...........+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            56788888887653  4467788643          1234567899999988654443  333 2222233345557789


Q ss_pred             Eecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC-cEEEEeecCccc
Q 016158          159 LEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  234 (394)
Q Consensus       159 ~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~  234 (394)
                      +|-+++  +|..++....  ..+.+......++.+++.++.-||+ .|+.|+|+.+.|||++.++. .++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998884  6766654321  1345677777889999999999999 89999999999999986552 499999997754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.80  E-value=9.1e-08  Score=82.82  Aligned_cols=108  Identities=20%  Similarity=0.309  Sum_probs=77.1

Q ss_pred             hhHHHHHHHHHcCCCcee--eeceEEEecCCCceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH
Q 016158          121 YKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL  196 (394)
Q Consensus       121 ~~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  196 (394)
                      ...+|...+..|...+|.  +.+.+........ ...++|+|++++  +|.+++...    ...+......++.+++..+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence            345788887777544443  3333333322222 456789999987  455555432    2256667788899999999


Q ss_pred             HHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecCccc
Q 016158          197 AYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  234 (394)
Q Consensus       197 ~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~  234 (394)
                      .-||. .||+|+|+++.|||++.++  ..+.|+||+.++.
T Consensus       132 ~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999 8999999999999999764  2599999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.75  E-value=3.5e-07  Score=78.17  Aligned_cols=135  Identities=17%  Similarity=0.198  Sum_probs=84.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhH-------------HHHHHHHHcCCC---ceeeeceEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLDHP---NIVALKHCFF  145 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------~E~~~l~~l~h~---~iv~~~~~~~  145 (394)
                      ..|.+.+++-......|.+...  +|+.+++|..+......+             +++..+..+...   ....++-+..
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            3588889998888887877765  478899997754332221             233333333222   2222222221


Q ss_pred             ecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcE
Q 016158          146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  224 (394)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~v  224 (394)
                      ..........+++|||++| .+.++.        .+++    .+...+..++.-||+ .|++|+|.+|.|++++.+  .+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~--~i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNN--GI  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECC--cE
Confidence            1111223345689999998 232221        1222    233467788999999 999999999999999955  49


Q ss_pred             EEEeecCcc
Q 016158          225 KLCDFGSAK  233 (394)
Q Consensus       225 kl~Dfg~a~  233 (394)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.70  E-value=5.1e-08  Score=94.59  Aligned_cols=137  Identities=22%  Similarity=0.257  Sum_probs=83.9

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccchhh--------------------------------------------hH
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--------------------------------------------KN  123 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~  123 (394)
                      .-|+.++-|.||+|+.+ +|+.||||+.+..-..                                            ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56899999999999995 5999999986432100                                            01


Q ss_pred             HHHHHHHHc----CCCceeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 016158          124 RELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY  198 (394)
Q Consensus       124 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  198 (394)
                      +|...+.++    ....-+.+-.+|.+....    -.++|||+.| .+.+.... ..  ..++.+.+.....++.  +..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l-~~--~g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAAL-KS--AGIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHH-Hh--cCCCHHHHHHHHHHHH--HHH
Confidence            344444444    222233444445322211    4589999998 33333211 11  4445333332222221  222


Q ss_pred             HHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       199 LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +=. .|++|.|.+|.||+++.++ .+.+.|||+.....
T Consensus       281 ~~~-dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~  316 (517)
T COG0661         281 LLR-DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD  316 (517)
T ss_pred             HHh-cCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence            223 6999999999999999998 79999999987654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.68  E-value=3e-07  Score=79.40  Aligned_cols=134  Identities=16%  Similarity=0.155  Sum_probs=88.7

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccchhh----------------------------hHHHHHHHHHcCCCc--
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY----------------------------KNRELQIMQMLDHPN--  136 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~E~~~l~~l~h~~--  136 (394)
                      ...|..|--+.||+|.. .++..+|+|++......                            ..+|+.-|+++..-+  
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888889999987 56889999987432111                            125777787774333  


Q ss_pred             eeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                      +.+-+.+.     .    -.+||||++...   ...-......+....+..+..+++..+.-|-...|+||+||+.-|||
T Consensus       132 vP~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         132 VPEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             CCCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence            33333322     1    348999998531   11101111233333677778888888888765479999999999999


Q ss_pred             EeCCCCcEEEEeecCcccc
Q 016158          217 VNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       217 ~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +. ++ .+.++|||-|-..
T Consensus       200 ~~-~~-~p~iID~~QaV~~  216 (268)
T COG1718         200 VH-DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             EE-CC-eEEEEECcccccc
Confidence            99 55 6999999988543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.56  E-value=6.6e-09  Score=99.76  Aligned_cols=246  Identities=19%  Similarity=0.186  Sum_probs=161.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCc-eeeeceEEEecCCCceeEEEEEEec
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN-IVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      .|...+.+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++     ....+.+..+.+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhhh
Confidence            4667788999999999999988776665 7776655 44456899999999999 333222     23556678899999


Q ss_pred             ccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCC
Q 016158          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  241 (394)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~  241 (394)
                      +.+.-.. ..........+..-....+.+.-+.++++||+ .-=+|+|    ||+..+.  ..+..||+....+......
T Consensus       316 ~s~~rs~-~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSS-ALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCccc-cccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence            8853000 00000001122223344455566778999998 5558888    8888753  5999999998766555555


Q ss_pred             ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCC
Q 016158          242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  321 (394)
Q Consensus       242 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  321 (394)
                      ....+++.++|||+..+.. +....|+|++++--.+|.-|-+|-...-.  ..    ...|..+              ..
T Consensus       388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~p--------------~s  446 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNGP--------------NS  446 (829)
T ss_pred             ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCCC--------------Cc
Confidence            6778899999999886554 89999999999877777777766543100  00    0000000              01


Q ss_pred             CCCCC-CCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          322 PQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       322 ~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      +.+.. ..|...+.       .++...|+...|..|+.+..++.|.+|...
T Consensus       447 ~~L~~~~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  447 PMLTDKSAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccchhhhcCcccc-------cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            11111 12222221       157788999999999999999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.53  E-value=5.8e-07  Score=92.20  Aligned_cols=206  Identities=19%  Similarity=0.289  Sum_probs=135.9

Q ss_pred             HHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 016158          123 NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  201 (394)
Q Consensus       123 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  201 (394)
                      +-|...+..+.|+|++.++.+-+...... ....+..+++.. .+..++..    -...+...++.+..+++.||.++|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            34677788889999999877765444332 122233455553 33333332    3678899999999999999999999


Q ss_pred             CCCceeecCCCC---cEEEeCCCCcEEEE--eecCccccccCCCCccccccccccccccccCCC-CCCchhhHHHHHHHH
Q 016158          202 CIGICHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVM  275 (394)
Q Consensus       202 ~~givH~Dlkp~---Nil~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il  275 (394)
                       ....|.-|...   +..++.++ .+.++  ||+...................+.++|...... ......|+|.+|...
T Consensus       305 -~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  305 -LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             66555555444   33344444 46666  888887776655555556677788888774322 123347999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC
Q 016158          276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL  355 (394)
Q Consensus       276 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  355 (394)
                      ..+..|..+-.-..      .+...                                ..........+++.+|+..|+++
T Consensus       383 ~~~~~~~~i~~~~~------~~~~~--------------------------------l~~~~~~~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA------VPVSL--------------------------------LDVLSTSELLDALPKCLDEDSEE  424 (1351)
T ss_pred             hhhhhcCccccccc------chhhh--------------------------------hccccchhhhhhhhhhcchhhhh
Confidence            99988764321110      00000                                00111226889999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCC
Q 016158          356 RCTALEACVHPFFDELRD  373 (394)
Q Consensus       356 Rpt~~ell~hp~f~~~~~  373 (394)
                      |+++.+++.|||.+-..+
T Consensus       425 Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  425 RLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             ccchhhhhhchhcccccc
Confidence            999999999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.45  E-value=3.2e-06  Score=74.53  Aligned_cols=74  Identities=16%  Similarity=0.201  Sum_probs=50.2

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCc--eeeeceEEEecCCCceeEEEEEEecc
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +..++...  ..+......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4679999999999999854  48999987654  345667888888885443  34444322  1222333467899999


Q ss_pred             cc
Q 016158          163 PE  164 (394)
Q Consensus       163 ~~  164 (394)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            86

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=1.2e-05  Score=70.66  Aligned_cols=135  Identities=18%  Similarity=0.147  Sum_probs=74.8

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCce--eeeceEEEecCCCceeEEEEEEeccc
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVP  163 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~  163 (394)
                      ..||.|..+.||+.    .|..+++|.....  .....+|.++++.+..-.+  .+.+.+.     .......++||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            46899999999983    2456788976542  3346789999988864443  3443333     11112457999998


Q ss_pred             cc--HHH-----------HHHH----hhhhcC----CCCHHH-HHHHHHH----------HHH-HHHHHHh---CCCcee
Q 016158          164 ET--VNR-----------IARN----YSRIHQ----RMPLIY-VKLYTYQ----------ICR-ALAYIHN---CIGICH  207 (394)
Q Consensus       164 ~~--l~~-----------~~~~----~~~~~~----~~~~~~-~~~~~~q----------i~~-al~~LH~---~~givH  207 (394)
                      |.  +..           +...    ..+.+.    ..+... ...+..+          +.. ..++|..   ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            73  110           1110    111111    111111 0011000          111 1222221   135799


Q ss_pred             ecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          208 RDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       208 ~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|+.|.||+++.++  +.|+||+.+.
T Consensus       158 gD~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC--cEEEechhcC
Confidence            99999999999754  8999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.28  E-value=1.1e-05  Score=78.23  Aligned_cols=137  Identities=20%  Similarity=0.279  Sum_probs=81.6

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccchhh-----------------------------------------hHHHH
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----------------------------------------KNREL  126 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~E~  126 (394)
                      +.||..+.|.||+|+.+. |+.||||+-...-..                                         +.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            569999999999999965 999999975321100                                         01233


Q ss_pred             HHHH----HcCCCc---eeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 016158          127 QIMQ----MLDHPN---IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY  198 (394)
Q Consensus       127 ~~l~----~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  198 (394)
                      +...    .+.|-+   -|.+-.++..-..    ...++||||+| .+.++ ....  ...++...+...+.+...  +-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl-~~i~--~~gi~~~~i~~~l~~~~~--~q  316 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDL-DAID--KRGISPHDILNKLVEAYL--EQ  316 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCH-HHHH--HcCCCHHHHHHHHHHHHH--HH
Confidence            3222    234444   2233333422111    25689999997 22222 1111  145666554443333222  11


Q ss_pred             HHhCCCceeecCCCCcEEEeC---CCCcEEEEeecCcccc
Q 016158          199 IHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  235 (394)
Q Consensus       199 LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~~  235 (394)
                      |=. .|++|+|=+|.||+++.   .+..+.+.|||+....
T Consensus       317 If~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  317 IFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHh-cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            222 59999999999999994   2447999999998655

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.25  E-value=7e-06  Score=67.24  Aligned_cols=128  Identities=20%  Similarity=0.302  Sum_probs=84.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      -.+.+.||+|.+|.||++.+.  |..+|+|+-+.+  ...+..|+++|..+.--++..=+-.+     ..   .++.|||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-----g~---~~i~me~   93 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-----GE---DFIRMEY   93 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-----ch---hhhhhhh
Confidence            345678999999999999986  678999976543  45667899999999776655322112     11   2356999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCC-CCcEEEeCCCCcEEEEeecCccc
Q 016158          162 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK-PQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       162 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlk-p~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +.| .|......       .....    ...++.+---|-. .||-|+.|. |..+++..++ .+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDR-LGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHH-hccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            998 44332221       11222    2345555444555 899999886 4444444455 699999999973

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.17  E-value=1.9e-05  Score=66.90  Aligned_cols=126  Identities=28%  Similarity=0.370  Sum_probs=87.6

Q ss_pred             ccEEEeeEeeecCc-eEEEEEEECCCCcEEEEEEecc--------------c-h----------hhhHHHHHHHHHc---
Q 016158           82 VSYIAEHVVGTGSF-GVVFQAKCRETGEIVAIKKVLQ--------------D-K----------RYKNRELQIMQML---  132 (394)
Q Consensus        82 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~--------------~-~----------~~~~~E~~~l~~l---  132 (394)
                      ..++.++.||.|.- |.||+++..  |+.+|||++..              . .          ..+..|-+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            46899999999999 999999985  78999998321              0 0          0122455554444   


Q ss_pred             CCCce--eeeceEEEecCC-------------CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 016158          133 DHPNI--VALKHCFFSTTD-------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (394)
Q Consensus       133 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~  197 (394)
                      .+.++  +++++++....+             .......||.||++...            .+....    +.+|.+-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            55566  888888754421             12234568888887522            122222    457888899


Q ss_pred             HHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       198 ~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+|. .||+-+|+++.|..      .-+|+|||.+
T Consensus       179 ~~~k-~gI~~~Dv~~~ny~------~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHK-LGIVPRDVKPRNYR------GGKLVDFSSS  206 (207)
T ss_pred             HHHH-CCeeeccCcccccc------CCEEEecccC
Confidence            9999 89999999999986      2589999965

>PLN02876 acyl-CoA dehydrogenase

Probab=98.03  E-value=8.7e-05  Score=77.69  Aligned_cols=77  Identities=16%  Similarity=0.195  Sum_probs=49.4

Q ss_pred             eeEeeecCceEEEEEEECCCC--cEEEEEEecc-----chhhhHHHHHHHHHcC-CCce--eeeceEEEecCCCceeEEE
Q 016158           87 EHVVGTGSFGVVFQAKCRETG--EIVAIKKVLQ-----DKRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~-----~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~  156 (394)
                      .+.|+.|.+..+|+......+  ..+++|+...     ......+|+++++.+. |.++  .+++.++...  ......+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            466799999999998765332  3577776532     2245678999999995 6664  4444443111  1112356


Q ss_pred             EEEeccccc
Q 016158          157 LVLEYVPET  165 (394)
Q Consensus       157 lv~e~~~~~  165 (394)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            899999863

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.98  E-value=0.00025  Score=60.58  Aligned_cols=123  Identities=21%  Similarity=0.311  Sum_probs=81.3

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccch--------------------hhhHHHHHHHHHcC------CCceeeec
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------RYKNRELQIMQMLD------HPNIVALK  141 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~~~  141 (394)
                      ..||+|+.=.||.  | ......+||++....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5689999999995  3 334557899886554                    44456777766665      67888988


Q ss_pred             eEEEecCCCceeEEEEEEeccc---c----cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          142 HCFFSTTDKEELYLNLVLEYVP---E----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                      |...+..+     ..+|+|.+.   |    +|.+++..     ..++. .+.   ..+-.-.++|-+ .+|+.+||+|.|
T Consensus        84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~---~~L~~f~~~l~~-~~Iv~~dl~~~N  148 (199)
T PF10707_consen   84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELR---QALDEFKRYLLD-HHIVIRDLNPHN  148 (199)
T ss_pred             EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHH---HHHHHHHHHHHH-cCCeecCCCccc
Confidence            87744333     455666553   2    45554432     45555 332   234445567777 899999999999


Q ss_pred             EEEeCCC--C-cEEEEe
Q 016158          215 LLVNPHT--H-QLKLCD  228 (394)
Q Consensus       215 il~~~~~--~-~vkl~D  228 (394)
                      |++....  . .+.|+|
T Consensus       149 Iv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEEecCCCceEEEEEe
Confidence            9996533  2 477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.97  E-value=8.1e-05  Score=65.86  Aligned_cols=30  Identities=33%  Similarity=0.407  Sum_probs=24.8

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|+|+.+.||+++.+. ..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            4599999999999998543 45799999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.90  E-value=0.00014  Score=64.77  Aligned_cols=68  Identities=16%  Similarity=0.084  Sum_probs=41.0

Q ss_pred             eeecCc-eEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCC-CceeeeceEEEecCCCceeEEEEEEecccc
Q 016158           90 VGTGSF-GVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE  164 (394)
Q Consensus        90 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (394)
                      |-.|.. ..||++...  +..+.||+.... .....+|+++++.+.. --+.+++.+..   ..  ...++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~---~~--~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS---DD--GRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe---cC--CccEEEEEeeCC
Confidence            334444 789998753  467888876432 2345679999888843 22334444331   11  224579999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.85  E-value=0.00029  Score=62.30  Aligned_cols=69  Identities=19%  Similarity=0.327  Sum_probs=43.7

Q ss_pred             eeEeeecCceEEEEEEECC-CCcEEEEEEeccch---hhhHHHHHHHHHcCCCcee-eeceEEEecCCCceeEEEEEEec
Q 016158           87 EHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      ++.|..|-...+|++.... .++.|++|+.....   ....+|+.+++.+...+++ +++...   .+      .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~~------~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF---QN------GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe---CC------cEEEEe
Confidence            3567788888999987643 35678899764322   2234788899988654443 332221   11      269999


Q ss_pred             ccc
Q 016158          162 VPE  164 (394)
Q Consensus       162 ~~~  164 (394)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.80  E-value=0.00013  Score=65.38  Aligned_cols=132  Identities=22%  Similarity=0.251  Sum_probs=72.6

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccchh----hhHHHHHHHHHcCCCcee-eeceEEEecCCCceeEEEEEEecccc
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYVPE  164 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (394)
                      +..|-.+.+|+...  +++.+++|.......    ...+|..+++.+....++ +++...     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            45677778888863  466788887543322    346799999998654443 322221     1    1478999886


Q ss_pred             cH------------HHHHHHhhhhc------CCCCHH-HHHHHHHHH---------HHHHHHHHh-------CCCceeec
Q 016158          165 TV------------NRIARNYSRIH------QRMPLI-YVKLYTYQI---------CRALAYIHN-------CIGICHRD  209 (394)
Q Consensus       165 ~l------------~~~~~~~~~~~------~~~~~~-~~~~~~~qi---------~~al~~LH~-------~~givH~D  209 (394)
                      ..            ..+.....+.+      ..++.. .+..+..++         ...++.+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            21            11111111111      111111 111221111         111222211       12589999


Q ss_pred             CCCCcEEEeCCCCcEEEEeecCccc
Q 016158          210 IKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       210 lkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +.|.||+++.++  +.|+||..|..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999999765  78999998853

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.76  E-value=0.00015  Score=66.44  Aligned_cols=136  Identities=18%  Similarity=0.211  Sum_probs=93.0

Q ss_pred             EEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------h------------------------hhhHHHHHHHHHcCC
Q 016158           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------K------------------------RYKNRELQIMQMLDH  134 (394)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~------------------------~~~~~E~~~l~~l~h  134 (394)
                      .|...|..|--+.||.|.. .+|..+|||+++.+      .                        ...++|++-|.++..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            4567788999999999987 57888999976321      0                        111358888888866


Q ss_pred             CceeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       135 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                      ..|..---+.+..       -.|||++++..-   ..........++...+..+-.|++.-+.-|-...++||.||.=-|
T Consensus       226 aGIP~PePIlLk~-------hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILLKN-------HVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceeeec-------ceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            5544322222111       348999998421   111111124566677888888888888887554799999999999


Q ss_pred             EEEeCCCCcEEEEeecCcc
Q 016158          215 LLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~  233 (394)
                      +|+. +| .+.|+|-+-+-
T Consensus       296 ~Lyh-dG-~lyiIDVSQSV  312 (520)
T KOG2270|consen  296 LLYH-DG-KLYIIDVSQSV  312 (520)
T ss_pred             heEE-CC-EEEEEEccccc
Confidence            9998 45 69999988763

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.64  E-value=6.2e-05  Score=67.67  Aligned_cols=128  Identities=16%  Similarity=0.178  Sum_probs=84.5

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEecc----------ch----------------hhhHHHHHHHHHcCCCc-
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DK----------------RYKNRELQIMQMLDHPN-  136 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~----------------~~~~~E~~~l~~l~h~~-  136 (394)
                      |.++..||-|--+-||.+-+ ..|.+.++|.-+.          ..                -...+|+..|+.|.... 
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            67888999999999999998 4688999995321          11                11135888888884322 


Q ss_pred             -eeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcE
Q 016158          137 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (394)
Q Consensus       137 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Ni  215 (394)
                       +.+.+++.        . -|+|||++.+-....+.      .   ......+...+..-+--|.. +|+||+|.+-=||
T Consensus       173 pVPkpiD~~--------R-H~Vvmelv~g~Pl~~v~------~---v~d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi  233 (465)
T KOG2268|consen  173 PVPKPIDHN--------R-HCVVMELVDGYPLRQVR------H---VEDPPTLYDDLMGLIVRLAN-HGLIHGDFNEFNI  233 (465)
T ss_pred             CCCCccccc--------c-eeeHHHhhcccceeeee------e---cCChHHHHHHHHHHHHHHHH-cCceecccchhee
Confidence             23333222        1 46899998862211111      1   11222334455555666777 8999999999999


Q ss_pred             EEeCCCCcEEEEeecCc
Q 016158          216 LVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       216 l~~~~~~~vkl~Dfg~a  232 (394)
                      +++.++ .++++||--.
T Consensus       234 mv~dd~-~i~vIDFPQm  249 (465)
T KOG2268|consen  234 MVKDDD-KIVVIDFPQM  249 (465)
T ss_pred             EEecCC-CEEEeechHh
Confidence            999877 6999999854

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.58  E-value=0.0017  Score=61.56  Aligned_cols=71  Identities=20%  Similarity=0.279  Sum_probs=46.1

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEecc-----------chhhhHHHHHHHHHcC---CCceeeeceEEEecCCCce
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+.||.|.+..||++.....++.|+||.-..           .......|.+.|+.+.   -.++++++.+-     .+.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            3679999999999999864335899997421           1223356788887763   23455655432     211


Q ss_pred             eEEEEEEecccc
Q 016158          153 LYLNLVLEYVPE  164 (394)
Q Consensus       153 ~~~~lv~e~~~~  164 (394)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              4589999874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.54  E-value=0.00048  Score=63.19  Aligned_cols=141  Identities=14%  Similarity=0.125  Sum_probs=76.6

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEecc-chhhhHHHHHHHHHcCCCc--eeeeceEEEecCC----CceeEEEEEE
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD----KEELYLNLVL  159 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~----~~~~~~~lv~  159 (394)
                      .+.|..|....+|+....  +..+++|+... .......|++++..+.+.+  +.+++..   ..+    ......++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~---~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIAD---RDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccC---CCCcEeeeeCCceEEEE
Confidence            456777888899988653  44688998763 3345567888888885443  2333221   000    0012246799


Q ss_pred             ecccccH---------HHHHHHhhhhc---CCCC--------HHHHHH------------HHHHHHHHHHHHHh------
Q 016158          160 EYVPETV---------NRIARNYSRIH---QRMP--------LIYVKL------------YTYQICRALAYIHN------  201 (394)
Q Consensus       160 e~~~~~l---------~~~~~~~~~~~---~~~~--------~~~~~~------------~~~qi~~al~~LH~------  201 (394)
                      ++++|..         ..+.+...+.+   ..+.        ......            ....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9987521         11111111100   0000        000000            01112233444432      


Q ss_pred             CCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       202 ~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ..+++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            14799999999999999764 46899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.51  E-value=0.0026  Score=58.32  Aligned_cols=74  Identities=9%  Similarity=0.011  Sum_probs=49.3

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCC---CceeeeceEEEecCCCceeEEEEEEec
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      .+.||.|..+.||..... ++ .+.+|....  ....+..|.+.|+.|..   -.+.++++++....  .....++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEec
Confidence            467999999999998653 23 467787543  23577889999998854   24556665542211  12225689999


Q ss_pred             ccc
Q 016158          162 VPE  164 (394)
Q Consensus       162 ~~~  164 (394)
                      +++
T Consensus        95 i~G   97 (297)
T PRK10593         95 LRG   97 (297)
T ss_pred             cCC
Confidence            886

>PRK05231 homoserine kinase; Provisional

Probab=97.49  E-value=0.0022  Score=59.48  Aligned_cols=30  Identities=27%  Similarity=0.286  Sum_probs=25.5

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||+|++|.||+++.+. ..-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            4899999999999999553 45899999875

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.49  E-value=0.0004  Score=58.97  Aligned_cols=102  Identities=23%  Similarity=0.177  Sum_probs=74.6

Q ss_pred             HHHHHHHHHcCC-CceeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 016158          123 NRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  200 (394)
Q Consensus       123 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  200 (394)
                      ..|.-+++.+.+ +++++++|.|     +    -.++.||.+. .+... ..........++.....++.+++..+++|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            358888999976 5899999988     2    2468899884 33211 000001134688899999999999999998


Q ss_pred             hC--CCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          201 NC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       201 ~~--~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ..  ..+.-.|++++|+-++.++ ++|++|...+...
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            62  1366689999999999887 6999999987543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.41  E-value=0.00055  Score=65.34  Aligned_cols=173  Identities=20%  Similarity=0.235  Sum_probs=107.3

Q ss_pred             hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 016158          121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  200 (394)
Q Consensus       121 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  200 (394)
                      .+.-...+++.+.|+|....+++--   ..... ..+|||+++-++.+.+....     +-.       .++.       
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r---~~~~r-~IVV~e~~~~Sled~~~~~~-----l~~-------~s~~-------   84 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSR---GKHER-VIVVMEHYTMSLEDILKTGN-----LKD-------ESLL-------   84 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeec---Cccce-EEEEehhhccchHHHHHhcc-----cch-------hhhc-------
Confidence            3345678899999999998876541   11222 66899999988888776522     100       0111       


Q ss_pred             hCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 016158          201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  280 (394)
Q Consensus       201 ~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt  280 (394)
                      . +|+.|-     |        .++.+| .++.    .           |  |-      ...+|+||||+|.++.++.-
T Consensus        85 ~-~~~~~~-----~--------~~~~td-~~~t----~-----------~--~~------~~~pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   85 A-HGVLHL-----N--------IIYITD-HFLT----K-----------Y--PS------PIGPKSDVWSLGFIILELYL  126 (725)
T ss_pred             c-ccccee-----h--------hhhccc-cccc----c-----------C--CC------CCCcchhhhhHHHHHHHHHH
Confidence            1 233332     1        233344 1110    0           0  10      11249999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH
Q 016158          281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  360 (394)
Q Consensus       281 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  360 (394)
                      |...+......+.+..+....-.+.......+                 ...+.-.++....+++..|+...|..||...
T Consensus       127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  127 GISLEAELTESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             hhHHHHHHHHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHHHhccCCccccccccchh
Confidence            99888766665555555443322222111110                 0012234677889999999999999999999


Q ss_pred             HHhcCCCCCCC
Q 016158          361 EACVHPFFDEL  371 (394)
Q Consensus       361 ell~hp~f~~~  371 (394)
                      ++.+|+-|.++
T Consensus       190 ~~~k~~i~~ev  200 (725)
T KOG1093|consen  190 ELSKRCSFTEV  200 (725)
T ss_pred             HHhcCccHHHH
Confidence            99999999876

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.37  E-value=0.0023  Score=59.02  Aligned_cols=145  Identities=13%  Similarity=0.100  Sum_probs=76.9

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCce--eeeceEEEec-CCCceeEEEEEEe
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFST-TDKEELYLNLVLE  160 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~-~~~~~~~~~lv~e  160 (394)
                      ..+.++.|....+|++.. .+| .+++|+....  ......|.+++..|....+  ++++...-.. ........+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            356677887789998865 334 5778976542  3445567888888754332  2322211000 0001123568999


Q ss_pred             cccccH---------HHHHHHhhhhc---CCC--------CHHH-----HH----------HHHHHHHHHHHHHHh----
Q 016158          161 YVPETV---------NRIARNYSRIH---QRM--------PLIY-----VK----------LYTYQICRALAYIHN----  201 (394)
Q Consensus       161 ~~~~~l---------~~~~~~~~~~~---~~~--------~~~~-----~~----------~~~~qi~~al~~LH~----  201 (394)
                      |++|..         ..+-......+   ..+        ....     ..          .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            987621         01111000000   100        0000     00          001112334554532    


Q ss_pred             --CCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          202 --CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       202 --~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                        ..+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence              26899999999999999775 56899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.19  E-value=0.0078  Score=55.35  Aligned_cols=30  Identities=33%  Similarity=0.576  Sum_probs=26.2

Q ss_pred             CCceeecCCCCcEEEeCC----CCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPH----THQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~----~~~vkl~Dfg~a~  233 (394)
                      ..++|+|+.+.|||++.+    + .+.|+||..|.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence            468999999999999974    5 69999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.18  E-value=0.0059  Score=57.22  Aligned_cols=32  Identities=28%  Similarity=0.676  Sum_probs=26.8

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ..++|+|+++.|||++.+...+.|+||..|..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            36899999999999986434799999998853

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.13  E-value=0.0072  Score=54.77  Aligned_cols=31  Identities=29%  Similarity=0.528  Sum_probs=25.6

Q ss_pred             CceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       204 givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++|+|++|.|||++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999996553456999998853

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.02  E-value=0.0081  Score=55.99  Aligned_cols=30  Identities=27%  Similarity=0.445  Sum_probs=25.8

Q ss_pred             ceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       205 ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++|+|+.+.|||++++++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999986544799999998853

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.97  E-value=0.017  Score=53.26  Aligned_cols=29  Identities=28%  Similarity=0.592  Sum_probs=25.2

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|+|+++.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            57999999999999996 4 58999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.95  E-value=0.014  Score=53.92  Aligned_cols=30  Identities=13%  Similarity=0.190  Sum_probs=26.7

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||+|+.+.|||++.++ .+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            4799999999999999776 69999999875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.89  E-value=0.016  Score=54.00  Aligned_cols=30  Identities=23%  Similarity=0.261  Sum_probs=25.3

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ..++|+|+.+.||+++.++  ++++||..+..
T Consensus       192 ~~llHGDl~~gNi~~~~~~--~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEHE--TKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCCC--CEEEcCccccc
Confidence            4689999999999998653  88999997753

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.88  E-value=0.0046  Score=56.83  Aligned_cols=76  Identities=18%  Similarity=0.260  Sum_probs=60.3

Q ss_pred             CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      .+..|.|++|++.++.+...        .....+++..++++.+..+.-+...-.+-|||+...||||+ +| .|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            56678889999988765321        33456677888888888888787656799999999999999 77 6999999


Q ss_pred             cCcccc
Q 016158          230 GSAKVL  235 (394)
Q Consensus       230 g~a~~~  235 (394)
                      -+++..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999843

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.75  E-value=0.015  Score=53.23  Aligned_cols=30  Identities=27%  Similarity=0.524  Sum_probs=26.8

Q ss_pred             CceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       204 givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++|+|+.+.|++++.++ .+-|.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            389999999999999887 499999999864

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.75  E-value=0.014  Score=55.08  Aligned_cols=71  Identities=17%  Similarity=0.236  Sum_probs=44.1

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEecc----------chhhhHHHHHHHHHcC--CC-ceeeeceEEEecCCCcee
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~  153 (394)
                      .+.||.|.-..||++.+...++.|+||.-..          ......-|.+.|+.+.  .| .+++++. +     ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-----D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-----DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-----CcHH
Confidence            5778999999999999843356799996421          1122245778887763  23 3445543 2     1111


Q ss_pred             EEEEEEecccc
Q 016158          154 YLNLVLEYVPE  164 (394)
Q Consensus       154 ~~~lv~e~~~~  164 (394)
                       ..+|||+++.
T Consensus       108 -~~~vMEdL~~  117 (409)
T PRK12396        108 -NCCVMEDLSD  117 (409)
T ss_pred             -hhHHHHhCcc
Confidence             3478998863

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.69  E-value=0.00085  Score=71.65  Aligned_cols=156  Identities=14%  Similarity=-0.011  Sum_probs=101.9

Q ss_pred             HHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016158          125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI  203 (394)
Q Consensus       125 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~  203 (394)
                      |+..++...|+++.....-...   .+..-.+..++|+. |.+...+-........+....+.....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4455666788887765433311   22222345777776 3455554443333344444444444434366666666522


Q ss_pred             C----ceeecCCCCcEEEeCCCCcEEEEeecCcccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHH
Q 016158          204 G----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  278 (394)
Q Consensus       204 g----ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  278 (394)
                      +    .+|++||+-|.+|..+- .+++.++|+.+.... ........+++.|++|++. +...++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~-N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK-NEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHH-HHHhhhhHHHHHHHHHHHHHH
Confidence            2    68999999999999876 699999999983322 2223345678889999987 445588889999999999999


Q ss_pred             HhCCCCC
Q 016158          279 LLGQPLF  285 (394)
Q Consensus       279 ltg~~pf  285 (394)
                      -.|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8887666

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.53  E-value=0.028  Score=52.07  Aligned_cols=140  Identities=18%  Similarity=0.207  Sum_probs=74.8

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCce------eeeceEEEecCCCceeEEEEEEec
Q 016158           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI------VALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        90 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i------v~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      |.+ .-..||+.... +|+ +++|+....  ...+..|.+.+..|.-..|      ..+-+-........ .+.+-+++|
T Consensus        34 l~s-~eN~~f~~~~~-~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTE-DGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEec-CCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeEEEEEe
Confidence            444 55678888874 344 489988764  4445567888887733222      22222222211122 356678889


Q ss_pred             ccccHHH------HHHH-------hhhhcCCC-----------CHH----H---------HHHHHHHHHHHHHHHHh---
Q 016158          162 VPETVNR------IARN-------YSRIHQRM-----------PLI----Y---------VKLYTYQICRALAYIHN---  201 (394)
Q Consensus       162 ~~~~l~~------~~~~-------~~~~~~~~-----------~~~----~---------~~~~~~qi~~al~~LH~---  201 (394)
                      ++|....      .+..       .-.....+           .+.    .         -.....++...++.+.+   
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            8863322      0000       00000111           111    0         00122234444444443   


Q ss_pred             ----CCC--ceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          202 ----CIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       202 ----~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                          ..+  +||+|+.|.||+++.+...+.++||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                123  99999999999999775338899999874

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.36  E-value=0.063  Score=50.99  Aligned_cols=69  Identities=16%  Similarity=0.191  Sum_probs=43.7

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEecc-----------chhhhHHHHHHHHHcC---CCceeeeceEEEecCCCce
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+.||.|....||+..+.  +..++||.-..           .......|.+.|+.+.   -.++++++.+.     .+.
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM  109 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence            567899999999998873  45688996431           1122234666666653   23566666554     211


Q ss_pred             eEEEEEEecccc
Q 016158          153 LYLNLVLEYVPE  164 (394)
Q Consensus       153 ~~~~lv~e~~~~  164 (394)
                        .+++||++++
T Consensus       110 --~vlvME~L~~  119 (418)
T PLN02756        110 --ALIGMRYLEP  119 (418)
T ss_pred             --CEEEEeecCC
Confidence              3578999864

>PTZ00384 choline kinase; Provisional

Probab=96.11  E-value=0.1  Score=49.57  Aligned_cols=29  Identities=28%  Similarity=0.389  Sum_probs=24.6

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ..++|.|+-+.||+.+.+  .+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            468999999999998744  59999999875

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.95  E-value=0.15  Score=47.43  Aligned_cols=28  Identities=25%  Similarity=0.367  Sum_probs=23.9

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||+|+.+.|||++ +  .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            5799999999999995 4  37899999874

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.33  E-value=0.042  Score=51.54  Aligned_cols=60  Identities=25%  Similarity=0.239  Sum_probs=39.5

Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~  220 (394)
                      .++-+|..| ++..+++.     ...+++..+.++.-.+.|+-.+---.+++|.|++|.||++..+
T Consensus       321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            355566665 44444443     5566667777776666666554322589999999999998543

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=95.29  E-value=0.042  Score=52.65  Aligned_cols=30  Identities=17%  Similarity=0.313  Sum_probs=24.6

Q ss_pred             ceeecCCCCcEEEeCCCC----cEEEEeecCccc
Q 016158          205 ICHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  234 (394)
Q Consensus       205 ivH~Dlkp~Nil~~~~~~----~vkl~Dfg~a~~  234 (394)
                      ++|+||...|||++.++.    -..|+||-++..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            799999999999998654    456889887754

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.19  E-value=0.52  Score=42.91  Aligned_cols=71  Identities=14%  Similarity=0.122  Sum_probs=42.5

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC---CCceeeeceEEEecCCCceeEEEEEEec
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      -.+.++.|....+|+..  .+++.+.||+-... ...+..|.+-|+.|.   --.+++++.+......     .+++|||
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLlle~   93 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLLEF   93 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEEE-
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEEEe
Confidence            34678899999999987  56788999976633 345678999888883   2334555554422221     2689999


Q ss_pred             cc
Q 016158          162 VP  163 (394)
Q Consensus       162 ~~  163 (394)
                      ++
T Consensus        94 l~   95 (288)
T PF03881_consen   94 LE   95 (288)
T ss_dssp             --
T ss_pred             ec
Confidence            86

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=95.12  E-value=0.036  Score=50.68  Aligned_cols=79  Identities=20%  Similarity=0.348  Sum_probs=46.9

Q ss_pred             EEEEecccccHHHHHHH-hhhhcCCCCHHHHHHHHHHHHHHHH---HHHhCCCceeecCCCCcEEEeCCCC---------
Q 016158          156 NLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALA---YIHNCIGICHRDIKPQNLLVNPHTH---------  222 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~al~---~LH~~~givH~Dlkp~Nil~~~~~~---------  222 (394)
                      .+|++++-++...+... ....+-..-...++.++.||+.-.-   .|-.+..++|-||||+|||+-+...         
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~  326 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR  326 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence            37888876554433222 1222223334567777778766431   1322367999999999999853221         


Q ss_pred             --------cEEEEeecCccc
Q 016158          223 --------QLKLCDFGSAKV  234 (394)
Q Consensus       223 --------~vkl~Dfg~a~~  234 (394)
                              .++|.||.++..
T Consensus       327 ~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  327 NYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             EEEecccceeeecccCHHHh
Confidence                    356778777754

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=94.85  E-value=0.039  Score=50.18  Aligned_cols=130  Identities=18%  Similarity=0.187  Sum_probs=84.1

Q ss_pred             EeeEeeecCceEEEEEEEC------C----CCcEEEEEEeccchhhh------------------------------HHH
Q 016158           86 AEHVVGTGSFGVVFQAKCR------E----TGEIVAIKKVLQDKRYK------------------------------NRE  125 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~------~----~~~~vaiK~~~~~~~~~------------------------------~~E  125 (394)
                      |...|..|--+.|+.|.--      .    .-..+|||+++.....+                              ++|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            5567888888999888320      0    12458999763211110                              135


Q ss_pred             HHHHHHc-----CCCceeeeceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 016158          126 LQIMQML-----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  200 (394)
Q Consensus       126 ~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  200 (394)
                      ..-|.++     ..|-+|.+...            .+||-|++..-   +..-......++..+.+..-.|+..++.-|-
T Consensus       336 mhNL~RMq~~GlpcP~vV~lkkh------------vLVMsFiGd~~---~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY  400 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLKKH------------VLVMSFIGDQG---LAAPKLKNVELTDDERRNAYDQVQSIMCRLY  400 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeeecc------------eEEEEeecCCC---CCCccccccccChHHHHHHHHHHHHHHHHHH
Confidence            4445554     45666665432            37999987421   1111122355777888877889988888774


Q ss_pred             hCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       201 ~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ...-+||.||.--|+|+...  .|.++|-.-+
T Consensus       401 ~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQs  430 (531)
T KOG2269|consen  401 KECLLVHADLSEYNLLWTPG--KVWVIDVSQS  430 (531)
T ss_pred             HhhheeecchhhhhheecCC--ceEEEechhc
Confidence            33789999999999999964  6999997765

>PRK06148 hypothetical protein; Provisional

Probab=94.81  E-value=0.76  Score=49.58  Aligned_cols=32  Identities=31%  Similarity=0.434  Sum_probs=26.0

Q ss_pred             CCceeecCCCCcEEEeCCC--CcEEEEeecCccc
Q 016158          203 IGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  234 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~  234 (394)
                      .++||+|+++.|||++.++  ...-|+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999764  2345999998753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	394
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-127
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-127
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-127
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-127
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-127
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-127
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-127
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-126
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-126
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-126
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-126
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-126
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-126
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-125
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-125
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-125
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-125
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-125
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-124
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-124
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-123
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-119
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-82
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-78
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-42
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-42
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-42
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-42
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-42
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-42
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-42
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-42
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-42
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-42
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-42
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-42
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-42
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-42
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-42
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-42
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-42
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-42
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-42
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-42
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-42
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-42
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-42
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-42
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-42
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-42
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-42
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-41
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-41
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-41
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-41
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-41
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-41
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-41
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-41
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-41
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-41
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-41
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-41
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-41
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-40
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-40
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-40
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-39
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-39
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-39
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-39
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-39
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-39
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-39
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-39
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-39
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-39
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-39
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-39
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-39
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-39
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-39
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-39
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-39
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-39
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-39
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-39
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-39
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-38
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-38
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-38
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-38
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-38
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-38
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-38
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-38
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-37
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-37
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-37
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-37
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-37
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-37
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-37
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-37
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-37
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-37
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-37
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-37
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-37
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-37
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-37
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-37
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-37
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-37
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-37
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-37
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-37
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-37
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-37
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-37
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-37
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-37
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-37
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-37
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-37
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-37
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-37
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-37
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-37
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-37
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-37
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-37
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-37
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-37
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-37
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-37
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-37
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-37
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-37
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-37
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-37
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-37
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-37
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-37
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-37
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-37
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-37
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-37
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-37
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-37
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-37
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-37
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-36
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-36
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-36
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-36
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-36
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-36
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-36
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-36
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-36
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-35
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-34
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-32
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-32
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-31
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-30
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-30
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-30
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-30
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-30
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-30
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-30
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-30
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-30
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-29
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-29
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-29
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-29
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-29
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-29
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-29
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-29
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-29
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-29
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-29
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-29
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-29
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-29
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-29
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-29
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-29
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-29
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-29
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-29
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-29
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-28
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-28
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-28
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-28
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-28
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-28
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-28
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-28
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-28
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-27
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-27
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-26
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-26
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-26
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-26
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-26
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-26
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-24
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-24
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-23
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-23
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-22
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-21
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-20
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-19
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-19
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-17
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-12
3soa_A	444	Full-Length Human Camkii Length = 444		7e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		9e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		8e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-05
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  451 bits (1161), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/335 (65%), Positives = 262/335 (78%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 362

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/335 (65%), Positives = 262/335 (78%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 407

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/335 (65%), Positives = 262/335 (78%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 366

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/335 (65%), Positives = 262/335 (78%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 356

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/335 (65%), Positives = 262/335 (78%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 364

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  450 bits (1157), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 219/334 (65%), Positives = 261/334 (78%), Gaps = 4/334 (1%)
Query: 60  GAETGHVIRTTIG--GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 117
           GA +   + T +   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 60
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 176
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 121 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
           +GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 180 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239
Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 240 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299
Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
            T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 300 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 333

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  450 bits (1157), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/335 (65%), Positives = 262/335 (78%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 341

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  448 bits (1153), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 219/335 (65%), Positives = 261/335 (77%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 362

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  447 bits (1150), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 219/335 (65%), Positives = 261/335 (77%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 340

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  447 bits (1150), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 216/319 (67%), Positives = 255/319 (79%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNF 328

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  447 bits (1149), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 219/335 (65%), Positives = 261/335 (77%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 336

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  447 bits (1149), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 219/335 (65%), Positives = 261/335 (77%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 340

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  447 bits (1149), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 219/335 (65%), Positives = 261/335 (77%), Gaps = 4/335 (1%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           R T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 347

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  446 bits (1146), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 218/334 (65%), Positives = 261/334 (78%), Gaps = 4/334 (1%)
Query: 58  GVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 117
            +G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 2   AMGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 59
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 176
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 120 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
           +GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 179 RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 239 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298
Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
            T LEAC H FFDELRDPN +LPNGR  P LFNF
Sbjct: 299 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 332

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  444 bits (1143), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 215/319 (67%), Positives = 254/319 (79%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNF 328

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  444 bits (1142), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 215/319 (67%), Positives = 254/319 (79%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 12  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 71
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 132 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 190
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 250
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 251 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 311 RDPNVKLPNGRDTPALFNF 329

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  444 bits (1142), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 215/319 (67%), Positives = 254/319 (79%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNF 328

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  444 bits (1141), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 215/319 (67%), Positives = 254/319 (79%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNF 328

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  441 bits (1135), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 214/319 (67%), Positives = 253/319 (79%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNF 328

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  441 bits (1133), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 213/319 (66%), Positives = 252/319 (78%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNF 328

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  437 bits (1124), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 212/319 (66%), Positives = 251/319 (78%), Gaps = 2/319 (0%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 372 RDPNTRLPNGRPLPPLFNF 390
           RDPN +LPNGR  P LFNF
Sbjct: 310 RDPNVKLPNGRDTPALFNF 328

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  425 bits (1092), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 205/326 (62%), Positives = 251/326 (76%), Gaps = 3/326 (0%)
Query: 66  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
           VI+          +++++Y    V+G GSFGVVFQAK  E+ E VAIKKVLQDKR+KNRE
Sbjct: 24  VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIY 184
           LQIM+++ HPN+V LK  F+S  DK               TV R +R+Y+++ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPNVS 
Sbjct: 143 IKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           ICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           +RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +Y+P+ R TA+EA  
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 365 HPFFDELRDPNTRLPNGRPLPPLFNF 390
           HPFFDELR    R+PNGR LPPLFN+
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNW 347

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  301 bits (770), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 154/351 (43%), Positives = 216/351 (61%), Gaps = 43/351 (12%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHC 143
           Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH NI+ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 144 FFSTTDK---------------------------------XXXXXXXXXXXXXXTVNRIA 170
           F++T D+                                               T++++ 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLVN   + LKLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           SAK L+  EP+V+ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
           +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+DL+ +  +
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 351 YSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKP 392
           Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSP 358

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  288 bits (737), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 152/324 (46%), Positives = 201/324 (62%), Gaps = 10/324 (3%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ---MLDHP 135
           K+   +  E + G G+FG V   K + TG  VAIKKV+QD R++NRELQIMQ   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 136 NIVALKHCFFS--TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           NIV L+  F++    D+              T++R  RNY R     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L   EPNV+YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 313 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
           NP++T+      K  PW  VF     +   EA DL+    QY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 370 ELRDPNTRLPNGRPLPP-LFNFKP 392
           EL DP T+LPN + LP  LF F P
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLP 343

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 109/321 (33%), Positives = 166/321 (51%), Gaps = 56/321 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 363 CVHPFFDELRDPNTRLPNGRP 383
             HPFF ++  P   L   RP
Sbjct: 286 LAHPFFQDVTKPVPHLRLERP 306

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 171/320 (53%), Gaps = 29/320 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------VSYICSRYYRA 252
            + HRD+KP NLL+N +   LK+CDFG A+++ +      EP       V ++ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 311
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 369 DELRDPNTRLPNGRPLPPLF 388
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/320 (31%), Positives = 170/320 (53%), Gaps = 29/320 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 252
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S           Y+ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 311
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 369 DELRDPNTRLPNGRPLPPLF 388
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 286 LAHPFFQDVTKP 297

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 97/305 (31%), Positives = 164/305 (53%), Gaps = 22/305 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIV 138
           Y     +G G++G+V  A        VAIKK+   + + Y  R   E+QI+    H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            ++    ++T +               + ++ ++     Q++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-----QQLSNDHICYFLYQILRGLKY 159
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPE 254
           IH+   + HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 313 --NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
               NY +   P      W K+F K    +A+DL+ R   ++PN R T  EA  HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 371 LRDPN 375
             DP 
Sbjct: 336 YYDPT 340

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 73  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 235
Query: 321 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 105/304 (34%), Positives = 159/304 (52%), Gaps = 26/304 (8%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 143 CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 199
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 174
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPE 254
           H+   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPE
Sbjct: 175 HSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           L+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +  
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                     P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  + 
Sbjct: 293 ERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351
Query: 372 RDPN 375
            DP+
Sbjct: 352 HDPD 355

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/304 (34%), Positives = 159/304 (52%), Gaps = 26/304 (8%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 143 CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 199
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPE 254
           H+   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPE
Sbjct: 176 HSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           L+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +  
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                     P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  + 
Sbjct: 294 ERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 372 RDPN 375
            DP+
Sbjct: 353 HDPD 356

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + L++ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLSFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEHVDQDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 72  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 234
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 321 FPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/308 (34%), Positives = 161/308 (52%), Gaps = 56/308 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDE 370
             HPFF +
Sbjct: 282 LAHPFFQD 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 248
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 309 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 362
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 363 CVHPFFDELRDP 374
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 101/320 (31%), Positives = 169/320 (52%), Gaps = 29/320 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 252
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S            + +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 311
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 369 DELRDPNTRLPNGRPLPPLF 388
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 155/294 (52%), Gaps = 31/294 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              F   ++                +  I ++ S +   +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPN 315
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 316 YTEFK-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           Y  FK FP I   P H +F      + +DL+   F ++P  R TA +A    +F
Sbjct: 246 YVTFKSFPGI---PLHHIFSAA-GDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 187
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 85  VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS 124
Query: 188 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 180
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 358
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 241 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 359 ALEACVHPFFDELRDPNTRLPNGRPL 384
           A +A  HPFF+  RDP       +P 
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPF 325

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 187
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 103 VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGMEFS 142
Query: 188 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 198
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 358
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 259 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 359 ALEACVHPFFDELRDPNTRLPNGRPL 384
           A +A  HPFF+  RDP       +P 
Sbjct: 318 AAQALTHPFFEPFRDPEEETEAQQPF 343

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 154/303 (50%), Gaps = 19/303 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I ++     Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKS-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 323 QIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380
            + P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P 
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PE 325
Query: 381 GRP 383
             P
Sbjct: 326 AEP 328

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PN 375
           P+
Sbjct: 323 PS 324

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 153/303 (50%), Gaps = 19/303 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 323 QIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380
            + P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P 
Sbjct: 267 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PE 325
Query: 381 GRP 383
             P
Sbjct: 326 AEP 328

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 318
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 318
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PN 375
           P+
Sbjct: 323 PS 324

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 374 PN 375
           P+
Sbjct: 339 PS 340

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PN 375
           P+
Sbjct: 319 PS 320

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/333 (30%), Positives = 168/333 (50%), Gaps = 57/333 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLD-HPNIVALKH 142
           +G G++G+V+++  R TGE+VA+KK+        D +   RE+ I+  L  H NIV L +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +  D+               V R A     +H++    YV    YQ+ + + Y+H+ 
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIR-ANILEPVHKQ----YV---VYQLIKVIKYLHSG 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK---------------------GEPN 241
            G+ HRD+KP N+L+N   H +K+ DFG ++  V                       +P 
Sbjct: 129 -GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 242 VS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++QL  II V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPH-------------PWHKVFQKRLPP-----EAV 342
           +  P+ E+++ +   + +     +K                W  +  K  P      EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 343 DLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           DL+ +  Q++PN R +A +A  HPF     +PN
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 152/303 (50%), Gaps = 19/303 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
            GI HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 143 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 198
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 199 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258
Query: 323 QIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 380
            + P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P 
Sbjct: 259 SLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PE 317
Query: 381 GRP 383
             P
Sbjct: 318 AEP 320

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 374 PN 375
           P+
Sbjct: 317 PS 318

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 269 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 374 PN 375
           P+
Sbjct: 327 PS 328

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PN 375
           P+
Sbjct: 319 PS 320

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 374 PN 375
           P+
Sbjct: 321 PS 322

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 158/301 (52%), Gaps = 26/301 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MNP 314
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                  P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  DP
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321
Query: 375 N 375
           +
Sbjct: 322 S 322

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 374 PN 375
           P+
Sbjct: 339 PS 340

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 266 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 374 PN 375
           P+
Sbjct: 324 PS 325

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 267 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 374 PN 375
           P+
Sbjct: 325 PS 326

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 258 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 374 PN 375
           P+
Sbjct: 316 PS 317

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PN 375
           P+
Sbjct: 323 PS 324

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PN 375
           P+
Sbjct: 319 PS 320

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 160/302 (52%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 374 PN 375
           P+
Sbjct: 321 PS 322

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 160/302 (52%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 374 PN 375
           P+
Sbjct: 317 PS 318

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAI+K+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PN 375
           P+
Sbjct: 323 PS 324

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 161/302 (53%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKC-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 374 PN 375
           P+
Sbjct: 323 PS 324

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 27/297 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + R+TG+IVAIKK L+       K+   RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--N 201
           F                      + +     R  + +P   VK  T+Q  +A+ + H  N
Sbjct: 71  F--------RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 258
           CI   HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G
Sbjct: 123 CI---HRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVG 176
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNY 316
            T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  +
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           +  K P  +     ++    +   A+ L+       P  R T  +   HP+F+ +R+
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 159/302 (52%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRY---KNRELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PN 375
           P+
Sbjct: 319 PS 320

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLW 165
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 307
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 308 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 364 VHPFFDE 370
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 159/299 (53%), Gaps = 22/299 (7%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 260
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 316
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+
Sbjct: 268 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 159/299 (53%), Gaps = 22/299 (7%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 260
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 316
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+
Sbjct: 269 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 325

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 307
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 308 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 364 VHPFFDE 370
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 249
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 307
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 308 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 364 VHPFFDE 370
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 157/311 (50%), Gaps = 25/311 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  +   ++G  +A+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  +T+ +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 172
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
               PQ+    +  VF     P AVDL+ +      + R TA EA  HP+F +  DP+  
Sbjct: 289 N-SLPQMPKRNFADVFIGA-NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE 346
Query: 378 LPNGRPLPPLF 388
            P   P    F
Sbjct: 347 -PESEPYDQSF 356

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 158/302 (52%), Gaps = 28/302 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRY---KNRELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 257
           + HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 313
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 374 PN 375
           P+
Sbjct: 319 PS 320

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I ++     Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKS-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 153
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 270 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 159/320 (49%), Gaps = 29/320 (9%)
Query: 73  GRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKR 120
            R+G  +Q+V+  A  V         VG+G++G V  A    TG  VAIKK+    Q + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 121 YKNR---ELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 177
           +  R   EL++++ + H N++ L   F  T D+                  + +     H
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVF--TPDETLDDFTDFYLVMPFMGTDLGKLMK--H 122
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           +++    ++   YQ+ + L YIH   GI HRD+KP NL VN    +LK+ DFG A+    
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--A 178
Query: 238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297
                  + +R+YRAPE+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI
Sbjct: 179 DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 298 IKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
           +KV GTP  E ++ +      NY +   P+++   +  +      P AV+L+ +      
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMK-GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDA 296
Query: 354 NLRCTALEACVHPFFDELRD 373
             R TA EA  HP+F+ L D
Sbjct: 297 EQRVTAGEALAHPYFESLHD 316

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 155/308 (50%), Gaps = 23/308 (7%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  V++ K + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L       T+K                     N   +H       VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKSLTLVFEYLDKDLKQYLDDCGNIINMHN------VKLFLFQLLRGLA 114
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           N  +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPFF  L 
Sbjct: 231 NEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 373 DPNTRLPN 380
           +   +LP+
Sbjct: 290 ERIHKLPD 297

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 95/290 (32%), Positives = 154/290 (53%), Gaps = 21/290 (7%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
           +VG GS+G+V + + ++TG IVAIKK L+       K+   RE+++++ L H N+V L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
                  K               ++ +    + +  ++    V+ Y +QI   + + H+ 
Sbjct: 90  --LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV----VQKYLFQIINGIGFCHSH 143
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGATE 261
             I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 144 -NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 319
           Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 320 KFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + P+IK   P  + + K L    +DL  +     P+ R    E   H FF
Sbjct: 262 RLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 154/301 (51%), Gaps = 34/301 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 320 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 374 P 374
           P
Sbjct: 292 P 292

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 142
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 258
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 259 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 153/301 (50%), Gaps = 34/301 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 320 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 374 P 374
           P
Sbjct: 292 P 292

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 141
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +       ++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----AKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 317
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 95/297 (31%), Positives = 148/297 (49%), Gaps = 26/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G++  V++   + TG  VA+K+V  D          RE+ +M+ L H NIV L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            +                    +R   N  R    + L  VK + +Q+ + LA+ H    
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPR---GLELNLVKYFQWQLLQGLAFCHEN-K 128
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYT 263
           I HRD+KPQNLL+N    QLKL DFG A+   +      S + + +YRAP+++ G+  Y+
Sbjct: 129 ILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYS 187
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNPNYT 317
           T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP         ++   NPN  
Sbjct: 188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN-- 245
Query: 318 EFKFPQIKPHPWHKVFQ----KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                Q  P    +V Q    + L    +D +    Q +P++R +A +A  HP+F E
Sbjct: 246 ---IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 154/297 (51%), Gaps = 24/297 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G G  G+VF A   +  + VAIKK++    Q  ++  RE++I++ LDH NIV +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 146 STTDKXXXXXXXXXXXXXXTVNR--IARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 201
            +  +               + +  +  + + + ++ PL+  + +L+ YQ+ R L YIH+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRYYRAPE 254
              + HRD+KP NL +N     LK+ DFG A+++   +P+ S+       + +++YR+P 
Sbjct: 139 A-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLSEGLVTKWYRSPR 194
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKC 311
           L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+   +E I V+    R+E+  
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + P Y   +    +PH         +  EAVD + +   +SP  R TA EA  HP+ 
Sbjct: 255 VIPVY--IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 128
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 185
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 306 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 362 ACVHPFFDELRDP 374
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 128
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 185
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 306 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 362 ACVHPFFDELRDP 374
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 137
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 369 DELRDP 374
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 314
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 363
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 364 VHPFFDELRDPN 375
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 144/292 (49%), Gaps = 25/292 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALKHCFFST 147
           +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L       
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL------- 97
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
            D                VN    ++ +++Q +    ++ Y Y+I +AL Y H  +GI H
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNT--DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMH 154
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 267
           RD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 268 IWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFK 320
           +WS GC++A ++   +P F G    DQLV I KVLGT        +  I+ ++P + +  
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI- 272
Query: 321 FPQIKPHPW----HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             +     W    H   Q  + PEA+D + +  +Y    R TA EA  HP+F
Sbjct: 273 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 101/357 (28%), Positives = 154/357 (43%), Gaps = 75/357 (21%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNI 137
           Y   H++GTGS+G V +A  +    +VAIKK+L+      D +   RE+ I+  L+H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V +         +                 ++ R    + +    +++K   Y +   + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVGVK 170
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------------- 243
           Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S              
Sbjct: 171 YVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 244 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--------- 280
                         ++ +R+YRAPELI     YT AID+WS GC+ AELL          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 281 --GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
               PLFPG S                      DQL  I  +LGTP+ E+I+ +     +
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELR 372
            ++ +I P        +R P  + D   L+ R   ++PN R T  E   HPFF E+R
Sbjct: 349 -RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 369 DELRDP 374
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 369 DELRDP 374
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 148 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 206
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 207 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 267 ------DGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVR 343

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 143
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 144 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 200
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320
Query: 369 DELRDP 374
           +   DP
Sbjct: 321 NVWYDP 326

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 369 DELRDP 374
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 151/305 (49%), Gaps = 21/305 (6%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 367 FFDEL 371
           +F +L
Sbjct: 299 YFQDL 303

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 369 DELRDP 374
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 DELRDP 374
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 369 DELRDP 374
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 369 DELRDP 374
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 151/305 (49%), Gaps = 21/305 (6%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 367 FFDEL 371
           +F +L
Sbjct: 299 YFQDL 303

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 137
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 369 DELRDP 374
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 129 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 187
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 188 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 248 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 301
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 302 RYDHQERLTALEAMTHPYFQQVR 324

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 303
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 304 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 349
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 144/301 (47%), Gaps = 31/301 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 369 D 369
           +
Sbjct: 322 N 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 202 YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                   KF ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 369 DELRDP 374
               DP
Sbjct: 322 TVWYDP 327

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 94  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 146
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+        V ++ +RYYRAPE+I G   
Sbjct: 147 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG- 203
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 204 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 263
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 264 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 322
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 323 INVWYDPS 330

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 93  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 263 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 322 INVWYDPS 329

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 149/302 (49%), Gaps = 21/302 (6%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 367 FF 368
           +F
Sbjct: 299 YF 300

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 145/306 (47%), Gaps = 31/306 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 142
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 143 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG- 199
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 319 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 369 DELRDP 374
               DP
Sbjct: 320 TVWYDP 325

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 149/305 (48%), Gaps = 50/305 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK-- 141
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 142 -------HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
                  H  F   +                     + Y   +  + +  +K + YQ+  
Sbjct: 102 IHHNHRLHLIFEYAENDL------------------KKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 195 ALAYIHN--CIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNVSY---I 245
            + + H+  C+   HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I
Sbjct: 144 GVNFCHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEI 198
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            + +YR PE++ G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P 
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258
Query: 306 REEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                 +   P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A 
Sbjct: 259 DTTWPGVTALPDWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 364 VHPFF 368
            HP+F
Sbjct: 318 EHPYF 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 14/208 (6%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+L++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKPHPW----HKVFQKRLPPE 340
            DQLV I KVLGT        +  I+ ++P + +    +     W    H   Q  + PE
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPE 296
Query: 341 AVDLVCRFFQYSPNLRCTALEACVHPFF 368
           A+D + +  +Y    R TA EA  HP+F
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 102/354 (28%), Positives = 162/354 (45%), Gaps = 75/354 (21%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
           +YI +H++G GS+G V+ A  + T + VAIKKV      L D +   RE+ I+  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQI 192
           I+ L                         V  IA +  +   + P+     ++K   Y +
Sbjct: 87  IIRLYDLIIPDD--------LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNV--------- 242
                +IH   GI HRD+KP N L+N     +K+CDFG A+ +  + + N+         
Sbjct: 139 LLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 243 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQ------ 282
                        S++ +R+YRAPELI     YT +IDIWSTGC+ AELL + Q      
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 283 ----PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
               PLFPG                 +S  DQL  I  ++GTPT +++K +N      K+
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV-IKY 315
Query: 322 PQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
            ++ PH      +++ P    + ++L+    +++PN R T  +A  HP+  ++R
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 14/208 (6%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKPHPW----HKVFQKRLPPE 340
            DQLV I KVLGT        +  I+ ++P + +    +     W    H   Q  + PE
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPE 296
Query: 341 AVDLVCRFFQYSPNLRCTALEACVHPFF 368
           A+D + +  +Y    R TA EA  HP+F
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 118 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 295
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 125 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 183
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 184 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 243
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 244 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 302
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ ++ Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 341
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 342 VDLVCRFFQYSPNLRCTALEACVHPFF 368
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 14/208 (6%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 291 VDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKPHPW----HKVFQKRLPPE 340
            DQLV I KVLGT        +  I+ ++P + +      +   W    H   Q  + PE
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDILGRHSRKR-WERFVHSENQHLVSPE 296
Query: 341 AVDLVCRFFQYSPNLRCTALEACVHPFF 368
           A+D + +  +Y    R TA EA  HP+F
Sbjct: 297 ALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 86  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 255
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 256 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 314
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 315 INVWYDPS 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 97  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 149
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 150 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 206
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 266
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 267 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 325
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 326 INVWYDPS 333

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 93/308 (30%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 179
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 180 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 239
Query: 291 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 338
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 240 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 295
Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 296 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 231
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 126 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 184
Query: 232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 290
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 185 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 244
Query: 291 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 338
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 245 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 300
Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 301 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP    +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 318
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 319 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 368 FDELRDPN 375
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 143
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 258
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 144 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 202
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 261
Query: 319 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 262 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 105/372 (28%), Positives = 158/372 (42%), Gaps = 80/372 (21%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRE 125
           G    N K   +Y  +H++G GS+G V+ A  +   + VAIKKV      L D +   RE
Sbjct: 18  GAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILRE 77
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-- 183
           + I+  L    I+ L H      D                V  IA +  +   + P+   
Sbjct: 78  ITILNRLKSDYIIRL-HDLIIPED-------LLKFDELYIVLEIADSDLKKLFKTPIFLT 129
Query: 184 --YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
             +VK   Y +     +IH   GI HRD+KP N L+N     +K+CDFG A+  +  + +
Sbjct: 130 EQHVKTILYNLLLGEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKD 186
Query: 242 V---------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCV 274
           +                           S++ +R+YRAPELI     YT +IDIWSTGC+
Sbjct: 187 IHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCI 246
Query: 275 MAELLLGQ-----------PLFPG-----------------ESGVDQLVEIIKVLGTPTR 306
            AELL              PLFPG                 +S  DQL  I  V+GTP  
Sbjct: 247 FAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPE 306
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---LPPEAVDLVCRFFQYSPNLRCTALEAC 363
           E++KC+       K+ ++ P        K+   +  E +DL+    +++   R T  +A 
Sbjct: 307 EDLKCITKQEV-IKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKAL 365
Query: 364 VHPFFDELRDPN 375
            HP+  ++R  N
Sbjct: 366 SHPYLKDVRKEN 377

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 140/299 (46%), Gaps = 35/299 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLD--- 133
           +G G++G V++A+   +G  VA+K V    R  N             RE+ +++ L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 134 HPNIVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTY 190
           HPN+V L   C  S TD+               V++  R Y        +P   +K    
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 191 QICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
           Q  R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +
Sbjct: 128 QFLRGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++ 
Sbjct: 185 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 244 P-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 95/341 (27%), Positives = 147/341 (43%), Gaps = 60/341 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 97  YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 149
Query: 195 ALAYIHN-CIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           AL ++    + I H D+KP+N+L+ NP    +K+ DFGS+  L  G+     I SR+YR+
Sbjct: 150 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 207
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P    I   
Sbjct: 208 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQ 265
Query: 313 NPNYTEFKFPQIKPHPWH----KVFQKRLPPEAV-------------------------- 342
            P   +F F ++    W+    K  ++   P                             
Sbjct: 266 APKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 324
Query: 343 -------DLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                  DL+ R   Y P  R     A  H FF +  D  T
Sbjct: 325 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 120/232 (51%), Gaps = 21/232 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 168
Query: 195 ALAYIHN-CIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           AL ++    + I H D+KP+N+L+ NP    +K+ DFGS+  L  G+     I SR+YR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 226
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 120/232 (51%), Gaps = 21/232 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 168
Query: 195 ALAYIHN-CIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           AL ++    + I H D+KP+N+L+ NP    +K+ DFGS+  L  G+     I SR+YR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 226
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQR---M 180
           RE+ +++ L HPN+++L+  F S  D+               + +  R  S+ +++   +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA-SKANKKPVQL 125
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL-- 235
           P   VK   YQI   + Y+H    + HRD+KP N+LV    P   ++K+ D G A++   
Sbjct: 126 PRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 236 -VKGEPNVS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-------- 285
            +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F        
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244
Query: 286 -PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK---------FPQIKPHPWHKV 332
                  DQL  I  V+G P     E+IK M  + T  K            IK    HKV
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304
Query: 333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
              +   +A  L+ +     P  R T+ +A   P+F  L DP
Sbjct: 305 ---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 148/320 (46%), Gaps = 51/320 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+I GA  
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGA-R 275
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +     F
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASKRAKNF 332
Query: 322 PQIKPHPWH------------------KVFQKRLPPEA---------------VDLVCRF 348
              K +P +                  +  + R PPE+               +D + + 
Sbjct: 333 VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 349 FQYSPNLRCTALEACVHPFF 368
            ++ P +R T  +A  HP+ 
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 148/320 (46%), Gaps = 51/320 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+I GA  
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGA-R 275
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +     F
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASKRAKNF 332
Query: 322 PQIKPHPWH------------------KVFQKRLPPEA---------------VDLVCRF 348
              K +P +                  +  + R PPE+               +D + + 
Sbjct: 333 VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 349 FQYSPNLRCTALEACVHPFF 368
            ++ P +R T  +A  HP+ 
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 112 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 163
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 164 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 223 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 266
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 267 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 111 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 162
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 163 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 222 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 265
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 266 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 145/320 (45%), Gaps = 51/320 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G G FG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H D+KP+N+L+       +K+ DFGS+    + +     I SR+YRAPE+I GA  
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGA-R 275
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P +   K ++ +     F
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ---KLLDASKRAKNF 332
Query: 322 PQIKPHPWH------------------KVFQKRLPPEA---------------VDLVCRF 348
              K +P +                  +  + R PPE+               +D + + 
Sbjct: 333 VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 349 FQYSPNLRCTALEACVHPFF 368
            ++ P +R T  +A  HP+ 
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 94  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGI 145
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 146 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 205 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 248
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 249 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 124/293 (42%), Gaps = 45/293 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I  L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IXKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            YT F+ PQ     W KV        A DL+ +   Y P+ R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 132
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 133 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 181
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 236
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 290
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 291 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 337
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 338 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 388
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 132
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 133 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 181
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 236
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 290
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 291 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 337
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 338 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 388
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 52/298 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIV 138
           ++I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQICR 194
            L+  + STT                        + RI +R   +Y +    L   Q+  
Sbjct: 70  TLEDIYESTTHYYLVMQLVSG----------GELFDRILERG--VYTEKDASLVIQQVLS 117
Query: 195 ALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSR-YYR 251
           A+ Y+H   GI HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
               Y EF+ P          F   +   A D +C   +  PN R T  +A  HP+ D
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 137/307 (44%), Gaps = 52/307 (16%)
Query: 76  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIM 129
           G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 130 QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIYV 185
           + LDHPNI+ L   F   TD                V   R+ R  + +RI +       
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------- 113
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
                 +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   +
Sbjct: 114 -----DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  GT
Sbjct: 168 KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT 223
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          F FP+     W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 224 ---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 364 VHPFFDE 370
            H +F++
Sbjct: 261 EHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 52/308 (16%)
Query: 75  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQI 128
            G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++I
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEI 76
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIY 184
           M+ LDHPNI+ L   F   TD                V   R+ R  + +RI +      
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------ 130
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
                  +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   
Sbjct: 131 ------DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           + + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  G
Sbjct: 184 TKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--G 239
Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
           T               F FP+     W  V      P+A  L+ R    SP  R T+L+A
Sbjct: 240 T---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 276
Query: 363 CVHPFFDE 370
             H +F++
Sbjct: 277 LEHEWFEK 284

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 49/308 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++                 +  I R     H    +I       Q+   + Y+H 
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK------QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+   ++  ++  P
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 380 NGRPLPPL 387
               LP L
Sbjct: 289 TISDLPSL 296

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 222
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 223 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 275
Query: 367 FFDE 370
           +  +
Sbjct: 276 WLQD 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 367 FFDE 370
           +  +
Sbjct: 277 WLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 229
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 230 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 282
Query: 367 FFDE 370
           +  +
Sbjct: 283 WLQD 286

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 367 FFDE 370
           +  +
Sbjct: 277 WLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQV-SLKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 367 FFDE 370
           +  +
Sbjct: 277 WLQD 280

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSASKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 103
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            CF                      N     Y R          + YT +I  AL Y+H 
Sbjct: 104 FCF--------QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 156 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 214 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 254
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 255 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 301
Query: 371 LRDPN 375
           +   N
Sbjct: 302 VTWEN 306

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 371 LRDPN 375
           +   N
Sbjct: 298 VTWEN 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 148 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 246
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 247 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 293
Query: 371 LRDPN 375
           +   N
Sbjct: 294 VTWEN 298

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 368
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 369 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 415
Query: 367 FFDE 370
           +  +
Sbjct: 416 WLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 248
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 249 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 355 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 367 FFDE 370
           +  +
Sbjct: 402 WLQD 405

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSAXKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVV + + R +G I+A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI + +    +   +  + R LAY+     
Sbjct: 84  YSDGE----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREKHQ 135
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE + G T Y+ 
Sbjct: 136 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERLQG-THYSV 192
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + EL +G+
Sbjct: 193 QSDIWSMGLSLVELAVGR 210

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 371 LRDPN 375
           +   N
Sbjct: 297 VTWEN 301

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 371 LRDPN 375
           +   N
Sbjct: 298 VTWEN 302

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 148 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 246
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 247 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 293
Query: 371 LRDPN 375
           +   N
Sbjct: 294 VTWEN 298

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 46/323 (14%)
Query: 89  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 205
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 206 CHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
            H D+KP+N+L                     +NP    +K+ DFGSA      E + + 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTL 194
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-- 302
           + +R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG  
Sbjct: 195 VSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 303 -------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
                  T  R+       ++ E      +     KP     + Q        DL+ +  
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y P  R T  EA  HPFFD L+
Sbjct: 314 EYDPAKRITLREALKHPFFDLLK 336

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 73
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 74  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 127 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 185 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 225
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 226 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
Query: 371 LRDPN 375
           +   N
Sbjct: 273 VTWEN 277

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 72
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 73  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 125
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 126 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 184 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 224
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 225 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 271
Query: 371 LRDPN 375
           +   N
Sbjct: 272 VTWEN 276

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 60/301 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 75
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 76  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 128
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 129 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 187 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 227
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 228 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 274
Query: 371 L 371
           +
Sbjct: 275 V 275

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 80  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 133 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 191 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 231
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 232 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 278
Query: 371 LRDPN 375
           +   N
Sbjct: 279 VTWEN 283

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 84
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQICRALAYIH 200
             +  +              +++ + R+     +  PL      +  YT QI   L Y+H
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELI-FG 258
           +   I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G
Sbjct: 140 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y  A DIWS GC + E+  G+P F                        +   P    
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 235
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           FK    K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 236 FKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 60/301 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 75  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 128 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 186 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 226
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 227 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 273
Query: 371 L 371
           +
Sbjct: 274 V 274

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 70
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQICRALAYIH 200
             +  +              +++ + R+     +  PL      +  YT QI   L Y+H
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELI-FG 258
           +   I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G
Sbjct: 126 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y  A DIWS GC + E+  G+P F                        +   P    
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 221
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           FK    K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 222 FKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 138
           +I +  +G+G+FG V   + R +G    IK + +D+          E+++++ LDHPNI+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +   F    D                + RI    +R  + +   YV     Q+  ALAY
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAY 139
Query: 199 IHNCIGICHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
            H+   + H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+
Sbjct: 140 FHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
                + T   DIWS G VM  LL G   F G S    L E+        +++     PN
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPN 243
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           Y      + +P          L P+AVDL+ +     P  R +A +   H +F +
Sbjct: 244 YA----VECRP----------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 133/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF     A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 371 LRDPN 375
           +   N
Sbjct: 295 VTWEN 299

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 134/323 (41%), Gaps = 46/323 (14%)
Query: 89  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 205
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 206 CHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
            H D+KP+N+L                     +NP    +K+ DFGSA      E + + 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTL 194
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-- 302
           +  R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG  
Sbjct: 195 VXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 303 -------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
                  T  R+       ++ E      +     KP     + Q        DL+ +  
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 350 QYSPNLRCTALEACVHPFFDELR 372
           +Y P  R T  EA  HPFFD L+
Sbjct: 314 EYDPAKRITLREALKHPFFDLLK 336

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 42  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 101 --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 258
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 154 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 316
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 212 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 252
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 370
            E+ FP                P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 253 -EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 299
Query: 371 LRDPN 375
           +   N
Sbjct: 300 VTWEN 304

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVVF+   + +G ++A       IK  ++++    RELQ++   + P IV    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F+S  +               +++++ +   RI +++    +   +  + + L Y+   
Sbjct: 134 AFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 185
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 186 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 242
Query: 263 TTAIDIWSTGCVMAELLLGQ 282
           +   DIWS G  + E+ +G+
Sbjct: 243 SVQSDIWSMGLSLVEMAVGR 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ-PLFPGESGVDQ 293
             DIWS G  + E+ +G+ P+ P ++  D 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 16/214 (7%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 93  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 144
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 145 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 201
Query: 265 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             DIWS G  + E+ +G+      SG   + E++
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 101 YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 152
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 153 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 209
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 48/284 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
            +G GSFG V   +  +T ++ A+K     K ++    +N  +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
           + F    D                V+ +     R H +  + +    VKL+  ++  AL 
Sbjct: 82  YSFQDEED------------MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           Y+ N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+  
Sbjct: 130 YLQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 258 G--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TRE 307
                 Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQE 246
Query: 308 EI----KCMNPN----YTEFK----FPQIKPHPWHKVFQKRLPP 339
            +    K + PN    +++      FP +    W  VFQKRL P
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 187
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 81
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 202
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 203 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 142 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 199
Query: 261 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 255
Query: 320 KFPQIKPHPWH 330
           KF  + P P H
Sbjct: 256 KFSSVLPTPNH 266

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 80
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 202
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 203 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 141 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 198
Query: 261 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 320 KFPQIKPHPWH 330
           KF  + P P H
Sbjct: 255 KFSSVLPTPNH 265

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ + +  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F  +T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDST----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  D    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFST 147
           +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V     +F  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
           TD                +    RN +     +  I          + L Y+H    I H
Sbjct: 97  TDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATIL-----QSTLKGLEYLHFMRKI-H 148
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYTTAI 266
           RDIK  N+L+N   H  KL DFG A  L       +  I + ++ APE+I     Y    
Sbjct: 149 RDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEIGYNCVA 206
Query: 267 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 326
           DIWS G    E+  G+P +        +  +  +   PT       NP  T F+    KP
Sbjct: 207 DIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT-------NPPPT-FR----KP 248
Query: 327 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             W   F         D V +    SP  R TA +   HPF
Sbjct: 249 ELWSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 45/287 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 142
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 72  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 203 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 124 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K                  +F 
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILK-------------RVEKGKFS 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 224 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 118 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 170
Query: 206 CHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYT 263
            H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    Y 
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 231 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 276
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 381
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 277 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 323
Query: 382 R-----------------PLPPL 387
           R                 PLPPL
Sbjct: 324 RYTKIRDSIKTKYDAWPEPLPPL 346

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 137/310 (44%), Gaps = 51/310 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G+G++G V   + + T    AIK + +     +       E+ ++++LDHPNI+ L + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL-YD 103
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHN 201
           FF   DK                + I      IH RM    +   +   Q+   + Y+H 
Sbjct: 104 FFE--DKRNYYLVMECYKGGELFDEI------IH-RMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 202 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
              I HRD+KP+NLL+        +K+ DFG + V    +     + + YY APE++   
Sbjct: 155 H-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--R 211
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            +Y    D+WS G ++  LL G P F G++  DQ  EI++          K     YT F
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----------KVEKGKYT-F 256
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
             P+     W     K +   A DL+ +  Q+    R +A +A  HP+  E+    ++  
Sbjct: 257 DSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM---CSKKE 303
Query: 380 NGRPLPPLFN 389
           +G  LP L N
Sbjct: 304 SGIELPSLAN 313

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 224 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 276
Query: 206 CHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYT 263
            H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    Y 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 337 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 382
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 381
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 383 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
Query: 382 R-----------------PLPPL 387
           R                 PLPPL
Sbjct: 430 RYTKIRDSIKTKYDAWPEPLPPL 452

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 209
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 93  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 144
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 145 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 200
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 243
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 244 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 92  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 142 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 200 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 230
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 75  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 126
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 127 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 182
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 225
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 226 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 45/287 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 142
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 89  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 203 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 141 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 197
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K +                +F 
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV-------------EKGKFS 240
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 241 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 77  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 128
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
           I HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T Y+ 
Sbjct: 129 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYSV 185
Query: 265 AIDIWSTGCVMAELLLGQ 282
             DIWS G  + E+ +G+
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 129/305 (42%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 131
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 182
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y+ APE
Sbjct: 183 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 240
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 241 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 284
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 285 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333
Query: 375 NTRLP 379
            + +P
Sbjct: 334 ASIVP 338

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 48/308 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 81
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 132
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 133 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 190
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 191 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 234
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 235 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 283
Query: 375 NTRLPNGR 382
            + +P  R
Sbjct: 284 ASIVPLMR 291

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 184
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 88
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 139
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 140 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 197
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 198 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 241
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 242 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 290
Query: 375 NTRLP 379
            + +P
Sbjct: 291 ASIVP 295

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 48/308 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 86
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 137
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 138 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 195
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 196 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 239
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 240 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 288
Query: 375 NTRLPNGR 382
            + +P  R
Sbjct: 289 ASIVPLMR 296

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 48/308 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 77
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 128
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 129 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 186
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 187 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 230
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 231 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
Query: 375 NTRLPNGR 382
            + +P  R
Sbjct: 280 ASIVPLMR 287

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 119/286 (41%), Gaps = 42/286 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    KK L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y+ A+D WS G +   LL G P F  E+      +I+K                  E++F
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-----------------AEYEF 237
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               P+ W  +        A D +    +  P  R T  +A  HP+
Sbjct: 238 DS--PY-WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 129/305 (42%), Gaps = 48/305 (15%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 208
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 259
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y+ APE
Sbjct: 260 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 317
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 318 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 361
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 362 NLP----PRLK--NLHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410
Query: 375 NTRLP 379
            + +P
Sbjct: 411 ASIVP 415

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+                         A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 122 CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 171
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 261 E--YTTAIDIWSTGCVMAELLLGQP 283
           E  Y   +D+WS G    EL   +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 184
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 209
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 130/314 (41%), Gaps = 51/314 (16%)
Query: 70  TIGGRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIK----KVL 116
           ++   NG S       AE +         +GTG+F  V  A+ + TG++ A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 117 QDKRYK-NRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSR 175
           + K      E+ +++ + H NIVAL+  + S                   +  + + +  
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYT 118
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL--CDFGSAK 233
                 LI       Q+  A+ Y+H  +GI HRD+KP+NLL      + K+   DFG +K
Sbjct: 119 EKDASTLIR------QVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 293
           +  KG+   +   +  Y APE +     Y+ A+D WS G +   LL G P F  E+    
Sbjct: 172 MEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
             +I+K                  E++F    P+ W  +        A D +    +  P
Sbjct: 231 FEQILK-----------------AEYEFDS--PY-WDDI-----SDSAKDFIRNLMEKDP 265
Query: 354 NLRCTALEACVHPF 367
           N R T  +A  HP+
Sbjct: 266 NKRYTCEQAARHPW 279

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 185
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
               F    +                ++R+ +++ +  + +P   V  Y  Q+C AL ++
Sbjct: 97  YYASFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFG 258
           H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I  
Sbjct: 153 HS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 209
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              Y    DIWS GC++ E+   Q  F G+
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 183
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 137/339 (40%), Gaps = 76/339 (22%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
           Y  +  +G GS+GVV  A   +T  I AIK + ++K          R K  E+++M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 134 HPNIVALKHCFFS--------------------------TTDKXXXXXXXXXXXXXXTVN 167
           HPNI  L   +                            +T K                N
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 168 RIARNYSRIHQRMPLIYV---KLYT---YQICRALAYIHNCIGICHRDIKPQNLLVNPH- 220
             A N S    R  L +V   KL +    QI  AL Y+HN  GICHRDIKP+N L + + 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNK 205
Query: 221 THQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELIFGATE-YTTAIDIWSTGCV 274
           + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D WS G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 275 MAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ 334
           +  LL+G   FPG +  D + +++        +++   NPNY                  
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN----------------- 301
Query: 335 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
             L P A DL+      + + R  A+ A  HP+  +  D
Sbjct: 302 -VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 73  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 124
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 125 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 180
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 223
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 224 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 260
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 266
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 267 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 62/292 (21%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNVSYICSRYYRAPEL 255
             + HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  PE+
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLPPEM 178
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           I G   +   +D+WS G +  E L+G+P F   +  +    I +V               
Sbjct: 179 IEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------- 222
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
             EF FP              +   A DL+ R  +++P+ R    E   HP+
Sbjct: 223 --EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+                         A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 83  CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 261 E--YTTAIDIWSTGCVMAELLLGQP 283
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 234
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + +     R  QR P    K Y  ++C AL Y+H+
Sbjct: 73  GTF---QDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSR-YYRAPELIFGA 259
              I +RD+KP+N+L++ + H +K+ DFG AK +    P+V+Y +C    Y APE++   
Sbjct: 125 K-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV-ST 177
Query: 260 TEYTTAIDIWSTGCVMAELLLG 281
             Y  +ID WS G ++ E+L G
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAG 199

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 185
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 30/261 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKR-YKNRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNYT- 317
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 318 ---------EFKFPQIKPHPW 329
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 75  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQ 130
           +G+++  +S  +  E  +G G+  +V++ K + T +  A+K  K   DK+    E+ ++ 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNI+ LK  F + T+                 +RI        +R     VK    
Sbjct: 104 RLSHPNIIKLKEIFETPTE---ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK---- 155
Query: 191 QICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSR 248
           QI  A+AY+H   GI HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C  
Sbjct: 156 QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCGT 213
Query: 249 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
             Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          R 
Sbjct: 214 PGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FRR 262
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            + C      E+ F      PW       +   A DLV +     P  R T  +A  HP+
Sbjct: 263 ILNC------EYYFIS----PW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 95  FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 145
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 146 SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 200
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  +  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SKG 235
Query: 262 YTTAIDIWSTGCVMAELLLGQPLF 285
           Y  A+D W+ G ++ E+  G P F
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/335 (24%), Positives = 138/335 (41%), Gaps = 48/335 (14%)
Query: 89  VVGTGSFGVVFQ-AKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDH--PNIVALKH 142
            +G G+FG V Q    R  G  VA+K +   ++YK     E+ +++ ++   P+   L  
Sbjct: 40  TLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCV 99
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D               T + +  N    +   P+  V+   +Q+C+A+ ++H+ 
Sbjct: 100 QMFDWFDYHGHMCISFELLGLSTFDFLKDNN---YLPYPIHQVRHMAFQLCQAVKFLHDN 156
Query: 203 IGICHRDIKPQNLLVNPHTHQL------------------KLCDFGSAKVLVKGEPNVSY 244
             + H D+KP+N+L     ++L                  ++ DFGSA      E + + 
Sbjct: 157 -KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHEHHSTI 213
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-T 303
           + +R+YRAPE+I     ++   D+WS GC++ E  +G  LF      + L  + ++LG  
Sbjct: 214 VSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 272
Query: 304 PTREEIKCMNPNY--------------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
           P+R   K     Y                +     KP   +   +     +  DL+    
Sbjct: 273 PSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESML 332
Query: 350 QYSPNLRCTALEACVHPFFDELRD--PNTRLPNGR 382
           +Y P  R T  EA  HPFF  LR   PN    + R
Sbjct: 333 EYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 30/261 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 316
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 317 --------TEFKFPQIKPHPW 329
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 30/261 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKR-YKNRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
           GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 316
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 317 --------TEFKFPQIKPHPW 329
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKG 214
Query: 262 YTTAIDIWSTGCVMAELLLGQPLF 285
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKG 214
Query: 262 YTTAIDIWSTGCVMAELLLGQPLF 285
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 260
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 130 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 189 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 222
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  +     ++G + A+K +      ++D+     E  I+  ++HP +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++   L 
Sbjct: 95  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 256
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 145 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 304
                ++ + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 203 -NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 39/284 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQ----IMQMLDHPNIVALKHC 143
           +G G++G V +   + +G+I+A+K++    D++ + + L     +M+  D P IV     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   D               + ++  +  YS +   +P   +   T    +AL ++   
Sbjct: 90  LFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 261
           + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +   
Sbjct: 145 LKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 262 --YTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTP---TREEIKCMNPN 315
             Y    D+WS G  + EL  G+  +P  + V DQL +++K  G P   +  E +  +P+
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSNSEEREFSPS 261
Query: 316 YTEF-------------KFPQIKPHPWHKVFQKRLPPEAVDLVC 346
           +  F             K+ ++  HP+  ++++R    AV++ C
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYEER----AVEVAC 301

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R ++  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FAEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 73  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 123
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE   +
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRT 169
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 144
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 145 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 199
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 151
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM-H 188
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ ++  G P F
Sbjct: 214 GYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 73  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 123
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE    
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRD 169
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 59/301 (19%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-RYKN------------- 123
           SY     +G+G++G V    C+E        I  IKK   DK RY +             
Sbjct: 37  SYFKVRKLGSGAYGEVLL--CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
            E+ +++ LDHPNI+ L   F    DK                 +I  N  +  +     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF---EDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAAN 150
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPN 241
            +K    QI   + Y+H    I HRDIKP+N+L+      L  K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
              + + YY APE++    +Y    D+WS G +M  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
                         Y +F       + W     K +  EA +L+     Y  N RCTA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 362 A 362
           A
Sbjct: 299 A 299

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 234
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 102
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 103 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 153
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 154 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 208
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 209 GYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +                          + +   +  L     Y  +I   L ++H+ 
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATE 261
            GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +
Sbjct: 138 -GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QK 194
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP Y  +  
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFYPRW-- 240
Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDEL 371
                          L  EA DL+ + F   P  R     +   HP F E+
Sbjct: 241 ---------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 40/299 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF- 117
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              DK                +RIA    ++ +   + Y++    Q C  L ++H    I
Sbjct: 118 --EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHEH-SI 170
Query: 206 CHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
            H DIKP+N++        +K+ DFG A  L   E       +  + APE++        
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGF 229
Query: 265 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 324
             D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  F  +
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAFSSV 277
Query: 325 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD-ELRDPNTRLPNGR 382
            P             EA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R
Sbjct: 278 SP-------------EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLHS 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 41/260 (15%)
Query: 60  GAETGHVIRTTIGGRNGNSK-QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
           G +TG++   TIGG+   ++   +  + E  +G+G+ G V++ + R+TG ++A+K++   
Sbjct: 7   GKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM--- 58
Query: 119 KRYKNRELQ---------IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRI 169
           +R  N+E           +++  D P IV     F + TD                +  +
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD------------VFIAMELM 106
Query: 170 ARNYSRIHQRM----PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225
                ++ +RM    P   +   T  I +AL Y+    G+ HRD+KP N+L++    Q+K
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIK 165
Query: 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG 281
           LCDFG +  LV  +          Y APE I        +Y    D+WS G  + EL  G
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 282 QPLFPGESGVDQLVEIIKVL 301
           Q  FP ++       + KVL
Sbjct: 226 Q--FPYKNCKTDFEVLTKVL 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH 134
           +Y  +  +G G+F  V  A+   TG  VA+K +  DK   N        RE++IM++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 135 PNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PNIV L    F   +                V     +Y   H RM     +    QI  
Sbjct: 74  PNIVKL----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVS 125
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           A+ Y H    I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APE
Sbjct: 126 AVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           L  G       +D+WS G ++  L+ G   F G++
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           YI    +G GSFG V  A   +T + VA+K + +    K+       RE+  +++L HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L     + TD                V +         +RM     + +  QI  A+
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---------KRMTEDEGRRFFQQIICAI 121
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y H    I HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            G       +D+WS G V+  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 222
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 150 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 223 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 209 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 265
Query: 280 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 326
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 266 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 325
Query: 327 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 326 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 222
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 223 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 186 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYY 242
Query: 280 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 326
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 243 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 302
Query: 327 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 303 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 84  YIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPN 136
           Y+A  + +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N
Sbjct: 46  YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V +   +    +                V          H RM    +      + RAL
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIATVCLSVLRAL 154
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPEL 255
           +Y+HN  G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+
Sbjct: 155 SYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV 212
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
           I     Y T +DIWS G ++ E++ G+P +  E
Sbjct: 213 I-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 222
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 223 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 233
Query: 280 LGQPLFPGESGVDQLVEIIKVLGTPTREEIK-------------CMNPNYTEFKFPQIKP 326
            G  LF      + LV + K+LG      I                + N ++ ++ +   
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 327 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           YI    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +I+ L     + +D                + +  R   +  +R+          QI   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQQILSG 128
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           + Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y APE+
Sbjct: 129 VDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNYAAPEV 186
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLG 281
           I G       +DIWS+G ++  LL G
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQML-DHPNIVAL 140
           V+G GSFG V  A+ +ETG++ A+K + +D   ++ +++       I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             C F T D+                 + +R +     R        Y  +I  AL ++H
Sbjct: 90  -FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-------FYAAEIISALMFLH 141
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 259
           +  GI +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I   
Sbjct: 142 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQE 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             Y  A+D W+ G ++ E+L G   F  E+  D L E I
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 193
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRA 252
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 41/288 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           ++G G FG V + +   TG  +A K +    ++DK     E+ +M  LDH N++ L   F
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            S  D                 +RI      + +   ++++K    QIC  + ++H    
Sbjct: 156 ESKND---IVLVMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMHQMY- 207
Query: 205 ICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-FGATEY 262
           I H D+KP+N+L VN    Q+K+ DFG A+     E       +  + APE++ +    +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSF 267
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
            T  D+WS G +   LL G   F G++  + L  I+        EE              
Sbjct: 268 PT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE-------------- 311
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                     FQ  +  EA + + +      + R +A EA  HP+  +
Sbjct: 312 ----------FQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-SK 213
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 193
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRA 252
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +         C    Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMA 189
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLF 285
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +    +                V+++  N  +I               + +ALAY+H   
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---------ATVCEAVLQALAYLH-AQ 160
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEY 262
           G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
            T +DIWS G ++ E++ G+P +  +S V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
           ++K    HKV      P   D + R     P  R TA E   HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 34/285 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 148
           ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H F +  
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 149 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
                                   + +   +  L     Y  +I   L ++H+  GI +R
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVYR 143
Query: 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEYTTAID 267
           D+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +Y  ++D
Sbjct: 144 DLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVD 201
Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
            WS G ++ E+L+GQ  F G+   +                I+  NP Y  +        
Sbjct: 202 WWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFYPRW-------- 241
Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDEL 371
                    L  EA DL+ + F   P  R     +   HP F E+
Sbjct: 242 ---------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 277

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 126
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 127 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 123 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 132
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 133 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 131
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 132 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES 289
              +D+WS G ++  +L  +  F  ES
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE   +   +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTPNY 208
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 141
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 76
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 77  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 130 K-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
               +D+WS G ++  L+ G   F G++
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 116/254 (45%), Gaps = 28/254 (11%)
Query: 62  ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
           E    + T   G+  +S     +    V+G GS+  V   + ++T  I A++ V ++   
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN 91
Query: 122 KNRELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNY 173
            + ++  +Q          +HP +V L  CF + +                 + R     
Sbjct: 92  DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----- 146
Query: 174 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
               +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K
Sbjct: 147 ---QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCK 201
Query: 234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF------- 285
             ++ G+   ++  +  Y APE++ G  +Y  ++D W+ G +M E++ G+  F       
Sbjct: 202 EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
Query: 286 -PGESGVDQLVEII 298
            P ++  D L ++I
Sbjct: 261 NPDQNTEDYLFQVI 274

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 112/251 (44%), Gaps = 28/251 (11%)
Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
             + T   G+  +S     +    V+G GS+  V   + ++T  I A+K V ++    + 
Sbjct: 3   EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE 62
Query: 125 ELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI 176
           ++  +Q          +HP +V L  CF + +                 + R        
Sbjct: 63  DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-------- 114
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 236
            +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K  +
Sbjct: 115 QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGL 172
Query: 237 KGEPNVSYICSR-YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF--------PG 287
           +     S  C    Y APE++ G  +Y  ++D W+ G +M E++ G+  F        P 
Sbjct: 173 RPGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231
Query: 288 ESGVDQLVEII 298
           ++  D L ++I
Sbjct: 232 QNTEDYLFQVI 242

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G     +  S  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 127
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 259
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 128 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 298
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 186 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 88  VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 135 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 192
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 193 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 229
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y      +IK + +     + + P A  L+ R     P LR +  E     FF  
Sbjct: 230 CLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 283 GYAP-MRLPTSCLTVPPRFS 301

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 123
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 259
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 124 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 298
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 182 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTPNY 208
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 250
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTPNY 208
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 371 LRDPNTRLPNG-RPLPPLFN 389
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQAHAERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  A+  +  E+    KVLQ K    K  E  IM       + + HP +V 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAY 198
           L H  F T DK               +N     Y    +R  L    + Y  +I  AL Y
Sbjct: 104 L-HFSFQTADKLYFVLDY--------INGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIF 257
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE + 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLF 285
               Y   +D W  G V+ E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKN--RELQIMQMLDHPNIV 138
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+        K               +NR+        +R+P   +  +  QI R + Y
Sbjct: 70  ALRGVCL----KEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNY 120
Query: 199 IHN--CIGICHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
           +H+   + I HRD+K  N+L+       +     LK+ DFG A+   +    +S   +  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYA 179
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
           + APE+I  A+ ++   D+WS G ++ ELL G+  F G  G+
Sbjct: 180 WMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 247 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 360 LEACVHPFF 368
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           Y+    +G G FG+V   +C ET        + V +K    D+    +E+ I+ +  H N
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRN 62
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F S  +                  RI  +   +++R  + YV    +Q+C AL
Sbjct: 63  ILHLHESFESMEE---LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 197 AYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
            ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +      +TA D+WS G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           YT   F +       + F K +  EA+D V R        R TA EA  HP+  +
Sbjct: 220 YT---FDE-------EAF-KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 247 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 360 LEACVHPFF 368
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 22  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 134 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 188
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 189 APESL-TESKFSVASDVWSFGVVLYELF 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 141
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 80  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G   
Sbjct: 133 K-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
               +D+WS G ++  L+ G   F G++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 23  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 135 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 189
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 190 APESL-TESKFSVASDVWSFGVVLYELF 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 25  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 137 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 191
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 192 APESL-TESKFSVASDVWSFGVVLYELF 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 24  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 136 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 190
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 191 APESL-TESKFSVASDVWSFGVVLYELF 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 49  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 161 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 215
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 216 APESL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWY 184
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 16  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 127
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 128 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 182
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 183 APESL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 17  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 128
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 129 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 183
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 184 APESL-TESKFSVASDVWSFGVVLYELF 210

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  A  + T E+ AIK + +D   ++ +++       ++ +LD P  +   
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  +        Y  +I   L ++
Sbjct: 86  HSCFQTVDRLYFVMEY--------VNGGDLMY-HIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 258
           H   GI +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I  
Sbjct: 137 HKR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-A 193
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGS------LREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 141
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
              F   +                V     +Y   H  M     +    QI  A+ Y H 
Sbjct: 72  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 125 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGES 289
               +D+WS G ++  L+ G   F G++
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 77  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 128
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 129 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 186
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 229
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 230 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 76  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 127
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 128 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 228
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 75  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 127 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 184
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 227
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 228 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 40/285 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + + T E+VA+K + +         RE+   + L HPNIV  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H+ + IC
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGR-FSEDEAR-------FFFQQLLSGVSYCHS-MQIC 138
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGK 197
Query: 266 I-DIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           I D+WS G  +  +L+G  P    E   D    I ++L                ++  P 
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSIPD 243
Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                       R+ PE   L+ R F   P  R +  E   H +F
Sbjct: 244 ----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 218 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 269
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 270 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 327
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 370
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 371 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 215 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 266
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 267 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 324
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 367
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 368 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  IVA+K + + +  K        RE++I   L HPNI+ L +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F+   D+                  + ++ +   QR   I  +L       AL Y H  
Sbjct: 91  YFY---DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-----ADALMYCHGK 142
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 143 -KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRM-H 198
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-----LGTPTREE---IKCMNP 314
              +D+W  G +  ELL+G P F   S  +    I+KV        PT  +    K +  
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRH 258
Query: 315 NYTE-FKFPQIKPHPWHKVFQKR-LPPEAVDLVC 346
           N +E     Q+  HPW +   +R LPP A+  V 
Sbjct: 259 NPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF   +    +TG++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICR 194
           +V L + F + T                 +N     ++ + QR       V++Y  +I  
Sbjct: 121 LVTLHYAFQTET---------KLHLILDYING-GELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 252
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 253 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297
           P+++ G  + +  A+D WS G +M ELL G   F  +   +   EI
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 16/222 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V  +  F    +                  RI      + Q   ++    +  QIC AL 
Sbjct: 86  VQYRESF---EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLALK 139
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI 256
           ++H+   I HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE I
Sbjct: 140 HVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPE-I 196
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                Y    DIW+ GCV+ EL   +  F   S  + +++II
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 125/317 (39%), Gaps = 60/317 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 377 RLP-NGRPLPPLFNFKP 392
           RLP     +PP F+  P
Sbjct: 279 RLPITCLTIPPXFSIAP 295

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 118/296 (39%), Gaps = 48/296 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G+F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 200 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
           H+   I HRD+KP+N+L+    ++  +KL DFG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I A+K++      Q+++    +L I  + +D P  V     
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 260
            + HRD+KP N+L+N    Q+K CDFG +  LV           + Y APE I       
Sbjct: 157 SVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQK 215
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y+   DIWS G    EL + +  FP +S            GTP ++             
Sbjct: 216 GYSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ------------- 249
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 250 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 136
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 196
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 197 ADVWSCGVTLYVMLVG 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 125/317 (39%), Gaps = 60/317 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 377 RLP-NGRPLPPLFNFKP 392
           RLP     +PP F+  P
Sbjct: 279 RLPITCLTIPPRFSIAP 295

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLD-HPNIVALKHC 143
           V+  G F  V++A+   +G   A+K++L ++  KNR    E+  M+ L  HPNIV     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL---IYVKLYTYQICRALAYIH 200
                ++                 ++     ++  R PL     +K++ YQ CRA+ ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAVQHMH 153
Query: 201 NCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----------- 248
                I HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R           
Sbjct: 154 RQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEEITRN 211
Query: 249 ---YYRAPELIFGATEYTTA--IDIWSTGCVMAELLLGQPLF 285
               YR PE+I   + +      DIW+ GC++  L   Q  F
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 125/317 (39%), Gaps = 60/317 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 88  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 136 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 192
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 193 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 230
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 231 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 282
Query: 377 RLP-NGRPLPPLFNFKP 392
           RLP     +PP F+  P
Sbjct: 283 RLPITCLTIPPRFSIAP 299

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 121/289 (41%), Gaps = 46/289 (15%)
Query: 90  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     A      +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 140
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           G+ HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 198
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 241
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+ 
Sbjct: 242 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 19  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 251
           +     I HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 131 LGTKRYI-HRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWY 185
Query: 252 APELIFGATEYTTAIDIWSTGCVMAELL 279
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 186 APESL-TESKFSVASDVWSFGVVLYELF 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 141
           ++G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    +                +NR  +N  +          + + +QI   + Y+H+
Sbjct: 78  NYF----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLHS 130
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT 260
             GI HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   +
Sbjct: 131 H-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRS 187
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            +    D+WS GC+   LL+G+P F  ++  + L +++                   +++
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LADYE 230
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
            P              L  EA DL+ +  + +P  R +      HPF    R+ +T+
Sbjct: 231 MPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS--RNSSTK 273

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 23/228 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F +  D                VN ++ NY      +P  + K YT ++  A
Sbjct: 136 WVVQL---FCAFQDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVLA 186
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS-AKVLVKGEPNV-SYICSRYYRAP 253
           L  IH+ +G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + +  Y +P
Sbjct: 187 LDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISP 244
Query: 254 ELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           E++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 253 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 130 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 180
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 181 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 237
Query: 253 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 253 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 240 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
              S   +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 355 LRCTALEACVHPFFDE 370
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 130 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 173
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 174 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 233 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 285
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 286 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 330
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 331 IMQSTKVPQTPLHTSRVL 348

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 167
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 279
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 280 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 324
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 325 IMQSTKVPQTPLHTSRVL 342

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 79  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 122
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 123 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 182 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 234
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 235 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 279
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 280 IMQSTKVPQTPLHTSRVL 297

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 86  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 129
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 130 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 189 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 241
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 242 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 286
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 287 IMQSTKVPQTPLHTSRVL 304

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 94  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 137
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 138 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 196
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 197 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 249
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 250 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 294
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 295 IMQSTKVPQTPLHTSRVL 312

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 121/307 (39%), Gaps = 56/307 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 83  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 134
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 135 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 190
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
              +D+W  G +  E L+G P F   S  +    I+ V                 + KFP
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DLKFP 233
Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 382
                         L   + DL+ +  +Y P  R        HP+       N+R    R
Sbjct: 234 PF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR----R 273
Query: 383 PLPPLFN 389
            LPP++ 
Sbjct: 274 VLPPVYQ 280

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 84  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 127
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 128 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 186
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 187 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 239
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 240 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 284
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 285 IMQSTKVPQTPLHTSRVL 302

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF--- 144
            ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH NIV    C+   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 145 ---------FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
                     S+  K              T+ +      R  +   ++ ++L+  QI + 
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFE-QITKG 134
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE 
Sbjct: 135 VDYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQ 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I  + +Y   +D+++ G ++AELL
Sbjct: 193 I-SSQDYGKEVDLYALGLILAELL 215

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 140/313 (44%), Gaps = 60/313 (19%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+ +     
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 247 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 356 RCTALEACVHPFF 368
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 85  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 128
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 129 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 188 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 240
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 241 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 285
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 286 IMQSTKVPQTPLHTSRVL 303

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 124/317 (39%), Gaps = 60/317 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 106 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 154 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 210
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 211 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 248
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 249 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 300
Query: 377 RLP-NGRPLPPLFNFKP 392
           RLP     +PP F+  P
Sbjct: 301 RLPITCLTIPPRFSIAP 317

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 124/317 (39%), Gaps = 60/317 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 108 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 156 YLHRN-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 212
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 250
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 251 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 302
Query: 377 RLP-NGRPLPPLFNFKP 392
           RLP     +PP F+  P
Sbjct: 303 RLPITCLTIPPRFSIAP 319

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 68
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 69  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 219
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 220 KEKKTYLNPWKKI 232

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 29/267 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 82  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 133
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 262
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 134 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 189
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPN 315
              +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249
Query: 316 YTEFKFP--QIKPHPWHKVFQKR-LPP 339
           +   + P   +  HPW K   +R LPP
Sbjct: 250 HPPQRLPLKGVMEHPWVKANSRRVLPP 276

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 124/317 (39%), Gaps = 60/317 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 82  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 256
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 130 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 186
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 224
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 225 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 276
Query: 377 RLP-NGRPLPPLFNFKP 392
           RLP     +PP F+  P
Sbjct: 277 RLPITCLTIPPRFSIAP 293

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 142
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 203 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
            G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 257 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
                Y    DIWS G ++  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
               KF  +    W+ V +      A DLV +     P+ R TA +   HP+  +
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++I ++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H R      +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVXEYASGGEV----FDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
               I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGES 289
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK             +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 14  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 199
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 72  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 200 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 176
Query: 258 GATEYTTAIDIWSTGCVMAELL 279
             + Y+   D++S G ++ E++
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVI 198

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF--F 145
            ++G+G FG VF+AK R  G+   I++V  +     RE++ +  LDH NIV    C+  F
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 77
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSR-----------------IHQRM-----PLI 183
               +                   +R+ ++                 I +R       ++
Sbjct: 78  DYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 137
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
            ++L+  QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 138 ALELFE-QITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
              +  Y +PE I  + +Y   +D+++ G ++AELL
Sbjct: 195 SKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 199
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 71  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 200 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 175
Query: 258 GATEYTTAIDIWSTGCVMAELL 279
             + Y+   D++S G ++ E++
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVI 197

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 142
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 203 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
            G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 257 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
                Y    DIWS G ++  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               KF  +    W+ V +      A DLV +     P+ R TA +   HP+
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 129
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 259
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 260 TEYTTAIDIWSTGCVMAELLLGQP 283
           T Y    DIWS G  + E+   +P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 137
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 259
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 260 TEYTTAIDIWSTGCVMAELLLGQP 283
           T Y    DIWS G  + E+   +P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP 220

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 139/313 (44%), Gaps = 60/313 (19%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 199 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 246
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 247 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 356 RCTALEACVHPFF 368
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 261
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 262 --YTTAIDIWSTGCVMAELLLGQP 283
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 261
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 262 --YTTAIDIWSTGCVMAELLLGQP 283
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 101/243 (41%), Gaps = 58/243 (23%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----------V 234
           V+ Y   + +AL  IH   GI HRD+KP N L N    +  L DFG A+           
Sbjct: 119 VREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 235 LVKGEP-------NVSYIC-SRY-----------YRAPELIFGATEYTTAIDIWSTGCVM 275
            V+ E        N   IC SR            +RAPE++      TTAID+WS G + 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 276 AELLLGQ-PLFPGESGVDQLVEIIKVLGT--------------------PTR------EE 308
             LL G+ P +     +  L +I+ + G+                    P +      E 
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER 297
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           ++ M+ +  +     I+ H  +      +P EA DL+ +    +P  R TA EA +HPFF
Sbjct: 298 LRGMDSSTPKLT-SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356
Query: 369 DEL 371
            ++
Sbjct: 357 KDM 359

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 108
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 109 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 165
Query: 240 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 226 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 260
Query: 355 LRCTALEACVHPFFDE 370
            R TA EA  HPFF +
Sbjct: 261 KRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 240 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 355 LRCTALEACVHPFFDE 370
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 77  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 128
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 129 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 228
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVAL 140
           I   V+G G FG   +   RETGE++ +K+++    + +R   +E+++M+ L+HPN++  
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK- 71
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              F     K              T+  I ++   +  + P      +   I   +AY+H
Sbjct: 72  ---FIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPN-------------VSYI 245
           + + I HRD+   N LV  + + + + DFG A+++V  K +P               + +
Sbjct: 126 S-MNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
            + Y+ APE+I G + Y   +D++S G V+ E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I  ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 180
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 220 DWKEKKTYLNPWKKI 234

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 254 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 305 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 361
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 421
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 422 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 300
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 301 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 339
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G+ G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 259
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 320 KFPQIKPHPWHKV 332
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 75  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 127 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 183
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 226
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 227 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 260
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 368
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 46/290 (15%)
Query: 90  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     A       I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 129
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           G+ HR++KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 187
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 230
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+  
Sbjct: 231 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N+L++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 57/306 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYKNRELQIM-Q 130
           Y  + V+G G   VV +   R TG   A+K            ++ + +    RE  I+ Q
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLY 188
           +  HP+I+ L   + S++                 + R    +  + +++ L     +  
Sbjct: 156 VAGHPHIITLIDSYESSS----------FMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
              +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE       + 
Sbjct: 206 MRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 249 YYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
            Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I      
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI------ 317
Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                   M   Y +F  P+     W             DL+ R  Q  P  R TA +A 
Sbjct: 318 --------MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQAL 358
Query: 364 VHPFFD 369
            HPFF+
Sbjct: 359 QHPFFE 364

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 261
           I HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 262 --YTTAIDIWSTGCVMAELLLGQP 283
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQI 128
           N ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 188
            + L HPNIV L       +                 +  +AR +         I     
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI----- 134
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYIC 246
             QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 135 -QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           +  Y +PE +     Y+  +DIW+ G ++  LL+G P F  E   DQ             
Sbjct: 193 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQ---------HRLY 239
Query: 307 EEIKCMNPNYTEFKFPQIKPHP-WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
            +IK    +Y         P P W  V      PEA  L+      +P  R TA +A   
Sbjct: 240 AQIKAGAYDY---------PSPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 366 PFF 368
           P+ 
Sbjct: 286 PWI 288

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 257
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 318 EFKFPQIKPHPWHKV 332
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+C FG +K  V        + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 41/292 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 142
           Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    D                +++I R      +    +      + I + + Y+H  
Sbjct: 84  VY---DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH-A 134
Query: 203 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
            G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 191
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y  A DIWS G ++  +L G   F      D   EI+  +G+             
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG------------ 238
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              KF  +    W+ V        A DLV +     P+ R TA     HP+ 
Sbjct: 239 ---KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 124/318 (38%), Gaps = 58/318 (18%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K  LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVXECLDG----------------GELFSRIQDRGDQAFTEREASEIX 167
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            YY APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR- 278
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
               +     EF  P+     W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 279 ----IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPW 324
Query: 368 FDE-LRDPNTRLPNGRPL 384
             +  + P T L   R L
Sbjct: 325 IXQSTKVPQTPLHTSRVL 342

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
              G +      D++S GCV+ E+L G+P F G+S
Sbjct: 190 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y+    +G G F  V   +    G   A+K++L    QD+    RE  + ++ +HPNI+ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 140 L-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIAR-----NYSRIHQRMPLIYVKLYTYQIC 193
           L  +C      K                N I R     N+    Q + L+        IC
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL------GIC 144
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKGEPNVSYI----- 245
           R L  IH   G  HRD+KP N+L+     Q  L D GS   A + V+G      +     
Sbjct: 145 RGLEAIH-AKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 246 --CSRYYRAPELIFGATEYTTA---IDIWSTGCVMAELLLGQ 282
             C+  YRAPEL F    +       D+WS GCV+  ++ G+
Sbjct: 203 QRCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 94
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 148
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 149 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 207 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 118/292 (40%), Gaps = 41/292 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 142
           Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    D                +++I R      +    +      + I + + Y+H  
Sbjct: 84  VY---DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH-A 134
Query: 203 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
            G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFVAPE-V 191
Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y  A DIWS G ++   L G   F      D   EI+  +G+             
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------------ 238
Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              KF  +    W+ V        A DLV +     P+ R TA     HP+ 
Sbjct: 239 ---KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G+FGV    + ++  E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + + 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYAH-AMQVA 137
Query: 207 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
           HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKV 197
Query: 266 IDIWSTGCVMAELLLG 281
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 200
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 201 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 127 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 183
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 184 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 230
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 377
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 231 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282
Query: 378 LPNGRPL 384
           L   R L
Sbjct: 283 LHTARVL 289

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 200
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 201 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 146 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 202
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 249
Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 377
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 250 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
Query: 378 LPNGRPL 384
           L   R L
Sbjct: 302 LHTARVL 308

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/107 (39%), Positives = 64/107 (59%), Gaps = 7/107 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YI 245
           +T QI   + + H+ + I HRDIKPQN+L++ +   LK+ DFG AK L +     +   +
Sbjct: 116 FTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVL 173
Query: 246 CSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
            +  Y +PE   G AT+  T  DI+S G V+ E+L+G+P F GE+ V
Sbjct: 174 GTVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 130
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 248
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 130
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 248
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 90  VGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG     +I+  KK+  +D +   RE +I ++L H NIV L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  A+ + H  +
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ-M 122
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
           G+ HRD+KP+NLL+        +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 223
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            FP  +   W  V      PEA +L+ +    +P  R TA EA  HP+
Sbjct: 224 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQ-------------------- 223
           +KLY  +I +AL Y+   + + H D+KP+N+L++ P+  +                    
Sbjct: 139 IKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 224 ---LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
              +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  
Sbjct: 198 STGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYT 254
Query: 281 GQPLFPGESGVDQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ------- 323
           G  LF     ++ L  +  ++           T T    K +N +  +  +P+       
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINS 313
Query: 324 ----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
                K  P +K+ +  L     D +    Q  P LR +  E   H F +
Sbjct: 314 IKHVKKCLPLYKIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPN 136
           +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I + L HPN
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L       +                 +  +AR +         I       QI  ++
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------QQILESI 117
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y +PE
Sbjct: 118 AYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 176
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
            +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 177 -VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 209

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 133
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 369 DELRDPNTRLPNGRPLPPLFNFKP 392
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 90  VGTGSFGVVFQAKCRE-----TGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +   +        +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I+      QI  ++ +IH   
Sbjct: 99  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH------QILESVNHIHQH- 149
Query: 204 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 259
            I HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPE-VLRK 207
Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 250
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            FP  +   W  V      PEA +L+ +    +P  R TA +A  HP+
Sbjct: 251 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 93  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 148
Query: 200 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
           H+   I HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 149 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 205
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 206 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 249
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 250 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 43/277 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD-HPNIVALKHCFF 145
           +G GSF +  +   +++ +  A+K +   KR +    +E+  +++ + HPNIV L   F 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D+                 RI +           I  KL +     A++++H+ +G+
Sbjct: 77  ---DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHD-VGV 127
Query: 206 CHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 262
            HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL+     Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGY 186
Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             + D+WS G ++  +L GQ  F            VEI+K +                +F
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-------------GDF 233
Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
            F   +   W  V Q     EA DL+       PN R
Sbjct: 234 SF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 133
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 368
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 369 DELRDPNTRLPNGRPLPPLFNFKP 392
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 200 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 254
           H+   I HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 8/177 (4%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
             I+ C+    ++   F +I+ HPW +     LP E  ++        P+ +  ALE
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAALE 291

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 20/164 (12%)
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ R + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 204 YSFQVARGMEFLSSRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 301
            +R    + APE IF    Y+T  D+WS G ++ E+  LG   +PG       V++ +  
Sbjct: 260 DTRLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDF 311
Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 345
            +  RE ++   P Y+  +  QI    WH+  ++R  P   +LV
Sbjct: 312 CSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELV 353

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 145
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYT 263
           I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 264 TAIDIWSTGCVMAELLLGQP 283
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 87  HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 258
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 138 QSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 194
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYT 263
           I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 182
Query: 264 TAIDIWSTGCVMAELLLGQP 283
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 50/302 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 72  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 123
Query: 199 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 124 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 183 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 229
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           + E  F                   A D + R     P  R T  ++  H +   +R  N
Sbjct: 230 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
Query: 376 TR 377
            R
Sbjct: 277 VR 278

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 408 HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 258
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 459 QS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 515
Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 7/160 (4%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 232
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDL 344
             I+ C+    ++   F +I+ HPW +     LP E  ++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEI 270

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 138
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 261
             I HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y +  DIWS G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 118 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 175
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 176 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 235
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 236 HLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 13/209 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +    F    +                +  I          +    +     ++   L Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRA 252
           +H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + A
Sbjct: 132 LHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLG 281
           PE++     Y    DIWS G    EL  G
Sbjct: 190 PEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 13/209 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +    F    +                +  I          +    +     ++   L Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRA 252
           +H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + A
Sbjct: 137 LHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLG 281
           PE++     Y    DIWS G    EL  G
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 125
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYT 263
           I HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 182
Query: 264 TAIDIWSTGCVMAELLLGQP 283
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 264
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 303
             +R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 249
Query: 304 PTREEIK-CMNPNYTEF-KFPQIKPHPW 329
             +  I+ C+    ++   F +I+ HPW
Sbjct: 250 ECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 251
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 252 HLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 146 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 242
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 243 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 302 GTPTRE 307
            + + E
Sbjct: 242 RSVSIE 247

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 142 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 199
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 200 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 154 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 307 EEIK-CMNPNYTEF-KFPQIKPHPW 329
             I+ C+    ++   F +I+ HPW
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 146 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 242
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 243 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 302 GTPTRE 307
            + + E
Sbjct: 242 RSVSIE 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 9   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 118
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 119 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 174
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 175 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 167 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 224
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 225 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 10  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 119
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 120 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 175
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 176 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 155
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 210
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++       LCDFG A  L       S +   Y      + APE++ G +   
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CD 269
Query: 264 TAIDIWSTGCVMAELLLG 281
             +D+WS+ C+M  +L G
Sbjct: 270 AKVDVWSSCCMMLHMLNG 287

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 22  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 131
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 132 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 187
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 188 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
           +P+  +K     +  + +YIHN   ICHRD+KP N+L++ +  ++KL DFG ++ +V  +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKK 206
Query: 240 PNVSYICSRYYRAPELIFGATEYTTA-IDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              S   +  +  PE     + Y  A +DIWS G  +  +      F  +     LVE+ 
Sbjct: 207 IKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELF 262
Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR-------LPPEAVDLVCRFFQY 351
             + T   E             +P  + H  + +  K+       L  E +D +  F + 
Sbjct: 263 NNIRTKNIE-------------YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 352 SPNLRCTALEACVHPFF-----DELRDPNTRLPNGR 382
           +P  R T+ +A  H +      ++LR+ +  L   R
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 174 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 228
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 229 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 276
           FG  + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 277 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 337 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 120
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 175
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 234
Query: 264 TAIDIWSTGCVMAELLLG 281
             +DIWS+ C+M  +L G
Sbjct: 235 AKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 136
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 191
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 250
Query: 264 TAIDIWSTGCVMAELLLG 281
             +DIWS+ C+M  +L G
Sbjct: 251 AKVDIWSSCCMMLHMLNG 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 94  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + +   + HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 6   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +                     +   R++ + H+ R+    + L
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 115
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 238
           Y+ QIC+ + Y+    C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 116 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVR 171
Query: 239 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 172 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE--- 125
           G + G +++ V  +   ++G G FG V++       GE   VA+K   +D    N+E   
Sbjct: 4   GPQYGIAREDV--VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM 61
Query: 126 --LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
               IM+ LDHP+IV L        ++                + + RN       + ++
Sbjct: 62  SEAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVL 113
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
            + LY+ QIC+A+AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E    
Sbjct: 114 TLVLYSLQICKAMAYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYK 170
Query: 244 YICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 285
              +R    + +PE I     +TTA D+W     M E+L    QP F
Sbjct: 171 ASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLDHPNIVALKHCFFSTT 148
           +G GS+G VF+ + +E G + A+K+ +   R  K+R  ++ ++  H  +     C     
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV--RL 122
Query: 149 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
           ++                  + ++       +P   V  Y      ALA++H+  G+ H 
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHL 181
Query: 209 DIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           D+KP N+ + P   + KL DFG         A  + +G+P         Y APEL+ G+ 
Sbjct: 182 DVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPELLQGS- 231
Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 294
            Y TA D++S G  + E+     L  G  G  QL
Sbjct: 232 -YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 50/302 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 93  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 144
Query: 199 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 145 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 204 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 250
Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
           + E  F                   A D + R     P  R    ++  H +   +R  N
Sbjct: 251 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297
Query: 376 TR 377
            R
Sbjct: 298 VR 299

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 22/223 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K + + +  K  E         ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           H  F   +               T+       S+   R+P    + Y  ++  A+  +H 
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTL------LSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 256
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G   Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 79  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 73  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 134
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 189
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 248
Query: 264 TAIDIWSTGCVMAELLLG 281
             +DIWS+ C+M  +L G
Sbjct: 249 AKVDIWSSCCMMLHMLNG 266

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 246
           +CR    AL ++H+   + HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 307 EEIKCMNPNYTEF 319
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 85  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 136
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 87  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 138
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 139 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 195
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 285
           E I     +TTA D+W     M E+L    QP F
Sbjct: 196 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 85  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 136
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 71  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 123 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 179
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 289
           E I     +TTA D+W     M E+L    QP F  E+
Sbjct: 180 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V         T+                +  +    ++  Q +   +V     Q+  AL 
Sbjct: 68  VRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 198 YIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRA 252
             H        + HRD+KP N+ ++     +KL DFG A++L   E     ++ + YY +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 185 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 136
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 191
Query: 210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 263
           +K  N+L++       LCDFG A  L         +   Y      + APE++ G +   
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CD 250
Query: 264 TAIDIWSTGCVMAELLLG 281
             +D+WS+ C+M  +L G
Sbjct: 251 AKVDVWSSCCMMLHMLNG 268

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 25/222 (11%)
Query: 72  GGRNGNSKQKVSYI-AEHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN- 123
            GR+   + + S I  E ++G+G  G V   + R  G+      I A+K    +++ ++ 
Sbjct: 38  AGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF 97
Query: 124 -RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
             E  IM   DHPNI+ L+        +              +++   R +      M L
Sbjct: 98  LSEASIMGQFDHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           + +      +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ 
Sbjct: 154 VGM---LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDA 207
Query: 243 SYICSR-----YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           +Y  +       + APE I   T +++A D+WS G VM E+L
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 31/193 (16%)
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNV 242
           +  AL ++H   GI HRD+KP+N+L         +K+CDF  GS   L         P +
Sbjct: 120 VAAALDFLHT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 243 SYIC-SRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QL 294
           +  C S  Y APE++      AT Y    D+WS G V+  +L G P F G  G D     
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 354
            E+ +V      E I+       +++FP      W       +  EA DL+ +       
Sbjct: 239 GEVCRVCQNKLFESIQ-----EGKYEFPD---KDW-----AHISSEAKDLISKLLVRDAK 285
Query: 355 LRCTALEACVHPF 367
            R +A +   HP+
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 22/202 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG V++     T E+VAIK +       +     +E+ ++   D P I      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 202
             +T                 +           +  PL   Y+     +I + L Y+H+ 
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLL-----------KPGPLEETYIATILREILKGLDYLHSE 135
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATE 261
             I HRDIK  N+L++     +KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 136 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 192
Query: 262 YTTAIDIWSTGCVMAELLLGQP 283
           Y    DIWS G    EL  G+P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 25/225 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 79  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 130
Query: 199 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           +          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPN+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        +               ++   R +     +  +I +      I   + Y
Sbjct: 108 HLE----GVVTRGKPVMIVIEFMENGALDAFLRKHD---GQFTVIQLVGMLRGIAAGMRY 160
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + AP
Sbjct: 161 LAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 123/295 (41%), Gaps = 38/295 (12%)
Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN------ 123
            G   QK S ++   +G+G+FG V+ A  +E  + V +K     KVL+D   ++      
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 124 -RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
             E+ I+  ++H NI+ +   F     +               ++  A  +   H R+  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFA--FIDRHPRLDE 129
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
                   Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+   
Sbjct: 130 PLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFY 187
Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVD--------- 292
           ++  +  Y APE++ G       +++WS G  +  L+  + P    E  V+         
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 293 --QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ---IKPHPWHKVFQKRLPPEAV 342
             +L+ ++  L  P  E    +    T+    Q   +  + W +VF+   P   V
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGV 302

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 89  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 142
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 255
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 143 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           +   +++  A D+WS G  + ELL
Sbjct: 201 LM-QSKFYIASDVWSFGVTLHELL 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGKFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 77  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 130
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 255
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 131 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           +   +++  A D+WS G  + ELL
Sbjct: 189 LM-QSKFYIASDVWSFGVTLHELL 211

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   +   +   +  +I +      I   + Y
Sbjct: 87  HLE----GVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 140 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G VM E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K + T  I A+K + + +  K  E         ++   D   I AL 
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 140
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 141 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 256
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K + T  I A+K + + +  K  E         ++   D   I AL 
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 156
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 157 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 256
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 210 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 257 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 174 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 228
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 229 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 276
           F   + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 277 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 337 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILIGELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 101/260 (38%), Gaps = 72/260 (27%)
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN---------------------- 214
           +Q +P+  VK    Q+ + L Y+H+   I H DIKP+N                      
Sbjct: 134 YQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQK 193
Query: 215 ------------------LLVNP------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
                             LLVNP         ++K+ D G+A  + K       I +R Y
Sbjct: 194 AGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQY 251
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTP 304
           R+ E++ GA  Y+T  DIWST C+  EL  G  LF   SG       D +  II++LG+ 
Sbjct: 252 RSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSI 310
Query: 305 TREEIKCMNPNYTEFKF---------PQIKPHPWHKVFQKRL------PPEAVDLVCRFF 349
            R     ++  Y+   F          ++KP     V  ++         +  D +    
Sbjct: 311 PRH--FALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPML 368
Query: 350 QYSPNLRCTALEACVHPFFD 369
           +  P  R +A E   HP+ +
Sbjct: 369 EMVPEKRASAGECLRHPWLN 388

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL---------QIMQMLDHPNIVAL 140
           +G G FGVVF+AK +      AIK++    R  NREL         + +  L+HP IV  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 141 KHCFF--STTDKXXXXXXXXXXXXXXTVNR------IARNYSRIHQRMPLIYVKLYTYQI 192
            + +   +TT+K               + R             I +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-QI 127
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVSY- 244
             A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 245 -----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
                + ++ Y +PE I G + Y+  +DI+S G ++ ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +Q+  A+ + HN  G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGVFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 30/261 (11%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 138
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 193
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLKEGT 264
Query: 310 KCMNPNYTEFKFPQIKPHPWH 330
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 199 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 251
           +HN    I HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + 
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWM 206
Query: 252 APELIFGATEYTTAIDIWSTGCVMAEL-LLGQP 283
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 108 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 160
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 161 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 217
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 218 EAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 146 STTDKXXXXXXXXXXXX---XXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +                  +V  + +N       +   ++     +I R L+++H  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 148
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 257
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 149 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 205
Query: 258 --GATEYTTAIDIWSTGCVMAELLLGQP 283
              AT Y    D+WS G    E+  G P
Sbjct: 206 NPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 73  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 248
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               + APE I    ++T+A D WS G VM E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V         T+                +  +    ++  Q +   +V     Q+  AL 
Sbjct: 68  VRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 198 YIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRA 252
             H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 185 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 98  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 150
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 151 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V         T+                +  +    ++  Q +   +V     Q+  AL 
Sbjct: 68  VRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 198 YIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRA 252
             H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 185 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 253
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H+ + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 70/260 (26%)
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 217
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 218 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTR 257
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 302
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 258 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 303 TPTREEIKCMNPNYTEFK-------FPQIKPHPWHKVFQKRLP---PEAV---DLVCRFF 349
              R+ I     +   F          ++KP    +V  ++      EA    D +    
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 376
Query: 350 QYSPNLRCTALEACVHPFFD 369
           +  P  R TA E   HP+ +
Sbjct: 377 ELIPEKRATAAECLRHPWLN 396

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            Y+H+ + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 250
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 303
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 304 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 252
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 305
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 306 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
           + L ++  Y++Q+ + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 240 PNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLV 295
             V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 243
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 296
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 297 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 70/260 (26%)
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 217
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 124 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 183
Query: 218 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 184 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTR 241
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 302
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 242 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 300
Query: 303 TPTREEIKCMNPNYTEFK-------FPQIKPHPWHKVFQKRLP---PEAV---DLVCRFF 349
              R+ I     +   F          ++KP    +V  ++      EA    D +    
Sbjct: 301 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 360
Query: 350 QYSPNLRCTALEACVHPFFD 369
           +  P  R TA E   HP+ +
Sbjct: 361 ELIPEKRATAAECLRHPWLN 380

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 199 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 251
           +HN    I HR++K  NLLV+   + +K+CDFG +++        +++ S+       + 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWM 206
Query: 252 APELIFGATEYTTAIDIWSTGCVMAEL-LLGQP 283
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 245
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 298
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 299 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARN---YSRIH------QRMPLIYVKLYTYQICRAL 196
              +                      N   Y  IH      QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 242
           +YIH+  GI HR++KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 243 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
            S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+K L
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNILKKL 241
Query: 302 GTPTRE 307
            + + E
Sbjct: 242 RSVSIE 247

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG VF+     T ++VAIK +  D      E++ +Q      I  L  C  S   
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQ----EITVLSQCDSSYVT 84
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNCIGICH 207
           K                     +   + +  P    ++ T   +I + L Y+H+   I H
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-H 143
Query: 208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAI 266
           RDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y +  
Sbjct: 144 RDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 201
Query: 267 DIWSTGCVMAELLLGQP 283
           DIWS G    EL  G+P
Sbjct: 202 DIWSLGITAIELAKGEP 218

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 18/222 (8%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ----MLDHPNIVALKHCF 144
           V+G G+F  V   K ++TG++ A+K + +    K  E+   +    +L + +   +    
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F+  D+               +  +    S+  +R+P    + Y  +I  A+  +H  +G
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSVHR-LG 182
Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEP-NVSYICSRYYRAPELIFGATEY 262
             HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++      
Sbjct: 183 YVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 263 TTAI------DIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                     D W+ G    E+  GQ  F  +S  +   +I+
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 37/264 (14%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIVALK 141
            V+   +FG+   A CR     VA+K + +     + R    EL+I+  +  H N+V L 
Sbjct: 44  QVIEADAFGIDKTATCR----TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 99
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP---------LIYVKLYTYQI 192
                                  T  R  RN    ++  P         L ++  Y++Q+
Sbjct: 100 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQV 159
Query: 193 CRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY- 249
            + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K    V    +R  
Sbjct: 160 AKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 250 --YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTR 306
             + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +
Sbjct: 216 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLK 267
Query: 307 EEIKCMNPNYTEFKFPQIKPHPWH 330
           E  +   P+YT  +  Q     WH
Sbjct: 268 EGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 98  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 150
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 252
           + + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 151 LAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 209 PEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 237
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 238 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 290
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 291 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 72  GGRNGNSKQKVSYI-AEHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN- 123
            GR+   + + S I  E ++G+G  G V   + R  G+      I A+K    +++ ++ 
Sbjct: 38  AGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF 97
Query: 124 -RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
             E  IM   DHPNI+ L+        +              +++   R +      M L
Sbjct: 98  LSEASIMGQFDHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           + +      +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ 
Sbjct: 154 VGM---LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDA 207
Query: 243 SYICSR-----YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           +   +       + APE I   T +++A D+WS G VM E+L
Sbjct: 208 AXTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
           +   I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 SQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 255
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 87  EHVVGTGSFGVVFQAKCRETG---EI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           + V+G G FG V++   + +    E+ VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L+        K               +++  R        + L+ +      I   + 
Sbjct: 109 IRLEGVI----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM---LRGIAAGMK 161
Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 252
           Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 162 YLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTA 218
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 219 PEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 128/300 (42%), Gaps = 47/300 (15%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIV 138
           K+S+  + V+G G+ G +      +  + VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                 +  T+K              T+          H  +  I +     Q    LA+
Sbjct: 82  R-----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL---LQQTTSGLAH 133
Query: 199 IHNCIGICHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNVSYIC----SRYY 250
           +H+ + I HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 251 RAPELIFGATEY--TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
            APE++    +   T  +DI+S GCV    ++ +   P    + +   I+  LG  +   
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS--- 246
Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + C++P                   +K     A +L+ +     P  R +A     HPFF
Sbjct: 247 LDCLHP-------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C                           R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 151
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELI 256
               I HRD+  +N+L++ +   +K+ DFG AK + +G              ++ APE +
Sbjct: 152 AQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 257 FGATEYTTAIDIWSTGCVMAELL 279
               ++  A D+WS G  + ELL
Sbjct: 210 -KEYKFYYASDVWSFGVTLYELL 231

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/332 (20%), Positives = 118/332 (35%), Gaps = 77/332 (23%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------- 123
           G +G+  Q   Y  +  +G GS+GVV  A         A+K + + K  +          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 124 ---------------------RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXX--- 159
                                +E+ I++ LDHPN+V L        +             
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 160 -XXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 218
                 T+  ++ + +R            Y   + + + Y+H    I HRDIKP NLLV 
Sbjct: 124 PVMEVPTLKPLSEDQAR-----------FYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG 171
Query: 219 PHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYTT--AIDIWSTGCVM 275
              H +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  +
Sbjct: 172 EDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
              + GQ  F                     E I C++         +IK        Q 
Sbjct: 231 YCFVFGQCPF-------------------MDERIMCLH--------SKIKSQALEFPDQP 263
Query: 336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +  +  DL+ R    +P  R    E  +HP+
Sbjct: 264 DIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
               I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 AQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G FG V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 179
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 30/261 (11%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 138
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 193
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           + + ++ +   I HRD+  +N+L++   + +K+ DFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRLKEGT 264
Query: 310 KCMNPNYTEFKFPQIKPHPWH 330
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 121/318 (38%), Gaps = 79/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 247
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK    GE        
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE-------- 173
Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
                        +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 174 -------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 214
Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 215 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 259
Query: 368 -FDELRDPNTRLPNGRPL 384
                + P T L   R L
Sbjct: 260 IMQSTKVPQTPLHTSRVL 277

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 75  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 248
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
               + APE I    ++T+A D WS G VM E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 67/131 (51%), Gaps = 19/131 (14%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-- 235
           Q++P+     Y  +I  AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +  
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINS 233
Query: 236 ---VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
              + G P         ++APE++   T  T A DI++ G  +A L L  P   G   VD
Sbjct: 234 FGYLYGTPG--------FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VD 282
Query: 293 QLVEIIKVLGT 303
            L E   VL T
Sbjct: 283 GLPEDDPVLKT 293

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + HPNI
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK--------NRELQIMQMLDHP 135
           Y+   ++G GS+G V +    ET    A+K + + K  +         +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N++ L    ++   +               +       S   +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD-----SVPEKRFPVCQAHGYFCQLIDG 121
Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRA 252
           L Y+H+  GI H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 253 PELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--------LGT 303
           PE+  G   ++   +DIWS G  +  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 304 PTREEIKCM--NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
           P  + +K M        F   QI+ H W   F+K+ PP
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSW---FRKKHPP 273

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 22/222 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 198 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  VS   +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 255 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGE 288
           +   A        +Y   +D+WS G        G  P  P E
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 129
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 130 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 184
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 185 ECL-KECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 128
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 253
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 129 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL 279
           E +    ++  A D+WS G  + ELL
Sbjct: 184 ECL-KECKFYYASDVWSFGVTLYELL 208

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 128
           G  +    ++     +H +G G +G V++   ++    VA+K + +D        +E  +
Sbjct: 1   GSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 60
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 188
           M+ + HPN+V L         +               +    R  +R  Q +  + +   
Sbjct: 61  MKEIKHPNLVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYM 114
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI  A+ Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 115 ATQISSAMEYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAK 171
Query: 249 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           +   + APE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 172 FPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 136
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGRLAD-GXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 194
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 142
Query: 195 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY--Y 250
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 136
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLAD-GTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 194
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 150
Query: 195 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY--Y 250
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 285
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAP 179
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 75  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 128
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 129 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 185
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 186 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 230

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 182
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 139 ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 198 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  V    +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 255 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGES 289
           +   A        +Y   +D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  + ++   +  +   +    Q  R + Y+H  
Sbjct: 72  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLH-A 126
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF-- 257
             I HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 127 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 24  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 83
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 84  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 137
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 138 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 194
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 195 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 239

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 72  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 124
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 252
           + + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 125 LAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL 279
           PE I    ++T+A D+WS G VM E++
Sbjct: 183 PEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 255
           +     HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 SK-RFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 256 IFGATEYTTAIDIWSTGCVMAELLL 280
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 2/91 (2%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS   L+  EP   +  +R Y
Sbjct: 147 QVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVY 204
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
             PE I     +     +WS G ++ +++ G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 89  VVGTGSFGVVFQAKC---RETGEIVAIK-KVLQDKRYKNR------ELQIM-QMLDHPNI 137
           V+G+G+FG V  A      +TG  + +  K+L++K   +       EL++M Q+  H NI
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 138 VALK---------HCFFSTTDKXXXXXXXXXXXXXXTVNRIA-RNYSRIHQRMPLIYVKL 187
           V L          +  F                   + + I   N  R+ +   L  +  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 188 -----YTYQICRALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240
                + YQ+ + + ++   +C+   HRD+  +N+LV  H   +K+CDFG A+ ++    
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVT-HGKVVKICDFGLARDIMSDSN 227
Query: 241 NVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 81  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 132
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 133 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 187
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 188 -NFRRFTSASDVWMFGVCMWEILM 210

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 80  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 131
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 132 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 186
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 187 -NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 75  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 126
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 127 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 181
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 182 -NFRRFTSASDVWMFGVCMWEILM 204

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 83  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 134
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 135 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 189
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 190 -NFRRFTSASDVWMFGVCMWEILM 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 106 GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 157
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 158 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 212
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 213 -NFRRFTSASDVWMFGVCMWEILM 235

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 278 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 331
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 332 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 389 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 433

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 85  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 73  VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 124
Query: 198 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 249
           Y+       HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        
Sbjct: 125 YLEE-KNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 178
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           + APE I    ++++  D+WS G  M E L
Sbjct: 179 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 76  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 201 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 305
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 306 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 350
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 249 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 303
Query: 351 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 391
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 304 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  + ++   +  +   +    Q  R + Y+H  
Sbjct: 84  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLH-A 138
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 257
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 255
           +     HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 SK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 256 IFGATEYTTAIDIWSTGCVMAELLL 280
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 92  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 201 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 305
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 306 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 350
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 265 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 319
Query: 351 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 391
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 257 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 316
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 317 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 370
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 371 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 427
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 428 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 472

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 183
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 253
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 182
Query: 254 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 299
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 71  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 121 YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 177
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 278
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEETSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 187
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTASTRDLLH 168
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 187
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTLSTRDLLH 168
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 85  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 399 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 450
Query: 198 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 249
           Y+       HR++  +N LLVN   H  K+ DFG +K L   +   SY  +R        
Sbjct: 451 YLEE-KNFVHRNLAARNVLLVN--RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           + APE I    ++++  D+WS G  M E L
Sbjct: 505 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 71  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 121 YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 177
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 238 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 278
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEYTSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 173 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 229 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 137
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 104
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 250
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 165 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 221 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 80  QKVSYIAEHVVGTGSFGVVF------QAKCRETGEIVAIKKVLQDKRYKN--RELQIMQM 131
           ++V   ++ V+G G FGVV+      QA+ R    I ++ ++ + ++ +   RE  +M+ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-YTY 190
           L+HPN++AL                          +     + R  QR P +   + +  
Sbjct: 79  LNHPNVLALIGIMLPPEG-------LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           Q+ R + Y+       HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R+ 
Sbjct: 132 QVARGMEYLAEQ-KFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHRHA 188
Query: 251 RAPELIFGATE------YTTAIDIWSTGCVMAELL 279
           R P + + A E      +TT  D+WS G ++ ELL
Sbjct: 189 RLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 78
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 133
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 134 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 190
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 191 SKSDIWAFGVLMWEI 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 72
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 127
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 128 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 184
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 185 SKSDIWAFGVLMWEI 199

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 71
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 126
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 127 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 183
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 184 SKSDIWAFGVLMWEI 198

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 67
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 122
Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 263
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 123 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 179
Query: 264 TAIDIWSTGCVMAEL 278
           +  DIW+ G +M E+
Sbjct: 180 SKSDIWAFGVLMWEI 194

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   +                  + +  + ++   +  LI +     Q  R + Y+H  
Sbjct: 84  LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK-KLIDI---ARQTARGMDYLH-A 138
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 257
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 105 LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC----VQIAKGMMYL 156
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 157 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 257 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 215 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 252
Query: 315 NYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 253 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 293
Query: 373 DPNTRL 378
              +R+
Sbjct: 294 AEFSRM 299

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 82  LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW----CVQIAKGMMYL 133
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 134 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 257 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 192 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 229
Query: 315 NYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 230 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 270
Query: 373 DPNTRL 378
              +R+
Sbjct: 271 AEFSRM 276

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 136
           ++     +H +G G +G V+    ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 30  ERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 89
Query: 137 IVALKHC------FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--Y 188
           +V L         F+  T+                      +Y R   R  +  V L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLL--------------DYLRECNREEVTAVVLLYM 135
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
             QI  A+ Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 136 ATQISSAMEYLEKK-NFIHRDLAARNCLVGEN-HVVKVADFGLSR-LMTGDTYTAHAGAK 192
Query: 249 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 287
           +   + APE +   T ++   D+W+ G ++ E+   G   +PG
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPG 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 256
                HRDI  +N+LV+ +   +KL DFG ++ +   E +     S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESI 184
Query: 257 FGATEYTTAIDIWSTGCVMAELLL 280
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 107 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 158 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 216 ILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICSR 248
           QI   + Y+H    I H D+KPQN+L++       +K+ DFG ++ +         + + 
Sbjct: 139 QILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
            Y APE I      TTA D+W+ G +   LL     F GE   +  + I +V    + E 
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 309 IKCMNPNYTEF------KFPQIKP-------HPWHKV--FQKRLPPE 340
              ++   T+F      K P+ +P       H W +   F+    PE
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPE 303

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 128
           GG      + ++++ E  +GTG FGVV   K R   + VAIK + +    ++    E ++
Sbjct: 1   GGSWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKV 57
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 188
           M  L H  +V L   +   T +               +N +     R   +  L   K  
Sbjct: 58  MMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK-- 112
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
              +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++  E    Y  SR
Sbjct: 113 --DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDE----YTSSR 164
Query: 249 YYR-----APELIFGATEYTTAIDIWSTGCVMAEL 278
             +     +P  +   +++++  DIW+ G +M E+
Sbjct: 165 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 88  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 139 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 197 ILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 92  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 143 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 201 ILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 163 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 218
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 219 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 142
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPNIV    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            + ST                 T+    + Y +  +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTL----KTYLKRFKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 203 IG-ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 262 YTTAIDIWSTG 272
           Y  ++D+++ G
Sbjct: 206 YDESVDVYAFG 216

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 248 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 171 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 246 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 227 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   + + R       N+E+     +M  +D+P++  
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 116 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 167 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 225 ILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 76  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 248 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 264 TAIDIWSTGCVMAELLLGQPLFPGE 288
              DI++  CV+ E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI   + Y
Sbjct: 79  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 130 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 188 ILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNRELQIMQML 132
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 133 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 277
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 248 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVS 243
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +
Sbjct: 172 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 244 Y------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 279
           Y      + ++ Y +PE I G   Y+  +DI+S G ++ ELL
Sbjct: 230 YATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 144
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 202
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE-LIFG 258
           I   HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
              Y++  D+WS G ++ E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 139
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 140 -LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L  C  ST                  ++ +  N  R+  +  L +      QI + ++Y
Sbjct: 84  LLGICLTSTVQ-----LVTQLMPYGCLLDHVRENRGRLGSQDLLNW----CMQIAKGMSY 134
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E 
Sbjct: 135 LED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     +T   D+WS G  + EL+
Sbjct: 193 IL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 149
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 150 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 141
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 202 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 141
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 202 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI  L  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             +ST  +                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQLAIVTQWCEG------SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 144
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 202
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 261
           I   HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 262 -----YTTAIDIWSTGCVMAELL-LGQPLFPGES 289
                Y++  D+WS G ++ E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 141
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 90  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 138
Query: 202 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 139 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 198 PEALRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 139
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 198
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 255
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 256 IFGATEYTTAIDIWSTGCVMAELL 279
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 124
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 125 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYKN----------RELQIMQMLDHP 135
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           NIV L +       +               +++       +  R+ L         I   
Sbjct: 84  NIVKL-YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML--------DIALG 134
Query: 196 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 249
           + Y+ N    I HRD++  N+ +        +C    DFG+++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLLGNFQ 191
Query: 250 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 285
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK-----NRELQI 128
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K + ++          RE  +
Sbjct: 46  RNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 129 MQMLDHPNIVAL--------KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 180
           M   D+PNIV L          C                     TV  ++ +      R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 181 ------PLIYVK--LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232
                 PL   +      Q+   +AY+       HRD+  +N LV      +K+ DFG +
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVG-ENMVVKIADFGLS 221
Query: 233 KVLVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           + +   +         YY+A            PE IF    YTT  D+W+ G V+ E+ 
Sbjct: 222 RNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 270

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 68/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNRELQIMQML 132
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 133 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 277
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 68/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNRELQIMQML 132
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 12  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 65
Query: 133 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +  +++    C           K               +    R+     +  P      
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 126 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 183
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 241
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 242 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 274
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 275 TFLEIVNLLKDDLHPSFPEV 294

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 142
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 143 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 16  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 74  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + + +  
Sbjct: 130 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 187
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 245
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 246 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 278
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 279 TFLEIVNLLKDDLHPSFPEV 298

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 259
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 260 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 186
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 277
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 48/222 (21%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK----NRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C      +   +VA+K + +          RE +++ ML H +IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 107
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 190
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 108 ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 191 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 165 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 213
Query: 250 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 214 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 14  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 72  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 127
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 128 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 185
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 243
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 244 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 276
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 277 TFLEIVNLLKDDLHPSFPEV 296

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 139
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 98  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 149
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 150 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 257 -FGATEYTTAIDIWSTGCVMAELL 279
            FG  +YT   D+WS G  + EL+
Sbjct: 208 HFG--KYTHQSDVWSYGVTVWELM 229

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 239
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 186
Query: 240 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 277
Query: 358 TALEAC------VHPFFDEL 371
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYK----------NRELQIMQMLDHP 135
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           NIV L +       +               +++       +  R+ L         I   
Sbjct: 84  NIVKL-YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML--------DIALG 134
Query: 196 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 249
           + Y+ N    I HRD++  N+ +        +C    DFG ++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQ 191
Query: 250 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 285
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 129/329 (39%), Gaps = 81/329 (24%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRET--GEI---VAIKKVLQDKRYKNR-----ELQ 127
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 128 IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 181
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + +    
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---- 182
Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
                + YYR            APE +     +TT+ D+WS G V+ E+  L +  + G 
Sbjct: 183 -----TAYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
           S  +Q+++ +             M+  Y +      +P           P    DL+   
Sbjct: 237 SN-EQVLKFV-------------MDGGYLD------QP--------DNCPERVTDLMRMC 268
Query: 349 FQYSPNLRCTALEAC------VHPFFDEL 371
           +Q++P +R T LE        +HP F E+
Sbjct: 269 WQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 90  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 84
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 190
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 85  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 191 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 142 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 190
Query: 250 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 191 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 231

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 139
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 80  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 131
Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 256
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 132 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 257 -FGATEYTTAIDIWSTGCVMAELL 279
            FG  +YT   D+WS G  + EL+
Sbjct: 190 HFG--KYTHQSDVWSYGVTVWELM 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 31/211 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHCFF 145
           V   G FG V++A+     E VA+K   +QDK+    E ++  +  + H NI+       
Sbjct: 31  VKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-- 203
             T                +++   +  + +     L ++      + R LAY+H  I  
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHI---AETMARGLAYLHEDIPG 143
Query: 204 -------GICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP---NVSYICSRYYR 251
                   I HRDIK +N+L+    + L  C  DFG A     G+        + +R Y 
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 252 APELIFGATEYT----TAIDIWSTGCVMAEL 278
           APE++ GA  +       ID+++ G V+ EL
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 48/222 (21%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK----NRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C      +   +VA+K + +          RE +++ ML H +IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 190
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 79  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 191 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 136 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 184
Query: 250 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 279
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 185 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 225

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEI-VAIKKVL-----QDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G+GSFG V++ K    G++ V I KV+     Q + ++N E+ +++   H NI+     
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----L 96
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F     K                  +    ++  Q   LI +     Q  + + Y+H   
Sbjct: 97  FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKF-QMFQLIDI---ARQTAQGMDYLH-AK 151
Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSY-ICSRYYRAPELIFGAT 260
            I HRD+K  N+ ++     +K+ DFG A V  +  G   V     S  + APE+I    
Sbjct: 152 NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 261 E--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
              ++   D++S G V+ EL+ G+  +   +  DQ++ ++
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 133
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALKH 142
           G G FGVV++     T   VA+KK+         + K+  ++E+++     H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               ++D                ++R+    S +    PL +     +  C+      N 
Sbjct: 87  -LGFSSDGDDLCLVYVYXPNGSLLDRL----SCLDGTPPLSW-----HXRCKIAQGAANG 136
Query: 203 IGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
           I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y AP
Sbjct: 137 INFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           E + G  E T   DI+S G V+ E++ G P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 129
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 142
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 203 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 237
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 280
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 228
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 229 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 264
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 260
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 261
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 42/209 (20%)
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 242
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +      V   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 243 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 280
Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNG 381
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	394
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-102
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-100
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-99
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-98
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-96
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-94
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-93
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-91
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-90
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-90
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-89
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-88
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-88
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-87
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-85
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-85
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-85
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-82
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-63
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-60
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-60
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-60
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-59
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-59
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-58
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-58
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-58
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-56
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-54
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-54
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-53
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-53
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-53
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-52
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-52
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-52
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-51
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-51
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-51
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-51
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-51
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-51
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-51
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-50
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-50
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-50
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-49
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-49
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-49
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-49
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-49
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-49
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-49
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-48
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-48
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-48
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-48
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-48
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-48
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-48
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-48
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-47
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-46
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-46
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-45
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-44
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-43
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-43
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-43
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-42
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-42
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-41
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-40
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-40
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-40
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-40
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-40
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-39
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-39
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-39
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-39
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-39
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-39
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-38
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-38
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-38
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-37
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-37
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-37
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-37
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-36
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-36
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-36
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-36
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-34
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-33
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  604 bits (1558), Expect = 0.0
 Identities = 231/337 (68%), Positives = 276/337 (81%), Gaps = 4/337 (1%)

Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K +E+YLNLVL+YVPETV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query: 356 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTT 364

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  600 bits (1550), Expect = 0.0
 Identities = 217/342 (63%), Positives = 269/342 (78%), Gaps = 4/342 (1%)

Query: 52  EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVA 111
               ++ +      +      G+ G  ++ ++Y    V+G GSFGVVFQAK  E+ E VA
Sbjct: 11  NGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VA 68

Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-ELYLNLVLEYVPETVNRIA 170
           IKKVLQDKR+KNRELQIM+++ HPN+V LK  F+S  DK+ E++LNLVLEYVPETV R +
Sbjct: 69  IKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS 128

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           R+Y+++ Q MP++ +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  LKL DFG
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFG 187

Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           SAK+L+ GEPNVSYICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG
Sbjct: 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

Query: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350
           +DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307

Query: 351 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 392
           Y+P+ R TA+EA  HPFFDELR    R+PNGR LPPLFN+  
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTK 349

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  579 bits (1495), Expect = 0.0
 Identities = 161/341 (47%), Positives = 217/341 (63%), Gaps = 12/341 (3%)

Query: 64  GHVIRTTIGGRNG--NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
           G ++           + K+   +  E + G G+FG V   K + TG  VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 122 KNRELQIMQML---DHPNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRI 176
           +NRELQIMQ L    HPNIV L+  F++    D+ ++YLN+V+EYVP+T++R  RNY R 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 177 HQRMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 235
               P I +K++ +Q+ R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
              EPNV+YICSRYYRAPELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYS 352
           EI++VLG P+RE ++ +NP++T+      K  PW  VF     +   EA DL+    QY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP-LFNFKP 392
           P  R    EA  HP+FDEL DP T+LPN + LP  LF F P
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLP 343

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  547 bits (1412), Expect = 0.0
 Identities = 163/359 (45%), Positives = 230/359 (64%), Gaps = 43/359 (11%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP 135
           G       Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 136 NIVALKHCFFSTTDK---------------------------------EELYLNLVLEYV 162
           NI+ L   F++T D+                                 +  YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH 222
           P+T++++ +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179

Query: 223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 282
            LKLCDFGSAK L+  EP+V+YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 283 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAV 342
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 343 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKP 392
           DL+ +  +Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSP 358

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  304 bits (782), Expect = e-102
 Identities = 106/312 (33%), Positives = 160/312 (51%), Gaps = 22/312 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + R+TG+IVAIKK L+ +          RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F     K  L+L  V EY   TV      Y    + +P   VK  T+Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 262
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 320
              +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 321 FPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
            P  +   P    F   +   A+ L+       P  R T  +   HP+F+ +R+    L 
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI-EDLA 298

Query: 380 NGRPLPPLFNFK 391
                P    + 
Sbjct: 299 KEHDKPAENLYF 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  299 bits (767), Expect = e-100
 Identities = 99/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG GS+G+V + + ++TG IVAIKK L+    K       RE+++++ L H N+V L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 K+  YL  V E+V  T+      +      +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 262
            I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 263 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 320
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 321 FPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            P+IK   P  + +  +L    +DL  +     P+ R    E   H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  296 bits (760), Expect = 6e-99
 Identities = 99/324 (30%), Positives = 167/324 (51%), Gaps = 33/324 (10%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLD 133
           +YI    +G G++  V++ K + T  +VA+K++    R ++         RE+ +++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           H NIV L         ++ L L  V EY+ + + +   +       + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDDCG---NIINMHNVKLFLFQLL 110

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 250
           R LAY H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 307
           R P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            I      +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 368 FDELRDPNTRLPNGRPLPPLFNFK 391
           F  L +   +LP+   +  L   +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQ 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  294 bits (756), Expect = 5e-98
 Identities = 107/312 (34%), Positives = 158/312 (50%), Gaps = 33/312 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F         ++LV +++   +  I ++ S     +   ++K Y     + L Y+H
Sbjct: 78  -LDAFGHKSN----ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 257
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 314
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
           +Y    F      P H +F      + +DL+   F ++P  R TA +A    +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 375 NTRLPNGRPLPP 386
                   P P 
Sbjct: 300 GPTPGCQLPRPN 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  289 bits (742), Expect = 3e-96
 Identities = 88/303 (29%), Positives = 146/303 (48%), Gaps = 23/303 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQML-DHPNIVAL 140
           Y     +G G +  VF+A      E V +K +  ++ K+ K RE++I++ L   PNI+ L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    +       V E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 260
           +  GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 261 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 317
            Y  ++D+WS GC++A ++   +P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 318 EFK--FPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            F     +     W +      Q  + PEA+D + +  +Y    R TA EA  HP+F  +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 372 RDP 374
              
Sbjct: 327 VKD 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  287 bits (737), Expect = 1e-95
 Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK    G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 +  L L  V E++ + + ++          +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 317
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           +  F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  287 bits (737), Expect = 1e-95
 Identities = 89/315 (28%), Positives = 148/315 (46%), Gaps = 34/315 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD----KR-YKNRELQIMQMLDHPNI 137
           Y+    +G G  G+VF A   +  + VAIKK+ L D    K     RE++I++ LDH NI
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 138 VALKHCF-----------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK 186
           V +                S T+   +Y+  V EY+   +  +          +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--- 243
           L+ YQ+ R L YIH+   + HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 244 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
             + +++YR+P L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 303 TPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
               E+ + +      +          P  ++    +  EAVD + +   +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 361 EACVHPFFDELRDPN 375
           EA  HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  286 bits (735), Expect = 3e-95
 Identities = 90/313 (28%), Positives = 151/313 (48%), Gaps = 41/313 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                    L+L  + EY    + +        +  + +  +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 204 GICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 313
            G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
           P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A  HP+F     
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325

Query: 374 PNTRLPNGRPLPP 386
                       P
Sbjct: 326 ---------DFDP 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  283 bits (726), Expect = 3e-94
 Identities = 101/294 (34%), Positives = 158/294 (53%), Gaps = 28/294 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 K+ L L  V E++ + + ++          +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 261 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 317
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E 
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  281 bits (721), Expect = 3e-93
 Identities = 97/318 (30%), Positives = 159/318 (50%), Gaps = 37/318 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G++  V++   + TG  VA+K+V    +  +         RE+ +M+ L H NIV L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                    + +L L  V E++   + +   +R      + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPEL 255
            H    I HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 312
           + G+  Y+T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 313 NPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            P Y      Q  P    +V Q      L    +D +    Q +P++R +A +A  HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 369 DELRDPNTRLPNGRPLPP 386
            E       +   R    
Sbjct: 298 AEYYHH-ASMGGSRSHHH 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  279 bits (717), Expect = 6e-93
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 28/298 (9%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                  ++L L  V E+  + + +   + +     +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 260
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 261 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 316
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
             +            V   +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 237 KPYPMYP-ATTSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  282 bits (723), Expect = 6e-93
 Identities = 104/332 (31%), Positives = 174/332 (52%), Gaps = 38/332 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-KR-YKNRELQIMQMLDHPN 136
           +  + ++G G++GVV  A  + TGEIVAIKK+          R    RE++I++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 137 IVALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ + +     + +   E+Y+  + E +   ++R+        Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLR 123

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 243
           A+  +H    + HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           ++ +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 304 PTREEI--KCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
           P  +       +P   E+    P     P  K+F + + P+ +DL+ R   + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPL-FNF 390
            EA  HP+     DPN   P G P+PP  F F
Sbjct: 301 KEALEHPYLQTYHDPN-DEPEGEPIPPSFFEF 331

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  280 bits (718), Expect = 3e-92
 Identities = 92/330 (27%), Positives = 153/330 (46%), Gaps = 37/330 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------------RELQI 128
           Y  +  + +GS+G V        G  VAIK+V                       RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 129 MQMLDHPNIVALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IY 184
           +    HPNI+ L+  F  F      +LYL  V E +   + ++        QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           ++ + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           +  R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 305 TREEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
             E++    +P   +Y       +    W  V      P A+DL+ +  +++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
           +A  HP+F+ L DP   L  G      F+F
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHF 339

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  277 bits (710), Expect = 5e-91
 Identities = 102/307 (33%), Positives = 164/307 (53%), Gaps = 31/307 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
           Y++   VG+G++G V  A  + +GE VAIKK+    Q     KR Y  REL +++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N++ L   F   +      + YL  V+ ++   + +I      +  +     ++   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKI------MGLKFSEEKIQYLVYQM 135

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 251
            + L YIH+  G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YR
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYR 190

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + +     +    PQ     + ++F  R  P+A DL+ +  +   + R TA +A  HPFF
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

Query: 369 DELRDPN 375
           +  RDP 
Sbjct: 310 EPFRDPE 316

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  277 bits (710), Expect = 6e-91
 Identities = 94/308 (30%), Positives = 166/308 (53%), Gaps = 28/308 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQD----KR-YKNRELQIMQMLDHPN 136
           Y     +G G++G+V  A        VAIKK+   +     +R    RE++I+    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 137 IVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ +       +    +++Y+  V + +   + ++ +      Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILR 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYY 250
            L YIH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
           RAPE++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 311 CM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           C+ N     +    P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 368 FDELRDPN 375
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  274 bits (704), Expect = 9e-91
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQML---DHPNI 137
           +G G++G V++A+   +G  VA+K V                 RE+ +++ L   +HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L     ++    E+ + LV E+V + +             +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 254
           ++H    I HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                    FP   P P   V    +      L+     ++P+ R +A  A  H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 372 RDPN 375
            + N
Sbjct: 304 -EGN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  275 bits (705), Expect = 1e-90
 Identities = 95/330 (28%), Positives = 158/330 (47%), Gaps = 33/330 (10%)

Query: 74  RNGNSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN-------RE 125
           ++G  +    Y     +G G++G VF+A+  +  G  VA+K+V      +        RE
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIRE 61

Query: 126 LQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL 182
           + +++ L   +HPN+V L      +    E  L LV E+V + +             +P 
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
             +K   +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++       +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-M 174

Query: 243 SY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           +    + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ 
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

Query: 300 VLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
           V+G P  E+     P         F      P  K     +     DL+ +   ++P  R
Sbjct: 234 VIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKR 288

Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPP 386
            +A  A  HP+F +L      L +   LPP
Sbjct: 289 ISAYSALSHPYFQDLERCKENLDS--HLPP 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  274 bits (703), Expect = 7e-90
 Identities = 97/305 (31%), Positives = 158/305 (51%), Gaps = 26/305 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     VG+G++G V  A    TG  VAIKK+          +   REL++++ + H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 138 VALKHCFF---STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           + L   F    +  D  + YL  V+ ++   + ++ ++     +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAP 253
            L YIH   GI HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 312
           E+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 313 NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           +     +    P+++   +  +      P AV+L+ +        R TA EA  HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 371 LRDPN 375
           L D  
Sbjct: 314 LHDTE 318

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  273 bits (701), Expect = 2e-89
 Identities = 97/331 (29%), Positives = 155/331 (46%), Gaps = 38/331 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A        VAIKK+    Q+    KR Y  REL +M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           NI+ L + F      E   ++Y+  V+E +   + ++      I   +    +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQV------IQMELDHERMSYLLYQM 136

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
              + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 313 NPNYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTA 359
            P    +    P+   + + K+F            K    +A DL+ +      + R + 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
            EA  HP+ +   DP+       P  P    
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQL 343

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  270 bits (692), Expect = 3e-88
 Identities = 88/315 (27%), Positives = 139/315 (44%), Gaps = 26/315 (8%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 144 FFSTTDKEELYLN---LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +             LV ++    +  +  N   +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNVSY---ICSRYYRAPEL 255
               I HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 312
           + G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 313 NPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
              Y + +  + +        +     P A+DL+ +     P  R  + +A  H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317

Query: 372 RDPNTRLPNGRPLPP 386
            DP      G     
Sbjct: 318 -DPMPSDLKGMLSTH 331

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  269 bits (690), Expect = 7e-88
 Identities = 104/307 (33%), Positives = 161/307 (52%), Gaps = 30/307 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     VG+G++G V  A   +TG  VA+KK+ +        KR Y  REL++++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N++ L   F      E   ++YL  V   +   +N I +      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 251
            R L YIH+   I HRD+KP NL VN    +LK+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 312 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           + + +   +     Q+    +  VF     P AVDL+ +      + R TA +A  H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 369 DELRDPN 375
            +  DP+
Sbjct: 316 AQYHDPD 322

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  272 bits (697), Expect = 1e-87
 Identities = 96/331 (29%), Positives = 156/331 (47%), Gaps = 40/331 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A        VAIKK+ +        KR Y  REL +M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           NI++L + F      E   ++YL  V+E +   + ++      I   +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQV------IQMELDHERMSYLLYQM 173

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
              + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+I G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 313 NPNYTEF--KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTA 359
            P    +    P+     + K+F            K    +A DL+ +     P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 360 LEACVHPFFDELRDPNTRLPNGRPLPPLFNF 390
            +A  HP+ +   DP        P P +++ 
Sbjct: 351 DDALQHPYINVWYDPAEVEA---PPPQIYDK 378

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  266 bits (682), Expect = 2e-85
 Identities = 107/366 (29%), Positives = 160/366 (43%), Gaps = 87/366 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y   H++GTGS+G V +A  +    +VAIKK+L+        KR    RE+ I+  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
           ++V +            +ELY+  VLE       ++          + L  +++K   Y 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYV--VLEIADSDFKKL------FRTPVYLTELHIKTLLYN 164

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 243
           +   + Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S        
Sbjct: 165 LLVGVKYVHSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 244 --------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--- 280
                               ++ +R+YRAPELI     YT AID+WS GC+ AELL    
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 281 --------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM 312
                     PLFPG S                      DQL  I  +LGTP+ E+I+ +
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342

Query: 313 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
              +   +   FP+ +     + F      +A+ L+ R   ++PN R T  E   HPFF 
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401

Query: 370 ELRDPN 375
           E+R   
Sbjct: 402 EVRIAE 407

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  265 bits (680), Expect = 2e-85
 Identities = 104/358 (29%), Positives = 159/358 (44%), Gaps = 79/358 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQD-KR-YKNRELQIMQMLDHP 135
           YI +H++G GS+G V+ A  + T + VAIKKV      L D KR    RE+ I+  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
            I+ L            +ELY+  VLE     + ++          + L   ++K   Y 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL------FKTPIFLTEEHIKTILYN 137

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 243
           +     +IH   GI HRD+KP N L+N     +K+CDFG A+ +   +            
Sbjct: 138 LLLGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 244 ---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ------ 282
                          ++ +R+YRAPELI     YT +IDIWSTGC+ AELL         
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 283 -----PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF 319
                PLFPG S                   DQL  I  ++GTPT +++K +  P   ++
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315

Query: 320 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
              FP  KP    + +   +  + ++L+    +++PN R T  +A  HP+  ++R   
Sbjct: 316 IKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  263 bits (674), Expect = 3e-85
 Identities = 96/341 (28%), Positives = 171/341 (50%), Gaps = 61/341 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---QD----KR-YKNRELQIMQ-MLDH 134
           Y     +G G++G+V+++  R TGE+VA+KK+    Q+    +R +  RE+ I+  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
            NIV L +   +  D++ +YL  V +Y+   ++ + R        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIK 120

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 243
            + Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 244 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 293 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLP----------- 338
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 339 ----PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
                EA+DL+ +  Q++PN R +A +A  HPF     +PN
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  255 bits (652), Expect = 9e-82
 Identities = 87/335 (25%), Positives = 151/335 (45%), Gaps = 44/335 (13%)

Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
           VG G++G V++AK ++    +  A+K++       +  RE+ +++ L HPN+++L+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 146 STTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           S  D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 201 NCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYYR 251
               + HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQLVEIIKVLG 302
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 303 TPTRE---------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
            P  +         E   +  ++    +       + +  + +   +A  L+ +     P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 354 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF 388
             R T+ +A   P+F E  DP             +
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPY 355

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  208 bits (531), Expect = 2e-63
 Identities = 92/338 (27%), Positives = 149/338 (44%), Gaps = 73/338 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
           Y    V+G GSFG V +A   +  + VA+K V  +KR+      E++I++ L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 135 PNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLI 183
            N++ +   F         F     E L +NL  +++      N+         Q   L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF-----ELLSMNLYELIKK-----NK--------FQGFSLP 200

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
            V+ + + I + L  +H    I H D+KP+N LL       +K+ DFGS+      +   
Sbjct: 201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVY 257

Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           +YI SR+YRAPE+I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG
Sbjct: 258 TYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316

Query: 303 TPTREEIK-----------CMNPNYTEFKF---------------PQIKPHPWHKVFQKR 336
            P+++ +               P Y                     +++  P  + +   
Sbjct: 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376

Query: 337 LPPEA----VDLVCRFFQYSPNLRCTALEACVHPFFDE 370
           L        +D + +  ++ P +R T  +A  HP+   
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  199 bits (507), Expect = 2e-60
 Identities = 86/340 (25%), Positives = 137/340 (40%), Gaps = 44/340 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 136 NIVALKHC-----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
           + +   H       F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNVSYI 245
           Q+   L Y+H   GI H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 299
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP--------------EAVDLV 345
           +LG      ++        F   +       K+    L                E  D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 346 CRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 385
               Q  P  R  A     HP+  +           R L 
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  199 bits (507), Expect = 2e-60
 Identities = 96/347 (27%), Positives = 143/347 (41%), Gaps = 78/347 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
           Y  + ++G GSFG V +A  R   E VAIK +   K + N    E+++++++        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 135 PNIVALKHCF---------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLI 183
             IV LK  F         F     E L  NL              +  R      + L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVF-----EMLSYNL-------------YDLLRNTNFRGVSLN 157

Query: 184 YVKLYTYQICRALAYIHNC-IGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPN 241
             + +  Q+C AL ++    + I H D+KP+N LL NP    +K+ DFGS+     G+  
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI 215

Query: 242 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
             YI SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VL
Sbjct: 216 YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274

Query: 302 GTPTRE--------------------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 341
           G P                        +K       E+K P  +        +   P   
Sbjct: 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334

Query: 342 ---------------VDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
                           DL+ R   Y P  R     A  H FF +  D
Sbjct: 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  195 bits (499), Expect = 6e-60
 Identities = 72/344 (20%), Positives = 123/344 (35%), Gaps = 68/344 (19%)

Query: 59  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--- 115
           +G E  +    ++ GR         Y     +G+G    VFQ    E  +I AIK V   
Sbjct: 13  LGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLE 63

Query: 116 -LQDKRYKN--RELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIA 170
              ++   +   E+  +  L   +  I+ L          + +Y+  V+E     +N   
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWL 118

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
           +      + +     K Y   +  A+  IH   GI H D+KP N L+      LKL DFG
Sbjct: 119 KK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFG 171

Query: 231 SAKVLVKGEPNV---SYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAE 277
            A  +     +V   S + +  Y  PE I             ++ +   D+WS GC++  
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231

Query: 278 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL 337
           +  G+  F         +  I             ++PN+ E +FP I             
Sbjct: 232 MTYGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI------------P 265

Query: 338 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 381
             +  D++    +  P  R +  E   HP+      P  ++  G
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  195 bits (497), Expect = 4e-59
 Identities = 79/346 (22%), Positives = 131/346 (37%), Gaps = 82/346 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
           ++    +G G+FG V   +  +  +  A+K V   K+Y      E  I++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 136 NIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLIY 184
           NIV     F         F     E L  +L  ++            NY        +  
Sbjct: 97  NIVKYHGKFMYYDHMCLIF-----EPLGPSLYEIIT---------RNNY----NGFHIED 138

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTH--------------------- 222
           +KLY  +I +AL Y+     + H D+KP+N LL +P+                       
Sbjct: 139 IKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 223 --QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
              +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  
Sbjct: 198 STGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYT 254

Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKPHPWHK 331
           G  LF     ++ L  +  ++    +  +         K +N +  +  +P+        
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314

Query: 332 VFQKRLPPEA--------VDLVCRFFQYSPNLRCTALEACVHPFFD 369
              K+  P           D +    Q  P LR +  E   H F +
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  194 bits (495), Expect = 6e-59
 Identities = 79/354 (22%), Positives = 129/354 (36%), Gaps = 76/354 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
           Y     +G G+FG V +      G   VA+K +    +Y+     E+ +++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
               V +   F         F     E L  N    L+           N+    Q  PL
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAF-----ELLGKNTFEFLK---------ENNF----QPYPL 122

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 224
            +V+   YQ+C AL ++H    + H D+KP+N+L                         +
Sbjct: 123 PHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
           ++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E   G  L
Sbjct: 182 RVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTL 238

Query: 285 FPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKPHPWHKVFQK 335
           F      + LV + K+LG      I               + E            K  + 
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298

Query: 336 RLPPEA------VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 383
            +  ++       DL+ R  ++ P  R T  EA +HPFF  L          R 
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  193 bits (493), Expect = 8e-59
 Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 60/319 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN- 136
           Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 137 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            I+ L          + +Y+  V+E     +N   +      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 120

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 252
           +  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 253 PELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           PE I             ++ +   D+WS GC++  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
                    ++PN+ E +FP I               +  D++    +  P  R +  E 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 363 CVHPFFDELRDPNTRLPNG 381
             HP+      P  ++  G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  195 bits (496), Expect = 1e-58
 Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 60/325 (18%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQM 131
           S +   Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 132 LDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
           L   +  I+ L          + +Y+  V+E     +N   +      + +     K Y 
Sbjct: 111 LQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYW 161

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYIC 246
             +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + 
Sbjct: 162 KNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 247 SRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
           +  Y  PE I             ++ +   D+WS GC++  +  G+  F         + 
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 356
            I             ++PN+ E +FP I               +  D++    +  P  R
Sbjct: 279 AI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQR 312

Query: 357 CTALEACVHPFFDELRDPNTRLPNG 381
            +  E   HP+      P  ++  G
Sbjct: 313 ISIPELLAHPYVQIQTHPVNQMAKG 337

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  192 bits (490), Expect = 1e-58
 Identities = 58/304 (19%), Positives = 110/304 (36%), Gaps = 27/304 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L      TT +    L  ++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTRH-KVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 197 AYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 254 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 304
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 365 HPFF 368
               
Sbjct: 303 ETSD 306

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  191 bits (487), Expect = 6e-58
 Identities = 79/345 (22%), Positives = 135/345 (39%), Gaps = 76/345 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q+++ L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
               V +   F         F     E L L+    ++            +        L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVF-----ELLGLSTYDFIK---------ENGF----LPFRL 117

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 224
            +++   YQIC+++ ++H+   + H D+KP+N+L                         +
Sbjct: 118 DHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 284
           K+ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  LG  +
Sbjct: 177 KVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 285 FPGESGVDQLVEIIKVLGTPTREEI-KCMNPNY---TEFKFPQIKP-----HPWHKVFQK 335
           FP     + L  + ++LG   +  I K     Y       + +            K  ++
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293

Query: 336 RLPPE------AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
            +  +        DL+ +  +Y P  R T  EA  HPFFD L+  
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  187 bits (477), Expect = 1e-56
 Identities = 67/287 (23%), Positives = 106/287 (36%), Gaps = 49/287 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM-QMLDHPNIVALK 141
            +G GS+G VF+ + +E G + A+K+ +      +D+  K  E+    ++  HP  V L+
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    +   LY  L  E    +   + ++       +P   V  Y      ALA++H+
Sbjct: 124 QAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             G+ H D+KP N+ + P     KL DFG    L              Y APEL+     
Sbjct: 176 Q-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGS 231

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y TA D++S G  + E+     L  G  G  QL +                         
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--------------------- 270

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           P+             L  E   ++    +  P LR TA      P  
Sbjct: 271 PEFTAG---------LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  185 bits (473), Expect = 2e-56
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 42/299 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++  +D RY      E+ + + L H NIV      
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +  +  E  ++ + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN 141

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGATE 261
             I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I     
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 262 -YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
            Y  A DIWS GC + E+  G+P F       +L E    +                 FK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------FK 237

Query: 321 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 379
               K HP      + +  EA   + + F+  P+ R  A +  V  F           P
Sbjct: 238 VGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  189 bits (482), Expect = 4e-56
 Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 51/302 (16%)

Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIV 138
           K+S+  + V+G G+ G +   +       VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                      K+  +  + +E         + +         P+  ++    Q    LA
Sbjct: 82  RYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLA 132

Query: 198 YIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNVSY---IC-SRY 249
           ++H+   I HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  
Sbjct: 133 HLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 250 YRAPELIFGATE--YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 306
           + APE++    +   T  +DI+S GCV   ++  G   F                G   +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQ 235

Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
            +   +            + H             A +L+ +     P  R +A     HP
Sbjct: 236 RQANILLGAC-SLDCLHPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHP 285

Query: 367 FF 368
           FF
Sbjct: 286 FF 287

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  186 bits (474), Expect = 1e-55
 Identities = 58/394 (14%), Positives = 105/394 (26%), Gaps = 57/394 (14%)

Query: 22  SSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQK 81
           S   + D   R++L+          E+   EP  +      T           +  S+ +
Sbjct: 2   SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61

Query: 82  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDH 134
                   +  G   VVF  +  E  E  A+K                +        L  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 135 PNIVALKHCF---------------------FSTTDKEELYLNLVLEYVP---ETVNRIA 170
            +    +                            D       L++       E +    
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230
                      ++ + + T Q+ R  A + +  G+ H    P NL + P    L L D  
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVS 239

Query: 231 SAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGES 289
           +   +  G    +      Y   E +      +T A++ W  G  +  +      F   +
Sbjct: 240 ALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
              +       L  P  +                             LP     L+ RF 
Sbjct: 298 PGIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFL 337

Query: 350 QYSPNLRCTALEACVHPFFDELRD-PNTRLPNGR 382
            +    R   LEA   P F +L++  ++ L  G+
Sbjct: 338 NFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  186 bits (475), Expect = 1e-55
 Identities = 63/313 (20%), Positives = 115/313 (36%), Gaps = 32/313 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L      TT +      L++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125

Query: 197 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 254 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 304
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 365 HPFFDELRDPNTR 377
             FF E  D   R
Sbjct: 300 --FFAETSDILHR 310

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  181 bits (461), Expect = 2e-54
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 61/320 (19%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD 133
           + +    +    V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60

Query: 134 HPNIVALKHCF--------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
           H  +V     +          T  K++  L + +EY       + I        +     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +    QI  AL+YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK + +    + 
Sbjct: 121 LFR----QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILK 174

Query: 244 YICSR---------------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288
                                Y A E++ G   Y   ID++S G +  E++   P   G 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGM 232

Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
                 V I+K L +                +FP     P    F          ++   
Sbjct: 233 E----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLL 267

Query: 349 FQYSPNLRCTALEACVHPFF 368
             + PN R  A       + 
Sbjct: 268 IDHDPNKRPGARTLLNSGWL 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  184 bits (469), Expect = 3e-54
 Identities = 75/323 (23%), Positives = 127/323 (39%), Gaps = 60/323 (18%)

Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD 133
           N     K   ++E ++G GS G V   +    G  VA+K++L D       E++++   D
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66

Query: 134 -HPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARN--YSRIHQRMPLIYVKLYT 189
            HPN++   +C  +      LY+   LE       + +          +           
Sbjct: 67  DHPNVIRY-YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVK 237
            QI   +A++H+   I HRD+KPQN+LV+  +             ++ + DFG  K L  
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 238 GEPNVSY----IC-SRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL-LGQPLF 285
           G+ +          +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 345
             +    +   II+                   F   ++K      +       EA DL+
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276

Query: 346 CRFFQYSPNLRCTALEACVHPFF 368
            +   + P  R TA++   HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  179 bits (457), Expect = 4e-54
 Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V          D+    L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 197 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 251
              H        + HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y    DIWS GC++ EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                 E KF +I               E  +++ R        R +  E   +P   E
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  188 bits (478), Expect = 7e-54
 Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 29/322 (9%)

Query: 72  GGRNGNSKQKV--SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----R 124
           GGR+ +   +    +  +  +GTG FG V +   ++TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP--ETVNRIARNYSRIHQRMP 181
           E+QIM+ L+HPN+V+ +             L  L +EY    +    + +        + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119

Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGE 239
              ++     I  AL Y+H    I HRD+KP+N+++ P   +   K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
               ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ----YSPNL 355
                + E I   +      KF  + P P        L       + R+ Q    +    
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTP------NHLSGILAGKLERWLQCMLMWHQRQ 288

Query: 356 RCTALEACVHPFFDELRDPNTR 377
           R T  +      F  L    + 
Sbjct: 289 RGTDPQNPNVGCFQALDSILSL 310

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  184 bits (468), Expect = 2e-53
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 52/318 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y     +G+G++G V   + + T    AIK +               E+ ++++LDHPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L   F     +++    LV+E     E  + I     ++        +   +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE-------VDAAVIIKQVL 146

Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
             + Y+H    I HRD+KP+N LL +      +K+ DFG + V    +     + + YY 
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++    +Y    D+WS G ++  LL G P F G++  DQ  EI+         +++ 
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
               +            W  V        A DL+ +  Q+    R +A +A  HP+  E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 372 RDPNTRLPNGRPLPPLFN 389
                       L     
Sbjct: 299 CSKKESGIELPSLANAIE 316

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  182 bits (465), Expect = 3e-53
 Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 49/296 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K +    ++ K  K    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ L   F     +++ Y  LV E     E  + I        +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLS 137

Query: 195 ALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRA 252
            + Y+H    I HRD+KP+N LL +      +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE++ G   Y    D+WSTG ++  LL G P F G +  +   +I+        ++++  
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              +            W KV        A DL+ +   Y P++R +A +A  H + 
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  182 bits (464), Expect = 4e-53
 Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 52/318 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y    ++G GSFG V + K R T +  A+K +       +D     RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
             + Y+H    I HRD+KP+N LL +      +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++ G   Y    D+WS G ++  LL G P F G++  +   +I+        + ++ 
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
               +            W  +       +A DL+ +   + P+LR TA +   HP+  + 
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 372 RDPNTRLPNGRPLPPLFN 389
                 + +   L     
Sbjct: 284 SSETPTISDLPSLESAMT 301

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  177 bits (450), Expect = 9e-53
 Identities = 66/328 (20%), Positives = 103/328 (31%), Gaps = 56/328 (17%)

Query: 70  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRE 125
            I  ++        Y+    +G G F  V   +    G   A+K++L    QD+    RE
Sbjct: 25  IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76

Query: 126 LQIMQMLDHPNIVALKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
             + ++ +HPNI+ L          K E +  L+L +    T+             +   
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----- 238
            +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS            
Sbjct: 135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSR 192

Query: 239 -----EPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 291
                +   +  C+  YRAPEL             D+WS GCV+  ++ G+  +      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 292 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 351
              V +  V                 +   PQ            R       L+      
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286

Query: 352 SPNLRCTALEACVHPFFDELRDPNTRLP 379
            P+ R             +   P     
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQHTT 314

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  175 bits (447), Expect = 1e-52
 Identities = 77/327 (23%), Positives = 121/327 (37%), Gaps = 68/327 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 77  VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 126

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 245
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 127 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 180

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K      
Sbjct: 181 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 230

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 231 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 266

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKP 392
            FF     P         +PP F+  P
Sbjct: 267 EFFTSGYIPARLPITCLTIPPRFSIAP 293

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  181 bits (460), Expect = 2e-52
 Identities = 81/306 (26%), Positives = 127/306 (41%), Gaps = 59/306 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------------REL 126
           Y     +G+G++G V   K +      AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY 184
            +++ LDHPNI+ L   F    DK+  Y  LV E+    E   +I  N  +  +      
Sbjct: 98  SLLKSLDHPNIIKLFDVF---EDKKYFY--LVTEFYEGGELFEQII-NRHKFDEC----D 147

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNV 242
                 QI   + Y+H    I HRDIKP+N LL N ++   +K+ DFG +    K     
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206

Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
             + + YY APE++    +Y    D+WS G +M  LL G P F G++  DQ  +II    
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
               ++++     +          + W  +       EA +L+     Y  N RCTA EA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 363 CVHPFF 368
               + 
Sbjct: 300 LNSRWI 305

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  178 bits (454), Expect = 3e-52
 Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 54/305 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQM 131
           YI    +G+G+ G V  A  R+T + VAI+ + + K                 E++I++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 245

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 247
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 360

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 361 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 366 PFFDE 370
           P+  +
Sbjct: 401 PWLQD 405

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  174 bits (444), Expect = 3e-52
 Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 56/297 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
            +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            + ST   ++  + LV E +   T+    + Y +  + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 202 C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSRYYRAP 253
               I HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E+     +Y  ++D+++ G  M E+   +  +       Q+   +               
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------------- 243

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                     +KP      F K   PE  +++    + + + R +  +   H FF E
Sbjct: 244 --------SGVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  175 bits (446), Expect = 6e-52
 Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 47/292 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKH 142
              +  VG GSFG V + K ++TG   A+KKV L+   ++  EL     L  P IV L  
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  +E  ++N+ +E +   ++ ++ +        +P      Y  Q    L Y+H 
Sbjct: 118 AV-----REGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHT 168

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPEL 255
              I H D+K  N+L++    +  LCDFG A  L       S +          + APE+
Sbjct: 169 R-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           + G       +DIWS+ C+M  +L G   +         ++I      P           
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI---------- 275

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                  +I P            P     +    +  P  R +A+E      
Sbjct: 276 ------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  174 bits (444), Expect = 1e-51
 Identities = 80/327 (24%), Positives = 122/327 (37%), Gaps = 68/327 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 103 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 152

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 245
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 153 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 206

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               Y APE++     ++  +D+WS GC+M  LL+G+P F        L E        T
Sbjct: 207 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKE--------T 249

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
              IK       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 250 YLRIKK-----NEYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 292

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKP 392
            FF     P         +PP F+  P
Sbjct: 293 EFFTSGYIPARLPITCLTIPPRFSIAP 319

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  172 bits (439), Expect = 2e-51
 Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 46/317 (14%)

Query: 65  HVIRTTIGGRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQ 117
           H    + G  N   +  +   +I +  +G+G+FG V   + R +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSR 175
                  E+++++ LDHPNI+ +   F    D   +Y  +V+E     E + RI    +R
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMY--IVMETCEGGELLERIVSAQAR 117

Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK 233
             + +   YV     Q+  ALAY H+   + H+D+KP+N+L    +    +K+ DFG A+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 293
           +    E + +   +  Y APE+     + T   DIWS G VM  LL G   F G S  + 
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
             +                     E  +               L P+AVDL+ +     P
Sbjct: 234 QQKATYK-----------------EPNYA---VECRP------LTPQAVDLLKQMLTKDP 267

Query: 354 NLRCTALEACVHPFFDE 370
             R +A +   H +F +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  176 bits (447), Expect = 2e-51
 Identities = 87/360 (24%), Positives = 135/360 (37%), Gaps = 48/360 (13%)

Query: 41  DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
            +V    D     D            +   +  + G+      Y     +G+G+FGVV +
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEELGSGAFGVVHR 69

Query: 101 AKCRETGEIVAIK----KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
              + TG +   K        DK     E+ IM  L HP ++ L   F    DK E+   
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---EDKYEMV-- 124

Query: 157 LVLEYVP--ETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213
           L+LE++   E  +RI A +Y      M    V  Y  Q C  L ++H    I H DIKP+
Sbjct: 125 LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPE 178

Query: 214 NLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 272
           N++        +K+ DFG A  L   E       +  + APE I          D+W+ G
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIG 237

Query: 273 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 332
            +   LL G   F GE  ++ L  + +                  +++F       +  V
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRC-----------------DWEFD---EDAFSSV 277

Query: 333 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPNGRPLPPLFNFK 391
                 PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R        K
Sbjct: 278 -----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 332

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  172 bits (438), Expect = 3e-51
 Identities = 58/305 (19%), Positives = 110/305 (36%), Gaps = 52/305 (17%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           + +  + +    ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH N
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65

Query: 137 IVALKHCF-----------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
           IV    C+            +++  +   L + +E+         I +   R  +++  +
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKV 122

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
                  QI + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
              +  Y +PE I    +Y   +D+++ G ++AELL                ++      
Sbjct: 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD---- 233

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                                       +       +   L+ +     P  R    E  
Sbjct: 234 ---------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

Query: 364 VHPFF 368
                
Sbjct: 267 RTLTV 271

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  172 bits (439), Expect = 3e-51
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 60/302 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
           +  E  +G G F  V++A C   G  VA+KKV        + +    +E+ +++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           ++     F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C A
Sbjct: 94  VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNVSYIC 246
           L ++H+   + HRDIKP N+ +   T  +KL D G  +           + G P      
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 247 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 305
             YY +PE I     Y    DIWS GC++ E+   Q  F G+   +  L + I+      
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       +  +P +               E   LV       P  R         
Sbjct: 252 ------------QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 366 PF 367
             
Sbjct: 292 AK 293

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  172 bits (437), Expect = 4e-51
 Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 66/306 (21%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKHC 143
           G G FG V+ A+ +++  I+A+K     ++ +        RE++I   L HPNI+ L   
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    D   +Y  L+LEY P       + +       +        Y  ++  AL+Y H+
Sbjct: 78  FH---DATRVY--LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS 127

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRAPE 254
              + HRDIKP+NLL+      LK+ DFG +            G  +        Y  PE
Sbjct: 128 K-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLPPE 177

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +I G   +   +D+WS G +  E L+G+P F   +  +    I +V              
Sbjct: 178 MIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 222

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
              EF FP      +       +   A DL+ R  +++P+ R    E   HP+       
Sbjct: 223 ---EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267

Query: 375 NTRLPN 380
            +   N
Sbjct: 268 PSNCQN 273

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  172 bits (438), Expect = 6e-51
 Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 54/303 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN--------RELQIMQM 131
           YI    +G+G+ G V  A  R+T + VAIK    +       +          E++I++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 72  LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 120

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 247
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 121 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 248 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 235

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 236 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 275

Query: 366 PFF 368
           P+ 
Sbjct: 276 PWL 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  171 bits (437), Expect = 7e-51
 Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 52/306 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIVA 139
           +I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRA 195
           L+  +         Y  LV++ V   E  +RI     Y+   ++   + ++    Q+  A
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118

Query: 196 LAYIHNCIGICHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRA 252
           + Y+H   GI HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE +     Y+ A+D WS G +   LL G P F  E+      +I +             
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                 ++F       W  +        A D +C   +  PN R T  +A  HP+ D   
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269

Query: 373 DPNTRL 378
             +  +
Sbjct: 270 ALHRDI 275

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  170 bits (433), Expect = 1e-50
 Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 52/307 (16%)

Query: 76  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIM 129
           G++K  ++  Y  E+ +G GS+G V  A  + T    A K      ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
           + LDHPNI+ L   F    D  ++Y  LV+E     E   R+     +            
Sbjct: 61  KSLDHPNIIRLYETF---EDNTDIY--LVMELCTGGELFERVVHKRVFRE-------SDA 108

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVS 243
                 +  A+AY H    + HRD+KP+N L    +    LKL DFG A     G+   +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

Query: 244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +    
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          F FP      W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 364 VHPFFDE 370
            H +F++
Sbjct: 261 EHEWFEK 267

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  172 bits (438), Expect = 1e-50
 Identities = 82/348 (23%), Positives = 133/348 (38%), Gaps = 84/348 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---------QDKRYKNRELQIMQMLDH 134
           Y  +  +G GS+GVV  A   +T  I AIK +          +D      E+++M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKL----- 187
           PNI  L   +    D++ + L  V+E       ++++         +  +  VK      
Sbjct: 88  PNIARLYEVY---EDEQYICL--VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 188 ------------------------------YTYQICRALAYIHNCIGICHRDIKPQN-LL 216
                                            QI  AL Y+HN  GICHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201

Query: 217 VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-----SRYYRAPELIFGATE-YTTAIDIWS 270
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 271 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 330
            G ++  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 331 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
            +      P A DL+      + + R  A+ A  HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  172 bits (438), Expect = 1e-50
 Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 48/294 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V  +  F     +E   L +V++Y    +   RI     +         +  +  QIC A
Sbjct: 86  VQYRESF-----EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLA 137

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L ++H+   I HRDIK QN+ +      ++L DFG A+VL            + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +      Y    DIW+ GCV+ EL   +  F   S +  LV  I             ++ 
Sbjct: 196 ICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------SGSFPPVSL 247

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
           +Y                       +   LV + F+ +P  R +        F 
Sbjct: 248 HY---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  169 bits (431), Expect = 8e-50
 Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 54/295 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVA---IKKVLQDKRYKNRELQIMQMLDHPNIVAL 140
           Y+    +G G FG+V +     + +      +K    D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VKLYTYQIC 193
              F      EEL   ++ E++   +   RI    +               +  Y +Q+C
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112

Query: 194 RALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 251
            AL ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y 
Sbjct: 113 EALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYY 170

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE +      +TA D+WS G ++  LL G   F  E+  +Q  +II        E I  
Sbjct: 171 APE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMN 217

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
               + E  F +I               EA+D V R        R TA EA  HP
Sbjct: 218 AEYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  169 bits (431), Expect = 1e-49
 Identities = 62/325 (19%), Positives = 122/325 (37%), Gaps = 52/325 (16%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN----------------RELQIM 129
             G F  +      +  +  A+K      + + + +                   ELQI+
Sbjct: 40  NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIY 184
             + +   +  +      T+ +E+Y+  + EY+      +               +P+  
Sbjct: 98  TDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +K     +  + +YIHN   ICHRD+KP N+L++ +   +KL DFG ++ +V  +   S 
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKKIKGS- 210

Query: 245 IC-SRYYRAPELIFGATEY-TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
              +  +  PE     + Y    +DIWS G  +  +      F  +  + +L   I+   
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR--- 266

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
               + I+   P      F     +         L  E +D +  F + +P  R T+ +A
Sbjct: 267 ---TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 363 CVHPFF-----DELRDPNTRLPNGR 382
             H +      ++LR+ +  L   R
Sbjct: 321 LKHEWLADTNIEDLREFSKELYKKR 345

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  167 bits (426), Expect = 1e-49
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 67/305 (21%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
           G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L + 
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    D   +Y  LVLE     E    +        +       + + +QI   + Y+H+
Sbjct: 80  F---EDSNYVY--LVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS 130

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYICSRYYRA 252
             GI HRD+   NLL+  +   +K+ DFG + ++ +  E        PN        Y +
Sbjct: 131 H-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPN--------YIS 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+    + +    D+WS GC+   LL+G+P F  ++  + L +++              
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------------ 227

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                +++ P      +       L  EA DL+ +  + +P  R +      HPF     
Sbjct: 228 -----DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

Query: 373 DPNTR 377
              ++
Sbjct: 271 STKSK 275

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  167 bits (426), Expect = 2e-49
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 52/299 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y    ++G GSFG V + K R T +  A+K + +            RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
             + Y+H    I HRD+KP+N+L+        +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APE++ G   Y    D+WS G ++  LL G P F G++  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                 ++ F       W  +       +A DL+ +   + P+LR TA +   HP+  +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  169 bits (431), Expect = 2e-49
 Identities = 85/325 (26%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
           Y    V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLY 188
           P+IV L   +   +    LY  +V E++   +    I +           +Y       Y
Sbjct: 86  PHIVELLETY---SSDGMLY--MVFEFMDGADLCFEIVK-----RADAGFVYSEAVASHY 135

Query: 189 TYQICRALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC 246
             QI  AL Y H+   I HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 247 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            + ++ APE +     Y   +D+W  G ++  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                       ++K     P  W  +        A DLV R     P  R T  EA  H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNF 390
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  167 bits (424), Expect = 3e-49
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 66/296 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
            +G G FG V+ A+ ++   I+A+K     ++ ++       RE++I   L HPNI+ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D++ +Y  L+LE+ P  E    + +     H R        +  ++  AL Y 
Sbjct: 81  NYFH---DRKRIY--LMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYC 130

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRA 252
           H    + HRDIKP+NLL+      LK+ DFG +            G  +        Y  
Sbjct: 131 HER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YLP 180

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE+I G   +   +D+W  G +  E L+G P F   S  +    I+ V            
Sbjct: 181 PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                + KFP     P+       L   + DL+ +  +Y P  R        HP+ 
Sbjct: 228 -----DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  173 bits (441), Expect = 4e-49
 Identities = 76/308 (24%), Positives = 130/308 (42%), Gaps = 45/308 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
           Y     +GTG+FGVV +   R TG   A K V      DK    +E+Q M +L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L   F    D  E+   ++ E++   E   ++A  ++++ +   + Y++    Q+C+ L 
Sbjct: 219 LHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF--DELRDP 374
            +  F  I               +  D + +     PN R T  +A  HP+         
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 375 NTRLPNGR 382
           ++++P+ R
Sbjct: 423 DSQIPSSR 430

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  167 bits (424), Expect = 4e-49
 Identities = 58/339 (17%), Positives = 101/339 (29%), Gaps = 90/339 (26%)

Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQ- 127
           G     S+    +     +G+G FG VF+   R  G I AIK+    L     +   L+ 
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 128 ---IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
                 +  H ++V     +      E+ ++ +  EY    ++        RI       
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH------------------THQLK 225
            +K    Q+ R L YIH+   + H DIKP N+ ++                        K
Sbjct: 116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 226 LCDFGSAKVL-----VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 280
           + D G    +      +G+          + A E++     +    DI++    +     
Sbjct: 175 IGDLGHVTRISSPQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAG 226

Query: 281 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP- 339
            +PL                                            WH++ Q RLP  
Sbjct: 227 AEPLPRNG--------------------------------------DQWHEIRQGRLPRI 248

Query: 340 ------EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                 E  +L+       P  R +A+    H       
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  167 bits (424), Expect = 4e-49
 Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 60/318 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIV 138
           +     +G G FGVVF+AK +      AIK++        +    RE++ +  L+HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 139 ALKHCFF-------STTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTY 190
              + +              ++YL + ++    E +         I +R           
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-- 248
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 249 -----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 297
                       Y +PE I G   Y+  +DI+S G ++ ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
           ++                    KFP +              P    +V      SP  R 
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272

Query: 358 TALEACVHPFFDELRDPN 375
            A+    +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  168 bits (427), Expect = 4e-49
 Identities = 79/319 (24%), Positives = 129/319 (40%), Gaps = 45/319 (14%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHC 143
           +++ V+G G  G V +   R TG+  A+K +L D     +E+         P+IV +   
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD- 89

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
            +      +  L +++E +   E        +SRI +R    +           I  A+ 
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           ++H+   I HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE
Sbjct: 143 FLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE 199

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            + G  +Y  + D+WS G +M  LL G P F   +G      + +         I+    
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-- 248

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRD 373
              ++ FP      W +V       +A  L+    +  P  R T  +   HP+    +  
Sbjct: 249 ---QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

Query: 374 PNTRLPNGRPLPPLFNFKP 392
           P T L   R L    +   
Sbjct: 298 PQTPLHTARVLQEDKDHWD 316

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  169 bits (429), Expect = 5e-49
 Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 45/304 (14%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNREL 126
           +  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLI 183
            +M  LDH N++ L   F     K ++   LV+EYV   E  +RI   +Y+     +  +
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTEL 187

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNV 242
              L+  QIC  + ++H    I H D+KP+N+L VN    Q+K+ DFG A+     E   
Sbjct: 188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246

Query: 243 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
               +  + APE +      +   D+WS G +   LL G   F G++  + L  I+    
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
                           +         +  +       EA + + +      + R +A EA
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

Query: 363 CVHP 366
             HP
Sbjct: 341 LKHP 344

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  167 bits (425), Expect = 5e-49
 Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 59/326 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYT 189
           H N++ L   +    ++ ++   L+LE V   E  + +A+  + S             + 
Sbjct: 74  HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSE-------EEATSFI 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
            QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 247 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
            +  + APE I          D+WS G +   LL G   F G++  + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                        + F       +           A D + +        R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFK 391
           P+     D    +     +  L NF+
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFR 298

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  167 bits (425), Expect = 1e-48
 Identities = 87/291 (29%), Positives = 123/291 (42%), Gaps = 46/291 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           +  E  +G G+  +V++ K + T +  A+K + +    K    E+ ++  L HPNI+ LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
             F       E+   LVLE V   E  +RI     YS   +R     VK    QI  A+A
Sbjct: 115 EIF---ETPTEIS--LVLELVTGGELFDRIVEKGYYS---ERDAADAVK----QILEAVA 162

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           Y+H   GI HRD+KP+NLL   P     LK+ DFG +K++       +   +  Y APE 
Sbjct: 163 YLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE- 220

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           I     Y   +D+WS G +   LL G   F  E G   +   I            C    
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC---- 266

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
             E+ F       W +V        A DLV +     P  R T  +A  HP
Sbjct: 267 --EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  165 bits (420), Expect = 1e-48
 Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 62/314 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG+  A K          +    +    RE+ I++ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
           HPNI+ L   F    +K ++   L+LE V   E  + +A   S                 
Sbjct: 67  HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKES---------LTEDEATQ 112

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +  QI   + Y+H+   I H D+KP+N+++   N    ++KL DFG A  +  G      
Sbjct: 113 FLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKN 170

Query: 245 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           I  +  + APE I          D+WS G +   LL G   F GE+  + L  I  V   
Sbjct: 171 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV--- 226

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          + F       +           A D + R     P  R T  ++ 
Sbjct: 227 --------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSL 264

Query: 364 VHPFFDELRDPNTR 377
            H +   +R  N R
Sbjct: 265 EHSWIKAIRRRNVR 278

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  167 bits (424), Expect = 2e-48
 Identities = 80/319 (25%), Positives = 120/319 (37%), Gaps = 51/319 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 91  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138

Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 139 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                  + +P      W  V      PEA  L+      +P  R TA +A   P+    
Sbjct: 246 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 372 RDPNTRLPNGRPLPPLFNF 390
               + +     +  L  F
Sbjct: 292 ERVASAIHRQDTVDCLKKF 310

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  165 bits (421), Expect = 3e-48
 Identities = 71/328 (21%), Positives = 121/328 (36%), Gaps = 63/328 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F VV + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
           HPN++ L   +    +K ++   L+LE V   E  + +A   S                 
Sbjct: 73  HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKES---------LTEEEATE 118

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           +  QI   + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G      
Sbjct: 119 FLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKN 176

Query: 245 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
           I  +  + APE I          D+WS G +   LL G   F G++  + L  +  V   
Sbjct: 177 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--- 232

Query: 304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                          ++F       +           A D + R     P  R T  ++ 
Sbjct: 233 --------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSL 270

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFK 391
            HP+    +D    L        +  FK
Sbjct: 271 QHPWIKP-KDTQQALSRKASAVNMEKFK 297

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  167 bits (424), Expect = 4e-48
 Identities = 83/311 (26%), Positives = 124/311 (39%), Gaps = 42/311 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRAL 196
             +         L +V+E +   E        +SRI  R    +           I  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 197 AYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 254
            Y+H+   I HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            + G  +Y  + D+WS G +M  LL G P F    G+     +           I+    
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR---- 280

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 373
              +++FP      W +V       E   L+    +  P  R T  E   HP+  +    
Sbjct: 281 -MGQYEFPN---PEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

Query: 374 PNTRLPNGRPL 384
           P T L   R L
Sbjct: 332 PQTPLHTSRVL 342

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  165 bits (421), Expect = 5e-48
 Identities = 71/329 (21%), Positives = 118/329 (35%), Gaps = 65/329 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VK 186
           HPNI+ L   +    ++ ++   L+LE V   E  + +  +                   
Sbjct: 74  HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKES----------LSEEEAT 118

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVS 243
            +  QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G     
Sbjct: 119 SFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176

Query: 244 YIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
            I  +  + APE I          D+WS G +   LL G   F G++  + L  I  V  
Sbjct: 177 NIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-- 233

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 362
                           + F       + +         A D + +        R T  EA
Sbjct: 234 ---------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEA 270

Query: 363 CVHPFFDELRDPNTRLPNGRPLPPLFNFK 391
             HP+     D    +     +  L NFK
Sbjct: 271 LRHPWITP-VDTQQAMVRRESVVNLENFK 298

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  167 bits (426), Expect = 6e-48
 Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 52/320 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G+F VV +      G+  A   +   K          RE +I ++L HPNI
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L       +++   Y  L+ + V   E    I     YS   +      ++    QI 
Sbjct: 73  VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYS---EADASHCIQ----QIL 120

Query: 194 RALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
            A+ + H   G+ HR++KP+NLL  +      +KL DFG A  +   +        +  Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            +PE +     Y   +D+W+ G ++  LL+G P F  E       +I             
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                   + FP      W  V      PEA DL+ +    +P+ R TA EA  HP+   
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

Query: 371 LRDPNTRLPNGRPLPPLFNF 390
                + +     +  L  F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  165 bits (419), Expect = 6e-48
 Identities = 74/319 (23%), Positives = 125/319 (39%), Gaps = 59/319 (18%)

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           H I   +   +        Y  +  +G GS+ V  +   + T    A+K + + KR    
Sbjct: 7   HSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64

Query: 125 ELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS----- 174
           E++I+     HPNI+ LK  +    D + +Y  +V E +   E +++I R   +S     
Sbjct: 65  EIEILLRYGQHPNIITLKDVY---DDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS 119

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGS 231
            +             + I + + Y+H   G+ HRD+KP N+L    + +   +++CDFG 
Sbjct: 120 AV------------LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGF 166

Query: 232 AKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           AK L      +   C +  + APE +     Y  A DIWS G ++  +L G   F     
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 291 VDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 349
                 + ++  G               +F         W+ V        A DLV +  
Sbjct: 226 DTPEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKML 262

Query: 350 QYSPNLRCTALEACVHPFF 368
              P+ R TA     HP+ 
Sbjct: 263 HVDPHQRLTAALVLRHPWI 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  161 bits (411), Expect = 2e-47
 Identities = 78/297 (26%), Positives = 115/297 (38%), Gaps = 51/297 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 68  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115

Query: 194 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                  + +P      W  V      PEA  L+      +P  R TA +A   P+ 
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  161 bits (410), Expect = 1e-46
 Identities = 68/309 (22%), Positives = 113/309 (36%), Gaps = 52/309 (16%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH-P 135
           +    +G G F VV Q   + TG+  A K +   KR +          E+ ++++    P
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCP 89

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
            ++ L   +    +  E+   L+LEY    E  +        + + +    V     QI 
Sbjct: 90  RVINLHEVY---ENTSEII--LILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQIL 141

Query: 194 RALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
             + Y+H    I H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y
Sbjct: 142 EGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEY 199

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE I      TTA D+W+ G +   LL     F GE   +  + I +V          
Sbjct: 200 LAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---------- 248

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                     +       +  V        A D +      +P  R TA     H +  +
Sbjct: 249 -------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

Query: 371 LRDPNTRLP 379
               N   P
Sbjct: 294 WDFENLFHP 302

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  161 bits (409), Expect = 1e-46
 Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 42/311 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQMLD-HPNIVALK 141
            + +  +G GSF +  +   +++ +  A+K + +       +E+  +++ + HPNIV L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
             F    D+   +  LV+E +   E   RI +  ++S   +            ++  A++
Sbjct: 73  EVF---HDQLHTF--LVMELLNGGELFERIKKKKHFS---ETE----ASYIMRKLVSAVS 120

Query: 198 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           ++H+  G+ HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE
Sbjct: 121 HMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            +     Y  + D+WS G ++  +L GQ  F            ++++     ++IK    
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG-- 231

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 373
              +F F       W  V       EA DL+       PN R        + +  +    
Sbjct: 232 ---DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

Query: 374 PNTRLPNGRPL 384
            +  L     L
Sbjct: 281 SSNPLMTPDIL 291

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  160 bits (407), Expect = 2e-46
 Identities = 77/317 (24%), Positives = 121/317 (38%), Gaps = 62/317 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYK-NRELQIMQ 130
           Y  + ++G G   VV +   + T +  A+K            + +Q+ R    +E+ I++
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 131 MLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
            +  HPNI+ LK  +         +  LV + +   E  + +      S    R      
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR------ 127

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
                 +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE      
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVC 184

Query: 246 CSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
            +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I+  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
                             ++F       W             DLV RF    P  R TA 
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279

Query: 361 EACVHPFFDELRDPNTR 377
           EA  HPFF +      R
Sbjct: 280 EALAHPFFQQYVVEEVR 296

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  159 bits (403), Expect = 1e-45
 Identities = 70/327 (21%), Positives = 114/327 (34%), Gaps = 58/327 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQML-DHPNIV 138
                V+  G F  V++A+   +G   A+K++L    +  R   +E+  M+ L  HPNIV
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 139 ALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                     +         L+L  + +               +    V    YQ CRA+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 197 AYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EPNV 242
            ++H     I HRD+K +NLL++     +KLCDFGSA  +                E  +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 243 SYICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
           +   +  YR PE+I  +         DIW+ GC++  L   Q  F   +     + I+  
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVNG 264

Query: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360
                            ++  P   PH                L+    Q +P  R +  
Sbjct: 265 -----------------KYSIP---PHD-------TQYTVFHSLIRAMLQVNPEERLSIA 297

Query: 361 EACVHPFFDELRDPNTRLPNGRPLPPL 387
           E        E+       P   P+  L
Sbjct: 298 EVVHQLQ--EIAAARNVNPK-SPITEL 321

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  157 bits (398), Expect = 4e-45
 Identities = 79/307 (25%), Positives = 121/307 (39%), Gaps = 72/307 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++    Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D E+LY    L Y    E +  I +              + YT +I  AL Y+
Sbjct: 97  FTF---QDDEKLY--FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYL 146

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS---------YICSRYY 250
           H   GI HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+     
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV----- 199

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            +PEL+        + D+W+ GC++ +L+ G P F   +    + + I            
Sbjct: 200 -SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------- 245

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP------NLRCTALEACV 364
                  E+ FP            ++  P+A DLV +                       
Sbjct: 246 -----KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

Query: 365 HPFFDEL 371
           HPFF+ +
Sbjct: 289 HPFFESV 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  158 bits (401), Expect = 5e-45
 Identities = 52/338 (15%), Positives = 108/338 (31%), Gaps = 80/338 (23%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
            ++  + +   V+G        +A  +ETGE   +      +R  +        E+  ++
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128

Query: 131 ML-------------------------DHPNIVALKHCFFSTTDKEELYLNLVLEYVPET 165
           +L                             ++ ++            +L   ++   +T
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 225
              +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P +++++     + 
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VF 246

Query: 226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELI----------FGATEYTTAIDIWSTGCVM 275
           L  F      V+    V    SR +  PEL              T  T + D W+ G V+
Sbjct: 247 LTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 276 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 335
             +         ++ +               E I         F+              K
Sbjct: 304 YWIWCADLPITKDAALG------------GSEWI---------FRSC------------K 330

Query: 336 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            +P     L+  F +Y    R   L+A   P +++LR 
Sbjct: 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  156 bits (395), Expect = 3e-44
 Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 65/309 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----------KVLQDKRYK-NRELQIMQM 131
           Y  + V+G G   VV +   R TG   A+K           + L++ R    RE  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS-RIHQRMPLIYV 185
           +  HP+I+ L   +        ++  LV + +   E  + +      S +          
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEKVALSEK--------ET 202

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           +     +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +
Sbjct: 203 RSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LREL 259

Query: 246 C-SRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 299
           C +  Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319

Query: 300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 359
                             +++F       W             DL+ R  Q  P  R TA
Sbjct: 320 G-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354

Query: 360 LEACVHPFF 368
            +A  HPFF
Sbjct: 355 EQALQHPFF 363

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  155 bits (394), Expect = 9e-44
 Identities = 79/320 (24%), Positives = 135/320 (42%), Gaps = 61/320 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +G GSFG V   +  +T ++ A+K     K ++    R   +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D+E+++  +V++ +   +    + +N            VKL+  ++  AL Y+
Sbjct: 82  YSF---QDEEDMF--MVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYL 131

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-- 257
            N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+    
Sbjct: 132 QNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPN 315
               Y+ A+D WS G    ELL G+  +   S     ++V   +                
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---------------- 233

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDP 374
            T   +P                 E V L+ +  + +P+ R + L      P+     D 
Sbjct: 234 TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---NDI 278

Query: 375 N-TRLPNGRPLPPLFNFKPP 393
           N   +   R +P    F P 
Sbjct: 279 NWDAVFQKRLIPG---FIPN 295

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  153 bits (389), Expect = 2e-43
 Identities = 70/316 (22%), Positives = 129/316 (40%), Gaps = 33/316 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           +     +G G+ GVVF+   + +G ++A K +   ++        RELQ++   + P IV
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                F+S  +     +++ +E++   +++++ +   RI    P   +   +  + + L 
Sbjct: 95  GFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRI----PEQILGKVSIAVIKGLT 145

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           Y+     I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + 
Sbjct: 146 YLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQ 203

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G   Y+   DIWS G  + E+ +G+   P     +  +     +     E          
Sbjct: 204 GTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 318 EFKFPQIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEA 362
                 +   P   +F+           +LP      E  D V +    +P  R    + 
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322

Query: 363 CVHPFFDELRDPNTRL 378
            VH F           
Sbjct: 323 MVHAFIKRSDAEEVDF 338

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  152 bits (386), Expect = 3e-43
 Identities = 77/332 (23%), Positives = 126/332 (37%), Gaps = 65/332 (19%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQML-DHPNIVA 139
           + E V+G G+   V       T +  A+K    +    +    RE++++     H N++ 
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT-------- 189
           L   F    +++  Y  LV E +             S IH+R      + +         
Sbjct: 76  LIEFF---EEEDRFY--LVFEKMRGGSI-------LSHIHKR------RHFNELEASVVV 117

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------P 240
             +  AL ++HN  GI HRD+KP+N+L  +P     +K+CDF     +           P
Sbjct: 118 QDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 241 NVSYIC-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
            +   C S  Y APE++      A+ Y    D+WS G ++  LL G P F G  G D   
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 296 EIIKVLGTPTR---EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 352
           +  +          E I+       +++FP      W  +        A DL+ +     
Sbjct: 237 DRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRD 283

Query: 353 PNLRCTALEACVHPFFDELRDPNTRLPNGRPL 384
              R +A +   HP+      P   LP    L
Sbjct: 284 AKQRLSAAQVLQHPWVQG-CAPENTLPTPMVL 314

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  151 bits (384), Expect = 3e-43
 Identities = 72/288 (25%), Positives = 107/288 (37%), Gaps = 54/288 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +         L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 201 NCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL  +   +  LKL DFG                     A E    
Sbjct: 135 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-- 171

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F    G+     +           I+       +
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MGQ 218

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
           ++FP      W +V       E   L+    +  P  R T  E   HP
Sbjct: 219 YEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  154 bits (389), Expect = 6e-43
 Identities = 59/430 (13%), Positives = 125/430 (29%), Gaps = 93/430 (21%)

Query: 13  SSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPD--IIDGVGAETGHV-IRT 69
            +    GF+ +      +      +   +     E   S  D  +   +        + +
Sbjct: 12  ENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES 71

Query: 70  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------ 123
            +G R        + +   V+G        +A  +ETGE   +      +R  +      
Sbjct: 72  ELGER------PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 125

Query: 124 -RELQIMQML-------------------------DHPNIVALKHCFFSTTDKEELYLNL 157
             E+  +++L                             ++ ++            +L  
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185

Query: 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV 217
            ++   +T   +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P ++++
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVL 244

Query: 218 NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY----YRAPELIFGA----TEYTTAIDIW 269
           +     + L  F        G   VS I   +      A  ++       T  T A D W
Sbjct: 245 DQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301

Query: 270 STGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW 329
           + G  +  +         ++ +                                      
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALGGS----------------------------------- 326

Query: 330 HKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD---PNTRLPNGRPL 384
             +F+  K +P     L+  F +Y    R   L+A   P +++LR        L      
Sbjct: 327 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386

Query: 385 PPLFNFKPPG 394
           P      PP 
Sbjct: 387 PTREGGAPPS 396

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  153 bits (388), Expect = 9e-43
 Identities = 78/316 (24%), Positives = 121/316 (38%), Gaps = 73/316 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKR--YKNRELQIMQMLDHPNIVALK 141
           V+G G+F  V   K ++TG++ A+K      +L+         E  ++   D   I  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D+  LY  LV+EY    + +  +    S+  +R+P    + Y  +I  A+  +
Sbjct: 128 FAF---QDENYLY--LVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 251
           H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+      
Sbjct: 179 HR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL------ 230

Query: 252 APELI------FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
           +PE++       G   Y    D W+ G    E+  GQ  F  +S   +    I       
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------- 282

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEA 362
                 ++        P +            +P EA D + R     P  R     A + 
Sbjct: 283 ------VHYK-EHLSLPLVDEG---------VPEEARDFIQRLLC-PPETRLGRGGAGDF 325

Query: 363 CVHPFF-----DELRD 373
             HPFF     D LRD
Sbjct: 326 RTHPFFFGLDWDGLRD 341

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  153 bits (389), Expect = 1e-42
 Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 57/307 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K     ++L+         E  ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D   LY  LV++Y    + +  +    S+   R+P    + Y  ++  A+  +
Sbjct: 141 YAF---QDDNNLY--LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRAPELI- 256
           H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++ 
Sbjct: 192 HQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 257 ---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
               G   Y    D WS G  M E+L G+  F  ES + +    I             MN
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MN 295

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN-LRCT-ALEACVHPFF--- 368
                F+FP              +   A DL+ R      + L      +   HPFF   
Sbjct: 296 HK-ERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345

Query: 369 --DELRD 373
             D +R+
Sbjct: 346 DWDNIRN 352

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  151 bits (382), Expect = 2e-42
 Identities = 44/297 (14%), Positives = 92/297 (30%), Gaps = 36/297 (12%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIK----KVLQDKRYKNRELQIMQMLD 133
                H++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
               +           +    L  V E       +N I    +   + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----------LKLCDFGSAKVLVKGEPN 241
           +   +  +H+C  I H DIKP N ++     +          L L D G +  +      
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 242 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEI 297
               +   +  ++  E++     +   ID +     +  +L G  +    E G  +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 298 IKVL-GTPTREEIKCMNPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQ 350
            + L       E   +  N  +               KVFQ+    +   L  R   
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  150 bits (382), Expect = 3e-42
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 46/294 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           Y     +G+G+FGV    + + T E+VA+K       + +     RE+   + L HPNIV
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
             K    + T    L   +++EY    E   RI         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGV 129

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           +Y H+ + ICHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 256 IFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           +    EY     D+WS G  +  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
              ++  P              + PE   L+ R F   P  R +  E   H +F
Sbjct: 238 ---KYSIP---DDIR-------ISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  148 bits (377), Expect = 3e-42
 Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 59/326 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---RELQIMQMLDHP 135
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           N++ L    ++   K+++Y  +V+EY      E ++ +        +R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEE-KQKMY--MVMEYCVCGMQEMLDSVP------EKRFPVCQAHGYFCQ 117

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SR 248
           +   L Y+H+  GI H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHSQ-GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 249 YYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            ++ PE+  G   ++   +DIWS G  +  +  G   F G++        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
            I         +  P                P   DL+    +Y P  R +  +   H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 368 FDELRDPNTRLPNGRPLPPLFNFKPP 393
           F +   P        P+PP  + K  
Sbjct: 267 FRKKHPPAEAPV---PIPPSPDTKDR 289

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  151 bits (382), Expect = 1e-41
 Identities = 87/374 (23%), Positives = 150/374 (40%), Gaps = 70/374 (18%)

Query: 41  DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVS-----YIAEHVVGTGSF 95
             V +   + +  ++    G+ + +     +       K +V+     Y+   ++G G+F
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK--LLGKGTF 161

Query: 96  GVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFSTT 148
           G V   K + TG   A+K      ++      +   E +++Q   HP + ALK+ F  T 
Sbjct: 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTH 220

Query: 149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
           D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+H+   + 
Sbjct: 221 DR--LCF--VMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVV 271

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTA 265
           +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++    +Y  A
Sbjct: 272 YRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRA 329

Query: 266 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 325
           +D W  G VM E++ G+  F  +   ++L E+I                   E +FP   
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP--- 369

Query: 326 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDPN-TRLP 379
                    + L PEA  L+    +  P  R       A E   H FF          + 
Sbjct: 370 ---------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AGIVWQHVY 417

Query: 380 NGRPLPPLFNFKPP 393
             +  PP   FKP 
Sbjct: 418 EKKLSPP---FKPQ 428

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  145 bits (367), Expect = 6e-41
 Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 50/296 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K     + +       +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SRYYRAP 253
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                          PW K     +    + L+ +    +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  146 bits (370), Expect = 1e-40
 Identities = 83/320 (25%), Positives = 133/320 (41%), Gaps = 64/320 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K      ++      +   E +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           +  F T D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+
Sbjct: 72  YA-FQTHDR--LC--FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYL 121

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIFG 258
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++  
Sbjct: 122 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I                   E
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------MEE 221

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 373
            +FP            + L PEA  L+    +  P  R       A E   H FF     
Sbjct: 222 IRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---LS 266

Query: 374 PN-TRLPNGRPLPPLFNFKP 392
            N   +   + LPP   FKP
Sbjct: 267 INWQDVVQKKLLPP---FKP 283

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  145 bits (369), Expect = 1e-40
 Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 50/313 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--SYIC-SRYYRAP 253
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V          + +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                          PW K     +    + L+ +    +P+ R T  +     ++++  
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

Query: 373 DPNTRLPNGRPLP 385
               + P      
Sbjct: 270 KKGAKRPRVTSGG 282

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  145 bits (368), Expect = 1e-40
 Identities = 78/317 (24%), Positives = 131/317 (41%), Gaps = 55/317 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           Y     +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           NIV L     +        L L++EY    E  + +       H RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIV 124

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
            A+ Y H    I HRD+K +NLL++     +K+ DFG +     G    ++  +  Y AP
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182

Query: 254 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           EL  G  +Y    +D+WS G ++  L+ G   F G++ + +L E +              
Sbjct: 183 ELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------- 227

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                +++ P      +       +  +  +L+ RF   +P  R T  +     + +   
Sbjct: 228 ---RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272

Query: 373 DPNTRLPNGRPLPPLFN 389
           + +   P   P   + +
Sbjct: 273 EEDELKPFVEPELDISD 289

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  149 bits (379), Expect = 2e-40
 Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 58/322 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG VF  + + TG++ A  K L  KR K R        E +I+  +    IV+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +  F T       L LV+  +   +    I       +          YT QI   L +
Sbjct: 251 AYA-FETKTD----LCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEH 304

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H    I +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+ 
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  EY  ++D ++ G  + E++  +  F       +  E+         + +      Y 
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTYP 413

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
           +                    P + D      Q  P  R      +      HP F   R
Sbjct: 414 DK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF---R 453

Query: 373 DPN-TRLPNGRPLPPLFNFKPP 393
           D +  +L  G   PP   F P 
Sbjct: 454 DISWRQLEAGMLTPP---FVPD 472

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  151 bits (382), Expect = 2e-40
 Identities = 73/324 (22%), Positives = 128/324 (39%), Gaps = 65/324 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V + + F      ++L    +L+ +   +    +++     H       ++ Y  +I   
Sbjct: 255 VCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 304

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 255
           L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE+
Sbjct: 305 LEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEV 361

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     Y ++ D +S GC++ +LL G   F      D             + EI      
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI------ 402

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CT---ALEACVHPFFDE 370
                                  PE   L+    Q   N R  C    A E    PFF  
Sbjct: 403 -----DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

Query: 371 LRDPN-TRLPNGRPLPPLFNFKPP 393
           L   +   +   +  PP     PP
Sbjct: 456 L---DWQMVFLQKYPPP---LIPP 473

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  143 bits (363), Expect = 3e-40
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G G++GVV + +   +G+I+A+K++   +  +  K    +L I M+ +D P  V    
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D     + + +E +  ++++  +      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG---A 259
           + + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
             Y+   DIWS G  M EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
             PQ+    +          E VD   +  + +   R T  E   HPFF       T +
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  143 bits (363), Expect = 5e-40
 Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 67/321 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
           Y    ++G+G FG V+          VAIK     ++       N      E+ +++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 134 H--PNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
                ++ L   +F   D     L  +LE      +  + I          +     + +
Sbjct: 105 SGFSGVIRLLD-WFERPDS--FVL--ILERPEPVQDLFDFITE-----RGALQEELARSF 154

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
            +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS  +L            +
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGT 211

Query: 248 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
           R Y  PE I     Y   +  +WS G ++ +++ G   F  +       EII+       
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257

Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
                      +  F             +R+  E   L+       P+ R T  E   HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 367 FFDELRDPNTRLP-NGRPLPP 386
           +  ++  P      +   L P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  148 bits (374), Expect = 1e-39
 Identities = 85/321 (26%), Positives = 135/321 (42%), Gaps = 59/321 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A  K L+ KR K R        E QI++ ++   +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +  + T D     L LVL  +   +    I   Y       P      Y  +IC  L  
Sbjct: 250 AYA-YETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++  
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              YT + D W+ GC++ E++ GQ  F       +  E+ ++        +K +   Y+E
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPEEYSE 410

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 373
                               P+A  L  +     P  R      +A E   HP F   + 
Sbjct: 411 R-----------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF---KK 450

Query: 374 PN-TRLPNGRPLPPLFNFKPP 393
            N  RL  G   PP   FKP 
Sbjct: 451 LNFKRLGAGMLEPP---FKPD 468

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  141 bits (358), Expect = 1e-39
 Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 40/289 (13%)

Query: 73  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------R 124
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
           E+Q +++  HP+I+ L     + TD    +  +V+EYV   E  + I +     H R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICK-----HGRVEE 110

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           +  +    QI  A+ Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 243 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 300
              C S  Y APE+I G       +DIWS G ++  LL G   F  E  V  L + I+  
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG 226

Query: 301 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
                  L       +  M   +P         I+ H W   F++ LP 
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW---FKQDLPS 271

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  144 bits (366), Expect = 1e-39
 Identities = 80/306 (26%), Positives = 125/306 (40%), Gaps = 68/306 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + T ++ A+K     ++++     +   E  IM   + P +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D   LY  +V+EY+P  + VN ++         +P  + + YT ++  AL  I
Sbjct: 136 YAF---QDDRYLY--MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAI 184

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 251
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI      
Sbjct: 185 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI------ 236

Query: 252 APELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 308
           +PE++    G   Y    D WS G  + E+L+G   F  +S    LV             
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS--------- 283

Query: 309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVH 365
            K MN       FP              +  EA +L+C F      +R       E   H
Sbjct: 284 -KIMNHK-NSLTFP---DDND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 330

Query: 366 PFFDEL 371
            FF   
Sbjct: 331 LFFKND 336

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  141 bits (359), Expect = 2e-39
 Identities = 80/326 (24%), Positives = 139/326 (42%), Gaps = 77/326 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + R  G   A+K      V++ K   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D ++++  ++++Y+   E  + + ++     QR P    K Y  ++C AL Y+
Sbjct: 73  GTF---QDAQQIF--MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYL 122

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 253
           H+   I +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y AP
Sbjct: 123 HSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIAP 172

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     Y  +ID WS G ++ E+L G   F   +   +  E I               
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 368
               E +FP                 +  DL+ R           NL+    +   HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

Query: 369 DELRDPN-TRLPNGRPLPPLFNFKPP 393
            E+      +L +     P   ++PP
Sbjct: 263 KEV---VWEKLLSRNIETP---YEPP 282

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  140 bits (356), Expect = 8e-39
 Identities = 89/324 (27%), Positives = 136/324 (41%), Gaps = 68/324 (20%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K      ++++ +       E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L + F  T  K  LYL  +LEY+   E   ++ R                Y  +I  A
Sbjct: 84  VDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMA 133

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPE 254
           L ++H   GI +RD+KP+N+++N   H +KL DFG  K  +         C    Y APE
Sbjct: 134 LGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++   + +  A+D WS G +M ++L G P F GE+   + ++ I                
Sbjct: 192 ILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL--------------- 234

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFD 369
              +   P              L  EA DL+ +  + +   R       A E   HPFF 
Sbjct: 235 -KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF- 280

Query: 370 ELRDPN-TRLPNGRPLPPLFNFKP 392
             R  N   L   +  PP   FKP
Sbjct: 281 --RHINWEELLARKVEPP---FKP 299

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  140 bits (356), Expect = 8e-39
 Identities = 86/322 (26%), Positives = 137/322 (42%), Gaps = 66/322 (20%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR-ELQIMQMLDHPNIVA 139
           V+G GSFG VF  K     +  ++ A+K      +    R + + E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L + F  T  K  LYL  +L+++   +   R+++             VK Y  ++  AL 
Sbjct: 91  LHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALD 140

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 256
           ++H+  GI +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE++
Sbjct: 141 HLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                +T + D WS G +M E+L G   F G+    + + +I                  
Sbjct: 199 NR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL----------------K 240

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDEL 371
            +   PQ             L PEA  L+   F+ +P  R         E   H FF   
Sbjct: 241 AKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF--- 285

Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
              +  +L      PP   FKP
Sbjct: 286 STIDWNKLYRREIHPP---FKP 304

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  138 bits (351), Expect = 2e-38
 Identities = 68/313 (21%), Positives = 114/313 (36%), Gaps = 73/313 (23%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---------------------- 123
           G GS+GVV  A         A+K     K+++   +                        
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 124 ---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQ 178
              +E+ I++ LDHPN+V L        +++ LY+  V E V     +           +
Sbjct: 82  QVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVPT------LK 132

Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
            +     + Y   + + + Y+H    I HRDIKP NLLV      +K+ DFG +      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGS 190

Query: 239 EPNVSYIC-SRYYRAPELIFGAT-EYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 295
           +  +S    +  + APE +      ++  A+D+W+ G  +   + GQ  F  E  +  L 
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLH 249

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
             IK                    +FP     P        +  +  DL+ R    +P  
Sbjct: 250 SKIK----------------SQALEFPD---QPD-------IAEDLKDLITRMLDKNPES 283

Query: 356 RCTALEACVHPFF 368
           R    E  +HP+ 
Sbjct: 284 RIVVPEIKLHPWV 296

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  138 bits (349), Expect = 5e-38
 Identities = 68/323 (21%), Positives = 115/323 (35%), Gaps = 68/323 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
           Y    ++G G FG VF          VAIK     +VL      +      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 134 ----HPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVK 186
               HP ++ L   +F T +     L  VLE      +  + I          +     +
Sbjct: 93  AGGGHPGVIRL-LDWFETQEG--FML--VLERPLPAQDLFDYITE-----KGPLGEGPSR 142

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
            +  Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS  +L           
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--D 199

Query: 247 -SRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
            +R Y  PE I    +Y      +WS G ++ +++ G   F  +       EI++     
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
                        E  FP              + P+   L+ R     P+ R +  E  +
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 365 HPFFDELRDPNTRLPNGRPLPPL 387
            P+     +     P+     PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  138 bits (351), Expect = 6e-38
 Identities = 79/326 (24%), Positives = 130/326 (39%), Gaps = 77/326 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K     KV++ K   +   E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D   LY  +V+EYV   E  + +     R   R    + + Y  QI     Y+
Sbjct: 108 FSF---KDNSNLY--MVMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 253
           H+   + +RD+KP+NLL++   + +++ DFG AK +        G P           AP
Sbjct: 158 HSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALAP 207

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I          +    
Sbjct: 208 EIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG-- 253

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 368
               + +FP                 +  DL+    Q        NL+    +   H +F
Sbjct: 254 ----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

Query: 369 DELRDPN-TRLPNGRPLPPLFNFKPP 393
                 +   +   +   P   F P 
Sbjct: 298 ATT---DWIAIYQRKVEAP---FIPK 317

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  138 bits (349), Expect = 1e-37
 Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 52/301 (17%)

Query: 78  SKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIM 129
           SK+ +  YI    +G GSFG V  A   +T + VA+K      + +   +    RE+  +
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLY 188
           ++L HP+I+ L     + TD   +   +V+EY   E  + I        +RM     + +
Sbjct: 64  KLLRHPHIIKLYDVITTPTD---IV--MVIEYAGGELFDYIVE-----KKRMTEDEGRRF 113

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
             QI  A+ Y H    I HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S
Sbjct: 114 FQQIICAIEYCH-RHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGS 170

Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 307
             Y APE+I G       +D+WS G V+  +L+G+  F  E  +  L + +         
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------- 221

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                      +  P      +       L P A  L+ R     P  R T  E    P+
Sbjct: 222 --------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

Query: 368 F 368
           F
Sbjct: 262 F 262

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  137 bits (346), Expect = 1e-37
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 28/220 (12%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT-----YQICRALAY 198
               +     + LV+EY    ++      Y+ +H   PL Y           Q  + +AY
Sbjct: 70  --CLNP----VCLVMEYAEGGSL------YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 199 IHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           +H+     + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+ 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
            G + Y+   D++S G ++ E++  +  F    G    + 
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  137 bits (347), Expect = 1e-37
 Identities = 64/358 (17%), Positives = 115/358 (32%), Gaps = 103/358 (28%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G FGVVF+AK +      AIK++    R        RE++ +  L+HP IV
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 139 ALKHCF----------------------------------------------------FS 146
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
                ++YL + ++   +   +   N     +            QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186

Query: 207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNVSYICSRYYRAP 253
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E I G   Y+  +DI+S G ++ ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                 KFP        K       P+   +V      SP  R  A +   +  F+ L
Sbjct: 288 ----NLKFP---LLFTQK------YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  137 bits (348), Expect = 2e-37
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLD-HPNIVAL 140
           V+G GSFG V  ++ + T E+ A+K      V+QD   +    E +++ +    P +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 87  HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 136

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I 
Sbjct: 137 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 195 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 236

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 237 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 281

Query: 373 DPN-TRLPNGRPLPPLFNFKP 392
             +  +L      PP   +KP
Sbjct: 282 YIDWEKLERKEIQPP---YKP 299

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  136 bits (345), Expect = 2e-37
 Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 46/301 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G+G+ G V++ + R+TG ++A+K++      +  K    +L + ++  D P IV    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F + TD     + + +E +     ++     R+   +P   +   T  I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI----FG 258
            G+ HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 317
             +Y    D+WS G  + EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 377
               P +  H            +    V          R    +   H F          
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 378 L 378
           +
Sbjct: 297 V 297

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  136 bits (345), Expect = 4e-37
 Identities = 82/318 (25%), Positives = 136/318 (42%), Gaps = 61/318 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
           ++G GSFG VF A+ ++T +  AIK      VL D   +    E +++ +  +HP +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F T +   L+   V+EY+   + +  I         +  L     Y  +I   L +
Sbjct: 84  FCT-FQTKEN--LF--FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQF 133

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           +H+  GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ 
Sbjct: 134 LHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  +Y  ++D WS G ++ E+L+GQ  F G+   ++L   I+                  
Sbjct: 192 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------MD 233

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDPN- 375
              +P            + L  EA DL+ + F   P  R         HP F   R+ N 
Sbjct: 234 NPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF---REINW 278

Query: 376 TRLPNGRPLPPLFNFKPP 393
             L      PP   F+P 
Sbjct: 279 EELERKEIDPP---FRPK 293

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  136 bits (344), Expect = 4e-37
 Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 39/300 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G G++G V +   + +G+I+A+K++   + +K  K    +L + M+  D P IV    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   D       + +E +  + ++  +  YS +   +P   +   T    +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
            + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 262 ---YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
              Y    D+WS G  + EL  G+  +P  + V   +  + V G P         P    
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP---------P---- 248

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 378
            +    +   +         P  ++ V        + R    E   HPF     +    +
Sbjct: 249 -QLSNSEEREF--------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  136 bits (345), Expect = 6e-37
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 64/320 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIM-QMLDHPNIVAL 140
           V+G GSFG V  A+ +      A+K      +L+ K  ++   E  ++ + + HP +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F T DK  LY   VL+Y+   E    + R      +       + Y  +I  AL Y
Sbjct: 105 HFS-FQTADK--LY--FVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGY 154

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE++ 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y   +D W  G V+ E+L G P F   +   ++ + I                   
Sbjct: 213 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NK 254

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----CTALEACVHPFFDELRD 373
             +                +   A  L+    Q     R       +E   H FF     
Sbjct: 255 PLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF---SL 299

Query: 374 PN-TRLPNGRPLPPLFNFKP 392
            N   L N +  PP   F P
Sbjct: 300 INWDDLINKKITPP---FNP 316

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  136 bits (344), Expect = 7e-37
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 66/322 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
           V+G GSFG V  A+ +ETG++ A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  L+   V+E+V   + +  I +      +R      + Y  +I  AL +
Sbjct: 90  FCC-FQTPDR--LF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMF 139

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 257
           +H+  GI +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE++ 
Sbjct: 140 LHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  A+D W+ G ++ E+L G   F  E+  D L E I                   
Sbjct: 198 E-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------ND 239

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 371
           E  +P              L  +A  ++  F   +P +R              HPFF   
Sbjct: 240 EVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF--- 284

Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
           ++ +  +L + +  PP   F+P
Sbjct: 285 KEIDWAQLNHRQIEPP---FRP 303

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  135 bits (343), Expect = 1e-36
 Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 66/328 (20%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDH-PN 136
           V+GTG++G VF  +     +TG++ A+K      ++Q  +       E Q+++ +   P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L + F  T  K  L+L  +L+Y+   E    +++      +R     V++Y  +I  
Sbjct: 121 LVTLHYAF-QTETK--LHL--ILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVL 170

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRA 252
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMA 228

Query: 253 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI           I  
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL- 279

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHP 366
                +E  +PQ             +   A DL+ R     P  R       A E   H 
Sbjct: 280 ----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323

Query: 367 FFDELRDPN-TRLPNGRPLPPLFNFKPP 393
           FF   +  N   L   +   P   FKP 
Sbjct: 324 FF---QKINWDDLAAKKVPAP---FKPV 345

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  137 bits (347), Expect = 2e-36
 Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 42/290 (14%)

Query: 73  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--R 124
            +  + + K+  YI    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
           E+Q +++  HP+I+ L     + +D   ++  +V+EYV   E  + I +     + R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSD---IF--MVMEYVSGGELFDYICK-----NGRLDE 115

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
              +    QI   + Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 243 SYIC-SRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300
              C S  Y APE+I G   Y    +DIWS+G ++  LL G   F  +  V  L + I  
Sbjct: 173 RTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICD 230

Query: 301 --------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 339
                   L       +K M   +P         I+ H W   F++ LP 
Sbjct: 231 GIFYTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW---FKQDLPK 276

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  135 bits (342), Expect = 2e-36
 Identities = 79/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQML-----DHP 135
           Y     +G G F  V+ +   +  + VA+K V   + Y      E+++++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 136 N---IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N   +V L   F   +     ++ +V E +   + +     +  +Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 193 CRALAYIHNCIGICHRDIKPQNLLV----------------------------------- 217
            + L Y+H    I H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 218 -------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 264
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 265 AIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 311
             DIWST C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLP------PEAVDLVCRFFQYSPNLRCTALEACVH 365
                      ++KP    +V  ++            D +    +  P  R TA E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 366 PFFD 369
           P+ +
Sbjct: 393 PWLN 396

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  133 bits (337), Expect = 6e-36
 Identities = 79/322 (24%), Positives = 138/322 (42%), Gaps = 57/322 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K      V  D+   +   E  + +   +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T  +  L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 76  HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 125

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 126 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
           G  +Y  ++D W+ G +M E++ G+  F      D   +        T + +        
Sbjct: 184 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-------- 227

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 371
              F  I          + L  +A  ++  F    P  R          +   HPFF   
Sbjct: 228 ---FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF--- 279

Query: 372 RDPN-TRLPNGRPLPPLFNFKP 392
           R+ +   +   + +PP   FKP
Sbjct: 280 RNVDWDMMEQKQVVPP---FKP 298

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  133 bits (336), Expect = 6e-36
 Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 66/308 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-------RELQIMQM 131
           Y     +G+G+FG V+ A  +E  + V +K     KVL+D   ++        E+ I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
           ++H NI+ +   F    ++      LV+E      +    I R     H R+        
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYI 135

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 247
             Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 248 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 306
             Y APE++ G   Y    +++WS G  +  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
                          P              +  E + LV    Q  P  R T  +    P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 367 FFDELRDP 374
           +  +  + 
Sbjct: 277 WVTQPVNL 284

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  133 bits (337), Expect = 1e-35
 Identities = 83/372 (22%), Positives = 148/372 (39%), Gaps = 64/372 (17%)

Query: 44  DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEH-----VVGTGSFGVV 98
           D D            +G+             +G +   +    +      V+G GS+  V
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG--LQDFDLLRVIGRGSYAKV 68

Query: 99  FQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVALKHCFFSTTDK 150
              + ++T  I A++      V  D+   +   E  + +   +HP +V L  C F T  +
Sbjct: 69  LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-FQTESR 127

Query: 151 EELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
             L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y+H   GI +R
Sbjct: 128 --LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE-RGIIYR 177

Query: 209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAID 267
           D+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G  +Y  ++D
Sbjct: 178 DLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 235

Query: 268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 327
            W+ G +M E++ G+  F      D   +        T + +           F  I   
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-----------FQVILEK 277

Query: 328 PWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC----VHPFFDELRDPN-TRLPN 380
                  + L  +A  ++  F    P  R  C           HPFF   R+ +   +  
Sbjct: 278 QIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF---RNVDWDMMEQ 332

Query: 381 GRPLPPLFNFKP 392
            + +PP   FKP
Sbjct: 333 KQVVPP---FKP 341

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  128 bits (323), Expect = 2e-34
 Identities = 50/224 (22%), Positives = 85/224 (37%), Gaps = 30/224 (13%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHP 135
           E  +G G FG+V + +  +   +VAIK ++                  RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           NIV L        +       +V+E+VP   +     + +     +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133

Query: 195 ALAYIHNC-IGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYICSRY 249
            + Y+ N    I HRD++  N+ +           K+ DFG ++           + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 250 YRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 292
           + APE I    E YT   D +S   ++  +L G+  F   S   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  127 bits (322), Expect = 2e-34
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIV 138
           E ++G G FG V++A     G+ VA+K    D             +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 139 ALK-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           AL+  C      +  L   LV+E+     +NR+        +R+P   +  +  QI R +
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118

Query: 197 AYIHNC--IGICHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
            Y+H+   + I HRD+K  N+L+             LK+ DFG A+   +    +S   +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177

Query: 248 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
             + APE+I  +  ++   D+WS G ++ ELL G+  F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  132 bits (332), Expect = 9e-34
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQM-LDHPNIVAL 140
           V+G GSFG V  ++ + T E+ A+K      V+QD        E +++ +    P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 408 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 457

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 257
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I 
Sbjct: 458 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 516 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 557

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 372
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 558 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 602

Query: 373 DPN-TRLPNGRPLPPLFNFKP 392
             +  +L      PP   +KP
Sbjct: 603 YIDWEKLERKEIQPP---YKP 620

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  125 bits (315), Expect = 3e-33
 Identities = 73/311 (23%), Positives = 120/311 (38%), Gaps = 46/311 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 139 ALKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           +    F     K+EL+  LV++      V + +  I          +    +     ++ 
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSR---- 248
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 249 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                  N        P ++     K   K+       ++    Q  P  R TA E   H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

Query: 366 PFFDELRDPNT 376
            FF + ++   
Sbjct: 289 KFFQKAKNKEF 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  126 bits (317), Expect = 7e-33
 Identities = 57/336 (16%), Positives = 114/336 (33%), Gaps = 47/336 (13%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           G      V  A+ + TGE V ++++      ++       EL + ++ +HPNIV  +  F
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            +  +     L +V  ++   +   +   +      M  + +      + +AL YIH+ +
Sbjct: 96  IADNE-----LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147

Query: 204 GICHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNVSYICSRYYRAPEL 255
           G  HR +K  ++L++    ++ L    S         +  V  +     +    + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 256 IF-GATEYTTAIDIWSTGCVMAELLLGQP----------LF-------PGESGVDQLVEI 297
           +      Y    DI+S G    EL  G            L        P       +   
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266

Query: 298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 357
              +          ++ + T               + +   P     V +  Q +P+ R 
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

Query: 358 TALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 393
           +A     H FF +++   +       LP L     P
Sbjct: 327 SASTLLNHSFFKQIKRRASEA-----LPELLRPVTP 357

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  124 bits (313), Expect = 7e-33
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ IM+ L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 141 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                   T    L   +V EY+   ++ R+    S   +++         Y + + + Y
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNY 152

Query: 199 IHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI 256
           +HN    I HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
                     D++S G ++ EL   Q  +  
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (325), Expect = 9e-33
 Identities = 60/259 (23%), Positives = 103/259 (39%), Gaps = 44/259 (16%)

Query: 49  RDSEPDIIDGVGAETGH--------VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
                   +G     G              + G+         Y  +  +  G  G ++ 
Sbjct: 48  DSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQ---------YEVKGCIAHGGLGWIYL 98

Query: 101 AKCRE-TGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           A  R   G  V +K  L               E Q +  + HP+IV +   F   TD+  
Sbjct: 99  ALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHPSIVQI-FNFVEHTDRHG 155

Query: 153 LYLN-LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI 210
             +  +V+EYV  +++ R         Q++P+     Y  +I  AL+Y+H+ IG+ + D+
Sbjct: 156 DPVGYIVMEYVGGQSLKRS------KGQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDL 208

Query: 211 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWS 270
           KP+N+++     QLKL D G+   +        Y  +  ++APE++      T A DI++
Sbjct: 209 KPENIMLTEE--QLKLIDLGAVSRI--NSFGYLYG-TPGFQAPEIVRTGP--TVATDIYT 261

Query: 271 TGCVMAELLLGQPLFPGES 289
            G  +A L L  P   G  
Sbjct: 262 VGRTLAALTLDLPTRNGRY 280

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (309), Expect = 4e-32
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 51/303 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            +  + C+            LV+EY   + + +   + +    +  + +   T+   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 257 FGATE--YTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
               E  Y   +D+WS G +   EL   +P     + +  L  I +              
Sbjct: 223 LAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ------------NE 269

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
                   P ++   W + F+        + V    Q  P  R T+     H F    R 
Sbjct: 270 S-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314

Query: 374 PNT 376
           P  
Sbjct: 315 PTV 317

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  121 bits (305), Expect = 1e-31
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKN--RELQIMQMLDHPNIVALKH 142
             V+G G FG   +   RETGE++ +K++++  ++  +   +E+++M+ L+HPN++    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                   + L    + EY+   T+  I ++      + P      +   I   +AY+H+
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS 126

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------------- 248
              I HRD+   N LV      + + DFG A+++V  +     + S              
Sbjct: 127 M-NIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 249 --YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
             Y+ APE+I G   Y   +D++S G V+ E++      P 
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (300), Expect = 4e-31
 Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------ 118
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 119 ---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYS 174
              KR++ RE+     L H NIV++        + +  YL  V+EY+   T+      Y 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
             H  + +     +T QI   + + H+ + I HRDIKPQN+L++     LK+ DFG AK 
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 235 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           L   E +++     + +  Y +PE   G        DI+S G V+ E+L+G+P F GE+ 
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

Query: 291 V 291
           V
Sbjct: 218 V 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (301), Expect = 4e-31
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 67  IRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRY 121
             + +  R         Y    ++G G    V  A+       VA+K VL     +D  +
Sbjct: 6   TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55

Query: 122 KNR---ELQIMQMLDHPNIVALKHCFF---STTDKEELYLNLVLEYVP-ETVNRIARNYS 174
             R   E Q    L+HP IVA+    +              +V+EYV   T+    R+  
Sbjct: 56  YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 234
                M            C+AL + H   GI HRD+KP N++++  T+ +K+ DFG A+ 
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARA 165

Query: 235 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290
           +     +V+     I +  Y +PE   G +      D++S GCV+ E+L G+P F G+S 
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSP 224

Query: 291 V 291
           V
Sbjct: 225 V 225

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (300), Expect = 5e-31
 Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G GSFG VF+     T ++VAIK +  ++         +E+ ++   D P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                +   T      L +++EY+   +   +          +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 256
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
             +  Y +  DIWS G    EL  G+P                    P  E    ++P  
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--------------------PHSE----LHPMK 226

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
             F  P+  P P     +        + V       P+ R TA E   H F        +
Sbjct: 227 VLFLIPKNNP-P---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

Query: 377 RL 378
            L
Sbjct: 283 YL 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (299), Expect = 6e-31
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 47/292 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+   +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               +    +     L +V+EY+   ++  +          M    +     +  +AL +
Sbjct: 82  YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEF 131

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 257
           +H+   + HRDIK  N+L+      +KL DFG    +   +    + + + Y+ APE++ 
Sbjct: 132 LHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 258 GATEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
               Y   +DIWS G +MA E++ G+P +  E+ +  L  I    GTP  +         
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN-------- 238

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                    P     +F+        D + R  +     R +A E   H F 
Sbjct: 239 ---------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  119 bits (301), Expect = 6e-31
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
              +G G +G V+  K R  GE VA+K     ++    RE +I Q   + H NI+  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
               T    +LYL  + +Y    ++    ++ +      + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 201 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 248
             I        I HRD+K +N+LV  +     + D G A   +     V    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 249 YYRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 279
            Y  PE++  +      +     D++S G ++ E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  118 bits (297), Expect = 1e-30
 Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
              VG G +G V++   +  GE VA+K    +D++   RE ++     L H NI+  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
              S     +L+L  +  Y    ++    +  +      + ++        I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122

Query: 201 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 248
             I        I HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 249 YYRAPELI-----FGATEYTTAIDIWSTGCVMAELL 279
            Y APE++         +    +DIW+ G V+ E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (296), Expect = 1e-30
 Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 26/224 (11%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
              +G+GSFG V++ K       VA+K +               E+ +++   H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
              F   +   +L +  V ++    ++            +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYL 136

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 256
           H    I HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 HAK-SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 257 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
                  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  117 bits (295), Expect = 1e-30
 Identities = 24/211 (11%), Positives = 71/211 (33%), Gaps = 22/211 (10%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
              +     G +++ + +  G  + +K +          R  N E   +++  HPN++ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                        +  L+  ++P  ++  +    +     +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL 127

Query: 200 HNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           H     I    +  ++++++      ++                +      + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182

Query: 259 --ATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
                   + D+WS   ++ EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  118 bits (297), Expect = 2e-30
 Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 43/298 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           +     +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +F  TD     L +V+EY    +V+ I       ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA 259
             +   HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 F-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 260 TEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             Y    DIWS G + A E+  G+P +     +  +  I      PT  +          
Sbjct: 201 -GYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK---------- 247

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                  P  W   F         D V +    SP  R TA +   HPF    +  + 
Sbjct: 248 -------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (295), Expect = 3e-30
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 47/286 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G GS G+V  A+ + +G  VA+K +     Q +     E+ IM+   H N+V +   + 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
                EEL++  ++E++    +  I         R+    +      + +ALAY+H   G
Sbjct: 113 V---GEELWV--LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QG 161

Query: 205 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 263
           + HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I   + Y 
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219

Query: 264 TAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 322
           T +DIWS G +M  E++ G+P +  +S V  +  +      P  +               
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN-------------- 263

Query: 323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
               H    V +        D + R     P  R TA E   HPF 
Sbjct: 264 ---SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (293), Expect = 4e-30
 Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 54/307 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           +     +G G+FG V++AK +ETG + A K +     ++      E++I+   DHP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 140 LKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           L   ++         L +++E+     V   +  + R        +    +++   Q+  
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLE 128

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAP 253
           AL ++H+   I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ AP
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 254 ELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           E++   T     Y    DIWS G  + E+   +P     + +  L++I K    PT    
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT- 244

Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 369
                           P  W   F+        D +      +P  R +A +   HPF  
Sbjct: 245 ----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVS 280

Query: 370 ELRDPNT 376
            +     
Sbjct: 281 SITSNKA 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  115 bits (291), Expect = 1e-29
 Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 42/307 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQML-DHPNIVA 139
           +    +VG G++G V++ +  +TG++ AIK +     ++    +E+ +++    H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 140 LKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
               F        +  L LV+E+    +V  + +N       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLS 143

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 256
           ++H    + HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 257 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           NP       P++K   W K FQ          +      + + R    +   HPF  +  
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 373 DPNTRLP 379
           +      
Sbjct: 295 NERQVRI 301

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  115 bits (290), Expect = 1e-29
 Identities = 56/259 (21%), Positives = 91/259 (35%), Gaps = 38/259 (14%)

Query: 44  DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKC 103
            +             +         T  G           Y    +VG G  G V++A+ 
Sbjct: 6   HHHHHSSGLVPRGSHMDGTAESREGTQFGP----------YRLRRLVGRGGMGDVYEAED 55

Query: 104 RETGEIVAIKKVL-----QDKRYK---NRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155
                IVA+K ++      D  ++    RE +    L  P++V +           +LY+
Sbjct: 56  TVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI---HDFGEIDGQLYV 111

Query: 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214
              +  +             R    +          QI  AL   H   G  HRD+KP+N
Sbjct: 112 --DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPEN 164

Query: 215 LLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWS 270
           +LV+       L DFG A      +  +    + + + YY APE    +   T   DI++
Sbjct: 165 ILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYA 220

Query: 271 TGCVMAELLLGQPLFPGES 289
             CV+ E L G P + G+ 
Sbjct: 221 LTCVLYECLTGSPPYQGDQ 239

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  113 bits (285), Expect = 7e-29
 Identities = 39/223 (17%), Positives = 83/223 (37%), Gaps = 37/223 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   +   H N+V  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 141 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C         L   ++       T+  + R+       + +   +    +I + + Y
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGY 145

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 252
           +H   GI H+D+K +N+  +     + + DFG   +    +        R       + A
Sbjct: 146 LHAK-GILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 253 PELIFGATE--------YTTAIDIWSTGCVMAELLLGQPLFPG 287
           PE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  114 bits (286), Expect = 9e-29
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
           +  +G G FG V++ K R  GE VA+K    +++R   RE +I Q   L H NI+  +  
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                    +L+L  V +Y    ++      Y+   + M    +KL        LA++H 
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157

Query: 202 CI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----RY 249
            I        I HRD+K +N+LV  +     + D G A         +    +     + 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 250 YRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 279
           Y APE++  +      E     DI++ G V  E+ 
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  112 bits (283), Expect = 1e-28
 Identities = 56/247 (22%), Positives = 98/247 (39%), Gaps = 35/247 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
             V   G FG V++A+     E VA+K    QDK+    E ++  +  + H NI+  +  
Sbjct: 29  LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               T+   +L+L  +  +          ++ + +         +    + R LAY+H  
Sbjct: 87  EKRGTSVDVDLWL--ITAFHE---KGSLSDFLKANVVSWNELCHIA-ETMARGLAYLHED 140

Query: 203 I---------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 249
           I          I HRDIK +N+L+  +     + DFG A      E   S   +      
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGDTHGQVGT 196

Query: 250 --YRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 303
             Y APE++ GA     +    ID+++ G V+ EL        G      L    ++   
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256

Query: 304 PTREEIK 310
           P+ E+++
Sbjct: 257 PSLEDMQ 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  113 bits (283), Expect = 2e-28
 Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 39/254 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHC 143
             ++G G +G V++         VA+K     +++    E  I ++  ++H NI      
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 144 FFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
               T    +   LV+EY P       ++ + S       L +       + R LAY+H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129

Query: 202 CI--------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 249
            +         I HRD+  +N+LV        + DFG +  L                  
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 250 -----YRAPELIFGA------TEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD-QLVE 296
                Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 297 IIKVLGTPTREEIK 310
             +V   PT E+++
Sbjct: 249 QTEVGNHPTFEDMQ 262

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (265), Expect = 6e-26
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 52/238 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  104 bits (262), Expect = 9e-26
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 46/218 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V   +       TGE+VA+KK LQ    ++     RE++I++ L H NI
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 138 VALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           V  K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ 
Sbjct: 74  VKYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 252 ----------APELIFGATEYTTAIDIWSTGCVMAELL 279
                     APE +   ++++ A D+WS G V+ EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 2e-25
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 44/217 (20%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIK--KVLQDKRYKN--RELQIMQMLDHPNIV 138
              +G G+FG V   +       TGE+VA+K  +   ++  ++  RE++I++ L H NIV
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 139 ALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
             K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL 279
                    APE +   ++++ A D+WS G V+ EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (255), Expect = 1e-24
 Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 44/235 (18%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G FG V           TGE+VA+K +  D   ++     +E+ I++ L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           +  K C     D     L LV+EYVP       R+Y   H  + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 198 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 252 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 297
                   APE +     +  A D+WS G  + ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (255), Expect = 1e-24
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V   +       TG +VA+K  LQ           RE+QI++ L    I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V  +        ++ L   LV+EY+P   +   R++ + H+ R+    + LY+ QIC+ +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+    C+   HRD+  +N+LV      +K+ DFG AK+L   +         YY    
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL 279
                    APE L      ++   D+WS G V+ EL 
Sbjct: 189 PGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (251), Expect = 3e-24
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G FG V   +       TGE VA+K +  +    +     +E++I++ L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRAL 196
           V  K      T+     + L++E++P   +   + Y   +  ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL 279
                    APE +  +  +  A D+WS G  + ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  100 bits (251), Expect = 3e-24
 Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 49/238 (20%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           + +  +G+G+FG V +   +    +  VA+K +     D   K+    E  +MQ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV +        + E     LV+E            Y + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    APE + +   ++++  D+WS G +M E    GQ  + G  G +   ++E
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 9e-24
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 254 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
           E L +   +++   D+W+ G ++ E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 254
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 255 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
            L     +++T  D+WS G ++ E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 49/238 (20%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R   +   VAIK + Q     +      E QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (250), Expect = 3e-23
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 254
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 255 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
            L     +++T  D+WS G ++ E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (250), Expect = 3e-23
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 33/226 (14%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
           E +     ++   D+W+ G ++ E+   G   +PG       +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 50/237 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 252 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.0 bits (242), Expect = 7e-23
 Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 38/231 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G FG V +      GE     V IK +      ++       +  +  LDH +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L            L   LV +Y+P        ++ R H+  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +     +     +   
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181

Query: 252 ---APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
              A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 96.2 bits (240), Expect = 8e-23
 Identities = 44/235 (18%), Positives = 79/235 (33%), Gaps = 50/235 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDKRYKN----RELQIMQMLDHP 135
              +G G+F  +F+   RE G+        V +K + +  R  +        +M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 136 NIVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQIC 193
           ++V     C       +E    LV E+V          Y + ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 194 RALAYI--HNCIGICHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNVSY 244
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 245 ICSRYYR------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                 +       PE I        A D WS G  + E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.8 bits (246), Expect = 1e-22
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 253
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
              +G G FG V+        + VA+K + Q     +    E  +M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  ++ EY+    N    ++ +    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
              APE + +G   +T   D+WS G ++ E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.1 bits (244), Expect = 2e-22
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 47/232 (20%)

Query: 85  IAEHVVGTGSFGVVFQAKCR-ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R    +I VAIK + Q     +      E QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +G+G FGVV   K +   + VA+K + +    ++   +E Q M  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C    + +  +Y  +V EY+    N    NY R H +       L   Y +C  +A++  
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
           H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y          
Sbjct: 123 HQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
              APE   +   +Y++  D+W+ G +M E+  LG+  +   +   V   V 
Sbjct: 170 KWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.4 bits (233), Expect = 5e-22
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 45/226 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C     ++  +   LV E++    +    +Y R  + +      L     +C  +AY+  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
              I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y          
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
              +PE   F    Y++  D+WS G +M E+   G+  +   S  +
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 47/232 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+ A   +  + VA+K +            E  +M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
                 KE +Y  ++ E++         ++ +  +       KL  ++ QI   +A+I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
              APE + FG   +T   D+WS G ++ E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.4 bits (233), Expect = 8e-22
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 48/230 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
             ++G G FG V++            VA+K   +D    N+     E  IM+ LDHP+IV
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L        ++E  +  +++E  P        +Y   ++  + ++ + LY+ QIC+A+A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+   NC+   HRDI  +N+LV      +KL DFG ++ +   +         YY+    
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                  +PE + F    +TTA D+W     M E+L  G+  F      D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 49/230 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
              +G G+FG VF  + R    +VA+K   +      +     E +I++   HPNIV L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 142 H--CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY 198
              C    T K+ +Y  +V+E V          + R       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 199 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 251
           +    CI   HRD+  +N LV    + LK+ DFG ++    G          Y       
Sbjct: 229 LESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLR 275

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                  APE L +G   Y++  D+WS G ++ E   LG   +P  S   
Sbjct: 276 QVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 52/239 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
             ++G G FG V +A+ ++       VA+K +  D    +      RE   M+  DHP++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYT 189
             L      S          ++L ++           +RI  N   +  +  L+    + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143

Query: 190 YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 247
             I   + Y+   N I   HRD+  +N ++      + + DFG ++ +  G+        
Sbjct: 144 VDIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD-------- 191

Query: 248 RYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
            YYR            A E L      YT   D+W+ G  M E++  GQ  + G    +
Sbjct: 192 -YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 52/239 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           ++ L    +       +   +V E  P        +  R HQ    L  +  Y  Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y   
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 252 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                     APE L      ++ A D W  G  + E+   GQ  + G +G      ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 51/238 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
             ++G G FG V +   ++       VA+K +  D   +        E   M+   HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
           + L       + +      ++L ++           +R+      I  +  L+    +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154

Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
            I   + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         
Sbjct: 155 DIALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD--------- 201

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
           YYR            A E L      YT+  D+W+ G  M E+   G   +PG    +
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 45/226 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C    T +  ++  ++ EY+    N    NY R  +        L     +C A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 251
              +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y          
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185

Query: 252 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
               PE L++   ++++  DIW+ G +M E+  LG+  +   +  +
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 90.8 bits (226), Expect = 7e-21
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                  APE + F    +T+A D+W  G  M E+L  G   F G    D    +E
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 60/250 (24%), Positives = 94/250 (37%), Gaps = 60/250 (24%)

Query: 91  GTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHPNIVA 139
           G G+FG V +A        +    VA+K +     L ++     EL+++  L +H NIV 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 140 LKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVK 186
           L       T        ++ EY                 +             + L    
Sbjct: 92  LLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 187 LYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           L +  YQ+ + +A++   NCI   HRD+  +N+L+       K+CDFG A+ +       
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKNDS--- 199

Query: 243 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 289
                  Y             APE IF    YT   D+WS G  + EL  LG   +PG  
Sbjct: 200 ------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 290 GVDQLVEIIK 299
              +  ++IK
Sbjct: 253 VDSKFYKMIK 262

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 51/238 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E ++G+G  G V   + R  G+    VAIK +      + R     E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRAL 196
            L+       T        +V EY+    N     + R H     I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 252 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 296
                    APE + F    +++A D+WS G VM E+L  G+  +   +  D    VE
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 198 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 251
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 506 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 552

Query: 252 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 296
                  APE + F    +T+A D+W  G  M E+L  G   F G     V   +E
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 31/263 (11%), Positives = 54/263 (20%), Gaps = 60/263 (22%)

Query: 50  DSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEI 109
                  D V    G  I     GR         Y      G       +QA        
Sbjct: 11  RESSAPPDDVQLVPGARI---ANGR---------YRLLIFHGGVPPLQFWQALDTALDRQ 58

Query: 110 VAIKKVL----QDKRYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162
           VA+  V                    +  +D P +  +         +    +  V E++
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--VAEWI 113

Query: 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 221
              ++  +A            +        +  A    H   G+      P  + V+   
Sbjct: 114 RGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-D 165

Query: 222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 281
             + L                                        DI   G  +  LL+ 
Sbjct: 166 GDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVN 198

Query: 282 QPLFPGESGVDQLVEIIKVLGTP 304
           +   P       L    +     
Sbjct: 199 RWPLPEAGVRSGLAPAERDTAGQ 221

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 47/231 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +   +    VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
            L+       T  + +   +V EY+    N    ++ R H  +  +I +      I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 197 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 251
            Y+     +   HRD+  +N+L+N +    K+ DFG  +VL              Y    
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRG 209

Query: 252 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                   +PE + +   ++T+A D+WS G V+ E++  G+  +   S  D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 55/236 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
           + V+G G FGVV+  +  +  +     AIK    + + +      RE  +M+ L+HPN++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           AL          E L   ++L Y+    +     + R  QR P    LI    +  Q+ R
Sbjct: 86  ALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E         YY  
Sbjct: 136 GMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE---------YYSV 182

Query: 252 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                        A E L      +TT  D+WS G ++ ELL  G P +      D
Sbjct: 183 QQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 46/231 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           + V+G G FG V++   + +       VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           + L+       +  + +   ++ EY+    N     + R       ++ +      I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 196 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 251
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL             Y    
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAT------YTTSG 209

Query: 252 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                   APE + +    +T+A D+WS G VM E++  G+  +   S  +
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 61/248 (24%)

Query: 91  GTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALK 141
           G G+FG VF A+C          +VA+K +    L  ++   RE +++  L H +IV   
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83

Query: 142 HCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKLY-- 188
                  D + L   +V EY+                 I  +      +  L   ++   
Sbjct: 84  GV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 189 TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
             QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++ +   +       
Sbjct: 139 ASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTD------- 187

Query: 247 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGV 291
             YYR             PE +++   ++TT  D+WS G ++ E+   G QP +   S  
Sbjct: 188 --YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-WFQLS-N 241

Query: 292 DQLVEIIK 299
            +++E I 
Sbjct: 242 TEVIECIT 249

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)

Query: 88  HVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HPN 136
             +G G+FG V +A         T   VA+K +       + R    EL+I+  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLI 183
           +V L      T     L   +++E+               E V             + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 184 YVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
           ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDIYKDP-- 202

Query: 242 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
                   Y             APE IF    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 203 -------DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV 254

Query: 289 SGVDQLVEIIK 299
              ++    +K
Sbjct: 255 KIDEEFCRRLK 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 55/236 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + Y+     +   HRD+  +N +++     +K+ DFG A+ +   E         YY  
Sbjct: 140 GMKYLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186

Query: 252 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                        A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 50/245 (20%), Positives = 99/245 (40%), Gaps = 54/245 (22%)

Query: 88  HVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLDHPNI 137
             +G GSFG+V++   +   +      VAIK V     ++++     E  +M+  +  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
           V L       +  +     +++E +            R A   + +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
           +I   +AY+  +  +   HRD+  +N +V      +K+ DFG  + + + +         
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
           YYR            +PE L  G   +TT  D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQV 249

Query: 295 VEIIK 299
           +  + 
Sbjct: 250 LRFVM 254

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 49/233 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 251
            + ++     +   HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 204 GMKFLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 252 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
                     A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 68/260 (26%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G FG V +A             VA+K +       + R    E  +++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
           ++ L       +    L   L++EY                      +      +     
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
               L    L  + +QI + + Y+     +   HRD+  +N+LV     ++K+ DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198

Query: 234 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-L 280
            + + +          Y             A E +F    YTT  D+WS G ++ E++ L
Sbjct: 199 DVYEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248

Query: 281 G-QPLFPGESGVDQLVEIIK 299
           G  P +PG    ++L  ++K
Sbjct: 249 GGNP-YPGIP-PERLFNLLK 266

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 58/251 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLD-HP 135
              +G G+FG V +A     G+      VA+K +       +K     EL+IM  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP---------ETVNRIARNYSRIHQRMPLIYVK 186
           NIV L       T    +   ++ EY                +  + +            
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 187 L--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 242
           L  ++ Q+ + +A++   NCI   HRD+  +N+L+    H  K+ DFG A+ ++      
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS--- 218

Query: 243 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 288
                  Y             APE IF    YT   D+WS G ++ E+  LG  P +PG 
Sbjct: 219 ------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGI 270

Query: 289 SGVDQLVEIIK 299
               +  +++K
Sbjct: 271 LVNSKFYKLVK 281

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 60/251 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNI 137
           +  +G G+FG VF A+C          +VA+K +       ++   RE +++ ML H +I
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP----------ETVNRIARNYSRIHQRMPLIYVKL 187
           V         T+   L   +V EY+              +             PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
                Q+   + Y+   + +   HRD+  +N LV      +K+ DFG ++ +   +    
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212

Query: 244 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 288
                YYR             PE +++   ++TT  D+WS G V+ E+   G QP +   
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQL 264

Query: 289 SGVDQLVEIIK 299
           S   + ++ I 
Sbjct: 265 S-NTEAIDCIT 274

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 50/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           IV        +      +  +++E +      +  R  R        + ++ +      I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 193 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 248
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 295 VEIIK 299
           +E + 
Sbjct: 255 LEFVT 259

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 59/260 (22%), Positives = 97/260 (37%), Gaps = 67/260 (25%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHP 135
             V+G+G+FG V  A             VA+K +       ++     EL++M  L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP------------------ETVNRIARNYSRIH 177
           NIV L       T    +Y  L+ EY                    E      +      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
               L +  L  + YQ+ + + ++   +C+   HRD+  +N+LV      +K+CDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220

Query: 234 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--L 279
            ++             Y             APE +F    YT   D+WS G ++ E+  L
Sbjct: 221 DIMSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270

Query: 280 LGQPLFPGESGVDQLVEIIK 299
              P +PG        ++I+
Sbjct: 271 GVNP-YPGIPVDANFYKLIQ 289

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           IV        +      +  ++LE +      +  R  R        + ++ +      I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 193 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 248
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 249 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 294
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 295 VEIIK 299
           +E + 
Sbjct: 296 LEFVT 300

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 83.0 bits (206), Expect = 4e-18
 Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 62/253 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G   FG V++         E  + VAIK +        +     E  +   L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYV 185
           +V L       T  + L   ++  Y                + +         +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 186 KL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 241
                  QI   + Y+  H+ +   H+D+  +N+LV      +K+ D G  + +   +  
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182

Query: 242 VSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFP 286
                  YY+            APE +++G  +++   DIWS G V+ E+   G QP + 
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YC 232

Query: 287 GESGVDQLVEIIK 299
           G S    +VE+I+
Sbjct: 233 GYS-NQDVVEMIR 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 56/261 (21%), Positives = 99/261 (37%), Gaps = 70/261 (26%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG VFQA+       E   +VA+K +        +    RE  +M   D+PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
           IV L          + +   L+ EY+                       +   R      
Sbjct: 112 IVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 233
              PL   +      Q+   +AY+     +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVVKIADFGLSR 222

Query: 234 VLVKGEPNVSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL- 279
            +   +         YY+             PE + +    YTT  D+W+ G V+ E+  
Sbjct: 223 NIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

Query: 280 LG-QPLFPGESGVDQLVEIIK 299
            G QP + G +  ++++  ++
Sbjct: 272 YGLQP-YYGMA-HEEVIYYVR 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.2 bits (206), Expect = 8e-18
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 61/254 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256

Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 306

Query: 286 PGESGVDQLVEIIK 299
           PG   V++L +++K
Sbjct: 307 PGIP-VEELFKLLK 319

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 61/254 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G+FG V  A+              VA+K +      +D      E+++M+M+  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY                          +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
               L    YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+ +   
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244

Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
           +         YY+            APE +F    YT   D+WS G ++ E+  LG   +
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPY 294

Query: 286 PGESGVDQLVEIIK 299
           PG   V++L +++K
Sbjct: 295 PGVP-VEELFKLLK 307

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 61/254 (24%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G+FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 238
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210

Query: 239 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 285
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 260

Query: 286 PGESGVDQLVEIIK 299
           PG   V++L +++K
Sbjct: 261 PGIP-VEELFKLLK 273

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 80.7 bits (198), Expect = 4e-17
 Identities = 46/330 (13%), Positives = 91/330 (27%), Gaps = 74/330 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----------RELQIMQML----- 132
           +G G FG VF  +       VAIK + ++     N            E+ I + L     
Sbjct: 28  IGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 133 ----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIY-- 184
                    + L            L L     Y     + N     +      + L +  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 185 -----------------VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 227
                             K   +Q+  +LA     +   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 287
              + K        +                  +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCGL-------------QVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 288 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPW--HKVFQKRLP 338
           +   D   +I +++           +P       +Y   K  +        +    K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 339 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            +  +       +S     +A +       
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
           Y     +G GSFGV+F+       + VAIK   +         E +  ++L     I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +       +E L+  LV++ +  ++  +     R   +  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123

Query: 201 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 233
               + +RDIKP N L+    + + + + + DFG  K
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 60/238 (25%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE--IVAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKL 187
            L         +  LY  L +EY P             +               L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 243
             +   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 244 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 287
                 Y             A E L +    YTT  D+WS G ++ E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 16/157 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQMLDH-PNIVAL 140
           +     +G G+FG +   K   T E VAIK   +       + E +  + L     I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +           Y  +VLE +  ++  +     R      L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122

Query: 201 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 233
           +   + +RD+KP+N L+    N     + + DF  AK
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 14/155 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
           Y     +G+GSFG ++       GE VAIK      ++     E +I +M+     I  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + C       E  Y  +V+E +  ++  +    SR   +  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122

Query: 201 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 233
           +     HRD+KP N L+      + + + DFG AK
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQML-DHPNIVAL 140
           +     +G+GSFG ++     +T E VAIK      ++     E +I ++L     I  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +         E  Y  LV++ +  ++  +   ++   +++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 201 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 233
           +     HRDIKP N L+      +Q+ + DFG AK
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 45/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 63  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK 122
            G V+    G +         ++    +G+G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 123 N---RELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVPET 165
                EL+  Q +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQL 224
           + +I    +          V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKI-SGQNG---TFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWSTG 272
            L D+G +        +  Y         +   G  E+ T++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 273 CVMAELLLGQ 282
             M   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 70.3 bits (173), Expect = 8e-14
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 56/236 (23%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQ 127
            N  ++   +  + +G G FGVV+  K       VA+KK+                 E++
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS------RIHQRMP 181
           +M    H N+V L     S+   +     LV  Y+P        N S       +    P
Sbjct: 83  VMAKCQHENLVELLGF--SSDGDDLC---LVYVYMP--------NGSLLDRLSCLDGTPP 129

Query: 182 LIYVKLYTYQIC----RALAYIH-NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSA 232
           L +      +I       + ++H N   I HRDIK  N+L+           K+ DFG A
Sbjct: 130 LSWHM--RCKIAQGAANGINFLHENHH-I-HRDIKSANILLDEAFTA-----KISDFGLA 180

Query: 233 KVLVKGEPNVSYICSR----Y-YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 283
           +   K     + + SR      Y APE + G  E T   DI+S G V+ E++ G P
Sbjct: 181 RASEKFA--QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 45/219 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVAL-K 141
           + ++G G FG V++   R+ G  VA+K+   +          E++ +    HP++V+L  
Sbjct: 44  KFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQIC----RA 195
            C       E   + L+ +Y+    N   +   Y      M + + +    +IC    R 
Sbjct: 103 FC------DERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARG 151

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 250
           L Y+H    I HRD+K  N+L++ +    K+ DFG +K   + +   +++ +       Y
Sbjct: 152 LHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVKGTLGY 207

Query: 251 RAPELIFGATEY------TTAIDIWSTGCVMAELLLGQP 283
             P       EY      T   D++S G V+ E+L  + 
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 46/252 (18%), Positives = 76/252 (30%), Gaps = 52/252 (20%)

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           G +I                +     +G G FG ++ A    + E V        K   +
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPS 75

Query: 124 R------ELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVP 163
                  EL+  Q    P  +                           + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTH 222
             + +I    ++   R     V   + +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWS 270
           Q+ L D+G A        + +Y             G  E+ T+I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 271 TGCVMAELLLGQ 282
            G  M + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 37/255 (14%), Positives = 78/255 (30%), Gaps = 56/255 (21%)

Query: 63  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG--------EIVAIK- 113
           TG V+    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 114 -----------KVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160
                         Q   K  +  + + +       I             ++ Y  LVL 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLP 138

Query: 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP- 219
            +  ++        +    +    V     ++  AL ++H      H ++  +N+ V+P 
Sbjct: 139 SLGRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPE 195

Query: 220 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------D 267
              Q+ L  +G A        +V+Y             G  E+  ++            D
Sbjct: 196 DQSQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSD 250

Query: 268 IWSTGCVMAELLLGQ 282
           + S G  M + L G 
Sbjct: 251 LQSLGYCMLKWLYGF 265

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 48/221 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
           ++++G G FG V++ +    G +VA+K++ +++          E++++ M  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-------RIHQRMPLIYVKLYTYQIC- 193
                 T  E L   LV  Y+         N S       R   + PL + K    +I  
Sbjct: 94  GF--CMTPTERL---LVYPYMA--------NGSVASCLRERPESQPPLDWPK--RQRIAL 138

Query: 194 ---RALAYIHN-C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 248
              R LAY+H+ C   I HRD+K  N+L++    +  + DFG AK++   +   +++ + 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTA 194

Query: 249 Y-----YRAPE-LIFG-ATEYTTAIDIWSTGCVMAELLLGQ 282
                 + APE L  G ++E T   D++  G ++ EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 29/127 (22%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K        
Sbjct: 198 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDP------ 247

Query: 246 CSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 292
               Y             APE IF    YT   D+WS G ++ E+  LG   +PG    +
Sbjct: 248 ---DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 293 QLVEIIK 299
           +    +K
Sbjct: 304 EFCRRLK 310

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	394
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.43
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.35
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.01
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.78
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.69
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.52
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.52
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.33
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.12
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.11
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.73
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.52
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.88
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.04

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4e-63  Score=444.82  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=201.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.       ...+.+|+++++.++||||+++++++.     ...
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence            34699999999999999999999999999999998543       234568999999999999999999983     334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+|+||||++|+|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            5889999999988777654    4689999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .........+..||+.|||||++.+...++.++|||||||++|+|+||+.||.+.+....+..+....            
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------  228 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------  228 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence            77665556678899999999999776656789999999999999999999998877666666655421            


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                           ..            ++..+|+++++||++||+.||++|||++|+|+||||+.
T Consensus       229 -----~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -----YT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -----CC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -----CC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                 11            12468999999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-62  Score=446.47  Aligned_cols=254  Identities=31%  Similarity=0.523  Sum_probs=218.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.++|||||+++++|     .....
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            4699999999999999999999999999999998643       23456899999999999999999998     33445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|+|||||+| +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus       107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGla~  180 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK  180 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence            8899999985 78777654    3689999999999999999999999 8999999999999999988 69999999998


Q ss_pred             ccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ......   ...+.+||+.|||||++.+.. |+.++|||||||++|+|+||+.||.+.+..+.+..+...          
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----------  249 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL----------  249 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence            764332   234568999999999997654 899999999999999999999999988877777777652          


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDPNT  376 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------ll~hp~f~~~~~~~~  376 (394)
                             .+.            ++..+++++++||++||++||++|||++|      |++||||+++....+
T Consensus       250 -------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          250 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             -------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             -------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence                   111            22468999999999999999999999987      589999999876655

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.7e-62  Score=450.97  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=217.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    ...+.+|+++|+.++|||||+++++|..     ...+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            4599999999999999999999999999999998542    3456789999999999999999999844     334889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      |||||++ +|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999985 77776653     679999999999999999999999 8999999999999999988 69999999998765


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .. ......+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+........          
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------  290 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------  290 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence            43 334567899999999999654 489999999999999999999999998887777766654211000          


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                      .....+|+++++||.+||++||++|||++|+|+||||++...+
T Consensus       291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence                            0124689999999999999999999999999999999987544

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-62  Score=452.45  Aligned_cols=255  Identities=26%  Similarity=0.385  Sum_probs=210.4

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++...      ...+.+|+++|+.++|||||++++++..     .
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~   95 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----N   95 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----C
Confidence            3346799999999999999999999999999999998643      2345689999999999999999999843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+|||||||+| +|.+++....  ...+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+
T Consensus        96 ~~~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl  171 (350)
T 4b9d_A           96 GSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGI  171 (350)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEccccc
Confidence            458899999984 8888776422  3567999999999999999999999 8999999999999999988 699999999


Q ss_pred             ccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      |+....... ....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+....-.       
T Consensus       172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------  243 (350)
T 4b9d_A          172 ARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------  243 (350)
T ss_dssp             ESCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------
T ss_pred             ceeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-------
Confidence            987643322 2346799999999999765 4899999999999999999999999998887777777652100       


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                           .++..+|+++++||.+||++||++|||++|+|+||||++-
T Consensus       244 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          244 ---------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             ---------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                                 0124689999999999999999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-61  Score=454.72  Aligned_cols=287  Identities=37%  Similarity=0.651  Sum_probs=237.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  155 (394)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+..      ....+|+++|+.++|||||++++++..... .....+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            5999999999999999999999999999999986432      234579999999999999999998743321 233558


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |||||||+|+|.+++..    ...+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+..
T Consensus       135 ~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~  208 (398)
T 4b99_A          135 YVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence            89999999988776643    4789999999999999999999999 8999999999999999988 6999999999865


Q ss_pred             ccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          236 VKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       236 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ...     ......+||+.|||||++.+...++.++||||+||++|+|++|++||.+.+..+++..|....+.++...+.
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            332     233457899999999999877778999999999999999999999999999999999999999998877654


Q ss_pred             ccCCCCc---ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          311 CMNPNYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       311 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      .......   ...++...+.+|...+ ..+++++++||.+||++||.+|||++|+|+||||++..++..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~  356 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD  356 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence            3321111   1123333444554443 468999999999999999999999999999999999877654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.8e-61  Score=453.15  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=217.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...|++++.||+|+||.||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|...     ..+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEE
Confidence            34699999999999999999999999999999998532    34567899999999999999999998543     3488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ||||||+| +|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+..
T Consensus       225 iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~  297 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQV  297 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceEC
Confidence            99999985 77776653     679999999999999999999999 8999999999999999988 6999999999876


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ... ......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+.......          
T Consensus       298 ~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------  366 (423)
T 4fie_A          298 SKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------  366 (423)
T ss_dssp             CSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred             CCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------
Confidence            543 334567899999999999654 48999999999999999999999999888777777665421100          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                            +          .....+|+++++||.+||++||++|||++|+|+||||++...+
T Consensus       367 ------~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          367 ------L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             ------C----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             ------C----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence                  0          0114689999999999999999999999999999999986544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-61  Score=439.69  Aligned_cols=264  Identities=29%  Similarity=0.434  Sum_probs=213.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|++++.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++++.++|||||++++++..     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            46999999999999999999984   46789999998542      2345679999999999999999999843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+|+|||||+| +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence            458899999985 78777654    3689999999999999999999999 8999999999999999988 699999999


Q ss_pred             ccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      |+..... ....+.+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+.+..         
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------  242 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK---------  242 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence            9865433 334567899999999999765 48999999999999999999999999988877777776521         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLP  385 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~~~~~~~~~~  385 (394)
                              ..            ++..+|+++++||++||++||++|||     ++|+++||||+++.....   ..+.++
T Consensus       243 --------~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l---~~~~~~  299 (304)
T 3ubd_A          243 --------LG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL---YRREIH  299 (304)
T ss_dssp             --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH---HTTCSC
T ss_pred             --------CC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH---HhCCCC
Confidence                    11            12468999999999999999999998     589999999998853332   223455


Q ss_pred             CCCC
Q 016158          386 PLFN  389 (394)
Q Consensus       386 ~~~~  389 (394)
                      |+|.
T Consensus       300 pP~~  303 (304)
T 3ubd_A          300 PPFK  303 (304)
T ss_dssp             CSSC
T ss_pred             cCcC
Confidence            6664

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-60  Score=429.92  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |.+.++||+|+||+||+|+++.+++.||+|++...      ...+.+|+++++.++|||||+++++|.... ....+++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            47888999999999999999999999999998543      234568999999999999999999885433 23456789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeC-CCCcEEEEeecCcc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSAK  233 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~  233 (394)
                      |||||++ +|.+++..    ...+++..++.++.||+.||+|||+ +|  |+||||||+||||+. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            9999985 78777654    4689999999999999999999999 78  999999999999985 55 79999999997


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .. ........+||+.|||||++.+  .|+.++|||||||++|+|+||+.||.+......+...+..... +        
T Consensus       181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-~--------  248 (290)
T 3fpq_A          181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-P--------  248 (290)
T ss_dssp             GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-C--------
T ss_pred             eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-C--------
Confidence            54 3334456789999999999854  4899999999999999999999999877665555443321111 1        


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                                       ..++..+++++++||.+||+.||++|||++|+|+||||++
T Consensus       249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                             1123567899999999999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-60  Score=438.61  Aligned_cols=258  Identities=25%  Similarity=0.364  Sum_probs=215.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      ...|++.++||+|+||.||+|+++.+|+.||||++..+. ...+|+.+++.++|||||++++++.     ...++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEe
Confidence            346999999999999999999999999999999987643 3357999999999999999999984     3345889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC
Q 016158          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (394)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~  239 (394)
                      ||+| +|.+++..    ...+++..++.++.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9985 88887764    3679999999999999999999999 8999999999999999887569999999998764432


Q ss_pred             C------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          240 P------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       240 ~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .      ....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+....+..+...  .++.       
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~-------  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPI-------  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGG-------
T ss_pred             cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCc-------
Confidence            1      1234699999999999765 4999999999999999999999999987776666666542  1100       


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-------------CVHPFFDELRDPNT  376 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-------------l~hp~f~~~~~~~~  376 (394)
                                       ..++..+++++.+||.+||++||.+|||+.||             |+|||+++.++|.-
T Consensus       276 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          276 -----------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             -----------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             -----------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence                             11235689999999999999999999999997             68999999877643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1e-58  Score=445.45  Aligned_cols=312  Identities=72%  Similarity=1.242  Sum_probs=284.7

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeEEEE
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNL  157 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~l  157 (394)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++........+|+++++.++|+||+++++++..... ....++++
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            34557999999999999999999999999999999998777777789999999999999999998865433 45677889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||+++++.+++..+......+++..++.++.||+.||+|||+ +||+||||||+||||+.++..+||+|||+++....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            99999999888888777777889999999999999999999999 89999999999999997765789999999987766


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      ........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..+.+..+++++.
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666778899999999997765699999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (394)
                      .+.++.....+|...+...+++++.+||++||++||.+|||+.|+|+||||+++.++...++++...|+.|+|+
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  363 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT  363 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCC
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCC
Confidence            99999999999999998899999999999999999999999999999999999999999889999999988874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.5e-58  Score=436.85  Aligned_cols=309  Identities=70%  Similarity=1.206  Sum_probs=282.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeEEEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLV  158 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv  158 (394)
                      ...+|++.++||+|+||.||+|++..+++ ||+|++........+|+++++.++||||+++++++..... ....++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            34579999999999999999999977665 8999887777777789999999999999999999876654 556778899


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe-CCCCcEEEEeecCcccccc
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~-~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+||+|||+++....
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA  194 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence            9999998888777777777899999999999999999999999 8999999999999999 555 799999999988766


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      ........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+..+++++.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66667788899999999997766799999999999999999999999999999999999999999999999999999888


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (394)
                      ...++.....++...+...+++++.+||.+||++||.+|||+.|+|+||||++++......+++...||+|+++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  348 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWT  348 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCC
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCC
Confidence            88899988999999898899999999999999999999999999999999999999999999999999999884

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-58  Score=440.70  Aligned_cols=311  Identities=52%  Similarity=1.005  Sum_probs=270.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCC-----------
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-----------  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----------  149 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||+++++++.....           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            346999999999999999999999999999999998877777899999999999999999999866443           


Q ss_pred             ----------------------CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcee
Q 016158          150 ----------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  207 (394)
Q Consensus       150 ----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH  207 (394)
                                            ....+.++||||++++|.+.+..+......+++..++.++.||+.||+|||+ .||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCcc
Confidence                                  3455688999999999998888877778899999999999999999999999 89999


Q ss_pred             ecCCCCcEEEeCCCCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016158          208 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  287 (394)
Q Consensus       208 ~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  287 (394)
                      |||||+|||++.+...+||+|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998543489999999998776666666778899999999987766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          288 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       288 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                      .+..+.+..+++.++.+..+.+..+++.+....++......|...++..+++++.+||.+||+.||.+|||+.|+|+|||
T Consensus       245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCC-------CCCCCCCC--CCCCCCCCCCC
Q 016158          368 FDELRD-------PNTRLPNG--RPLPPLFNFKP  392 (394)
Q Consensus       368 f~~~~~-------~~~~~~~~--~~~~~~~~~~~  392 (394)
                      |++++.       ....++++  ..+|++|+|++
T Consensus       325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (383)
T 3eb0_A          325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSP  358 (383)
T ss_dssp             GHHHHHC------------------CCCCSCCCH
T ss_pred             HHHHHhhccccccccccCCCcccCCCCCCCCCCH
Confidence            998765       55666777  77899999865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.1e-58  Score=428.64  Aligned_cols=278  Identities=27%  Similarity=0.442  Sum_probs=212.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccch--hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|++.+.||+|+||+||+|+++   .+++.||||++.+..  ....+|+++|+.+ +||||++++++|.     ...++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCEE
Confidence            46999999999999999999875   467899999886543  3456899999988 6999999999983     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      |+||||+++ +|.+++       +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            899999984 676554       358999999999999999999999 89999999999999998744899999999975


Q ss_pred             cccCC-----------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 016158          235 LVKGE-----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF  285 (394)
Q Consensus       235 ~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf  285 (394)
                      .....                             .....+||+.|+|||++.+...++.++||||+||++|+|+||+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            43221                             1223578999999999987767999999999999999999999998


Q ss_pred             CC-CCcHHHHHHHHHHhCCCChhhhhccCCC-------C--------------cccCCCCC----CCCCccccccccCCH
Q 016158          286 PG-ESGVDQLVEIIKVLGTPTREEIKCMNPN-------Y--------------TEFKFPQI----KPHPWHKVFQKRLPP  339 (394)
Q Consensus       286 ~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~----~~~~~~~~~~~~~~~  339 (394)
                      .. .+..+++..|...+|.+...........       .              .....+..    ............+|+
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            54 5566888888888775443222110000       0              00000000    000001112346899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          340 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       340 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      ++++||++||++||++|+||+|+|+||||++++
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999999874

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.1e-58  Score=417.71  Aligned_cols=261  Identities=23%  Similarity=0.393  Sum_probs=193.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCC-------
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD-------  149 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------  149 (394)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....     ..+.+|+.+|+.++|||||++++++.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999999999999999985422     345689999999999999999999865443       


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      ....++|+|||||.+ +|.+++..... ....++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEcc
Confidence            234568999999985 78777764221 2334566788999999999999999 8999999999999999988 699999


Q ss_pred             ecCccccccCCC-------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016158          229 FGSAKVLVKGEP-------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  295 (394)
Q Consensus       229 fg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  295 (394)
                      ||+|+.......             ....+||+.|||||++.+. .|+.++|||||||++|||++   ||.+..  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999987644322             1235799999999999765 49999999999999999996   775432  2222


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      .+........+.                         .....++.+.+||++||+.||.+|||+.|+|+||||+++..+.
T Consensus       236 ~~~~~~~~~~p~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPP-------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCH-------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCC-------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            222221111100                         0123467789999999999999999999999999999986554


Q ss_pred             C
Q 016158          376 T  376 (394)
Q Consensus       376 ~  376 (394)
                      .
T Consensus       291 ~  291 (299)
T 4g31_A          291 K  291 (299)
T ss_dssp             -
T ss_pred             c
Confidence            4

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-56  Score=441.96  Aligned_cols=258  Identities=24%  Similarity=0.366  Sum_probs=209.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHH---HHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRE---LQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+..       ....+|   +.+++.++|||||+++++|     .
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence            457999999999999999999999999999999986432       112233   4556667999999999998     3


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      ....+|+|||||.| +|..++..    ...+++..++.++.||+.||+|||+ +|||||||||+||||+.+| .+||+||
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL~DF  336 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDL  336 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEECCC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEeccc
Confidence            44458899999985 77776654    3679999999999999999999999 8999999999999999998 5999999


Q ss_pred             cCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      |+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|+|++|++||.+.+..+...........      
T Consensus       337 GlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~------  409 (689)
T 3v5w_A          337 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------  409 (689)
T ss_dssp             TTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC------
T ss_pred             ceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC------
Confidence            999876443 3456789999999999965556999999999999999999999999865432222111111100      


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNT  376 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~~~~  376 (394)
                              ..            .++..+|+++++||.+||++||.+|++     ++|+++||||+++.....
T Consensus       410 --------~~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          410 --------AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             --------CC------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             --------CC------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence                    01            123568999999999999999999998     799999999999865444

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-55  Score=435.89  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=221.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .++|++++.||+|+||.||+|+++.+|+.||||++...    .....+|+.+|+.++||||++++++|     .....++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            35799999999999999999999999999999988643    33456899999999999999999998     3445588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC-CCcEEEEeecCccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKV  234 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~  234 (394)
                      ||||||.| +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       231 iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999985 77655532   23679999999999999999999999 899999999999999864 23799999999998


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      +.........+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.......+.        
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  377 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  377 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS--------
T ss_pred             ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc--------
Confidence            7666666677899999999999765 4899999999999999999999999998888877777653221111        


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                       .....+|+++++||++||++||.+|||+.|+|+||||+....+..
T Consensus       378 -----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          378 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             -----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence                             112468999999999999999999999999999999998766543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-55  Score=400.00  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=206.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++...    ...+.+|+++|++++|||||++++++..     
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----
Confidence            356999999999999999999875     35789999998643    2445689999999999999999999843     


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhh---------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYS---------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~  221 (394)
                      ...+++|||||+ |+|.+++....         .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCC
Confidence            233789999998 58888887532         123579999999999999999999999 8999999999999999888


Q ss_pred             CcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 016158          222 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  297 (394)
Q Consensus       222 ~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i  297 (394)
                       .+||+|||+|+.......   .....||+.|||||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             699999999986543322   1234689999999999765 49999999999999999998 89999988877776666


Q ss_pred             HHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      .+... +                           ..+..+|+++.+||.+||+.||++|||+.++  |+|++++.
T Consensus       244 ~~~~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          244 TQGRV-L---------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HcCCC-C---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            54211 0                           0125689999999999999999999999999  45777653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-54  Score=400.78  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=197.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .+|.+.++||+|+||+||+|+++     .+++.||||++...    ...+.+|+++|++++|||||++++++..     .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            46999999999999999999875     36889999998643    2446689999999999999999999833     3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~  220 (394)
                      ..++||||||+ |+|.+++.....           ....+++..+..++.||+.||+|||+ ++||||||||+||||+.+
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECCC
Confidence            34789999998 588888765321           23569999999999999999999999 899999999999999988


Q ss_pred             CCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 016158          221 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  296 (394)
Q Consensus       221 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~  296 (394)
                      + .+||+|||+|+.......   .....||+.|||||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..
T Consensus       195 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          195 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             T-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             C-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            8 799999999986643322   2345789999999999654 49999999999999999999 8999998887776666


Q ss_pred             HHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       297 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      +.+... +                           .++..+++++.+||.+||+.||++|||+.||+++
T Consensus       273 i~~g~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGRE-L---------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCC-C---------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCC-C---------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            654211 0                           0225689999999999999999999999999863

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=395.24  Aligned_cols=245  Identities=20%  Similarity=0.273  Sum_probs=194.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .++++.+.||+|+||+||+|++.   ..||||+++..      ...+.+|+.++++++|||||++++++..    +  .+
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~~  106 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--NL  106 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--SC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--eE
Confidence            45889999999999999999875   35999988532      2345689999999999999999997621    1  15


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +||||||+ |+|.+++...   ...+++..+..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+.
T Consensus       107 ~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~  181 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGLATV  181 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSSCBC
T ss_pred             EEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccCcee
Confidence            79999998 4887776542   3679999999999999999999999 8999999999999999888 799999999986


Q ss_pred             cccCC---CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          235 LVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       235 ~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      .....   ......||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..++......+.   
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---  258 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD---  258 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC---
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC---
Confidence            54322   23346799999999998643  34899999999999999999999999988777666655542211110   


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  363 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  363 (394)
                                          ...++..+++++.+||.+||+.||++|||+.|++
T Consensus       259 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~  292 (307)
T 3omv_A          259 --------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL  292 (307)
T ss_dssp             --------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred             --------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence                                0112356899999999999999999999999765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-54  Score=396.31  Aligned_cols=248  Identities=20%  Similarity=0.271  Sum_probs=202.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+++.+.||+|+||+||+|++.     .+++.||||++...     ...+.+|+.++++++|||||++++++..     
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----  100 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----  100 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----
Confidence            35889999999999999999864     46789999998543     2456789999999999999999999843     


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~  218 (394)
                      ...+++|||||+ |+|.+++....            .....+++..+..++.||+.||+|||+ ++||||||||+||||+
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEEC
Confidence            233789999998 58888876432            123568999999999999999999999 8999999999999999


Q ss_pred             CCCCcEEEEeecCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016158          219 PHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  294 (394)
Q Consensus       219 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  294 (394)
                      .++ .+||+|||+|+......   ......||+.|||||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+
T Consensus       180 ~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          180 DKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             GGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             CCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            888 69999999998664332   23345789999999999765 49999999999999999998 89999988876666


Q ss_pred             HHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       295 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..+.... .+                           ..+..+++++.+|+.+||+.||++|||+.||+++
T Consensus       258 ~~i~~~~-~~---------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRNRQ-VL---------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCC-CC---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5554311 00                           0125689999999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-53  Score=400.02  Aligned_cols=304  Identities=48%  Similarity=0.900  Sum_probs=251.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh---hHHHHHHHHHcCCCceeeeceEEEecCC--CceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLDHPNIVALKHCFFSTTD--KEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~  155 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||||++......   ..+++..++.++||||+++++++.....  ....+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            34699999999999999999999999999999988654333   3456667788899999999999866443  445678


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCceeecCCCCcEEEeC-CCCcEEEEeecCc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--NCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSA  232 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~givH~Dlkp~Nil~~~-~~~~vkl~Dfg~a  232 (394)
                      ++||||+++++...+.........+++..++.++.|++.||.|||  + .||+||||||+|||++. ++ .+||+|||++
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG-TLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTT-EEEECCCTTC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCC-cEEEeeCCCc
Confidence            899999999988877776667788999999999999999999999  8 89999999999999997 55 7999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.++.+.+..+
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            87766666666788999999999977666899999999999999999999999999999999999999999999988887


Q ss_pred             CCCCcccCCCCCCCCCccccccc---cCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP  386 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~  386 (394)
                      .+......+......+|...+..   ..++++.+||.+||+.||.+|||+.|+|+||||++..++....++...+|.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~  336 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPE  336 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCG
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCc
Confidence            77666666665555566555433   367899999999999999999999999999999999999988888777763

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-53  Score=396.13  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCC-----CcEEEEEEeccc-----hhhhHHHHHHHHHcCC-CceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQD-----KRYKNRELQIMQMLDH-PNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~  149 (394)
                      .++|++.+.||+|+||+||+|++..+     ++.||||++...     ...+.+|+++|.++.| ||||+++++|.... 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-
Confidence            45799999999999999999998654     368999988643     2345679999999976 89999999884322 


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                         ..+++|||||+ |+|.+++......            ...+++..+..++.||+.||+|||+ ++||||||||+|||
T Consensus       142 ---~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL  217 (353)
T 4ase_A          142 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  217 (353)
T ss_dssp             ---SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence               23679999998 5888888764321            2458999999999999999999999 89999999999999


Q ss_pred             EeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016158          217 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  292 (394)
Q Consensus       217 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  292 (394)
                      ++.++ .+||+|||+|+........   ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+....+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99888 7999999999876444322   245679999999999765 49999999999999999998 999999876555


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+..++.....++                           ++..+++++.+||.+||+.||++|||+.+|++|
T Consensus       296 ~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5555444221111                           224679999999999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-52  Score=382.76  Aligned_cols=280  Identities=34%  Similarity=0.562  Sum_probs=225.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..     ....+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   77 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEEE
Confidence            5999999999999999999999999999999986432      344579999999999999999999843     34578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        78 lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAFG  152 (292)
T ss_dssp             EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceecC
Confidence            9999999987665543   34679999999999999999999999 8999999999999999888 69999999998664


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence            33 2234457799999999997766689999999999999999988766 666677788888888888887766544322


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      .......+..............+++++++||++||+.||++|||++|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            1111111111111122223356899999999999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-52  Score=399.69  Aligned_cols=298  Identities=32%  Similarity=0.626  Sum_probs=227.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.+. ||||+++++++...   +...
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence            4699999999999999999999999999999988532      233457999999997 99999999988542   2234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +|+||||++++|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+.
T Consensus        86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence            789999999988877764     679999999999999999999999 8999999999999999888 699999999976


Q ss_pred             cccC----------------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016158          235 LVKG----------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (394)
Q Consensus       235 ~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  292 (394)
                      ....                      .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                      112345789999999999776679999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCC------CCCCCCCccccc------------cccCCHHHHHHHHHhcccCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPN  354 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~  354 (394)
                      .+..+...++.|..+.+......+....+      .......+...+            ...+++++.+||++||++||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            99999999999988776543322110000      000000111111            126789999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          355 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  389 (394)
Q Consensus       355 ~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  389 (394)
                      +|||++|+|+||||+....+...........++|.
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~  353 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN  353 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC--
T ss_pred             cCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCcc
Confidence            99999999999999998877665444444444443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-52  Score=407.97  Aligned_cols=286  Identities=31%  Similarity=0.534  Sum_probs=226.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-Ccee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            34699999999999999999999999999999998643      2334579999999999999999999854332 2335


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++||||+++++.+.+.      ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            678999999998765543      459999999999999999999999 8999999999999999988 69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.+..+.+....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            77655555667899999999999765 58999999999999999999999999999999999999999999887775443


Q ss_pred             CCCccc--CCCCCCCCCcccccccc-----------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          314 PNYTEF--KFPQIKPHPWHKVFQKR-----------LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       314 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      .....+  ..+......+...++..           .++++++||++||++||++|||++|+|+||||+...++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  366 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA  366 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence            211111  11111111222222221           256799999999999999999999999999999765543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.6e-52  Score=384.49  Aligned_cols=279  Identities=35%  Similarity=0.665  Sum_probs=226.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|++.+.||+|+||.||+|++. +|+.||+|++....      ....+|+++++.++||||+++++++     ......
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   94 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERCL   94 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSCE
T ss_pred             hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCEE
Confidence            46999999999999999999995 58999999986432      3345799999999999999999988     333457


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+++++.+.+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        95 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~  169 (311)
T 3niz_A           95 TLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLARAF  169 (311)
T ss_dssp             EEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEET
T ss_pred             EEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCceec
Confidence            89999999988776654   23569999999999999999999999 8999999999999999888 6999999999866


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+...++.+....+.....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence            433 2233457799999999997766689999999999999999999999999998899999999988877665543321


Q ss_pred             C--CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          315 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       315 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      -  +....+......++.. +...+++++.+||++||++||.+|||++|+|+||||+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             cchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            1  1111112222223322 3356889999999999999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-52  Score=405.53  Aligned_cols=294  Identities=35%  Similarity=0.568  Sum_probs=222.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .+|++.++||+|+||.||+|++..+|+.||||++...      ...+.+|+.+|+.++||||+++++++..........+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            4699999999999999999999999999999988542      2345579999999999999999998865443444568


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |+||||++++|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+++..
T Consensus       133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCT
T ss_pred             EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccchhc
Confidence            89999999988777653    4679999999999999999999999 8999999999999999988 6999999999865


Q ss_pred             ccCC----------------------------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-------
Q 016158          236 VKGE----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-------  280 (394)
Q Consensus       236 ~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-------  280 (394)
                      ....                            ......||+.|+|||++.....++.++|||||||++|||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            4221                            12345679999999987666669999999999999999999       


Q ss_pred             ----CCCCCCCCC--------------------cHHHHHHHHHHhCCCChhhhhccCCCCc---ccCCCCCCCCCccccc
Q 016158          281 ----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYT---EFKFPQIKPHPWHKVF  333 (394)
Q Consensus       281 ----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  333 (394)
                          |+++|.+..                    ..+++..+...+|.+..+.+........   ...++......+...+
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                777787654                    2577888899999999887654432110   0112222222232222


Q ss_pred             cccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 016158          334 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR  382 (394)
Q Consensus       334 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~  382 (394)
                       ..+++++.+||++||++||.+|||++|+|+||||+++..+........
T Consensus       367 -~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~  414 (458)
T 3rp9_A          367 -PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATE  414 (458)
T ss_dssp             -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSS
T ss_pred             -CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCC
Confidence             457999999999999999999999999999999999987776543333

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-52  Score=383.09  Aligned_cols=285  Identities=28%  Similarity=0.522  Sum_probs=231.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHc---CCCceeeeceEEEecC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQML---DHPNIVALKHCFFSTT  148 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~  148 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....         ....+|+.+++.+   .||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            346999999999999999999999999999999986422         2445788877776   4999999999997766


Q ss_pred             CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      .....+.+++|||++++|.+++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEee
Confidence            66667789999999999888776532  2349999999999999999999999 8999999999999999888 799999


Q ss_pred             ecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99998776655566778899999999997654 89999999999999999999999999999999999999988887765


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      +..... .....++.....+.. .....+++++.+||.+||++||.+|||+.|+|+||||++..
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          243 WPRDVS-LPRGAFPPRGPRPVQ-SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SCSSCS-SCGGGSCCCCCCCHH-HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ccchhh-ccccccCCCCCCcHH-HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            532111 011112221222222 23356899999999999999999999999999999998754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-51  Score=396.91  Aligned_cols=300  Identities=33%  Similarity=0.535  Sum_probs=232.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++|+||+++++++..........+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            4699999999999999999999999999999998642      2345589999999999999999998854433333457


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      |+||||++++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus       106 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~~~  179 (432)
T 3n9x_A          106 YIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcccc
Confidence            89999999988777653    4669999999999999999999999 8999999999999999888 6999999999876


Q ss_pred             ccCCC-----------------------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-----------C
Q 016158          236 VKGEP-----------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-----------G  281 (394)
Q Consensus       236 ~~~~~-----------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-----------g  281 (394)
                      .....                       .....||+.|+|||++.....++.++|||||||++|+|++           |
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            43321                       2456789999999997666679999999999999999998           4


Q ss_pred             CCCCCCCC-----------------cHHHHHHHHHHhCCCChhhhhccCCCCcc---cCCCCCCCCCccccccccCCHHH
Q 016158          282 QPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEA  341 (394)
Q Consensus       282 ~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  341 (394)
                      .++|.+.+                 ..+++..+...+|.++.+.+.........   ..++......+...+ ..+++++
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~  338 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDDG  338 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHHH
Confidence            45555543                 35778889999999998877654321100   011222222222222 4589999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          342 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF  388 (394)
Q Consensus       342 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~  388 (394)
                      .+||++||++||.+|||++|+|+||||+++.++...........++|
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~  385 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPF  385 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSS
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCCh
Confidence            99999999999999999999999999999988776543333333444

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-51  Score=381.00  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=216.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+++++.++||||+++++++.     ....
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence            446999999999999999999999999999999986432      23457999999999999999999883     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||+++ ++.+.+..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        89 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  162 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFSN  162 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCCG
T ss_pred             EEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCce
Confidence            7899999974 77666644    3679999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....            
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------  230 (328)
T 3fe3_A          163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK------------  230 (328)
T ss_dssp             GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred             ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence            77666556677899999999999876645689999999999999999999999887766666655421            


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                           +.            ++..+++++.+||++||+.||.+|||++|+++||||+...+..
T Consensus       231 -----~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  275 (328)
T 3fe3_A          231 -----YR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED  275 (328)
T ss_dssp             -----CC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred             -----CC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence                 11            1235789999999999999999999999999999999865443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.4e-52  Score=377.86  Aligned_cols=277  Identities=35%  Similarity=0.634  Sum_probs=221.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +|++.+.||+|+||.||+|++ .+|+.||+|++....      ....+|+.+++.++||||+++++++...     ...+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV   76 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence            599999999999999999999 678999999985432      3445899999999999999999988432     3478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           77 LVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAFG  151 (288)
T ss_dssp             EEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHC
T ss_pred             EEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECccccccC
Confidence            99999999887766542   3679999999999999999999999 8999999999999999888 69999999997654


Q ss_pred             cC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence            32 22334567999999999976666899999999999999999999999999888888899888887765544322110


Q ss_pred             C-cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          316 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       316 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      . ....+......+|.. +...+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            0 000111222223332 335689999999999999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-51  Score=382.37  Aligned_cols=289  Identities=32%  Similarity=0.558  Sum_probs=217.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++     ......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence            35999999999999999999999999999999886432     3456899999999999999999988     3334578


Q ss_pred             EEEecccccHHHHHHHhhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          157 LVLEYVPETVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +||||++++|.+++......  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            99999999988877654321  2458999999999999999999999 8999999999999999888 699999999986


Q ss_pred             cccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          235 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       235 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6433 223455789999999999765568999999999999999999999999999989999999988887766554321


Q ss_pred             C--CCcccCCCCCCCCCcc----ccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 016158          314 P--NYTEFKFPQIKPHPWH----KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL  378 (394)
Q Consensus       314 ~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~  378 (394)
                      .  .+. ..+.......+.    ......++.++.+||.+||+.||++|||+.|+|+||||++...++...
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~  307 (317)
T 2pmi_A          238 KLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMG  307 (317)
T ss_dssp             GCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-----
T ss_pred             hhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhcc
Confidence            1  100 011111111111    122346889999999999999999999999999999999987766543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-52  Score=385.92  Aligned_cols=292  Identities=33%  Similarity=0.624  Sum_probs=231.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-----hhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....     ...+|+.+++.++||||+++++++..     ....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            359999999999999999999999999999998864332     23369999999999999999998843     23478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+++++.+.+...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999887766542   3569999999999999999999999 8999999999999999888 69999999997654


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 2234567999999999977666899999999999999999999999999999999999999998887665433211


Q ss_pred             --CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 016158          316 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL  384 (394)
Q Consensus       316 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~  384 (394)
                        +..+..+........ .....+++++.+||++||+.||.+|||++|+|+||||+++.+.....+....+
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~  301 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSI  301 (324)
T ss_dssp             HHHHHTCCCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCG
T ss_pred             hhhcccccccccchhhh-hhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcH
Confidence              111122222222221 12346899999999999999999999999999999999998877766655544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.4e-51  Score=383.95  Aligned_cols=287  Identities=31%  Similarity=0.618  Sum_probs=237.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++.+.||+|+||.||+|++..+++.||||++....     ....+|+++++.++||||+++++++...........++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            5999999999999999999999999999999986422     34457999999999999999999885544344455789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||++++|.+++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus       108 v~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          108 VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP  180 (364)
T ss_dssp             EEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred             EEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEecCC
Confidence            999999998887764     679999999999999999999999 8999999999999999888 699999999976543


Q ss_pred             CCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          238 GEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       238 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ...    .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+....
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            322    2345789999999998766668999999999999999999999999999999999999999999887765432


Q ss_pred             CCC---cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          314 PNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       314 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ...   .....+.....+|... ...+++++.+||.+||++||.+|||+.|+|+||||++...+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~  326 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE  326 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred             hhhHHHHHHhcCCccCCCHHHh-CCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccc
Confidence            110   0112222223333332 25679999999999999999999999999999999998665543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7e-51  Score=382.59  Aligned_cols=256  Identities=25%  Similarity=0.361  Sum_probs=216.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .+.|++.+.||+|+||.||+|+++.+|+.||+|++....          ..+.+|+.+++.++||||+++++++.     
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE-----   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence            346999999999999999999999999999999986432          34568999999999999999999883     


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC---cEEE
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  226 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl  226 (394)
                      .....++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   .+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            3345889999996 577666543    4679999999999999999999999 89999999999999987653   5999


Q ss_pred             EeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus       161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  239 (361)
T 2yab_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE  239 (361)
T ss_dssp             CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             EecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            999999877665555667899999999999654 4899999999999999999999999988877777666543222111


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      .                         +...+++++++||++||..||.+|||+.|+|+||||+...
T Consensus       240 ~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          240 E-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             H-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             h-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            1                         2246799999999999999999999999999999998653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-51  Score=385.08  Aligned_cols=285  Identities=33%  Similarity=0.614  Sum_probs=227.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            3599999999999999999999999999999998542      2334579999999999999999998854322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++||||++++|.+++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            679999998888887764     679999999999999999999999 8999999999999999888 699999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.+.+..+..
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            533  334567899999999997756699999999999999999999999999999999999999999999877654432


Q ss_pred             CCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ....   ..++......+...+ ..+++++.+||.+||+.||.+|||++++|+||||+++.++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             HHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence            1100   112222333333332 567999999999999999999999999999999999887665

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=386.76  Aligned_cols=252  Identities=28%  Similarity=0.473  Sum_probs=208.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.++||+|+||.||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||+++++++     ...
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            346999999999999999999999999999999986532       2345788999988 799999999988     333


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+++||||+.+ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DFG~  170 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGM  170 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEccccc
Confidence            458899999985 77666543    3679999999999999999999999 8999999999999999988 699999999


Q ss_pred             cccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....         
T Consensus       171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------  240 (353)
T 3txo_A          171 CKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------  240 (353)
T ss_dssp             CBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             eeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence            975432 2334456789999999999654 48999999999999999999999999988877777776521         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  373 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~  373 (394)
                              ..            ++..+++++.+||++||+.||.+||++      +++++||||+++..
T Consensus       241 --------~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          241 --------VV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             --------CC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                    11            124578999999999999999999999      89999999998753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=372.94  Aligned_cols=285  Identities=35%  Similarity=0.615  Sum_probs=220.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            36999999999999999999999999999999885432      334579999999999999999999843     3347


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||++++....+   ......+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHH---HHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHH---HhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            899999997543322   2334679999999999999999999999 8999999999999999888 7999999999766


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC-
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  313 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  313 (394)
                      .... ......+|+.|+|||++.+...++.++||||||+++|+|++|..||.+....+.+..+....+........... 
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            4322 23355789999999999776678999999999999999999999999999888888888888776665433221 


Q ss_pred             -CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          314 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                       ..+.....+..............++.++.+||++||+.||.+|||++|+|+||||+++++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence             111122222222111122223568999999999999999999999999999999999876654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.6e-51  Score=378.62  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=212.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ....
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCCE
Confidence            46999999999999999999999999999999986532       23457999999999999999999883     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        80 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~  153 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccchh
Confidence            8899999986 67665543    3679999999999999999999999 8999999999999999988 69999999997


Q ss_pred             cccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...            
T Consensus       154 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------  220 (337)
T 1o6l_A          154 EGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------  220 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             hcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence            6432 3334566789999999999654 4899999999999999999999999887766666555441            


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~  373 (394)
                           ...            ++..+++++.+||.+||+.||.+||     +++++++||||+.+..
T Consensus       221 -----~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                 111            2246799999999999999999999     9999999999998753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.2e-51  Score=380.30  Aligned_cols=282  Identities=31%  Similarity=0.551  Sum_probs=226.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..     ...
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  107 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----NHR  107 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----CCE
Confidence            456999999999999999999999999999999985432      234579999999999999999999843     334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC----CcEEEEeec
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDFG  230 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~Dfg  230 (394)
                      .++||||++++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++    ..+||+|||
T Consensus       108 ~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          108 LHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            789999999988777654    3569999999999999999999999 8999999999999995332    259999999


Q ss_pred             CccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          231 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       231 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+....+
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            99765432 22334567999999999977666899999999999999999999999999999999999998888776655


Q ss_pred             hccCCC-CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          310 KCMNPN-YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       310 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      ...... .....++......+...+...+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            322110 011233344444555556667899999999999999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-51  Score=380.78  Aligned_cols=286  Identities=34%  Similarity=0.582  Sum_probs=228.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....         ....+|+.+++.++||||+++++++..     
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence            346999999999999999999999999999999986421         234579999999999999999998832     


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ....++||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            233779999999987666543   23568999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            98664332 23456789999999999766668999999999999999999999999999999999999988888776665


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ..........+......++.. +...++.++.+||++||+.||.+|||+.|+|+||||++...+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~  304 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG  304 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred             hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCc
Confidence            433221111121111122222 235678999999999999999999999999999999987666543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.3e-51  Score=388.46  Aligned_cols=259  Identities=28%  Similarity=0.471  Sum_probs=216.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.++||+|+||.||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~  142 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR  142 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence            45799999999999999999999999999999998642       23356899999999999999999988     3445


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ++++||||++ ++|.+++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEecccee
Confidence            5889999996 478776653     579999999999999999999999 8999999999999999988 6999999999


Q ss_pred             cccccCCC--CccccccccccccccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      +.......  .....||+.|+|||++.+..   .++.++|||||||++|+|++|+.||.+.+....+..+......    
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----  291 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----  291 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc----
Confidence            86644332  23567899999999996543   2788999999999999999999999988887777777643100    


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                 ..++.          ...+++++++||++||+.+|.+  |++++|+++||||+++...+.
T Consensus       292 -----------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~  341 (410)
T 3v8s_A          292 -----------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  341 (410)
T ss_dssp             -----------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred             -----------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence                       01110          1357999999999999999988  999999999999999865544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-50  Score=387.96  Aligned_cols=281  Identities=30%  Similarity=0.529  Sum_probs=227.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHc------CCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML------DHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+      +|+||+.+++++..     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence            346999999999999999999999999999999987643   3345688888887      56799999998843     


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC-cEEEEeec
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg  230 (394)
                      ...+++||||+++++.+++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++. .+||+|||
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            34588999999999888776532  2569999999999999999999999 89999999999999998762 29999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++....  .......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.++...+.
T Consensus       248 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            996543  3344567899999999997654 8999999999999999999999999999999999999999999887664


Q ss_pred             ccCCC--------CcccC----------------------CCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH
Q 016158          311 CMNPN--------YTEFK----------------------FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  360 (394)
Q Consensus       311 ~~~~~--------~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  360 (394)
                      .....        +..+.                      ........|...+....++++.+||++||++||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            33211        00000                      0001122344455556789999999999999999999999


Q ss_pred             HHhcCCCCCCCC
Q 016158          361 EACVHPFFDELR  372 (394)
Q Consensus       361 ell~hp~f~~~~  372 (394)
                      |+|+||||++..
T Consensus       405 e~L~Hpw~~~~~  416 (429)
T 3kvw_A          405 QALRHPWLRRRL  416 (429)
T ss_dssp             HHHTSTTTC---
T ss_pred             HHhCChhhccCC
Confidence            999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.4e-50  Score=368.05  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=213.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...    .....+|+.+++.++||||+++++++...     ...+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            45699999999999999999999999999999988543    33456899999999999999999988443     3478


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+. ++|.+++..     ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence            9999996 578777654     579999999999999999999999 8999999999999999888 6999999998766


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+........         
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  236 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------  236 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------
T ss_pred             CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            4433 23456789999999999765 489999999999999999999999988877666665544221100         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                       ..+..++..+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       237 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          237 -----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             -----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence                             012467999999999999999999999999999999987643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-51  Score=383.30  Aligned_cols=252  Identities=29%  Similarity=0.421  Sum_probs=210.0

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++..     .
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~   81 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----P   81 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----C
Confidence            345799999999999999999999999999999998643       2345689999999999999999998843     3


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ...++||||+++++.+.+..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~s  155 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGLS  155 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSCT
T ss_pred             CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEeccc
Confidence            34789999999888776654    3679999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+               
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------  220 (336)
T 3h4j_B          156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------  220 (336)
T ss_dssp             BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------
T ss_pred             eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------
Confidence            87766555566789999999999976654588999999999999999999999764322110000               


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      .              .....++..+++++.+||++||+.||.+|||++|+++||||+..
T Consensus       221 ~--------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          221 N--------------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             C--------------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             H--------------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            0              00011235689999999999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-50  Score=381.99  Aligned_cols=254  Identities=26%  Similarity=0.477  Sum_probs=207.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.++||+|+||.||+|+++.+++.||+|++.+..       ....+|..++..+ +||||+++++++.     ..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence            457999999999999999999999999999999986532       2345788888877 8999999999883     34


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFGl  199 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGM  199 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEeecce
Confidence            458899999986 67655543    3679999999999999999999999 8999999999999999988 699999999


Q ss_pred             cccc-ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhC
Q 016158          232 AKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLG  302 (394)
Q Consensus       232 a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~  302 (394)
                      ++.. ..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....        .+.+...+... 
T Consensus       200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-  277 (396)
T 4dc2_A          200 CKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-  277 (396)
T ss_dssp             CBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-
T ss_pred             eeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-
Confidence            9863 333445567899999999999665 489999999999999999999999964321        11122211110 


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCCC
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRDP  374 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~~  374 (394)
                                     ...            ++..+++++++||++||+.||.+||++      +|+++||||+++...
T Consensus       278 ---------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          278 ---------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             ---------------CCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             ---------------ccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence                           011            234689999999999999999999985      799999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-50  Score=371.80  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=215.6

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      -.++|.+.+.||+|+||.||+|++..+|+.||+|++...          ...+.+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            345699999999999999999999999999999988642          234668999999999999999999883    


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC---cEE
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLK  225 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vk  225 (394)
                       .....++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   .+|
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEE
Confidence             33457899999974 77766543    4679999999999999999999999 89999999999999987652   599


Q ss_pred             EEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      |+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+.......+
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            9999999877655555567889999999998544 489999999999999999999999998877776666655322211


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      ..                         ....++..+.+||++||+.||.+|||+.++|+||||+...
T Consensus       238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            11                         1245789999999999999999999999999999998653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.7e-51  Score=383.64  Aligned_cols=285  Identities=35%  Similarity=0.594  Sum_probs=218.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4699999999999999999999999999999998542      2334579999999999999999998844321 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++++|+++++|.+++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            679999999888776654     679999999999999999999999 8999999999999999888 699999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+.....
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            532  234567899999999997756689999999999999999999999999999999999999999998877654432


Q ss_pred             CCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ....   ..++......+...+ ..+++++.+||.+||+.||.+|||+.++|+||||++..++..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  323 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  323 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence            1100   012222223333332 467899999999999999999999999999999999877664

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.5e-51  Score=373.82  Aligned_cols=255  Identities=21%  Similarity=0.219  Sum_probs=187.0

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-hh--HHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YK--NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +|.+.+.||+|+||+||+|++  +|+.||||++..... ..  +.|+..+..++|||||++++++.... .....++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence            599999999999999999998  489999999865432 22  23555566789999999999986543 2234578999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------CceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--------givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      |||+ |+|.+++..     ..+++..+..++.|++.||+|||+ .        +|+||||||+||||+.++ .+||+|||
T Consensus        81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            9998 588887764     679999999999999999999997 5        899999999999999988 69999999


Q ss_pred             CccccccCCCC-----ccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--------
Q 016158          231 SAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVD--------  292 (394)
Q Consensus       231 ~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------  292 (394)
                      +|+........     ....||+.|||||++.+..     .++.++|||||||++|||+||..||.......        
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876443322     2357899999999996532     25779999999999999999987764322110        


Q ss_pred             ---HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          293 ---QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       293 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                         ....+......          ..        ..+..-........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~----------~~--------~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCE----------QK--------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTT----------SC--------CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhc----------cc--------CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               01111111100          00        000000000011234578999999999999999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-50  Score=375.57  Aligned_cols=255  Identities=26%  Similarity=0.388  Sum_probs=215.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...   .....+|+.+++.++||||+++++++..     ....++|
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv   79 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEEE
Confidence            4699999999999999999999999999999988643   2345689999999999999999998843     3347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC--CCCcEEEEeecCcccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVL  235 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~~~vkl~Dfg~a~~~  235 (394)
                      |||+++ +|.+.+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.  ++ .+||+|||++...
T Consensus        80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeEC
Confidence            999985 77665532   23469999999999999999999999 89999999999999987  45 7999999999877


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+.......+...       
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence            655555567789999999999654 479999999999999999999999998887777777766432222221       


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                        ...++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                              145799999999999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.2e-50  Score=375.63  Aligned_cols=258  Identities=29%  Similarity=0.379  Sum_probs=211.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++...         ...+.+|+.+++.++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            34699999999999999999999999999999998532         3446789999999999999999998843     


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC--cEEEEe
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCD  228 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~D  228 (394)
                      ....++||||+. ++|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+|
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEec
Confidence            335789999998 47777666655555679999999999999999999999 89999999999999986542  499999


Q ss_pred             ecCccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          229 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       229 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ......+..........
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~  254 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR  254 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence            999987654332 3356789999999999654 48999999999999999999999998743 33344443321111111


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                               ....+++++.+||++||+.||++|||+.++|+||||++.
T Consensus       255 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          255 -------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                                     114578999999999999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-49  Score=365.91  Aligned_cols=291  Identities=31%  Similarity=0.530  Sum_probs=233.5

Q ss_pred             cccccEEEeeEeeecCceEEEEEEEC-CCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCceeeeceEEEecC
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTT  148 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~  148 (394)
                      ....+|++.+.||+|+||.||+|++. .+|+.||||++....      ....+|+.+++.+   .||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34457999999999999999999995 678999999885422      2445788877776   8999999999986544


Q ss_pred             CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      .......++||||++++|.+++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECS
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEec
Confidence            45667788999999999888776532  2458999999999999999999999 8999999999999999888 799999


Q ss_pred             ecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ||++.............+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+....+.+..+....+.+....
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            9999766544444456789999999999654 489999999999999999999999999998889999998888877665


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      +...... ....+..... .....+...++..+.+||.+||+.||.+|||+.++|+||||+++.....
T Consensus       243 ~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          243 WPRDVAL-PRQAFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             SCTTCSS-CGGGSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             Ccccccc-chhhhcccCc-chhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence            4321110 0001111111 1122234678999999999999999999999999999999999876554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-50  Score=383.02  Aligned_cols=286  Identities=31%  Similarity=0.542  Sum_probs=217.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            4699999999999999999999999999999998642      1334579999999999999999998844321 22346


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+++++.+.+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  176 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  176 (371)
T ss_dssp             EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred             eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence            78999999998876653      568999999999999999999999 8999999999999999888 699999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+..+.+
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            6554444566789999999999764 489999999999999999999999999998899999988888887766544322


Q ss_pred             CCccc--CCCCCCCCCccccc-----------cccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTEF--KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ....+  ..+......+...+           ....+.++++||++||+.||.+|||++|+|+||||+...++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~  330 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  330 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHH
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccc
Confidence            11000  00111111111111           1123678999999999999999999999999999998766543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8e-50  Score=376.60  Aligned_cols=288  Identities=28%  Similarity=0.569  Sum_probs=227.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---------------hhhHHHHHHHHHcCCCceeeeceEEEe
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKHCFFS  146 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~~~  146 (394)
                      .+|++.+.||+|+||.||+|.+.. |+.||||++....               ....+|+.+++.++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            469999999999999999999854 8999999885321               345689999999999999999999877


Q ss_pred             cCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEE
Q 016158          147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                      ........+++||||+++++.+.+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl  175 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DITI  175 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEE
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEEE
Confidence            66566667899999999988776653   23579999999999999999999999 8999999999999999887 6999


Q ss_pred             EeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999986655555556778999999999976566899999999999999999999999999999999999999998887


Q ss_pred             hhhhccCCCC----cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          307 EEIKCMNPNY----TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       307 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ..........    ............|. .....+++.+.+||.+||+.||.+|||+.++|+||||+.+..+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence            6654322110    00111111122222 233567899999999999999999999999999999999866544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-50  Score=370.58  Aligned_cols=251  Identities=26%  Similarity=0.467  Sum_probs=213.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|+++.+|+.||+|++.+.       .....+|+.+++.++||||+++++++.     ...
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence            35699999999999999999999999999999998643       233457999999999999999999883     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcc
Confidence            58899999985 77776654    3679999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      +....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....           
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  219 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------  219 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred             eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            76532  33456789999999999654 48999999999999999999999999888777776665521           


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  374 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  374 (394)
                            ..            ++..+++++.+||++||+.||++||     +++++++||||+++...
T Consensus       220 ------~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          220 ------LR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             ------CC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ------CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                  11            1245789999999999999999999     99999999999987543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.8e-50  Score=378.58  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=210.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++.     ...
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            356999999999999999999999999999999986432       34457999999999999999999883     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+.+ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~a  162 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFNIA  162 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEecccee
Confidence            57899999975 66665543    4679999999999999999999999 8999999999999999988 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhh
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~  308 (394)
                      .............||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||......  ..+.......       
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------  235 (384)
T 4fr4_A          163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-------  235 (384)
T ss_dssp             EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-------
T ss_pred             eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-------
Confidence            877666666678899999999998642  34789999999999999999999999764332  2222221110       


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDELRDP  374 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell~hp~f~~~~~~  374 (394)
                               ..            .++..++.++.+||.+||+.||.+||+ ++++++||||+++...
T Consensus       236 ---------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          236 ---------VV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             ---------cc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence                     00            022457899999999999999999998 8999999999987543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-49  Score=372.94  Aligned_cols=290  Identities=29%  Similarity=0.476  Sum_probs=227.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC---Cc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            457999999999999999999999999999999885432      234579999999999999999998855332   11


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...+++||||+++++...+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccchh
Confidence            3457899999999887666542   3579999999999999999999999 8999999999999999888 799999999


Q ss_pred             ccccccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +......     .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+....+..+.
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9765422     22234567999999999977666899999999999999999999999999998999999988888776


Q ss_pred             hhhhccCCC--CcccCCCCCCCCCcc-ccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          307 EEIKCMNPN--YTEFKFPQIKPHPWH-KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       307 ~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      ..+......  +.............. .......++++.+||.+||+.||++|||++|+|+||||+....+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            655432211  011111111111111 111112478899999999999999999999999999998765443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.8e-50  Score=383.08  Aligned_cols=263  Identities=26%  Similarity=0.422  Sum_probs=217.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.++||+|+||+||+|+++.+++.||+|++.+.       .....+|+.++..++||||+++++++     ....
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence            35799999999999999999999999999999998642       12356899999999999999999988     3344


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+++||||++ ++|..++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            5889999996 5787776542   3679999999999999999999999 8999999999999999988 6999999999


Q ss_pred             cccccCCCC--cccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          233 KVLVKGEPN--VSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       233 ~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +........  ....||+.|+|||++.    +...++.++|||||||++|||++|+.||.+.+..+.+..+......   
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---  299 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER---  299 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence            766443322  2357899999999986    2345899999999999999999999999998887777777542110   


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                                  ..++.         ....+++++++||++||+.+|++  |++++|+++||||+++.....+
T Consensus       300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence                        11111         01357999999999999999888  9999999999999998766654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.1e-50  Score=375.63  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=212.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++.+..       ....+|..++..+ .||+|+++++++     ...
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence            346999999999999999999999999999999986532       2345688888877 899999999988     333


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~  167 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM  167 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCCc
Confidence            458899999975 77766653    3679999999999999999999999 8999999999999999988 699999999


Q ss_pred             cccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....         
T Consensus       168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------  237 (353)
T 2i0e_A          168 CKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------  237 (353)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             ccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence            976432 2334456789999999999654 48999999999999999999999999888777776666521         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  374 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  374 (394)
                              ..            ++..+++++.+||++||+.||.+||     +++++++||||+.+...
T Consensus       238 --------~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          238 --------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             --------CC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             --------CC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                    11            2246899999999999999999999     47999999999987543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-49  Score=373.64  Aligned_cols=296  Identities=33%  Similarity=0.626  Sum_probs=231.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++...........+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            46999999999999999999999999999999985322     2345799999999999999999877443323345578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+.++|.+++..     ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        91 lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           91 IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARIID  163 (353)
T ss_dssp             EEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEecccccccc
Confidence            9999999988877764     679999999999999999999999 8999999999999999888 69999999997654


Q ss_pred             cCCC-----------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          237 KGEP-----------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       237 ~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      ....           .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            3211           12346799999999986656689999999999999999999999999988888888888877765


Q ss_pred             hhhhhccCCCCc--c--cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016158          306 REEIKCMNPNYT--E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  381 (394)
Q Consensus       306 ~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~  381 (394)
                      ............  .  ...+......+. .....+++++.+||.+||+.||++|||+.++|+||||+....+... +.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~-~~~  321 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE-PEG  321 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS-CCC
T ss_pred             hhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc-ccc
Confidence            322111000000  0  011111111111 1234689999999999999999999999999999999999888765 445


Q ss_pred             CCCCC
Q 016158          382 RPLPP  386 (394)
Q Consensus       382 ~~~~~  386 (394)
                      .++||
T Consensus       322 ~~~~~  326 (353)
T 2b9h_A          322 EPIPP  326 (353)
T ss_dssp             CCCCG
T ss_pred             CCCCc
Confidence            55543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.7e-50  Score=376.25  Aligned_cols=255  Identities=28%  Similarity=0.380  Sum_probs=213.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++....      ..+.+|+.+++.++||||+++++++.     ....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            356999999999999999999999999999999986432      34567999999999999999999883     3445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~  231 (394)
                      .++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++  ..+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            7899999986 66555432    3678999999999999999999999 8999999999999998653  2599999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......+..    
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----  252 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----  252 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred             ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc----
Confidence            9877655555567899999999999654 48999999999999999999999999887766666665532111111    


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                           ....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       253 ---------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          253 ---------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ---------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ---------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                 114579999999999999999999999999999999753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-49  Score=376.96  Aligned_cols=289  Identities=34%  Similarity=0.610  Sum_probs=229.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCC-ceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~  154 (394)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4699999999999999999999999999999998643      23445799999999999999999998543321 1223


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+.+++...+      ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            4799999998876554      2569999999999999999999999 8999999999999999888 699999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.+....++.
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            532  234567899999999997756689999999999999999999999999999999999999999888776654432


Q ss_pred             CCccc---CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016158          315 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  381 (394)
Q Consensus       315 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~  381 (394)
                      .....   ..+......+. .....+++++.+||++||+.||.+|||+.|+|+||||+.+..+.......
T Consensus       272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~  340 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ  340 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS
T ss_pred             hhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccc
Confidence            11100   11111111121 12346799999999999999999999999999999999987776544333

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.6e-49  Score=359.46  Aligned_cols=268  Identities=27%  Similarity=0.370  Sum_probs=222.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence            356999999999999999999999999999999986432      3445799999999999999999988     33445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC--cEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~  231 (394)
                      .++||||+.+ ++.+.+..    ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++.  .+||+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7899999986 66555543    3679999999999999999999999 89999999999999986542  499999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.............+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.......+.......+..    
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----  229 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch----
Confidence            9877665555567889999999999654 48999999999999999999999998887776666665532211111    


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL  384 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~  384 (394)
                                           ....+++++.+||.+||+.||++|||+.|+|+||||++............++
T Consensus       230 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~  281 (284)
T 3kk8_A          230 ---------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV  281 (284)
T ss_dssp             ---------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCCCC
T ss_pred             ---------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcCCCc
Confidence                                 1135789999999999999999999999999999999988877776666554

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.7e-50  Score=373.24  Aligned_cols=251  Identities=27%  Similarity=0.489  Sum_probs=211.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++.+..       .....|..++..+ +||||+++++++.     ..
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~~   90 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TK   90 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----eC
Confidence            346999999999999999999999999999999986532       2345688888876 9999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+++||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~  164 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGM  164 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeEChh
Confidence            458899999975 77766654    3679999999999999999999999 8999999999999999988 699999999


Q ss_pred             ccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....         
T Consensus       165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  234 (345)
T 1xjd_A          165 CKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------  234 (345)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             hhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------
Confidence            9764332 334456789999999999654 48999999999999999999999999887776666654411         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELR  372 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~f~~~~  372 (394)
                              ..            ++..+++++.+||.+||+.||.+||++. ++++||||+++.
T Consensus       235 --------~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          235 --------PF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             --------CC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             --------CC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence                    00            1245789999999999999999999998 999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=377.36  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=215.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.++||+|+||.||+|+++.+|+.||||++.+.       .....+|..++..++||||+++++++     ....
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  134 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN  134 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence            45799999999999999999999999999999998642       23356799999999999999999988     3344


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ++|+||||++ ++|..++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGla  209 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGSC  209 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechhh
Confidence            5889999996 5887776542   3579999999999999999999999 8999999999999999988 6999999999


Q ss_pred             cccccCCC--CccccccccccccccccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          233 KVLVKGEP--NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      +.......  .....||+.|+|||++..      ...++.++|||||||++|||++|+.||.+.+..+.+..+...... 
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-  288 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-  288 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-
Confidence            87644332  224578999999999862      345899999999999999999999999988877777766542100 


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~ell~hp~f~~~~~~~~~  377 (394)
                                    ..++.         +...+++++++||++||+ ||.+|   ++++|+++||||+++.....+
T Consensus       289 --------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          289 --------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             --------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             --------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence                          00110         124689999999999999 99998   599999999999998766553

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.6e-49  Score=372.77  Aligned_cols=276  Identities=25%  Similarity=0.422  Sum_probs=220.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-----CCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----HPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   .....|+.+++.+.     ||||+++++++...     .
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~  109 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----D  109 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----T
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----C
Confidence            46999999999999999999999999999999986432   34457999999996     99999999988443     3


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC--------------
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--------------  219 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--------------  219 (394)
                      ..++||||++++|.+++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.              
T Consensus       110 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          110 HMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             eeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhccc
Confidence            488999999889988877532  2469999999999999999999999 89999999999999974              


Q ss_pred             -----------CCCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 016158          220 -----------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  288 (394)
Q Consensus       220 -----------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  288 (394)
                                 ++ .+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus       187 ~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          187 DGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             TCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                       44 799999999976432  33456789999999999755 4899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCChhhhhccCCCCcc---------cCCCCCCCC--------CccccccccCCHHHHHHHHHhccc
Q 016158          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTE---------FKFPQIKPH--------PWHKVFQKRLPPEAVDLVCRFFQY  351 (394)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~  351 (394)
                      +..+.+..+....+..+...+.........         ...+.....        .....+....++.+.+||++||+.
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            988888888888888777655432211000         001100000        000111223457889999999999


Q ss_pred             CCCCCCCHHHHhcCCCCC
Q 016158          352 SPNLRCTALEACVHPFFD  369 (394)
Q Consensus       352 dP~~Rpt~~ell~hp~f~  369 (394)
                      ||++|||+.|+|+||||+
T Consensus       343 dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccC
Confidence            999999999999999996

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-49  Score=371.78  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=212.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ...
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence            346999999999999999999999999999999986432       23457999999999999999999883     334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+++||||++ ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg~a  188 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEcccccc
Confidence            5889999997 577776654    3679999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      +....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....           
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-----------  254 (350)
T 1rdq_E          189 KRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----------  254 (350)
T ss_dssp             EECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             eeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            86533  23456789999999999654 48999999999999999999999999887777666665521           


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~  373 (394)
                            ..            ++..+++++.+||++||+.||.+||+     ++++++||||+.+..
T Consensus       255 ------~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          255 ------VR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ------CC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ------CC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                  11            12467999999999999999999998     999999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-49  Score=370.41  Aligned_cols=252  Identities=27%  Similarity=0.488  Sum_probs=205.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|+++.+++.||+|++.+..       ....+|..+++.+ +||||+++++++.     ..
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence            456999999999999999999999999999999986532       2345788999887 8999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFG~  156 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGM  156 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEeccc
Confidence            458899999975 77666553    3679999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHH-HHHHHHh
Q 016158          232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQL-VEIIKVL  301 (394)
Q Consensus       232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~-~~i~~~~  301 (394)
                      ++... .........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....        ...+ ..+... 
T Consensus       157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-  234 (345)
T 3a8x_A          157 CKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-  234 (345)
T ss_dssp             CBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-
T ss_pred             cccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-
Confidence            97643 23334556889999999999654 489999999999999999999999975311        1112 222210 


Q ss_pred             CCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCCC
Q 016158          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  373 (394)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~f~~~~~  373 (394)
                                      ...            ++..++.++++||++||+.||.+||++      +++++||||+++..
T Consensus       235 ----------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          235 ----------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             ----------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             ----------------CCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                            001            224679999999999999999999995      89999999998753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=380.66  Aligned_cols=292  Identities=28%  Similarity=0.478  Sum_probs=213.7

Q ss_pred             ccEEE-eeEeeecCceEEEEEEEC--CCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIA-EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +.|.+ .++||+|+||.||+|+++  .+++.||||++...  .....+|+.+++.++||||+++++++....   ...++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEE
Confidence            45887 458999999999999976  56889999998654  234568999999999999999999986533   23578


Q ss_pred             EEEecccccHHHHHHHhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE----eCCCCcEEEE
Q 016158          157 LVLEYVPETVNRIARNYSRIH-----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLC  227 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~----~~~~~~vkl~  227 (394)
                      +||||+++++.+++.......     ..+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||+
T Consensus        97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl~  174 (405)
T 3rgf_A           97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIA  174 (405)
T ss_dssp             EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEEC
T ss_pred             EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEEE
Confidence            999999999888776544321     249999999999999999999999 899999999999999    4455 79999


Q ss_pred             eecCccccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHH
Q 016158          228 DFGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQL  294 (394)
Q Consensus       228 Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~  294 (394)
                      |||+++.....    .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+...         .+.+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999866432    2223467899999999997766689999999999999999999999976544         4788


Q ss_pred             HHHHHHhCCCChhhhhccCCCCcc---------cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          295 VEIIKVLGTPTREEIKCMNPNYTE---------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       295 ~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..+...++.+....|.....-...         ..........+........++.+.+||++||++||.+|||++|+|+|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            889999998887655432110000         00000000000011112347889999999999999999999999999


Q ss_pred             CCCCCCCCCCCCC
Q 016158          366 PFFDELRDPNTRL  378 (394)
Q Consensus       366 p~f~~~~~~~~~~  378 (394)
                      |||++...+....
T Consensus       335 p~f~~~~~~~~~~  347 (405)
T 3rgf_A          335 PYFLEDPLPTSDV  347 (405)
T ss_dssp             GGGTSSSCCCSST
T ss_pred             hhhccCCCCcccc
Confidence            9999877665543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-49  Score=371.04  Aligned_cols=288  Identities=33%  Similarity=0.578  Sum_probs=226.1

Q ss_pred             cCCCCcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEec
Q 016158           74 RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFST  147 (394)
Q Consensus        74 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~  147 (394)
                      .+.......+|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.  
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--   94 (331)
T 4aaa_A           17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK--   94 (331)
T ss_dssp             --CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             chhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee--
Confidence            3344455668999999999999999999999999999999875432      23457999999999999999999884  


Q ss_pred             CCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          148 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                         .....++||||+++++...+   ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus        95 ---~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~  166 (331)
T 4aaa_A           95 ---KKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKLC  166 (331)
T ss_dssp             ---ETTEEEEEEECCSEEHHHHH---HHSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEEC
T ss_pred             ---cCCEEEEEEecCCcchHHHH---HhhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEEE
Confidence               33447899999998654333   2234679999999999999999999999 8999999999999999888 79999


Q ss_pred             eecCccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          228 DFGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       228 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      |||++...... .......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+....+.+..+....+....
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (331)
T 4aaa_A          167 DFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP  246 (331)
T ss_dssp             CCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence            99999765432 22334578999999999977656899999999999999999999999999999999988888887766


Q ss_pred             hhhhcc--CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          307 EEIKCM--NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       307 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      .....+  .+.+.....+..............+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            544322  22223333333333333333345689999999999999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-49  Score=360.13  Aligned_cols=255  Identities=28%  Similarity=0.412  Sum_probs=206.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+++++.++||||+++++++.     .....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeE
Confidence            356999999999999999999999999999999986543     44568999999999999999999883     33457


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC---CCCcEEEEeecC
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGS  231 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~  231 (394)
                      ++||||+++ +|.+.+.........+++..++.++.|++.||+|||+ .||+||||||+|||++.   ++ .+||+|||+
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~  173 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHS-PIKIIDFGL  173 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTC-CEEECCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCC-CEEEEeeec
Confidence            899999985 8888777766666889999999999999999999999 89999999999999953   34 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.............+|+.|+|||++.+  .++.++||||||+++|+|++|+.||.+....+....+.......       
T Consensus       174 a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------  244 (285)
T 3is5_A          174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY-------  244 (285)
T ss_dssp             CCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred             ceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc-------
Confidence            987655555556778999999999843  48999999999999999999999998876555444433211000       


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                                         ......+++++.+||++||+.||++|||+.|+|+||||++
T Consensus       245 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          245 -------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                               0011347899999999999999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=381.44  Aligned_cols=255  Identities=26%  Similarity=0.359  Sum_probs=210.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++     .....
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence            45799999999999999999999999999999998643      23456899999999999999999988     33445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC--CCcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vkl~Dfg~  231 (394)
                      .++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+  +..+||+|||+
T Consensus        85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            7899999985 77665543    3679999999999999999999999 899999999999999842  23699999999


Q ss_pred             ccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      +........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+..   
T Consensus       160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---  235 (444)
T 3soa_A          160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP---  235 (444)
T ss_dssp             CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred             eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc---
Confidence            976644332 3456789999999999654 48999999999999999999999999888777777766532211111   


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                            ....+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       236 ----------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          236 ----------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ----------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                  114579999999999999999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-50  Score=367.72  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=203.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------------------------------hhhHHHHHHHH
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQ  130 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~  130 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....                              ..+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            456999999999999999999999999999999985432                              33567999999


Q ss_pred             HcCCCceeeeceEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeec
Q 016158          131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (394)
Q Consensus       131 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~D  209 (394)
                      .++||||+++++++...   .....++||||+++ ++.++.     ....+++..++.++.||+.||+|||+ .||+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccC
Confidence            99999999999988432   23457899999985 443321     23679999999999999999999999 8999999


Q ss_pred             CCCCcEEEeCCCCcEEEEeecCccccccCCC-CccccccccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCC
Q 016158          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFP  286 (394)
Q Consensus       210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~  286 (394)
                      |||+|||++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|+.||.
T Consensus       163 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999888 699999999986643322 234578999999999865432  4788999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016158          287 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (394)
Q Consensus       287 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  366 (394)
                      +.........+....                 ..++.          ...+++++.+||.+||+.||++|||+.|+|+||
T Consensus       242 ~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          242 DERIMCLHSKIKSQA-----------------LEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             CSSHHHHHHHHHHCC-----------------CCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             CccHHHHHHHHhccc-----------------CCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            776555444443311                 00110          135789999999999999999999999999999


Q ss_pred             CCCC
Q 016158          367 FFDE  370 (394)
Q Consensus       367 ~f~~  370 (394)
                      ||++
T Consensus       295 ~~~~  298 (298)
T 2zv2_A          295 WVTR  298 (298)
T ss_dssp             HHHC
T ss_pred             cccC
Confidence            9964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-49  Score=366.63  Aligned_cols=258  Identities=27%  Similarity=0.351  Sum_probs=207.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+|+.+++.++||||+++++++     ......+
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~   81 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQY   81 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeEE
Confidence            4699999999999999999999999999999988533     24457899999999999999999988     3344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+.+    .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  155 (323)
T 3tki_A           82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (323)
T ss_dssp             EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeecccee
Confidence            99999975 654443    234569999999999999999999999 8999999999999999888 6999999999765


Q ss_pred             ccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ....   ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...................        
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------  227 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------  227 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------
Confidence            3322   22356789999999999776655889999999999999999999998765543222221110000        


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                   ..+     ...++..+.+||++||+.||.+|||+.|+++||||++......
T Consensus       228 -------------~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~  273 (323)
T 3tki_A          228 -------------LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA  273 (323)
T ss_dssp             -------------STT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCCC
T ss_pred             -------------CCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccccccc
Confidence                         000     1457899999999999999999999999999999987654433

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.8e-49  Score=374.87  Aligned_cols=287  Identities=20%  Similarity=0.330  Sum_probs=208.8

Q ss_pred             cccEEEeeEeeec--CceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .++|++.+.||+|  +||.||+|++..+|+.||||++....      ..+.+|+.+++.++||||+++++++..     .
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----D   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----C
Confidence            4579999999999  99999999999999999999986432      344579999999999999999999843     3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+. ++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~dfg~  174 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRS  174 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCGGG
T ss_pred             CEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEccccc
Confidence            34789999998 47777766532  2569999999999999999999999 8999999999999999888 799999998


Q ss_pred             ccccccCC--------CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016158          232 AKVLVKGE--------PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (394)
Q Consensus       232 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  302 (394)
                      +.......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....-
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            86543221        12234678999999999763 4589999999999999999999999988766655544332110


Q ss_pred             C--------CChhhhhccC-----CCCccc---CCC-CCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          303 T--------PTREEIKCMN-----PNYTEF---KFP-QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       303 ~--------~~~~~~~~~~-----~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .        +.........     ......   ..+ ..........+...+++++.+||++||+.||++|||+.|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0        0000000000     000000   000 0000001112345689999999999999999999999999999


Q ss_pred             CCCCCCCCCCC
Q 016158          366 PFFDELRDPNT  376 (394)
Q Consensus       366 p~f~~~~~~~~  376 (394)
                      |||+++.....
T Consensus       335 p~f~~~~~~~~  345 (389)
T 3gni_B          335 SFFKQIKRRAS  345 (389)
T ss_dssp             GGGGGC---CC
T ss_pred             HHHHHHhhcch
Confidence            99999876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-49  Score=375.31  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=197.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.++||||+++++++..     ....++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEEE
Confidence            446999999999999999999999999999999986532   445689999999999999999999843     344789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC-cEEEEeecCcccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVL  235 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~~  235 (394)
                      ||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||+++..
T Consensus        94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            9999974 77666643    3679999999999999999999999 89999999999999986652 4999999999765


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.+.....           
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-----------  237 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-----------  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-----------
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-----------
Confidence            544455567789999999999766534455999999999999999999998765433333332221000           


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                        ...++.          ...+++++.+||++||+.||.+|||+.|+++||||++...
T Consensus       238 --~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          238 --KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             --CCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             --CCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence              001110          1357899999999999999999999999999999976543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-49  Score=373.76  Aligned_cols=254  Identities=24%  Similarity=0.415  Sum_probs=207.5

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-------hhHHHHHH-HHHcCCCceeeeceEEEecCCCc
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...+|++.+.||+|+||.||+|+++.+++.||||++.+...       ...+|..+ ++.++||||+++++++.     .
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----T  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----C
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----e
Confidence            34579999999999999999999999999999999865432       12234444 46679999999999883     3


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ...+|+||||+.+ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DFG  184 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFG  184 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeCc
Confidence            3458899999985 77666553    3679999999999999999999999 8999999999999999988 69999999


Q ss_pred             Ccccccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          231 SAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       231 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      +++.... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....        
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  255 (373)
T 2r5t_A          185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------  255 (373)
T ss_dssp             BCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------
T ss_pred             cccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Confidence            9986433 3344567889999999999654 48999999999999999999999999887777776665520        


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRDP  374 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~f~~~~~~  374 (394)
                               ..            ++..++.++++||++||+.||.+||++    .++++||||+.+...
T Consensus       256 ---------~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          256 ---------LQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             ---------CC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------cC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence                     11            124689999999999999999999986    699999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-49  Score=392.02  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=211.8

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...+|++.++||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ..
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TK  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eC
Confidence            3457999999999999999999999999999999985432       23457999999999999999999883     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+++||||++ ++|..++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFGl  332 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLGL  332 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEeccc
Confidence            45889999997 47766665421  2459999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhh
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPTREE  308 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~  308 (394)
                      +.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....   ..+...+....      
T Consensus       333 a~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------  405 (576)
T 2acx_A          333 AVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------  405 (576)
T ss_dssp             CEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------
T ss_pred             ceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------
Confidence            9877655555567899999999999654 4899999999999999999999999876432   22222222110      


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  374 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  374 (394)
                                .            .++..+++++++||++||+.||.+||     +++|+++||||+++...
T Consensus       406 ----------~------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          406 ----------E------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             ----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ----------c------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                      0            12246899999999999999999999     89999999999987543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-49  Score=371.43  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=207.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+......+|++++.++ +||||+++++++     ....+.++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence            4569999999999999999999999999999999988777778899999888 799999999988     3345688999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC---cEEEEeecCcccc
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLCDFGSAKVL  235 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl~Dfg~a~~~  235 (394)
                      ||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||+..+.+   .+||+|||++...
T Consensus        96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99975 77665543    3679999999999999999999999 89999999999999854321   4999999999866


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCChhhhhc
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      .... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+..   ..+.+..+....          
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~----------  239 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK----------  239 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC----------
T ss_pred             cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC----------
Confidence            4432 33456789999999998654 38899999999999999999999998642   223333332210          


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                             +.++        ......+++++.+||++||+.||++|||+.++|+||||++.
T Consensus       240 -------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          240 -------FSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             -------CCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             -------cccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                   0000        00124689999999999999999999999999999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-48  Score=361.78  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=215.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++...          ...+.+|+.+++.+.||||+++++++.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            45699999999999999999999999999999988643          234678999999999999999999883     


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC---cEEE
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  226 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl  226 (394)
                      .....++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++.   .+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEE
Confidence            3345789999996 478776653    4678999999999999999999999 89999999999999997763   5999


Q ss_pred             EeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +|||++.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+.+..+.......+.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            999999877655555566789999999998654 4899999999999999999999999888776666665542211111


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                               .+...+++.+.+||++||+.||.+|||+.++|+||||+...
T Consensus       240 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          240 -------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             -------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                                     12246789999999999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-49  Score=372.78  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=213.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++.     .....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            34699999999999999999999999999999998643    335568999999999999999999883     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC-CCcEEEEeecCccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKV  234 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~  234 (394)
                      +||||+.+ +|.+.+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.+ ...+||+|||++..
T Consensus       125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999975 77555432   23578999999999999999999999 899999999999999753 23699999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....-..+         
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------  270 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------  270 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            7555544556789999999999654 489999999999999999999999998877776666654211100         


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                      ......+++++.+||++||+.||.+|||+.++|+||||+....
T Consensus       271 ----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          271 ----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             ----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             ----------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence                            0011457999999999999999999999999999999987543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-49  Score=362.89  Aligned_cols=248  Identities=27%  Similarity=0.378  Sum_probs=197.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHH-cCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.++||+|+||+||+|++..+|+.||||++....      ....+|+..+.. ..|+||+++++++.     ...
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~  130 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG  130 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence            357999999999999999999999999999999875422      112234444444 49999999999983     334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ..++||||+++++.+.+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus       131 ~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~  205 (311)
T 3p1a_A          131 ILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLV  205 (311)
T ss_dssp             EEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCE
T ss_pred             EEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeee
Confidence            58899999999887766543   3679999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.....   .+..  +..+        
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~--------  270 (311)
T 3p1a_A          206 ELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLP--------  270 (311)
T ss_dssp             ECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCC--------
T ss_pred             ecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCC--------
Confidence            7755555556678999999999865  48999999999999999999977665432221   1111  0111        


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                                       ..+...+++++.+||.+||+.||++|||++++|+||||++
T Consensus       271 -----------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 -----------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             -----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             -----------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                             1123568999999999999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.7e-49  Score=365.99  Aligned_cols=282  Identities=30%  Similarity=0.512  Sum_probs=217.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.+. ||||+++++++...   .....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEE
Confidence            35699999999999999999999999999999998643 455678999999997 99999999988432   23447799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+.+ ++..++       ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999985 554433       348999999999999999999999 89999999999999997775799999999987766


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCChhhh-hccCCC
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEI-KCMNPN  315 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~-~~~~~~  315 (394)
                      ........+++.|+|||++.+...++.++|||||||++|+|++|+.||.. ....+.+..+....+.+..... ......
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            55556678899999999997656689999999999999999999999854 4555666666665554322111 000000


Q ss_pred             Cccc---CCCCCCCCCcccc----ccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          316 YTEF---KFPQIKPHPWHKV----FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       316 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      ....   .........|...    ....+++++.+||++||++||.+|||++|+|+||||+++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            0000   0000011112111    12347999999999999999999999999999999998764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-49  Score=381.98  Aligned_cols=252  Identities=28%  Similarity=0.420  Sum_probs=214.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----P   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            3457999999999999999999999999999999986432       345689999999999999999998833     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+++ +|.+++.    ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG~  162 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL  162 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEeccc
Confidence            347899999964 7766553    24679999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+....          
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------  232 (476)
T 2y94_A          163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------  232 (476)
T ss_dssp             CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC----------
T ss_pred             hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------
Confidence            9877655555567899999999999776655889999999999999999999999887766666554321          


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                             +.            .+..+++++.+||++||+.||.+|||+.++++||||++.
T Consensus       233 -------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 -------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                   00            123578999999999999999999999999999999874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=372.13  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=206.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      |...+.||+|+||.||+|++..+|+.||+|++...    ...+.+|+++++.++||||+++++++.     .....++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEE
Confidence            34467899999999999999999999999998653    345668999999999999999999883     334478999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe--CCCCcEEEEeecCccccc
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--PHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~--~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||+++ +|.+.+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++  .++ .+||+|||+++...
T Consensus       166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK  240 (373)
T ss_dssp             ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence            99975 77665543   23568999999999999999999999 8999999999999994  344 79999999998776


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+..         
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------  310 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE---------  310 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG---------
T ss_pred             CccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh---------
Confidence            6555556679999999999854 458999999999999999999999999988877777776632111110         


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                      ....+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus       311 ----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          311 ----------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                            1145799999999999999999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-49  Score=383.98  Aligned_cols=255  Identities=26%  Similarity=0.391  Sum_probs=206.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----H  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----T
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----C
Confidence            3457999999999999999999999999999999986432       233468888999999999999998843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||+
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~  295 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGL  295 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCC
Confidence            347899999986 66655543    367999999999999999999999536999999999999999888 699999999


Q ss_pred             ccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....         
T Consensus       296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  365 (446)
T 4ejn_A          296 CKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------  365 (446)
T ss_dssp             CCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             ceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------
Confidence            9764332 333456789999999999654 48999999999999999999999998887766666655411         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  374 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  374 (394)
                              ..            ++..+++++.+||.+||+.||.+||     |++|+++||||+++...
T Consensus       366 --------~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          366 --------IR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             --------CC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             --------CC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                    11            2245789999999999999999999     99999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.7e-48  Score=356.87  Aligned_cols=271  Identities=26%  Similarity=0.425  Sum_probs=224.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++|+||+++++++.     ...
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence            35699999999999999999999999999999988543       234457999999999999999999883     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+++ ++.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  162 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  162 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccCc
Confidence            57899999984 66665543    3679999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ...... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...           
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------  230 (294)
T 2rku_A          163 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------  230 (294)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred             eecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------
Confidence            766432 223345689999999998654 4899999999999999999999999887765554444321           


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (394)
                            ...            ++..+++.+.+||.+||+.||++|||++++++||||++...+..........||.|.+.
T Consensus       231 ------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (294)
T 2rku_A          231 ------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA  292 (294)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred             ------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCcccC
Confidence                  001            12457899999999999999999999999999999999888777666677788888874


Q ss_pred             C
Q 016158          392 P  392 (394)
Q Consensus       392 ~  392 (394)
                      |
T Consensus       293 ~  293 (294)
T 2rku_A          293 P  293 (294)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-48  Score=354.85  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=215.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .++|++.+.||+|+||.||+|++..++..||+|++...    .....+|+++++.++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            34699999999999999999999999999999988643    345668999999999999999999883     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE---eCCCCcEEEEeecCc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA  232 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a  232 (394)
                      +||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||+   +.++ .++|+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999975 77665543    3679999999999999999999999 899999999999999   6555 7999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .............+|+.|+|||.+.+  .++.++||||||+++|+|++|+.||......+....+.......+...+   
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---  231 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred             eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence            87766555566788999999999854  3899999999999999999999999988877777666653332222211   


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                            ..+++.+.+||++||+.||.+|||+.++|+||||++....
T Consensus       232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence                                  3578999999999999999999999999999999876443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.9e-49  Score=359.08  Aligned_cols=258  Identities=24%  Similarity=0.361  Sum_probs=198.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh------hhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....      ...++...++.++||||+++++++....     .
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence            4579999999999999999999999999999999864321      1223444577789999999999885332     3


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||+++++.+++.........+++..++.++.|++.||+|||+ + ||+||||||+|||++.++ .+||+|||++.
T Consensus        81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T 3fme_A           81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGISG  158 (290)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred             EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            78999999999988888776667889999999999999999999999 7 999999999999999887 79999999998


Q ss_pred             ccccCCCCccccccccccccccc---cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhh
Q 016158          234 VLVKGEPNVSYICSRYYRAPELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ............+|+.|+|||++   .....++.++||||||+++|+|++|+.||.... ....+..........     
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  233 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-----  233 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-----
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-----
Confidence            76555555556789999999997   234458999999999999999999999998643 333343333311000     


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                            .....+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          234 ----------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             ----------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                                  01135789999999999999999999999999999998653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=365.14  Aligned_cols=257  Identities=28%  Similarity=0.388  Sum_probs=195.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+++++.++||||+++++++.     .....++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEEE
Confidence            34699999999999999999999999999999998653  344567999999999999999999883     33447899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC---CCCcEEEEeecCccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  234 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~  234 (394)
                      |||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.   ++ .+||+|||+++.
T Consensus       127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC----
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCccccc
Confidence            999975 77665543    4668999999999999999999999 89999999999999975   55 799999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...... +..+.......+        
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~--------  271 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI--------  271 (349)
T ss_dssp             ------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC--------
T ss_pred             cCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC--------
Confidence            6554444556789999999999654 489999999999999999999999987766543 333322110000        


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                       ......++.++.+||++||+.||++|||+.++|+||||++....
T Consensus       272 -----------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          272 -----------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             -----------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             -----------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence                             00124578999999999999999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.9e-49  Score=384.16  Aligned_cols=257  Identities=23%  Similarity=0.381  Sum_probs=211.6

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...+|.+.++||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~  257 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TK  257 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eC
Confidence            3467999999999999999999999999999999986432       23457999999999999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+|+||||+++ +|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DFGl  335 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDLGL  335 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeecce
Confidence            458899999984 7777766544444679999999999999999999999 8999999999999999988 699999999


Q ss_pred             ccccccCCCC-ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~  306 (394)
                      ++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...    ......+...      
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~------  408 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ------  408 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC------
T ss_pred             eeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc------
Confidence            9876544332 345899999999999664 489999999999999999999999987642    2222222221      


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~  373 (394)
                                 ..            .++..+++++.+||++||+.||.+||+     ++++++||||+++..
T Consensus       409 -----------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 -----------AV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             -----------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             -----------cc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                       00            022467999999999999999999995     589999999998753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-48  Score=371.76  Aligned_cols=282  Identities=26%  Similarity=0.379  Sum_probs=220.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC--------CCceeeeceEEEecCCC
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD--------HPNIVALKHCFFSTTDK  150 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~~~~~~~~~~~~  150 (394)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.        |+||+++++++.... .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-V  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-T
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-C
Confidence            46999999999999999999999999999999987543   34457999999885        788999999885332 2


Q ss_pred             ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeecCCCCcEEEeCCC--------
Q 016158          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT--------  221 (394)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~--------  221 (394)
                      ...+.++||||+++++.+.+....  ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++        
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            456788999999988877665422  2579999999999999999999999 8 999999999999998764        


Q ss_pred             ----------------------------------------CcEEEEeecCccccccCCCCccccccccccccccccCCCC
Q 016158          222 ----------------------------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE  261 (394)
Q Consensus       222 ----------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  261 (394)
                                                              ..+||+|||++......  .....+|+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence                                                    16999999999765432  34567899999999997654 


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCChhhhhccCCCCcc-------cCCCCCCCCC
Q 016158          262 YTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTE-------FKFPQIKPHP  328 (394)
Q Consensus       262 ~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~  328 (394)
                      ++.++|||||||++|+|++|+.||.+.+      ....+..+.+.++.++...+.........       ..+.......
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999998654      45677788888888887665432211110       1111111111


Q ss_pred             ccc------cccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          329 WHK------VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       329 ~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                      ...      ......+..+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000      012334567999999999999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=367.50  Aligned_cols=285  Identities=34%  Similarity=0.627  Sum_probs=225.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCC-ceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~  154 (394)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4699999999999999999999999999999998543      23345799999999999999999988443221 1123


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+.+++...+      ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            5799999998775443      2469999999999999999999999 8999999999999999888 699999999976


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.+....+..
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            432  233457799999999997656689999999999999999999999999998899999999988888776654432


Q ss_pred             CCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ....   ..++......+.. ....+++++.+||.+||+.||++|||+.++|+||||+....+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~  318 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  318 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence            1100   0111111111111 224679999999999999999999999999999999988776543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.6e-48  Score=361.09  Aligned_cols=251  Identities=29%  Similarity=0.457  Sum_probs=203.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccch--------hhhHHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.+.||+|+||.||+|++.   .+|+.||+|++.+..        ....+|+.+++.++||||+++++++..   
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence            346999999999999999999985   689999999986431        234579999999999999999998843   


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                        ....++||||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        93 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~D  164 (327)
T 3a62_A           93 --GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKLTD  164 (327)
T ss_dssp             --SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEECC
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEEEe
Confidence              3347899999974 77666553    3678999999999999999999999 8999999999999999888 699999


Q ss_pred             ecCccccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          229 FGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       229 fg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....      
T Consensus       165 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------  237 (327)
T 3a62_A          165 FGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK------  237 (327)
T ss_dssp             CSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred             CCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------
Confidence            9998754332 223456789999999999654 48999999999999999999999999888777766665521      


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                                 ..            ++..++.++.+||.+||+.||.+||     ++.++++||||+++.
T Consensus       238 -----------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          238 -----------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             -----------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             -----------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence                       01            1245789999999999999999999     899999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-48  Score=382.03  Aligned_cols=258  Identities=27%  Similarity=0.427  Sum_probs=213.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||+||+|++..+++.||||++...      .....+|+++++.++||||+++++++.     ....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence            45799999999999999999999999999999998532      344568999999999999999999883     3445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~  231 (394)
                      +++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            7899999985 66665543    3679999999999999999999999 8999999999999996432  2699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+..........    
T Consensus       171 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  244 (486)
T 3mwu_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP----  244 (486)
T ss_dssp             TTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG----
T ss_pred             CeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc----
Confidence            987765555566789999999999964  48999999999999999999999999888777777665532111111    


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                                           ....+++++++||++||+.||.+|||+.++|+||||++.....
T Consensus       245 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          245 ---------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             ---------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             ---------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence                                 1146799999999999999999999999999999999875443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.1e-48  Score=364.58  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=211.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..|.+.+.||+|+||.||+|++..+|+.||||++....       ..+.+|+++++.++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            45999999999999999999999999999999985321       2355799999999999999999988443     34


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++||||+.+++.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            7899999999887766542   3679999999999999999999999 8999999999999999887 799999999976


Q ss_pred             cccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|+.||.+.+....+..+.......        
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------  272 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------  272 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Confidence            532   234578999999999853  3458999999999999999999999998887766666554421000        


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                         .....+++.+.+||.+||+.||++|||++++|+||||.....+
T Consensus       273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence                               0113578999999999999999999999999999999876443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.7e-48  Score=361.40  Aligned_cols=271  Identities=26%  Similarity=0.417  Sum_probs=223.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++...       ...+.+|+.+++.++|+||+++++++.     ...
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            34699999999999999999999999999999998643       234567999999999999999999883     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~  188 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  188 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeeccCc
Confidence            57899999984 77665543    3679999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ...... .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+....          
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------  257 (335)
T 2owb_A          189 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE----------  257 (335)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------
T ss_pred             eecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC----------
Confidence            866432 223445689999999999654 48999999999999999999999998877665555444311          


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (394)
                             ..            ++..+++.+.+||++||+.||++|||+.++|+||||+....+..........||.+...
T Consensus       258 -------~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (335)
T 2owb_A          258 -------YS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA  318 (335)
T ss_dssp             -------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred             -------CC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCCccccC
Confidence                   11            12457899999999999999999999999999999998877666555556677777664


Q ss_pred             C
Q 016158          392 P  392 (394)
Q Consensus       392 ~  392 (394)
                      |
T Consensus       319 ~  319 (335)
T 2owb_A          319 P  319 (335)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.4e-48  Score=364.26  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=212.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHc-CCCceeeeceEEEecC
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  148 (394)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            46999999999999999999999999999999885432            2345799999999 8999999999883   


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                        .....++||||+.+ +|.+++..    ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence              34458899999986 77776653    3679999999999999999999999 8999999999999999888 69999


Q ss_pred             eecCccccccCCCCccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 016158          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  302 (394)
Q Consensus       228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~  302 (394)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987766555566788999999999853     23478899999999999999999999988776666665554322


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                      ......                         ...++..+.+||.+||+.||++|||+.++|+||||++
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            211111                         1357899999999999999999999999999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=361.66  Aligned_cols=288  Identities=30%  Similarity=0.491  Sum_probs=217.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecC---------
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT---------  148 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---------  148 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            45999999999999999999999999999999885432    34567999999999999999998873221         


Q ss_pred             CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      .......++||||++++|.+++..     ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence            123356789999999988776643     679999999999999999999999 89999999999999986555799999


Q ss_pred             ecCccccccC----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          229 FGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       229 fg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      ||++......    .......+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+....+.+..+.......
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865322    122345668899999998765668999999999999999999999999988888888887776655


Q ss_pred             ChhhhhccCCCCcccCCC-CCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKFP-QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      ..............+... ..........+...++.++.+||++||+.||.+|||+.++|+||||+....+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            544332211110000000 00000111122356899999999999999999999999999999999875554

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-48  Score=381.14  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=214.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----------------hhhHHHHHHHHHcCCCceeeeceE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------------RYKNRELQIMQMLDHPNIVALKHC  143 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~~iv~~~~~  143 (394)
                      ..+|.+.+.||+|+||.||+|+++.+++.||||++....                 ....+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356999999999999999999999999999999986432                 335579999999999999999999


Q ss_pred             EEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC
Q 016158          144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  222 (394)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~  222 (394)
                      +     ....+.++||||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus       115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTC
T ss_pred             E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCC
Confidence            8     334458899999975 77665543    3679999999999999999999999 89999999999999987653


Q ss_pred             --cEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016158          223 --QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       223 --~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~  300 (394)
                        .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence              599999999987766555566789999999999853  4899999999999999999999999998877777776653


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      ....+...                         ...+++++++||++||++||.+|||++|+|+||||++....
T Consensus       263 ~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          263 KYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             CCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            22222111                         14579999999999999999999999999999999886543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-48  Score=366.44  Aligned_cols=264  Identities=30%  Similarity=0.460  Sum_probs=210.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....         ..+.+|+.+++.++||||+++++++     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence            357999999999999999999999999999999985432         3456799999999999999999998     33


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhh------------------------------------cCCCCHHHHHHHHHHHHH
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRI------------------------------------HQRMPLIYVKLYTYQICR  194 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~qi~~  194 (394)
                      ....++||||++ ++|.+.+..+...                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            445889999997 4776655321110                                    122467788899999999


Q ss_pred             HHHHHHhCCCceeecCCCCcEEEeCCCC-cEEEEeecCccccccCCC-----CccccccccccccccccCC-CCCCchhh
Q 016158          195 ALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEP-----NVSYICSRYYRAPELIFGA-TEYTTAID  267 (394)
Q Consensus       195 al~~LH~~~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~D  267 (394)
                      ||+|||+ .||+||||||+|||++.++. .+||+|||++........     .....+|+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999999 89999999999999986542 699999999976533221     2355789999999998642 45899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHH
Q 016158          268 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  347 (394)
Q Consensus       268 iwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  347 (394)
                      ||||||++|+|++|+.||.+....+.+..+.......+.                         .....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHH
Confidence            999999999999999999988877777766653211111                         0113578999999999


Q ss_pred             hcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          348 FFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       348 ~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      ||+.||.+|||+.++|+||||+++.+.-
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~~  341 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDKI  341 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHhh
Confidence            9999999999999999999999986543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.3e-48  Score=368.18  Aligned_cols=282  Identities=32%  Similarity=0.552  Sum_probs=216.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-CC-----ceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-HP-----NIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+. |+     +|+.+++++..     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence            346999999999999999999999999999999987543   33456888888885 44     48888888743     


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCceeecCCCCcEEEeC--CCCcEEEEe
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIGICHRDIKPQNLLVNP--HTHQLKLCD  228 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~givH~Dlkp~Nil~~~--~~~~vkl~D  228 (394)
                      ....++||||++++|.+++....  ...+++..++.++.|++.||.|||. ..||+||||||+|||++.  ++ .+||+|
T Consensus       128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred             CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence            33588999999999988877533  2568999999999999999999993 169999999999999964  44 699999


Q ss_pred             ecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ||+++....  ......+|+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+....+.++...
T Consensus       205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999976532  33456789999999999765 489999999999999999999999999999999999999998888766


Q ss_pred             hhccCC-----------CCccc-------CCCCCCCCCcccccc-----------------ccCCHHHHHHHHHhcccCC
Q 016158          309 IKCMNP-----------NYTEF-------KFPQIKPHPWHKVFQ-----------------KRLPPEAVDLVCRFFQYSP  353 (394)
Q Consensus       309 ~~~~~~-----------~~~~~-------~~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~~dP  353 (394)
                      +.....           .+...       .+.......+...+.                 ...++++++||++||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            532210           00000       000000000000000                 0011478999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCCC
Q 016158          354 NLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       354 ~~Rpt~~ell~hp~f~~~~~  373 (394)
                      ++|||++|+|+||||++..+
T Consensus       362 ~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC---
T ss_pred             hhCCCHHHHhcCcccccCCC
Confidence            99999999999999988643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.5e-49  Score=384.02  Aligned_cols=257  Identities=30%  Similarity=0.480  Sum_probs=215.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++     ....
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            45799999999999999999999999999999998532       34456899999999999999999988     3344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe---CCCCcEEEEee
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDF  229 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~---~~~~~vkl~Df  229 (394)
                      +.++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++   .++ .+||+||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Df  173 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRIIDF  173 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEEee
Confidence            58899999975 66555543    4679999999999999999999999 8999999999999994   445 7999999


Q ss_pred             cCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      |++.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+..........  
T Consensus       174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  249 (484)
T 3nyv_A          174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP--  249 (484)
T ss_dssp             THHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG--
T ss_pred             eeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc--
Confidence            99987766555566789999999999965  48999999999999999999999999988777777766532111110  


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                                             ....+++++++||++||+.||.+|||+.++|+||||+......
T Consensus       250 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~  292 (484)
T 3nyv_A          250 -----------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ  292 (484)
T ss_dssp             -----------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred             -----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccccc
Confidence                                   1146799999999999999999999999999999999875533

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-48  Score=360.74  Aligned_cols=265  Identities=24%  Similarity=0.337  Sum_probs=209.7

Q ss_pred             ccEEEe-eEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ++|.+. +.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.+ .||||+++++++     ....
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~  102 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS  102 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence            468887 8999999999999999999999999988643      23456799999998 569999999988     3334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC---CCCcEEEEee
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDF  229 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Df  229 (394)
                      ..++||||+.+ +|.+++..  .....+++..++.++.||+.||+|||+ .||+||||||+|||++.   ++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence            57899999986 66544322  223679999999999999999999999 89999999999999987   45 7999999


Q ss_pred             cCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          230 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       230 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      |++.............+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+.......+..  
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  255 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE--  255 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch--
Confidence            999877655555567789999999999654 48999999999999999999999999888777776666533222111  


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  381 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~  381 (394)
                                             ....+++.+.+||.+||+.||.+|||++++|+||||++........+..
T Consensus       256 -----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~~~~  304 (327)
T 3lm5_A          256 -----------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE  304 (327)
T ss_dssp             -----------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-----
T ss_pred             -----------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccccCccC
Confidence                                   1145789999999999999999999999999999999987665544333

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.6e-48  Score=352.71  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=211.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++...          ...+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            4699999999999999999999999999999988543          344678999999999999999999883     2


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC---cEEEE
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC  227 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl~  227 (394)
                      ....++||||++ ++|.+++..    ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++.   .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence            344789999996 578776653    3679999999999999999999999 89999999999999987652   59999


Q ss_pred             eecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      |||++.............+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+....+.+..+.......+. 
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  232 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-  232 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence            99999876555555566789999999998654 4899999999999999999999999888766665555432211111 


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                                              .....++..+.+||.+||+.||++|||+.++|+||||++++....+
T Consensus       233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence                                    1224578999999999999999999999999999999987665543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.6e-48  Score=368.28  Aligned_cols=260  Identities=27%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             cccEEEe-eEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHH-HHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..+|.+. ++||+|+||+||+|++..+|+.||||++... ....+|+.++ +..+||||+++++++.... ....++++|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence            3458776 7999999999999999999999999998643 4456788886 4568999999999874322 235568899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC---CCCcEEEEeecCccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  234 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~  234 (394)
                      |||+.+ +|.+++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.   ++ .+||+|||+++.
T Consensus       138 ~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~  213 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE  213 (400)
T ss_dssp             EECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEecccccc
Confidence            999975 7877766422  2469999999999999999999999 89999999999999997   45 799999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCChhhhh
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~  310 (394)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....    ....+...          
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----------  282 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----------  282 (400)
T ss_dssp             CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----------
T ss_pred             cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----------
Confidence            655545556778999999999854 458999999999999999999999998754322    22222211          


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                             .+.++.        .....++.++.+||++||+.||.+|||+.++|+||||.+..
T Consensus       283 -------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          283 -------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             -------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             -------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                   011110        01145799999999999999999999999999999998643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.1e-48  Score=356.53  Aligned_cols=254  Identities=27%  Similarity=0.413  Sum_probs=210.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..|...+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++...     ...++
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  119 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV  119 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            35888999999999999999999999999999986432    3456899999999999999999988543     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++..     ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus       120 v~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          120 LMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQIS  192 (321)
T ss_dssp             EECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeeecc
Confidence            9999975 67665542     579999999999999999999999 8999999999999999888 69999999987664


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+...... ..         
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~---------  261 (321)
T 2c30_A          193 KDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KL---------  261 (321)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CC---------
T ss_pred             cCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-Cc---------
Confidence            432 23456789999999999654 4899999999999999999999999887766655554432100 00         


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                      .....+++.+.+||.+||+.||++|||+.++|+||||++...+
T Consensus       262 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          262 ----------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             ----------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             ----------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence                            0113578999999999999999999999999999999876544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4e-48  Score=359.50  Aligned_cols=256  Identities=23%  Similarity=0.403  Sum_probs=187.3

Q ss_pred             ccEEEe---eEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAE---HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|.+.   +.||+|+||.||+|++..+|+.||||++.+. .....+|+.+++.+. ||||+++++++.     .....+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEE
Confidence            357775   7899999999999999999999999998754 345568999999997 999999999983     344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC--cEEEEeecCcc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK  233 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~a~  233 (394)
                      +||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 77666654    4679999999999999999999999 89999999999999986542  69999999997


Q ss_pred             ccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 016158          234 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT  305 (394)
Q Consensus       234 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~i~~~~~~~~  305 (394)
                      ...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..       +.+..+......  
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--  234 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--  234 (325)
T ss_dssp             ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--
Confidence            654332 23345679999999998654 4899999999999999999999999865432       122222110000  


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                             +.......+++++++||++||+.||.+|||+.++++||||++...
T Consensus       235 -----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          235 -----------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             -----------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             -----------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence                                   011112458999999999999999999999999999999997643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-47  Score=351.39  Aligned_cols=261  Identities=27%  Similarity=0.392  Sum_probs=213.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------------hhhhHHHHHHHHHcC-CCceeeeceEEEe
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------------KRYKNRELQIMQMLD-HPNIVALKHCFFS  146 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  146 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...             .....+|+++++.+. ||||+++++++  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--   93 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   93 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence            34699999999999999999999999999999998532             123457999999995 99999999988  


Q ss_pred             cCCCceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEE
Q 016158          147 TTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  225 (394)
Q Consensus       147 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vk  225 (394)
                         ......++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .+|
T Consensus        94 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~k  164 (298)
T 1phk_A           94 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIK  164 (298)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEE
T ss_pred             ---ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cEE
Confidence               33445789999998 478777654    3679999999999999999999999 8999999999999999888 699


Q ss_pred             EEeecCccccccCCCCcccccccccccccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016158          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~  300 (394)
                      |+|||++.............+++.|+|||++.     ....++.++||||||+++|+|++|+.||...........+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999998776555555667899999999985     2345789999999999999999999999887766665555542


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ....+.                         .....++..+.+||.+||+.||.+|||+.++|+||||++......+
T Consensus       245 ~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          245 NYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             CCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred             CcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence            111110                         0114578999999999999999999999999999999998766554

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.2e-48  Score=380.24  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=210.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||.||+|+++.++..||||++...      .....+|+.+++.++||||+++++++.     ....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            34699999999999999999999999999999998643      244568999999999999999999983     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~  231 (394)
                      .++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++..+  ..+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            7899999985 66555543    3679999999999999999999999 8999999999999997643  2599999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.......+..    
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  259 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----  259 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence            987766555566789999999999843  48999999999999999999999999888777777666532211111    


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                           ....+++.+++||++||+.||.+|||+.++|+||||++.
T Consensus       260 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          260 ---------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ---------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ---------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                 114579999999999999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.9e-48  Score=359.10  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=200.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCC------
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD------  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  149 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            45799999999999999999999999999999998632     2345689999999999999999998865432      


Q ss_pred             ----------------------------------------------CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCH
Q 016158          150 ----------------------------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPL  182 (394)
Q Consensus       150 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~  182 (394)
                                                                    ....+.++||||+.+ +|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                          123357899999986 77777665322 234566


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC-------------CCcccccccc
Q 016158          183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNVSYICSRY  249 (394)
Q Consensus       183 ~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~t~~  249 (394)
                      ..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            6789999999999999999 8999999999999999888 79999999998765432             2234568999


Q ss_pred             ccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCc
Q 016158          250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  329 (394)
Q Consensus       250 y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (394)
                      |+|||++.+. .++.++|||||||++|+|++|..|+.     .....+..........                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc----------------------
Confidence            9999999765 48999999999999999999876542     1111111111110000                      


Q ss_pred             cccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          330 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       330 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                         .....++++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               113457788999999999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.4e-48  Score=372.07  Aligned_cols=256  Identities=30%  Similarity=0.439  Sum_probs=198.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCceeeeceEEEecC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  148 (394)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....            ..+.+|+.+++.++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            457999999999999999999999999999999986532            13568999999999999999999872   


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLK  225 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vk  225 (394)
                        ... .++||||+++ +|.+.+    .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++  ..+|
T Consensus       211 --~~~-~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SSE-EEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cCc-eEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence              112 5799999975 554333    334679999999999999999999999 8999999999999997543  2599


Q ss_pred             EEeecCccccccCCCCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016158          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  303 (394)
Q Consensus       226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  303 (394)
                      |+|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|+.||........+...+.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987765555556788999999999853  345788999999999999999999999876544333333321111


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ..                        .......+++.+.+||++||+.||.+|||++++|+||||++.
T Consensus       363 ~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            00                        011124579999999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-48  Score=392.71  Aligned_cols=254  Identities=25%  Similarity=0.409  Sum_probs=213.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|+++++||+|+||.||+|+++.+++.||||++.+..       .....|..++..+ .|++|+.+++++     ...
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence            457999999999999999999999999999999986532       2344688888877 799999998887     444


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+|+||||+.+ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DFGl  488 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM  488 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCCTT
T ss_pred             CEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeecce
Confidence            558899999985 77666654    3679999999999999999999999 8999999999999999988 699999999


Q ss_pred             ccccc-cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....         
T Consensus       489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------  558 (674)
T 3pfq_A          489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------  558 (674)
T ss_dssp             CEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------
T ss_pred             eeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence            98643 23334567889999999999654 48999999999999999999999999988777777665411         


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPN  375 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~f~~~~~~~  375 (394)
                              ..            ++..+++++.+||++||+.||.+||++     +||++||||+.+....
T Consensus       559 --------~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          559 --------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             --------CC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             --------CC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                    11            224689999999999999999999997     9999999999875443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6e-48  Score=350.64  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=209.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++.     ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence            345799999999999999999999999999999998543       234567999999999999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+++ ++.+.+..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg~  155 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGW  155 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCCE
T ss_pred             CEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEeccc
Confidence            457899999985 67666554    3679999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+.....         
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  224 (279)
T 3fdn_A          156 SVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------  224 (279)
T ss_dssp             ESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------
T ss_pred             cccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---------
Confidence            8654332 23456789999999998654 489999999999999999999999988776666665544211         


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                              .            ++..+++.+.+||.+||+.||.+|||+.|+|+||||+.......
T Consensus       225 --------~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~  269 (279)
T 3fdn_A          225 --------T------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS  269 (279)
T ss_dssp             --------C------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred             --------C------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCcc
Confidence                    0            12457899999999999999999999999999999998755443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=361.92  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=205.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCceeeeceEEEecC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  148 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....            ..+.+|+.+++.++||||+++++++    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            457999999999999999999999999999999986532            2345799999999999999999988    


Q ss_pred             CCceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEE
Q 016158          149 DKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                       ......++||||+.+  ++..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL  171 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKL  171 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEE
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEE
Confidence             334457899998864  66555543    4579999999999999999999999 8999999999999999887 6999


Q ss_pred             EeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||......      ..       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence            99999987766655566788999999999977664588999999999999999999999652210      00       


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                ...            ..+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       239 ----------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 ----------AAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ----------TCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ----------hcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                      000            0123478999999999999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=354.66  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=212.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...        ...+.+|+.+++.++|+||+++++++...   ...
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EKQ   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCC
Confidence            4699999999999999999999999999999998643        23456899999999999999999987432   233


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ..++||||+.+++.+++....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence            478999999988777666533  3679999999999999999999999 8999999999999999887 79999999997


Q ss_pred             ccccCC---CCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          234 VLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ......   ......+|+.|+|||++.+.. .++.++||||||+++|+|++|+.||.+.+.......+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--------  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--------  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--------
Confidence            654321   223456799999999986532 24789999999999999999999998877665555544310        


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                               ..            ++..+++.+.+||.+||+.||.+|||+.++++||||++...+..
T Consensus       230 ---------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~  275 (305)
T 2wtk_C          230 ---------YA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE  275 (305)
T ss_dssp             ---------CC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred             ---------CC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence                     00            12457899999999999999999999999999999998766554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7e-48  Score=356.47  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=197.3

Q ss_pred             cccEEEe-eEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ...|++. +.||+|+||.||+|++..+++.||||++...    .....+|++++.++ +||||+++++++..     ...
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence            3469985 7899999999999999999999999998643    24456899999885 79999999999843     335


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC--cEEEEeecC
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~  231 (394)
                      .++||||+. ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.  .+||+|||+
T Consensus        86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            789999997 577776654    3679999999999999999999999 89999999999999987652  399999999


Q ss_pred             ccccccCC--------CCccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------
Q 016158          232 AKVLVKGE--------PNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--------  291 (394)
Q Consensus       232 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--------  291 (394)
                      +.......        ......||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+....        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            87553221        11234589999999998531    33788999999999999999999999875421        


Q ss_pred             -------HHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          292 -------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       292 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                             .....+.......+.                         .....+++++++||++||+.||.+|||+.|+|+
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHHHHHHHHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   112222221100010                         011357899999999999999999999999999


Q ss_pred             CCCCCCCC
Q 016158          365 HPFFDELR  372 (394)
Q Consensus       365 hp~f~~~~  372 (394)
                      ||||++..
T Consensus       296 hp~~~~~~  303 (316)
T 2ac3_A          296 HPWVQGCA  303 (316)
T ss_dssp             STTCC---
T ss_pred             ChhhcCCC
Confidence            99999764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-47  Score=356.70  Aligned_cols=280  Identities=26%  Similarity=0.470  Sum_probs=219.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEE-CCCCcEEEEEEeccch---hhhHHHHHHHHHcCCC------ceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKC-RETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~  151 (394)
                      .+|++.+.||+|+||.||+|.+ ..+++.||||++....   ....+|+.+++.++|+      +++++++++..     
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-----   88 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-----   88 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-----
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-----
Confidence            4699999999999999999998 5678999999986533   3456799999988665      48899888733     


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC------------
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP------------  219 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~------------  219 (394)
                      ....++||||+++++.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.            
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence            33588999999989888776532  2468999999999999999999999 89999999999999986            


Q ss_pred             -------CCCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016158          220 -------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (394)
Q Consensus       220 -------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  292 (394)
                             ++ .+||+|||++.....  ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+
T Consensus       166 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   34 699999999976432  33456789999999999654 48999999999999999999999999998888


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcc----cCCCCCC---------CCCcc--ccccccCCHHHHHHHHHhcccCCCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTE----FKFPQIK---------PHPWH--KVFQKRLPPEAVDLVCRFFQYSPNLRC  357 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rp  357 (394)
                      .+..+....+..+...+.........    .......         ..++.  .......++++.+||.+||+.||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            88888888888777665432211000    0000000         00000  001123457899999999999999999


Q ss_pred             CHHHHhcCCCCCCCCC
Q 016158          358 TALEACVHPFFDELRD  373 (394)
Q Consensus       358 t~~ell~hp~f~~~~~  373 (394)
                      |+.|+|+||||+++++
T Consensus       322 t~~ell~hp~f~~~~~  337 (339)
T 1z57_A          322 TLREALKHPFFDLLKK  337 (339)
T ss_dssp             CHHHHTTSGGGGGGGC
T ss_pred             CHHHHhcCHHHHHHhc
Confidence            9999999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.2e-47  Score=347.93  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=203.7

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCc
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  151 (394)
                      +...+|++.+.||+|+||.||+|++..+++.||||++...      .....+|+..+..+ +||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----   82 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----   82 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence            3456799999999999999999999999999999998642      23345688888888 99999999998843     


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC---------
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---------  221 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~---------  221 (394)
                      ....++||||+++ +|.+++.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccccc
Confidence            3357899999975 9998888766666789999999999999999999999 8999999999999998432         


Q ss_pred             ---------CcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016158          222 ---------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (394)
Q Consensus       222 ---------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  292 (394)
                               ..+||+|||++......   ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++.....  
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                     25999999999766433   2345899999999997665577899999999999999999987754432  


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                       ...+....                   .         ..++..+++++.+||.+||+.||++|||+.++++||||++..
T Consensus       237 -~~~~~~~~-------------------~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          237 -WHEIRQGR-------------------L---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             -HHHHHTTC-------------------C---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             -HHHHHcCC-------------------C---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence             22221100                   0         012246899999999999999999999999999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=348.11  Aligned_cols=252  Identities=28%  Similarity=0.457  Sum_probs=184.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence            356999999999999999999999999999999986432       34568999999999999999999883     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~  159 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLA  159 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence            57899999975 77666653   23678999999999999999999999 8999999999999999887 6999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ...... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||........+..+..            
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            765432 223345689999999998654 489999999999999999999999987654332221100            


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                           ...            ..+..++.++.+||.+||+.||++|||++++++||||++..
T Consensus       227 -----~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 -----ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             -----SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             -----ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                 000            01245789999999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.4e-47  Score=345.37  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=206.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..|.+.+.||+|+||.||+|.+..++..||+|++....      ..+.+|+.+++.++||||+++++++.... ....++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            35999999999999999999999999999999885432      33467999999999999999999875443 345667


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEe-CCCCcEEEEeecC
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVN-PHTHQLKLCDFGS  231 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~-~~~~~vkl~Dfg~  231 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ .|  |+||||||+|||++ .++ .+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~  178 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGL  178 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTG
T ss_pred             EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCC-CEEEeeCCC
Confidence            899999975 88777654    3679999999999999999999999 78  99999999999998 555 799999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +..... .......+|+.|+|||++.+  .++.++||||||+++|+|++|+.||..................        
T Consensus       179 ~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------  247 (290)
T 1t4h_A          179 ATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--------  247 (290)
T ss_dssp             GGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--------
T ss_pred             cccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--------
Confidence            965432 23345678999999998853  4899999999999999999999999886665544433321100        


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                        ...+....++++.+||.+||+.||.+|||+.++|+||||++-
T Consensus       248 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          248 ------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             ------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             ------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence                              011234578899999999999999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.5e-47  Score=344.78  Aligned_cols=256  Identities=26%  Similarity=0.341  Sum_probs=205.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++||||+++++++..     ....+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEEE
Confidence            46999999999999999999999999999999986432     445689999999999999999998843     34478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+.+.    ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~  155 (276)
T 2yex_A           82 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (276)
T ss_dssp             EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence            99999985 6654432    24579999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhc
Q 016158          236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  311 (394)
                      ....   ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||........ +..+......        
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------  227 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------
Confidence            3322   223456899999999997655457899999999999999999999987654322 2222210000        


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                               .     .     ....+++.+.+||.+||+.||.+|||+.++++||||++.....
T Consensus       228 ---------~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          228 ---------L-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             ---------S-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             ---------c-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence                     0     0     0145789999999999999999999999999999998875443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-47  Score=347.47  Aligned_cols=252  Identities=28%  Similarity=0.414  Sum_probs=202.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            456999999999999999999999999999999986432       245679999999999999999998833     34


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+.+ +|.+++..    ...+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~  158 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLS  158 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCCGG
T ss_pred             eEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeecccc
Confidence            57899999974 88777654    3578999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .............+++.|+|||.+.+....+.++||||||+++|+|++|+.||...........+....           
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  227 (276)
T 2h6d_A          159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-----------  227 (276)
T ss_dssp             GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Confidence            876554444556789999999999765545789999999999999999999998776655554443311           


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                            ..            ++..++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus       228 ------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          228 ------FY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             ------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             ------cc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence                  00            1245788999999999999999999999999999998753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.1e-47  Score=346.01  Aligned_cols=251  Identities=27%  Similarity=0.459  Sum_probs=209.8

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..++|.+.+.||+|+||.||+|++..+++.||||++...       .....+|+++++.++||||+++++++.     ..
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   86 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DR   86 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cC
Confidence            345799999999999999999999999999999998543       234568999999999999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~  160 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFGW  160 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEecccc
Confidence            457899999975 77766654    3579999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+....          
T Consensus       161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------  228 (284)
T 2vgo_A          161 SVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD----------  228 (284)
T ss_dssp             CEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC----------
T ss_pred             cccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc----------
Confidence            8655332 23355789999999999654 48999999999999999999999998877665554443310          


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                             ..            ++..++.++.+||.+||+.||.+|||++++++||||+...
T Consensus       229 -------~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          229 -------LK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             -------CC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             -------cC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                   00            1245789999999999999999999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.2e-48  Score=363.70  Aligned_cols=265  Identities=16%  Similarity=0.138  Sum_probs=189.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHc--CCCceeeec-------eEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML--DHPNIVALK-------HCF  144 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l--~h~~iv~~~-------~~~  144 (394)
                      ...|.+.+.||+|+||.||+|++..+|+.||||++....       ..+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999987532       2334675555555  699988754       333


Q ss_pred             EecCC------------CceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHH------HHHHHHHHHHHHHHHhCCCce
Q 016158          145 FSTTD------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV------KLYTYQICRALAYIHNCIGIC  206 (394)
Q Consensus       145 ~~~~~------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~qi~~al~~LH~~~giv  206 (394)
                      .....            .....+++||||++++|.+++....   ..+.....      ..++.||+.||+|||+ +||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence            22211            0114578999999999988887653   23444444      5677999999999999 8999


Q ss_pred             eecCCCCcEEEeCCCCcEEEEeecCccccccCCCCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 016158          207 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLF  285 (394)
Q Consensus       207 H~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf  285 (394)
                      ||||||+|||++.++ .+||+|||+++....  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999888 699999999986532  22245677999999999541 35899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+......                    ..+............+.......+++.+.+||.+||+.||++|||+.++|+|
T Consensus       294 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            87642100                    0000000000000111111124689999999999999999999999999999


Q ss_pred             CCCCCCC
Q 016158          366 PFFDELR  372 (394)
Q Consensus       366 p~f~~~~  372 (394)
                      |||+++.
T Consensus       354 p~f~~~~  360 (371)
T 3q60_A          354 PEFLQLQ  360 (371)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7e-47  Score=357.76  Aligned_cols=287  Identities=29%  Similarity=0.456  Sum_probs=221.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-----------CCceeeeceEEEe
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFS  146 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~  146 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.           |+||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            346999999999999999999999999999999987543   34567888888876           8999999998854


Q ss_pred             cCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeecCCCCcEEEeCCC----
Q 016158          147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT----  221 (394)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~----  221 (394)
                      .. ....+.+++||+++++|.+++....  ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++    
T Consensus        98 ~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCcC
Confidence            43 3445788999999889988877543  3569999999999999999999999 8 999999999999995322    


Q ss_pred             -CcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHH
Q 016158          222 -HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQL  294 (394)
Q Consensus       222 -~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~  294 (394)
                       ..+||+|||++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..      ....+
T Consensus       174 ~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             cceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence             2699999999976543  233457899999999997654 8999999999999999999999998654      45677


Q ss_pred             HHHHHHhCCCChhhhhccCC-------CCcccCCCCCCCCCccc------cccccCCHHHHHHHHHhcccCCCCCCCHHH
Q 016158          295 VEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPWHK------VFQKRLPPEAVDLVCRFFQYSPNLRCTALE  361 (394)
Q Consensus       295 ~~i~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  361 (394)
                      ..+...++..+...+.....       ......+......+...      .++..++.++.+||.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            88888888888765532211       00001111111111111      122345678999999999999999999999


Q ss_pred             HhcCCCCCCCCCC
Q 016158          362 ACVHPFFDELRDP  374 (394)
Q Consensus       362 ll~hp~f~~~~~~  374 (394)
                      +|+||||++....
T Consensus       331 ll~hp~f~~~~~~  343 (373)
T 1q8y_A          331 LVNHPWLKDTLGM  343 (373)
T ss_dssp             HHTCGGGTTCTTC
T ss_pred             HhhChhhhcccCc
Confidence            9999999986443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.7e-47  Score=353.61  Aligned_cols=256  Identities=30%  Similarity=0.460  Sum_probs=204.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCceeeeceEEEecC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  148 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++....            ..+.+|+++++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            356999999999999999999999999999999885432            235689999999999999999998732  


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC--cEE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLK  225 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vk  225 (394)
                        ..  .++||||+.+ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+|
T Consensus        87 --~~--~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 --ED--YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             --SS--EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred             --Cc--eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence              11  6799999975 6765543    24679999999999999999999999 89999999999999986552  499


Q ss_pred             EEeecCccccccCCCCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 016158          226 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  303 (394)
Q Consensus       226 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~  303 (394)
                      |+|||++.............+|+.|+|||++.  +...++.++|||||||++|+|++|..||........+...+.....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998764433333456899999999973  3445899999999999999999999999876544333332221111


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ..                        .......++..+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       238 ~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             cc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            00                        011124578999999999999999999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-48  Score=357.17  Aligned_cols=275  Identities=21%  Similarity=0.309  Sum_probs=207.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.++||+|+||.||+|++..+|+.||||++....     ....+|+++++.++||||+++++++....   ....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence            46999999999999999999999999999999986432     34458999999999999999999874332   23478


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE----eCCCCcEEEEeecC
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFGS  231 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~----~~~~~~vkl~Dfg~  231 (394)
                      +||||++ ++|.+++..... ...+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCCC
Confidence            9999997 588777765322 2349999999999999999999999 899999999999998    5555 699999999


Q ss_pred             ccccccCCCCccccccccccccccccC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHH
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFG-------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKV  300 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~~  300 (394)
                      ++............+|+.|+|||++..       ...++.++|||||||++|+|++|+.||.....    .+.+..+...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            987766665566788999999999852       34589999999999999999999999975443    2333333332


Q ss_pred             hCCCChhhhhccCC-CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 016158          301 LGTPTREEIKCMNP-NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  367 (394)
Q Consensus       301 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  367 (394)
                         .+...+..... ....+....  ..+....+...++..+.+||++||+.||++|||++|+|+||-
T Consensus       243 ---~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 ---KPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             ---CCTTCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             ---CCcccchhhhcccCCccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence               22111111000 000000000  001111223456778999999999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.6e-47  Score=355.28  Aligned_cols=281  Identities=25%  Similarity=0.447  Sum_probs=218.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCC-cEEEEEEeccc---hhhhHHHHHHHHHcCCCc------eeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQD---KRYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~  151 (394)
                      .+|++.+.||+|+||.||+|++..++ +.||||++...   .....+|+.+++.+.|++      ++.+.+++..     
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-----   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-----   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-----
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-----
Confidence            46999999999999999999998777 68999998653   334557999999987655      7787777732     


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE--------------
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--------------  217 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~--------------  217 (394)
                      ....++||||+++++.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||+              
T Consensus        94 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           94 HGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence            33578999999988877665422  2569999999999999999999999 899999999999999              


Q ss_pred             -----eCCCCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 016158          218 -----NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  292 (394)
Q Consensus       218 -----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  292 (394)
                           +.++ .+||+|||++.....  ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus       171 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 4455 799999999976432  33456789999999999654 48999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCccc----CCCCCC---------CCCccc--cccccCCHHHHHHHHHhcccCCCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIK---------PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRC  357 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rp  357 (394)
                      .+..+....+..+...+..........    ..+...         ..++..  ......+.++.+||++||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            888888888888776654322110000    000000         000000  01112356899999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCC
Q 016158          358 TALEACVHPFFDELRDP  374 (394)
Q Consensus       358 t~~ell~hp~f~~~~~~  374 (394)
                      |+.|+|+||||+++...
T Consensus       327 t~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             CHHHHTTSGGGGGCCHH
T ss_pred             CHHHHhcChhhcCCChh
Confidence            99999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=354.79  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=198.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCC--CceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~  153 (394)
                      .+|++.+.||+|+||.||+|.+ .+++.||||++....      ..+.+|+.+++.+.|  +||+++++++.     ...
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~   82 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ   82 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence            4599999999999999999998 468999999885432      345679999999987  99999999883     334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +.++|||+.+++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++ ++ .+||+|||+++
T Consensus        83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a~  155 (343)
T 3dbq_A           83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIAN  155 (343)
T ss_dssp             EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeeccccc
Confidence            6889999888888877764    4679999999999999999999999 8999999999999998 45 69999999998


Q ss_pred             ccccCCC---CccccccccccccccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 016158          234 VLVKGEP---NVSYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIK  299 (394)
Q Consensus       234 ~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~  299 (394)
                      .......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  235 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  235 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence            6643322   234578999999999853          245889999999999999999999999865433 22222221


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                         ..                        ....++...+.++.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus       236 ---~~------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  284 (343)
T 3dbq_A          236 ---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  284 (343)
T ss_dssp             ---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC--
T ss_pred             ---CC------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCcc
Confidence               00                        00012244678999999999999999999999999999998765543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.1e-47  Score=359.58  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=198.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcC--CCceeeeceEEEecCCCceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .|++.+.||+|+||.||+|.+.. ++.||||++....      ..+.+|+.+++.+.  |+||+++++++..     ..+
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~~  130 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQY  130 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CCE
Confidence            59999999999999999999865 8999999985432      34568999999996  5999999998843     334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+.+++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++ ++ .+||+|||+++.
T Consensus       131 ~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~  203 (390)
T 2zmd_A          131 IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SS-CEEECCCSSSCC
T ss_pred             EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CC-eEEEEecCcccc
Confidence            889999877888777764    3578999999999999999999999 8999999999999996 45 699999999986


Q ss_pred             cccCCC---CccccccccccccccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH
Q 016158          235 LVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKV  300 (394)
Q Consensus       235 ~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~  300 (394)
                      ......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||...... ..+..+...
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  283 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  283 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence            643322   2345789999999998641          34899999999999999999999999875433 333332210


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                      .               ....            ++...+.++.+||.+||+.||.+|||+.|+|+||||+....+.
T Consensus       284 ~---------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~  331 (390)
T 2zmd_A          284 N---------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  331 (390)
T ss_dssp             T---------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC---
T ss_pred             c---------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCccc
Confidence            0               0000            1234578999999999999999999999999999998765543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.3e-47  Score=348.25  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=209.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            35699999999999999999999999999999998643    234568999999999999999999883     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE---eCCCCcEEEEeecCc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA  232 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a  232 (394)
                      +||||+++ +|.+.+..    ...+++..++.++.|++.||.|||+ .||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            99999974 77666543    3679999999999999999999999 899999999999999   5555 7999999998


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ..... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||.+.........+.......+       
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------  227 (304)
T 2jam_A          157 KMEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE-------  227 (304)
T ss_dssp             CCCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC-------
T ss_pred             eecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence            75432 223445689999999998654 489999999999999999999999988777666666554211100       


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                        ..+...+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       228 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          228 ------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             ------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             ------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                              112246789999999999999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2e-47  Score=352.72  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=209.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ..+.+|+.+++.++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            346999999999999999999999999999999986532       23457889999999999999999875443 2334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      +.++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence            5689999997 588777654    3679999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ........    .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+......++.  
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--  240 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--  240 (311)
T ss_dssp             ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH--
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc--
Confidence            76543322    2235689999999999765 4899999999999999999999999988776666555542211111  


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                             .....+++++.+||.+||+.||.+||++.+++.|+|++.......
T Consensus       241 -----------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~  285 (311)
T 3ork_A          241 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP  285 (311)
T ss_dssp             -----------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred             -----------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence                                   112458999999999999999999999999999999987654433

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-47  Score=360.00  Aligned_cols=271  Identities=28%  Similarity=0.446  Sum_probs=209.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccc--------hhhhHHHHHHHHHc-CCCceeeeceEEEecC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  148 (394)
                      ..+|++.+.||+|+||.||+|++.   .+|+.||||++...        .....+|+++++.+ .|+||+++++++..  
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  130 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  130 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence            457999999999999999999984   58999999988542        23345799999999 69999999998843  


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                         ....++||||+.+ +|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus       131 ---~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~  201 (355)
T 1vzo_A          131 ---ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLT  201 (355)
T ss_dssp             ---TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEES
T ss_pred             ---CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEEEe
Confidence               3347899999985 77776654    3679999999999999999999999 8999999999999999888 69999


Q ss_pred             eecCccccccCC--CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          228 DFGSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       228 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      |||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.+.....
T Consensus       202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  281 (355)
T 1vzo_A          202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  281 (355)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence            999997653322  22345789999999999653 347899999999999999999999997644322222222211000


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLP  379 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~  379 (394)
                                   .            ..++..++..+.+||.+||+.||.+||     |++++++||||+++.....   
T Consensus       282 -------------~------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l---  333 (355)
T 1vzo_A          282 -------------E------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL---  333 (355)
T ss_dssp             -------------C------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH---
T ss_pred             -------------C------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh---
Confidence                         0            001246789999999999999999999     9999999999998753322   


Q ss_pred             CCCCCCCCCCC
Q 016158          380 NGRPLPPLFNF  390 (394)
Q Consensus       380 ~~~~~~~~~~~  390 (394)
                      .....|++|.+
T Consensus       334 ~~~~~~~p~~p  344 (355)
T 1vzo_A          334 AAKKVPAPFKP  344 (355)
T ss_dssp             HTTCSCCSCCC
T ss_pred             hhccCCCCCCC
Confidence            22334555544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7e-47  Score=345.04  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=210.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...      ...+.+|+++++.++||||+++++++.     ....
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            34799999999999999999999999999999998543      234568999999999999999999883     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~  231 (394)
                      .++||||+.+ ++.+.+..    ...+++..++.++.||+.||.|||+ .||+|+||||+||+++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            7899999974 66655543    3579999999999999999999999 8999999999999997643  2699999999


Q ss_pred             ccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +.............+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+....+.......+.     
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  243 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-----  243 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred             ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----
Confidence            987655554455678999999999854  3899999999999999999999999887766655555442111000     


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                          .....+++++.+||++||+.||.+|||+.++|+||||++...
T Consensus       244 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          244 --------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             --------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             --------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                                011457899999999999999999999999999999987644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.7e-49  Score=371.48  Aligned_cols=254  Identities=17%  Similarity=0.230  Sum_probs=193.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHH---HHHHcCCCceeeec-------eE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQ---IMQMLDHPNIVALK-------HC  143 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~---~l~~l~h~~iv~~~-------~~  143 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...       ...+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999999999999998632       244567884   45555899999998       44


Q ss_pred             EEecC---------CCcee---EEEEEEecccccHHHHHHHhhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCceee
Q 016158          144 FFSTT---------DKEEL---YLNLVLEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALAYIHNCIGICHR  208 (394)
Q Consensus       144 ~~~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~givH~  208 (394)
                      +....         +....   ..+++|||++|+|.+++.......   ..+++..++.++.||+.||+|||+ +||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence            42221         11111   267999999999988887643211   123347888899999999999999 899999


Q ss_pred             cCCCCcEEEeCCCCcEEEEeecCccccccCCCCccccccccccccccccCC----------CCCCchhhHHHHHHHHHHH
Q 016158          209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAEL  278 (394)
Q Consensus       209 Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l  278 (394)
                      ||||+|||++.++ .+||+|||+++...  .......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999887 79999999997532  23334556 999999999654          2489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC
Q 016158          279 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  358 (394)
Q Consensus       279 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  358 (394)
                      ++|+.||.+.........+..                                 ....+++++.+||.+||+.||++|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFR---------------------------------SCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGGS---------------------------------SCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhhh---------------------------------hccCCCHHHHHHHHHHcCCCchhCCC
Confidence            999999976442211110000                                 01467999999999999999999999


Q ss_pred             HHHHhcCCCCCCCC
Q 016158          359 ALEACVHPFFDELR  372 (394)
Q Consensus       359 ~~ell~hp~f~~~~  372 (394)
                      +.++++||||+++.
T Consensus       354 ~~e~l~hp~f~~~~  367 (377)
T 3byv_A          354 PLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHTSHHHHHHH
T ss_pred             HHHHhhChHHHHHH
Confidence            99999999998764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=347.70  Aligned_cols=261  Identities=23%  Similarity=0.380  Sum_probs=206.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCceeeeceEEEecCCC-ceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~  155 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...   .....+|+.+++.+ +||||+++++++...... .....
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~  102 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL  102 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence            34699999999999999999999999999999998543   34566899999998 899999999998654321 13467


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|||++..
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  178 (326)
T 2x7f_A          103 WLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  178 (326)
T ss_dssp             EEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC-
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCcee
Confidence            899999986 8888776532  3679999999999999999999999 8999999999999999887 699999999876


Q ss_pred             cccCC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          235 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       235 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ..... ......+++.|+|||++..    ...++.++|||||||++|+|++|..||.+......+..+..... +     
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-----  252 (326)
T 2x7f_A          179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P-----  252 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----
T ss_pred             cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c-----
Confidence            54322 2334568999999999852    34488999999999999999999999988776655544433110 0     


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                           ......++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus       253 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          253 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             ---------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             ---------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence                                 001245789999999999999999999999999999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.6e-46  Score=343.62  Aligned_cols=256  Identities=26%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++++...     ...++
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   93 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLWI   93 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEE
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEEE
Confidence            4699999999999999999999999999999988543    23456799999999999999999988432     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ ++..++..   ....+++..++.++.|++.||.|||+ .|++||||||+|||++.++ .+||+|||++....
T Consensus        94 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNL  168 (302)
T ss_dssp             EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCcccc
Confidence            9999986 66555543   23679999999999999999999999 8999999999999999887 69999999875432


Q ss_pred             cC-CCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          237 KG-EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       237 ~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      .. .......+|+.|+|||.+.    ....++.++||||||+++|+|++|..||...+....+..+.......       
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  241 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-------  241 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-------
Confidence            11 1223456899999999984    34458999999999999999999999998877666655554421000       


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                         ...+..++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus       242 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          242 -------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             -------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             -------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                               0112457899999999999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.2e-46  Score=340.19  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=211.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++...      ...+.+|+.+++.++||||+++++++....   ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cce
Confidence            35699999999999999999999999999999998542      234567999999999999999999875432   335


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ceeecCCCCcEEEeCCCCcEEEEe
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g-----ivH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      .++||||+++ +|.+++.........+++..++.++.|++.||+|||+ .|     |+||||||+|||++.++ .+||+|
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~d  159 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  159 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEECC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEEec
Confidence            7899999975 8988887766556679999999999999999999999 78     99999999999999887 699999


Q ss_pred             ecCccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          229 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       229 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ||++........ .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+....+.....     
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-----  233 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----  233 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----
T ss_pred             CchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-----
Confidence            999976543321 1234679999999999655 489999999999999999999999988776555555443210     


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                             ..++..++.++.+||.+||+.||.+|||+.++++|+|+.+-.
T Consensus       234 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          234 -----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -----------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                                   011245789999999999999999999999999999998753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.8e-47  Score=358.02  Aligned_cols=283  Identities=24%  Similarity=0.416  Sum_probs=207.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++..     ....
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence            45699999999999999999999999999999998643     2345689999999999999999998843     3347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||++.
T Consensus       107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  180 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG  180 (360)
T ss_dssp             EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred             EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence            899999975 88777654    3579999999999999999999998 5 999999999999999888 69999999987


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCChhhhhcc
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  312 (394)
                      ..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +..........
T Consensus       181 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          181 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            55332 23345789999999999654 48999999999999999999999998766544332221111 10000000000


Q ss_pred             C--CCCcccCCCCCCC------------CCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          313 N--PNYTEFKFPQIKP------------HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       313 ~--~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      .  .....+.......            ..........++.++.+||++||+.||++|||++++|+||||++......
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence            0  0000000000000            00001112347889999999999999999999999999999998655444

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-46  Score=343.72  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=209.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..|++.+.||+|+||.||+|++..+++.||||++...     ...+.+|+.+++.++||||+++++++..     ....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            3599999999999999999999999999999998543     2455689999999999999999998843     23478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+++..     ..+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999986 77666542     679999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .... ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...........+....  +          
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------  236 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P----------  236 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------
T ss_pred             CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------
Confidence            4332 22345689999999999654 48999999999999999999999998776655554443310  0          


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                                      ..+...++..+.+||.+||+.||.+|||+.++++||||.+...
T Consensus       237 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          237 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             ----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             ----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence                            0122467899999999999999999999999999999977544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=342.47  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=206.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.++||||+++++++...     ...++||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~  103 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIVM  103 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEe
Confidence            4599999999999999999999999999999998654  34566899999999999999999988442     3478999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|.+++..   ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence            99986 77776653   24679999999999999999999999 8999999999999999888 6999999999765433


Q ss_pred             C-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCc
Q 016158          239 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  317 (394)
Q Consensus       239 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  317 (394)
                      . ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+..... +             
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------------  243 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P-------------  243 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-------------
T ss_pred             ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c-------------
Confidence            2 22345689999999998654 489999999999999999999999987766554443332110 0             


Q ss_pred             ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      .+            ..+..++..+.+||.+||+.||.+|||+.++|+||||+....
T Consensus       244 ~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          244 TF------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             CC------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            00            012457899999999999999999999999999999998653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.7e-46  Score=350.27  Aligned_cols=265  Identities=24%  Similarity=0.359  Sum_probs=185.3

Q ss_pred             ccccEEEee-EeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           80 QKVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        80 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      -.++|.+.+ +||+|+||.||+|+++.+|+.||||++........+....++.++|+||+++++++.... ....+.++|
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  104 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLII  104 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEE
Confidence            345699955 699999999999999999999999998776555555556678889999999999885433 335567899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecCcccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  235 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~~  235 (394)
                      |||+.+ +|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++  ..+||+|||++...
T Consensus       105 ~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          105 MECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            999986 8877776422  2579999999999999999999999 8999999999999998643  25999999999765


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+......            
T Consensus       182 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  247 (336)
T 3fhr_A          182 TQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------  247 (336)
T ss_dssp             -----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred             ccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc------------
Confidence            432 23355679999999998544 4899999999999999999999999766543322211111000            


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                       ....++        ......+++++.+||++||+.||.+|||+.++|+||||++.
T Consensus       248 -~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 -GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence             000000        00114579999999999999999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.2e-47  Score=346.94  Aligned_cols=268  Identities=25%  Similarity=0.358  Sum_probs=191.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...     .....+|+.+++.++||||+++++++....     ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   88 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----EL   88 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----Cc
Confidence            34699999999999999999999889999999987543     233457888999999999999999884433     37


Q ss_pred             EEEEeccc-ccHHHHHHHhhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          156 NLVLEYVP-ETVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ++||||++ ++|.+++......    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg  166 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADFG  166 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEecc
Confidence            89999996 4888777654322    3558999999999999999999999 8999999999999999888 69999999


Q ss_pred             CccccccCC------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          231 SAKVLVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       231 ~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      ++.......      ......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||...................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            987654322      12245689999999998653458999999999999999999999998877665544332211000


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      ..                   ...........++.++.+||.+||+.||.+|||+.++++||||++....
T Consensus       247 ~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          247 LE-------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             TT-------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             cc-------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            00                   0000011224678999999999999999999999999999999987544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=343.82  Aligned_cols=257  Identities=23%  Similarity=0.371  Sum_probs=189.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....      ....++..+++.++||||+++++++..     ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence            3457999999999999999999999999999999986432      122234456788899999999998843     33


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+++.+..+...   ....+++..++.++.|++.||.|||+ . ||+|+||||+|||++.++ .+||+|||++
T Consensus        98 ~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  172 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGIS  172 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             cEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence            5789999997666554432   24679999999999999999999998 6 999999999999999888 6999999999


Q ss_pred             cccccCCCCcccccccccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~  307 (394)
                      .............+|+.|+|||++.    ....++.++||||||+++|+|++|+.||..... .+.+..+..... +   
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~---  248 (318)
T 2dyl_A          173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-P---  248 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-C---
T ss_pred             hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-C---
Confidence            7765554455567899999999985    234578999999999999999999999987443 344444433110 0   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                  ..+          ....+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       249 ------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 ------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             ------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             ------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                        000          0135789999999999999999999999999999998754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-45  Score=337.75  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=198.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCC--------
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD--------  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--------  149 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            346999999999999999999999999999999986543   344579999999999999999998854321        


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      ......++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEee
Confidence            235678899999975 888777642   3467888999999999999999999 8999999999999999888 699999


Q ss_pred             ecCccccccC---------------CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-H
Q 016158          229 FGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-D  292 (394)
Q Consensus       229 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~  292 (394)
                      ||++......               .......+|+.|+|||++.+...++.++|||||||++|+|++   ||...... .
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765321               122345679999999999766568999999999999999998   55432222 2


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ....+.....                 .        +...+....+..+.+||++||+.||.+|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~-----------------~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSVSI-----------------E--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHSTTC-----------------C--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhcccccc-----------------c--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            2222211000                 0        0111234567889999999999999999999999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.8e-46  Score=339.00  Aligned_cols=255  Identities=27%  Similarity=0.393  Sum_probs=200.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...       ...+.+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            34699999999999999999999999999999987432       23456799999999999999999988     3344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  158 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIA  158 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence            57899999975 88776654    3579999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          233 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       233 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      .......  ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.............. .+.     
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~-----  231 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPN-----  231 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCC-----
T ss_pred             cccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCC-----
Confidence            7654332  223456899999999997654 8999999999999999999999998877655544433211 000     


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                        ........+++.+.++|.+||+.||.+||+..+.+.+.|.+-+
T Consensus       232 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 ------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             ------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                              1111235689999999999999999999966666666655443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.7e-46  Score=349.55  Aligned_cols=273  Identities=20%  Similarity=0.327  Sum_probs=207.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---------------------hhhHHHHHHHHHcCCCceee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------------RYKNRELQIMQMLDHPNIVA  139 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~~iv~  139 (394)
                      .++|++.+.||+|+||.||+|++  +|+.||||++....                     ..+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            45799999999999999999999  79999999986432                     55678999999999999999


Q ss_pred             eceEEEecCCCceeEEEEEEecccc-cHHHHHHH----hhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARN----YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       140 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                      +++++..     ....++||||+++ +|.+++..    .......+++..++.++.|++.||.|||+..||+||||||+|
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999843     3457899999986 66544110    011146799999999999999999999963599999999999


Q ss_pred             EEEeCCCCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCc-HH
Q 016158          215 LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESG-VD  292 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~-~~  292 (394)
                      ||++.++ .+||+|||++...... ......+++.|+|||++.+...++. ++||||||+++|+|++|..||..... .+
T Consensus       183 il~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9999888 6999999999765433 3345678999999999976534555 99999999999999999999988766 44


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                      ....+.......+...        ..+..+ . ...........++.++.+||.+||+.||.+|||+.++++||||++..
T Consensus       261 ~~~~i~~~~~~~~~~~--------~~~~~~-~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDR--------NHFLYP-L-TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHTSCCCCCCCSS--------SSSTTT-T-CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhccCcCCccch--------hhhhcc-c-cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            4433322111000000        000000 0 00001122256899999999999999999999999999999999865

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=337.53  Aligned_cols=259  Identities=26%  Similarity=0.415  Sum_probs=198.3

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEec
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  161 (394)
                      ...+||+|+||.||+|++..+++.||||++...    ...+.+|+.+++.++||||+++++++..     ....++||||
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  100 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFMEQ  100 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEEC
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEEEe
Confidence            344899999999999999999999999988643    2345689999999999999999998843     3347899999


Q ss_pred             cc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC-
Q 016158          162 VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  239 (394)
Q Consensus       162 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~-  239 (394)
                      ++ ++|.+++.... ....+++..++.++.|++.||+|||+ .||+|+||||+|||++.....+||+|||++....... 
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            96 57877766421 22456788999999999999999999 8999999999999999733379999999997654322 


Q ss_pred             CCccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcc
Q 016158          240 PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  318 (394)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  318 (394)
                      ......+++.|+|||++.+. ..++.++||||||+++|+|++|+.||...................              
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------  244 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--------------  244 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC--------------
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc--------------
Confidence            22345689999999998543 237899999999999999999999997654433222111111100              


Q ss_pred             cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                                  ..++..+++++.+||.+||+.||++|||+.++|+||||+........
T Consensus       245 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~  291 (295)
T 2clq_A          245 ------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT  291 (295)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-------
T ss_pred             ------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCCC
Confidence                        01224678999999999999999999999999999999987655543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.5e-46  Score=348.34  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcC--CCceeeeceEEEecC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTT  148 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  148 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+.  |+||+++++++.   
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~---  118 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE---  118 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe---
Confidence            346999999999999999999999999999999986532          33457999999996  599999999883   


Q ss_pred             CCceeEEEEEEeccc--ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEE
Q 016158          149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                        .....++|||++.  ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+...+||
T Consensus       119 --~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          119 --RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             --CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             --cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEE
Confidence              3334789999987  577776654    3679999999999999999999999 899999999999999943337999


Q ss_pred             EeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +|||++...... ......+|+.|+|||++.+...++.++||||||+++|+|++|+.||....      .+...  .   
T Consensus       192 ~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~--~---  259 (320)
T 3a99_A          192 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q---  259 (320)
T ss_dssp             CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C---
T ss_pred             eeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc--c---
Confidence            999999866432 33345789999999998766545789999999999999999999996532      11110  0   


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                  .            .+...+++++.+||.+||+.||.+|||++++++||||++...+
T Consensus       260 ------------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          260 ------------V------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             ------------C------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ------------c------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence                        0            0124679999999999999999999999999999999987644

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-45  Score=343.39  Aligned_cols=265  Identities=24%  Similarity=0.357  Sum_probs=186.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHH-HHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+. +++.++||||+++++++..     ...
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence            456999999999999999999999999999999986432     12223444 6677899999999998843     234


Q ss_pred             EEEEEecccccHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-CceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          155 LNLVLEYVPETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~-givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .++||||+++++.+++..... ....+++..++.++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||++
T Consensus        96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  173 (327)
T 3aln_A           96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGIS  173 (327)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred             eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence            789999999988777765333 25789999999999999999999999 8 999999999999999887 7999999999


Q ss_pred             cccccCCCCcccccccccccccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      .............+|+.|+|||++.   ....++.++||||||+++|+|++|+.||.+.....  ..+....        
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~--------  243 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVV--------  243 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCC--------
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHh--------
Confidence            8765544444557899999999983   23348999999999999999999999997643211  0000000        


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                                   ......+.......+++.+.+||.+||+.||.+|||+.++++||||++.....
T Consensus       244 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  296 (327)
T 3aln_A          244 -------------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA  296 (327)
T ss_dssp             -------------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred             -------------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhH
Confidence                         00000011111245789999999999999999999999999999998765443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-45  Score=341.30  Aligned_cols=247  Identities=19%  Similarity=0.199  Sum_probs=199.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...  ...+.+|+.+++.+ +|+||+++++++..     ..+.++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence            3599999999999999999999999999999988543  34567899999999 99999999998743     3457899


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc-----EEEEeecCcc
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAK  233 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~-----vkl~Dfg~a~  233 (394)
                      |||++++|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .     +||+|||+++
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCE
T ss_pred             EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEcccce
Confidence            999988998887653   3689999999999999999999999 8999999999999999776 4     9999999998


Q ss_pred             ccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhC
Q 016158          234 VLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLG  302 (394)
Q Consensus       234 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~  302 (394)
                      .......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....   +.+..+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            6644322        2356789999999999654 4899999999999999999999999875433   23333322211


Q ss_pred             CCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..+...                        ....++ ++.+||..||+.||.+||++++|++
T Consensus       238 ~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111110                        112344 9999999999999999999988875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.1e-45  Score=337.65  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=194.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||.||+|++  +|+.||||++....      ..+.+|+++++.++||||+++++++..     ...
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~  108 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN  108 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence            45799999999999999999987  48899999985432      234579999999999999999998832     233


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .++||||+.+ +|.+++.... ....+++..++.++.|++.||+|||+ .|  |+||||||+|||++.++ .+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCCCC
Confidence            6799999975 8877776422 12348999999999999999999999 89  99999999999999887 799999999


Q ss_pred             ccccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          232 AKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       232 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.......      
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------  258 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------  258 (309)
T ss_dssp             ----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC------
T ss_pred             CccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence            97543332 23346789999999999655 48999999999999999999999998877666555443311110      


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  370 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~  370 (394)
                                           .++..+++++.+||.+||+.||.+|||+.++++  +++++.
T Consensus       259 ---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          259 ---------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                 123568999999999999999999999999997  455544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-45  Score=340.13  Aligned_cols=264  Identities=19%  Similarity=0.253  Sum_probs=189.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCc---EEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc-
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-  151 (394)
                      .+|++.+.||+|+||.||+|++..++.   .||||++...      ...+.+|+++++.++||||+++++++....... 
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            469999999999999999999887765   8999988543      234568999999999999999999885543321 


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      ....++||||+.+ +|..++......  ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl~D  180 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCVAD  180 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEEee
Confidence            1234799999986 887777653321  2268999999999999999999999 8999999999999999887 799999


Q ss_pred             ecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          229 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       229 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      ||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  258 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-  258 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred             ccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC-
Confidence            999976543322   2234457789999998654 48999999999999999999 99999988776666555432100 


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-------ALEACVHPFFDELRDPNT  376 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~f~~~~~~~~  376 (394)
                                                 ..+..+++++.+||.+||+.||.+|||       ++++++|||+......-.
T Consensus       259 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl  310 (323)
T 3qup_A          259 ---------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL  310 (323)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred             ---------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence                                       012457899999999999999999999       888899999988655444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.4e-44  Score=331.36  Aligned_cols=249  Identities=19%  Similarity=0.193  Sum_probs=202.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.+ +|+|++++++++     ......++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~lv   84 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV   84 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEEE
Confidence            3599999999999999999999999999999988543  34567899999999 899999999887     333457899


Q ss_pred             EecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC----cEEEEeecCccc
Q 016158          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  234 (394)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~----~vkl~Dfg~a~~  234 (394)
                      |||++++|.+++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.    .+||+|||++..
T Consensus        85 ~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999988998887643   3569999999999999999999999 89999999999999987652    399999999986


Q ss_pred             cccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCC
Q 016158          235 LVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGT  303 (394)
Q Consensus       235 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~  303 (394)
                      ......        .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+...   ...+..+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            644322        2345689999999998654 489999999999999999999999987532   3333333332211


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+..                        .+...+++++.+||.+||+.||++|||++++++
T Consensus       240 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1111                        112467999999999999999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=349.12  Aligned_cols=255  Identities=19%  Similarity=0.229  Sum_probs=203.2

Q ss_pred             cccEEEeeEeeecCceEEEEEE-----ECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ..+|++.+.||+|+||.||+|+     +..+++.||||++...     .....+|+.+++.++||||+++++++..    
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            4579999999999999999999     4457789999998532     2345579999999999999999998832    


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcE
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL  224 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~v  224 (394)
                       ....++||||+.+ +|.+++.....   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ..+
T Consensus       146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceE
Confidence             2335799999965 88888776432   12458999999999999999999999 8999999999999998544  259


Q ss_pred             EEEeecCccccccC---CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016158          225 KLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       225 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~  300 (394)
                      ||+|||+++.....   .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+...
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999754322   223345678899999998655 48999999999999999998 99999888766655554432


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                      ....                            .+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus       303 ~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRMD----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            1100                            12457899999999999999999999999999877643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=336.96  Aligned_cols=247  Identities=25%  Similarity=0.482  Sum_probs=199.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...    ...+.+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            35699999999999999999999999999999987542    3445689999999999999999999843     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+.+ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999975 887776542   3679999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCCCC---------------ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHH
Q 016158          236 VKGEPN---------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-----QLV  295 (394)
Q Consensus       236 ~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----~~~  295 (394)
                      ......               ....||+.|+|||++.+. .++.++||||||+++|+|++|..||.......     ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence            433221               145689999999999654 48999999999999999999999987543211     001


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ....                               ...+..+++.+.+||.+||+.||++|||+.++++  |++++
T Consensus       238 ~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          238 GFLD-------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HHHH-------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             cccc-------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            1110                               1123567899999999999999999999999987  55544

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=339.19  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...+|++.+.||+|+||.||+|++..+++   .||||++...     ...+.+|+.+++.++||||+++++++     ..
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  121 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR  121 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            34579999999999999999999986655   4999998643     23456799999999999999999988     33


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ....++||||+.+ +|.+++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  196 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFG  196 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             CCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCCC
Confidence            3447799999975 887776542   3579999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          231 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       231 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      +++........    ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+......+ 
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-  274 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-  274 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-
Confidence            99876443221    123346789999999654 48999999999999999999 999998887766665554421110 


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                 .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       275 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          275 ---------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                       12467899999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.4e-45  Score=343.38  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEEC-------CCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEe
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS  146 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~  146 (394)
                      ...+|++.+.||+|+||.||+|++.       .++..||||++....     ..+.+|+.+++.+ +||||+++++++. 
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC-
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc-
Confidence            3467999999999999999999975       345679999986432     3456799999999 8999999999883 


Q ss_pred             cCCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCC
Q 016158          147 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (394)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~  213 (394)
                          ....+++||||+.+ +|.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus       158 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~  232 (370)
T 2psq_A          158 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR  232 (370)
T ss_dssp             ----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred             ----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence                23337799999985 88888775321            12458999999999999999999999 89999999999


Q ss_pred             cEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016158          214 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  289 (394)
Q Consensus       214 Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  289 (394)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999888 699999999986543322   2234567889999999765 48999999999999999999 999998877


Q ss_pred             cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ..+....+.....                            ...+..++.++.+||.+||+.||.+|||+.|++++
T Consensus       311 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6655544432110                            01124678999999999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-45  Score=334.99  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=209.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecC-----------C
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT-----------D  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------~  149 (394)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++........+|+++++.++||||+++++++....           .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            35699999999999999999999999999999999887778889999999999999999999874311           1


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      ......++||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEECc
Confidence            235568899999996 8888876532  3679999999999999999999999 8999999999999999887 799999


Q ss_pred             ecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       229 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ||++.............+++.|+|||.+.+. .++.++||||||+++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence            9999877655555566789999999999654 48999999999999999999998874211  11111110         


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                                            ..++..++..+.+||.+||+.||.+|||+.++++|.|.-.
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                  0012457889999999999999999999999999977644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.3e-44  Score=334.12  Aligned_cols=256  Identities=24%  Similarity=0.332  Sum_probs=196.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcC--CCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++...      .....+|+.+++.+.  |+||+++++++.     ..
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CS
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cC
Confidence            346999999999999999999985 5899999998532      234567999999997  599999999883     33


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+.++|||+.+++|.+++..    ...+++..++.++.|++.||.|||+ .||+||||||+|||++. + .+||+|||++
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred             CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeecccc
Confidence            45889999888888877764    3678999999999999999999999 89999999999999974 5 7999999999


Q ss_pred             cccccCCC---CccccccccccccccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH
Q 016158          233 KVLVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEII  298 (394)
Q Consensus       233 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~  298 (394)
                      ........   .....+++.|+|||.+.+.          ..++.++||||||+++|+|++|+.||...... ..+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            76543322   2245689999999998541          35788999999999999999999999765433 2222221


Q ss_pred             HHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ...                           ....++...+.++.+||.+||+.||.+|||+.++|+||||+....+..
T Consensus       254 ~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          254 DPN---------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             CTT---------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             hcc---------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence            100                           000112346889999999999999999999999999999987655443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.9e-45  Score=341.21  Aligned_cols=268  Identities=21%  Similarity=0.229  Sum_probs=197.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..+|++.++||+|+||.||+|++.  ++.||||++....   ....+|+.+++.++||||+++++++..... ....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence            346999999999999999999986  7899999986543   233457888999999999999999865432 2345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------CceeecCCCCcEEEeCCCCcEEE
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------GICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~----------givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                      ||||+++ +|.+++..     ..+++..++.++.|++.||+|||+ .          ||+||||||+|||++.++ .+||
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence            9999975 88887764     569999999999999999999998 8          999999999999999887 7999


Q ss_pred             EeecCccccccCCC---CccccccccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 016158          227 CDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  299 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~  299 (394)
                      +|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|+||+.||.+............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999976644322   2335789999999999653    2356688999999999999999999987543221111111


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ....+....+......      ....+...........++++.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVH------KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTT------SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhc------ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1122222111100000      0000000000011223566999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-44  Score=327.54  Aligned_cols=245  Identities=20%  Similarity=0.327  Sum_probs=200.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..+|++.+.||+|+||.||+|++. +++.||+|++...   .....+|+++++.++||||+++++++.     .....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEE
Confidence            356999999999999999999986 5778999998653   345678999999999999999999883     2333789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEecccccccccc
Confidence            9999975 777766542   3568999999999999999999999 8999999999999999887 69999999997653


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ...  ......+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||......+....+......          
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------  226 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred             ccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC----------
Confidence            221  22234557789999999654 48999999999999999999 99999887776666555432110          


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                        ..+..+++.+.+||.+||+.||++|||+.++++|
T Consensus       227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 ------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                              1124578999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7e-45  Score=342.33  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=201.5

Q ss_pred             cccEEEeeEeeecCceEEEEEE-----ECCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      .++|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+++++.+ +||||+++++++...  
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--   98 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   98 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC--
Confidence            4579999999999999999999     55677999999986532     3456899999999 789999999988432  


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhh----------------------------------------------------
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRI----------------------------------------------------  176 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------------------------------------------------  176 (394)
                        ....++||||+.+ +|.+++......                                                    
T Consensus        99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence              2236789999985 888877654321                                                    


Q ss_pred             ----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCC---Ccc
Q 016158          177 ----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVS  243 (394)
Q Consensus       177 ----------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~  243 (394)
                                ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++........   ...
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence                      1228999999999999999999999 8999999999999999887 699999999976543322   223


Q ss_pred             ccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCC
Q 016158          244 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  322 (394)
Q Consensus       244 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  322 (394)
                      ..+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+......+...........                 
T Consensus       255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------  316 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-----------------  316 (359)
T ss_dssp             CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-----------------
T ss_pred             cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-----------------
Confidence            5668899999998654 48999999999999999998 9999988776555554444221111                 


Q ss_pred             CCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          323 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                .+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       317 ----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          317 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                      124578999999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.1e-44  Score=339.82  Aligned_cols=257  Identities=16%  Similarity=0.118  Sum_probs=195.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCC-----CcEEEEEEeccchhhhHHHHH---------------HHHHcCCCceeeec
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYKNRELQ---------------IMQMLDHPNIVALK  141 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~E~~---------------~l~~l~h~~iv~~~  141 (394)
                      .+|++.+.||+|+||.||+|.+..+     ++.||||++........+|++               .++.++|+||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3699999999999999999998764     588999998765544444444               44556799999999


Q ss_pred             eEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe--C
Q 016158          142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--P  219 (394)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~--~  219 (394)
                      +++.... ....+.++||||++++|.+++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence            9886543 23466889999998888887764   23679999999999999999999999 8999999999999998  6


Q ss_pred             CCCcEEEEeecCccccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Q 016158          220 HTHQLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV  291 (394)
Q Consensus       220 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  291 (394)
                      ++ .+||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+....
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 799999999976543221        12345899999999996554 899999999999999999999999864333


Q ss_pred             HHHHH-HHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          292 DQLVE-IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       292 ~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..... ................-                   ....++.++.+||..||+.||.+||++.+|++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCF-------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHS-------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhc-------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            22222 22111111111110000                   01457899999999999999999999998874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.9e-44  Score=324.29  Aligned_cols=246  Identities=20%  Similarity=0.300  Sum_probs=200.3

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.+++.++||||+++++++     ......+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence            3457999999999999999999885 5778999998653   34456899999999999999999988     3333478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            99999974 687776543   3569999999999999999999999 8999999999999999888 6999999999765


Q ss_pred             ccCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ......  ....+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||...........+......         
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------  224 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence            433221  233456789999998654 48999999999999999999 99999887766655554331100         


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                         ..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       225 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 -------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                               0123468899999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.9e-45  Score=349.60  Aligned_cols=257  Identities=28%  Similarity=0.414  Sum_probs=189.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      .|.+.+.||+|+||+||.+. ..+|+.||||++.... ....+|+.+++.+ +||||+++++++     ....+.++|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence            48888999999999998764 4679999999886543 3456799999876 899999998887     33455889999


Q ss_pred             cccccHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC------------CcEE
Q 016158          161 YVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT------------HQLK  225 (394)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~------------~~vk  225 (394)
                      |++++|.+++.........   ..+..++.++.||+.||+|||+ +||+||||||+|||++.++            ..+|
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            9999998888753322111   1233457789999999999999 8999999999999997532            2699


Q ss_pred             EEeecCccccccCCC-----CccccccccccccccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 016158          226 LCDFGSAKVLVKGEP-----NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  293 (394)
Q Consensus       226 l~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  293 (394)
                      |+|||++........     .....||+.|+|||++.+      ...++.++|||||||++|+|+| |..||.+..... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            999999987654322     123568999999999864      2458999999999999999999 999997654432 


Q ss_pred             HHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       294 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                       ..+....                 ...+..     .......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 -~~i~~~~-----------------~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 -SNIIRGI-----------------FSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -HHHHHTC-----------------CCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -HHHhcCC-----------------CCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence             2222211                 000000     00011345688999999999999999999999999999964

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=339.76  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=196.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHc----CCCceeeeceEEEec
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQML----DHPNIVALKHCFFST  147 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~~~~~~~~~  147 (394)
                      ++|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+    +|+||+++++++.  
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~--  108 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE--  108 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe--
Confidence            46999999999999999999999999999999985432          2334699999998    8999999999873  


Q ss_pred             CCCceeEEEEEEec-cc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe-CCCCcE
Q 016158          148 TDKEELYLNLVLEY-VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQL  224 (394)
Q Consensus       148 ~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~-~~~~~v  224 (394)
                         .....++|||+ +. ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++ .++ .+
T Consensus       109 ---~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~  179 (312)
T 2iwi_A          109 ---TQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG-CA  179 (312)
T ss_dssp             -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-EE
T ss_pred             ---cCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-eE
Confidence               23346789998 44 577776654    3579999999999999999999999 8999999999999999 555 79


Q ss_pred             EEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          225 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       225 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      ||+|||++...... ......+++.|+|||++.+....+.++||||||+++|+|++|+.||....      .+...    
T Consensus       180 kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~----  248 (312)
T 2iwi_A          180 KLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA----  248 (312)
T ss_dssp             EECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT----
T ss_pred             EEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh----
Confidence            99999999866433 33456689999999998665544669999999999999999999996431      11110    


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                                   ..            .++..++..+.+||.+||+.||++|||++++++||||+...+..
T Consensus       249 -------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~  294 (312)
T 2iwi_A          249 -------------EL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV  294 (312)
T ss_dssp             -------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred             -------------cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence                         00            02246789999999999999999999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=338.90  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ..+|++.+.||+|+||.||+|++.     .+++.||||++...     ...+.+|+.+++.++||||+++++++..    
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----  121 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV----  121 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc----
Confidence            457999999999999999999997     35589999998653     2345689999999999999999998832    


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeec
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSRI--------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~D  209 (394)
                       ....++||||+++ +|.+++......                    ...+++..++.++.||+.||.|||+ +||+|||
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D  199 (343)
T 1luf_A          122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  199 (343)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence             3347799999985 888887753211                    2679999999999999999999999 8999999


Q ss_pred             CCCCcEEEeCCCCcEEEEeecCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 016158          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF  285 (394)
Q Consensus       210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf  285 (394)
                      |||+|||++.++ .+||+|||++.......   ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||
T Consensus       200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcC
Confidence            999999999887 79999999997653321   223456688999999986544 8999999999999999999 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+....+....+.....                            ..++..++.++.+||++||+.||.+|||+.++++
T Consensus       278 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            88776655554433110                            0012467899999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=350.30  Aligned_cols=253  Identities=24%  Similarity=0.355  Sum_probs=189.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +|.+.++||+|+||+||.. ...+|+.||||++... .....+|+.+++.+ +||||+++++++     ....+.++|||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~E   98 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEEE
Confidence            5999999999999997643 3467899999998653 34457899999999 899999999887     33445789999


Q ss_pred             cccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC----CcEEEEeecCccccc
Q 016158          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDFGSAKVLV  236 (394)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~----~~vkl~Dfg~a~~~~  236 (394)
                      |++++|.+++...   ...+.+..++.++.||+.||+|||+ .||+||||||+|||++.++    ..+||+|||+++...
T Consensus        99 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            9999988877642   2345555667899999999999999 8999999999999995322    158899999998764


Q ss_pred             cCC----CCccccccccccccccccC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          237 KGE----PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       237 ~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      ...    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||........ ..+   .+....   
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~---~~~~~~---  247 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL---LGACSL---  247 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH---TTCCCC---
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH---hccCCc---
Confidence            332    2234568999999999864  3347889999999999999999 8999965443222 111   111000   


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                  ....       .....+..+.+||.+||+.||.+|||+.++++||||..+
T Consensus       248 ------------~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          248 ------------DCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             ------------TTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ------------cccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                        0000       002245668999999999999999999999999999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=339.13  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=202.2

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCC-------CcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEE
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFF  145 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~  145 (394)
                      ...++|.+.+.||+|+||.||+|++..+       +..||||++....     ....+|+++++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            3456799999999999999999997543       3579999986432     3455799999999 9999999999883


Q ss_pred             ecCCCceeEEEEEEecccc-cHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCC
Q 016158          146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (394)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp  212 (394)
                      .     ....++||||+.+ +|.+++......            ...+++..++.++.||+.||+|||+ .||+||||||
T Consensus       146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp  219 (382)
T 3tt0_A          146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA  219 (382)
T ss_dssp             S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred             c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence            2     2336799999975 888887764321            2459999999999999999999999 8999999999


Q ss_pred             CcEEEeCCCCcEEEEeecCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 016158          213 QNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  288 (394)
Q Consensus       213 ~Nil~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  288 (394)
                      +|||++.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999887 79999999998664332   22334568889999999764 48999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       289 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ...+....+.....                            ...+..+++++.+||++||+.||++|||+.+++++
T Consensus       298 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76555544433110                            00124678999999999999999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.7e-44  Score=325.04  Aligned_cols=241  Identities=28%  Similarity=0.439  Sum_probs=188.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .+|++.+.||+|+||.||+|++.  |+.||||++...        .....+|+++++.++||||+++++++     ....
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   79 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKEP   79 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC-
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCC
Confidence            46999999999999999999985  889999987542        23456799999999999999999988     3344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC---ceeecCCCCcEEEeC--------CC
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG---ICHRDIKPQNLLVNP--------HT  221 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g---ivH~Dlkp~Nil~~~--------~~  221 (394)
                      ..++||||+++ ++.+++.     ...+++..++.++.|++.||+|||+ .|   |+||||||+|||++.        ++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             ceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence            47899999974 6666553     3689999999999999999999999 78   999999999999986        34


Q ss_pred             CcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016158          222 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (394)
Q Consensus       222 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  301 (394)
                       .+||+|||++....... .....+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus       154 -~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          154 -ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             -CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             -ceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence             69999999997654332 3355789999999998654 48999999999999999999999998877655544433211


Q ss_pred             CCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .                           ...++..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       231 ~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 L---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             C---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            0                           001224678999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.9e-44  Score=325.69  Aligned_cols=249  Identities=21%  Similarity=0.222  Sum_probs=199.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.+.|++++..+..+...    ..+.++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~   84 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM   84 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEEE
Confidence            4699999999999999999999999999999987543  34567899999999998877776665432    23478999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe---CCCCcEEEEeecCccccc
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~---~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||++++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++   .++ .+||+|||++....
T Consensus        85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             EecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccc
Confidence            99988998877642   3679999999999999999999999 8999999999999994   555 79999999998765


Q ss_pred             cCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCC
Q 016158          237 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPT  305 (394)
Q Consensus       237 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~  305 (394)
                      ....        .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+...   ...+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4332        23557899999999996544 89999999999999999999999987432   233333333211111


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..                        .+...+++++.+||.+||+.||.+|||+.++++
T Consensus       239 ~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            11                        112457899999999999999999999999886

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-44  Score=342.14  Aligned_cols=247  Identities=22%  Similarity=0.305  Sum_probs=199.5

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ....+|++.+.||+|+||.||+|++..+++.||||++...     ...+.+|+++++.++||||+++++++.     ...
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~  185 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQ  185 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCC
Confidence            3456799999999999999999999989999999988643     234567999999999999999999883     223


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||++ ++|.+++...   ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s  260 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGMS  260 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCCc
Confidence            3679999997 5787776542   3568999999999999999999999 8999999999999999887 7999999999


Q ss_pred             cccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      +.......   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+....+....+.... ..    
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----  334 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RL----  334 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CC----
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence            75432211   1122346789999998654 48999999999999999998 999998877655444332211 00    


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                             ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       335 -----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 -----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                   012457899999999999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-44  Score=332.43  Aligned_cols=250  Identities=20%  Similarity=0.336  Sum_probs=200.7

Q ss_pred             ccccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      ...+|.+.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence            3457999999999999999999983     456899999986432     345579999999999999999998832   


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceee
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHR  208 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~  208 (394)
                        ....++||||+. ++|.+++.....                    ....+++..++.++.||+.||+|||+ +||+||
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~  174 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR  174 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence              333779999998 588888776432                    12348999999999999999999999 899999


Q ss_pred             cCCCCcEEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 016158          209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL  284 (394)
Q Consensus       209 Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p  284 (394)
                      ||||+|||++.++ .+||+|||++........   .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999887 799999999976543322   2234557889999998654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          285 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       285 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      |.+.........+.....                            ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            988776555444332110                            0012467999999999999999999999999987


Q ss_pred             C
Q 016158          365 H  365 (394)
Q Consensus       365 h  365 (394)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.9e-44  Score=328.89  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHH--cCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .++|++.+.||+|+||.||+|++  +|+.||||++.... ....+|.+++..  ++||||+++++++.... ......++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence            34699999999999999999998  58999999986543 334467777777  79999999999875543 33456789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      ||||+++ +|.+++..     ..+++..++.++.|++.||+|||        + .||+||||||+|||++.++ .+||+|
T Consensus        84 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~D  156 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIAD  156 (301)
T ss_dssp             EECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEECC
T ss_pred             ehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEee
Confidence            9999985 88777643     67999999999999999999999        8 8999999999999999888 799999


Q ss_pred             ecCccccccCCCC-----ccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 016158          229 FGSAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLG----------QPLFPGE  288 (394)
Q Consensus       229 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg----------~~pf~~~  288 (394)
                      ||++.........     ....||+.|+|||++.+..     .++.++|||||||++|+|+||          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            9999765433222     2347899999999996543     244799999999999999999          8888654


Q ss_pred             Cc----HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          289 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       289 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..    ...+.......+..                     .......+....++++.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVDQQR---------------------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCSSCCHHHHHHHHTTSCCC---------------------CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCcchhhhhHHHhccCCC---------------------CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            22    22222222111000                     000111122345688999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.9e-44  Score=325.29  Aligned_cols=249  Identities=21%  Similarity=0.226  Sum_probs=198.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++|++.+.||+|+||.||+|++..+++.||||++..  ......+|+.+++.+.|++++..+..+...    ..+.++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEEE
Confidence            469999999999999999999999999999998643  334567899999999999888777766432    23478999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE---eCCCCcEEEEeecCccccc
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||++++|.+++...   ...+++..++.++.||+.||.|||+ .||+||||||+|||+   +.++ .+||+|||++....
T Consensus        85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             EccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceecc
Confidence            99988988877632   3679999999999999999999999 899999999999999   5566 79999999998764


Q ss_pred             cCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 016158          237 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPT  305 (394)
Q Consensus       237 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~  305 (394)
                      ....        .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+....   ..+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            4322        23457899999999996554 899999999999999999999999875432   23333322211111


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..                        .....+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11                        112457899999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.5e-44  Score=325.71  Aligned_cols=246  Identities=21%  Similarity=0.293  Sum_probs=198.5

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++...   .....+|+++++.++|+||+++++++.     .....+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   95 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF   95 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeE
Confidence            3457999999999999999999886 6778999998653   345668999999999999999999883     333478


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+. ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~  170 (283)
T 3gen_A           96 IITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYV  170 (283)
T ss_dssp             EEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGGB
T ss_pred             EEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEccccccccc
Confidence            9999996 5787766542   3579999999999999999999999 8999999999999999888 6999999999765


Q ss_pred             ccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ....  ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||......+....+.......        
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------  241 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------  241 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred             cccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC--------
Confidence            3221  122344577899999996554 8999999999999999998 999998887766666554421110        


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                          .+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       242 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          242 --------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                124568899999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5e-44  Score=330.01  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=202.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEE-----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.+.||+|+||.||+|++     ..+++.||||++...     .....+|+.+++.+ +||||+++++++..   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence            45799999999999999999985     456789999998643     24456899999999 99999999998833   


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                        ....++||||+++ +|.+++.....              ....+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N  175 (313)
T 1t46_A           99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (313)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence              2336799999975 88887765332              12358999999999999999999999 899999999999


Q ss_pred             EEEeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016158          215 LLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  290 (394)
                      ||++.++ .+||+|||++.........   ....+|+.|+|||.+.+. .++.++||||||+++|+|+| |..||.+...
T Consensus       176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999887 7999999999766544321   234567889999998654 48999999999999999999 9999988776


Q ss_pred             HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ...+..........                           ..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            55555554422111                           0124578999999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=334.97  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=184.8

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----hhhHHHHHHHHHcC-CCceeeeceEEEecCC---CceeE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD---KEELY  154 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~~  154 (394)
                      +|++.++||+|+||.||+|++..+|+.||||++....    ....+|+.+++.+. ||||+++++++.....   .....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            6999999999999999999999999999999885432    34457999999995 9999999998854332   44566


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ++++|||+.++|.+++..... ...+++..++.++.||+.||+|||+ .|  |+||||||+|||++.++ .+||+|||++
T Consensus       109 ~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~  185 (337)
T 3ll6_A          109 FLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFGSA  185 (337)
T ss_dssp             EEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCTTC
T ss_pred             EEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCccc
Confidence            889999999999887765332 4569999999999999999999999 89  99999999999999888 6999999999


Q ss_pred             cccccCCCC-------------cccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 016158          233 KVLVKGEPN-------------VSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI  297 (394)
Q Consensus       233 ~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i  297 (394)
                      .........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|+.||............
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  265 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK  265 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence            766433221             1345799999999983  2344789999999999999999999999754432211100


Q ss_pred             HHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 016158          298 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  366 (394)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  366 (394)
                                           ...          ......+..+.+||++||+.||.+|||+.++++|-
T Consensus       266 ---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          266 ---------------------YSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ---------------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             ---------------------ccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                                 000          01134677899999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=350.47  Aligned_cols=272  Identities=21%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+|++.++||+|+||.||+|++..+|+.||||++....     ....+|+++++.++||||+++++++....   ....+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence            46999999999999999999999999999999986432     34458999999999999999999874332   23467


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE----eCCCCcEEEEeecC
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFGS  231 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~----~~~~~~vkl~Dfg~  231 (394)
                      +||||+.+ +|.+++.... ....+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCCC
Confidence            99999974 7777665432 22349999999999999999999999 899999999999998    5454 699999999


Q ss_pred             ccccccCCCCccccccccccccccccCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHH
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKV  300 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~i~~~  300 (394)
                      ++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+.+..+.. 
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~-  241 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT-  241 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH-
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc-
Confidence            9877555555567789999999998531       347789999999999999999999997533    2233333332 


Q ss_pred             hCCCChhhhhccCCC-CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          301 LGTPTREEIKCMNPN-YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                        ..+...+...... ...+....  ..+....+...++..+.+||++||++||++|||+.++++
T Consensus       242 --~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 --GKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             --SCCTTCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             --CCCcccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence              2222211111000 00000000  001111223456678999999999999999999999854

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-43  Score=323.96  Aligned_cols=245  Identities=23%  Similarity=0.337  Sum_probs=195.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----------hhhHHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....           ..+.+|+.+++.++||||+++++++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----   92 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM-----   92 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee-----
Confidence            346999999999999999999999999999999885321           3456899999999999999999987     


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeCCCC----
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTH----  222 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~----  222 (394)
                      ....  ++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ .|  |+||||||+|||++.++.    
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCce
Confidence            2222  48999998 577665543   23679999999999999999999999 89  999999999999987662    


Q ss_pred             cEEEEeecCccccccCCCCccccccccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHH
Q 016158          223 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKV  300 (394)
Q Consensus       223 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~  300 (394)
                      .+||+|||++.....  ......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||........ .......
T Consensus       167 ~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  244 (287)
T 4f0f_A          167 CAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE  244 (287)
T ss_dssp             CEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred             eEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence            299999999975432  3345678999999999842 33478899999999999999999999987654332 1222221


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+.                          ...++..+++++.+||.+||+.||.+|||+.++++
T Consensus       245 ~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          245 EGL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             SCC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            110                          01123567999999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-44  Score=330.00  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=192.7

Q ss_pred             cccEEEeeEeeecCceEEEEEE----ECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|+    +..+++.||||++....    ..+.+|+++++.++||||+++++++....   .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence            4579999999999999999999    56789999999986532    34568999999999999999999874321   2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCcc
Confidence            236799999964 888777653   2459999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      +........    .....++..|+|||.+.+. .++.++||||||+++|+|+||..||......  .   ....+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~  234 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQG  234 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCT
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCcccc
Confidence            986643322    2233467789999999655 4899999999999999999999998643211  1   1111111000


Q ss_pred             h------hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 E------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .      .......             .....+..+++++.+||.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          235 QMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0      0000000             000113568999999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.8e-44  Score=333.21  Aligned_cols=261  Identities=21%  Similarity=0.270  Sum_probs=208.5

Q ss_pred             ccccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      ...+|++.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++.++||||+++++++..   
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence            3457999999999999999999886     357889999986432     234579999999999999999998832   


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  222 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~  222 (394)
                        ....++||||+.+ +|.+++......      ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ 
T Consensus       100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~-  175 (322)
T 1p4o_A          100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-  175 (322)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-
T ss_pred             --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC-
Confidence              2336799999975 888887764432      2467899999999999999999999 8999999999999999887 


Q ss_pred             cEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 016158          223 QLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  298 (394)
Q Consensus       223 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~  298 (394)
                      .+||+|||++........   .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            699999999976543321   1234558889999998654 48999999999999999999 899998877655554443


Q ss_pred             HHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC------CCCCCCC
Q 016158          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH------PFFDELR  372 (394)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h------p~f~~~~  372 (394)
                      .... +                           ..+..++..+.+||.+||+.||.+|||+.++++|      |+|+++.
T Consensus       255 ~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          255 EGGL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             TTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             cCCc-C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            3110 0                           0124678999999999999999999999999976      8888775


Q ss_pred             CCCC
Q 016158          373 DPNT  376 (394)
Q Consensus       373 ~~~~  376 (394)
                      ....
T Consensus       307 ~~~~  310 (322)
T 1p4o_A          307 FYYS  310 (322)
T ss_dssp             STTS
T ss_pred             cccc
Confidence            5444

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.5e-44  Score=327.15  Aligned_cols=247  Identities=21%  Similarity=0.344  Sum_probs=202.9

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++||||+++++++.     .....+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCEE
Confidence            4557999999999999999999999999999999986543   34568999999999999999999883     333378


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+. ++|.+++....  ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCccceec
Confidence            9999998 58877776432  3568999999999999999999999 8999999999999999887 6999999999766


Q ss_pred             ccCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ......  ....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+.......+.....          
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  230 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------  230 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred             cCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC----------
Confidence            433221  234457889999999655 48999999999999999999 9999988776555444433110          


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                        ...+..+++.+.+||++||+.||.+|||+.++++
T Consensus       231 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                              0112467899999999999999999999999976

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-44  Score=334.11  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=200.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEE-----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|.+.+.||+|+||.||+|++     ..++..||||++...     ...+.+|+.+++.+ +||||+++++++..   
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---  120 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  120 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee---
Confidence            45799999999999999999997     345678999998643     23456899999999 99999999998833   


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeec
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRI-------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~D  209 (394)
                        ....++||||+++ +|.+++......                   ...+++..++.++.||+.||+|||+ .||+|||
T Consensus       121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D  197 (344)
T 1rjb_A          121 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  197 (344)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             --CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence              2337799999975 888877653211                   1347999999999999999999999 8999999


Q ss_pred             CCCCcEEEeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 016158          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF  285 (394)
Q Consensus       210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf  285 (394)
                      |||+|||++.++ .+||+|||++.........   ....+|+.|+|||.+.+. .++.++||||||+++|+|+| |..||
T Consensus       198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999887 7999999999766443322   234567889999998654 48999999999999999998 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+......+..+......+                           ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       276 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            8877655555544421100                           0124578999999999999999999999999985


Q ss_pred             C
Q 016158          366 P  366 (394)
Q Consensus       366 p  366 (394)
                      -
T Consensus       329 l  329 (344)
T 1rjb_A          329 L  329 (344)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=330.70  Aligned_cols=254  Identities=23%  Similarity=0.345  Sum_probs=198.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...    .....+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4699999999999999999999999999999987532    334568999999999999999999886433 23456789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+.+ +|.+++.........+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999986 8888888766666889999999999999999999999 8999999999999999887 69999999987543


Q ss_pred             cCCCC----------ccccccccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Q 016158          237 KGEPN----------VSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGT  303 (394)
Q Consensus       237 ~~~~~----------~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~  303 (394)
                      .....          ....||+.|+|||++.+..  .++.++||||||+++|+|++|+.||...... ..+......   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence            21111          1234689999999985433  2688999999999999999999999531100 001111110   


Q ss_pred             CChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          304 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                    ....+          ....++.++.+||.+||+.||.+|||+.++++|
T Consensus       263 --------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 --------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                          00000          114578999999999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=334.10  Aligned_cols=256  Identities=16%  Similarity=0.136  Sum_probs=192.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECC---CCcEEEEEEeccchhh---------------hHHHHHHHHHcCCCceeeeceE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRY---------------KNRELQIMQMLDHPNIVALKHC  143 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~~~~~  143 (394)
                      .+|++.+.||+|+||.||+|++..   ++..||||++......               ..+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            469999999999999999999987   7889999988654322               2356677788899999999998


Q ss_pred             EEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC-C
Q 016158          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-H  222 (394)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~-~  222 (394)
                      +.... ....+.++||||++++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence            86533 23556889999997788776543    2479999999999999999999999 8999999999999998764 2


Q ss_pred             cEEEEeecCccccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHH
Q 016158          223 QLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQ  293 (394)
Q Consensus       223 ~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~  293 (394)
                      .+||+|||+++.......        .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            699999999976533211        1345789999999999765 4899999999999999999999999653 22332


Q ss_pred             HHHHHH-HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          294 LVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       294 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ...... .....+.......                    -...+++++.+||.+||+.||++|||++++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            322222 2212221111110                    01268899999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.3e-44  Score=326.15  Aligned_cols=253  Identities=17%  Similarity=0.231  Sum_probs=196.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC-------cEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.+.||+|+||.||+|++..++       ..||+|++....    ..+.+|+.+++.++||||+++++++...  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG--   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence            457999999999999999999998777       469999985433    3456799999999999999999988432  


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc-----
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----  223 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~-----  223 (394)
                         ...++||||+. ++|.+++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++..     
T Consensus        85 ---~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           85 ---DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             ---TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             ---CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCccccccc
Confidence               23578999998 5888877652   2448999999999999999999999 899999999999999977621     


Q ss_pred             --EEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHH
Q 016158          224 --LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       224 --vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~  300 (394)
                        +||+|||++.....   .....+|+.|+|||++.+...++.++||||||+++|+|++|. +||..... .........
T Consensus       158 ~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~  233 (289)
T 4fvq_A          158 PFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED  233 (289)
T ss_dssp             CEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHT
T ss_pred             ceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHhhc
Confidence              99999999865422   234457889999999976466899999999999999999965 45544443 333332221


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  377 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  377 (394)
                      ..                             .++...++++.+||.+||+.||.+|||+.++++  .|+++..+...
T Consensus       234 ~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l~~p~~~  279 (289)
T 4fvq_A          234 RH-----------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSLFTPDLV  279 (289)
T ss_dssp             TC-----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTCC-----
T ss_pred             cC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhcCCCCC
Confidence            10                             011345788999999999999999999999998  45555555543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.7e-44  Score=323.55  Aligned_cols=246  Identities=26%  Similarity=0.356  Sum_probs=189.0

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCC---CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...+|++.+.||+|+||.||+|++..+   +..||+|++...     ...+.+|+.+++.++||||+++++++.    ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----EN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc----cC
Confidence            345799999999999999999998654   457999987542     234567999999999999999999872    11


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                        ..++||||+.+ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        89 --~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg  161 (281)
T 1mp8_A           89 --PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFG  161 (281)
T ss_dssp             --SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC--
T ss_pred             --ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECccc
Confidence              25689999985 787776542   3468999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          231 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++........  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+......    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~----  236 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----  236 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----
T ss_pred             cccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC----
Confidence            9976643322  1233457789999998654 48999999999999999996 99999887776665554431100    


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                              .++..+++++.+||.+||+.||++|||+.+++++
T Consensus       237 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    0124689999999999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-43  Score=327.66  Aligned_cols=254  Identities=19%  Similarity=0.263  Sum_probs=193.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC---CCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|.+.+.||+|+||.||+|++..   +++.||+|++...      ...+.+|+.+++.++||||+++++++.......
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            3469999999999999999998865   4568999998643      133567999999999999999999986554433


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEe
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      ....++||||+.+ +|..++....  .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl~D  190 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCVAD  190 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEECS
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEEee
Confidence            3456899999985 7877765432  234669999999999999999999999 8999999999999999887 699999


Q ss_pred             ecCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          229 FGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       229 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      ||++.......   ......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.........+.....  
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--  267 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--  267 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC--
Confidence            99997654332   12234567889999999654 48999999999999999999 8999988776665555443110  


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                                ...+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       268 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 --------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      01124678999999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-43  Score=330.33  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=201.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCc-----EEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|.+.+.||+|+||.||+|.+..+++     .||+|++...     ...+.+|+.+++.+ +||||+++++++..   
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  121 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH---  121 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence            4569999999999999999999977664     7999988643     23456899999999 89999999998832   


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~  218 (394)
                        ....++||||+++ +|.+++......          ...+++..++.++.||+.||+|||+ .||+||||||+|||++
T Consensus       122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence              2337799999975 888887764432          3568999999999999999999999 8999999999999999


Q ss_pred             CCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 016158          219 PHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  294 (394)
Q Consensus       219 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  294 (394)
                      .++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++||||||+++|+|+| |..||.+......+
T Consensus       199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            887 7999999999765443321   234557889999998654 48999999999999999998 99999887666555


Q ss_pred             HHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          295 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       295 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..+........                           .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          277 YKLVKDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            55544221110                           12346889999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.9e-44  Score=333.93  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEE--EEEEecc-----chhhhHHHHHHHHHc-CCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .++|++.+.||+|+||.||+|++..+|..+  |+|.+..     ....+.+|+++++.+ +||||+++++++..     .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----C
Confidence            457999999999999999999998888865  9998754     233456799999999 99999999998833     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  219 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~  219 (394)
                      ...++||||+++ +|.+++....            .....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcC
Confidence            357899999975 8888776533            123479999999999999999999999 89999999999999998


Q ss_pred             CCCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 016158          220 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  298 (394)
Q Consensus       220 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~  298 (394)
                      ++ .+||+|||+++............+++.|+|||++.+. .++.++||||||+++|+|++ |+.||.+....+....+.
T Consensus       178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            87 6999999999754433333445568889999998654 48999999999999999998 999998877655444332


Q ss_pred             HHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      ....                            ...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGYR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2100                            00124578999999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.5e-44  Score=332.35  Aligned_cols=245  Identities=22%  Similarity=0.290  Sum_probs=194.2

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcE----EEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+++.    ||+|.+...     .....+|+.+++.++||||+++++++.     .
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence            44699999999999999999999888876    677765432     133457999999999999999999772     1


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                       ...++||||+. ++|.+.+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg  160 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVADFG  160 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECSCS
T ss_pred             -CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECCCC
Confidence             12668999998 5776666542   3578999999999999999999999 8999999999999999888 69999999


Q ss_pred             CccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          231 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       231 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +++.......   .....+++.|+|||++.+.. ++.++|||||||++|+|+| |..||.+....+....+.....    
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----  235 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----  235 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----
Confidence            9987644332   23345677899999996544 8999999999999999999 9999988765554444332100    


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                              ...+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       236 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 ------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00123467889999999999999999999999976

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.3e-44  Score=331.19  Aligned_cols=245  Identities=22%  Similarity=0.332  Sum_probs=191.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEE----EEEEecc-----chhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+++.+    |+|.+..     ....+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence            456999999999999999999998887765    7776642     224456899999999999999999988432    


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                       . .+++++|+. ++|.+.+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        90 -~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg  162 (327)
T 3poz_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEccCc
Confidence             1 457788887 4776666542   3679999999999999999999999 8999999999999999888 79999999


Q ss_pred             CccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +++........   ....+|+.|+|||++.+. .++.++|||||||++|+|+| |+.||.+.........+.... ..  
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--  238 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL--  238 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CC--
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-CC--
Confidence            99866443322   233457789999999754 48999999999999999999 999998776655443333211 00  


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                               ..+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus       239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 -------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                     0124578899999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=335.69  Aligned_cols=255  Identities=13%  Similarity=0.097  Sum_probs=197.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCC--------CcEEEEEEeccchhhhHHHHHHHHHcCCCceee--------------
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRET--------GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------------  139 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~--------------  139 (394)
                      .+|++.+.||+|+||.||+|++..+        ++.||||++... ....+|+++++.++||||++              
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4699999999999999999999874        889999988754 56678999999999999987              


Q ss_pred             -eceEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEe
Q 016158          140 -LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  218 (394)
Q Consensus       140 -~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~  218 (394)
                       +++++..    ...+.++||||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence             4444422    234578999999889988887532  3679999999999999999999999 8999999999999999


Q ss_pred             CCCC-cEEEEeecCccccccCCC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016158          219 PHTH-QLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES  289 (394)
Q Consensus       219 ~~~~-~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  289 (394)
                      .++. .+||+|||+++.......        .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            7751 599999999976543221        1334789999999999654 48999999999999999999999998764


Q ss_pred             -cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          290 -GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       290 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                       ....+..........+.....                   .......+++++.+||.+||+.||.+|||++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGPFVG-------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCCEEC-------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhhhhh-------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             333333333221111000000                   00011357899999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.2e-43  Score=324.33  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=191.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++...     
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----
Confidence            345699999999999999999999999999999988631       23455799999999999999999988542     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+.+ +|.+++.........+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence            347899999986 8888888766667789999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhh
Q 016158          232 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       232 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  309 (394)
                      +........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+... ...+.........++    
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  257 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP----  257 (310)
T ss_dssp             ----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC----
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC----
Confidence            876543322 2345679999999998654 489999999999999999999999976432 222222222111000    


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                            .....+++++.+||.+||+.||.+|||+.++++
T Consensus       258 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          258 ----------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ----------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                  011457899999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-44  Score=334.74  Aligned_cols=271  Identities=21%  Similarity=0.292  Sum_probs=204.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ++|.+.+.||+|+||.||+|++ .+|+.||||++....     ..+.+|+++++.++||||+++++++..     ....+
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~  103 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTERL  103 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSCCE
T ss_pred             hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCceE
Confidence            4699999999999999999986 468999999986432     245789999999999999999999843     23367


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      +||||+.+ +|.+++.........+++..++.++.|++.||+|||+ .   ||+||||||+|||++.++ .+||+|||++
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~  181 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA  181 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence            99999975 8888887755555669999999999999999999999 8   999999999999999887 6999999999


Q ss_pred             cccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCCh
Q 016158          233 KVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE----SGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       233 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~i~~~~~~~~~  306 (394)
                      ........  .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...    .............     
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  255 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-----  255 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT-----
T ss_pred             cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH-----
Confidence            86643322  22345899999999986544 899999999999999999999999521    1111111111100     


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  375 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  375 (394)
                               .................+....+..+.+|+.+||+.||.+|||+.++++|-+-..+.+..
T Consensus       256 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  315 (326)
T 3uim_A          256 ---------LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW  315 (326)
T ss_dssp             ---------TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred             ---------hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence                     000011111111111122234467899999999999999999999999986655554443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-45  Score=350.34  Aligned_cols=254  Identities=19%  Similarity=0.211  Sum_probs=192.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCC-Cce---------eeeceE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDH-PNI---------VALKHC  143 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-~~i---------v~~~~~  143 (394)
                      ...|.+.++||+|+||.||+|++..+|+.||||++...       ...+.+|+.+++.+.| +|.         +.....
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34599999999999999999999999999999988622       2345689999998877 221         111111


Q ss_pred             EE------------ecCCCceeEEEEEEecccccHHHHHHHhh---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceee
Q 016158          144 FF------------STTDKEELYLNLVLEYVPETVNRIARNYS---RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR  208 (394)
Q Consensus       144 ~~------------~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~  208 (394)
                      +.            ..........+++|+++.++|.+++....   .....+++..+..++.||+.||+|||+ +||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence            10            00001122357889998899988876432   223457788889999999999999999 899999


Q ss_pred             cCCCCcEEEeCCCCcEEEEeecCccccccCCCCcccccccccccccccc---------CCCCCCchhhHHHHHHHHHHHH
Q 016158          209 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF---------GATEYTTAIDIWSTGCVMAELL  279 (394)
Q Consensus       209 Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll  279 (394)
                      ||||+|||++.++ .+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999988 6999999998765332  334566 9999999983         3344788999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCH
Q 016158          280 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  359 (394)
Q Consensus       280 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  359 (394)
                      ||+.||.+.+.......+                       +.          ....+++++.+||.+||+.||.+|||+
T Consensus       312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999765432111100                       00          013578999999999999999999999


Q ss_pred             HHHhcCCCCCCCC
Q 016158          360 LEACVHPFFDELR  372 (394)
Q Consensus       360 ~ell~hp~f~~~~  372 (394)
                      .++++||||+++.
T Consensus       359 ~~~l~~~~~~~~~  371 (413)
T 3dzo_A          359 LQAMETPEYEQLR  371 (413)
T ss_dssp             HHHTTSHHHHHHH
T ss_pred             HHHHhCHHHHHHH
Confidence            9999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.7e-43  Score=339.46  Aligned_cols=245  Identities=23%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ....+|++.+.||+|+||.||+|.+.  |+.||||++...  ...+.+|+.+++.++||||+++++++....    ...+
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence            34567999999999999999999985  789999998754  344568999999999999999999875432    2377


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  339 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence            99999975 8888776532  2347999999999999999999999 8999999999999999887 6999999999754


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+....+.....            
T Consensus       340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------  404 (450)
T 1k9a_A          340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------  404 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC------------
T ss_pred             ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            322  2233567889999999654 48999999999999999998 9999988776655554433110            


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                      ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       405 ----------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 ----------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            0122468999999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.5e-43  Score=327.55  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=198.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC-------CCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEec
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  147 (394)
                      ..+|++.+.||+|+||.||+|++.       .++..||||++....     ....+|+.+++.+ +||||+++++++.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence            457999999999999999999985       456789999986432     3356799999999 9999999999883  


Q ss_pred             CCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                         .....++||||+.+ +|.+++.....            ....+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus       112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  187 (334)
T 2pvf_A          112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  187 (334)
T ss_dssp             ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred             ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccce
Confidence               23347799999975 88887765331            12358999999999999999999999 899999999999


Q ss_pred             EEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016158          215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  290 (394)
                      ||++.++ .+||+|||++........   .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+...
T Consensus       188 Ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          188 VLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             EEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999887 699999999976543322   2234557889999998654 48999999999999999999 9999988776


Q ss_pred             HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+....+......                            ..+..++.++.+||.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 EELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5555444432100                            0124578999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-43  Score=328.97  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=198.7

Q ss_pred             cccccEEEeeEeeecCceEEEEEE----ECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ....+|++.+.||+|+||.||+|+    +..+++.||||++....    ..+.+|+++++.++|+||+++++++..   .
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence            344579999999999999999999    46788999999986432    335689999999999999999998753   2


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      .....++||||++ ++|.+++....   ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~~kl~Df  171 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-HVKIADF  171 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-CEEEccc
Confidence            3345789999996 58877776432   469999999999999999999999 8999999999999999887 7999999


Q ss_pred             cCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          230 GSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       230 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      |++........    .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||.........  ........+
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~  248 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERDVP  248 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----CC
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hcccccccc
Confidence            99986644332    2234568889999998654 4799999999999999999999998654321100  000000000


Q ss_pred             -hh-hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          306 -RE-EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       306 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                       .. .......+             .....+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       249 ~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          249 ALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             00 00000000             0001125689999999999999999999999999653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-43  Score=323.72  Aligned_cols=246  Identities=24%  Similarity=0.303  Sum_probs=189.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ..+.+|+.+++.++||||+++++++..     ..
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence            346999999999999999999999999999999986432       345679999999999999999998843     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~  181 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFGIA  181 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCCC-
T ss_pred             eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCccC
Confidence            47899999986 88777654    3679999999999999999999999 8999999999999999887 7999999998


Q ss_pred             cccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          233 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       233 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      .......  ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.... .+........ +      
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~-~------  252 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI-P------  252 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC-C------
T ss_pred             ccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC-C------
Confidence            7654332  22345689999999998654 4899999999999999999999999876543 2222222110 0      


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACV  364 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~ell~  364 (394)
                                        ........++.++.+||.+||+.||.+|| |++++++
T Consensus       253 ------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 ------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                              01112356899999999999999999999 8888775

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.1e-43  Score=319.04  Aligned_cols=246  Identities=28%  Similarity=0.385  Sum_probs=195.7

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECC---CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...+|++.+.||+|+||.||+|++..   ++..||+|++...     ...+.+|+.+++.++||||+++++++..    .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----C
Confidence            34579999999999999999998753   3456999998653     3445679999999999999999998721    1


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      .  .++||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        86 ~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg  158 (281)
T 3cc6_A           86 P--TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGDFG  158 (281)
T ss_dssp             S--CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECCCC
T ss_pred             C--CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCccC
Confidence            1  468999998 4787776542   3568999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          231 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       231 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ++........  .....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+......+   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---  234 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---  234 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---
T ss_pred             CCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---
Confidence            9976543321  2234557889999998654 48999999999999999998 999998777666555444321100   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                               .+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       235 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 -------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                     124578999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-43  Score=327.16  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=200.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEE-----CCCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      ..+|++.+.||+|+||.||+|++     ..+++.||||++....     ....+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            45799999999999999999985     4567899999986532     3455799999999 789999999988432  


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                        ....++||||+++ +|.+++......            ...+++..++.++.|++.||.|||+ .||+||||||+|||
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence              2336789999985 888877653321            1238899999999999999999999 89999999999999


Q ss_pred             EeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 016158          217 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  292 (394)
Q Consensus       217 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  292 (394)
                      ++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++||||||+++|+|+| |..||.+.....
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99887 6999999999765443322   234568889999998654 48999999999999999998 999998876554


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+...........                           .+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444433211100                           124578999999999999999999999999976

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-43  Score=347.26  Aligned_cols=248  Identities=20%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ....+|++.+.||+|+||.||+|++..++..||||++...   ...+.+|+.+++.++||||+++++++..     ...+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~  291 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF  291 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcE
Confidence            3456799999999999999999999988999999998653   3455689999999999999999998832     2336


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+. ++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  367 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRL  367 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEEC
T ss_pred             EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeeccccee
Confidence            79999998 58888776532  2568999999999999999999999 8999999999999999887 799999999986


Q ss_pred             cccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          235 LVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       235 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ......  .....+++.|+|||++... .++.++|||||||++|+|+| |..||.+.+..+....+.....         
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------  437 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------  437 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            543221  1223456789999998654 48999999999999999999 9999988776555444332110         


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                         ...+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus       438 -------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 -------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                               0112468899999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.3e-43  Score=320.00  Aligned_cols=243  Identities=26%  Similarity=0.351  Sum_probs=187.5

Q ss_pred             cccEEEe-eEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHH-HHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ..+|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.++||||+++++++.... ....+.++|
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv   93 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   93 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEE
Confidence            3458887 7899999999999999999999999998653 4456788887 6679999999999884322 235568899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC---CCCcEEEEeecCccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  234 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a~~  234 (394)
                      |||+++ +|.+++....  ...+++..++.++.|++.||+|||+ .||+||||||+|||++.   ++ .+||+|||++..
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~  169 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE  169 (299)
T ss_dssp             ECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred             EeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEeccccccc
Confidence            999975 8887776522  2469999999999999999999999 89999999999999997   45 799999999864


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..                      ...++.++|||||||++|+|++|+.||.+.........+..               
T Consensus       170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---------------  212 (299)
T 3m2w_A          170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---------------  212 (299)
T ss_dssp             CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---------------
T ss_pred             cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---------------
Confidence            31                      12378899999999999999999999976543221110000               


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                         ..   ......+.......+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       213 ---~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 ---RI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ---SS---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ---HH---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence               00   00000111111246799999999999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.4e-43  Score=317.03  Aligned_cols=245  Identities=19%  Similarity=0.317  Sum_probs=199.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++...   .....+|+++++.++||||+++++++..     ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence            346999999999999999999996 6788999998654   3456689999999999999999998833     233679


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEcccccccccc
Confidence            9999974 787776542   2568999999999999999999999 8999999999999999887 69999999987653


Q ss_pred             cCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ...  ......+++.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+.....           
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-----------  223 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----------  223 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred             cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence            221  12234557789999998654 48999999999999999999 8999988776665555433110           


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                       ...+..++..+.+||.+||+.||++|||+.+++++
T Consensus       224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             00123568899999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.5e-43  Score=322.03  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=194.8

Q ss_pred             cccEEEeeEeeecCceEEEEEE----ECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...|++.+.||+|+||.||+|+    +..+++.||||++....     ....+|+.+++.++||||+++++++...   .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            4469999999999999999999    56789999999986432     4456899999999999999999988532   2


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ...+++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECccc
Confidence            2347799999975 887776542   3569999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      ++........    .....+|..|+|||++.+.. ++.++||||||+++|+|++|..|+....     .......+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccc
Confidence            9987654432    22345688899999986544 8899999999999999999998864221     111111111110


Q ss_pred             hhh-----hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          307 EEI-----KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       307 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ...     ......             .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVNTLKEG-------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHhcc-------------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            000     000000             000123468999999999999999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=328.02  Aligned_cols=244  Identities=22%  Similarity=0.326  Sum_probs=189.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEE----EEEEecc-----chhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..+++.|    |+|.+..     ....+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            346999999999999999999998888766    5555532     234556899999999999999999988432    


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                       . .+++++|+.+ ++.+.+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        90 -~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~DfG  162 (327)
T 3lzb_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence             1 4578888774 776666542   3679999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          231 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       231 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +++........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---  238 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---  238 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            99866433222   233457789999999754 48999999999999999999 99999887766554443321100   


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                               ..+..++.++.+||++||+.||.+|||+.++++
T Consensus       239 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 -------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     012457889999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1e-43  Score=335.76  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=187.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC---CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|.+.+.||+|+||.||+|++.   .++..||||++...     ...+.+|+.+++.++||||+++++++.     ..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence            457999999999999999999986   46778999998643     234568999999999999999999883     23


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||++ ++|.+++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~  193 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGL  193 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcCcc
Confidence            34779999996 5887777542   3579999999999999999999999 8999999999999999888 699999999


Q ss_pred             ccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      ++........    ....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+......+  
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~--  270 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP--  270 (373)
T ss_dssp             --------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC--
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            9866433211    122346789999999654 48999999999999999998 999998877665554443311100  


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                .+..++..+.+||.+||+.||.+|||+.++++
T Consensus       271 --------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 --------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                      11357889999999999999999999998875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.8e-44  Score=330.65  Aligned_cols=255  Identities=18%  Similarity=0.221  Sum_probs=197.8

Q ss_pred             cccEEEeeEeeecCceEEEEEE-----ECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ..+|++.+.||+|+||.||+|+     +..+++.||||++...     .....+|+.+++.++||||+++++++..    
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence            4569999999999999999999     5567889999998532     2345579999999999999999998833    


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcE
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL  224 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~v  224 (394)
                       ....++||||++ ++|.+++......   ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++  ..+
T Consensus       105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcceE
Confidence             233679999995 5888877754321   1458999999999999999999999 8999999999999998433  269


Q ss_pred             EEEeecCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 016158          225 KLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       225 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~  300 (394)
                      ||+|||++.......   ......+++.|+|||++.+. .++.++||||||+++|+|+| |..||......+....+...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            999999987543322   22344668899999998654 48999999999999999998 99999887665554444331


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                      .. +                           ..+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus       262 ~~-~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          262 GR-M---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-C---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            10 0                           012457899999999999999999999999999988643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.9e-43  Score=337.99  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=201.2

Q ss_pred             CcccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        78 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .....+|.+.+.||+|+||.||+|.+. .+..||||++...   ...+.+|+.+++.++||||+++++++.    .+  .
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----~~--~  256 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT----KE--P  256 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC----SS--S
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe----CC--c
Confidence            334567999999999999999999985 4778999998653   345668999999999999999998872    11  2


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||+. ++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~  332 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLAR  332 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGG
T ss_pred             cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCce
Confidence            678999997 48888776432  2468899999999999999999999 8999999999999999887 79999999998


Q ss_pred             ccccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          234 VLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       234 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ......  ......+++.|+|||++... .++.++|||||||++|+|+| |+.||.+.+..+.+..+......+      
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------  405 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------  405 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------
T ss_pred             EcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            653221  11223457789999999654 48999999999999999999 999999887776666555421111      


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                            .+..+++++.+||.+||+.||++|||+++|++
T Consensus       406 ----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 ----------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                  12457899999999999999999999999976

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-43  Score=325.04  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=191.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC----cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|++.+.||+|+||.||+|++..++    ..||||++...     ...+.+|+.+++.++||||+++++++.     .
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----c
Confidence            446999999999999999999987553    45999998643     233457999999999999999999883     3


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ....++||||+++ +|.+++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg  192 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFG  192 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECCCC
Confidence            3347899999986 78777654   23679999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          231 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       231 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      ++........    .....+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+....+....+......+ 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-  270 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-  270 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-
T ss_pred             cchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC-
Confidence            9976543321    1123447789999999654 48999999999999999999 999998877665554443311000 


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                                 .+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       271 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          271 ---------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       123578999999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4e-43  Score=317.06  Aligned_cols=244  Identities=13%  Similarity=0.198  Sum_probs=197.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ..+|++.+.||+|+||.||+|++.  ++.||||++...      ...+.+|+.+++.++||||+++++++...   ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            456999999999999999999985  889999998643      23456799999999999999999988432   1234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      .++||||+++ +|.+++....  ...+++..++.++.|++.||+|||+ .|  |+||||||+|||++.++ .++|+|||+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~  159 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMADV  159 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGGGS
T ss_pred             eEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEeccc
Confidence            6799999985 8888776421  2358999999999999999999999 89  99999999999999887 699999998


Q ss_pred             ccccccCCCCccccccccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          232 AKVLVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       232 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      +...    ......+|+.|+|||.+.+...  ++.++||||||+++|+|++|+.||.+.........+......+     
T Consensus       160 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----  230 (271)
T 3kmu_A          160 KFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-----  230 (271)
T ss_dssp             CCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred             eeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-----
Confidence            7543    2234567999999999975432  3338999999999999999999998887766655554421111     


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                            .++..+++++.+||.+||+.||.+|||+.++++
T Consensus       231 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 ----------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  122568999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.5e-43  Score=319.12  Aligned_cols=247  Identities=20%  Similarity=0.285  Sum_probs=186.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|++.   ..||+|++...      ...+.+|+.+++.++|+||++++++..    .  ..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~--~~   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST----A--PQ   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----S--SS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc----C--Cc
Confidence            346999999999999999999874   35999988532      234568999999999999999988541    1  12


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        94 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~  168 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFGLAT  168 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC---
T ss_pred             cEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEccceecc
Confidence            5689999984 66655532   23679999999999999999999999 8999999999999999887 79999999997


Q ss_pred             ccccC---CCCcccccccccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          234 VLVKG---EPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       234 ~~~~~---~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .....   .......+|+.|+|||++.  ....++.++||||||+++|+|++|+.||.+....+.+..+.......+.  
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  246 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD--  246 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC--
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc--
Confidence            55321   2223456899999999985  2344788999999999999999999999987777666665543221110  


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                           ...+...+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 ---------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ---------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                 00112467899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-43  Score=326.62  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=188.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHHc--CCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ++|++.+.||+|+||.||+|++.  |+.||||++.... ....+|.+++..+  +||||+++++++.... ......++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence            46999999999999999999985  8999999986543 2334566665554  9999999999885543 222457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------CceeecCCCCcEEEeCCCCcEEEEee
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--------givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      |||+.+ +|.+++..     ..+++..++.++.|++.||.|||+ .        ||+||||||+|||++.++ .+||+||
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            999975 88887754     579999999999999999999998 7        999999999999999888 7999999


Q ss_pred             cCccccccCCCC-----ccccccccccccccccCCCCCCc------hhhHHHHHHHHHHHHhC----------CCCCCCC
Q 016158          230 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLG----------QPLFPGE  288 (394)
Q Consensus       230 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~~lltg----------~~pf~~~  288 (394)
                      |++.........     ....||+.|+|||++.+.. ...      ++|||||||++|+|+||          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433222     2457899999999996544 333      49999999999999999          6677543


Q ss_pred             Cc----HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          289 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       289 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..    ............                     .............+++++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKK---------------------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSC---------------------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhc---------------------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            22    122222211100                     00000011112346778999999999999999999999987


Q ss_pred             C
Q 016158          365 H  365 (394)
Q Consensus       365 h  365 (394)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-44  Score=334.95  Aligned_cols=260  Identities=20%  Similarity=0.243  Sum_probs=195.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ++|++.+.||+|+||.||+|++ .+|+.||||++...    ...+.+|+.+++.++||||+++++++.     .....++
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l  112 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNEMIL  112 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTCCEE
T ss_pred             hccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEEE
Confidence            4599999999999999999997 46899999987543    234568999999999999999999873     2233679


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++.........+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISKKGT  190 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCEECS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence            9999975 7765554332223468999999999999999999999 8999999999999999887 79999999997643


Q ss_pred             cCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HH-HHHhCCCChhhhh
Q 016158          237 KGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EI-IKVLGTPTREEIK  310 (394)
Q Consensus       237 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~i-~~~~~~~~~~~~~  310 (394)
                      ...   ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+...  .. .....        
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--------  261 (321)
T 2qkw_B          191 ELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN--------  261 (321)
T ss_dssp             SSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT--------
T ss_pred             cccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc--------
Confidence            221   12334579999999998654 48999999999999999999999997654322111  00 00000        


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                        ..     .+...........+....+..+.+++.+||+.||++|||+.++++|
T Consensus       262 --~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          262 --NG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             --TT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --cc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              00     0000000111112234456789999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.9e-43  Score=318.05  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=191.9

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ...+|++.+.||+|+||.||+|.+.  |+.||||++...  ...+.+|+.+++.++||||+++++++...    ....++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~l   92 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI   92 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceEE
Confidence            3457999999999999999999884  889999998654  34456899999999999999999987432    224679


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++.....  ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  168 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred             EEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeecccccccc
Confidence            9999986 88887765322  348899999999999999999999 8999999999999999887 79999999987543


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..  .....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||......+....+....              
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------------  231 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  231 (278)
T ss_dssp             ---------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred             cc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            32  2234568889999998654 48999999999999999998 999998776555444332210              


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                    ....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       232 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 --------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                          00122467999999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-43  Score=317.68  Aligned_cols=245  Identities=26%  Similarity=0.326  Sum_probs=196.9

Q ss_pred             cccEEEee-EeeecCceEEEEEEEC--CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|.+.+ .||+|+||.||+|.+.  .++..||||++...     .....+|+++++.++||||+++++++ ...    
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~----   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE----   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence            34577776 9999999999999864  46788999998652     23456799999999999999999987 211    


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                       ..++||||+++ +|.+++..   ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus        83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~  156 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGL  156 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECcccc
Confidence             16799999986 77666542   23569999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      +........    .....+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+.... .   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~---  231 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-R---  231 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-C---
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-c---
Confidence            986643322    1223457889999998644 48999999999999999998 999998877666554443310 0   


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                              ..++..+++++.+||.+||+.||.+|||+.++++|
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    01224689999999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-42  Score=317.72  Aligned_cols=243  Identities=23%  Similarity=0.300  Sum_probs=194.6

Q ss_pred             cccEEEee-EeeecCceEEEEEEE--CCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEH-VVGTGSFGVVFQAKC--RETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||||++...      ...+.+|+.+++.++||||+++++++ ...   
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~---   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE---   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence            34699998 999999999999954  567789999998643      23456899999999999999999987 211   


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                        ..++||||+. ++|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccCC
Confidence              2679999998 477776654    3569999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          231 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       231 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      ++.........    ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.... .+ 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~-  239 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM-  239 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC-
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC-
Confidence            99766443321    1233468899999986544 8899999999999999999 999998877655444433210 00 


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                .++..+++.+.+||.+||+.||.+|||+.++++
T Consensus       240 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 --------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      012467999999999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.2e-43  Score=340.28  Aligned_cols=249  Identities=20%  Similarity=0.220  Sum_probs=197.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++|++.++||+|+||.||+|++..+++.||||++..  ....+.+|+++++.+.|.+.+..+..+..    ...+.++||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lvm   82 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLVM   82 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEEE
Confidence            469999999999999999999999999999998753  33456789999999988665555444432    233478999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEE---eCCCCcEEEEeecCccccc
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~---~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||++++|.+++...   ...+++..++.++.||+.||+|||+ +||+||||||+||||   +.++ .+||+|||+++...
T Consensus        83 e~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~  157 (483)
T 3sv0_A           83 DLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYR  157 (483)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             ECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCcceecc
Confidence            99988998887642   3679999999999999999999999 899999999999999   4555 79999999998765


Q ss_pred             cCCCC--------ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 016158          237 KGEPN--------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPT  305 (394)
Q Consensus       237 ~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~  305 (394)
                      .....        ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....   ..+..+........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            43321        256789999999999655 4899999999999999999999999876543   23333322111111


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .                        ..+...++.++.+||.+||+.||.+||++.+|++
T Consensus       237 ~------------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 I------------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             H------------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             H------------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1                        1122467999999999999999999999987763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=329.31  Aligned_cols=282  Identities=21%  Similarity=0.288  Sum_probs=193.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh-hhHHHHHH--HHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQI--MQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .++|++.+.||+|+||.||+|++  +++.||||++..... ....|.++  +..++|+||+++++.+..........+++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            45699999999999999999987  589999999864432 22334444  44589999999998776555555667789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------CceeecCCCCcEEEeCCCCcEEEE
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------GICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---------givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                      ||||+++ +|.+++..     ...++..++.++.||+.||+|||+ .         ||+||||||+|||++.++ .+||+
T Consensus        90 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~  162 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVIS  162 (336)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEEEC
T ss_pred             EEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEEEe
Confidence            9999964 88887754     556889999999999999999998 8         999999999999999887 79999


Q ss_pred             eecCccccccCC---------CCccccccccccccccccCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-H
Q 016158          228 DFGSAKVLVKGE---------PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLLGQPLFPGESG-V  291 (394)
Q Consensus       228 Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~  291 (394)
                      |||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||..... .
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999997654321         12245689999999998652      2356789999999999999999766543221 1


Q ss_pred             HHHHHHHH-HhCCCChhhhhcc-CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHH------h
Q 016158          292 DQLVEIIK-VLGTPTREEIKCM-NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------C  363 (394)
Q Consensus       292 ~~~~~i~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l  363 (394)
                      .....+.. ....+........ ........++.    .+..  ...+++++.+||.+||+.||++|||+.|+      +
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            11001111 1111111111100 00000001110    0000  01245689999999999999999999999      4


Q ss_pred             cCCCCCCCCCCCCC
Q 016158          364 VHPFFDELRDPNTR  377 (394)
Q Consensus       364 ~hp~f~~~~~~~~~  377 (394)
                      .++|-++...+-++
T Consensus       317 l~~~~~~~~~~~~~  330 (336)
T 3g2f_A          317 MMIWERNKSVSPTA  330 (336)
T ss_dssp             HHCCCC--------
T ss_pred             HHHHHhcccCCCcc
Confidence            57888876655443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-42  Score=314.62  Aligned_cols=245  Identities=22%  Similarity=0.313  Sum_probs=198.1

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++...   ...+.+|+++++.++||||+++++++.    .+  ..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~~--~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT----QE--PIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC----SS--SCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc----CC--CcE
Confidence            3457999999999999999999985 5678999998653   345568999999999999999998872    11  156


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+. ++|.+++....  ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence            8999996 58877665422  2479999999999999999999999 8999999999999999887 6999999999766


Q ss_pred             ccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .....  .....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.||.+....+....+.....          
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------  228 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence            43321  1233457789999998644 48999999999999999999 9999988776665554433110          


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                        ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              0112467899999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.9e-45  Score=361.89  Aligned_cols=284  Identities=25%  Similarity=0.334  Sum_probs=206.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  155 (394)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+++++.++||||+++++++..... ......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4699999999999999999999999999999987643     2345679999999999999999887632111 113446


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC--cEEEEeecCc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA  232 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~--~vkl~Dfg~a  232 (394)
                      ++||||++ ++|.+++.... ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++.  .+||+|||++
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            79999996 48877766422 12368999999999999999999999 89999999999999997653  3899999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .............+|+.|+|||.+.+. .++.++||||||+++|+|++|..||.+..........   ............
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~  247 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVY  247 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSC
T ss_pred             cccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhh
Confidence            877666555667889999999998654 5899999999999999999999999775433211100   000000000000


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      ........+...  .+....+...+++.+.+||.+||++||++|||+.++++||||+++.+
T Consensus       248 ~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          248 DDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            000011111111  11122234557889999999999999999999999999999988543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-42  Score=317.16  Aligned_cols=246  Identities=21%  Similarity=0.314  Sum_probs=193.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ..+|++.+.||+|+||.||+|++..++   ..||+|.+...     .....+|+.+++.++||||+++++++...    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            346999999999999999999975433   45899987642     23455799999999999999999986432    2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECcccc
Confidence            236789999986 88777653   23668999999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCC-----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          232 AKVLVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       232 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      +.......     ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |.+||.+....+....+......  
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--  251 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--  251 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC--
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC--
Confidence            97653322     12334567889999999654 48999999999999999999 66777776655555444331110  


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                ..+..++..+.+||.+||+.||.+|||+.++++
T Consensus       252 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          252 --------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      112457899999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-42  Score=336.61  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=198.7

Q ss_pred             cccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ....+|++.+.||+|+||.||+|.+.. +..||||++...   ...+.+|+.+++.++||||+++++++..      ...
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            345679999999999999999999964 567999998653   3456789999999999999999998722      126


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+.+ +|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~  329 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARL  329 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred             EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCcccee
Confidence            789999975 8887775422  3568999999999999999999999 8999999999999999887 699999999976


Q ss_pred             cccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          235 LVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       235 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ......  .....+++.|+|||.+... .++.++||||||+++|+|++ |+.||.+....+.+..+......        
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------  400 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------  400 (452)
T ss_dssp             -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred             cCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            543221  1233457789999998654 48999999999999999999 99999988776655554332110        


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  370 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~  370 (394)
                                          ..+..+++.+.+||.+||+.||++|||++++++  ..++..
T Consensus       401 --------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 --------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                                012467899999999999999999999999987  345543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=317.07  Aligned_cols=254  Identities=28%  Similarity=0.414  Sum_probs=192.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      .+|++.+.||+|+||.||+|++.  ++.||||++...  ...+.+|+.+++.++||||+++++++.     +.  .++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEEE
Confidence            46999999999999999999985  788999998654  344568999999999999999988762     22  56899


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||+++ +|.+++.... ....+++..++.++.|++.||+|||+.  +||+||||||+|||++.++..+||+|||++....
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             ECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99975 8877776422 123578899999999999999999972  4899999999999999887558999999997553


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..  .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||........ ...... .+..           
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~-----------  222 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTR-----------  222 (307)
T ss_dssp             ---------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCC-----------
T ss_pred             cc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCC-----------
Confidence            22  2345689999999999654 489999999999999999999999976543221 111111 0100           


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc-----CCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPN  375 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-----hp~f~~~~~~~  375 (394)
                                     ..+...++..+.+||.+||+.||.+|||+.++++     .+++.....+.
T Consensus       223 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          223 ---------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             ---------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             ---------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence                           0112467899999999999999999999999987     35665554443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-42  Score=313.71  Aligned_cols=246  Identities=21%  Similarity=0.306  Sum_probs=193.0

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCc---EEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...|.+.++||+|+||.||+|++..+++   .||+|++....     ..+.+|+.+++.++||||+++++++....    
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            4468999999999999999999765554   79999886422     34457999999999999999999884322    


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...+++|||+. ++|.+++..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~  170 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADFGL  170 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCTTS
T ss_pred             CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcCCC
Confidence            22468999986 577776654   24678999999999999999999999 8999999999999999887 699999999


Q ss_pred             ccccccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCC
Q 016158          232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      +......     .......+++.|+|||.+.+. .++.++||||||+++|+|++|. +||...+..+....+......  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--  247 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL--  247 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--
Confidence            9754322     222345668899999999654 4899999999999999999955 555555544444433321100  


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       248 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 --------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                      012457899999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-43  Score=329.86  Aligned_cols=247  Identities=20%  Similarity=0.300  Sum_probs=187.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...|.+.+.||+|+||.||+|++..++   ..||+|.+...     ...+.+|+.+++.++||||+++++++....    
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----  163 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----  163 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----
Confidence            346999999999999999999975432   46899987542     234567999999999999999999874322    


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++||||+++ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DFG~  238 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL  238 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeeccc
Confidence            235789999985 88777653   23568899999999999999999999 8999999999999999887 799999999


Q ss_pred             ccccccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          232 AKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       232 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      ++.......     .....+++.|+|||++.+. .++.++|||||||++|+|+| |.+||.+.+..+....+.....   
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~---  314 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  314 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC---
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC---
Confidence            976533221     1234567889999998654 48999999999999999999 7788887665554444332110   


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                               ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       315 -------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     00124578999999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-42  Score=340.25  Aligned_cols=245  Identities=24%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++...   ...+.+|+++|+.++|+||+++++++..      ...+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            45679999999999999999999964 567999998653   2456789999999999999999998722      1267


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+.+ +|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence            99999985 8887775422  3568999999999999999999999 8999999999999999887 6999999999765


Q ss_pred             ccCC--CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ....  ......++..|+|||++... .++.++|||||||++|+|++ |+.||.+....+.+..+......         
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  483 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  483 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            3211  11233457789999998654 48999999999999999999 99999888766655554331100         


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                         ..+..++..+.+||.+||+.||++|||+++|++
T Consensus       484 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          484 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                               012467899999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-42  Score=319.12  Aligned_cols=256  Identities=21%  Similarity=0.273  Sum_probs=194.8

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      |...+.||+|+||.||+|.+  +++.||||++...        ...+.+|+.+++.++||||+++++++..     ....
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCce
Confidence            66678999999999999987  5889999988542        2345689999999999999999998832     2336


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||++ ++|.+++.... ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  182 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDFGLARA  182 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence            79999996 58877776432 24569999999999999999999999 8999999999999999887 799999999876


Q ss_pred             cccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          235 LVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       235 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      ......   .....||+.|+|||.+.+  .++.++||||||+++|+|++|..||........+..+..............
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            543222   223568999999999854  479999999999999999999999987654433333332221111100000


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .....              .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       261 ~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          261 IDKKM--------------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCSSC--------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccccc--------------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00000              00113356789999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.6e-42  Score=315.14  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=188.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-CCc--EEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ..+|++.+.||+|+||.||+|++.. +++  .||||++...       ...+.+|+.+++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3469999999999999999998643 333  6899987532       23445799999999999999999988321   


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                       .  .++||||+. ++|.+.+...   ...+++..++.++.|++.||.|||+ .||+|+||||+|||++.++ .+||+||
T Consensus        94 -~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           94 -P--MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             -S--CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -C--ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEccc
Confidence             1  568999998 4777766542   3568999999999999999999999 8999999999999999887 7999999


Q ss_pred             cCccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          230 GSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       230 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      |++.........    ....+++.|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+.+..+.......
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL  244 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence            999776443321    233457789999998654 47899999999999999999 999998887666555543311100


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                 .....++.++.++|.+||+.||.+|||+.++++
T Consensus       245 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                       012467899999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-42  Score=320.00  Aligned_cols=246  Identities=26%  Similarity=0.370  Sum_probs=191.3

Q ss_pred             EEEeeEeeecCceEEEEEEE----CCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      |++.+.||+|+||.||++.+    ..+++.||||++...     ...+.+|+++++.++||||+++++++....   ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence            59999999999999988764    457899999998653     234568999999999999999999885432   345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +++||||+++ +|.+++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCccccc
Confidence            7899999975 77766643     569999999999999999999999 8999999999999999887 79999999998


Q ss_pred             ccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----------HHHHHH
Q 016158          234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-----------QLVEII  298 (394)
Q Consensus       234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-----------~~~~i~  298 (394)
                      .......    .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.......           ....+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            7654332    22345678899999996544 8899999999999999999999996532110           011111


Q ss_pred             HHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..+.           ..             .....+..+++++.+||++||+.||.+|||+.++++
T Consensus       262 ~~~~-----------~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          262 ELLE-----------RG-------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHH-----------TT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHh-----------cc-------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1100           00             000122568899999999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.9e-42  Score=320.67  Aligned_cols=253  Identities=21%  Similarity=0.226  Sum_probs=193.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHH--cCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|++.+.||+|+||.||+|++  +|+.||||++... .....+|.+++..  ++||||+++++++.... ......++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            4699999999999999999998  4899999998654 3344678888888  79999999999885433 122357899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      |||+++ +|.+++..     ..+++..++.++.|++.||+|||        + .||+||||||+|||++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999986 88887754     57999999999999999999999        7 8999999999999999888 7999999


Q ss_pred             cCccccccCCC-----CccccccccccccccccCCCC-----CCchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 016158          230 GSAKVLVKGEP-----NVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLG----------QPLFPGES  289 (394)
Q Consensus       230 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~~  289 (394)
                      |++........     .....+|+.|+|||++.+...     ++.++|||||||++|+|+||          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99976644432     234568999999999865432     23689999999999999999          77886643


Q ss_pred             c----HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          290 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       290 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .    ...+..........                     ...........++..+.+||.+||+.||++|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLR---------------------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCC---------------------CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhC---------------------CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2    12222211100000                     0000001112345689999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=324.19  Aligned_cols=243  Identities=16%  Similarity=0.174  Sum_probs=188.4

Q ss_pred             cccEEEeeEeeecCceEEEEE-----EECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC---CCceeeeceEEEecCCCc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQA-----KCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  151 (394)
                      ..+|.+.+.||+|+||.||+|     .+..+++.||||++... .....+|+++++.+.   |+||+.+++++....   
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~---  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN---  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS---
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC---
Confidence            346999999999999999999     46778999999998654 344567888888887   899999999884433   


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC----------
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----------  219 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~----------  219 (394)
                        ..++||||++ ++|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.          
T Consensus       141 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 --GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             --CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred             --CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence              3679999998 588888876544 24679999999999999999999999 89999999999999987          


Q ss_pred             -CCCcEEEEeecCcccccc---CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 016158          220 -HTHQLKLCDFGSAKVLVK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  295 (394)
Q Consensus       220 -~~~~vkl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  295 (394)
                       ++ .+||+|||+|+....   ........||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.......   
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence             56 799999999965432   22234567899999999997654 8999999999999999999999996432210   


Q ss_pred             HHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       296 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                             +........       ...++.+.+++..||+.+|.+|++..+.+.
T Consensus       293 -----------------------~~~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          293 -----------------------CKPEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             -----------------------EEECSCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             -----------------------eeechhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                                   000000000       123567889999999999999975544443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-42  Score=317.19  Aligned_cols=259  Identities=26%  Similarity=0.420  Sum_probs=195.2

Q ss_pred             cccccEEEeeEeeecCceEEEEEE----ECCCCcEEEEEEeccch----hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           79 KQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        79 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      ....+|++.+.||+|+||.||+|+    +..+|+.||||++....    ..+.+|+.+++.++||||+++++++...   
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence            344579999999999999999999    45689999999986432    3456899999999999999999987432   


Q ss_pred             ceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEee
Q 016158          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  229 (394)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Df  229 (394)
                      .....++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecC
Confidence            22346799999975 887777642   2568999999999999999999999 8999999999999999887 7999999


Q ss_pred             cCccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          230 GSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       230 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      |++........    .....++..|+|||.+.+.. ++.++||||||+++|+|+||..||....  ..+   .+..+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~~~---~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--AEF---MRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHH---HHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--HHH---HHhhcccc
Confidence            99987644332    12334577899999986544 8999999999999999999998886421  111   11111111


Q ss_pred             hhh------hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REE------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ...      .......   .          ....+..++.++.+||.+||+.||++|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~---~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNN---G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CTHHHHHHHHHHHHTT---C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHHHHhhcC---C----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            000      0000000   0          00112467899999999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-41  Score=340.22  Aligned_cols=240  Identities=23%  Similarity=0.302  Sum_probs=191.3

Q ss_pred             EEE-eeEeeecCceEEEEEEE--CCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           84 YIA-EHVVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~-~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      +.+ .+.||+|+||.||+|.+  ..+++.||||++....      ..+.+|+++++.++||||+++++++..     .. 
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~-  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES-  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS-
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC-
Confidence            444 35899999999999955  4567899999986432      345689999999999999999998721     11 


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            5699999985 77776643    4679999999999999999999999 8999999999999999887 79999999998


Q ss_pred             ccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          234 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       234 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......     
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----  591 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----  591 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            6644322    1223457889999999654 48999999999999999998 99999988776655554432100     


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                             ..+..+++++.+||.+||+.||++|||+.+|++
T Consensus       592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                   012468999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=339.33  Aligned_cols=243  Identities=26%  Similarity=0.319  Sum_probs=192.4

Q ss_pred             ccEEEee-EeeecCceEEEEEEEC--CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++.+.+ .||+|+||.||+|.++  .++..||||++...     ...+.+|+++++.++||||+++++++..    +  
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~--  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----E--  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----S--
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----C--
Confidence            3466665 8999999999999875  35567999998642     3455689999999999999999998732    1  


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+.+ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla  483 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLS  483 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred             CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence            16799999985 67666543   23569999999999999999999999 8999999999999999887 7999999999


Q ss_pred             cccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      +........    ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.....     
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----  557 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  557 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            866433221    122346789999999654 48999999999999999998 9999998887766655543110     


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                             ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus       558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                   0122468999999999999999999999998853

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9e-44  Score=331.86  Aligned_cols=248  Identities=17%  Similarity=0.161  Sum_probs=184.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------------hhhHHHHHHHHHcC---------CCceee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD---------HPNIVA  139 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~~iv~  139 (394)
                      ..+|++.+.||+|+||.||+|++  +|+.||||++....            ....+|+.+++.++         |+||+.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            34699999999999999999998  68999999986542            45578999999885         777777


Q ss_pred             eceEEEecCC-------------------------CceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHH
Q 016158          140 LKHCFFSTTD-------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQIC  193 (394)
Q Consensus       140 ~~~~~~~~~~-------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~  193 (394)
                      +.+++.....                         ......++||||+.+ ++.+.+.     ...+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence            7666532110                         013457899999875 3433221     26789999999999999


Q ss_pred             HHHHHHH-hCCCceeecCCCCcEEEeCCC-------------------CcEEEEeecCccccccCCCCcccccccccccc
Q 016158          194 RALAYIH-NCIGICHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP  253 (394)
Q Consensus       194 ~al~~LH-~~~givH~Dlkp~Nil~~~~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aP  253 (394)
                      .||+||| + +||+||||||+|||++.++                   ..+||+|||+|+....    ....||+.|+||
T Consensus       172 ~aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aP  246 (336)
T 2vuw_A          172 ASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCS
T ss_pred             HHHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccCh
Confidence            9999999 8 8999999999999999775                   1699999999986643    245789999999


Q ss_pred             ccccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccc
Q 016158          254 ELIFGATEYTTAIDIWSTGCV-MAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  331 (394)
Q Consensus       254 E~~~~~~~~~~~~DiwslG~i-l~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (394)
                      |++.+..  +.++|||||+++ .+++++|..||.+..... ....+........                      ....
T Consensus       247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~  302 (336)
T 2vuw_A          247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT----------------------KCNT  302 (336)
T ss_dssp             GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------------------CCCS
T ss_pred             hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------------------ccch
Confidence            9996543  889999998777 777888999984321111 1112221100000                      0001


Q ss_pred             cccccCCHHHHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q 016158          332 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC-VHPFFD  369 (394)
Q Consensus       332 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell-~hp~f~  369 (394)
                      .....+++++++||++||++|     |++|+| +||||+
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            122457889999999999987     999999 999996

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=314.67  Aligned_cols=252  Identities=18%  Similarity=0.249  Sum_probs=193.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .+|++.+.||+|+||.||+|++..   .||+|++...      ...+.+|+.+++.++|+||+++++++...     ...
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  104 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PHL  104 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----SCE
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----Cce
Confidence            459999999999999999999853   4999988542      23345799999999999999999988433     237


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +++|||+.+ +|.+++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++ ++ .+||+|||++..
T Consensus       105 ~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~  178 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLFSI  178 (319)
T ss_dssp             EEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred             EEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCccc
Confidence            899999974 77666543   23468999999999999999999999 8999999999999998 55 699999999865


Q ss_pred             ccc------CCCCccccccccccccccccC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 016158          235 LVK------GEPNVSYICSRYYRAPELIFG--------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  300 (394)
Q Consensus       235 ~~~------~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~  300 (394)
                      ...      ........+++.|+|||++.+        ...++.++||||||+++|+|++|+.||...........+...
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  258 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG  258 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence            421      122233457899999999864        234788999999999999999999999887766555444331


Q ss_pred             hCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ....                           .....++.++.+||.+||+.||.+|||+.++++  .|+++.....
T Consensus       259 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~  305 (319)
T 2y4i_B          259 MKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNR  305 (319)
T ss_dssp             CCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-----
T ss_pred             CCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhc
Confidence            1000                           011357889999999999999999999999997  5666554433

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-40  Score=335.70  Aligned_cols=245  Identities=27%  Similarity=0.353  Sum_probs=196.6

Q ss_pred             ccccEEEeeEeeecCceEEEEEEECCC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ...+|++.+.||+|+||.||+|++..+   +..||||++....     ..+.+|+.+++.++||||+++++++.    .+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----EN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence            456799999999999999999998654   4679999875432     34567999999999999999999872    11


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                        ..++||||+. ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       464 --~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DFG  536 (656)
T 2j0j_A          464 --PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFG  536 (656)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             --ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEecC
Confidence              2578999998 5887776542   3468999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          231 SAKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       231 ~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      +++........  ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+......    
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----  611 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----  611 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            99866433221  223457889999999654 48999999999999999997 99999988777666665442110    


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                              .++..+++.+.+||.+||+.||.+|||+.++++
T Consensus       612 ------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    012467899999999999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-41  Score=343.68  Aligned_cols=242  Identities=25%  Similarity=0.351  Sum_probs=195.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||.||+|++.. +|+.||||++...     ...+.+|+.+++.++||||+++++++.........+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3579999999999999999999976 7899999988542     123457999999999999999999987665545556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .|+||||+++ +|.+.+.      ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+  .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccch
Confidence            7899999985 5544332      479999999999999999999999 899999999999999964  69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|..||.+.....                     
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------  283 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------  283 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------
T ss_pred             hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc---------------------
Confidence            65433   456789999999998643  4899999999999999999998886421100                     


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                             ++.       .......++.+.+||.+||+.||.+||+..+.+.|+|+..+
T Consensus       284 -------~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 -------LPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------CCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------ccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                   000       00001246789999999999999999999999999988643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.8e-39  Score=293.54  Aligned_cols=225  Identities=13%  Similarity=0.059  Sum_probs=175.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....       ..+.+|+.+++.++||||+++++++..     ...
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence            45999999999999999999999999999999986432       345679999999999999999998843     234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .|+||||+++ +|.+++.      .......+..++.||+.||+|||+ +||+||||||+|||++.++ .+||++++   
T Consensus       106 ~~lv~e~~~g~~L~~~l~------~~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~---  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPA---  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHT------TCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCC---
T ss_pred             EEEEEEecCCCCHHHHHh------cCCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEecc---
Confidence            7899999974 7777653      234566788899999999999999 8999999999999999888 69987443   


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                                      |++        .++.++|||||||++|+|+||+.||.+.+....+.....              
T Consensus       175 ----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~--------------  216 (286)
T 3uqc_A          175 ----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER--------------  216 (286)
T ss_dssp             ----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB--------------
T ss_pred             ----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH--------------
Confidence                            332        278999999999999999999999987653221100000              


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                             ... ........+...+++++.+||.+||+.||.+| |+.++++  .++++
T Consensus       217 -------~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~  263 (286)
T 3uqc_A          217 -------DTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQA  263 (286)
T ss_dssp             -------CTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred             -------Hhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHH
Confidence                   000 00011112335689999999999999999999 9999987  44443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.2e-32  Score=270.77  Aligned_cols=178  Identities=17%  Similarity=0.077  Sum_probs=123.3

Q ss_pred             EeeecCceEEEEEEECCCCcEEEEEEeccc--------------hhhhHHHHHHHHHc-CCCceeeeceEEEecCCCcee
Q 016158           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ..+.|+.|.+..++....|+.||+|++.+.              ...+.+|+++|+++ .|+||+++++++     .+..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            367788888888888888999999998542              13456799999999 799999999988     4445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..||||||++| +|.+++..    ...+++.   .|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccC
Confidence            58899999997 77777654    3566654   478899999999999 8999999999999999988 6999999999


Q ss_pred             cccccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 016158          233 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  282 (394)
Q Consensus       233 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  282 (394)
                      +..... ....+.+||+.|+|||++.+  .+..++|+||+|++++++.++.
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            876443 23445689999999999965  3677899999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=3.1e-27  Score=232.67  Aligned_cols=179  Identities=17%  Similarity=0.249  Sum_probs=132.4

Q ss_pred             EEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        85 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      ...++||+|+||.||+|..  .++.+++|+....            ...+.+|+++++.++||||+++..++.....   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            4567899999999999954  4788999975321            1224689999999999999965554443222   


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                        .++||||++ ++|.+++..            +..++.|++.||+|||+ +||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence              479999997 577665543            45789999999999999 89999999999999997   599999999


Q ss_pred             ccccccCCCC--------ccccccccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 016158          232 AKVLVKGEPN--------VSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFP  286 (394)
Q Consensus       232 a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~  286 (394)
                      ++........        ....||+.|+|||++... ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9876443221        245789999999999541 237788899999998888888776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.3e-24  Score=194.07  Aligned_cols=137  Identities=18%  Similarity=0.170  Sum_probs=108.8

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----------------------hhhhHHHHHHHHHcCCCceeeec
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------------------KRYKNRELQIMQMLDHPNIVALK  141 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~E~~~l~~l~h~~iv~~~  141 (394)
                      |.+.+.||+|+||.||+|++ .+|+.||||++...                      .....+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55669999999999999999 88999999998532                      223568999999999  5 6666


Q ss_pred             eEEEecCCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC
Q 016158          142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (394)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~  220 (394)
                      +++..      ...++||||+++ +|.+ +          .......++.|++.||.|||+ .||+||||||+|||++ +
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T
T ss_pred             eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-C
Confidence            65521      224799999986 6643 1          123345689999999999999 8999999999999999 7


Q ss_pred             CCcEEEEeecCccccccCCCCccccccccccccccc
Q 016158          221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI  256 (394)
Q Consensus       221 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~  256 (394)
                      + .+||+|||+|+.            +..++|||.+
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l  251 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREIL  251 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHH
Confidence            6 799999999864            3347888887

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.6e-21  Score=174.20  Aligned_cols=135  Identities=17%  Similarity=0.238  Sum_probs=102.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcE--EEEEEeccch----------------------------hhhHHHHHHHHHc
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK----------------------------RYKNRELQIMQML  132 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l  132 (394)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            388999999999999999999778999  9999864321                            1356799999999


Q ss_pred             CCCceeeeceEEEecCCCceeEEEEEEecccc------cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCc
Q 016158          133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCIGI  205 (394)
Q Consensus       133 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~gi  205 (394)
                      .|+++... ..+..      ...++||||+++      .+.+...       ..++..+..++.|++.||.||| + .||
T Consensus       128 ~~~~i~~p-~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYTY------MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL  192 (258)
T ss_dssp             HHTTCCCC-CEEEE------ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred             HhCCCCCC-eEEEc------CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            88765221 11211      114689999953      4443321       1234567788999999999999 8 899


Q ss_pred             eeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       206 vH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999996   5999999999653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=6.8e-18  Score=156.91  Aligned_cols=132  Identities=12%  Similarity=0.137  Sum_probs=92.4

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchh--------------------------hhHHHHHHHHHcCCCce
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------YKNRELQIMQMLDHPNI  137 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~E~~~l~~l~h~~i  137 (394)
                      |.+.+.||.|+||.||+|.+. +|+.||||+++....                          ...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            999999999999999999984 699999998642110                          01235566666644443


Q ss_pred             eeeceEEEecCCCceeEEEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          138 VALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       138 v~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                      ... ..+...  .    .++||||++|. +.+          -........++.||+.+|.+||+ .|||||||||.|||
T Consensus       176 ~vp-~p~~~~--~----~~LVME~i~G~~L~~----------l~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          176 PVP-EPIAQS--R----HTIVMSLVDALPMRQ----------VSSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNIL  237 (397)
T ss_dssp             SCC-CEEEEE--T----TEEEEECCSCEEGGG----------CCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred             CCC-eeeecc--C----ceEEEEecCCccHhh----------hcccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEE
Confidence            211 111111  1    25899999873 311          11222345678999999999999 89999999999999


Q ss_pred             EeCCCC---------cEEEEeecCccc
Q 016158          217 VNPHTH---------QLKLCDFGSAKV  234 (394)
Q Consensus       217 ~~~~~~---------~vkl~Dfg~a~~  234 (394)
                      ++.++.         .+.|+||+-+-.
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EeCCCCcccccccccceEEEEeCCccc
Confidence            987652         289999997743

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=1.4e-11  Score=109.84  Aligned_cols=134  Identities=14%  Similarity=0.095  Sum_probs=98.6

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc----chhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .|++...++.|+.+.||++...  ++.+++|+...    ....+.+|+++++.+. +..+.++++++.     .....++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence            4889999999999999999753  67899998763    3345788999999985 556667776652     2234679


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------  202 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----------------------------------  202 (394)
                      |||+++| ++....         .+......++.+++.+|..||+.                                  
T Consensus        88 v~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999998 443220         01122335677899999999970                                  


Q ss_pred             ------------------------CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 ------------------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ------------------------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                                              ..++|+|++|.|||++.+. .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                    2489999999999998543 46799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=6.3e-11  Score=105.22  Aligned_cols=131  Identities=16%  Similarity=0.107  Sum_probs=87.9

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCCCce--eeeceEEEecCCCceeEEEEEEe
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      |.+..+.+.|..+.||++.. .+|..+++|+.... .....+|+.+++.+.+.++  .+++.+...     ....++|||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~e   95 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLG   95 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEE
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEEE
Confidence            55544445666799999965 56778999987543 2446789999999865443  456655421     122678999


Q ss_pred             cccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC------------------------------------
Q 016158          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG------------------------------------  204 (394)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g------------------------------------  204 (394)
                      |++|.... .       .....   ..++.+++.+|..||+ ..                                    
T Consensus        96 ~i~G~~l~-~-------~~~~~---~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           96 EVPGQDLL-S-------SHLAP---AEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             CCSSEETT-T-------SCCCH---HHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             ecCCcccC-c-------CcCCH---hHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            99973211 0       11111   2345667777777775 33                                    


Q ss_pred             ----------------------ceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          205 ----------------------ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       205 ----------------------ivH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                                            ++|+|++|.|||++.++ .+.|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                  99999999999998654 46799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=7.3e-10  Score=103.36  Aligned_cols=140  Identities=16%  Similarity=0.182  Sum_probs=97.6

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEec--c-----chhhhHHHHHHHHHcCC--CceeeeceEEEecCCCceeEEE
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--Q-----DKRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~-----~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      -.+.|+.|.++.||++...  +..+++|+..  .     ......+|+.+++.+..  ..+++++..+...  ......+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            3567899999999998864  4678899765  2     23456789999999974  3456666654221  1112345


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------  202 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----------------------------------  202 (394)
                      +||||++|...   ..  .....++......++.+++.+|..||+.                                  
T Consensus       118 ~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            89999997321   00  1123467777888889999999999961                                  


Q ss_pred             -----------------------CCceeecCCCCcEEEeCCCC-cEEEEeecCccc
Q 016158          203 -----------------------IGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  234 (394)
Q Consensus       203 -----------------------~givH~Dlkp~Nil~~~~~~-~vkl~Dfg~a~~  234 (394)
                                             ..++|+|+++.|||++.++. .+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                   36999999999999997652 368999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=4.1e-10  Score=102.58  Aligned_cols=186  Identities=12%  Similarity=0.162  Sum_probs=110.2

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcC-CCceeeeceEEEecCC-CceeEEEEEEeccc
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPNIVALKHCFFSTTD-KEELYLNLVLEYVP  163 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~-~~~~~~~lv~e~~~  163 (394)
                      +.++.|....||++.     ..+++|+....  .....+|.++++.+. +..+ .+...+..... ......++||++++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v-~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPL-PIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSS-CCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCC-CCCceEeecCCCCCCCcceEEEcccC
Confidence            458999999999863     45889976543  345678999998884 3332 22222222111 11223467899999


Q ss_pred             cc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 016158          164 ET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------------  202 (394)
Q Consensus       164 ~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----------------------------------------  202 (394)
                      |. +.....      ..++......++.+++..|..||+.                                        
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            73 321111      3455666666677777777777740                                        


Q ss_pred             -----------------CCceeecCCCCcEEEeCC-CCcEEEEeecCccccccCCCCcccccccccccccccc------C
Q 016158          203 -----------------IGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF------G  258 (394)
Q Consensus       203 -----------------~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~------~  258 (394)
                                       ..++|+|++|.||+++.+ +..+.|+||+.+.................-..|+...      +
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             247999999999999974 4368899999886432110000000000001222110      0


Q ss_pred             CC-------CCCchhhHHHHHHHHHHHHhCCCCC
Q 016158          259 AT-------EYTTAIDIWSTGCVMAELLLGQPLF  285 (394)
Q Consensus       259 ~~-------~~~~~~DiwslG~il~~lltg~~pf  285 (394)
                      ..       ......+.|+++.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00       0122368999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=4.8e-07  Score=82.20  Aligned_cols=68  Identities=12%  Similarity=-0.045  Sum_probs=44.8

Q ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCc---eeeeceEEEecCCCceeEEEEEEecc
Q 016158           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN---IVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      +.++.|....||+.     |..+++|+....  .....+|.++|+.+.+..   +.+++.+..  ..  ....+++|+++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~~--~g~~~~v~e~i   95 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--RS--DGNPFVGYRKV   95 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--CT--TSCEEEEEECC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--cC--CCceEEEEecc
Confidence            45788898999988     466889975432  245678999999997532   333333321  11  12245899999


Q ss_pred             cc
Q 016158          163 PE  164 (394)
Q Consensus       163 ~~  164 (394)
                      +|
T Consensus        96 ~G   97 (306)
T 3tdw_A           96 QG   97 (306)
T ss_dssp             CS
T ss_pred             CC
Confidence            97

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.43  E-value=3.6e-06  Score=74.80  Aligned_cols=130  Identities=15%  Similarity=0.144  Sum_probs=80.7

Q ss_pred             eeecCce-EEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCC-CceeeeceEEEecCCCceeEEEEEEecccc-c
Q 016158           90 VGTGSFG-VVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-T  165 (394)
Q Consensus        90 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~  165 (394)
                      +..|..+ .||+......+..+.+|+-... .....+|...|+.+.. -.+.+++.++..   .  ...++|||+++| .
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~---~--~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT---P--DDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE---T--TEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE---C--CeEEEEEEeeCCcc
Confidence            3445444 6999888777788999976543 3446789999998843 224455554422   1  235689999987 3


Q ss_pred             HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 016158          166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------------------------------------------  202 (394)
Q Consensus       166 l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-------------------------------------------  202 (394)
                      +.+.....        ......+..++...|..||..                                           
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            33322110        111123344555555555530                                           


Q ss_pred             --------------CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 --------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 --------------~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                                    ..++|+|+.+.|||++.++ .+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                          0179999999999999654 56799999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.19  E-value=7e-06  Score=75.47  Aligned_cols=30  Identities=23%  Similarity=0.469  Sum_probs=26.6

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            6899999999999997665 69999999874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.14  E-value=1.2e-05  Score=75.68  Aligned_cols=71  Identities=18%  Similarity=0.195  Sum_probs=44.2

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccc-----------hhhhHHHHHHHHHcCC--Cc-eeeeceEEEecCCCce
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--PN-IVALKHCFFSTTDKEE  152 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~~  152 (394)
                      .+.||.|..+.||++....+++.++||.....           ......|.++++.+..  +. +.+++.+  ..   +.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~---~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---EM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---TT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC---Cc
Confidence            46789999999999977656788999975321           1223578888888743  33 3344332  11   11


Q ss_pred             eEEEEEEecccc
Q 016158          153 LYLNLVLEYVPE  164 (394)
Q Consensus       153 ~~~~lv~e~~~~  164 (394)
                        .++|||++++
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              3589999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.01  E-value=1.4e-05  Score=73.97  Aligned_cols=78  Identities=9%  Similarity=0.106  Sum_probs=48.7

Q ss_pred             EEeeEe-eecCceEEEEEEEC--C----CCcEEEEEEeccch-------hhhHHHHHHHHHcCC---CceeeeceEEEec
Q 016158           85 IAEHVV-GTGSFGVVFQAKCR--E----TGEIVAIKKVLQDK-------RYKNRELQIMQMLDH---PNIVALKHCFFST  147 (394)
Q Consensus        85 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~~~~~~~~~  147 (394)
                      ...+.| +.|....+|+....  .    ++..+++|+.....       ....+|+.+++.+..   -.+.+++.+... 
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~-  101 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT-  101 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS-
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC-
Confidence            345677 88888999988753  0    15678899765432       356789999988843   234555554311 


Q ss_pred             CCCceeEEEEEEecccc
Q 016158          148 TDKEELYLNLVLEYVPE  164 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~  164 (394)
                       .......++|||+++|
T Consensus       102 -~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 -GDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             -STTTSSCEEEEECCCC
T ss_pred             -CCccCCceEEEEecCC
Confidence             1101123579999986

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.78  E-value=0.00069  Score=57.01  Aligned_cols=98  Identities=18%  Similarity=0.112  Sum_probs=63.7

Q ss_pred             cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCccc
Q 016158          165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY  244 (394)
Q Consensus       165 ~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~  244 (394)
                      +|.+++..+   +.++++.++|.++.|.+.+|.-+-....-..+=+.|..|++..+| .|.+.+ ..+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            677777765   489999999999999999988762211212333557889999998 466543 1110           


Q ss_pred             cccccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 016158          245 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  280 (394)
Q Consensus       245 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt  280 (394)
                      .....+.|||...  ...+.+.-|||||+++|..+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1123467888762  346789999999999999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=0.00051  Score=61.38  Aligned_cols=70  Identities=14%  Similarity=0.138  Sum_probs=48.7

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCC---ceeeeceEEEecCCCceeEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ..-...+|.|..+.||+++. .+|+.|.+|+-...    ...+..|++.|+.|...   .+++++..   ..      -+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~------~~   86 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DD------RT   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET------TE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---cC------ce
Confidence            45678899999999999987 57899999975432    23467899999988532   22333322   11      24


Q ss_pred             EEEeccc
Q 016158          157 LVLEYVP  163 (394)
Q Consensus       157 lv~e~~~  163 (394)
                      +||||+.
T Consensus        87 lv~e~l~   93 (288)
T 3f7w_A           87 LAMEWVD   93 (288)
T ss_dssp             EEEECCC
T ss_pred             EEEEeec
Confidence            7899886

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.69  E-value=0.00019  Score=64.64  Aligned_cols=65  Identities=12%  Similarity=0.063  Sum_probs=40.3

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCcee-eeceEEEecCCCceeEEEEEEecc
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      .+.|+.|....+|++      ..+++|+.....   ....+|+.+++.+...++. +++...     .+.  -++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            577889999999998      458889765432   2235788888877443333 333221     111  13689999


Q ss_pred             -cc
Q 016158          163 -PE  164 (394)
Q Consensus       163 -~~  164 (394)
                       ++
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             64

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.52  E-value=0.00031  Score=66.51  Aligned_cols=77  Identities=13%  Similarity=-0.037  Sum_probs=46.8

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCccccccCCCCccccc--cccccccccccCCC--CCCchhhHHHHHHHHHHH
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGAT--EYTTAIDIWSTGCVMAEL  278 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l  278 (394)
                      ..++|+|++|.|||++.++  ++|+||+.+..-...-.......  ...|++|+......  ......++..+...+|..
T Consensus       232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6899999999999998654  99999998864321111111111  23466766552111  012234555777777777


Q ss_pred             HhC
Q 016158          279 LLG  281 (394)
Q Consensus       279 ltg  281 (394)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.52  E-value=0.001  Score=60.16  Aligned_cols=71  Identities=14%  Similarity=0.065  Sum_probs=49.7

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcCC---CceeeeceEEEecCCCceeEEEEEEecc
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      .+.|+.|....+|+...  ++..+++|+.... ...+..|.+.|+.|..   ..+++++.....     ....++|||++
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence            46689999999999875  4678889976543 3456789998888842   445566554421     12367899999


Q ss_pred             cc
Q 016158          163 PE  164 (394)
Q Consensus       163 ~~  164 (394)
                      ++
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            85

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.47  E-value=0.00045  Score=65.58  Aligned_cols=69  Identities=17%  Similarity=0.254  Sum_probs=46.1

Q ss_pred             eeEeeecCceEEEEEEECC-------CCcEEEEEEecc-ch-hhhHHHHHHHHHcCCCce-eeeceEEEecCCCceeEEE
Q 016158           87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ-DK-RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~  156 (394)
                      .+.|+.|....||++....       .+..+++|+... .. ....+|..+++.|...++ +++++.+     .+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence            4568888889999998743       257899998744 22 344579998888854444 3555443     22    1


Q ss_pred             EEEecccc
Q 016158          157 LVLEYVPE  164 (394)
Q Consensus       157 lv~e~~~~  164 (394)
                      +|+||++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            68899875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.33  E-value=0.00076  Score=62.72  Aligned_cols=138  Identities=20%  Similarity=0.267  Sum_probs=76.0

Q ss_pred             eEeeecCceEEEEEEECC-------CCcEEEEEEecc---chhhhHHHHHHHHHcCCCce-eeeceEEEecCCCceeEEE
Q 016158           88 HVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        88 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~  156 (394)
                      +.|..|-...+|++....       +++.+++|+.-.   ......+|..+++.|...++ .++++.+     .++    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~g----  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PEG----  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TTE----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CCc----
Confidence            456677778888887642       357788997532   23344579999888843333 3454443     221    


Q ss_pred             EEEeccccc------------HHHHHHHhhhhcC-------CCC--HHHHHHHHHHHHH-------------------HH
Q 016158          157 LVLEYVPET------------VNRIARNYSRIHQ-------RMP--LIYVKLYTYQICR-------------------AL  196 (394)
Q Consensus       157 lv~e~~~~~------------l~~~~~~~~~~~~-------~~~--~~~~~~~~~qi~~-------------------al  196 (394)
                      +||||++|.            ...+.....+.+.       ...  ...+..+..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            789998751            1122222222211       111  2344445443321                   22


Q ss_pred             HHHH----h---CCCceeecCCCCcEEEeCC---CCcEEEEeecCccc
Q 016158          197 AYIH----N---CIGICHRDIKPQNLLVNPH---THQLKLCDFGSAKV  234 (394)
Q Consensus       197 ~~LH----~---~~givH~Dlkp~Nil~~~~---~~~vkl~Dfg~a~~  234 (394)
                      ..|.    .   ...++|+|+.+.|||++.+   ...+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    1   1359999999999999876   23699999998853

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.32  E-value=0.002  Score=58.41  Aligned_cols=142  Identities=13%  Similarity=0.063  Sum_probs=74.9

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCCCce--eeeceEEEecCCC----ceeEEEE
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTDK----EELYLNL  157 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~----~~~~~~l  157 (394)
                      -.+.|+.|....+|++... .| .+++|+...  .......|..+++.+...++  .+++..   ..+.    .....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence            3466788888999999763 33 688998765  34456678888887743232  233211   0000    0122468


Q ss_pred             EEecccccH---------HHH---HHHhhhhcCC--------CCHHHHHHH---------------HHHHHHHHHHHHh-
Q 016158          158 VLEYVPETV---------NRI---ARNYSRIHQR--------MPLIYVKLY---------------TYQICRALAYIHN-  201 (394)
Q Consensus       158 v~e~~~~~l---------~~~---~~~~~~~~~~--------~~~~~~~~~---------------~~qi~~al~~LH~-  201 (394)
                      ++++++|..         ..+   +...-.....        .........               ...+...++.+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999988621         011   1110000000        011100000               0113344555542 


Q ss_pred             -----CCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          202 -----CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       202 -----~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                           ..+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence                 14799999999999999654 45799999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0015  Score=59.61  Aligned_cols=32  Identities=38%  Similarity=0.561  Sum_probs=26.8

Q ss_pred             CCceeecCCCCcEEEeCC---CCcEEEEeecCccc
Q 016158          203 IGICHRDIKPQNLLVNPH---THQLKLCDFGSAKV  234 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~---~~~vkl~Dfg~a~~  234 (394)
                      ..++|+|+.+.||+++.+   ...+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            579999999999999864   13699999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.21  E-value=0.0034  Score=59.87  Aligned_cols=69  Identities=16%  Similarity=0.193  Sum_probs=45.3

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeccchh---hhHHHHHHHHHcCCCcee-eeceEEEecCCCceeEEEEEEecc
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV  162 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~  162 (394)
                      .+.|+.|-...+|++.....+..+++|+......   ...+|..+++.|...++. ++++.+     .+.    +||||+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~G----~v~e~I  183 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TNG----RIEEFM  183 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TTE----EEEECC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CCe----EEEEee
Confidence            4578889999999998754457888997643221   225899999999765553 555544     221    489998


Q ss_pred             cc
Q 016158          163 PE  164 (394)
Q Consensus       163 ~~  164 (394)
                      +|
T Consensus       184 ~G  185 (458)
T 2qg7_A          184 DG  185 (458)
T ss_dssp             CS
T ss_pred             CC
Confidence            75

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.12  E-value=0.0013  Score=60.92  Aligned_cols=69  Identities=13%  Similarity=0.152  Sum_probs=40.6

Q ss_pred             eeEeeecCceEEEEEEECC--------CCcEEEEEEeccchh---hhHHHHHHHHHcCCCce-eeeceEEEecCCCceeE
Q 016158           87 EHVVGTGSFGVVFQAKCRE--------TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELY  154 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~  154 (394)
                      ...|+.|....+|++....        .+..+++|+......   ....|..+++.+...++ .++++..     .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence            3567788888999998643        126788997654322   23678888888854443 3444332     11   


Q ss_pred             EEEEEecccc
Q 016158          155 LNLVLEYVPE  164 (394)
Q Consensus       155 ~~lv~e~~~~  164 (394)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             368999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.11  E-value=0.0021  Score=58.43  Aligned_cols=72  Identities=14%  Similarity=0.009  Sum_probs=42.9

Q ss_pred             EeeecCceEEEEEEECCCCcEEEEEEecc---chhhhHHHHHHHHHcCCCc--eeeeceEEEecCC--CceeEEEEEEec
Q 016158           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD--KEELYLNLVLEY  161 (394)
Q Consensus        89 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e~  161 (394)
                      .|+ |....||++.. .+|+.+++|+...   .......|..+++.+....  +++++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            455 77788998765 3466799998763   2345567888888874322  3333322  0000  001234678999


Q ss_pred             ccc
Q 016158          162 VPE  164 (394)
Q Consensus       162 ~~~  164 (394)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.73  E-value=0.0036  Score=57.34  Aligned_cols=31  Identities=26%  Similarity=0.532  Sum_probs=26.7

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            4699999999999998665 699999988754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.88  E-value=0.033  Score=52.39  Aligned_cols=69  Identities=14%  Similarity=0.147  Sum_probs=44.0

Q ss_pred             eeEeeecCceEEEEEEECCC-------CcEEEEEEeccch---hhhHHHHHHHHHcCCCce-eeeceEEEecCCCceeEE
Q 016158           87 EHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK---RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL  155 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  155 (394)
                      .+.|..|-...+|++.....       ++.+++|+.....   ....+|..+++.+...++ .++++.+     .+    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~----  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE----  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC----
Confidence            45567788889999987521       5778999764322   223579999888854333 3444322     11    


Q ss_pred             EEEEecccc
Q 016158          156 NLVLEYVPE  164 (394)
Q Consensus       156 ~lv~e~~~~  164 (394)
                      ++||+|++|
T Consensus       146 ~~I~efI~G  154 (424)
T 3mes_A          146 GRIEEFIDG  154 (424)
T ss_dssp             EEEEECCCS
T ss_pred             CEEEEEeCC
Confidence            468999886

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.04  E-value=0.24  Score=46.13  Aligned_cols=30  Identities=30%  Similarity=0.546  Sum_probs=24.4

Q ss_pred             ceeecCCCCcEEEeC-----CCCcEEEEeecCccc
Q 016158          205 ICHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  234 (394)
Q Consensus       205 ivH~Dlkp~Nil~~~-----~~~~vkl~Dfg~a~~  234 (394)
                      ++|+|+.+.|||+..     +...+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999942     233699999998854

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	394
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-120
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-71
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-71
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-68
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-67
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-67
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-66
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-66
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-66
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-65
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-63
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-62
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-60
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-59
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-58
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-57
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-57
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-53
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-52
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-49
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-49
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-44
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  350 bits (899), Expect = e-120
 Identities = 227/321 (70%), Positives = 268/321 (83%), Gaps = 2/321 (0%)

Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70

Query: 133 DHPNIVALKHCFFST-TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+   K+E+YLNLVL+YVPETV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

Query: 372 RDPNTRLPNGRPLPPLFNFKP 392
           RDPN +LPNGR  P LFNF  
Sbjct: 310 RDPNVKLPNGRDTPALFNFTT 330

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 2e-71
 Identities = 95/320 (29%), Positives = 164/320 (51%), Gaps = 20/320 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKN---RELQIMQMLDHPNIV 138
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +     + T ++   + LV   +   + ++ +      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 124

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 254
           IH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 312
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 313 -NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 372 RDPNTRLPNGRPLPPLFNFK 391
            DP+       P        
Sbjct: 302 YDPSDEPIAEAPFKFDMELD 321

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 2e-71
 Identities = 99/303 (32%), Positives = 149/303 (49%), Gaps = 23/303 (7%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
            +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F     K  + L  V +++      +          +   ++K Y     + L Y+
Sbjct: 65  LLDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 258
           H    I HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+FG
Sbjct: 117 HQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
           A  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+   M      
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 376
             F      P H +F      + +DL+   F ++P  R TA +A    +F     P    
Sbjct: 235 VTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293

Query: 377 RLP 379
           +LP
Sbjct: 294 QLP 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 8e-71
 Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 31/305 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G+ GVVF+   + +G ++A K +  + +        RELQ++   + P IV
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                F       E+ +   +E++            +   R+P   +   +  + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +     I HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 317
            T Y+   DIWS G  + E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 318 EFKF--------------PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
              +                I   P  K+       E  D V +    +P  R    +  
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 364 VHPFF 368
           VH F 
Sbjct: 297 VHAFI 301

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 7e-68
 Identities = 102/307 (33%), Positives = 165/307 (53%), Gaps = 21/307 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           +     +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L         + +LYL  V E++ + + +     +     +PL  +K Y +Q+ + LA
Sbjct: 64  VKLLDVI---HTENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLA 116

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
           + H+   + HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 315
            G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
             +  FP+     + KV    L  +   L+ +   Y PN R +A  A  HPFF ++  P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 376 TRLPNGR 382
             +P+ R
Sbjct: 293 --VPHLR 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  213 bits (544), Expect = 4e-67
 Identities = 89/300 (29%), Positives = 147/300 (49%), Gaps = 21/300 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALK 141
           Y     +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  D       LV E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 262 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 320
           Y  ++D+WS GC++A ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 321 FPQIKPHPWHKVFQKRLP--------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
           F  I      K +++ +         PEA+D + +  +Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 9e-67
 Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 138 VALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           V L     +     ++ +  + LV ++     + +A   S +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-----SYICSRY 249
            L YIH    I HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           YR PEL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 310 KCMNPNYTEFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 366
             ++      K   +K        ++      P A+DL+ +     P  R  + +A  H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 367 FFDELRDPN 375
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 1e-66
 Identities = 97/316 (30%), Positives = 158/316 (50%), Gaps = 21/316 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     VG+G++G V  A    TG  VAIKK+ +  + +       REL++++ + H N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           + L   F      ++     LV+ ++   + ++ +     H+++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGL 134

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            YIH   GI HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 317 TEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 373
            +      P+++   +  +      P AV+L+ +        R TA EA  HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 374 PNTRLPNGRPLPPLFN 389
                P  +     F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  213 bits (542), Expect = 2e-66
 Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 41/309 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y     +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F    D  E+ +  + E++      +    +  H +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 200 HNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 376
                             +  +  D + +     PN R T  +A  HP+      P  ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 377 RLPNGRPLP 385
           ++P+ R   
Sbjct: 294 QIPSSRYTK 302

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-66
 Identities = 98/316 (31%), Positives = 154/316 (48%), Gaps = 23/316 (7%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL++++ + H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   F      EE     ++ ++         N     Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           YIH+   I HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
               Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 318 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                   Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 375 NTRLPNGRPLPPLFNF 390
           +       P+   ++ 
Sbjct: 311 DD-----EPVADPYDQ 321

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (526), Expect = 5e-65
 Identities = 96/299 (32%), Positives = 150/299 (50%), Gaps = 18/299 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L           +  L LV E+       + + +   +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
           + H+   + HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           FGA  Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                +P             +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-64
 Identities = 90/299 (30%), Positives = 147/299 (49%), Gaps = 17/299 (5%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDKRYKN------RELQIMQML---D 133
           Y     +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN+V L      +    E  L LV E+V +  +            +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--DLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
           R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++   + Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                  F      P  K     +     DL+ +   ++P  R +A  A  HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  203 bits (516), Expect = 2e-63
 Identities = 96/295 (32%), Positives = 151/295 (51%), Gaps = 20/295 (6%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NI
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L           +  L LV E++      + +        +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 256
           Y H+   + HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 315
            G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
             +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 34/309 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++  +    P+IV +  
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 72

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + +     +  L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 73  VYENLYAGRK-CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 201 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 258
           +   I HRD+KP+NLL         LKL DFG AK         +   + YY APE++  
Sbjct: 129 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +Y  + D+WS G +M  LL G P F    G+     +   +                +
Sbjct: 188 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------Q 233

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTR 377
           ++FP  +           +  E   L+    +  P  R T  E   HP+     + P T 
Sbjct: 234 YEFPNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 378 LPNGRPLPP 386
           L   R L  
Sbjct: 286 LHTSRVLKE 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  201 bits (513), Expect = 4e-62
 Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 44/302 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
            +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               DK E+ L  +LE++   E  +RIA        +M    V  Y  Q C  L ++H  
Sbjct: 96  ---EDKYEMVL--ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 203 IGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
             I H DIKP+N++        +K+ DFG A  L   E       +  + APE++     
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EP 204

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
                D+W+ G +   LL G   F GE  ++ L  + +       +              
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------ 252

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPN 380
                          + PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299

Query: 381 GR 382
            R
Sbjct: 300 SR 301

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-62
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 44/295 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                             L LEY          +       MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCS---GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 255
           +H   GI HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 256 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
           +     +   +D+WS G V+  +L G+  +   S   Q                      
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------------- 219

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
               K  +   +PW K+         + L+ +    +P+ R T  +     ++++
Sbjct: 220 ----KEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 1e-60
 Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 49/305 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            +  + C+     +   +  LV+EY        +       + +  + +   T+   + L
Sbjct: 77  TIQYRGCY---LREHTAW--LVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 257 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 374
                + P ++   W             + V    Q  P  R T+     H F    R P
Sbjct: 229 ----NESPALQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 375 NTRLP 379
              + 
Sbjct: 277 TVIMD 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-60
 Identities = 95/328 (28%), Positives = 152/328 (46%), Gaps = 32/328 (9%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G+G+ G+V  A        VAIKK+ +  + +       REL +M+ ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 138 VALKHCFFSTTDKEEL-YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++L + F      EE   + LV+E +       A     I   +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMD------ANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            ++H+  GI HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 312
            G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +    
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 313 ------NPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 363
                  P Y    FP++ P    P      K    +A DL+ +     P  R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 364 VHPFFDELRDPNTRLPNGRPLPPLFNFK 391
            HP+ +   DP        P P +++ +
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQ 334

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 2e-60
 Identities = 60/289 (20%), Positives = 117/289 (40%), Gaps = 40/289 (13%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
           +  +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +  + +T K +  + LV E +    +   + Y +  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 201 -NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 259
                I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 260 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 319
            +Y  ++D+++ G  M E+   +  +       Q+   +     P               
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233

Query: 320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                        F K   PE  +++    + + + R +  +   H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 7e-60
 Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 44/294 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
           +     +G G+FG V++A+ +ET  + A K +     ++      E+ I+   DHPNIV 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F     +  L++  ++E+       +      + + +    +++   Q   AL Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFG 258
           H+   I HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 259 AT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
            T     Y    D+WS G  + E+   +P     + +  L++I K               
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------------- 230

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
                  P             R      D + +  + + + R T  +   HPF 
Sbjct: 231 EPPTLAQP------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  196 bits (497), Expect = 7e-60
 Identities = 95/349 (27%), Positives = 150/349 (42%), Gaps = 49/349 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 141 KH----------CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
                         F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNVSYI 245
           Q+   L Y+H   GI H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 299
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 300 VLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKV------FQKRLPPEAVDLVC 346
           +LG      ++      T F          ++K  P   V      F K    E  D + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 347 RFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 388
              Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 9e-60
 Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V         T+     L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 197 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 251
              H        + HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           +PE +     Y    DIWS GC++ EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                 E KF +I               E  +++ R        R +  E   +P 
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-59
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    D   +YL  +LEY P           +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           +Y H+   + HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
            G   +   +D+WS G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 368
            EF FP              +   A DL+ R  +++P+ R    E   HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 42/293 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVAL 140
           Y+    +G G FG+V +     + +    K V     D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              F      EEL +  + E++   +   RI  +   +++R     +  Y +Q+C AL +
Sbjct: 67  HESF---ESMEELVM--IFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117

Query: 199 IHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 257
           +H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+  
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 258 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
                +TA D+WS G ++  LL G   F  E+    +  I+    T   E          
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                            K +  EA+D V R        R TA EA  HP+  +
Sbjct: 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 7e-58
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 45/309 (14%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +      +EL++  V+EY+                 M    +     +
Sbjct: 74  NKNPNIVNYLDSY---LVGDELWV--VMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 250
             +AL ++H+   + HRDIK  N+L+      +KL DFG    +   +   S +  + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP      
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                  E + P            ++L     D + R        R +A E   H F   
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Query: 371 LRDPNTRLP 379
            +  ++  P
Sbjct: 276 AKPLSSLTP 284

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 1e-57
 Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 42/303 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y    V+GTG+F  V  A+ + T ++VAIK + +            E+ ++  + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL   +        LYL  +++ V         +                 +Q+  A+ Y
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 199 IHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
           +H+   I HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 376
                           +   +   A D +    +  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 377 RLP 379
            + 
Sbjct: 276 NIH 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 54/306 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------------LQDKRYKNRELQIMQ 130
           Y  + ++G G   VV +   + T +  A+K +              + +    +E+ I++
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 131 ML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
            +  HPNI+ LK  +     +   +  LV + +         +Y      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 249
             +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 250 YRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 304
           Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 364
                  M+ NY +F  P+                   DLV RF    P  R TA EA  
Sbjct: 228 -------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 365 HPFFDE 370
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 6e-57
 Identities = 84/304 (27%), Positives = 125/304 (41%), Gaps = 56/304 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPN 136
           +    ++G GSF  V  A+   T    AIK + +    K        RE  +M  LDHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            V L   F    D E+LY    L Y     N     Y R          + YT +I  AL
Sbjct: 70  FVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAP 253
            Y+H    I HRD+KP+N+L+N   H +++ DFG+AKVL          S++ +  Y +P
Sbjct: 122 EYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           EL+        + D+W+ GC++ +L+ G P F   +      +IIK+             
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPF 367
               E+ FP+            +  P+A DLV +        R    E         HPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

Query: 368 FDEL 371
           F+ +
Sbjct: 270 FESV 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 9e-53
 Identities = 65/317 (20%), Positives = 120/317 (37%), Gaps = 49/317 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
           Y     +G+G F VV + + + TG   A K + + +   +          RE+ I++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN++ L   +    +K ++ L  +LE V         ++    + +       +  QI 
Sbjct: 72  HPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 194 RALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
             + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
            APE++          D+WS G +   LL G   F G++  + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 370
                                 +       A D + R     P  R T  ++  HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 371 LRDPNTRLPNGRPLPPL 387
            +D    L +    P  
Sbjct: 277 -KDTQQALSSAWSHPQF 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-52
 Identities = 79/319 (24%), Positives = 133/319 (41%), Gaps = 55/319 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ--------IMQMLDHP 135
           +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++        +    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +  +   F     KE L+  +  EY+          + +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF---QTKENLFFVM--EYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 254
           L ++H+  GI +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 255 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
           ++ G  +Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFFDELRD 373
            Y  +                 L  EA DL+ + F   P  R         HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262

Query: 374 PNTRLPNGRPLPPLFNFKP 392
               L      PP   F+P
Sbjct: 263 -WEELERKEIDPP---FRP 277

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-52
 Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 56/303 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
           Y    ++G+G FG V+          VAIK V +D+               E+ +++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 134 --HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
                ++ L   F            L+LE       +   ++      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 251
           +  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 252 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
            PE I     +  +  +WS G ++ +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
                                F++R+  E   L+       P+ R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 372 RDP 374
             P
Sbjct: 262 LLP 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  174 bits (442), Expect = 1e-51
 Identities = 69/325 (21%), Positives = 122/325 (37%), Gaps = 57/325 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
           +    ++G G FG V+  +  +TG++ A+K + + +            +   L ++   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
            P IV + + F      ++L    +L+ +          +   H       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 313
           E++     Y ++ D +S GC++ +LL G   F      D+  EI +              
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------------- 219

Query: 314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFF 368
                                    PE   L+    Q   N R       A E    PFF
Sbjct: 220 -----------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 369 DELRDPNTRLPNGRPLPPLFNFKPP 393
             L      +   +  PP     PP
Sbjct: 269 RSL--DWQMVFLQKYPPP---LIPP 288

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  172 bits (437), Expect = 2e-51
 Identities = 74/322 (22%), Positives = 134/322 (41%), Gaps = 59/322 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
           +     +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ +   F     ++   + ++++Y+         +  R  QR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 256
            Y+H+   I +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 257 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDEL 371
            E +FP                 +  DL+ R      + R         +   HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

Query: 372 RDPNTRLPNGRPLPPLFNFKPP 393
                +L +     P   ++PP
Sbjct: 264 -VWE-KLLSRNIETP---YEPP 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (419), Expect = 3e-49
 Identities = 65/295 (22%), Positives = 106/295 (35%), Gaps = 43/295 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           Y    ++G G    V  A+       VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IVA+ +              +V+EYV        R+       M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRA 252
            + H   GI HRD+KP N++++   + +K+ DFG A+ +     +V    + I +  Y +
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           PE   G        D++S GCV+ E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
                                 + L  +   +V +    +P  R           
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 7e-49
 Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 59/328 (17%)

Query: 81  KVS---YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
           KV+   +    ++G G+FG V   + + TG   A+K + ++             E +++Q
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
              HP + ALK+ F      + L        +          +    +       + Y  
Sbjct: 61  NTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGA 112

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 250
           +I  AL Y+H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    
Sbjct: 113 EIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 251 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 310
                +    +Y  A+D W  G VM E++ G+  F  +        I+            
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------- 219

Query: 311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVH 365
                  E +FP            + L PEA  L+    +  P  R       A E   H
Sbjct: 220 ------EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 366 PFFDELRDPNTRLPNGRPLPPLFNFKPP 393
            FF  +      +   + LPP   FKP 
Sbjct: 262 RFFLSIN--WQDVVQKKLLPP---FKPQ 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-47
 Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 47/294 (15%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
                  +G+GSFG V++ K       VA+K +               E+ +++   H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+                L +V ++   +   +  +   I  +  +I +     Q  + +
Sbjct: 66  ILLFMGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 253
            Y+H    I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + AP
Sbjct: 118 DYLH-AKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 254 ELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           E+I       Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++             
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------- 224

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
               Y      +++ +          P     L+    +   + R    +    
Sbjct: 225 ---GYLSPDLSKVRSN---------CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 2e-46
 Identities = 56/315 (17%), Positives = 103/315 (32%), Gaps = 54/315 (17%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
           +G R         Y     +G+GSFG ++       GE VAIK      ++     E +I
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
            +M+     +       +  D    Y  +V+E +  ++  +   ++   ++  L  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLL 108

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNV---- 242
             Q+   + YIH+     HRD+KP N L+        +   DFG AK       +     
Sbjct: 109 ADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 243 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 298
               +   +  Y +     G  E +   D+ S G V+    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225

Query: 299 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 358
                                +  + K     +V  K  P E    +        + +  
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 359 A---LEACVHPFFDE 370
                +   + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (391), Expect = 6e-45
 Identities = 48/280 (17%), Positives = 96/280 (34%), Gaps = 33/280 (11%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
           +G           Y     +G GSFGV+F+       + VAIK   +         E + 
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
            ++L     +   + F      E L+  LV++ +  ++  +     R   +  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNV-- 242
             Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 243 ------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 296
                 +   +  Y +     G  E +   D+ + G V    L G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 297 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 336
             ++        ++ +   + E +F +   +  +  F   
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 54/281 (19%), Positives = 99/281 (35%), Gaps = 43/281 (15%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
             +G G FG V        G  VA+K +  D   +    E  +M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
                    L +V EY+ +  + +    SR    +    +  ++  +C A+ Y+      
Sbjct: 71  EEKG----GLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 265
            HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++T 
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180

Query: 266 IDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 324
            D+WS G ++ E+   G+  +P     D +  + K                         
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------------- 215

Query: 325 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
               +        PP   +++   +     +R + L+    
Sbjct: 216 ---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (389), Expect = 5e-44
 Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 57/312 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K         E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++   +   +    +   + R          R    + + Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 202 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 261
              + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I     
Sbjct: 160 L-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KG 214

Query: 262 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 321
           Y  A+D W+ G ++ E+  G P F  +  +    +I                        
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------------ 250

Query: 322 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPNT 376
                      F      +  DL+    Q        NL+    +   H +F      + 
Sbjct: 251 -----VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTDW 302

Query: 377 RLPNGRPLPPLF 388
                R +   F
Sbjct: 303 IAIYQRKVEAPF 314

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 61/337 (18%)

Query: 79  KQKVS---YIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKV--------LQDKRYKNR 124
            +KV    +    V+GTG++G VF  +     +TG++ A+K +         +   +   
Sbjct: 18  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           E Q+++ +     +   H  F    + +L+L L      E    +++      +R     
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQ-----RERFTEHE 130

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 244
           V++Y  +I  AL ++H   GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y
Sbjct: 131 VQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAY 188

Query: 245 IC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 301
                  Y     +  G + +  A+D WS G +M ELL G   F  +   +   EI +  
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-- 246

Query: 302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----- 356
                                  +       + + +   A DL+ R     P  R     
Sbjct: 247 -----------------------RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

Query: 357 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 393
             A E   H FF ++   +  L   +   P   FKP 
Sbjct: 284 RDADEIKEHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-42
 Identities = 58/299 (19%), Positives = 110/299 (36%), Gaps = 35/299 (11%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVA 139
           + + +  +G G FG V+  + +  GE VA+K     +    ++  E+    ML H NI+ 
Sbjct: 4   TIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                 +  +     L LV +Y     +    +Y      + +  +          LA++
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHE---HGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116

Query: 200 HNCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICS 247
           H  I        I HRD+K +N+LV        + D G A         +       + +
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 248 RYYRAPELIFGA-----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 302
           + Y APE++  +      E     DI++ G V  E+     +  G     QL     V  
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPS 234

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
            P+ EE++ +          +++P+  ++            ++   +  +   R TAL 
Sbjct: 235 DPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 7e-41
 Identities = 67/300 (22%), Positives = 110/300 (36%), Gaps = 47/300 (15%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVA 139
           S   E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L         +E +Y+  V EY+ +             + + L  +     QI   +AY+
Sbjct: 77  LYAVV----SEEPIYI--VTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIF 257
                  HRD++  N+LV  +    K+ DFG A+++   E            + APE   
Sbjct: 130 ERM-NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 258 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 316
               +T   D+WS G ++ EL   G+  +PG    + L ++ +    P   E        
Sbjct: 188 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------- 239

Query: 317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFFDELRDP 374
                                P    DL+C+ ++  P  R T   L+A +  +F      
Sbjct: 240 ---------------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
                 +G G FG V+          VA+K + Q     +    E  +M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    +E +Y+  + EY+    + +    +    ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 258
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
              +T   D+WS G ++ E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE--ACVHPFF 368
                      +  V     P E   L+   ++  P  R T     + +  FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 65/309 (21%), Positives = 117/309 (37%), Gaps = 54/309 (17%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVL-----QDKRYKNRELQIMQMLDH 134
               E V+G G FG V     +  G+    VAIK +      + +R    E  IM   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PN++ L+      T    +   ++ E++      +     +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------ 248
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 249 YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 307
            + APE I    ++T+A D+WS G VM E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 367
           +                             P     L+   +Q   N R    +  V+  
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQ-IVNTL 287

Query: 368 FDELRDPNT 376
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 1e-39
 Identities = 53/293 (18%), Positives = 114/293 (38%), Gaps = 43/293 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
              +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                  T +   Y+    E++               Q +  + +     QI  A+ Y+ 
Sbjct: 79  LGVC---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 132

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--YYRAPELIFG 258
                 HRD+  +N LV  + H +K+ DFG ++++                + APE +  
Sbjct: 133 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 259 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 318
             +++   D+W+ G ++ E+            + Q+ E+++                   
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYR 234

Query: 319 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 371
            + P            +  P +  +L+   +Q++P+ R +  E  +H  F+ +
Sbjct: 235 MERP------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-39
 Identities = 57/298 (19%), Positives = 103/298 (34%), Gaps = 53/298 (17%)

Query: 89  VVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIV 138
            +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L              + +V E  P     +     +      L  +  Y  Q+   + Y
Sbjct: 75  RLYGVV------LTPPMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 255
           + +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +      
Sbjct: 127 LESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 256 IFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 314
                 ++ A D W  G  + E+   GQ  + G +G   L +I K      R E      
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE------ 238

Query: 315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 372
                                  P +  +++ + + + P  R T +   +  F  E +
Sbjct: 239 ---------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 7e-39
 Identities = 47/282 (16%), Positives = 96/282 (34%), Gaps = 43/282 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
            +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L     
Sbjct: 12  EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              ++  +   LV E++      ++              +      +C  +AY+     +
Sbjct: 70  --LEQAPIC--LVFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CV 122

Query: 206 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGATEYT 263
            HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y+
Sbjct: 123 IHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYS 180

Query: 264 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 323
           +  D+WS G +M E+     +        ++VE I                         
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------------------ 216

Query: 324 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                +     +        ++   ++  P  R         
Sbjct: 217 ---TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 1e-38
 Identities = 68/300 (22%), Positives = 111/300 (37%), Gaps = 54/300 (18%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R   +   VAIK + Q     +     RE QIM  LD+P I
Sbjct: 12  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L          +   L LV+E        + +      + +P+  V    +Q+   + 
Sbjct: 72  VRLIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 198 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAP 253
           Y+       HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + AP
Sbjct: 124 YLE-EKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           E I    ++++  D+WS G  M E L  GQ  +    G + +  I +             
Sbjct: 182 ECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------ 228

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFFD 369
                  K  +  P           PPE   L+   + Y    R   L         ++ 
Sbjct: 229 -------KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 1e-38
 Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 56/301 (18%)

Query: 85  IAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
           + +  +G+G+FG V +   +  +  + VA+K +  +            E  +MQ LD+P 
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV +        + E   L  V+E            Y + ++ +    +    +Q+   +
Sbjct: 70  IVRMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 197 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NVSYICSRYYRA 252
            Y+       HRD+  +N+L+    H  K+ DFG +K L   E              + A
Sbjct: 121 KYLEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 253 PELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 311
           PE I    ++++  D+WS G +M E    GQ  + G  G +    + K            
Sbjct: 179 PECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-- 235

Query: 312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFF 368
                                     P E  DL+   + Y    R       +   + ++
Sbjct: 236 --------------------------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269

Query: 369 D 369
           D
Sbjct: 270 D 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 62/317 (19%), Positives = 107/317 (33%), Gaps = 70/317 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDKRYKN-----RELQIMQML- 132
                V+G+G+FG V  A      +      VA+K + +            EL++M  L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------------ETVNRIARN 172
            H NIV L       T    +Y  L+ EY                      E  N+    
Sbjct: 99  SHENIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 173 YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 232
                  +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLA 211

Query: 233 KVLVKGEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 288
           + ++     V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348
                  ++I+               N  +   P                 E   ++   
Sbjct: 271 PVDANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSC 303

Query: 349 FQYSPNLRCTALEACVH 365
           + +    R +       
Sbjct: 304 WAFDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 4e-38
 Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 45/288 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
                 +GTG FGVV   K R     VAIK + +    ++    E ++M  L H  +V L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                  T +  ++  ++ EY+      +      +  R     +      +C A+ Y+ 
Sbjct: 65  YGVC---TKQRPIF--IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 201 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAPELIFG 258
                 HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++  
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 259 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 317
            +++++  DIW+ G +M E+  LG+  +   +  +    I + L                
Sbjct: 176 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------------- 218

Query: 318 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
               P +               +   ++   +    + R T      +
Sbjct: 219 RLYRPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-37
 Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 53/303 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L     ++T      + L+ + +P     +          +   Y+  +  QI + + Y+
Sbjct: 76  LLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 200 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR---YYRAPELI 256
            +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E I
Sbjct: 128 EDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 257 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 315
                YT   D+WS G  + EL+  G   + G     ++  I++      +  I      
Sbjct: 186 LH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI------ 237

Query: 316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 375
                                   +   ++ + +    + R    E  +  F    RDP 
Sbjct: 238 ---------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQ 275

Query: 376 TRL 378
             L
Sbjct: 276 RYL 278

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-36
 Identities = 62/308 (20%), Positives = 106/308 (34%), Gaps = 65/308 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQML- 132
                 +G G+FG V +A        +    VA+K +              EL+++  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP---------------ETVNRIARNYSRIH 177
           +H NIV L       T        ++ EY                               
Sbjct: 85  NHMNIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
             + L  +  ++YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197

Query: 238 GEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
               V    +R    + APE IF    YT   D+WS G  + EL  LG   +PG     +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
             ++IK                             +  +  +  P E  D++   +   P
Sbjct: 257 FYKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 354 NLRCTALE 361
             R T  +
Sbjct: 290 LKRPTFKQ 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 5e-35
 Identities = 61/318 (19%), Positives = 108/318 (33%), Gaps = 73/318 (22%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
            +G G+FG VFQA+       E   +VA+K + ++          RE  +M   D+PNIV
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP---------------------ETVNRIARNYSRIH 177
                       + + L  + EY+                        ++  AR  S   
Sbjct: 80  ---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
             +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ +  
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIYS 192

Query: 238 GEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
            +      +      +  PE IF    YTT  D+W+ G V+ E+   G   + G +  + 
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
           +  +                          I   P      +  P E  +L+   +   P
Sbjct: 252 IYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKLP 283

Query: 354 NLRCTALEACVHPFFDEL 371
             R +     +H     +
Sbjct: 284 ADRPSFCS--IHRILQRM 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 6e-35
 Identities = 52/304 (17%), Positives = 106/304 (34%), Gaps = 57/304 (18%)

Query: 87  EHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K + +            E  IM+   HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +L      +    E    +VL Y+     R             +  +  +  Q+ + + +
Sbjct: 92  SLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145

Query: 199 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAP 253
           +       HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           E +    ++TT  D+WS G ++ EL+  G P +P  +  D  V +++       E     
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--- 259

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHP 366
                                    P    +++ + +     +R +       + A    
Sbjct: 260 -------------------------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 367 FFDE 370
           F  E
Sbjct: 295 FIGE 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 7e-35
 Identities = 66/293 (22%), Positives = 100/293 (34%), Gaps = 50/293 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHP 135
                 +G G FG V Q            VAIK               +E   M+  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +IV L           E  + +++E        +          + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 196 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAP 253
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 254 ELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 312
           E I     +T+A D+W  G  M E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                                    PP    L+ + + Y P+ R    E    
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-34
 Identities = 55/292 (18%), Positives = 98/292 (33%), Gaps = 50/292 (17%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLD 133
               + V+G G FG V++   + +       VAIK +      K       E  IM    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           H NI+ L+         +   + ++ EY+        +          ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC----SRY 249
             + Y+ N     HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 250 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 309
           + APE I    ++T+A D+WS G VM E++        E    ++++ I           
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 361
                              +        P     L+ + +Q     R    +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 3e-34
 Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 56/300 (18%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI--VAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQRMPLIYV 185
            L             YL L +EY P                +      +     +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 245
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 246 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 305
               + A E +   + YTT  D+WS G ++ E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 365
                         + P                 E  DL+ + ++  P  R +  +  V 
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDKRYKN-----RELQIMQM 131
            +    +G G+FG V  A+     +        VA+K +  D   K+      E+++M+M
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIH 177
           +  H NI+   +   + T    LY+  ++EY              P  +           
Sbjct: 75  IGKHKNII---NLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 237
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 238 GEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 293
            +             + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 294 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 353
           L +++K                  E        +            E   ++   +   P
Sbjct: 246 LFKLLK------------------EGHRMDKPSN---------CTNELYMMMRDCWHAVP 278

Query: 354 NLRCTALEA 362
           + R T  + 
Sbjct: 279 SQRPTFKQL 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 4e-33
 Identities = 58/310 (18%), Positives = 107/310 (34%), Gaps = 62/310 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQML 132
                 +G G+FG V +A         T   VA+K + +       +   +    ++ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQR 179
            H N+V L              L +++E+               E V             
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 239
           + L ++  Y++Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 240 PNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLV 295
             V          + APE IF    YT   D+WS G ++ E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 296 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 355
             +K                 T  + P                PE    +   +   P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 356 RCTALEACVH 365
           R T  E   H
Sbjct: 281 RPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-31
 Identities = 55/315 (17%), Positives = 114/315 (36%), Gaps = 63/315 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD 133
                 +G GSFG+V++   +     E    VAIK V     ++++     E  +M+  +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVK 186
             ++V         +  +     +++E +            R A   + +     L  + 
Sbjct: 82  CHHVV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 246
               +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +       
Sbjct: 137 QMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGK 194

Query: 247 ---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLG 302
                 + +PE +     +TT  D+WS G V+ E+  L +  + G S    L  +++   
Sbjct: 195 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--- 250

Query: 303 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--- 359
                                +   P         P    +L+   +QY+P +R +    
Sbjct: 251 -------------------GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 360 ---LEACVHPFFDEL 371
              ++  + P F E+
Sbjct: 286 ISSIKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.0 bits (212), Expect = 2e-20
 Identities = 31/204 (15%), Positives = 57/204 (27%), Gaps = 34/204 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV--------------LQDKRYKNRELQIMQMLDH 134
           ++G G    VF     E      +K                     + +         + 
Sbjct: 7   LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 135 PNIVALKHCFFSTT-DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
             +  L+          E   +  ++E             ++   R+ +         I 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 253
             +A  ++   I H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 254 ELIFGATEYTTAIDIWSTGCVMAE 277
              F    Y T  DI S    + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	394
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.92
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.9
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.3

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-63  Score=465.49  Aligned_cols=310  Identities=73%  Similarity=1.248  Sum_probs=280.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeEEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLVL  159 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~  159 (394)
                      ..+|+..++||+|+||+||+|+++.+|+.||||++..+.....+|+++|++++|+||++++++|..... .+..++++||
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            336999999999999999999999999999999998877777899999999999999999999866543 4567889999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccCC
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  239 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~  239 (394)
                      ||+++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            999998877777766767889999999999999999999999 8999999999999999887679999999998876666


Q ss_pred             CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCCccc
Q 016158          240 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  319 (394)
Q Consensus       240 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  319 (394)
                      ......||+.|+|||.+.+...++.++||||+||++|||++|+.||...+..+.+..+.+.+|.+..+.+....+.+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            66778899999999998777779999999999999999999999999999999999999999999999999888888888


Q ss_pred             CCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          320 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  391 (394)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  391 (394)
                      .++.....++.......+++++.+||.+||++||++||||.|+|+||||+++.++.+++++...++..++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~  329 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT  329 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCC
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCC
Confidence            888888888888888889999999999999999999999999999999999999999999999999888873

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-60  Score=422.96  Aligned_cols=253  Identities=27%  Similarity=0.333  Sum_probs=207.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...     ...+.+|+++++.++||||+++++++..     ...++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----CceeE
Confidence            4699999999999999999999999999999998543     2345689999999999999999999843     34588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +||||+++ +|.+++.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus        80 ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~  153 (271)
T d1nvra_          80 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  153 (271)
T ss_dssp             EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhheee
Confidence            99999985 6655443    34679999999999999999999999 8999999999999999888 6999999999876


Q ss_pred             ccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          236 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       236 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      ....   ......||+.|+|||++.+...++.++|||||||++|+|+||+.||....................       
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-------  226 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------  226 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------
Confidence            4332   234567999999999997766567889999999999999999999987654433333222110000       


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                    .     ....+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       227 --------------~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         227 --------------N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             --------------T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             --------------C-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence                          0     114679999999999999999999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-59  Score=426.87  Aligned_cols=280  Identities=34%  Similarity=0.589  Sum_probs=228.2

Q ss_pred             EeeEeeecCceEEEEEEECCCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        86 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++||||+++++++..     ..+++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence            4688999999999999999999999999985432         234589999999999999999999833     33478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      +||||+.+++...+   ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~---~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHH---TTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccC
Confidence            99999998664433   3335779999999999999999999999 8999999999999999888 69999999997664


Q ss_pred             cCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          237 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       237 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ... ......||+.|+|||++.....++.++|||||||++|+|+||.+||.+.+..+.+..+.+.++.+..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 3345678999999999976666899999999999999999999999999999999999999998887766544333


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      .....+......++... ...+++++.+||++||+.||++||||+|+|+||||++...+..
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~  291 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  291 (299)
T ss_dssp             TTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             chhhhhccCCCCChHHh-cccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence            22223333233333332 2467999999999999999999999999999999997655443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=425.12  Aligned_cols=250  Identities=25%  Similarity=0.375  Sum_probs=212.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      +|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+++++.++||||+++++++..     ..++++|
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv   95 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV   95 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEEE
Confidence            599999999999999999999999999999998643    2345689999999999999999999843     3347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ||||++ +|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus        96 mEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeecc
Confidence            999985 66665443     679999999999999999999999 8999999999999999888 699999999987644


Q ss_pred             CC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .. ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+........           
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------  236 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----------  236 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----------
T ss_pred             ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence            33 34456799999999999664 489999999999999999999999998887777766655321100           


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                     ..+..+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       237 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         237 ---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             ---------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ---------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                           0125689999999999999999999999999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=418.34  Aligned_cols=248  Identities=30%  Similarity=0.492  Sum_probs=211.6

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|+++++.++||||+++++++.     +..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence            35699999999999999999999999999999998542       234567999999999999999999983     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeeccccee
Confidence            58899999985 77666653    3679999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      +..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.            
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------  219 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------  219 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence            765433 34466899999999999765 4899999999999999999999999887776666655431            


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                           ...            ++..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       220 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         220 -----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                 111            22457999999999999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=419.88  Aligned_cols=269  Identities=23%  Similarity=0.355  Sum_probs=219.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.          ...+.+|+.+|+.++||||+++++++     ..
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence            4699999999999999999999999999999998532          23456899999999999999999998     33


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC---cEEEE
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC  227 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~---~vkl~  227 (394)
                      ...+++|||||++ +|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++.   .+||+
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEec
Confidence            4458899999985 77777654    3679999999999999999999999 89999999999999987653   49999


Q ss_pred             eecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      |||+|.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.......+. 
T Consensus       160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-  237 (293)
T d1jksa_         160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-  237 (293)
T ss_dssp             CCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             chhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-
Confidence            99999887666666677899999999999654 4899999999999999999999999988877777766553221111 


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPL  387 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~  387 (394)
                                              .+...+|+++++||++||+.||++|||++|+|+||||+......  .......||.
T Consensus       238 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~--~l~~~~~~P~  291 (293)
T d1jksa_         238 ------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ--ALSSAWSHPQ  291 (293)
T ss_dssp             ------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---------------CC
T ss_pred             ------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH--hhccCCCCcC
Confidence                                    12356899999999999999999999999999999999764332  3344456666


Q ss_pred             C
Q 016158          388 F  388 (394)
Q Consensus       388 ~  388 (394)
                      |
T Consensus       292 f  292 (293)
T d1jksa_         292 F  292 (293)
T ss_dssp             C
T ss_pred             C
Confidence            6

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-59  Score=419.82  Aligned_cols=254  Identities=31%  Similarity=0.522  Sum_probs=212.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..       ..+.+|++++++++||||+++++++.     ....
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence            46999999999999999999999999999999986422       34568999999999999999999883     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|+||||+++ +|.+++..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEecccccce
Confidence            7899999985 77665543    4789999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          234 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       234 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      ......   ......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+..+.+..+.+.          
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~----------  225 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------  225 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----------
T ss_pred             ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----------
Confidence            764332   223467999999999997654 899999999999999999999999988777766665541          


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDPNT  376 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------ll~hp~f~~~~~~~~  376 (394)
                             ...            ++..+++++++||++||+.||++|||++|      +++||||+++.....
T Consensus       226 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         226 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             -------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             -------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence                   111            22468999999999999999999999987      588999999865544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-58  Score=420.97  Aligned_cols=283  Identities=35%  Similarity=0.640  Sum_probs=230.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...      .....+|++++++++||||+++++++..     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            3699999999999999999999999999999998543      2345689999999999999999999943     3348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++||||+.+++...+...  ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceec
Confidence            899999998776655432  34679999999999999999999999 8999999999999999887 7999999999876


Q ss_pred             ccC-CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ... .......||+.|+|||.+.....++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            443 2334567899999999987777678999999999999999999999999998999999998888877655443211


Q ss_pred             CC-cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          315 NY-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       315 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      .. ....++......... ....+++++.+||++||++||.+|||++|+|+||||+++.+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            10 011111212222221 234678999999999999999999999999999999999776

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-59  Score=416.86  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....      ..+.+|+++++.++||||+++++++...   ....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence            357999999999999999999999999999999985432      3355799999999999999999988532   2334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ceeecCCCCcEEEeCCCCcEEEEe
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCD  228 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g-----ivH~Dlkp~Nil~~~~~~~vkl~D  228 (394)
                      +++|||||++ +|.+++.........+++..++.++.||+.||+|||+ .|     |+||||||+|||++.++ .+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            7899999985 8988888777777889999999999999999999998 56     99999999999999888 699999


Q ss_pred             ecCccccccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          229 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       229 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      ||+|+....... .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+....+....-     
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-----  231 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----  231 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            999987654332 3456789999999999654 489999999999999999999999998877666666554210     


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  368 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  368 (394)
                                             ..++..+|+++.+||++||+.||.+|||++|+|+|||+
T Consensus       232 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 -----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                   01224689999999999999999999999999999996

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=416.83  Aligned_cols=286  Identities=31%  Similarity=0.548  Sum_probs=233.5

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCC-CcEEEEEEeccc------hhhhHHHHHHHHHc---CCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.|   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45799999999999999999999765 667999998542      22345788887766   799999999998766656


Q ss_pred             ceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ...+++++|||+.+++..+...  .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeecchh
Confidence            6778899999999876554443  234779999999999999999999999 8999999999999999888 69999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      +++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99876655556677899999999999665 49999999999999999999999999999999999999999988776654


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      ....... ..+......+ ...+...+++++.+||++||++||++|||++|+|+||||+++..
T Consensus       241 ~~~~~~~-~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         241 RDVALPR-QAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TTCSSCG-GGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccchh-hhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            3221111 1111111112 22344678999999999999999999999999999999999854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-58  Score=416.06  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=210.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .|++++.||+|+||+||+|+++.+|+.||||++...    ...+.+|+++++.++||||+++++++..     ...+++|
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~lv   87 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   87 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEEE
Confidence            599999999999999999999999999999998542    2456789999999999999999999843     3347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ +|..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus        88 mEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  162 (288)
T ss_dssp             EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECHH
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccCC
Confidence            999985 66665443   23679999999999999999999999 8999999999999999988 699999999976533


Q ss_pred             CC-CCccccccccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          238 GE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       238 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .. ......||+.|+|||++..    ...++.++|||||||++|+|+||+.||.+.+..+.+..+.......        
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~--------  234 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT--------  234 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC--------
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            21 2235678999999999842    3447899999999999999999999999988877777666521000        


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                                        ...+..+|+++++||++||+.||++|||++|+|+||||+.
T Consensus       235 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 ------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                              0112468999999999999999999999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.9e-58  Score=427.25  Aligned_cols=260  Identities=26%  Similarity=0.396  Sum_probs=219.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++...    ...+.+|+.+|+.++||||+++++++..     ...+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998643    2345689999999999999999999843     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC-CCcEEEEeecCcccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  235 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~-~~~vkl~Dfg~a~~~  235 (394)
                      |||||++ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+..
T Consensus       101 vmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999985 77665532   23679999999999999999999999 899999999999999643 237999999999887


Q ss_pred             ccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.......+.         
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------  246 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------  246 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC---------
T ss_pred             ccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------
Confidence            6666666788999999999997654 899999999999999999999999988887777777663222111         


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                                      .....+|+++++||++||+.||++|||++|+|+||||++...+..
T Consensus       247 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~  291 (350)
T d1koaa2         247 ----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  291 (350)
T ss_dssp             ----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSC
T ss_pred             ----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCc
Confidence                            112468999999999999999999999999999999998765543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-58  Score=420.98  Aligned_cols=253  Identities=27%  Similarity=0.419  Sum_probs=198.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  156 (394)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++.+..     ..+.+|+.+++.++||||+++++++     .....++
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            45999999999999999999999999999999986432     3345799999999999999999988     3344588


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC---CCCcEEEEeecCc
Q 016158          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSA  232 (394)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~---~~~~vkl~Dfg~a  232 (394)
                      +|||||+ ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||+..   ++ .+||+|||+|
T Consensus        84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a  157 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS  157 (307)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred             EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEecccee
Confidence            9999998 588777653    4689999999999999999999999 89999999999999953   45 6999999999


Q ss_pred             cccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          233 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       233 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.......+       
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------  229 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD-------  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-------
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-------
Confidence            877666556677899999999999655 489999999999999999999999998877766666554211111       


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                        ......+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       230 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         230 ------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                              01224689999999999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-58  Score=410.58  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=206.0

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      |++.++||+|+||+||+|++..+++.||+|++....      ..+.+|+++++.++||||+++++++.... .....+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            578889999999999999999999999999885432      34568999999999999999999885543 33456789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC--ceeecCCCCcEEEeC-CCCcEEEEeecCcc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSAK  233 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~g--ivH~Dlkp~Nil~~~-~~~~vkl~Dfg~a~  233 (394)
                      ||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ ++  |+||||||+|||++. ++ .+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCC-CEEEeecCcce
Confidence            9999985 77666653    3679999999999999999999999 78  999999999999975 55 79999999997


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ... ........||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+...+... ..+        
T Consensus       164 ~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~--------  231 (270)
T d1t4ha_         164 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP--------  231 (270)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC--------
T ss_pred             ecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC--------
Confidence            543 333446789999999999854  48999999999999999999999998776655444333211 111        


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  369 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  369 (394)
                                       ..++...++++.+||.+||+.||++|||++|+|+|||||
T Consensus       232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                             112356789999999999999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-58  Score=421.92  Aligned_cols=250  Identities=27%  Similarity=0.431  Sum_probs=213.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||+++++++     .+..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence            4699999999999999999999999999999998643       23345799999999999999999998     44456


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +|+||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~  153 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence            8899999996 66555443    4789999999999999999999999 8999999999999999988 69999999998


Q ss_pred             cccc-CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhcc
Q 016158          234 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  312 (394)
Q Consensus       234 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  312 (394)
                      .... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+...            
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------  220 (337)
T d1o6la_         154 EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------  220 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             ccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------
Confidence            7644 33345678999999999997654 899999999999999999999999998877766665541            


Q ss_pred             CCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 016158          313 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  372 (394)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  372 (394)
                           ...            ++..+|+++++||++||++||.+|+     +++|+++||||+++.
T Consensus       221 -----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                 111            2356899999999999999999999     499999999998864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-58  Score=419.86  Aligned_cols=252  Identities=27%  Similarity=0.413  Sum_probs=210.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .|++++.||+|+||+||+|++..+|+.||||++....       ..+.+|+.+++.++||||+++++++..     ...+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence            5999999999999999999999999999999986432       234579999999999999999999843     3348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      ++|||||.++......   .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|...
T Consensus        91 ~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence            8999999976544332   234789999999999999999999999 8999999999999999887 7999999999865


Q ss_pred             ccCCCCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ..   .....||+.|+|||++.+.  ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.......         
T Consensus       166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~---------  233 (309)
T d1u5ra_         166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---------  233 (309)
T ss_dssp             SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred             CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence            33   3456799999999998642  348999999999999999999999999888777776665521100         


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                                        .....+|+++.+||.+||+.||.+|||++|+|+||||++...+
T Consensus       234 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         234 ------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             ------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence                              0124578999999999999999999999999999999875433

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-58  Score=425.94  Aligned_cols=255  Identities=26%  Similarity=0.386  Sum_probs=216.1

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +.|++++.||+|+||.||+|+++.+|+.||||++...    ...+.+|+.+|+.++||||++++++|.     ....+++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            4599999999999999999999999999999998643    234567999999999999999999983     3445789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeC--CCCcEEEEeecCccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKV  234 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~--~~~~vkl~Dfg~a~~  234 (394)
                      |||||++ +|.+.+.   .....+++..++.++.||+.||+|||+ +||+||||||+||||+.  ++ .+||+|||+|+.
T Consensus       104 vmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~  178 (352)
T d1koba_         104 ILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKAS-SVKIIDFGLATK  178 (352)
T ss_dssp             EEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCC-CEEECCCTTCEE
T ss_pred             EEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCC-eEEEeeccccee
Confidence            9999985 6644332   234579999999999999999999999 89999999999999983  45 799999999998


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.......+.        
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~--------  249 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--------  249 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS--------
T ss_pred             cCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence            7766666677899999999999654 4899999999999999999999999998888877777663222111        


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                       .....+++++.+||.+||++||.+|||++|+|+||||++..
T Consensus       250 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         250 -----------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             -----------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                             11246899999999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-57  Score=414.14  Aligned_cols=249  Identities=27%  Similarity=0.470  Sum_probs=212.4

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++.     ....
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4699999999999999999999999999999998643       234568999999999999999999983     3445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      +++||||+.| ++..++.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccce
Confidence            8899999986 4444333    35778999999999999999999999 8999999999999999988 69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+....            
T Consensus       153 ~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------  217 (316)
T d1fota_         153 YVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------  217 (316)
T ss_dssp             ECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred             Eecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------------
Confidence            7643  33457899999999999654 48999999999999999999999999888777777766521            


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~  373 (394)
                           ..            ++..+++++.++|.+||+.||.+|+     |++++|+||||+++..
T Consensus       218 -----~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         218 -----LR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             -----CC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             -----CC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence                 11            1245799999999999999999996     9999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.2e-57  Score=405.39  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=216.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------------hhhHHHHHHHHHcC-CCceeeeceEEEec
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFST  147 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  147 (394)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..             ....+|+.+++.++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            46999999999999999999999999999999985431             23457999999997 99999999998   


Q ss_pred             CCCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEE
Q 016158          148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  226 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl  226 (394)
                        .+..++|+||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEE
Confidence              344558899999985 88777754    4689999999999999999999999 8999999999999999888 6999


Q ss_pred             EeecCccccccCCCCccccccccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 016158          227 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  301 (394)
Q Consensus       227 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~  301 (394)
                      +|||+++............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+...-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999988766656666789999999999852     3347889999999999999999999999888777776666531


Q ss_pred             CCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          302 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      -..+.                         .....+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus       232 ~~~~~-------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         232 YQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCCC-------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            11110                         0124689999999999999999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.2e-57  Score=408.59  Aligned_cols=277  Identities=35%  Similarity=0.631  Sum_probs=223.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|+++++||+|+||+||+|+++ +|+.||||++...      ...+.+|+.+|++++||||+++++++....     ..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence            36999999999999999999995 7899999998543      234568999999999999999999984433     37


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++||++.+++...+.   .....+++..++.++.||+.||+|||+ .|||||||||+|||++.++ .+||+|||.|...
T Consensus        76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            8999999987755443   334789999999999999999999999 8999999999999999988 6999999999776


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            43322 34456899999999998777789999999999999999999999999998899999999888877665543221


Q ss_pred             CCc-ccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 016158          315 NYT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  370 (394)
Q Consensus       315 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  370 (394)
                      ... ..........++ ..+...+++++++||++||++||++|||++|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            111 111111122222 2334678999999999999999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-58  Score=422.95  Aligned_cols=281  Identities=25%  Similarity=0.430  Sum_probs=206.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...     .....+|+.+|+.++||||++++++|.     ....+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            45699999999999999999999999999999998543     234568999999999999999999994     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||+.+ +|..++..    ...+++..++.++.|++.||.|||+.+||+||||||+|||++.++ .+||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence            899999995 77776654    367999999999999999999999614999999999999999888 699999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhccC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  313 (394)
                      .... ......||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ........+...........
T Consensus       155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            6433 23456899999999999765 499999999999999999999999987654332 22122222211110000000


Q ss_pred             CC--Cccc---CCCCC---------CCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          314 PN--YTEF---KFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       314 ~~--~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      ..  ....   ..+..         ............+|.++++||.+||+.||.+|||++|+|+||||++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence            00  0000   00000         0000001112346889999999999999999999999999999987543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-56  Score=417.13  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=212.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+|+.++||||+++++++     .....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence            46999999999999999999999999999999986432       2345799999999999999999988     33445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||+.+ ++...+..    ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus       116 ~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~  189 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             cccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeeceeee
Confidence            7899999985 55555443    3679999999999999999999999 8999999999999999888 69999999998


Q ss_pred             ccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          234 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       234 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+....+..+.....           
T Consensus       190 ~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----------  255 (350)
T d1rdqe_         190 RVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----------  255 (350)
T ss_dssp             ECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred             eccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----------
Confidence            7643  33457899999999999765 489999999999999999999999998887777776655211           


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  373 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~  373 (394)
                            .            ++..+++++.+||++||+.||.+|+     |++++++||||+++..
T Consensus       256 ------~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         256 ------R------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ------C------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ------C------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                  1            1246899999999999999999995     9999999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-56  Score=419.41  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=206.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHH---HHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRE---LQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      ++|++.++||+|+||.||+|+++.+|+.||||++.+..       ....+|   +.+++.++||||+++++++.     .
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence            46999999999999999999999999999999985432       112233   55666778999999999883     3


Q ss_pred             eeEEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      ...+|+||||++ ++|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DFG  152 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLG  152 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeeec
Confidence            345789999998 477776654    4678999999999999999999999 8999999999999999888 69999999


Q ss_pred             CccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Q 016158          231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  310 (394)
Q Consensus       231 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  310 (394)
                      +|+..... ......||+.|+|||++.....++.++|||||||++|+|+||+.||.+....+...........+      
T Consensus       153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------  225 (364)
T d1omwa3         153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------  225 (364)
T ss_dssp             TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC------
T ss_pred             eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------
Confidence            99866443 34456899999999999765668999999999999999999999998765443332222211100      


Q ss_pred             ccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 016158          311 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  373 (394)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~f~~~~~  373 (394)
                                          ..++..+++++++||.+||+.||++|||     |+|+++||||+++..
T Consensus       226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         226 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             --------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                                0123568999999999999999999999     899999999998753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-57  Score=413.36  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=216.6

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....   ....+|+++|+.++||||+++++++..     ...+|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEE
Confidence            45999999999999999999999999999999986543   345689999999999999999999843     3458899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC-CcEEEEeecCccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-HQLKLCDFGSAKVLV  236 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~-~~vkl~Dfg~a~~~~  236 (394)
                      ||||++ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++...
T Consensus        80 mE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999985 77665543   23479999999999999999999999 8999999999999998543 369999999998776


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .........+|+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.....+..         
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------  225 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------  225 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---------
T ss_pred             cCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh---------
Confidence            65555667889999999998654 48999999999999999999999999988888887777643222222         


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                                      ....+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus       226 ----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         226 ----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ----------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                            124589999999999999999999999999999999763

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=413.91  Aligned_cols=285  Identities=33%  Similarity=0.606  Sum_probs=227.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+..      ....+|+++|+.++||||++++++|..... .....
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            46999999999999999999999999999999986432      234579999999999999999999854332 12345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +|+||||++.++..+...     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        98 ~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~  170 (346)
T d1cm8a_          98 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  170 (346)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-ccccccccceec
Confidence            789999998887776553     689999999999999999999999 8999999999999999988 699999999986


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...  ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+....+..+....+.++...+.....
T Consensus       171 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            533  344577899999999998777789999999999999999999999999999999999999999988876654332


Q ss_pred             CCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ....   ...+......+... ...+++++.+||++||+.||.+|||++|+|+||||+++.+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~  312 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  312 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence            1110   11222222333322 3568999999999999999999999999999999999876544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-57  Score=404.67  Aligned_cols=245  Identities=25%  Similarity=0.393  Sum_probs=203.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----------hhhHHHHHHHHHcC--CCceeeeceEEEecCC
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTTD  149 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  149 (394)
                      ++|++.++||+|+||+||+|++..+|+.||||++.+..          ....+|+.++++++  ||||+++++++.    
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~----   79 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE----   79 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence            46999999999999999999999999999999986432          22458999999996  899999999983    


Q ss_pred             CceeEEEEEEecccc--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          150 KEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                       .....++||||+.+  ++..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||+
T Consensus        80 -~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          80 -RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             -CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             -eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence             33447899999974  45444433    4789999999999999999999999 8999999999999999765579999


Q ss_pred             eecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Q 016158          228 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       228 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      |||+|+.... .......||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+      .+.+.       
T Consensus       154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-------  219 (273)
T d1xwsa_         154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  219 (273)
T ss_dssp             CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             ccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence            9999976533 334456799999999999766656788999999999999999999997532      12221       


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  372 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  372 (394)
                                ..            .++..+|+++++||++||+.||++|||++|+|+||||+++.
T Consensus       220 ----------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ----------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ----------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----------cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                      00            12356899999999999999999999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=405.56  Aligned_cols=250  Identities=28%  Similarity=0.516  Sum_probs=209.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHH-HHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|..++ +.++||||+++++++     ....
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            36999999999999999999999999999999986432       1233466655 468999999999998     3344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+|+||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchh
Confidence            58899999985 77666653    4679999999999999999999999 8999999999999999888 6999999999


Q ss_pred             cccccCC-CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhc
Q 016158          233 KVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  311 (394)
Q Consensus       233 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  311 (394)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            8664433 33446789999999999765 4899999999999999999999999988877766666541  11       


Q ss_pred             cCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 016158          312 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELR  372 (394)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~f~~~~  372 (394)
                              .            ++..+|+++.+||++||+.||.+|||+. ++++||||+++.
T Consensus       221 --------~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         221 --------F------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             --------C------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             --------C------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                    1            2246899999999999999999999996 899999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-55  Score=396.70  Aligned_cols=283  Identities=33%  Similarity=0.540  Sum_probs=224.9

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|++++.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++.     .....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            3699999999999999999999999999999998543      234468999999999999999999883     33447


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccc
Q 016158          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  235 (394)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~  235 (394)
                      +++++++.+.....+   ....+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHH---HHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeeccccccccc---cccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            889999987653332   2345789999999999999999999999 8999999999999999887 6999999999876


Q ss_pred             ccCCC-CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          236 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       236 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ..... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            54432 3344568889999998776668999999999999999999998854 455567777777777777665544332


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      ........+..............+++.+.+||++||+.||.+||||+|+|+||||+++..|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            2212222222222222333446789999999999999999999999999999999987554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.2e-55  Score=406.61  Aligned_cols=282  Identities=29%  Similarity=0.492  Sum_probs=221.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .++|+++++||+|+||+||+|+++.+|+.||||++... .....+|+++|+.+. ||||+++++++...   ...++++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEE
Confidence            35799999999999999999999999999999998754 345678999999995 99999999988432   23347889


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+.+ +|..       ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+....
T Consensus       111 ~e~~~~~~L~~-------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         111 FEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EECCCSCBGGG-------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EeecCCCcHHH-------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999996 4422       23679999999999999999999999 89999999999999998776799999999988776


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      ........+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.... ..+....+...++.+....+.......
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            6666777889999999999777778999999999999999999999997654 445566666666644333221111000


Q ss_pred             ccc----CCCCCCCCCccc----cccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 016158          317 TEF----KFPQIKPHPWHK----VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  373 (394)
Q Consensus       317 ~~~----~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  373 (394)
                      ...    .........+..    .....+++++++||++||++||++|||++|+|+||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            000    000111111111    122457899999999999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-55  Score=405.95  Aligned_cols=286  Identities=32%  Similarity=0.627  Sum_probs=230.5

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      +|++++.||+|+||+||+|+++.+|+.||||++.+..     ....+|+++|+.++||||+++++++.........++++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            5999999999999999999999999999999986432     23457999999999999999999986555444555778


Q ss_pred             EEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      ++++++++|.+++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus        89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP  161 (345)
T ss_dssp             EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred             EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeeccC
Confidence            888888899888764     579999999999999999999999 8999999999999999888 699999999976533


Q ss_pred             CC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          238 GE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       238 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ..    ......||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+....+......+.........
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            22    23445689999999998666668999999999999999999999999998888888888887777765443221


Q ss_pred             CC---CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          314 PN---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       314 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ..   ......+.....++...+ ..+++++++||.+||++||.+|||++|+|+||||++...+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~  306 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD  306 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence            10   001123333334444333 467899999999999999999999999999999998877654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=399.65  Aligned_cols=286  Identities=29%  Similarity=0.467  Sum_probs=222.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC---Cc
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  151 (394)
                      .++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+++|+.++|+||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            457999999999999999999999999999999875432      234589999999999999999998854322   12


Q ss_pred             eeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ...++++|||+.+++....   ......+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeecce
Confidence            3457899999998764433   3345789999999999999999999999 8999999999999999988 699999999


Q ss_pred             ccccccC-----CCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      ++.....     .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9765422     22234578999999999977767999999999999999999999999999999999999998888776


Q ss_pred             hhhhccCCCCcccCCCCCC--CCCcc-ccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIK--PHPWH-KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      +.............+....  ..... .......++++++||.+||++||++||||+|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            6554433221111111111  11111 11112357889999999999999999999999999999854

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=406.24  Aligned_cols=263  Identities=26%  Similarity=0.355  Sum_probs=208.9

Q ss_pred             ccEEEee-EeeecCceEEEEEEECCCCcEEEEEEeccchhhhHHHHHHHHH-cCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           82 VSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        82 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      ++|.+.. .||+|+||+||+|++..+|+.||||++... ....+|++++.+ .+||||++++++|.... ....++|+||
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ivm   88 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVM   88 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEEE
Confidence            4698875 699999999999999999999999998653 456689988654 58999999999884322 3356689999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC--CcEEEEeecCccccc
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV  236 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~--~~vkl~Dfg~a~~~~  236 (394)
                      |||+| +|.+++...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+.  ..+||+|||+|+...
T Consensus        89 Ey~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          89 ECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             ECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             ECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeecc
Confidence            99984 888877642  23579999999999999999999999 8999999999999998632  269999999998877


Q ss_pred             cCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          237 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       237 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .........||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+.......+......             
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-------------  231 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-------------  231 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-------------
T ss_pred             CCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-------------
Confidence            66666778899999999998654 4899999999999999999999999877655444433321100             


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  371 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  371 (394)
                      ..+.++        ......+|+++.+||++||+.||++|||+.|+|+||||++.
T Consensus       232 ~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         232 GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             CSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            011111        11124589999999999999999999999999999999764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=404.23  Aligned_cols=284  Identities=31%  Similarity=0.525  Sum_probs=218.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      .+|+++++||+|+||+||+|+++.+|+.||||++.+.      .....+|+.+++.++||||++++++|..... ....+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            3599999999999999999999999999999998643      2235589999999999999999999854332 24567


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      +|+||||+.+++...+      ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccccc-ceeeechhhhhc
Confidence            8999999998875543      3679999999999999999999999 8999999999999999988 699999999987


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ...........+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+....+.+..+.+.....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            7666666677889999999999765 589999999999999999999999999999999999999988888877654432


Q ss_pred             CCcccC--CCCCCCCCc-----------cccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 016158          315 NYTEFK--FPQIKPHPW-----------HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  374 (394)
Q Consensus       315 ~~~~~~--~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  374 (394)
                      ......  .+......+           ........++++.+||++||++||++||||+|+|+||||++..++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence            211100  000000111           111122357789999999999999999999999999999986543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=400.30  Aligned_cols=285  Identities=35%  Similarity=0.579  Sum_probs=227.2

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch------hhhHHHHHHHHHcCCCceeeeceEEEecCC-CceeE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  154 (394)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..      ....+|+++|+.++||||+++++++..... ....+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            35999999999999999999999999999999986432      234579999999999999999998854432 22334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      .++++++.+++|.+++..     +++++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++..
T Consensus        98 ~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhcc
Confidence            556666666788776643     679999999999999999999999 8999999999999999988 699999999865


Q ss_pred             cccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          235 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       235 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      ..  .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....+.+..+.......
T Consensus       171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            42  3344567899999999987777789999999999999999999999999999999999999888887766543322


Q ss_pred             CCcc---cCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 016158          315 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  376 (394)
Q Consensus       315 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  376 (394)
                      ....   ..........+... ...+++++++||++||+.||.+|||++|+|+||||+++.++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~  312 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  312 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence            1110   01112122222222 2468999999999999999999999999999999999876554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.8e-53  Score=382.87  Aligned_cols=255  Identities=27%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....       ..+.+|+++++.++||||+++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            456999999999999999999999999999999985432       23568999999999999999999886543 3345


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhh
Confidence            57899999996 56554433    4689999999999999999999999 8999999999999999888 6999999998


Q ss_pred             cccccCC----CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      .......    ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+......++.  
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--  235 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--  235 (277)
T ss_dssp             EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG--
T ss_pred             hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc--
Confidence            6553322    23456789999999999654 4899999999999999999999999988877777666553211111  


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-CHHHHhcCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFD  369 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~ell~hp~f~  369 (394)
                                             .....+|+++.+||.+||++||++|| |++++ .|+|.+
T Consensus       236 -----------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r  273 (277)
T d1o6ya_         236 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR  273 (277)
T ss_dssp             -----------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred             -----------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence                                   12256899999999999999999999 55554 566653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-53  Score=381.85  Aligned_cols=247  Identities=20%  Similarity=0.302  Sum_probs=201.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++..+   ...+.+|+++++.++||||+++++++..     ...+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeEE
Confidence            34699999999999999999999999999999998654   3445689999999999999999999833     233679


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||++ |++..++...  ....+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            999998 4777666542  23678999999999999999999999 8999999999999999888 79999999998764


Q ss_pred             cCCCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCC
Q 016158          237 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  314 (394)
Q Consensus       237 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  314 (394)
                      .....  ....+++.|+|||++.+. .++.++|||||||++|||++|..||........+..++.....           
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-----------  234 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-----------  234 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-----------
Confidence            43322  234578899999998655 4899999999999999999977666555555544444432110           


Q ss_pred             CCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          315 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                      ..++..+++++.+||.+||+.||.+|||++++++
T Consensus       235 ----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         235 ----------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                            0123568999999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-53  Score=377.90  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=196.3

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      ++|++.+.||+|+||+||+|++.   ..||||++...      ...+.+|+.++++++||||+++++++..    .  .+
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~~   78 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--QL   78 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--SC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--EE
Confidence            45999999999999999999864   35999998532      2345689999999999999999987621    1  25


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++||||++ |+|.+++..   ....+++..+..++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~  153 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATV  153 (276)
T ss_dssp             EEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCSCC
T ss_pred             EEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEccccceee
Confidence            79999998 578776653   23569999999999999999999999 8999999999999999888 699999999976


Q ss_pred             cccCC---CCccccccccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Q 016158          235 LVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  309 (394)
Q Consensus       235 ~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  309 (394)
                      .....   ......||+.|+|||++.+.  ..++.++|||||||++|||+||+.||.+.+....+.........++.   
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~---  230 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD---  230 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC---
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc---
Confidence            54322   22345789999999998643  34799999999999999999999999988777666555543211110   


Q ss_pred             hccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          310 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                          ...+...+++++.+||.+||+.||++|||+.++++|
T Consensus       231 --------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 --------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                111235689999999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=385.08  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=202.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCc-----EEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      .++|++.++||+|+||+||+|++..+++     .||+|.+...     ...+.+|+.+++++ +|||||++++++..   
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee---
Confidence            3579999999999999999999876553     6999987532     23456799999988 89999999999833   


Q ss_pred             CceeEEEEEEecccc-cHHHHHHHhhh-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeec
Q 016158          150 KEELYLNLVLEYVPE-TVNRIARNYSR-------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (394)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~D  209 (394)
                        ...+++|||||++ +|.+++.....                   ....+++..++.++.||+.||+|||+ +||+|||
T Consensus       113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD  189 (325)
T d1rjba_         113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  189 (325)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence              3337899999984 88887765321                   12458999999999999999999999 8999999


Q ss_pred             CCCCcEEEeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 016158          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF  285 (394)
Q Consensus       210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf  285 (394)
                      |||+|||++.++ .+||+|||+|+........   ....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||
T Consensus       190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999888 7999999999876554432   245579999999998655 48999999999999999997 89999


Q ss_pred             CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+.+....+..++.....+                           .++..+|+++.+||.+||+.||++|||++||++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9877766666665522111                           1224689999999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=373.82  Aligned_cols=243  Identities=19%  Similarity=0.319  Sum_probs=189.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +|++.+.||+|+||.||+|++. +++.||||++...   ...+.+|+++++.++||||+++++++...     ...++||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv~   79 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVF   79 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEEE
Confidence            5999999999999999999985 5778999998643   34567899999999999999999998432     2367999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+++ +|.+++..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus        80 E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC--------
T ss_pred             EecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheeccCC
Confidence            99984 77666553   23668999999999999999999999 8999999999999999888 6999999999866443


Q ss_pred             CCC--ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          239 EPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       239 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ...  ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+......            
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------------  221 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------  221 (263)
T ss_dssp             ----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC------------
T ss_pred             CceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence            322  235678999999999655 49999999999999999999 46666666655555555442110            


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                      ..+..+++++.+||.+||+.||++|||++++++|
T Consensus       222 ----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 ----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            1124578999999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=375.44  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      ..+|++.+.||+|+||.||+|+++ +++.||||++...   ...+.+|++++++++||||+++++++..    +.  .++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~--~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----EP--IYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----CC--eEE
Confidence            356999999999999999999985 5788999998653   3446789999999999999999997621    11  468


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+++ +|.+++...  ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+...
T Consensus        85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~  160 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIE  160 (272)
T ss_dssp             EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEcc
Confidence            9999985 666554332  23569999999999999999999999 8999999999999999888 69999999998765


Q ss_pred             cCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ....  .....+|+.|+|||++.+. .++.++|||||||++|||+||. +||......+.+..+.... .          
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-~----------  228 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-R----------  228 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C----------
T ss_pred             CCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-C----------
Confidence            4332  2345678999999999654 4899999999999999999954 5555555555444443211 0          


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFD  369 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~  369 (394)
                                       ...+..+++++.+||.+||+.||++|||++++++  |+||.
T Consensus       229 -----------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 -----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                             0122468999999999999999999999999998  78875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-52  Score=379.95  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=188.7

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .+|++.++||+|+||+||+|+++.+++   .||||.+...     ...+.+|+++|++++|||||++++++...     .
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            469999999999999999999987765   5899987532     23456899999999999999999998332     2


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      .+++|||||++ +|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla  175 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  175 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred             EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCcccc
Confidence            37899999986 66665443   23579999999999999999999999 8999999999999999888 7999999999


Q ss_pred             cccccCCCC------ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          233 KVLVKGEPN------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       233 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      +........      ....+|+.|+|||.+.+. .++.++|||||||++|||+| |+.||.+....+.+..+......+ 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-  253 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-  253 (299)
T ss_dssp             --------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            876443221      123568899999999654 58999999999999999998 899999887766665554321111 


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                                 .+..+++++.+||.+||+.||++|||+.|++++
T Consensus       254 ---------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ---------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                       124579999999999999999999999998764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=386.23  Aligned_cols=270  Identities=27%  Similarity=0.446  Sum_probs=212.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEE---CCCCcEEEEEEeccc--------hhhhHHHHHHHHHcCC-CceeeeceEEEecC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD--------KRYKNRELQIMQMLDH-PNIVALKHCFFSTT  148 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~  148 (394)
                      .++|++++.||+|+||+||+|++   +.+|+.||||++.+.        .....+|++++++++| |||+++++++.   
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec---
Confidence            35699999999999999999987   447899999988542        2345579999999977 79999998883   


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEE
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  227 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~  227 (394)
                        .....+++|||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus       100 --~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~  171 (322)
T d1vzoa_         100 --TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLT  171 (322)
T ss_dssp             --ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEES
T ss_pred             --cCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEe
Confidence              33358899999985 66665543    4678899999999999999999999 8999999999999999988 69999


Q ss_pred             eecCccccccCC--CCccccccccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 016158          228 DFGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  304 (394)
Q Consensus       228 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~  304 (394)
                      |||+++......  ......|++.|+|||.+.+.. .++.++|||||||++|+|++|+.||.+....+....+.+.....
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            999997654322  234567899999999996543 47889999999999999999999998876555554444322100


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCCCCCCCCC
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNTRLP  379 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~  379 (394)
                      .                         ..++..+++++++||.+||+.||.+||     |++|+|+||||+++....   .
T Consensus       252 ~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~---l  303 (322)
T d1vzoa_         252 E-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD---L  303 (322)
T ss_dssp             C-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH---H
T ss_pred             C-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH---H
Confidence            0                         012246899999999999999999999     589999999999874322   2


Q ss_pred             CCCCCCCCCC
Q 016158          380 NGRPLPPLFN  389 (394)
Q Consensus       380 ~~~~~~~~~~  389 (394)
                      ..+.+||+|-
T Consensus       304 ~~~~~~~p~~  313 (322)
T d1vzoa_         304 AAKKVPAPFK  313 (322)
T ss_dssp             HTTCSCCSCC
T ss_pred             HhCCCCcCCC
Confidence            3444556654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=369.79  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=201.4

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc---chhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +|++.++||+|+||+||+|+++ +++.||||++.+   ....+.+|+.++++++||||+++++++...     ..+++||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv~   78 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEEE
Confidence            5889999999999999999985 788999999865   345567899999999999999999988432     2378999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccccC
Q 016158          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~~  238 (394)
                      ||+.+ ++..++..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus        79 Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          79 EYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             ECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSS
T ss_pred             EccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccCC
Confidence            99984 66555433   24678999999999999999999999 8999999999999999887 6999999999765443


Q ss_pred             CC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCC
Q 016158          239 EP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  315 (394)
Q Consensus       239 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  315 (394)
                      ..  .....+|+.|+|||.+.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....            
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------  220 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------  220 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC------------
T ss_pred             CceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence            22  2235678999999999755 48999999999999999998 89999988877666555432110            


Q ss_pred             CcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          316 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                      ..+...++++.+||.+||+.||++|||++++++|
T Consensus       221 ----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 ----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            1124578999999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=375.07  Aligned_cols=249  Identities=26%  Similarity=0.337  Sum_probs=200.7

Q ss_pred             cccEEEeeE-eeecCceEEEEEEECC--CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHV-VGTGSFGVVFQAKCRE--TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .++|.+.+. ||+|+||+||+|.++.  ++..||||++...     ...+.+|+++|++++||||+++++++..    +.
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~   82 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----EA   82 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----SS
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----Ce
Confidence            356888885 9999999999998764  3457999998542     2345689999999999999999998732    11


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                        +++||||+++ +|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        83 --~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGl  155 (285)
T d1u59a_          83 --LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGL  155 (285)
T ss_dssp             --EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             --EEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchh
Confidence              6799999995 77665432   23679999999999999999999999 8999999999999999888 799999999


Q ss_pred             ccccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCh
Q 016158          232 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  306 (394)
Q Consensus       232 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~  306 (394)
                      |+.......    .....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.... .+  
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~~--  231 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RM--  231 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CC--
T ss_pred             hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--
Confidence            987644322    2234578999999999655 48999999999999999998 999999887766655544311 00  


Q ss_pred             hhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 016158          307 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFD  369 (394)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~f~  369 (394)
                                               .++..+|+++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       232 -------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         232 -------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                                     1235689999999999999999999999877   6788874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=372.91  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=194.6

Q ss_pred             EEEe-eEeeecCceEEEEEEEC--CCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeE
Q 016158           84 YIAE-HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (394)
Q Consensus        84 y~~~-~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  154 (394)
                      +.+. ++||+|+||+||+|.+.  .+++.||||++...      ...+.+|++++++++||||+++++++..    +.  
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~----~~--   81 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----ES--   81 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----SS--
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc----CC--
Confidence            4444 57999999999999864  45678999998542      2345689999999999999999998721    11  


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .++||||+++ +|.+++..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        82 ~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla~  155 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK  155 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhhh
Confidence            4689999985 77666543    4679999999999999999999999 8999999999999999888 79999999998


Q ss_pred             ccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          234 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       234 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      ........    ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+.. .+    
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~----  229 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM----  229 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC----
T ss_pred             hccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence            66443222    234678999999999654 48999999999999999998 899999877665554443310 00    


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFD  369 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~f~  369 (394)
                                             .++..+|+++.+||.+||+.||++|||++++   |+|+|++
T Consensus       230 -----------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         230 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                                   1225689999999999999999999999988   4676654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=366.19  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=195.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .++|++.+.||+|+||.||+|+++.+ +.||||++...   ...+.+|+.++++++|+|||++++++. .    .. +++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~----~~-~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E----EP-IYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S----SS-CEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-c----CC-eEE
Confidence            35799999999999999999999654 67999998643   345678999999999999999999872 1    11 568


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccccc
Q 016158          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  236 (394)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~  236 (394)
                      ||||+.+ ++..++...  ....+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+|+...
T Consensus        89 v~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhhcc
Confidence            9999995 565554432  23679999999999999999999999 8999999999999999887 79999999998664


Q ss_pred             cCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCChhhhhccC
Q 016158          237 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  313 (394)
Q Consensus       237 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  313 (394)
                      ....  .....+|+.|+|||++... .++.++|||||||++|||+||..| |......+.+..+.... .+         
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-~~---------  233 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM---------  233 (285)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC---------
T ss_pred             CCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CC---------
Confidence            3322  2335679999999999654 489999999999999999996555 45454444444443311 10         


Q ss_pred             CCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCC
Q 016158          314 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDEL  371 (394)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~  371 (394)
                                        .++..+++++.+||.+||+.||++|||++++++  |+||+..
T Consensus       234 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                              122568999999999999999999999999988  8899654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=364.70  Aligned_cols=243  Identities=23%  Similarity=0.282  Sum_probs=184.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCC----cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      .|++.++||+|+||.||+|.++.++    ..||||++...     ...+.+|++++++++|||||++++++...     .
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----K   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----C
Confidence            4999999999999999999987655    46999998542     23456899999999999999999988332     3


Q ss_pred             EEEEEEeccccc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                      ..++||||+.++ +...+.   .....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||++
T Consensus        83 ~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla  157 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  157 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred             ceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccchh
Confidence            377899999864 444333   234679999999999999999999999 8999999999999999988 7999999999


Q ss_pred             cccccCCC----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChh
Q 016158          233 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEIIKVLGTPTRE  307 (394)
Q Consensus       233 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~  307 (394)
                      +.......    .....||+.|+|||++.+. .++.++|||||||++|||++|..|| ......+.+..+... ..+   
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~---  232 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRL---  232 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC---
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCC---
Confidence            87644322    2234578999999999655 5899999999999999999965554 444444433333221 111   


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                              ..+..++.++.+||.+||+.||++|||+.|+++
T Consensus       233 ------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 ------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                    122457899999999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=370.19  Aligned_cols=243  Identities=22%  Similarity=0.335  Sum_probs=192.3

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCcee
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      +|+++++||+|+||+||+|++..+|+    .||+|.+...     ...+.+|+.++++++|||||++++++...     .
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~   84 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----T   84 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----S
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----C
Confidence            59999999999999999999988876    4788876432     23467899999999999999999998432     1


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCc
Q 016158          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  232 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a  232 (394)
                       .+++++++. +++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        85 -~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGla  158 (317)
T d1xkka_          85 -VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGLA  158 (317)
T ss_dssp             -EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSHH
T ss_pred             -eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeeccccc
Confidence             345666665 566554443   35789999999999999999999999 8999999999999999888 7999999999


Q ss_pred             cccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          233 KVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       233 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      +........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.... .++   
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~---  233 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP---  233 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCC---
T ss_pred             eecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC---
Confidence            876443322   234578999999999765 48999999999999999998 789998877665554443321 111   


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                              .+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       234 ------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         234 ------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                    124678999999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=362.75  Aligned_cols=245  Identities=26%  Similarity=0.344  Sum_probs=189.3

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCce
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  152 (394)
                      .++|++.+.||+|+||.||+|++..++   ..||||.+...     ...+.+|+.+++.++||||+++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            346999999999999999999986543   46899987532     2345689999999999999999998721      


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecC
Q 016158          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  231 (394)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~  231 (394)
                      ..+++||||+.+ ++..++..   ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchh
Confidence            126799999985 55554432   34678999999999999999999999 8999999999999999888 799999999


Q ss_pred             ccccccCCC--CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Q 016158          232 AKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  308 (394)
Q Consensus       232 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  308 (394)
                      |+.......  .....+|+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+......     
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-----  228 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----  228 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred             heeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            986543322  2344568999999999654 48999999999999999998 89999988877776665442100     


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                             .++..+|+++.+||.+||+.||++|||+.||++|
T Consensus       229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   1235689999999999999999999999999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=364.68  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=190.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  149 (394)
                      .++|++.+.||+|+||.||+|++..     +++.||||++...     .....+|..++.++ .|+||+.+++++...  
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence            3569999999999999999999754     4478999998643     22334566666666 688999998877432  


Q ss_pred             CceeEEEEEEeccc-ccHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEE
Q 016158          150 KEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (394)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil  216 (394)
                        ...+++|||||+ |+|.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+|||
T Consensus        90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  166 (299)
T ss_dssp             --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred             --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence              223678999998 588888765432            13458999999999999999999999 89999999999999


Q ss_pred             EeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHH
Q 016158          217 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD  292 (394)
Q Consensus       217 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~  292 (394)
                      |+.++ .+||+|||+|+.......   .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+....+
T Consensus       167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99888 699999999986543322   2345789999999999765 489999999999999999986 56888776666


Q ss_pred             HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          293 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       293 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .+...+.....+.                           ++..+++++.+||.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5555544321111                           224678999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=357.62  Aligned_cols=244  Identities=22%  Similarity=0.330  Sum_probs=194.1

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .++|++.+.||+|+||.||+|+++  |+.||||++..+  ...+.+|++++++++||||+++++++....    ..+++|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEE
Confidence            346999999999999999999985  788999998654  345678999999999999999999884322    226799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCcccccc
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  237 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~~~~  237 (394)
                      |||+++ +|.+++....  ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC------
T ss_pred             EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeecccccceecCC
Confidence            999985 7877776432  2468999999999999999999999 8999999999999999988 699999999976533


Q ss_pred             CCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhhhccCCCC
Q 016158          238 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  316 (394)
Q Consensus       238 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  316 (394)
                      .  .....+++.|+|||++.+. .++.++|||||||++|||+| |++||...+..+.+..+....               
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---------------  217 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------  217 (262)
T ss_dssp             --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred             C--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            2  2345678899999999755 48999999999999999998 788888776666555543210               


Q ss_pred             cccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          317 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                   ...++..+++++.+||.+||+.||.+|||+.+++++
T Consensus       218 -------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 -------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                         011235678999999999999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-49  Score=361.19  Aligned_cols=248  Identities=23%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             cccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|++.+.||+|+||+||+|+++     .+++.||||++...     ...+.+|+++++.++||||+++++++...   
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~---   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG---   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence            456999999999999999999975     35678999998643     23456899999999999999999988432   


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhh--------------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeec
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYS--------------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~D  209 (394)
                        ...+++|||++ ++|.+++....                    .....+++..+..++.|++.||+|||+ ++|||||
T Consensus        89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD  165 (301)
T d1lufa_          89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  165 (301)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence              23678999998 57877775421                    123458899999999999999999999 8999999


Q ss_pred             CCCCcEEEeCCCCcEEEEeecCccccccCC---CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 016158          210 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF  285 (394)
Q Consensus       210 lkp~Nil~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf  285 (394)
                      |||+|||++.++ .+||+|||+|+......   ......+++.|+|||.+.+. .++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999888 69999999997653332   22345678999999999755 4899999999999999999985 678


Q ss_pred             CCCCcHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          286 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       286 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      .+.+..+.+..+.+.. .+                           .++..+++++.+||.+||+.||++|||+.||++
T Consensus       244 ~~~~~~e~~~~v~~~~-~~---------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGN-IL---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCC-CC---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8777776666554311 00                           123568999999999999999999999999965

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=355.68  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=189.5

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCC-C--cEEEEEEeccc-------hhhhHHHHHHHHHcCCCceeeeceEEEecCCCc
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  151 (394)
                      .+|++.+.||+|+||.||+|++..+ +  ..||||++.+.       ...+.+|+.+++.++||||+++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            3599999999999999999987533 3  36899987532       2345689999999999999999998832     


Q ss_pred             eeEEEEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      . ..++||||+.+ ++.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccch
Confidence            1 25689999985 65554443   23679999999999999999999999 8999999999999999887 79999999


Q ss_pred             CccccccCCCC----ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 016158          231 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  305 (394)
Q Consensus       231 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~  305 (394)
                      +++........    ....++..|+|||.+.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+......+ 
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-  234 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-  234 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence            99876444322    223467889999999754 48999999999999999998 899999888777776665421111 


Q ss_pred             hhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          306 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                                                ..+..+|+++.+||.+||+.||++|||+.+|++
T Consensus       235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                      122568999999999999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-48  Score=364.13  Aligned_cols=283  Identities=30%  Similarity=0.459  Sum_probs=209.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch---hhhHHHHHHHHHcC-----------CCceeeeceEEEecC
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFSTT  148 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~~  148 (394)
                      +|+++++||+|+||+||+|+++.+|+.||||++.++.   ....+|+.+++.+.           |+||+++++++....
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            4999999999999999999999999999999997653   33457888888775           578999998874332


Q ss_pred             CCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCC-----c
Q 016158          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----Q  223 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~-----~  223 (394)
                       ....+.++.+++..++......  ......+++..++.++.||+.||+|||+..||+||||||+|||++.++.     .
T Consensus        94 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          94 -PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             -TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             -ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence             2233333444444444333333  3345789999999999999999999997579999999999999986542     4


Q ss_pred             EEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHH
Q 016158          224 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEI  297 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~i  297 (394)
                      ++++|||.+.....  ......+|+.|+|||++.+.. ++.++||||+||++++|++|+.||....      ..+.+..+
T Consensus       171 ~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         171 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            99999999975533  335667899999999997654 8999999999999999999999997543      34566777


Q ss_pred             HHHhCCCChhhhhccCC-------CCcccCCCCCCCCCcccc------ccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          298 IKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPWHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       298 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ...+|..+...+.....       ......+......++...      +....++++.+||.+||++||.+||||+|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            78888877766543211       111112222222222211      12345678999999999999999999999999


Q ss_pred             CCCCCCC
Q 016158          365 HPFFDEL  371 (394)
Q Consensus       365 hp~f~~~  371 (394)
                      ||||++.
T Consensus       328 Hp~f~~~  334 (362)
T d1q8ya_         328 HPWLKDT  334 (362)
T ss_dssp             CGGGTTC
T ss_pred             CcccCCC
Confidence            9999965

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=363.59  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcE--EEEEEecc-----chhhhHHHHHHHHHc-CCCceeeeceEEEecCCCcee
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  153 (394)
                      ++|++.++||+|+||.||+|+++.+|..  ||||.+..     ....+.+|+++|+++ +||||+++++++...     .
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            4699999999999999999999888864  67777643     223467899999998 799999999998543     3


Q ss_pred             EEEEEEeccc-ccHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC
Q 016158          154 YLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  220 (394)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~  220 (394)
                      ..++||||++ |+|.+++....            .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCC
Confidence            4789999999 58888775431            234679999999999999999999999 899999999999999988


Q ss_pred             CCcEEEEeecCccccccCCCCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHH
Q 016158          221 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIK  299 (394)
Q Consensus       221 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~  299 (394)
                      + .+||+|||+++............+|+.|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+.+..+.+
T Consensus       164 ~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             G-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             C-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            7 79999999998765555555667899999999997654 899999999999999999975 57877665555444332


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                      .. .                           ..++..+++++.+||.+||+.||++|||++++++|
T Consensus       242 ~~-~---------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 GY-R---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TC-C---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cC-C---------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            10 0                           01224678999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=357.69  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=193.4

Q ss_pred             cccEEEeeEeeecCceEEEEEEECCCC-------cEEEEEEeccch-----hhhHHHHHHHHHc-CCCceeeeceEEEec
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  147 (394)
                      .++|++.+.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +||||+++++++.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            357999999999999999999986554       479999885432     3334677888777 89999999999843 


Q ss_pred             CCCceeEEEEEEecccc-cHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCc
Q 016158          148 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (394)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~N  214 (394)
                          ...+++||||+.+ ++..++.....            ....+++..++.++.||+.||+|||+ .|||||||||+|
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N  165 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  165 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence                3347899999984 78777764321            23568999999999999999999999 899999999999


Q ss_pred             EEEeCCCCcEEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 016158          215 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  290 (394)
Q Consensus       215 il~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  290 (394)
                      ||++.++ .+||+|||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|||++ |.+||.+.+.
T Consensus       166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            9999988 699999999986654332   2345678999999999765 49999999999999999998 7889987776


Q ss_pred             HHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       291 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ......+... ..+                           .++..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            5544433321 111                           122568999999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-48  Score=355.21  Aligned_cols=255  Identities=21%  Similarity=0.239  Sum_probs=197.9

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEEEEEEe
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  160 (394)
                      +|++.+.||+|+||.||+|++..+|+.||||++...  ...+.+|+++++.++|++++..+..+...    ....++|||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivme   83 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVME   83 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEEE
Confidence            599999999999999999999999999999987543  34567899999999988776665555332    234778999


Q ss_pred             cccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC--CCcEEEEeecCccccccC
Q 016158          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKG  238 (394)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~--~~~vkl~Dfg~a~~~~~~  238 (394)
                      |+++++...+..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++..  ...+||+|||+|+.....
T Consensus        84 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            999887665443   34689999999999999999999999 899999999999998642  236999999999876543


Q ss_pred             CC--------CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCChh
Q 016158          239 EP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG---TPTRE  307 (394)
Q Consensus       239 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---~~~~~  307 (394)
                      ..        .....||+.|+|||++.+. .++.++|||||||++|||+||+.||...........+.....   ..+. 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence            22        2345789999999999654 489999999999999999999999987665544333322110   0111 


Q ss_pred             hhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCCCC
Q 016158          308 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL---EACVHPFFDE  370 (394)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~---ell~hp~f~~  370 (394)
                                             ..+...+|+++.+||.+||+.||++||++.   ++|+|+|.+.
T Consensus       238 -----------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 -----------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             -----------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -----------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                                   112246899999999999999999999987   5577887654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=357.44  Aligned_cols=255  Identities=21%  Similarity=0.282  Sum_probs=204.8

Q ss_pred             cccEEEeeEeeecCceEEEEEEECC-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCceeeeceEEEecCCC
Q 016158           81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (394)
Q Consensus        81 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  150 (394)
                      .++|++.+.||+|+||.||+|+++.     ++..||||++....     ..+.+|+.++++++||||+++++++..    
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence            3569999999999999999998853     35789999986432     234689999999999999999998832    


Q ss_pred             ceeEEEEEEeccc-ccHHHHHHHhhh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCc
Q 016158          151 EELYLNLVLEYVP-ETVNRIARNYSR------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  223 (394)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~  223 (394)
                       ....++||||+. |++..++.....      ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .
T Consensus        95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-C
T ss_pred             -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc-e
Confidence             223679999998 477776654332      12346888999999999999999999 8999999999999999888 7


Q ss_pred             EEEEeecCccccccCCC---CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHH
Q 016158          224 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIK  299 (394)
Q Consensus       224 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~  299 (394)
                      +||+|||+|+.......   .....+|+.|+|||.+.+.. ++.++||||||+++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999986644322   23346799999999997554 89999999999999999998 488888777666665543


Q ss_pred             HhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCC
Q 016158          300 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL  371 (394)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~  371 (394)
                      ... +                           ..+..+++.+.+||.+||+.||++|||+++|++      +|+|+++
T Consensus       251 ~~~-~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         251 GGL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CCC-C---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            110 0                           012467899999999999999999999999997      7887654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=353.87  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             ccccEEEeeEeeecCceEEEEEEEC-----CCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCceeeeceEEEecC
Q 016158           80 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (394)
Q Consensus        80 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  148 (394)
                      ..++|++.++||+|+||.||+|++.     .+++.||||++...     ...+.+|+.+++.+ +||||+++++++..  
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence            3457999999999999999999863     46678999998643     23345799999998 69999999999833  


Q ss_pred             CCceeEEEEEEecccc-cHHHHHHHhh--------------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCC
Q 016158          149 DKEELYLNLVLEYVPE-TVNRIARNYS--------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (394)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~  213 (394)
                         ....+++||||++ ++..++....              .....+++..+..++.||+.||+|||+ +|++||||||+
T Consensus        99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~  174 (311)
T d1t46a_          99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (311)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccccc
Confidence               3337799999985 7777765432              123468999999999999999999999 89999999999


Q ss_pred             cEEEeCCCCcEEEEeecCccccccCCCC---ccccccccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016158          214 NLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  289 (394)
Q Consensus       214 Nil~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  289 (394)
                      |||++.++ .+||+|||.++........   ....+|+.|+|||.+.+. .++.++|||||||++|||+| |.+||.+..
T Consensus       175 NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            99999887 7999999999876543322   235679999999999654 48999999999999999998 667777777


Q ss_pred             cHHHHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          290 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       290 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      ..+.+..++.....+.                           .+..+++++.+||.+||+.||.+|||+++|++
T Consensus       253 ~~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         253 VDSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7677766665321111                           12457899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=349.49  Aligned_cols=244  Identities=19%  Similarity=0.261  Sum_probs=188.7

Q ss_pred             EEEeeEeeecCceEEEEEEECCCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCceeeeceEEEecCCCceeEE
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  155 (394)
                      +...++||+|+||+||+|++..++   ..||||++...     ...+.+|++++++++||||+++++++....    ...
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence            344688999999999999986543   36899988532     244568999999999999999999875432    247


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCCCcEEEEeecCccc
Q 016158          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  234 (394)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~~  234 (394)
                      ++|||||++ ++.+++..   ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchhh
Confidence            799999995 56555443   33567888899999999999999999 8999999999999999887 799999999986


Q ss_pred             cccCCC-----CccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhh
Q 016158          235 LVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  308 (394)
Q Consensus       235 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  308 (394)
                      ......     .....||+.|+|||.+... .++.++||||||+++|||+||..||...... +....+... ..+    
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~----  253 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRL----  253 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCC----
T ss_pred             ccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC----
Confidence            644322     2234678999999998654 4899999999999999999987777654332 222222221 000    


Q ss_pred             hhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016158          309 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  365 (394)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  365 (394)
                                             ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       254 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 -----------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   1224578999999999999999999999999988

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-47  Score=345.16  Aligned_cols=248  Identities=19%  Similarity=0.196  Sum_probs=197.1

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEecc--chhhhHHHHHHHHHcCC-CceeeeceEEEecCCCceeEEEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVL  159 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~  159 (394)
                      +|+++++||+|+||+||+|++..+|+.||||++..  ......+|+++++.+.| +|++.+++++     ......++||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~vm   80 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLVI   80 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEEE
Confidence            59999999999999999999999999999998754  33456789999999976 8888888877     3334578999


Q ss_pred             ecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCC----CCcEEEEeecCcccc
Q 016158          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVL  235 (394)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~----~~~vkl~Dfg~a~~~  235 (394)
                      ||++++|..++..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++.+    .+.+||+|||+|+..
T Consensus        81 e~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9999998776654   23679999999999999999999999 899999999999999742    236999999999876


Q ss_pred             ccCC--------CCccccccccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCC
Q 016158          236 VKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTP  304 (394)
Q Consensus       236 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~i~~~~~~~  304 (394)
                      ....        ......||+.|+|||++.+. .++.++|||||||++|+|+||..||.+......   ...+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            4321        22345789999999999654 499999999999999999999999986544322   22232211111


Q ss_pred             ChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          305 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                      +..                        .+...+|+++.+++..|+..+|++||+.+.+.+
T Consensus       236 ~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111                        112468899999999999999999998776644

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=346.53  Aligned_cols=256  Identities=21%  Similarity=0.215  Sum_probs=188.0

Q ss_pred             ccEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccchhh-hHH--HHHHHHHcCCCceeeeceEEEecCCCceeEEEEE
Q 016158           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNR--ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (394)
Q Consensus        82 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~--E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  158 (394)
                      .+|.+.+.||+|+||.||+|++  +|+.||||++...... ..+  |+..+..++||||+++++++.... .....+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            3599999999999999999997  4899999998654322 223  444556789999999999986554 333457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCceeecCCCCcEEEeCCCCcEEEEeec
Q 016158          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IGICHRDIKPQNLLVNPHTHQLKLCDFG  230 (394)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-------~givH~Dlkp~Nil~~~~~~~vkl~Dfg  230 (394)
                      |||+.+ +|..++..     ..+++.....++.|++.||+|||..       +||+||||||+||||+.++ .+||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecC
Confidence            999975 88887764     5799999999999999999999961       5999999999999999888 79999999


Q ss_pred             CccccccCCC-----CccccccccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--------
Q 016158          231 SAKVLVKGEP-----NVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVD--------  292 (394)
Q Consensus       231 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------  292 (394)
                      +++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||..||.......        
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            9987654332     23457899999999985432     25678999999999999999998775422110        


Q ss_pred             ---HHHHHHHHhCCCChhhhhccCCCCcccCCCCCCCCCccccccccCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016158          293 ---QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  364 (394)
Q Consensus       293 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  364 (394)
                         ....+.+....                  ....+..............+.+|+.+||+.||++|||+.||++
T Consensus       234 ~~~~~~~~~~~~~~------------------~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         234 SDPSVEEMRKVVCE------------------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SSCCHHHHHHHHTT------------------SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHhc------------------cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence               01111111000                  0000000111111223456999999999999999999999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.6e-26  Score=191.83  Aligned_cols=165  Identities=16%  Similarity=0.113  Sum_probs=117.1

Q ss_pred             EEEeeEeeecCceEEEEEEECCCCcEEEEEEeccch----------------------hhhHHHHHHHHHcCCCceeeec
Q 016158           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK  141 (394)
Q Consensus        84 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~  141 (394)
                      |.+.+.||+|+||.||+|++. +|+.||||++....                      ....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568899999999999999984 78999999864211                      1123578889999999988876


Q ss_pred             eEEEecCCCceeEEEEEEecccccHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCceeecCCCCcEEEeCCC
Q 016158          142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  221 (394)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~givH~Dlkp~Nil~~~~~  221 (394)
                      ++.     .    .+++|||+++..          ...++...+..++.|++.||.|||+ +||+||||||+|||++.+ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-
Confidence            543     1    258999999732          1335556677889999999999999 899999999999999964 


Q ss_pred             CcEEEEeecCccccccCCCCccccc-cccccccccccCCCCCCchhhHHHHHHHH
Q 016158          222 HQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVM  275 (394)
Q Consensus       222 ~~vkl~Dfg~a~~~~~~~~~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il  275 (394)
                       .++|+|||.|......... .... ... .-.+.+  ...|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~-~~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWR-EILERDVR-NIITYF--SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHH-HHHHHHHH-HHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcH-HHHHHHHH-HHHHHH--cCCCCCcccHHHHHHHH
Confidence             4999999998755322211 0000 000 001222  13478899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.31  E-value=1.9e-06  Score=74.08  Aligned_cols=76  Identities=16%  Similarity=0.112  Sum_probs=48.7

Q ss_pred             cEEEeeEeeecCceEEEEEEECCCCcEEEEEEeccc----hhhhHHHHHHHHHcC-CCceeeeceEEEecCCCceeEEEE
Q 016158           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (394)
Q Consensus        83 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  157 (394)
                      .|++.+..+.++.+.||+..  ..++.+.||+....    .....+|...++.+. +--+.+++.+.     ......++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            47777766666667899886  34667888977543    234568898888774 22234554443     12234678


Q ss_pred             EEeccccc
Q 016158          158 VLEYVPET  165 (394)
Q Consensus       158 v~e~~~~~  165 (394)
                      ||++++|.
T Consensus        88 v~~~l~G~   95 (263)
T d1j7la_          88 LMSEADGV   95 (263)
T ss_dssp             EEECCSSE
T ss_pred             EEEecccc
Confidence            99999873

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=1.2e-05  Score=68.37  Aligned_cols=68  Identities=18%  Similarity=0.157  Sum_probs=42.8

Q ss_pred             eecC-ceEEEEEEECCCCcEEEEEEeccch-hhhHHHHHHHHHcCCCce--eeeceEEEecCCCceeEEEEEEecccc
Q 016158           91 GTGS-FGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVPE  164 (394)
Q Consensus        91 g~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (394)
                      ..|. -+.||+... .++..+.+|...... ..+..|...++.+....+  .+++.+..   +.  ...++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~---~~--~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT---EA--GRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE---CS--SCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc---cc--cceEEEEEeeec
Confidence            3444 468898876 456678899765433 346789999888754433  34444432   11  235689999975

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.92  E-value=3.3e-05  Score=70.34  Aligned_cols=71  Identities=17%  Similarity=0.156  Sum_probs=42.5

Q ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEecc-----------chhhhHHHHHHHHHcC-C--CceeeeceEEEecCCCce
Q 016158           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD-H--PNIVALKHCFFSTTDKEE  152 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~~  152 (394)
                      .+.||.|....||++....+++.|+||.-..           .......|.+.|+.+. +  ..+++++.+  ...   .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~---~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE---M  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT---T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC---C
Confidence            4568999999999999877788899996422           1122345888888763 2  234444332  211   1


Q ss_pred             eEEEEEEecccc
Q 016158          153 LYLNLVLEYVPE  164 (394)
Q Consensus       153 ~~~~lv~e~~~~  164 (394)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              2479999874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.00095  Score=58.61  Aligned_cols=39  Identities=18%  Similarity=0.019  Sum_probs=29.0

Q ss_pred             ceEEEEEEECCCCcEEEEEEeccc---hhhhHHHHHHHHHcCC
Q 016158           95 FGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDH  134 (394)
Q Consensus        95 ~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h  134 (394)
                      --.||+++. .+|..|++|+.+..   ...+..|...+..|..
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~   76 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVN   76 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHH
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHh
Confidence            368999987 56888999987653   3556678888887743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.90  E-value=0.0029  Score=57.02  Aligned_cols=69  Identities=17%  Similarity=0.236  Sum_probs=44.8

Q ss_pred             eeEeeecCceEEEEEEECC-------CCcEEEEEEeccc--hhhhHHHHHHHHHcCCCcee-eeceEEEecCCCceeEEE
Q 016158           87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLN  156 (394)
Q Consensus        87 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~  156 (394)
                      ++.|+.|-.-.+|++....       ..+.|.+++.-..  .....+|..+++.+.-.++. ++++++     .+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence            3578888899999998743       2356777765422  23345788888888544444 565554     22    3


Q ss_pred             EEEecccc
Q 016158          157 LVLEYVPE  164 (394)
Q Consensus       157 lv~e~~~~  164 (394)
                      +|+||++|
T Consensus       118 ~I~efi~g  125 (395)
T d1nw1a_         118 RLEEYIPS  125 (395)
T ss_dssp             EEECCCCE
T ss_pred             eEEEEecc
Confidence            68888874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.30  E-value=0.0097  Score=51.47  Aligned_cols=30  Identities=27%  Similarity=0.269  Sum_probs=26.1

Q ss_pred             CCceeecCCCCcEEEeCCCCcEEEEeecCcc
Q 016158          203 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  233 (394)
Q Consensus       203 ~givH~Dlkp~Nil~~~~~~~vkl~Dfg~a~  233 (394)
                      .|+||+|+.++||+++.+. ..-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc-ceeEecccccc
Confidence            5799999999999999765 56899999875